,processed_text
0,consequence sars cov- infection include short term long term mild severe clinical symptom cardiovascular system include endothelial cell vascular smooth muscle cell cardiac myocyte important target sars cov- february finding large cohort individual diagnose covid- set control cohort evaluate risk -month cardiovascular disease burden individual covid- increase risk heart failure increase risk myocardial infarction increase risk ischemic stroke compare control result independent gender race age cardiovascular risk factor include diabetes obesity hypertension hyperlipidemia chronic kidney disease  april world health organization report  million people  million people uk  million people worldwide infect sars cov- editorial aim present currently know cardiovascular outcome year follow sars cov- infection highlight primary care physician mindful covid- infection status patient evaluate cardiovascular health
1,background aim severe acute respiratory syndrome coronavirus  sars cov)i highly contagious virus infect  million individual december severity coronavirus disease  covid- depend complex interplay viral factor host inflammatory response trigger cascadeeventually lead multiorgan failure contradictory evidence angiotensin convert enzyme acei angiotensin receptor blocker arb affect mortality patient severe covid- theoretically interaction bradykinin pathway aim explore association acei arb use mortality severe sars cov infection severe acute respiratory yndrome coronavirus sars cov highly contagious virus infect  million individual december severity covid- depend complex interplay viral factor host inflammatory response trigger cascadeeventually lead multiorgan failure contradictory evidence angiotensin convert enzyme acei angiotensin receptor blocker arb affect mortality patient severe covid- theoretically interaction bradykinin pathway aim explore association acei arb use mortality severe sars cov infection materials methodology multicenter retrospective observational study enrol  covid- patient admit hospital southern california usa march  august primary outcome association pre hospital use acei arb hospital mortality covid- patient relevant deidentifie patient datum extract sql program electronic medical record bivariate analysis relationship acei arb use different study variable chi t test finally backward selection cox multivariate regression analysis mortality dependent variable result  patient study hypertension present .% congestive heart failure .% acei arb .% .% patient respectively .% patient medication adjust confound variable multivariate analysis use acei hr ci arb hr ci independently associate increase mortality conclusion result consistent clinical guideline position statement international society hypertension indication stop use acei arb covid- patient
2,introduction inherent difference health disparity rural urban population warrant study focus characteristic outcome covid- patient rural setting aim study describe element patient infect sars cov hospitalize single center rural pennsylvania method patient sars cov infection hospitalize march december  study datum obtain electronic health record generate report retrospectively analyze patient classify group accord severity distribution variable study group certain variable run logistic regression analysis study odd death requirement mechanical ventilation mv result  hospitalize patient infect sars cov age  year increase severity clinical status hospital mortality gender affect odd death need mv hypertension common comorbidity diabetes mellitus chronic obstructive pulmonary disease copd increase risk death term laboratory parameter datum suggest maximum ldh marginally increase risk death maximum wbc marginally increase risk need mv death conclusion basic analysis characteristic sars cov positive patient admit rural hospital identify certain risk factor associate severe disease increase hospital mortality find largely similar current literature study urban population bolster reproducibility generalizability exist knowledge information lay foundation future study investigate role factor morbidity mortality associate covid- depth
3,objective study aim investigate association covid- disease severity numerous patient characteristic develop convenient severity prediction scale use self assessment home preliminary screening community healthcare setting setting participant datum patient infect covid- january  february  extract municipal notifiable disease report system wuhan china primary secondary outcome measures categorize covid- disease severity base chinese diagnosis treatment protocol covid- nonsevere group asymptomatic mild ordinary disease versus severe group severe critical illness result scale item age gender illness duration dyspnea shortness breath clinical evidence altered breathing hypertension pulmonary disease diabetes cardio cerebrovascular disease number comorbiditie neutrophil percentage lymphocyte percentage identify show good predictive ability area curve exclude community healthcare laboratory parameter remain model final self assessment scale show similar area curve (= conclusion covid- severity self assessment scale patient community predict risk develop severe illness need medical assistance tool practical use preliminary screening community healthcare setting study construct covid- severity self assessment scale patient community predict risk develop severe illness need medical assistance
4,background role angiotensin convert enzyme inhibitor acei angiotensin ii receptor blocker arb pandemic context coronavirus disease  covid- continue debate patient hypertension diabetes mellitus chronic renal failure cerebro cardiovascular disease chronic obstructive pulmonary disease copd use acei arb risk severe covid- datum available association acei arb use covid- severity population method study observational study patient positive severe acute respiratory syndrome coronavirus  test inpatient treatment healthcare facility registry information coviregi jp primary outcome hospital death ventilator support extracorporeal membrane oxygenation support intensive care unit admission  patient  patient preexisting hypertension diabetes mellitus chronic renal failure cerebro cardiovascular disease copd enrol result factor associate increase risk primary outcome age male sex copd severe renal impairment diabetes mellitus correlation observe acei arb cerebro cardiovascular disease hypertension associated factor male patient age renal impairment hypertension diabete female patient factor associate increased risk age acei arb renal impairment diabetes hypertension associate low risk primary outcome conclusion independent factor primary outcome age male sex copd severe renal impairment diabetes acei arb base registry datum analysis detailed datum collection analysis need cooperation multiple healthcare facility
5,introduction globally ravage effect coronavirus disease- covid- pandemic evident public health global economy aim describe clinical characteristic management outcome covid- patient abuja nigeria method conduct retrospective study review hospital chart  covid- patient admit isolation center university abuja teaching hospital uath gwagwalada extract datum include demographic datum clinical symptom underlie comorbiditie clinical outcome outcome interest discharge die datum analyze statistical package social sciences spss version result median age  year range year majority patient male affected age group year child adolescent affect  year constitute year constitute common symptom presentation fever cough ninety patient underlying comorbiditie common hypertension base disease severity  mild disease  moderate disease  severe disease common complication acute respiratory distress syndrome ards see  patient  case manage  .% discharge stable condition  .% die patient lie comorbiditie .% death rate comorbiditie .% death rate conclusion nigerian patient covid- affect male female child adolescent affect study highlight clinical feature covid- patient overall mortality rate low nigerian patient compare patient usa europe study show advanced age presence underlie comorbiditie disease severity associate risk die covid-
6,background severe acute respiratory syndrome coronavirus  sars cov- etiological agent coronavirus disease  covid- pandemic risk factor associate severity disease presence metabolic disorder reason aim research identify comorbiditie laboratory parameter covid- patient admit intensive care unit icu compare patient require invasive mechanical ventilation imv require imv order determine clinical characteristic associate covid- severity method carry cross sectional study  patient admit icu april  st july  st comorbiditie laboratory parameter associate sars cov- infection severity identify datum patient group main group patient require imv patient require imv nonparametric mann whitney u test continuous datum chi  test categorical datum compare variable group result  covid- patient admit icu  require imv  require imv comorbiditie find patient high prevalence type  diabetes mellitus tdm hypertension obesity observe patient require imv vs. require imv p concern laboratory parameter glucose interleukin  il- lactate dehydrogenase ldh c reactive protein crp significantly high patient require imv require imv p conclusion study perform mexican population indicate comorbiditie tdm hypertension obesity elevated level glucose il- ldh crp associate covid- severity
7,aim study aim review indicate discuss impact cardiovascular risk factor obesity diabetes lipid profile hypertension smoking course mortality covid- infection background coronavirus disease  covid- pandemic spread world major public health crisis coronaviruse know affect cardiovascular system strong correlation cardiovascular risk factor severe clinical complication include death covid- patient mention risk factor widespread constitute significant worldwide health problem modifiable awareness connection covid- progress crucial impact current possible upcoming infection data collection search research paper describe impact select cardiovascular risk factor course severity complication mortality covid- infection form pubmed google scholar database term example covid- cardiovascular disease mortality covid- hypertension diabetes mellitus obesity dyslipidemia cardiovascular risk factor covid- mortality related term list subtitle publication select accord time publication january  december pubmed database obtain  result study seek manually search reference list relevant article relevant article select base title abstract text article exclude clearly relate subject matter publish english type article mainly randomized control trial systematic review additional criterion researcher co morbidity age patient study group review publication  select work subheading include finding result intention review summarize current knowledge comorbiditie development covid- infection try focus course mortality abovementioned virus disease patient concomitant cv risk factor unfortunately unable assess quality datum screen paper study choose heterogenicity group conduct study different endpoint include different group patient term nationality age race clinical status decide divide main subject research separately describe subtitle obesity lipid profile hypertension diabetes smoking believe study include gather interesting modern present day clinical datum approach covid- infection specific division patient
8,background hypertension heart failure know risk factor coronavirus disease  covid- severity mortality outcome beta blocker drug choice treat condition purpose study explore relationship pre admission beta blocker use covid- outcome method pubmed europe pmc database search strategy combine keyword relate aim december th article relate covid- beta blocker retrieve review manager comprehensive meta analysis  software perform statistical analysis result total  study consist patient include analysis meta analysis show use beta blocker associate increase risk covid- ci p random effect modelling clinical progression ci p random effect modelling mortality covid- ci p random effect modelling meta regression show association mortality outcome influence age p hypertension p conclusion risk benefit beta blocker drug choice treat hypertensive patient account individually case case know association high incidence severity covid- infection line antihypertensive drug consider alternative therapy risk administer beta blocker outweigh benefit covid- infection
9,angiotensin convert enzyme  ace receptor identify entry receptor severe acute respiratory syndrome coronavirus  sars cov- abundantly express organ respect role circulate ace receptor expression pathogenesis sars cov- infection debate disease hypertension pharmacotherapie include ace inhibitor angiotensin receptor blocker affect ace receptor expression modulate severity outcome coronavirus disease  covid- test hypothesis treatment ace inhibitor ramipril affect organ specific ace receptor mrna protein expression serum metabolome biobreeding bb rat male biobreeding rat randomly divide ramipril mg kg body weight treatment group control group n n  group period seven day ramipril treatment result reduction acylcarnitine c c  metabolite different organ study lung ramipril treatment significantly increase ace mrna ace receptor membrane protein level increased ace receptor lung expression ramipril treatment associate difference ace serum concentration experimental group datum provide experimental vivo evidence ace inhibitor ramipril selectively increase pulmonary ace receptor mrna protein level reduce acylcarnitine
10,introduction acute kidney injury aki associate increase mortality rate hospitalize patient coronavirus disease  covid- current review aim evaluate symptom complication treatment perform manage aki patient covid- method search pubmed medline web science embase relevant scientific literature publish february following keyword covid- sars cov- acute kidney injury result study total number  covid- patient aki mean age year include systematic review common comorbiditie patient covid- suffering aki history diabetes hypertension hyperlipidemia  include study report history chronic kidney disease ckd group patient focal segmental glomerulosclerosis fsgs acute tubular necrosis atn common pathological evidence average length hospital stay  day average duration need mechanical ventilation  day conclusion current systematic review show aki frequently complicate course covid- hospitalization associate increase severity illness prolonged duration hospitalization poor prognosis give extent adverse impact aki early detection comorbiditie renal complication essential improve outcome covid- patient
11,introduction coronavirus disease  covid- pandemic hit world badly high mortality severe acute respiratory syndrome coronavirus  sars cov- infection increase covid- burden developed develop country unavailability prove treatment option vitamin d important anti inflammatory immunomodulator anti viral function present study conduct evaluate relationship vitamin d covid- method cross sectional study conduct tertiary care hospital patna india patient enrol period month chemiluminescence base immunoassay analyzer quantify vitamin d covid- patient study compare vitamin d deficiency insufficiency different group i.e. age sex bmi comorbidity etc diabetes hypertension evaluate risk factor mortality result total  patient investigate .% vitamin d deficiency .% insufficiency vitamin d level statistically significant different age group sex smoker patient aged year  time likely severe illness adjust aor ci age   year  time likely severe illness aor ci patient comorbiditie hand tenfold great chance severe covid- aor ci deficiency vitamin d increase chance illness nearly time aor ci conclusion vitamin d level associate severity illness estimate prognosis coivd- patient aid modification treatment protocol
12,mucormycosis angioinvasive disease cause mold fungus genus rhizopus mucor india report surge case covid  associate mucormycosis past month increase frequency risk factor like corticosteroid therapy uncontrolled diabetes neutropenia obesity study show eukaryote cell membrane contain cholesterol fungal cell wall contain ergosterol lanosterol precursor ergosterol essential mitochondrial dna maintenance fungus cholesterol human current study base hypothesis fungus use human cholesterol raw material maintain cell function accentuate multiplication indirectly show association deranged lipid parameter individual severity mucormycosis present study aim estimate lipid parameter correlate serum lipid parameter clinical profile stage disease duration onset mucormycosis patient covid associate mucormycosis material cross sectional study conduct  patient diagnose covid  associate mucormycosis admit hospital attach bmcri july  september serum fast lipid profile biochemical parameter determine correlation lipid level clinical profile onset staging mucormycosis patient obtain observation age distribution vary yr yr majority male patient mucormycosis severity stage nasal block .% find common symptom follow headache(.% patient mucormycosis frequent associate comorbidity diabetes mellitus dm follow hypertension htn follow dm htn follow ischemic heart disease ihd follow dm htn ihd study show statistically significant correlation severity mucormycosis increase progressive worsen lipid parameter show statistically significant correlation patient increase tc ldl vldl tg level short covid  onset mucormycosis onset duration conclusion study show positive correlation serum lipid profile staging mucormycosis negative correlation lipid level duration onset covid  onset mucormycosis serum lipid profile excellent marker predict severity prognosis covid  associate mucormycosis
13,covid  infection highly transmissible spread globally include population high vaccination rate covid- vaccination india start month january  healthcare worker hcw vaccinate lot debate efficacy vaccine study highlight breakthrough covid- infection vaccinated hcw compare clinical lab parameter hospitalize non hospitalize material retrospective study conduct questionnaire assess covid- like symptom confirm covid  infection fully vaccinate hcw faculty include nurse wardboy professor post graduate student intern institute period  month march  june number infection match hospital record observation  hcw receive dose covishield vaccine male  female mean age find ne people co morbidity include diabetes hypertension  hcw  people require hospitalization ie case mild symptom require oxygen support significant difference hospitalize non hospitalize regard routine lab parameter significant elevation inflammatory marker positive  hospitalize case p value significant p&lt conclusion study identify breakthrough infection vaccinated hcws(health care worker common breakthrough infection mild asymptomatic persistent symptom occur finding suggest covid- severe hospitalize patient compare non hospitalized infection occur result severe form mortality indicate vaccination prevent severe form disease preventive measure continue vaccinate individual
14,sars  cause covid  disease b l pneumonia systemic inflammation coagulation activation ard multiorgan failure key feature covid patient need icu admission proinflammatory cytokine tnf il  beta cause cytokine storm covid  disease material single center retrospective cross sectional study clinical laboratory characteristic  patient severe covid- collect  patient severe covid incidence thromboembolism symptom  patient ie control incidence thromboembolism severe case define include following criterion respiratory rate gt;/ min oxygen saturation pao hg patient shock respiratory failure require mechanical ventilation combine organ failure require admission intensive care unit icu pe case patient high clinical suspicion tachycardia gt bpm systolic arterial tension lt mmhg sign right ventricular pressure overload pe severity assess simplified pulmonary embolism severity index s -pesi observation  patient severe covid-  .% incidence thromboembolism compare patient severe covid- incidence thromboembolism patient incidence thromboembolism old susceptible receive mechanical ventilation admission icu high mortality addition patient severe covid- thromboembolism high level leukocyte count neutrophil count high sensitivity c reaction protein procalcitonin ferritin interleukin il  receptor il- il- tumor necrosis factor alpha d dimer fibrinogen lactic dehydrogenase n terminal probrain natriuretic peptide patient severe covid- incidence thromboembolism non survivor man vs woman non survivor severe inflammatory response cardiac hepatic renal coagulation impairment finally kaplan meier survival curve show trend poor survival patient severe covid- incidence thromboembolism patient incidence thromboembolism hr ci .- p adjustment age sex hypertension cardiovascular disease cerebrovascular disease cox regression median survival duration hospital admission patient severe covid- incidence thromboembolism  day  day respectively conclusion mortality rate patient severe covid- incidence thromboembolism high incidence thromboembolism lead increase risk death
15,objective treatment original variant fully determine variant covid- emerge clinic covid- change variation controversial present study aim examine covid- severity treatment responsiveness critically ill patient original virus emergent variation comprehensive set measure patient method treatment response laboratory finding clinical condition critically ill patient covid- identify variant february st th examine medical intensive care units icu tertiary care center patient receive treatment icu week result patient original variant pov critically ill patient include study sofa score blood glucose total bilirubin urea creatinine lactate dehydrogenase level decrease significantly pov p=. p=. p=. p=. p=. respectively overall patient emergent variant pev m sd low partial pressure oxygen fraction inspire oxygen ratio p f pov m sd use prone position steroid therapy result significant improvement oxygenation critically ill pev hypertension identify common comorbidity pev or=. conclusion show state pev severe pov time icu admission prone position steroid efficient improve p f ratio p f ratio pev significantly low non invasive ventilation result suggest early intubation necessary pev
16,importance sars cov- entry require tmprss cell surface protease antiandrogen therapy reduce expression tmprss objective determine temporary androgen suppression induce degarelix improve clinical outcome inpatient hospitalize covid- design setting participant hormonal intervention treatment veteran covid- requiring hospitalization hitch phase placebo control double blind randomized clinical trial compare efficacy degarelix plus standard care vs placebo plus standard care clinical outcome man hospitalize covid- require invasive mechanical ventilation inpatient enrol  department veterans affairs hospital july april datum analyze august  october intervention patient stratify age history hypertension disease severity centrally randomized degarelix subcutaneous dose  mg saline placebo standard care include limit supplemental oxygen antibiotic vasopressor support peritoneal dialysis hemodialysis intravenous fluid remdesivir convalescent plasma dexamethasone main outcomes measures composite primary end point mortality ongoing need hospitalization requirement mechanical ventilation day  randomization secondary end point time clinical improvement inpatient mortality length hospitalization duration mechanical ventilation time achieve temperature reference range maximum severity covid- composite end point  day result trial stop futility plan interim analysis time  evaluable patient include  patient randomize degarelix group  patient placebo group  initially plan median range age year common comorbiditie include chronic obstructive pulmonary disorder patient hypertension patient cardiovascular disease patient asthma patient diabetes patient chronic respiratory failure require supplemental oxygen baseline prior covid- patient primary end point significant difference degarelix placebo group patient vs  patient p similarly difference observe degarelix placebo group secondary end point include inpatient mortality patient vs  patient cause mortality patient vs  patent difference degarelix placebo group overall rate adverse event patient vs  patient adverse event patient vs  patient unexpected safety concern conclusion relevance randomized clinical trial androgen suppression vs placebo usual care man hospitalize covid- degarelix result amelioration covid- severity trial registration clinicaltrials.gov identifier nct
17,background december outbreak pneumonia cause severe acute respiratory syndrome coronavirus- sars cov- lead life threaten ongoing pandemic worldwide retrospective study chow show aspirin use associate decrease intensive care unit icu admission hospitalize coronavirus disease  covid- patient recently recovery trial show associate reduction -d mortality progression mechanical ventilation patient conflict finding study aim evaluate impact daily aspirin intake outcome covid- patient aim study aim evaluate impact daily aspirin intake outcome covid- patient method retrospective cohort study conduct  covid- positive patient subgroup analysis evaluate association demographic comorbiditie undertake impact chronic aspirin use assess survival outcome need mechanical ventilation progression icu variable evaluate chi square test multinomial logistic regression analysis result  patient study .% daily aspirin .% cross tabulation clinical parameter show hypertension p hyperlipidemia diabetes mellitus p significantly associate aspirin intake regression analysis progression icu need mechanical ventilation survival outcome daily aspirin intake show statistical significance conclusion study suggest daily aspirin intake protective impact covid- illness associate survival outcome mechanical ventilation progression icu level care
18,background coronavirus disease  covid- pandemic tertiary hospital south africa world wide describe limited datum publish finding article aim describe patient admit large district hospital cape town south africa wave severe acute respiratory syndrome coronavirus  sars cov- infection compare clinical feature investigate survivor deceased covid- patient method single centre retrospective review clinical record laboratory datum patient admit positive sars cov- polymerase chain reaction pcr april  august result total  patient positive sars cov- pcr admit study centre night long patient  die covid- median age patient die covid-  year  year survivor hypertension diabetes mellitus obesity common comorbiditie patient survive die covid- major difference compare severity infiltrate chest x ray cxr covid- survivor deceased patient half deceased patient die  day follow admission hospital substantial number patient die covid- associate acute kidney injury n conclusion acute kidney injury high prevalence patient die covid- delay transfer intensive care unit icu limited icu capacity disease severity contribute substantial number patient die  day admission
19, confirm coronavirus disease  covid- case india declare pandemic world health organization march risk severe covid- consistent individual uncertainty link disease development covid- result relate systemic inflammation predictor covid- increase level inflammatory marker associate cytokine storm coagulopathy endothelial dysfunction significant research suggest result role cause death individual suffer severe form covid- aim experience covid- gitam institute medical sciences research gimsr visakhapatnam analyze datum  patient admit dedicated covid hospital post unlock ul india august  august mean age year male mohfw india severity guideline .% mild .% moderate .% severe case fatigue .% common complaint follow anosmia .% fever .% diarrhea .% shortness breath .% common preexist comorbidity see patient diabetes mellitus hypertension respectively laboratory parameter reveal mean hemoglobin .+/- gm dl mean total leukocyte count .+/- cell cumm mean platelet count .+/- lakh cumm mean erythrocyte sediment rate mm hr mean ferritin level ng ml mean d dimer level ng ml mean crp mg l. severity associate high age symptomatic presentation elevated leucocyte elevate inflammatory marker
20,objective describe cerebrovascular manifestation patient hospitalize treatment severe covid- highlight comorbiditie observe play relevant role risk factor severe outcome method case series retrospective analyze june november patient admit emergency department positive nasopharyngeal swab polymerase chain reaction assay sars cov- present neurological symptom positive finding brain imaging study result sample clinical severity symptom varied mild critical ischemic stroke observe patient hemorrhagic event occur case patient evolve large parenchymal hemorrhage present petechial bleed foci case observe subarachnoid hemorrhage associate bilateral hypodensity globus pallidus typical posterior reversible encephalopathy syndrome finding observe patient brain compute tomography conclusion patient neurovascular complication relate covid- positive finding brain imaging neurological symptom pathological entity observe draw attention neurological risk patient sars cov- infection include bad outcome individual medical history include clinical comorbiditie especially hypertension obesity
21,recent outbreak coronavirus sars cov- declare worldwide pandemic multi organ involvement ocular manifestation describe conjunctivitis retinopathy prevalence severity retinal lesion relation severity systemic disease unknown perform prospective observational study  consecutively hospitalize patient acute confirm covid- infection patient undergo screen widefield fundus photography time hospital admission despite ocular vision relate symptom find cotton wool spot cws and/or hemorrhage patient diabetes history overweight elevate c reactive protein frequently observe patient retinal abnormality history systemic hypertension frequently observe patient retinal finding follow visit cws subside patient
22,covid- risk increase comorbiditie effect magnify contribution individual combine comorbiditie overall clinical outcome aim explore influence demographic factor clinical manifestation underlie comorbiditie mortality severity hospital stay covid- patient retrospective chart review perform identify laboratory confirm case sars cov- infection apollo hospitals hyderabad march  august total  confirm sars cov- case identify  .% patient male  .% female confirm case  .% comorbiditie  .% devoid comorbiditie study show old age underlying comorbiditie significantly increase mortality hospital stay severity covid- infection presence comorbiditie diabetes mellitus dm hypertension htn coronary artery disease cad chronic kidney disease ckd confer severity high mortality ci observe hospital stay ci group multivariate analysis reveal nonsurvivor high dm htn cad ckd category odd ratio ci age gender comorbiditie adjust odd ratio decrease median survival  day observe dm htn cad ckd category summary presence underlie comorbiditie contribute high mortality rate great risk severe disease extend hospitalization period result overall poor clinical outcome hospitalize covid- patient
23,background coronavirus disease  infection global pandemic affect world population aim evaluate prognostic role cross sectional area muscle index muscle attenuation value compute tomography base skeletal group erector spinae muscle pectoralis muscle total skeletal muscle patient hospitalize coronavirus disease   cardiovascular risk factor method total  patient coronavirus disease   cardiovascular risk factor enrol study retrospectively cross sectional area muscle index attenuation erector spine muscle pectoralis muscle total skeletal muscle automatically measure compute tomography image study population assign tertile basis total smcsa index relationship value obtain length hospital stay admission intensive care unit need invasive mechani cal ventilation mortality investigate result admission intensive care unit need invasive mechanical ventilation mor tality high tertile  group group p value statistically muscle measurement significantly low tertile  p diabetes mellitus hypertension total smcsa index predictor hospital mortality patient coronavirus disease  basis cox regression analysis kaplan meier analysis proportion survivor relative total smcsa index tertile  high mortal ity survival rate p conclusion sarcopenia attendant cardiovascular comorbiditie effectively assess dis ease severity predict outcome patient coronavirus disease
24,background angiotensin convert enzyme  ace receptor serve receptor severe acute respiratory syndrome coronavirus  sars cov- virus cause covid- enter lung angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb increase expression ace result concern patient covid- receive agent increase risk severe disease study conduct investigate effect acei arb severity covid- hospitalize hypertensive patient method study retrospective observational study medical record adult hypertensive patient hospitalize dammam medical complex dmc march december covid- hypertensive patient receive acei arb compare hypertensive patient acei arb result total  hypertensive patient include analysis consist  male  female patient respectively nearly half patient saudi patient total  patient acei arb group  patient control group difference group age diabetic status history chronic kidney disease initial blood pressure measurement initial oxygen requirement control group contain few female patient versus saudi patient versus acei arb group p value respectively use aceis arb associate significant reduction icu admission versus p value need intubation versus p value death versus p value significant negative association use acei arb mortality observe multivariate analysis adjustment possible confounder odd ratio confidence interval ci conclusion acei arb adverse effect clinical prognosis covid- patient hypertension use beneficial protective future large study need confirm effect continue covid- hypertensive patient use contraindicate reason e.g. hypotension hyperkalemia acute kidney injury aki
25,introduction interest revolve coronavirus disease  covid- reinfection escalate rapidly definition reinfection denote severe acute respiratory syndrome coronavirus  sars cov- pcr redetection covid- recurrence month initial symptom main aim current systematic review evaluate feature covid- relapse patient material method study string term develop skilled librarian systematical search pubmed web science embase eligible study clinical survey type include january  march eligible study consist positive assessment separate negative result rt pcr result study include  case covid- reinfection child likely covid- relapse patient age group year asthenia .% headache .% cough .% prevalent symptom sars cov- infection asthenia .% myalgia .% headache .% frequent second common treatment option covid- infection lopinavir ritonavir oxygen support .% oseltamivir treatment second infection antibiotic dexamethasone remdesivir addition obesity .% kidney failure hypertension .% common comorbiditie unfortunately approximately .% patient die conclusion find potency covid- recurrence outstanding issue feature regard covid- management furthermore second covid- similar clinical feature clinically practical comparison symptom severity epoch infection uniform datum require suggest future study undertake homogenous approach establish clinical pattern reinfection phenomenon
26,background coronavirus disease  pandemic make proper resource allocation prioritisation important frailty increase risk adverse outcome quantify clinical frailty scale aim study determine role clinical frailty scale patient year age coronavirus disease risk factor critical coronavirus disease  measure intensive care unit admission death risk factor death method retrospective observational study patient /= year hospitalise coronavirus disease  verify polymerase chain reaction  march   july association clinical frailty scale composite primary outcome intensive care unit admission death  day post hospitalisation secondary outcome death  day post hospitalisation analyse multivariable logistic regression model adjust gender age body mass index hypertension diabetes clinical frailty scale categorical variable fit score frail score severely frail score result total  patient include .% woman mean age year fully adjust model adjust odd ratio intensive care unit admission death -confidence interval p frail p severely frail compare fit patient death adjust odd ratio p frail p severely frail compare fit patient conclusion high clinical frailty scale score independent risk factor composite outcome intensive care unit admission death secondary outcome death
27,interim result large multinational trial coronavirus disease  covid- combination antiviral drug appear little effect -day mortality hospital course vivid interest find alternate purpose drug nutrition supplement halt slow disease severity review multiple preclinical study partially support clinical evidence show quercetin possible therapeutic prophylaxis efficacy severe acute respiratory syndrome coronavirus sars cov comorbiditie like chronic obstructive pulmonary disease copd diabetes mellitus obesity coagulopathy hypertension currently  interventional clinical trial underway assess efficacy quercetin antiviral drug nutritional supplement prophylaxis treatment option covid- present review tempting suggest base circumstantial scientific evidence preliminary clinical datum flavonoid quercetin ameliorate covid- infection symptom act concert parallel independent path inhibit key factor responsible sars cov- infection mitigate clinical manifestation disease patient comorbid condition despite broad therapeutic property quercetin high power randomized clinical trial need firmly establish clinical efficacy covid-
28,background patient comorbiditie increase risk severe coronavirus disease covid- symptom include abnormal inflammation chest x ray c reactive protein crp level frequently evaluate severity inflammation aim study investigate correlation comorbiditie chest x ray finding crp level patient covid- material method cross sectional analytic observational study perform quantitative approach study population include patient confirmed covid- secondary datum medical record patient analyse determine correlation comorbiditie chest x ray crp level result datum  patient .% female  male evaluate comorbiditie  .% patient hypertension  .% diabetes mellitus  .% dyspepsia chest x ray show  .% patient pneumonia  .% total  .% patient show increase crp level  .% increase patient show pneumonia chest x ray tend increase crp level result show chest x ray finding correlate crp level diabetes mellitus hypertension significantly correlate crp level p dyspepsia significant relationship crp level p patient hypertension .-fold risk having increase crp level compare patient hypertension patient pneumonia .-fold increase risk increase crp level compare pneumonia conclusion hypertension diabetes mellitus significantly correlate crp level chest x ray finding significantly correlate crp level
29,objective study aim investigate medical treatment attitude patient spondylarthritis rheumatoid arthritis ra biological drug novel coronavirus- covid- pandemic patient method multi center cross sectional study total  patient male  female median age  year range   year biological disease modify anti rheumatic drug bdmards rheumatic disease reach phone june st  june th  include demographic characteristic work status type rheumatic disease comorbiditie smoking habit type bdmard record disease activity evaluate visual analog scale vas patient ask continue treatment plan change change change plan happen change result patient  spondylarthritis  ra total .% patient smoker common comorbidity hypertension totally .% patient history contact covid- positive person .% patient diagnose covid- infection die patient .% continue treatment .% adopt change patient decision treatment plan n= .% .% consult physician .% consult health staff significant parameter change drug course receive intravenous bdmards infusion hospital p=. patient high disease activity measure vas compare patient receive non infusion therapy p=. result change severity symptom increase  patient disruption regular biological treatment prior infusion therapy likely worsen complaint p p=. respectively conclusion intravenous bdmard therapy main factor affect continuity treatment pandemic period pandemic period alternative treatment option consider infusion therapy interrupt treatment patient
30,background severe aki strongly associate poor outcome coronavirus disease  covid- datum renal recovery lack method retrospectively analyze association  hospitalize patient covid-  acute respiratory illness test negative covid- uni- multivariable analysis study mortality recovery kidney disease improving global outcomes stages   aki aki-/ machine learning predict aki recovery admission datum long term renal function outcome study subgroup aki-/ survivor result  covid negative patient aki-/ partial complete renal recovery die  covid- positive patient aki-/ low recovery high mortality note partial renal recovery complete renal recovery die multivariable analysis intensive care unit admission acute respiratory distress syndrome associate nonrecovery recovery significantly associate survival covid positive patient machine learning able predict recovery covid associated aki-/ average precision strong predictor recovery initial arterial partial pressure oxygen carbon dioxide serum creatinine potassium lymphocyte count creatine phosphokinase follow  survivor aki-/ covid positive covid negative patient incident progressive ckd conclusion recovery covid associate moderate severe aki predict admission datum associate severity respiratory disease hospital death risk ckd similar covid positive -negative patient
31,viral infection persist globally age gender ethnicity particular importance covid- associate asymptomatic severe symptom include complication mortality cardiovascular disease cvd involve heart blood vessel disorder include coronary heart disease cerebrovascular disease peripheral artery disease thrombosis cvd associate severe covid- include heart failure coronary artery disease cardiomyopathy hypertension cerebrovascular disease stroke datum acquire pubmed google scholar centers disease prevention control lexi comp search term covid- cardiovascular pathology covid- induce cvd viral infection induce cvd viral infection induce heart damage covid induce cvd mechanism include direct viral entry inflammation cytokine storm hypoxia interferon mediate immune response plaque destabilization stress drug induce cause viral pathology cause cvd include atherosclerosis inflammation cytokine storm plaque destabilization individual parameter old age male high body mass index bmi likely experience viral associate complication possibly explain patient risk factor comorbiditie population high risk include old male elevated bmi viral mechanism associate cvd similar differ disease severity potentially explain diverse cytokine profile covid- activate different type high quantity
32,covid- significantly affect transplant community lead decrease transplant activity increase waiting list time expect covid- cause substantial mortality eskd kidney transplant population underlie ckd high prevalence comorbid condition diabetes mellitus hypertension cardiovascular disease group transplant program face difficult decision weigh risk benefit transplantation pandemic hand risk covid- exposure lead infection patient maximum immunosuppression alternatively risk delay transplantation increase waitlist time lead waitlist associate morbidity mortality cautious thoughtful selection recipient donor post transplant management require pandemic mitigate risk morbidity mortality associate covid- review article aim discuss previous publication relate clinical outcome covid- disease kidney transplant recipient patient eskd dialysis transplant waiting list precaution transplant center decision making recipient donor selection immunosuppressive management pandemic transplantation milieu correct decision careful patient donor selection safeguard protocol infection prevention center conduct risk assessment basis patient age medical comorbiditie waitlist time degree sensitization cold ischemia time status vaccination severity pandemic region
33,introduction present study undertake describe quantify spectrum radiographic finding coronavirus disease  covid- patient study aim analyse change chest x ray cxr disease progression method covid- patient admit period  march   july  retrospectively enrol cxr image assess report normal abnormal severity score calculate warren radiographic assessment lung edema scoring correlation severity score calculate seek age sex clinical manifestation presence comorbiditie result patient male  female enrol median age  year fever cough common symptom significant correlation abnormal cxr find dyspnoea cxr normal abnormal patient common comorbiditie diabetes mellitus cardiovascular disease include hypertension coronary artery disease congestive heart failure predominant pattern ground glass opacity reticular alteration consolidation peak second week symptom onset frequent distribution bilateral peripheral middle low predominance increase age male sex presence dyspnoea comorbiditie correlate abnormal finding cxr critical illness mortality correlate strongly increase age male sex presence dyspnoea presence comorbiditie conclusion current scenario clinician radiologist work tandem cxr promising tool provide relevant information simplified way
34,coronavirus disease  covid- illness cause novel coronavirus call severe acute respiratory syndrome coronavirus  sars cov- mutation genetic coding variation spike protein critical virus mechanism facilitate fusion human host make disease severe recent research indicate comorbiditie include diabetes hypertension renal disease heart failure atherosclerosis play significant role severity high mortality rate covid- suggest metabolic syndrome component associate covid- morbidity primarily angiotensin convert enzyme  ace receptor identify entrance receptor sars cov- increased ace expression endothelial dysfunction play vital role progression severity complication develop covid- review discuss association management cardiorenal disease covid-
35,background multiple study attempt elucidate relationship chronic hypoxia sars cov- infection high altitude associate low covid- relate mortality incidence rate datum come observational study look prospectively collect clinical datum severely ill patient reside significantly different altitude method prospective cohort center study covid- confirm adult patient admit low sea level high altitude m icu unit ecuador conduct thirty confirmed patient enrol march th july th result  patient  man .%  woman median age patient  year  .% patient underlie comorbidity include hypertension .% diabetes .% chronic kidney failure apache ii scale score estimate icu mortality  hour especially high low altitude group median  point iqr compare  point iqr obtain high altitude group evidence difference survival favor high altitude group p median survival  day compare  day low altitude group conclusion substantial improvement survival people admit high altitude icu reside high altitude associate improved survival especially patient comorbiditie covid- patient admit high altitude icu unit improve severity disease classification system score  hour
36,background objectives year covid- advance outbreak pandemic spread rapidly globally devastating impact pathophysiological link covid- acute kidney injury aki currently debate scientist study conclude mechanism aki covid- patient complex fully understand claim aki rare complication covid related disorder consider information gap possible influence covid associated aki management study aim explore prevalence aki identify possible risk factor associate aki development covid- hospitalize patient material method retrospective cohort study include  laboratory confirm covid- patient hospitalize isolation department tertiary hospital zagazig city egypt june august patient young  year age diagnose end stage kidney disease nephrotoxic medication exclude study participant complete blood count liver renal function test hemostasis parameter examine inflammatory marker serum electrolyte routine urinalysis arterial blood gas non enhanced chest abdominal computer tomography ct scan result  patient aki develop  .% .% stage stage .% stage patient aki old patient aki hypertension diabete common comorbiditie risk factor aki include increase age hypertension diabetes mellitus high sequential organ failure assessment sofa score conclusion aki occur considerable percentage patient covid- especially elderly male hypertension diabetes high sequential organ failure assessment sofa score presence aki take account important index risk spectrum disease severity covid- patient
37,background background sars cov- virus large rna virus include coronavirus group show tropism airway epithelial cell sars cov- cause acute respiratory infectious disease covid- accord report mortality covid- high elderly burden comorbiditie diabetes obstructive pulmonary disease coronary artery disease cancer hypertension hepatitis b obesity chronic kidney disease objective aim study review current literature influence importance vitamin d level course sars cov- infection material method systematic review study publish january  june  perform purpose bibliographic database pubmed scopus search follow keyword combination covid- vitamin d -hydroxy vitamin d vitamin d supplementation sars cov- result show vitamin d play important role mechanism innate immunity course acute respiratory infection overlap factor severity covid- disease vitamin d deficiency prevalence obesity age scare ethnicity lead researcher hypothesize vitamin d supplementation promise preventive therapeutic measure covid- conclusion important factor immunomodulatory character vitamin d adequate supplementation preventive therapeutic measure case sars cov- infection especially elderly people obesity chronic disease
38,background individual susceptibility develop acute respiratory distress syndrome relate age frequent comorbiditie far know severe acute respiratory syndrome coronavirus  sars cov- primarily infect type ii pneumocyte human help transmembrane serine protease type  tmprss know transcriptional promoter gene code tmprss androgenic theoretically elevated level androgen androgen receptor lead high expression tmprss high level viremia consequence aim aim research indirectly investigate severity sars cov- infection dependent expression androgen receptor method observational study analyse male patient hospitalize sars cov- infection respect length hospitalisation outcome disease type necessary oxygen support presence comorbiditie hairiness hairiness estimation adapt version hamilton norwood scale presence gabrin sign result total  patient enrol study statistically significant difference compare average age patient different type alopecia group divide accord presence gabrin sign t p outcome type need minimal oxygen support compare type alopecia case gabrin classification show statistically significant difference outcome disease p statistically significant difference distribution comorbiditie alopecia group hypertension relate poor covid- prognosis conclusion finding suggest gabrin sign hypertension relate poor covid- prognosis
39,background patient hospitalize coronavirus disease  covid- pulmonary infection sequelae impaired exercise capacity aim determine frequency long term exercise capacity limitation survivor severe covid- pulmonary infection factor associate limitation method patient severe covid- pulmonary infection enrol  month hospital discharge covulnerability prospective cohort undergo cardiopulmonary exercise testing pulmonary function test echocardiography skeletal muscle mass evaluation result  patient include reduce exercise capacity vopeak predict compare patient normal exercise capacity patient reduce exercise capacity man .% vs. .% p diabetes .% vs. .% p renal dysfunction .% vs. .% p differ term initial acute disease severity altered exercise capacity associate impaired respiratory function assess decrease force vital capacity p fev p total lung capacity p dlco p uncover decrease muscular mass index grip test reduce exercise capacity group p p respectively whilst .% patient low exercise capacity sarcopenia compare .% normal exercise capacity p myocardial function normal similar systolic diastolic parameter group whilst reduce exercise capacity associate slightly short pulmonary acceleration time despite pulmonary hypertension conclusion month severe covid- pulmonary infection patient impairment exercise capacity associate reduce pulmonary function reduce skeletal muscle mass function significant impairment cardiac function
40,objective despite numerous study coronavirus disease  covid- datum impact pre existing diagnosis alzheimer disease ad parkinson disease pd susceptibility outcome covid- limited aim determine patient ad pd high likelihood contract covid- experience bad outcome method datum patient confirmed diagnosis covid- n january june  control participant n randomly select match patient basis age sex extract korean national health insurance database pre exist diagnosis ad pd identify base medical claim code association pre exist ad pd contracting covid- develop severe covid- die covid- examine logistic regression model participant age sex income comorbidity score history hypertension diabete assess covariate result covid- case likely pre exist ad diagnosis adjust odd ratio aor confidence interval ci p value control covid- case likely pre existing pd diagnosis control estimate reach statistical significance aor ci p value pre exist ad relate severe disease mortality covid- aor ci aor ci pre exist pd associate mortality aor ci associate severe disease aor ci conclusion find covid- infection significantly associate pre existing diagnosis ad pre existing diagnosis pd patient pre exist ad high odd develop severe covid- die pre exist pd associate high odd develop severe covid-
41,background objective coronavirus disease  covid- report china year ago primarily lung infection associate cough fever spread rapidly world declare pandemic early  million people infect million death worldwide date approximately death occur covid- united states number continue rise extrapulmonary manifestation disease acute kidney injury aki cardiovascular event gastrointestinal gi indication emphasize initially subsequent study united states canada note gi involvement disease large number case group take care patient early phase pandemic observe frequent presentation gi symptom diarrhea hepatic dysfunction study examine method undertake retrospective study  consecutive adult patient hospitalize center confirmed covid- infection view elucidate gi hepatic involvement early breakout march -may illness result major comorbiditie associate illness cohort patient include hypertension htn diabetes mellitus dm obesity chronic kidney disease ckd common gi manifestation diarrhea interestingly third patient liver function abnormality common liver function abnormality elevate serum aspartate aminotransferase ast elevated ast significantly correlate p inflammatory marker d dimer lactate dehydrogenase ldh ferritin aki bi variate analysis salient observation study include high mortality frequent aki cardiovascular event male patient p liver injury cohort suspect multifactorial involve excessive cytokine release viral infiltration hepatocyte cholangiocyte play role transaminitis mean /-sd duration hospital stay day admission icu overall mortality significant difference african americans caucasians patient admit icu high mortality rate compare admit intermediate care imc)/acute care severity illness associated pulmonary complication conclusion study evaluate presence comorbiditie dm htn obesity patient hospitalize covid- community hospital mid atlantic region united states statistical analysis datum obtain cohort reveal high frequency gi symptom diarrhea predominant common initial manifestation disease serum ast elevation common correlate inflammatory marker aki male gender significantly associate development aki high frequency cardiovascular event increase mortality overall mortality note high mortality patient admit icu compare imc floor observation spur future investigation role comorbiditie development diarrhea hepatic dysfunction covid-
42,background objective people coronavirus disease  covid- wide range symptom report fever chill cough shortness breath difficulty breathing fatigue muscle body ache headache new loss taste smell sore throat congestion runny nose nausea vomiting diarrhea severity disease mortality symptom covid- show significant variation different part world purpose study describe epidemiological characteristic symptom confirmed covid- patient identify factor associate severity disease method cross sectional descriptive study conduct hospitalize covid- patient  july obtain datum demographic characteristic symptom infection severity  patient pre tested semi structured interview information record microsoft excel sheet export spss statistics armonk ny ibm corp. analysis result median age patient year patient female .% patient symptomatic .% patient asymptomatic common symptom time admission fever .% sore throat .% cough .% rhinitis .% body ache comorbidity report .% patient common comorbidity hypertension history contact know confirm case covid-  day present patient presence coexist illness significantly high patient severe disease non severe disease vs. .% p=. conclusion high proportion covid- patient asymptomatic study fever cough common symptom presence coexist illness significantly high patient severe disease non severe disease
43,background study aim compare outbreak coronavirus disease  covid- belgium tomographic biological clinical aspect artificial intelligence ai methodology perform observational retrospective study adult patient symptomatic seven day covid- infection diagnose chest compute tomography ct and/or reverse transcription polymerase chain reaction include study wave pandemic last march second wave last october december wave subgroup define depend respiratory failure occur course disease quantitative estimation covid- lung lesion perform ai radiologist radiology resident chest ct severity score calculate ai result  patient include study find statistically significant difference obesity hypertension asthma difference predominant second wave mixed distribution central peripherical pulmonary lesion note second wave difference note mortality respiratory failure complication radiological biological element chest ct severity score risk factor mortality respiratory failure mild agreement ai visual evaluation pulmonary lesion extension k conclusion march december cohort majority parameter analyze record significant change wave ai reduce experience performance gap radiologist well establish hospitalization criterion
44,background global problem control coronavirus epidemic role different medicine unknown policymaker study conduct evaluate effect losartan mortality rate covid- hypertensive patient method research sample analytical study include  patient present covid- diagnostic center yazd examine month datum analyze descriptive statistic chi square fisher exact test t test logistic regression result  subject study  hypertensive  test positive sars cov- pcr result show low chance death  time hypertensive patient losartan p effect losartan prevention covid- hypertensive patient find medicine play protective role relationship statistically significant p conclusion result show losartan reduce chance mortality hypertensive patient recommend effect losartan blood pressure medicine covid- patient investigate large study laboratory investigation
45,objective coronavirus disease- covid- primarily affect respiratory system case heart kidney liver circulatory system nervous system affect covid related acute kidney injury aki occur hospitalize patient patient intensive care unit icu study aim review prevalence covid related acute kidney injury risk factor hospital icu length stay need renal replacement therapy examine effect aki mortality patient icu treat -year period patient method file patient covid- n= treat icu march st june st analyze retrospectively demographic datum patient laboratory datum treatment examine patient divide group group patient aki group ii patient aki patient aki evaluate accord thekidney disease improving global outcomes kdigo classification grade result  patient include study  female  male mean age patient aki .+/- year statistically significantly high aki .+/- year p patient aki icu length stay acute physiology chronic health evaluation apache ii score initial lactate level need mechanical ventilation duration mechanical ventilation secondary infection rate find statistically significantly high discharge rate icu patient aki statistically high .% vs. .% mortality rate significantly high patient aki .% vs. .% conclusion study conduct show patient covid- risk aki closely relate age sex disease severity presence aki patient covid- increase mortality evident patient hospitalize icu study prevalence aki high old patient high apache ii score initial lactate level comorbiditie hypertension chronic kidney disease coronary artery disease patient aki high aki
46,introduction coronavirus disease  covid- vaccine protect severe illness datum post vaccination covid- breakthrough infection limited method analytical cross sectional study conduct  july   covid positive healthcare worker divide vaccinate group n= unvaccinated group n= pre test questionnaire circulate healthcare worker google forms chest compute tomography ct severity score primary outcome variable analyze coguide result average age study population  year group year respondent male hypertension diabetes common underlie disease significant difference age cardiac disease observe group p p gender hypertension diabete unvaccinated respondent increase ct severity score difference study group significant p vaccinate individual  .% receive vaccination dose  .% receive dose ct severity score decrease receive vaccination dose difference ct severity score vaccination status significant p conclusion covid- mild vaccinated group chest ct severity score index consider efficient tool predict prognosis monitor disease patient covid- india
47,background high prevalence severity formidable morbidity mark recent emergence novel coronavirus disease covid- pandemic significant association pre existing co morbid condition increase disease burden global health emergency push patient healthcare worker facility verge complete disruption method meta analysis pooled datum undertake assess cumulative risk assessment multiple co morbid condition associate severe covid- pubmed scopus google scholar search january st june th  generate order analytical critical review exercise begin key requisite keyword follow inclusion exclusion criterion data extraction quality evaluation final statistical meta analysis risk factor critical severe non critical covid- infection carry microsoft excel ver medcalc ver revman software ver result investigate  eligible study comprise  covid- disease patient represent people republic china prc usa europe n total patient critical severe covid- disease pooled analysis show significant association covid- disease severity risk cardiovascular disease rr p follow diabetes rr p hypertension rr p smoking rr p conclusion review involve sample size  covid- patient wide geographical distribution report focusse association individual risk assessment co morbid condition heightened risk covid- disease present meta analysis cumulative risk assessment co morbidity cardiovascular disease diabetes hypertension smoking signal novel interpretation inherent risk factor exacerbate covid- disease severity consequently exist definite window opportunity increase survival covid- patient high risk co morbid condition timely identification implementation appropriately suitable treatment modality
48,purpose determine incidence clinical predictor intrathoracic complication covid- patient association outcome method retrospective cross sectional study include  patient age   year male test positive sars cov- march -april  undergo chest imaging  radiograph  patient  ct  patient intrathoracic complication include pneumothorax pneumomediastinum pneumopericardium lobar collapse pleural effusion pneumatocele formation result high rate intrathoracic complication pleural effusion common complication pneumothorax pneumatocele frequent history hypertension high initial cxr severity score independent risk factor complication patient intrathoracic complication admission risk icu admission adjust odd ratio aor p intubation aor p reduction successful extubation aor p long length stay median  versus  day p difference overall survival patient complication log rank p conclusion covid- patient undergo chest imaging   patient intrathoracic complication associate high level care prolonged hospital stay hypertension history high cxr severity score confer increase risk complication summary intrathoracic complication covid- common predictive icu admission need intubation successful extubation long length stay predictive mortality
49,retrieve datum online database italian ministry health concern previous ongoing wave severe acute respiratory syndrome coronavirus  sars cov- epidemic italy analyze prevalence variant number sars cov- diagnosis hospitalization intensive care unit icu admission patient coronavirus disease  covid- compare  similar day january number positive case  nearly fourfold higher compare period presumably owe high transmissibility omicron variant considerable decrease covid- relate hospitalization -% icu admission -% observe recent period omicron variant largely prevalent covid- vaccination widespread
50,year pass outbreak report time wuhan coronavirus disease  covid- severe acute respiratory syndrome sars)-cov- coronavirus rapidly evolve pandemic infectious disease stress global health care system mortality rate high particularly elderly population patient comorbiditie hypertension diabetes mellitus cardiovascular disease chronic lung disease chronic renal disease malignancy subject diabetes high risk develop severe form covid- increase mortality diabetes contribute covid- severity remain unclear hypothesize correlate effect hyperglycemia systemic inflammatory response immune system dysfunction vitamin d vd modulator immune response datum literature show vitamin d deficiency covid- patient increase covid- severity likely negative impact immune inflammatory response use vitamin d play role aspect infection particularly inflammatory state immune system function patient piece evidence highlight link vitamin d deficiency obesity diabetes factor associate covid- severity give background perform overview systematic review assess association vitamin d supplementation inflammatory marker patient diabetes furthermore vitamin d possible role covid- patient assess database medline pubmed central cochrane library systematic reviews retrieve pertinent datum aim review provide insight recent advance molecular basis relationship vitamin d immune response inflammation diabetes covid-
51,covid- endothelial disease major comorbiditie increase risk severe sars cov- infection severe covid- include old age obesity diabetes hypertension respiratory disease compromise immune system coronary artery disease heart failure associate dysfunctional endothelium genetic environmental factor epigenetic major risk factor endothelial dysfunction individual metabolic syndrome increase risk severe sars cov- infection poor covid- outcome high risk mortality old age non modifiable risk factor risk factor modifiable review identify dietary risk factor endothelial dysfunction potential dietary prevention address endothelial dysfunction sequelae important role prevent sars cov- infection severity key factor future research address review present dietary bioactive demonstrate efficacy dysfunctional endothelial cell review cover dietary bioactive efficacy sars cov- infection dietary bioactive compound prevent endothelial dysfunction sequelae especially gastrointestinal tract result effective prevention sars cov- variant infection severity key factor future food research address
52,coronavirus disease  covid- epidemic cause sars cov- severe acute respiratory syndrome coronavirus population risk develop complication people chronic disease diabetes hypertension elderly severe symptom sars cov- infection associate immune failure dysfunction approach strengthen immunity right choice order save life review aim provide overview current information reveal importance bee product strengthen immune system covid- highlight immunomodulatory antiviral effect zinc polyphenol actively contribute improve symptom prevent complication cause covid- counteract viral infection review pave way conduct advanced experimental research evaluate zinc polyphenol rich bee product prevent reduce severity covid- symptom
53,background inhale corticosteroid establish long term treatment inflammatory respiratory disease asthma chronic obstructive pulmonary disease investigate treatment coronavirus disease  covid- anti inflammatory action inhale corticosteroid potential reduce risk severe illness result hyperinflammation covid- objective assess inhale corticosteroid effective safe treatment covid- maintain currency evidence living systematic review approach search method search cochrane covid- study register include central pubmed embase clinicaltrials.gov ictrp web science science citation index emerging citation index covid- global literature coronavirus disease identify complete ongoing study  october selection criterion include randomised control trial rct evaluate inhale corticosteroid covid- irrespective disease severity age sex ethnicity include follow intervention type dose inhale corticosteroid include follow comparison inhale corticosteroid plus standard care versus standard care placebo exclude study examine nasal topical steroid data collection analysis follow standard cochrane methodology risk bias assessment cochrane rob  tool rate certainty evidence grade approach outcome mortality admission hospital death symptom resolution time symptom resolution adverse event adverse event infection main result inhale corticosteroid plus standard care versus standard care placebo people confirm diagnosis moderate severe covid- find study include people confirm diagnosis moderate severe covid- people confirm diagnosis asymptomatic sars cov- infection mild covid- include rct allocate  participant  confirm mild covid- analyse subset total number participant recruit study female trial platform design participant allocate treatment group simultaneously include study community base recruit people able use inhaler device deliver steroid rely remote assessment self reporting outcome people old  year co morbidity hypertension lung disease diabetes study conduct high income country prior wide scale vaccination programme total  participant analyse inhaled corticosteroid arm budesonide  participant ciclesonide  participant  participant control arm study include people asymptomatic sars cov- infection respect follow outcome inhale corticosteroid compare standard care result little difference cause mortality day risk ratio rr confidence interval ci  participant low certainty evidence absolute term mean death  people receive inhale corticosteroid death  people receive intervention ci    people probably reduce admission hospital death  day rr ci  participant moderate certainty evidence probably increase resolution initial symptom day  rr ci  participant moderate certainty evidence reduce duration symptom resolution day day ci control group rate  day  participant low certainty evidence evidence uncertain effect adverse event study period rr ci  participant low certainty evidence result little difference adverse event day rr ci  participant low certainty evidence result little difference infection study period rr ci  participant low certainty evidence study report outcome subgroup e.g. age ethnicity sex perform subgroup analysis author conclusion people confirmed covid- mild symptom able use inhaler device find moderate certainty evidence inhale corticosteroid probably reduce combine endpoint admission hospital death increase resolution initial symptom day low certainty evidence suggest corticosteroid little difference cause mortality day  decrease duration symptom resolution know inhale corticosteroid increase decrease adverse event heterogeneity way report study low certainty evidence inhale corticosteroid decrease infection evidence identify come study high income setting budesonide ciclesonide prior vaccination roll out identify lack evidence concern quality life assessment adverse event people asymptomatic infection moderate severe covid-  ongoing complete unpublished rct identify trial registry address similar setting research question current body evidence expect incorporate finding study future version review monitor newly publish result rct inhale corticosteroid weekly basis update review evidence certainty evidence change
54,background acute viral infection include coronavirus disease  covid- characterize dysregulation iron metabolism result high serum ferritin low iron level research design method study aim evaluate prospective impact iron metabolism dysregulation express serum ferritin iron ratio fir hospital prognosis patient covid- serum level ferritin iron iron metabolism marker recognize prognostic indicator covid- severity measure  patient consecutively hospitalize covid- prospective relationship fir risk composite outcome intensive care unit icu admission hospital death analyze result population examine mean age   year male rate radiographic sign pneumonia respiratory distress need noninvasive ventilation high patient high fir /=. th percentile low fir th percentile p comparison high fir associate hr ci p high risk icu admission hospital death conclusion increase fir value significantly independently predict bad hospital prognosis hospitalize patient covid-
55,objective post covid- symptom experience survivor devastating effect study aim analyze risk factor associate long covid- prospective cohort hospitalize patient include require intensive care unit icu transfer take account objective measure covid- severity method hospitalize patient confirmed covid- enrol structured follow visit perform  month hospital admission multivariable adjusted regression model analyse association parameter acute phase persistent symptom result follow visit perform  patient include  .% discharge icu mean age year  patient .% man female sex odd ratio confidence interval ci .- p hypertension ci p number initial symptom nis ci p significantly associate long covid- number persistent symptom significantly associate nis adjust incidence rate ratio ci p female sex airr ci p hypertension airr ci p length stay hospital airr ci p conclusion study suggest female sex hypertension nis significant impact persistent symptom hospitalize patient contrast severity acute covid- infection
56,objective aim study evaluate association pre existing cardiovascular comorbiditie include hypertension coronary heart disease coronavirus disease  covid- severity mortality method pubmed sciencedirect scopus search january july identify eligible study random effect model estimate pool event rate pre existing cardiovascular disease comorbiditie odd ratio confidence interval ci disease severity mortality associate exposure interest result total  study involve patient covid- infection meet inclusion criterion prevalence pre existing cardiovascular disease include study pre exist cardiovascular disease covid- patient associate severe outcome ci mortality ci hypertension coronary heart disease increase risk severe outcome time ci time ci respectively significant publication bias indicate conclusion covid- patient pre existing cardiovascular comorbiditie high risk severe outcome mortality awareness pre existing cardiovascular comorbidity important early management covid-
57,severe acute respiratory syndrome coronavirus  sars cov- responsible current coronavirus disease  covid- pandemic affect  country cause death  million people worldwide genetic background represent factor predispose way host respond sars cov- infection sense genetic variant ace ace explain observed interindividual variability covid- outcome order improve understanding genetic variant ace ace involve severity covid- include total  individual show clinical manifestation covid- diagnose reverse transcription pcr rt pcr genomic dna extract peripheral blood saliva sample ace insertion deletion polymorphism evaluate high resolution melting method ace single nucleotide polymorphism snp rs ace snp rs rs genotype taqman probe assess association ace ace polymorphism disease severity logistic regression analysis adjust age sex hypertension type  diabetes obesity severity illness study population divide mild severe critical illness additionally individual die male result show codominant model contribution ace gene rs t t genotype critical outcome odd ratio ci p require oxygen supplementation ci p addition strong association t allele variant develop critical illness male individual ci p suggest t allele rs represent risk factor severe critical outcome covid- especially man regardless age hypertension obesity type  diabetes
58,background study design investigate impact anti tumor approach include chemotherapy target therapy endocrine therapy immunotherapy surgery radiotherapy outcome cancer patient covid- method electronic database search identify relevant trial primary endpoint severe disease death cancer patient treat anti tumor therapy covid- diagnosis addition stratified analysis implement type anti tumor therapy prognostic factor furthermore odd ratio ors adopt measure outcome corresponding confidence interval cis result indicate study consist  individual  cohort total anti tumor therapy covid- diagnosis elevate risk death cancer patient ci p incidence severe covid- ci p anti tumor approach chemotherapy distinguish increase incidence death ci p severe covid- ci p cancer patient covid- cancer patient covid- surgery target therapy add risk death ci p incidence severe covid- ci p respectively subgroup analysis incidence death ci p raise case chemotherapy adopt solid tumor covid- age gender hypertension copd smoking lung cancer serve potential prognostic factor death severe disease cancer patient covid- conclusion anti tumor therapy especially chemotherapy augment risk severe disease death cancer patient covid- surgery risk death target therapy incidence severe covid-
59,coronavirus disease  cause severe acute respiratory syndrome coronavirus  usually mild condition case result severe sickness death understand reason grave outcome great importance coronavirus disease  periodontitis share intriguing characteristic lead systemic inflammation alteration coagulation pathway share confounding factor diabetes hypertension obesity accordingly possible association condition hypothesize literature objective review evaluate scientific evidence link disease possible underlying mechanism evidence show coronavirus disease  present oral manifestation affect periodontal tissue study show possible association coronavirus disease  severity presence periodontitis current evidence suggest association explain direct role periodontal bacteria aggravating lung infection indirect effect periodontiti induce systemic inflammation priming immune system exacerbate reaction severe acute respiratory syndrome coronavirus  infection future research need confirm observation explore possible role periodontal care play coronavirus disease  pandemic
60,background coronavirus disease  covid- continue circulate change affect billion people worldwide lead increase mortality rate especially holy city makkah kingdom saudi arabia ksa study aim investigate epidemiological feature covid- makkah city ksa method retrospective analysis conduct investigate prevalence covid- association severity mortality covid- demographic factor comorbiditie result covid- patient incidence rate observe male .% noor specialized hospital high incidence rate .% find age group  year old follow age group year furthermore high frequency observe patient saudi arabia .% follow patient myanmar .% bangladesh .% overall frequency covid- severity death .% respectively body mass index analysis show patient underweight .% overweight .% obese addition .% diabetes .% hypertension .% heart disease .% chronic disease conclusion study conclude overall percentage severe covid- intensive care unit case death makkah city ksa .% respectively high incidence male patient severity infection show strong significant correlation different chronic disease nationality body mass index death rate mortality heart disease length hospital stay p despite finding study need explain underlie mechanism influence overall health status patient specific characteristic comorbiditie
61,covid- disease knowledge construction high transmissibility consensual treatment available identification patient high risk evolve critical form disease fundamental study aim determine risk factor associate severity covid- adult patient observational retrospective study cohort adult patient covid- admit public hospital march august medical record evaluate association possible severity predictor poisson regression primary outcome critical form disease need admission intensive care unit and/or invasive mechanical ventilation include  patient man .% progress critical form disease year old hypertension diabetes mellitus obesity frequent comorbiditie .% patient progress critical form disease hospital mortality rate critical patient independent factor associate severity disease obesity rr ci p spo fio ratio  mg l rr ci p lymphocyte rr ci p advanced age comorbiditie dependent factor strongly associate critical form disease
62,background coronavirus disease  covid- account  million case million death globally affect population nation develop transitional gender age extent specific involvement known study aim analyze determine different second wave covid- pandemic assess compute tomography severity score ct ss methodology retrospective cross sectional observational study perform tertiary care institution include  patient undergo ct chest june october  patient undergo ct chest february april include patient symptomatic confirm covid- positive compare ct ss dataset addition analyze distribution ct ss concern age comorbiditie gender difference wave covid- analysis perform spss version  ibm corp. armonk ny usa artificial intelligence platform u net architecture xception encoder analysis result study datum reveal mean ct ss differ statistically wave covid- age group affect second wave decade young overall disease predilection affect male finding show female afflict second wave covid- compare wave particular disease increase severity case comorbiditie hypertension diabetes mellitus bronchial asthma tuberculosis conclusion assessment demonstrate significant difference radiological severity score wave covid- secondary objective reveal wave show demographical difference iterate demographical subset population consider low risk disease manifestation heterogeneous
63,introduction evidence presence coronavirus kidney resultant acute kidney injury aki information effect chronic kidney disease ckd covid- outcome pathogenesis currently lack method retrospective observational study evaluate outcome consecutive patient hospitalize covid- outbreak meir medical center serum creatinine level assess hospitalization baseline serum creatinine admission minimum maximum serum creatinine level hospitalization result  patient  egfr  ml min term ckd group  patient serve control patient ckd group old high prevalence hypertension diabetes mellitus atherosclerosis disease severity clinical presentation ckd group comparable control group odd ratio aki ci p ckd group vs. control group ci .- renal replacement therapy p ckd group .% die covid- infection versus .% control p mortality increase ckd stage increase .% control .% ckd stage .% ckd stage  p conclusion despite comparable disease severity presentation patient ckd significantly aki event require renal replacement therapy hospitalization control patient mortality increase ckd stage increase
64,aim determine frequency common symptom long covid effect quality life determine factor contribute severe long covid method study enrol  patient refer long covid outpatient clinic inpatient undergo rehabilitation datum collect december  evaluate symptom experience acute long covid comorbiditie functional status assess post covid functional status pcfs result final sample consist  patient acute covid- period weeks patient impair functional status .% report functional impairment pcfs scale high pcfs score associate female sex p oxygen therapy requirement acute disease p=. associate have pre exist lung disease p=. disease severity pose risk develop severe long covid conclusion woman great risk develop great functional impairment long covid explanation malignant disease hypertension present risk factor great functional impairment study warrant determine patient certain lung disease susceptible long covid
65,purpose acute respiratory syndrome coronavirus  sars cov- pandemic high impact patient chronic disease literature different perspective asthma comorbidity risk factor covid- severity patient method aim retrospective study  allergy department spain determine severity covid- asthmatic adult follow allergy department relationship atopy clinical demographic characteristic phenotype laboratory datum addition lung function test asthma control test act covid- analyze datum obtain electronic medical record march  april result asthmatic patient diagnose covid- infection validate detection test patient admit bilateral pneumonia advanced age elevated d dimer low number lymphocyte eosinophil heart disease hypertension associate severe covid- allergic mixed allergic eosinophilic phenotype biomarker total ige aeroallergens sensitization allergic rhinitis blood eosinophilia relate few hospital admission poor control lower forced expiratory volume second fev relate bad prognosis covid- conclusion asthmatic patient allergic eosinophilic phenotype well evolution covid- low risk admission old patient cardiovascular comorbiditie aerd eosinopenia relate severity covid-
66,purpose outline clinical laboratorial profile patient obesity undergo bariatric surgery present positive reverse transcription polymerase chain reaction rt pcr severe acute respiratory syndrome coronavirus- sars cov- preoperative period symptom presentation method case series  patient undergo bariatric surgery present positive rt pcr sars cov- preoperative period reported symptom datum collect include demographic characteristic length hospital stay wait time surgery inflammatory marker serum level micronutrient dengue virus denv serology result total  patient undergo bariatric surgery institution study period incidence asymptomatic case sample comprise .% woman mean age year mean preoperative body mass index bmi kg m. thirty percent sample previous diagnosis diabetes .% hypertension mean time elapse positive rt pcr operation  day mean length postoperative hospital stay day mean lymphocyte count mean platelet lymphocyte ratio mean c reactive protein value mg dl ferritin mark microg l. denv igg identify patient test mean level vitamin d zinc ng ml microg dl respectively postoperative complication report conclusion include patient present laboratory marker relate disease severity important notice patient test denv specific igg detect serum
67,coronavirus disease  covid- pandemic cause human infect coronavirus draw global attention time appear wuhan city china late december detection responsible viral pathogen name severe acute respiratory syndrome coronavirus  sars cov- possible pathogenesis lead forming hypothesis factor affect patient outcome sars cov- infection concern potential role angiotensin convert enzyme ace inhibitor angiotensin receptor blocker arb covid- patient morbidity mortality study demonstrate sars cov- use human ace cell receptor entry receptor invade cell association antihypertensive drug raas inhibitor specifically aceis arb covid- disease datum scarce conflicting acei arb consumption influence disease outcome single conclusion reach accord literature review article evidentially support theory use raas inhibitor covid- medication include acei arb associate increase risk infection disease severity patient prognosis study need support hypothesis
68,abstract background systematic review meta analysis aim assess tricuspid annular plane systolic excursion tapse prognostic tool patient coronavirus disease  covid- method study relationship tapse covid- february standardized mean difference smd confidence interval assess effect size potential publication bias assess contour enhance funnel plot egger test meta regression perform assess difference tapse survivor nonsurvivor affect age sex hypertension diabetes result sixteen study comprise  patient include meta analysis tapse low nonsurvivor smd p subgroup analysis indicate tapse low critically ill patient smd p heterogeneity significantly reduce pooled result show patient develop right ventricular dysfunction low tapse smd p statistically significant difference tapse patient sustain cardiac injury vs smd p significant publication bias detect p heterogeneity include study significant meta regression show heterogeneity significantly great incidence hypertension diabetes conclusion low tapse level associate poor covid- disease outcome tapse level modulate disease severity prognostic utility skew pre exist patient comorbiditie trial retrospectively registered february prospero crd
69,objective describe hospital variation use guideline base care acute respiratory distress syndrome ards covid- design retrospective observational study setting society critical care medicine discovery viral infection respiratory illness universal study covid- registry patient adult patient ards covid- february april intervention hospital level use guideline base care ards include low tidal volume ventilation plateau pressure  cm ho prone ventilation pao fio ratio measurement main result adult covid- ards receive care  hospital .% receive care consistent ards clinical practice guideline adjust patient demographic severity illness hospital characteristic pandemic timing hospital admission contribute risk adjust variation guideline base care patient treat randomly select hospital high use guideline base care median odd ratio ci .- receipt guideline base care compare patient receiving treatment randomly select hospital low use recommend therapy median adjust inhospital mortality interquartile range -% nonsignificantly decrease risk mortality patient admit hospital high use guideline base care quartile compare low use quartile odd ratio ci p conclusion year covid- pandemic half patient receive guideline base care ards management wide practice variation hospital strategy improve adherence recommend ards management strategy need
70,coronavirus disease  covid- ongoing global pandemic cause severe acute respiratory syndrome coronavirus  sars cov- severity mortality rate covid- affect factor respiratory disease diabetes hypertension bacterial coinfection factor contribute severity covid- limited study investigate morbidity mortality microbial coinfection covid- patient retrospectively study effect bacterial coinfection intensive care unit icu)-admitted patient covid- asir province saudi arabia analyze electronic medical record hospitalize patient covid- asir central hospital total  patient include clinical datum  patient infect sars cov-  patient coinfecte sars cov- bacterial infection analyze study datum show length stay hospital patient infect sars cov- bacterial infection day compare day patient infect sars cov- p addition high mortality rate associate patient coinfection group compare sars cov infected group vs. .% respectively study show gram negative bacteria commonly isolate bacteria covid- patient conclude study find individual covid- present bacterial infection high risk long stay hospital potentially death study large population warrant well understand clinical outcome covid- bacterial infection
71,million covid- infection  thousand associate death report malaysia meta analysis prevalence covid- different clinical stage national covid- vaccination program malaysia lack address disease severity total  admit covid- patient initially record early phase study datum later pool meta analysis aim provide insight prevalence covid-  different clinical stage outset covid- pandemic malaysia conduct systematic literature search pubmed web science scopus sciencedirect database relevant study specified inclusion exclusion criterion quality assessment include study perform newcastle ottawa scale heterogeneity examine index q test funnel plot egger test perform determine publication bias meta analysis overall  study  patient include pooled prevalence rate meta analysis calculate random effect model high prevalence covid- malaysia observe stage  case .% follow stage  .% stage  .% stage  .% stage  .% third number case morbidity high percentage hypertension .% obesity diabetes mellitus .% stage  patient conclusion meta analysis suggest high prevalence covid- occur stage prevalence rate stage  appear low covid- patient implement vaccination program malaysia meta analysis datum critically useful design screening vaccination program improve disease management country
72,hypertension chronic kidney disease ckd common comorbiditie associate coronavirus disease  covid- severity mortality risk renin angiotensin system ras blocker cornerstone treatment hypertension proteinuric ckd early month covid- pandemic hypothesis emerge suggest use ras blocker increase susceptibility covid- infection disease severity population hypothesis base fact angiotensin convert enzyme  ace counter regulatory component ras act receptor severe acute respiratory syndrome coronavirus  cell entry extrapolation preliminary animal study lead speculation upregulation ace ras blocker increase risk covid relate adverse outcome hypothesis support emerge evidence observational randomized clinical trial human suggest association describe physiological role ace ras discuss central role covid- infection present original update evidence human study association ras blockade covid- infection related outcome particular focus hypertension ckd
73,objective evaluate blood lipid profile patient coronavirus disease  covid- explore association disease severity method case control study include patient covid- refer medical center kermanshah iran july  december healthy control lipid profile evaluate patient group accord severe intensive care unit icu severe outpatient form covid- healthy control compare group result total  participant include comprise icu n outpatient n control n group mean cholesterol level low patient group control high density lipoprotein cholesterol hdl c level high icu group versus outpatient low density lipoprotein cholesterol ldl c level low icu group versus outpatient frequency diabetes hypertension high icu group outpatient group furthermore ldl c level associate disease severity odd ratio confidence interval conclusion lipid profile differ severe severe form covid- ldl c level useful indicator covid- severity
74,background aim conflicting evidence association proton pump inhibitor ppi risk acquisition severity acute respiratory syndrome coronavirus  sars cov- infection aim evaluate association ppi exposure infection development severe disease patient infect sars covin large population base historical cohort method datum extract health maintenance organization database israel insure individual country patient undergo sars cov- testing march november  include logistic regression match analysis compare patient prescribe expose ppi prescribe ppi sars cov- positivity addition sars cov- positive patient n likelihood develop severe disease define composite endpoint death icu admission prolonged hospitalization compare expose expose ppi result adult patient undergo sars cov- testing pcr .% positive sars cov- .% patient prescribe ppi  month testing multivariable logistic regression model control age gender smoking status bmi diabetes mellitus hypertension copd history ischemic heart disease fast blood glucose fbg level significant association find ppi sars cov- positivity p aor ci .- sars cov- positive patient  severe infection multivariate logistic regression control abovementioned confounder show association ppi severe covid- p elevated fbg level significantly associate ppi exposure p severe covid- infection p result reinforce match analysis n  pair conclusion ppi spuriously associate severe covid- presence elevated fbg confounder study account fbg level patient know risk factor severe covid- infection reason discrepancy prior study result aid understand potential confounder evaluate potential association ppi respiratory viral disease
75,introduction coronavirus disease  covid- associate high rate morbidity mortality primary hypothyroidism common comorbid condition little know association covid- severity outcome study aim identify frequency hypothyroidism hospitalize patient covid- describe difference outcome patient pre existing hypothyroidism observational multinational registry method observational cohort study enrol patient  year old laboratory confirm severe acute respiratory syndrome coronavirus- infection march  february primary outcome disease severity define world health organization scale clinical improvement ordinal outcome correspond high severity level record patient index covid- hospitalization hospital mortality hospital free day secondary outcome rate intensive care unit icu admission icu mortality result adult patient include study pre existing hypothyroidism identify  .% median age hypothyroidism group  interquartile range year female white common comorbiditie hypertension diabetes dyslipidemia obesity adjust age body mass index sex admission date quarter year march race smoking history comorbid condition coronary artery disease hypertension diabetes dyslipidemia pre existing hypothyroidism associate high odd severe disease world health organization disease severity index odd ratio confidence interval ci p hospital mortality ci p difference hospital free day estimate difference day ci p pre exist hypothyroidism associate icu admission icu mortality unadjusted adjust analysis conclusion international registry hypothyroidism identify   adult hospitalize patient covid- pre exist hypothyroidism hospitalize patient covid- associate high disease severity increase risk mortality icu admission research possible effect covid- thyroid gland function need future
76,objective systematic review meta analysis aim evaluate dyslipidemia affect mortality severity covid- aim evaluate comorbiditie influence association method systematic literature search pubmed embase europepmc perform  october study main outcome poor composite outcome comprise mortality severe covid- result  study  patient prevalence dyslipidemia pooled analysis -% dyslipidemia associate increase composite poor outcome rr p .% p subgroup analysis show dyslipidemia associate severe covid- rr p .% p meta regression show association dyslipidemia poor outcome vary age coefficient p male gender coefficient p hypertension coefficient p diabetes coefficient p cardiovascular disease coefficient p inverted funnel plot relatively symmetrical egger test indicate pool analysis statistically significant small study effect p conclusion dyslipidemia potentially increase mortality severity covid- association strong patient old age male hypertension prospero registration number crd
77,old individual chronic health condition high risk adverse clinical outcome covid- widespread belief risk young relatively low risk individual negligible assess rate predictor life threaten complication relatively low risk adult hospitalize covid-  adult hospitalize covid- hospital new york city march  relatively low risk base absence preexist health condition multivariable logistic regression model examine hospital development life threaten complication major medical event intubation death covariate include age sex race ethnicity hypertension weight insurance type area level sociodemographic factor poverty crowdedness limit english proficiency individual year old n .% experience life threaten complication .% intubate .% die /= year age ci male sex ci publicly insure versus commercial insurance medicare ci medicaid ci live area relatively high limit english proficiency high versus low quartile ci predict life threaten complication year sociodemographic factor significantly predict life threaten complication substantial proportion relatively low risk patient hospitalize covid- experience life threaten complication   die public messaging need effectively convey relatively low risk individual risk complication
78,hypertension diabetes mellitus coronary artery disease common comorbiditie dangerous factor infection covid- polymorphism gene associate comorbiditie help observe susceptibility disease severity variation specific genetic factor extent explain variation susceptibility severity unclear evaluate candidate gene associate covid- hypertension diabetes mellitus coronary artery disease particular perform search omim ncbi database protein protein interaction network construction kegg pathway enrichment analysis result show associated overlap gene tlr nlrp mbl il ilrn ilb cxcr ccr agt ace f. kegg analysis yield  term q  signal pathway q respectively mainly include coronavirus disease covid- cytokine cytokine receptor interaction il agt central ppi   connection respectively study identify  gene associate covid- comorbiditie contribute infection disease severity key gene il agt involve regulate immune response cytokine activity viral infection raas inhibitor agt antisense nucleotide cytokine inhibitor vitamin d fenofibrate vaccine regulate non immune immune factor potential strategy prevent cure covid- study provide basis investigation gene pathway predictive value risk infection prognosis help guide drug vaccine development improve treatment efficacy development personalised treatment especially covid- individual common comorbiditie
79,coronaviruse disease  covid- spread continuously worldwide new vaccine drug approve prevention disease crucial study reveal promising effect alternative therapy vitamin d supplementation covid- prevention require sufficient evidence current retrospective multicenter cross sectional study aim determine primary association vitamin d status hospitalize covid- severity mortality total  covid- admit king faisal hospital noor specialist hospital makkah complex king faisal hospital taif westering region saudi arabia sa june august demographic clinical characteristic laboratory test include serum oh)d admission intensive care unit icu length stay hospital mechanical ventilation mv support mortality record analyze vitamin d deficiency oh)d  ng ml find .% study population multiple logistic regression adjust covariance age gender diabetes hypertension chronic kidney disease ckd statistically significant show icu admission odd ratio confidence interval ci .- p mv support odd ratio confidence interval ci .- p mortality odd ratio confidence interval ci .- p datum support association serum oh)d severity disease hospitalize covid- patient
80,introduction coronavirus disease  covid- multisystemic disease cause severe acute respiratory syndrome coronavirus  sars cov- lead broad spectrum disease severity asymptomatic severe respiratory disease addition mortality rate exceedingly high covid- patient admit icu purpose study examine difference survivor non survivor critically ill covid- patient admit icu method multicenter retrospective observational study conduct hospital southern california usa compare characteristic icu patient die survive chi square test categorical variable t test continuous variable p value consider significant finally backward selection cox multivariate regression analysis mortality dependent variable result patient admit covid- study period number  .% admit icu patient admit icu  .% die  .% survive multivariate cox regression analysis c reactive protein crp hr ci tachycardia hr ci age hr ci .- independently associate mortality patient bmi comorbiditie hypertension diabetes chronic obstructive pulmonary disease chronic kidney disease predict mortality conclusion age elevated crp tachycardia independent risk factor mortality covid- patient admit icu appear factor predict severe disease covid- patient bmi comorbiditie important patient admit icu
81,objective severity symptom affect treatment option coronavirus disease  covid- patient treatment pattern mild moderate non icu case evaluate particularly current scenario mutation variant strain effective decision making method objective retrospective analysis assess clinical treatment outcome mild moderate symptom non icu patient covid- admit major tertiary care hospital baha saudi arabia april august result total  people admit covid- treatment age range  diabetes mellitus n hypertension n common comorbid condition hydroxychloroquine hcq treat group g n md  iqr time hospital .% mortality rate non hcq group g n md  iqr time hospital .% mortality rate combination antiviral antibiotic treatment find effective frequent intervention analgesic .% anticoagulant mineral zinc vit d conclusion therapy clinical outcome past guide factor treat covid variant infection future patient treat hcq high mortality rate give non hcq combination great clinical outcome profile data availability datum available request ethical restriction anonymize datum present study available request corresponding datum publicly available maintain privacy adhere guideline ethic protocol
82,background covid- pandemic lead unprecedented global health care challenge medical institution researcher recognize different covid- subphenotype division population patient meaningful subgroup drive clinical feature severity characterization assist clinician clinical course vaccination process research effort surveillance system allocation limited resource objective aim discover age sex unbiased covid- patient subphenotype base easily available phenotypical datum admission pre existing comorbiditie lifestyle habit demographic feature study potential early severity stratification capability discover subgroup characterize severity pattern include prognostic intensive care unit icu morbimortality outcome method mexican government covid- open datum include sars cov- population base patient level datum september apply meta clustering technique consist -stage clustering approach combine dimensionality reduction ie principal component analysis multiple correspondence analysis hierarchical clustering ward minimum variance method euclidean square distance result independent age sex clustering analysis  cluster support  clinically distinguishable meta cluster mcs mc show high recovery rate .%-.% include healthy patient age child comorbiditie priority receive medical resource ie high rate hospitalization intubation icu admission compare adult subgroup similar condition young obese smoker mc show moderate recovery rate include patient hypertension diabetes age obese patient pneumonia hypertension diabete mc show low recovery rate .%-.% include immunosuppressed patient high comorbidity rate patient chronic kidney disease poor survival length probability recovery old smoker chronic obstructive pulmonary disease old adult severe diabetes hypertension old obese smoker chronic obstructive pulmonary disease mild cardiovascular disease group outcome conform recent literature dedicated age sex group mexican state type clinical institution show relevant heterogeneity severity potentially link socioeconomic health inequality conclusion propose -stage cluster analysis methodology produce discriminative characterization sample explainability age sex result potentially help understand clinical patient stratification automate early triage test laboratory result available location additional test available help decide resource allocation vulnerable subgroup prioritize vaccination treatment
83,background covid- pneumonia case severe hypoxemia early stage case sudden deterioration respiratory status silent hypoxia lead death report case summary -year old japanese man essential hypertension dyslipidemia chronic kidney disease emphysema hospitalize novel coronavirus disease hypoxemia disproportionate severity pneumonia indicate compute tomography ct coagulation abnormality speculate high possibility develop ventilation blood flow imbalance pulmonary intravascular coagulopathy pic hypoxic pulmonary vasoconstriction hpv case early short term combination therapy remdesivir nafamostat mesylate low dose dexamethasone dex successful conclusion covid- patient multiple comorbiditie hypoxemia coagulation abnormality disproportionate severity pneumonia ct important commence antiviral anticoagulant therapy soon possible follow use low dose dex
84,introduction recent global pandemic coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- involve  million people worldwide associate death clear information know potential risk factor covid- factor adversely influence clinical course mortality analyze role obesity type  diabetes hypertension risk factor covid- method identify article inclusion search pubmed google scholar access  june retrospective review literature analysis epidemiological datum concern obesity prevalence covid- incidence particularly italy usa results datum retrospective study prevalence show patient hypertension type  diabetes obesity severe covid- intensive care unit admission high mortality rate definitively clear independent association general prevalence obesity patient covid- general population world obesity associate severe disease mortality young  year strict connection propose use drug inhibit angiotensin convert enzyme  ace- dipeptidyl dipeptidase  dpp- influence viral activity disease severity ace- dpp- receptor mediate sars cov- entry host cell evidence exist date show case conclusion overall diabetes hypertension obesity negatively affect clinical course disease outcome patient covid- datum need confirmation study accurate data registration
85,background severe acute respiratory syndrome coronavirus  sars cov- report december severity coronavirus disease  covid- range asymptomatic severe potentially fatal aim describe clinical laboratory feature outcome hospitalise patient covid- abu dhabi healthcare services facilities seha method retrospective analysis patient datum collect electronic health record ehrs available seha health information system include patient admit  march   laboratory confirm pcr diagnosis sars cov- infection datum clinical feature co morbidity laboratory marker length hospital stay treatment receive mortality analyse accord severe versus non severe disease result study include  patient patient divide severe non severe group seven patient require intensive care remain patient .% mild moderate disease mean patient age cohort year low global average population male predominance include nationality major co morbidity hypertension diabetes mellitus chronic kidney disease laboratory test reveal significant difference lactate dehydrogenase ferritin c reactive protein interleukin- creatinine level neutrophil count severe non severe group common anti viral therapy combination hydroxychloroquine favipiravir overall hospital mortality rate rate severe group mortality rate high adult young  year old  year .% vs. .% conclusion analysis suggest abu dhabi low covid- morbidity mortality rate report rate china italy affected population relatively young international representation globally abu dhabi high testing rate relation population volume believe early identification patient young age result favourable outcome
86,introduction emerge datum demonstrate increase mortality covid- patient suffer comorbid condition type ii diabetes hypertension cardiovascular disease underlie risk patient increase bodyweight obesity adverse health effect obesity factor enhance risk mortality covid- patient unexplored objective enhance fat deposition risk factor increase mortality covid- patient method collect information online database pubmed google scholar researchgate highlight systematic link obesity associated risk covid- result report study pandemic france new york currently report study mexico find individual bmi kg m kg m great risk develop critical illness covid- increase mortality conclusion study suggest obesity childhood adolescence adulthood consider profound risk factor great susceptibility severity covid- associate nutritional lifestyle cardiac respiratory renal immunological alteration potentiate complication sars cov- infection suggest check bmi pandemic situation
87,new coronavirus disease  covid- pandemic cancer patient consider particularly susceptible population compare type magnitude covid- clinical manifestation cancer patient center non cancer covid- affected patient include  patient cancer patient  non cancer patient hepatocellular carcinoma breast carcinoma leukemia common cancer diabetes hypertension prevalent comorbiditie dyspnea cough fatigue myalgia diarrhea statistically indifferent group fatigue pronounced cancer patient p early onset bilateral patchy consolidation hr p
88,background infection sars cov- virus produce human disease highly variable unpredictable severity presence frequent genetic single nucleotide polymorphism snps population lead great susceptibility infection exaggerated inflammatory response sars cov- require presence ace protein enter cell ace regulator renin angiotensin system accordingly study association  snp agtr ace ace gene severity disease produce sars cov- virus method  aged .+/- year male covid- patient group base severity symptom outpatient n .% hospitalize ward n .% intensive care unit icu n .% deceased n .% comorbidity datum diabetes hypertension obesity lung disease cancer collect adjustment genotype distribution  select snp severity group analyze result snp ace associate severity disease rs andrsshowe protector effectassume overdominant model inheritance g vs. gg aa ci p g vs. aa gg ci p respectively snp rs rswere associate increase risk hospitalize severity course disease recessive model inheritance c c vs. t c t t ci p vs. gg g ci p expect old age male gender comorbiditie increase risk admit icu death vs benign outpatient course multivariable analysis demonstrate role certain genotype ace severity covid- rs rs rs r respectively hardy weinberg equilibrium hospitalize group d snp ace show p association disease association covid- disease different agtr snp evidence multivariable genotype rs show high hospitalization risk patient comorbiditie conclusion different genetic variant ace associate severe clinical course death group patient covid- ace common snp population modulate severity covid- infection independently know marker like gender age comorbiditie
89,background retrospectively data mine case record reverse transcription polymerase chain reaction rt pcr confirm covid- patient hospitalize tertiary care centre derive mortality predictor formulate risk score prioritize admission method findings datum clinical manifestation comorbiditie vital sign basic lab investigation collect routine medical management admission covid- tertiary care centre chengalpattu south india november  retrospectively analyse ascertain predictor mortality univariate analysis relative difference distribution survivor non survivor regression coefficient factor remain significant multivariable logistic regression utilise risk score formulation validate  bootstrap dataset  covid- patient hospitalise survivor  non survivor death slight male predilection .% high mortality rate observe year age group .% high diabetic patient elevated urea level adjusted odd ratio factor ci significant multivariable logistic regression sao/= mg dl neutrophil lymphocytic ratio nlr age /= year pulse rate coexist diabetes mellitus hypertension gender retain significance individual risk score sao/= mg dl- nlr age years- pulse rate coexist diabete mellitus- acronyme collectively ard score show sum score  predict mortality sensitivity-% specificity-% auc conclusion ard risk score derive easily assessable factor predict mortality offer tangible solution prioritize admission covid- tertiary care centre enhance patient care unduly strain health system
90,objective co rads scoring system diagnostic tool datum association co morbid disease effectiveness predict intensive care need short term mortality lack study aim investigate association co rads score co morbid disease intensive care need -day mortality patient method study include  patient covid- infection suspicion    october result sensitivity ct specificity high ct score associate rate positive pcr test result p old patient high co rads score young patient p hypertension p=. diabetes mellitus p=. associate significantly high co rads score patient treat intensive care unit icu co rads score co rads score   .% patient transfer intensive care unit worsen clinical condition p -day mortality significantly high patient co rads score  patient score  .% vs. .% p conclusion irrespective pcr result high co rads score give useful information icu need mortality risk alert early treatment reduce risk transmission intensive care need mortality particularly patient co morbid disease
91,introduction coronavirus disease  covid- disease attribute severe acute respiratory syndrome coronavirus  sars cov- show association fungal opportunistic infection mucormycosis invasive candidiasis aspergillosis contribute mortality disease india incidence mucormycosis rise rapidly second wave ample literature demonstrate role iron pathogenesis mucormycosis hyperferritinemia associate covid- play significant role promote invasion extent fungus aim objective study aim analyze association serum ferritin level extent involvement mucormycosis patient affect covid- methodology single center cross sectional study conduct retrospective hospital record datum g*power statistical analysis software compute sample size  radiological datum determine extent involvement result statistically significant difference see level serum ferritin p radiologically judge group mild extent invasion mucormycosis rhinosinusitis severe extent invasion rhino orbital cerebral mucormycosis severe extent see group have high level serum ferritin severe extent invasion see .% patient diabetes mellitus .% patient diabete hypertension conclusion hyperferritinemia present marker systemic inflammatory process covid- indicate increase free iron aid growth extent involvement fungus r hizopus oryzae individual diabetes hypertension severity great control catastrophic outcome individual high serum ferritin level necessitate extra caution
92,background investigate use influenza datum develop prediction model covid- increase speed prediction model reliably develop validate early pandemic develop covid- estimated risk cover score quantify patient risk hospital admission pneumonia cover h hospitalization pneumonia require intensive service death cover fatality cover f follow covid- diagnosis historical datum patient influenza flu like symptom test covid- patient method analyze federated network electronic medical record administrative claim datum  datum source  country contain datum collect -step process develop  score historical datum patient influenza flu like symptom time prior step create data drive model lasso regularize logistic regression covariate develop aggregate covariate second step cover score develop small set feature  cover score externally validate patient influenza flu like symptom confirm suspect covid- diagnosis  database south korea spain united states outcome include hospitalization pneumonia ii hospitalization pneumonia require intensive service death iii death  day index date result overall covid- patient include model validation identify  predictor history cancer chronic obstructive pulmonary disease diabetes heart disease hypertension hyperlipidemia kidney disease combine age sex discriminate patient experience outcome model achieve good performance influenza covid- cohort covid- auc range cover h cover cover f calibration vary validation covid- validation calibrate influenza validation conclusion research demonstrate utility proxy disease develop prediction model  cover model -predictor develop influenza datum perform covid- patient predict hospitalization intensive service fatality score show good discriminatory performance transfer covid- population miscalibration covid- validation potentially difference symptom severity disease possible solution recalibrate model location use
93,background coronavirus disease- covid- associate high risk acute kidney injury aki require renal replacement therapy rrt serum cystatin c scysc serum neutrophil gelatinase associated lipocalin sngal emerge biomarker kidney injury suggest superior serum creatinine scr clinical setting elevated scysc associate disease severity mortality covid- aim assess utility scysc sngal predict covid associated aki need rrt need intensive care unit icu admission measure presentation emergency department ed method patient present ed laboratory confirm covid- include primary outcome development covid associated aki secondary outcome nee rrt icu admission result  covid- patient  .% develop aki require rrt scr scysc demonstrate excellent performance predict aki auc respectively need rrt auc respectively sngal display acceptable performance predict aki auc need rrt auc conclusion scr scysc measure ed presentation highly accurate predictor aki need rrt sngal demonstrate adequate diagnostic performance scyc previously show superior scr diagnostic biomarker kidney injury certain etiology finding demonstrate scr comparable scyc context predict covid associated aki give high sensitivity biomarker predict need rrt scysc associate mortality covid- patient recommend measurement enable risk stratification early intervention
94,introduction severity sars cov- induce coronavirus disease  covid- depend presence risk factor host gene variability preliminary result gene polymorphism renin angiotensin system influence susceptibility mortality covid- angiotensin ii type  receptor atr gene candidate exert influence aim study elaborate association ac atr polymorphic variant susceptibility severity covid- ukrainian population method study population consist ukrainian population poltava region covid- divide clinical group accordance oxygen requirement patient oxygen therapy n non invasive n invasive n oxygen therapy ac polymorphism atr determine polymerase chain reaction subsequent restrictase analysis attempt well explain role ac atr polymorphism compare association covid- essential hypertension n renoparenchimal hypertension n dyscirculatory encephalopathy n datum comparison obtain meta analysis result observe significant difference frequency aa ac cc genotype group covid- patient non invasive invasive oxygen therapy comparison control subject frequency combine ac cc genotype group covid- patient type oxygen therapy patient oxygen therapy frequency c allele high covid- patient invasive oxygen therapy ci p obtain important result indicate difference frequency atr polymorphism patient cardiovascular disease severe covid- invasive oxygen therapy die covid- conclusion study indicate presence association ac atr polymorphism severity covid- ukrainian population carrier c atr severity covid- oxygen dependency high compare allele carrier possibly cardiovascular disorder
95,importance coronavirus disease  covid- confer significant risk acute kidney injury aki patient covid- aki high mortality rate objective individual african ancestry  copy apolipoprotein l apol variant g g high risk group significantly increase rate kidney disease test hypothesis apol high risk group associate high risk covid associated aki death design setting participant retrospective cohort study include  participant african ancestry enrol million veteran program hospitalize covid- march  january  available genetic information exposure primary exposure have  apol risk variant rv apol high risk group compare have   risk variant apol low risk group main outcomes measures primary outcome aki secondary outcome stage aki severity death multivariable logistic regression analysis adjust preexisting comorbiditie medication inpatient aki risk factor  principal component ancestry perform study association perform subgroup analysis individual normal kidney function prior hospitalization estimate glomerular filtration rate /= ml min/. m result  participant african ancestry  .% male median iqr age  year overall  .% patient develop aki  develop stage   aki  require dialysis  .% die .% participant apol high risk group patient categorize apol high risk group significantly high odd aki adjusted odd ratio ci p high aki severity stage ci p death ci p association aki persist subgroup normal kidney function ci p data analysis conduct february  april conclusion relevance cohort study veteran african ancestry hospitalize covid- infection apol kidney risk variant associate high odd aki aki severity death individual prior normal kidney function
96,background purpose coronavirus disease  covid- rapidly result pandemic information patient history cerebrovascular disease cvd infect severe acute respiratory syndrome coronavirus  sars cov- limited study investigate clinical feature risk factor develop adverse outcome patient covid- previous cvd method single center retrospective clinical study include confirm case covid- wuhan huoshenshan hospital february  april difference clinical characteristic compare patient history cvd incidence severe event comprise cause death intensive care unit admission shock mechanical ventilation usage hospitalization group compare propensity score match analysis multivariate logistic regression analysis risk factor develop severe event patient covid- history cvd analyze result total consecutive patient include study  .% medical history cvd patient cvd tend old comorbiditie include hypertension diabetes coronary heart disease chronic obstructive pulmonary disease level white blood cell neutrophil c reactive protein creatine kinase isoenzyme lactate dehydrogenase high level lymphocyte albumin low cvd group compare cvd patient cvd likely severe event age matching vs. .% p adjust confound effect age sex smoking comorbiditie odd ratio develop severe event history cvd ci p patient cvd decrease lymphocyte count ci .- p increase blood urea nitrogen ci .- p high risk develop severe event hospitalization conclusion patient cvd history tend adverse clinical outcome infect sars cov- decreased lymphocyte count increase blood urea nitrogen level risk factor adverse outcome patient covid- cvd
97,"background covid- pandemic start little later ethiopia rest world initial case report mild disease course favorable outcome change disease spread population vulnerable begin develop severe disease understand risk factor severe disease ethiopia need provide optimal health care service resource limited setting objective study assess covid- patient admit millennium covid- care center ethiopia characteristic associate covid- disease severity method cross sectional study conduct june august   randomly select patient chi square test detect presence statistically significant difference characteristic patient base disease severity mild vs moderate vs severe multinomial logistic regression model identify factor associate covid- disease severity adjust odds ratio aor ci aor p value significance testing result have moderate compare mild disease significantly associate have hypertension aor ci diabetes mellitus aor ci .,.for diabetes mellitus fever aor ci headache aor ci similarly have severe disease compare mild disease associate age group aor ci year aor ci  year sex aor ci hypertension aor ci diabetes mellitus aor ci fever aor ci headache aor ci addition risk factor severe disease compare moderate disease find significantly associate age group aor ci year aor ci  year fever aor ci headache aor ci conclusion significant factor associate severe covid- ethiopia old  year old male diagnosis hypertension diabetes mellitus presence fever headache consistent severity indicator identify suggest initial finding mild disease ethiopia people covid- country relatively young few health problem"
98,latin american society nephrology hypertension conduct prospective cohort multinational registry latin american patient kidney impairment associate covid- infection objective describe characteristic acute kidney disease circumstance study carry open invitation order describe characteristic disease region seventy patient  country include median age  year patient male diverse comorbiditie acute kidney injury aki hospital acquire .% non oliguric .% multiorgan dysfunction syndrome mods covid- volume depletion main factor contribute aki .% .% respectively kidney replacement therapy start .% non recovery renal function observe .% .% patient admit icu .% undergo mechanical ventilation proteinuria admission present .% patient proteinuria hospital stay occur .% patient proteinuria admission high burden comorbiditie high baseline scr mod severe hand patient de novo proteinuria low incidence comorbiditie near normal scr admission show adverse course disease covid- mods main cause aki group cause mortality general population associate age sepsis cause aki severity condition admission oliguria mechanical ventilation non recovery renal function hospital complication hospital stay conclusion study contribute well knowledge condition highlight relevance detection proteinuria clinical course
99,infection sars cov- cause coronavirus disease  covid- associate life threaten condition include acute respiratory distress syndrome ards severity mortality relate cytokine storm imbalance oxidative stress pro thrombotic state conduct observational retrospective cohort study community base large population hospitalize covid- pcr patient admit march january integrate primary tertiary care information castilla la mancha spain explore potential benefit antioxidant anti inflammatory anti thrombotic drug n acetylcysteine nac administer orally high dose mg  h add standard care covid- patient free text information contain electronic health record ehrs).out patient diagnosis covid- hospitalize study  user oral nac high dose covid- patient treat nac old predominantly male comorbiditie hypertension dyslipidemia diabetes copd compare nac p despite great baseline risk use nac covid- patient associate significantly low mortality ci finding remain significant multivariate analysis adjust baseline characteristic concomitant use corticosteroid significant difference use nac mean duration hospitalization admission intensive care unit use invasive mechanical ventilation observed association signal well relevant outcome covid- patient treat nac high dose explore setting population randomized control trial
100,beginning covid- pandemic scientific community explore determinant covid  disease severity majority study base hospital patient high risk collider- selection bias present investigation detail risk factor associate overall mortality hospitalization intensive care unit icu admission covid- infection complete population coverage high resolution datum patient characteristic comorbid condition population base observational study comprise resident  year old stockholm region- million inhabitant real time covid- monitoring framework observation period last march  december hazard ratio hr risk factor covid- disease severity assess cox proportional hazard model total  death hospitalization  icu admission relate covid- occur study period kidney failure diabetes obesity increase risk mortality heart failure ischemic heart disease atrial fibrillation hypertension risk hospitalization follow similar pattern admission intensive care differ triage process clearly present certain co morbid condition associate low icu admission observe difference risk mortality hospitalization patient covid  raise important question potentially protective comedication address real time covid- monitoring framework
101,protection emerge sars cov- variant pre exist antibody elicit current vaccination natural infection global concern aim investigate rate sars cov- infection clinical feature infection naive infected vaccinate post infection vaccinate individual cohort design icddr b staff register covid- testing real time reverse transcriptase polymerase chain reaction rrt pcr reinfection case confirm genome sequencing  march   march  mean age year male participant enrol  .% test negative add negative cohort positive cohort include  positive patient baseline  negative cohort follow .% hospitalize .% die hospitalize patient .% severe critical disease .% require oxygen support hypertension diabetes mellitus find significantly high hospitalise patient compare patient risk ratio respectively risk infection positive cohort low negative cohort ci .-.% p genome sequence show genetically distinct sars cov- strain responsible reinfection naturally infected population likely reinfecte sars cov- infection naive vaccinate individual reinfecte individual suffer severe disease remarkable proportion naturally infect vaccinate individual re)-infecte emerge variant
102,background aim coronavirus disease  covid- worldwide pandemic threat global health patient experience cytokine storm tend high mortality rate date study investigate impact cytokine storm material method retrospective cohort study include covid- positive patient hospitalize private hospital west jakarta march september patient vaccinate period treatment base guideline ministry health indonesia convenience sampling method patient meet inclusion criterion enrol result clinical outcome covid- patient follow medical therapy cure .% die .% .% patient report cytokine storm .% lead fatality plasma immunoglobulin gammaraas(r and/or tocilizumab interleukin- receptor antagonist actemra(r injection utilise treat cytokine storm remdesivir oseltamivir administer ameliorate covid- .% patient experience cytokine storm male mean age  year interestingly patient experience cytokine storm hypertension diabetes complication fever cough shortness breath common symptom .% patient cytokine storm treat intensive care unit icu .% patient cytokine storm receive hydroxychloroquine antibiotic azithromycin levofloxacin meropenam critically ill patient vitamin vitamin c b complex mineral unfortunately group .% patient die remain patient recover significant p correlation establish cytokine storm age presence comorbidity diabetes hypertension fever shortness breath have oxygen saturation spo cold fatigue ward admission severity covid- disease duration treatment use remdesivir actemra(r gammaraas(r patient recover receive combination treatment oseltamivir remdesivir antibiotics vitamin mineral approximately  day survival rate contrary patient receive oseltamivir hydroxychloroquine gammaraas(r antibiotic vitamin mineral survival rate admit hospital day conclusion factor influence development cytokine storm include age duration treatment comorbidity symptom type admission ward severity infection patient .% cytokine storm receive gammaraas(r)/actemra(r survive severe critical level overall base treatment duration survival rate effective therapy combination oseltamivir favipiravir hydroxychloroquine antibiotic vitamin mineral
103,coronavirus disease  covid- cause highly pathogenic emerge virus call severe acute respiratory syndrome coronavirus  sars cov- knowledge pathogenesis virus infancy investigation pathogenic mechanism sars cov- underway covid- remarkable characteristic wide range disease manifestation severity see individual different ethnic background geographical location effectively manage covid- population sars cov- detection serological response assessment analytic technique critical obtain knowledge risk individual comprehend identify variation disease severity general population level factor contribute variation disease presentation include population density gender age difference comorbid circumstance include diabetes mellitus hypertension obesity genetic factor presumably influence sars cov- infection susceptibility covid- link high risk mortality man certain ethnic group reveal host genetic characteristic affect individual risk death genetic variant involve pathologic process include virus entrance cell antiviral immunity inflammatory response entirely understand sars cov- infection characteristic present review suggest genetic polymorphism influence virus pathogenicity host immunity significant implication understanding interpret matter genetic sars cov- pathogenicity customize integrative medical care base population investigation
104,background patient comorbiditie rapid disease progression poor prognosis aim aim investigate characteristic comorbiditie relationship disease progression outcome covid- patient method total  covid- patient divide clinical type group age interval group characteristic comorbiditie compare different clinical type group different age interval group relationship disease progression outcome covid- patient assess result approximately covid- patient young  year old approximately comorbiditie common comorbiditie include non alcoholic fatty liver disease nafld hyperlipidaemia hypertension diabetes mellitus dm chronic hepatitis b chb hyperuricaemia gout covid- patient comorbiditie old especially chronic obstructive pulmonary disease copd cardiovascular disease cvd hypertension dm copd chronic kidney disease ckd cvd mainly find severe covid- patient accord spearman correlation analysis number comorbiditie correlate positively disease severity number comorbiditie nafld correlate positively virus negative conversion time hypertension ckd cvd primarily associate die mention correlation exist independently age risk factor include age number comorbiditie hyperlipidaemia disease severity number comorbiditie hyperlipidaemia nafld copd virus negative conversion time number comorbiditie ckd prognosis number comorbiditie age play predictive role disease progression outcome conclusion high number specific comorbiditie age closely relate progression poor prognosis patient covid- finding provide reference clinician focus number specific comorbiditie age covid- patient predict disease progression prognosis clinical trial registry chinese clinical trial register chictr
105,coronavirus disease  covid- result considerable morbidity mortality worldwide december disease diabetes hypertension cardiovascular pulmonary disease common comorbiditie covid- patient correlate increase disease severity comorbiditie lead covid- patient vicious infectious circle substantially associate significant morbidity mortality study aim estimate prevalence comorbiditie severe category covid survivor non survivor patient multiple comorbiditie admit icu survive compare comorbiditie diabetes follow hypertension common comorbidity patient comorbid individual adopt vigilant preventive measure include vaccination require intensive management well outcome
106,comparison histopathological feature microbiological finding decedent respiratory symptom sars cov- infection cause setting high prevalence hiv mycobacterium tuberculosis mtb infection report death associate positive ante mortem sars cov- pcr test and/or respiratory disease symptom chris hani baragwanath academic hospital soweto south africa th april nd november wave south african covid- epidemic investigate deceased adult patient post mortem minimally invasive tissue sampling mit perform investigate sars cov- infection molecular detection putative pathogen blood lung sample histopathology examination lung liver heart tissue study period mit patient display symptom respiratory disease include  covid related death covid+  non covid related death covid- prevalence hiv infection low covid+ covid- mtb detection common covid+ vs lung histopathology finding show difference covid+ covid- severity morphological appearance type ii pneumocyte alveolar injury repair initiate sars cov- infection liver necrotise granulomatous inflammation common covid+ difference find heart analysis prevalence bacterial co infection high covid+ indicator respiratory distress syndrome undifferentiated covid+ covid- type ii pneumocyte hiv mtb infection appear datum meaningful correspondence covid relate death
107,background coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  virus commonly present respiratory symptom gastrointestinal gi manifestation presentation hospitalization common impact clinical outcome controversial study describe bad outcome covid- patient gi symptom show association protective effect need consistent standard describe gi symptom covid- patient assess effect clinical outcome include mortality disease severity aim investigate prevalence gi symptom hospitalize covid- patient correlation disease severity clinical outcome method retrospectively  consecutive adult covid- patient require hospitalization gi symptom record admission hospitalization demographic clinical laboratory treatment datum retrieve clinical outcome include cause mortality disease severity presentation need intensive care unit icu admission development acute respiratory distress syndrome need mechanical ventilation multivariate logistic regression model identify independent predictor adverse outcome result prevalence gi symptom admission hospitalization common symptom nausea patient diarrhea patient vomiting patient epigastric pain discomfort patient difference mortality group .% vs .% p patient gi symptom likely severe disease presentation .% vs .% p  year associate increase mortality risk odd ratio confidence interval ci p icu admission ci p need mechanical ventilation ci:.- p hypertension independent risk factor icu admission ci:.- p need mechanical ventilation ci p conclusion patient gi symptom likely severe disease presentation mortality disease progression different group
108,background role remdesivir treatment patient hospital covid- remain ill define global context world health organization solidarity randomize control trial rct evaluate remdesivir patient country canada enrol patient expand data collection format canadian treatments covid- catco trial report canadian finding additional demographic characteristic clinical outcome explore potential differential effect different health care system method perform open label pragmatic rct canadian hospital conjunction solidarity trial randomize patient  day remdesivir mg intravenously iv day follow  mg iv daily plus standard care standard care primary outcome hospital mortality secondary outcome include change clinical severity oxygen- ventilator free day  d incidence new oxygen mechanical ventilation use duration hospital stay adverse event rate perform priori subgroup analysis accord duration symptom enrolment age sex severity symptom presentation result  canadian hospital randomize  patient aug. apr. remdesivir n standard care n  withdraw consent hospital total sample  patient patient assign receive remdesivir hospital mortality compare .% standard care arm relative risk rr confidence interval ci -day mortality .% .% respectively ci patient mechanically ventilate baseline need mechanical ventilation assign remdesivir .% receive standard care rr ci mean oxygen free ventilator free day day  standard deviation sd sd receive remdesivir sd sd receive standard care p respectively difference safety event new dialysis change creatinine new hepatic dysfunction  group interpretation remdesivir compare standard care modest significant effect outcome important patient health system need mechanical ventilation trial registration clinicaltrials.gov nct
109,importance little know covid- outcome child adolescent sub saharan africa preexisting comorbiditie prevalent objective assess clinical outcome factor associate outcome child adolescent hospitalize covid-  country sub saharan africa design setting participant cohort study retrospective record review datum  hospital democratic republic congo ghana kenya nigeria south africa uganda march  december include  hospitalize patient age   year sars cov- infection exposure age sex preexisting comorbiditie region residence main outcomes measures ordinal primary outcome scale comprise  category hospitalization oxygen supplementation hospitalization oxygen supplementation icu admission invasive mechanical ventilation death secondary outcome length hospital stay result  hospitalize child adolescent median age year iqr year  patient .% male  .% comorbiditie total  patient .% central africa  .% eastern africa  .% southern africa  .% western africa eighteen patient suspect n confirm n multisystem inflammatory syndrome child thirty patient .% die include   patient .% require intensive care unit admission   patient .% suspect confirm multisystem inflammatory syndrome child  patient  .% discharge  .% remained hospitalize likelihood outcome high vs low severity child young  year express adjust odd ratio aor ci time high adolescent age   year presence hypertension aor ci .- chronic lung disease aor ci .- hematological disorder aor ci .- associate severe outcome age young  year adjust subdistribution hazard ratio ashr ci .- presence  comorbidity ashr ci .- presence  comorbiditie ashr ci .- associate reduce rate hospital discharge conclusion relevance cohort study child adolescent hospitalize covid- sub saharan africa high rate morbidity mortality observe infant patient noncommunicable disease comorbiditie suggest covid- vaccination therapeutic intervention need young population region
110,background hyperglycemic condition compromise immune system thrive coronavirus disease- covid- infection increase disease severity require relatively long recovery period diabetic patient objective systematic review conduct look cytokine level prevalence risk factor comorbiditie covid- patient diabetes mellitus early covid- outbreak method systematic literature search conduct pubmed central pmc europe database web science include article publish  dec   june systematic review perform accord preferred reporting items systematic reviews meta analyses prisma result systematic search generate article end  article  article datum comparison cytokine diabetic non diabetic subject covid-  datum cytokine compare diabetes patient severity disease rate survival study cytokine interleukin- interleukin- tumor necrosis factor alpha cause bad prognosis fatality diabetic patient increased cytokine indicate high mortality link risk factor comorbiditie hypertension cardiovascular disease management diabetes insulin treatment reduce rate mortality diabetic patient contraindicate diabetic patient covid- previous comorbidity especially hypertension cvd conclusion pathophysiological mechanism link cytokine storm diabetic patient lead design treatment strategy future improve early diagnosis therapeutic strategy mitigate cytokine storm associate morbidity mortality
111,background effect renin angiotensin system ras blockade angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb coronavirus disease  covid- susceptibility mortality severity inadequately describe examine association ras blockade covid- diagnosis prognosis large population base cohort patient hypertension htn method cohort study regional health record identify individual age year  healthcare reference area main health provider catalonia spain history htn primary care record datum link covid- test result hospital pharmacy mortality record  march   august define exposure ras blocker dispensation acei arb  month covid- diagnosis  march primary outcome covid- infection severe progression hospitalize patient covid- composite need invasive respiratory support death outcome exposure interest ras blockade acei arb estimate association age- sex- healthcare area- propensity score match sample result cohort  inhabitant identify  patient htn history recent use acei arb patient htn associate low cumulative incidence covid- diagnosis confidence interval ci versus ci p  patient covid- infection use acei arb associate high risk hospitalization need invasive respiratory support death p conclusion ras blockade patient htn associate high risk covid- infection bad progression disease
112,covid- associate rarer extra parenchymal manifestation pneumothorax ptx pneumomediastinum pm lead complication increase mortality study aim describe prevalence risk factor mortality radiological characteristic outcome ptx pm patient admit covid- retrospective single centre observational study patient confirmed covid- present non iatrogenic ptx pm april  detail pertain demographic presentation radiological characteristic management outcome collect case classify spontaneous barotraumatic ptx pm group comparison perform chi square t test total  case mean age year male confirm covid- patient develop ptx pm calculated incidence .%  case spontaneous ptx pm remain  case attribute barotrauma common comorbiditie diabetes mellitus .% hypertension majority case large ptx .% tension  case predominant right side pneumothorace diagnose bronchopleural fistula .% case associate subcutaneous emphysema median duration ptx pm symptom onset delay day respectively mean ct severity score ctss fibrosis .% bronchiectatic change cystic cavitary change statistically significant difference spontaneous barotrauma cohort case die majority belong barotrauma cohort imperative consider possibility ptx pm patient have covid- especially deterioration disease course spontaneously breathe mechanically ventilate patient patient high incidence death reflect gravity covid-
113,background objective factor associate chronic heart failure chf patient systemic lupus erythematosus sle receive little attention recent datum use hydroxychloroquine treatment sars cov- infection cast doubt cardiac safety factor associate chf include therapy antimalarial analyze large multicenter sle cohort method cross sectional study include patient sle acr- criterion include spanish society rheumatology lupus register relesser base historically gather datum patient chf prior diagnosis sle exclude multivariable analysis explore factor associate chf conduct result study population comprise  patient sle acr- criterion chf sle control ninety percent woman patient chf old present great sle severity organ damage mortality chf multivariable model reveal factor associate chf ischemic heart disease p cardiac arrhythmia p pulmonary hypertension p valvulopathy p non cardiovascular damage p calcium vitamin d treatment p female sex p antimalarial p prove protective factor conclusion patient sle chf experience severe sle treatment antimalarial appear confer cardioprotective effect
114,background coronavirus disease covid- result death million people worldwide covid- affect lung different comorbiditie impact outcome perform overview review assess effect chronic kidney disease ckd contract covid- hospitalization mortality disease severity method search publish database update review search primary study publish august prioritize review update high quality amstar tool result include  systematic review  primary study review report prevalence ckd patient covid- range .% systematic review show increase risk hospitalization patient ckd covid- rr ci moderate certainty primary study show statistically significant increase hospitalization patient thirty seven systematic review assess mortality risk patient ckd covid- pooled estimate primary study mortality patient ckd covid- show hr ci moderate certainty ci moderate certainty rr ci low certainty conclusion review highlight impact ckd poor outcome covid- underscore importance identify strategy prevent covid- infection patient ckd
115,passive immunotherapy convalescent covid- plasma ccp therapeutic procedure country include serbia study analyze association demographic factor covid- severity reactivity anti sars cov- antibody abs serbian ccp donor individual n recover confirm sars cov- infection willing donate plasma passive immunization covid- patient enrol study plasma sample test presence igg reactive sars cov- spike glycoprotein s nucleocapsid antigen individual characterize accord age gender comorbiditie covid- severity abo blood type rhd factor total  candidate .% reach level anti sars cov- igg qualify inclusion ccp donation program statistical analysis show male individual p old age group p existence hypertension p severe covid- p link high level anti sars cov- abs finding guide selection ccp donor serbia study need conduct assess neutralization potency clinical efficiency ccp collect serbian donor high anti sars cov- igg reactivity
116,background hypertension diabetes obesity common comorbiditie portend bad outcome coronavirus disease  covid- metabolic syndrome common denominator condition study aim characterize association metabolic syndrome surrogate biomarker severity covid- illness method retrospective study include adult patient test covid- academic tertiary care institution march metabolic syndrome define modify world health organization criterion outcome hospitalization intensive care unit icu admission death analyze result patient test covid-  .% positive result metabolic syndrome present   patient available datum patient metabolic syndrome tend old male african american heavy comorbiditie metabolic syndrome associate high rate hospital admission death p multivariable analysis patient metabolic syndrome increase risk hospitalization icu admission death p high ast alt tg hdl c ratio associate hospitalization icu admission mortality conclusion patient metabolic syndrome significantly bad hospitalization mortality rate covid- adjust covariate target obesity hyperglycemia dyslipidemia hypertension address modifiable risk factor reduce mortality covid-
117,objective study aim observe association presence hypertension covid- vaccine effectiveness healthcare worker receive coronavac vaccination method conduct prospective cohort study saiful anwar general hospital malang indonesia  healthcare worker age year old receive twice coronavac sinovac life science beijing china injection -day interval hypertension diagnose accord  international society hypertension subject monitor month primary outcome rate covid- diagnose pharyngeal swab real time reverse transcription polymerase chain reaction rt pcr examination secondary endpoint severity covid- infected participant rate hospitalization anti srbd antibody level measure eclia result  participant .% diagnose hypertension .% desirable bp target accord current guideline subject hypertension especially uncontrolled blood pressure high incidence covid- infection subject hypertension subject symptomatic covid- hospitalize covid- high participant hypertension anti srbd antibody level low second month coronavac vaccination hypertensive subject contrast comparable anti srbd level see group sixth month vaccination conclusion hypertension associate low vaccine effectiveness healthcare worker subject hypertension high risk infect covid- despite get complete dose vaccination low antibody production
118,introduction coronavirus disease  covid- pandemic india characteristic hospitalize covid- patient base demographic mortality predictor presence comorbiditie find associate poor outcome objective study identify epidemiological clinical characteristic patient admit tertiary care center india predispose covid related mortality method retrospective observational study conduct department medicine india institute medical sciences new delhi  include  covid- confirm patient medical history demographic characteristic comorbiditie clinical finding laboratory datum patient obtain datum analyze identify significant clinical laboratory parameter lead adverse final outcome result hypertension common comorbidity presence diabetes hypertension lead poorer final outcome low oxygen saturation requirement oxygen supplementation admission bad prognostic score admission lead poor outcome seven patient need non invasive ventilation niv hospital course ultimately land  patient manage invasive mechanical ventilation imv multivariate logistic regression analysis perform identify covid- severity admission co existence hypertension diabetes mellitus systolic blood pressure  mm hg serum creatinine great mg dl associate high covid- mortality conclusion covid- patient have co existence diabetes hypertension constitute high risk group target prompt vaccination strategy presence severe disease need oxygen therapy intensive care intervention ultimately lead unfavorable outcome
119,immune response dysregulation play key role severe acute respiratory syndrome coronavirus  sars cov- pathogenesis study evaluate immune endothelial blood cell profile patient coronavirus disease  covid- determine critical difference mild moderate severe covid- spectral flow cytometry examine suite immune phenotype include monocyte t cell nk cell b cell endothelial cell neutrophil alongside surface intracellular marker activation result show progressive lymphopenia depletion t cell subset cd(+ cd(+ cd(+ patient severe disease significant increase cd(+)cd(+)ki(+)ifn gamma(+ monocyte population patient moderate severe covid- previously describe enhance circulate endothelial cell cd(-)cd(+)cd(+)cd(+ circulate endothelial progenitor cd(-)cd(+)cd(+/-)cd(- neutrophil cdb(+)cdb(+ coevaluate covid- severity spearman correlation analysis demonstrate synergism age obesity hypertension upregulated cd(+ monocyte endothelial cell decrease t cell lead severe outcome sars cov- infection circulate monocyte endothelial cell represent important cellular marker monitor postacute sequela impact sars cov- infection convalescence role immune host defense high risk adult vaccination
120,hypertension find frequently patient covid- treat ace inhibitor aceis angiotensin receptor blocker arb sars cov- pathogen covid- bind receptor ace enter alveolar cell raise question drug salutary harmful respect propensity covid- disease prognosis investigate impact acei arb clinical prognosis patient hypertension covid- study  patient hypertension year old covid- recruit patient chronic disease hypertension study population group accord antihypertensive medication acei arb user non acei arb user patient follow clinical prognosis biochemical radiological finding hospital stay adverse cardiovascular event myocardial infarction cause death stroke transfer intensive care unit severity symptom treatment course length hospital stay effort capacity treadmill stress test record hospital stay significant difference term length hospital stay medication covid- leave ventricular ejection fraction echocardiography metabolic equivalent treadmill stress test patient treat acei arb treatment covid- significant difference clinical adverse event effort capacity clinical course patient acei arb appear patient covid- continue use acei arb acei arb add safely antihypertensive treatment
121,angiotensin convert enzyme  ace require cellular entry severe acute respiratory syndrome coronavirus ace ang-(-)-mas r axis antihypertensive cardioprotective effect renin angiotensin system study hospitalize covid- patient hypertension hypertensive human(h ace transgenic mouse determine outcome covid- receptor atr blocker treatment severity illness level serum cardiac biomarker ck ck bm ctni inflammation marker il- il- crp less hypertensive covid- patient treat atr blocker treat antihypertensive drug hypertensive hace transgenic mouse pretreate atr blocker increase ace expression sars cov- kidney heart  day post infection conclude hypertensive patient treat atr blocker high risk sars cov- infection atr blocker effect severity illness instead protect covid- patient heart injury ace angiotensin mas receptor axis
122,background covid- infection global pandemic affect routine health service patient fear consult medical health problem acute abdominal pain subsequently incidence complicated appendicitis increase covid- pandemic study aim evaluate recurrent appendicitis successful drainage appendicular abscess covid- material method prospective cohort study conduct surgical emergency unit universities hospitals march  august  include patient admit diagnosis appendicular abscess undergo open radiological drainage main outcome include incidence severity risk factor recurrent appendicitis patient interval appendectomy result total  patient include analysis mean age patient  year sd third patient male .% co morbidity type  diabetes mellitus tdm .% hypertension .% frequent approximately quarter .% confirm covid  infection patient .% recurrent appendicitis half .% show recurrence month .% patient show recurrence month frequent grade grade patient .% undergo open surgery age tdm hypertension covid- infection abscess size cm significantly risk predictor recurrent appendicitis conclusion interval appendectomy suggest prevent .% recurrent appendicitis occur  month recommend perform interval appendectomy old age people diabetes covid- infect abscess  cm diameter research question interval appendectomy prevent high incidence recurrent appendicitis successful drainage appendicular abscess covid- pandemic
123,introduction severe acute respiratory syndrome coronavirus  sars cov- start pathology chiefly affect low respiratory tract encounter wuhan china infection unknown etiology extensively study order establish profile respect probable manifestation require medical management hematological profile patient typically affect coronavirus disease  covid- show lymphopenia alter neutrophil lymphocyte ratio raise inflammatory marker like d dimer interleukin  il- c reactive protein crp lactate dehydrogenase serum ferritin prognostic significance marker study cross sectional study patient method data collect consecutive subject admit intensive care unit acharya vinobha bhave rural hospital sawangi meghe wardha aged  year later confirm positive covid- throat nasal swab rapid antigen test reverse transcription polymerase chain reaction rt pcr write informed consent signature thumbprint obtain participant statistical analysis descriptive inferential statistic help chi square test z test difference mean software analysis spss ibm corp. armonk ny graphpad prism graphpad software san diego p consider level significance result total  patient study point percent succumb  year age significant number comorbiditie like diabetes mellitus hypertension chronic kidney disease significant positive correlation mortality rate mean platelet volume p=. neutrophil lymphocyte ratio p=. raise d dimer p=. serum ferritin p=. lactate dehydrogenase p=. c reactive protein p=. conclusion analysis datum collect highlight correlation study hematological manifestation covid  association severity disease
124,objective s adenosylmethionine sam s adenosylhomocysteine sah indicator global transmethylation play important role marker severity covid- method level plasma sam sah determine patient admit covid- n mean age lung injury identify compute tomography ct accordance ct- classification result sam find potential marker lung damage risk covid- patient sam  nm ct vs. ct relative ratio rr p sam sah find marker lung injury ct- vs. ct rr p negative association sam glutathione level rho p interleukin- il- level associate sam rho p sah rho p level conclusion high sam level high methylation index associate risk lung injury patient covid- association sam il- glutathione indicate important role transmethylation development cytokine imbalance oxidative stress patient covid-
125,background aim investigate infection rate clinical characteristic outcome covid disease cohort people live hiv madrid spain year pandemic setting observational single center study include hiv infect patient aged  year laboratory confirm severe acute respiratory syndrome coronavirus  sars cov- infection february hospital universitario  de octubre method confirmed disease define patient positive antigen test reverse transcriptase polymerase chain reaction serology sars cov- compare characteristic patient mild disease asymptomatic include moderate severe disease require admission result  hiv infect patient  .% male median age year diagnose sars cov- infection rate .% confidence interval thirty individual .% moderate severe disease .% mild disease .% asymptomatic hypertension .% obesity .% prevalent comorbiditie .%  comorbiditie patient .% rna hiv viral load copy milliliter  cd cell count cell cubic millimeter infection admit hospital require oxygen support .% invasive mechanical ventilation patient die patient take tenofovir disoproxil fumarate require admission multivariate analysis age remain independent factor moderate severe disease odd ratio confidence interval p conclusion people live hiv risk severe sars cov- infection age variable independent association moderate severe disease adjust comorbiditie factor
126,prevent spread coronavirus disease  covid- japanese government announce state emergency result major stress population aim study investigate possible association change daily stress blood pressure bp japanese patient retrospectively investigate  patient chronic disease treat sagamihara physicians association determine change stress covid- state emergency  april  state emergency office bp significantly increase p p respectively contrast home bp significantly decrease p p respectively ratio white coat hypertension significantly increase p percent patient worry adverse effect hypertension condition contribute severity poor prognosis covid- decrease amount exercise worsen diet composition observe patient respectively conclusion significant increase office bp white coat phenomenon observe state emergency increase related stress prevent cardiovascular event general practitioner pay attention bp management stressful global event include covid- pandemic
127,venous thromboembolism vte patient covid- intensive care unit icu frequent risk factor rf remain unidentified meta analysis crd search observational study icu report association vte rf medline embase  april reviewer independently extract datum duplicate assess certainty evidence grade approach analysis conduct random effect model produce non adjusted odd ratio analyse  rf  study patient find moderate certainty evidence association vte d dimer peak ci length hospitalization ci intubation ci identify low certainty evidence association vte crp ci d dimer ci troponin t ci requirement inotropic drug ci traditional vte rf i.e. history cancer previous vte event obesity find associate vte covid- anticoagulation associate decrease vte risk vte rf severe covid- correspond individual illness severity inflammatory coagulation parameter
128,objective soluble st sst reflect inflammation endothelial dysfunction myocardial fibrosis produce lung established biomarker heart failure seek determine role sst covid- assess pathophysiological correlate association hospital outcome method enrol  consecutive hospitalise patient covid- prospective observational covid- mech study biobank sample collect baseline day  day key exposure variable sst outcome icu treatment mechanical ventilation hospital death result concentration sst baseline median  iqr ng ml elevate concentration ng ml high baseline sst concentration associate old age male sex white race smoking diabetes hypertension chronic kidney disease baseline sst associate presence sars cov- viraemia low oxygen saturation high respiratory rate increase concentration biomarker reflect inflammation thrombosis cardiovascular disease hospitalisation  patient die  survivor receive intensive care unit icu treatment baseline sst concentration demonstrate grade association disease severity median iqr medical ward  ng ml icu  ng ml non survivor  ng ml p comparison association persist day  day  conclusion sst concentration associate sars cov- viraemia hypoxaemia concentration inflammatory cardiovascular biomarker robust association baseline sst disease severity independent superior establish risk factor sst reflect key pathophysiology promising biomarker covid- trial registration number nct
129,coronavirus disease  covid- primary respiratory infectious disease result pulmonary cardiovascular complication appearance city wuhan china infection spread worldwide lead declaration pandemic march clinical research sars cov- severe acute respiratory syndrome coronavirus suggest virus determine change pulmonary hemodynamic mechanism endothelial dysfunction vascular leak thrombotic microangiopathy venous thromboembolism similar lead pulmonary hypertension ph current available study report echocardiographic sign ph approximately  hospitalize patient covid- chronic pulmonary obstructive disease congestive heart failure pulmonary embolism prior ph increase risk develop worsen ph evidence ph associate increase disease severity poor outcome importance pulmonary hemodynamic pathophysiology covid- grow interest explore potential therapeutical benefit inhaled vasodilator patient covid- treatment inhale nitric oxide prostacyclin show encouraging result improvement systemic oxygenation reduction systolic pulmonary arterial pressure prevention right ventricular failure datum randomized control trial require
130,introduction short- long term effect coronavirus disease  covid- erectile function penile vasculature remains poorly understand particular importance virus find present penile tissue aim determine association covid- infection subsequent diagnosis erectile dysfunction method assess risk ed man covid- united states trinetx research network federated electronic medical record network  healthcare organization  million patient identify adult man  year record covid- infection icd cm b. u. u. j. j. b. january compare equivalent number adult man covid- timeframe man prior history diagnosis ed january  exclude account confound variable propensity score match age race body mass index bmi history follow comorbid medical condition diabetes mellitus e hypertension ischemic heart disease i- hyperlipidemia e outcomes assess association covid- ed n primary outcome regression analysis statistical significance assess p result prior propensity score matching man covid- find old man covid- vs year additionally man covid- note increase prevalence diabetes mellitus dm hypertension htn compare man covid- dm htn vs dm htn propensity score matching compare man covid- man covid- find covid- diagnosis significantly associate ed odd ratio confidence interval .- p= clinical implication finding indicate clinician consider evaluate erectile dysfunction man recent covid- diagnosis counsel risk develop erectile dysfunction strengths limitation strength include large sample size adjustment confound variable limitation include reliance global federated dataset retrospective study design lack datum ed mild vs moderate vs severe covid- infection severity history prostate cancer radiation conclusion increase chance new onset erectile dysfunction post covid- infection chu ky nackeeran s horodyski l covid- infection associate new onset erectile dysfunction insight national registry sex med
131,introduction novel coronavirus covid- tuberculosis tb new old global threat respectively covid- era health system focus covid- epidemic national tb control program receive attention lead worsening global tb epidemic study review characteristic tb patient coinfecte covid- material method scopus pubmed medline embase web science database systematic search perform case report case series tb covid- coinfection publish january  february  collect limitation publication language result case series  case report identify  country majority india n china n overall  patient man  woman coinfecte tb covid- enrol smoking .% diabetes .% hypertension .% frequent comorbiditie patient covid- patient tb mainly suffer fever .% cough .% respiratory distress hydroxychloroquine .% lopinavir ritonavir .% common treatment mortality rate .% rate discharge patient conclusion global prevalence covid related death result show .% patient tb covid- die study indicate coinfection tb covid- increase mortality respiratory symptom tb covid- similar cause misdiagnose addition tb diagnose later covid- severity disease worsen especially patient underlying condition patient tb screen regularly covid- era prevent spread tb covid- coinfection
132,objective present study aim assess psychological clinical determinant coronavirus disease  covid- association disease severity outcome method prospective study conduct hayatabad medical complex peshawar pakistan admit patient screen covid- reverse transcription polymerase chain reaction rt pcr subsequently  covid positive patient include final analysis datum obtain patient medical chart demographic clinical characteristic record structured questionnaire psychological determinant include anxiety depression measure hospital anxiety depression scale hads predictor disease severity outcome recovery vs. mortality study result total  patient include study  patient recover deadly virus  die base psychological assessment .% enrol covid- patient poor hads score patient die .% severe symptom poor hads score similarly .% total case observe poor hads .% die severe depression conclusion conclude study result psychological distress frequent covid- patient age hypertension fatigue abnormal respiratory rate oxygen saturation ferritin poor hads sore determine significant predictor covid- severity outcome
133,evidence show chronic disease associate covid- severity death study aim estimate fraction hospitalization death covid- attributable chronic disease associate poor nutrition smoking adult test positive covid- mexico analyze adult age /= test positive covid- march  december chronic disease consider obesity chronic obstructive pulmonary disease copd hypertension diabetes cardiovascular disease chronic kidney disease ckd calibrate database bias quantification method consider undiagnosed disease case estimate total impact multiple disease define multimorbidity variable accord number disease risk hospitalization death estimate poisson regression model calculate population attributable fraction pafs chronic disease account ci ci ci hospitalization adult  year old respectively covid related death ci ci ci .%-.% attributable chronic disease adult  year old respectively chronic disease link poor nutrition smoking contribute large burden hospitalization death covid- mexico particularly young adult medical structural intervention curb chronic disease incidence facilitate disease control urgently need
134,objective post covid- symptom feature recover patient similar post severe acute respiratory syndrome study aim assess outcome manifestation post covid follow period recover patient method ambidirectional longitudinal study conduct recovered covid- patient tertiary care hospital near chennai telephonic interview discharge total admit patient june november    die  transfer hospital totally  consent study rest wrong number willing participate chi square test multinominal logistic regression analysis result majority .% .% year year respectively majority admit fever .% cough body pain post covid symptom report fatigue .% stress anxiety .% mood change patient newly diagnose diabetes mellitus hypertension tb discharge have diabetes mellitus independent risk neurological cardio respiratory symptom patient discharge minimal support independent risk factor renal symptom follow subject conclusion follow symptom associate patient comorbiditie age severity illness environmental factor
135,background hypertension comorbidity accompany covid- relate angiotensin convert enzyme  receptor ace r endothelial dysregulation important role blood pressure regulation anti hypertensive agent believe trigger hyperinflammation process aim association use anti hypertensive drug disease progression covid- patient method study observational cohort study covid- adult patient moderate critically ill admit universitas airlangga hospital uah surabaya history hypertension receive anti hypertensive drug result patient receive beta blocker long length stay angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker acei arb calcium channel blocker respectively high rate intensive care unit icu admission acei arb p high mortality rate significant difference length stay icu admission mortality rate day death single double triple anti hypertensive group mortality rate group take acei arb low combination conclusion hypertension increase severity covid- use acei arb ace- receptor regulation think aggravate condition covid- patient prove consistent finding anti hypertensive group
136,objective determine association angiotensin convert enzyme inhibitor aceis angiotensin ii receptor blocker arb use coronavirus disease  covid- severity outcome veteran patient method retrospectively examine adult veteran test positive covid- march november logistic regression cox proportional hazard model propensity score ps weight adjustment matching examine odd event  day follow covid positive case date time death respectively accord acei and/or arb prescription  month prior covid positive case date result overlap ps weight logistic regression model show low odd intensive care unit icu admission odd ratio ci death  day .- acei arb prescription veteran arb prescription low odd icu admission overlap ps weighted model similarly show low risk time cause mortality veteran acei arb prescription hr ci arb prescription veteran acei prescription high odd experience septic event  day covid positive case date conclusion study national cohort veteran find use acei arb patient covid- associate increase mortality bad outcome future study examine underlying pathway confirm relationship acei prescription sepsis
137,aim cardiac dysfunction coronavirus disease- covid- report acute phase serial change study determine serial change type severity echocardiographic leave right heart function perform prospective study method result successive covid- patient discharge hospital june december  enrol clinical detail obtain echocardiography perform philips iex matrix follow evaluation perform  month total  covid- patient evaluate baseline echocardiography perform  eligible patient man woman mean age  year hypertension .% diabete .% coronary disease .% covid- mild .% moderate .% severe .% baseline cardiac parameter impaired severe vs. moderate mild covid-  month  patient baseline follow datum available decline observe select leave leave ventricular internal diameter diastole mm leave atrial volume ml m mitral e e leave ventricular ejection fraction lvef right right ventricular internal diameter diastole mm right atrial internal dimension mm tricuspid vmax cm tricuspid annulus plane systolic excursion tapse mm heart variable p compare mild covid- decline significantly great moderate severe disease lvef vs. .% mitral e e vs. tricuspid vmax vs. cm tapse vs. mm p conclusion study show impaired cardiac function severe moderate covid- compare mild hospital discharge progressive decline left right heart function  month impairment significantly great patient moderate severe disease
138,background early identification patient severe coronavirus disease covid- increase risk progression promote individualized treatment scheme optimize use medical resource study aim investigate utility c reactive protein albumin crp alb ratio early risk stratification patient method retrospectively  patient covid- confirmed outcome discharge decease admit west court union hospital wuhan china january  april patient severe covid- n divide stable n progressive n group accord progress critical illness death hospitalization predict disease progression crp alb ratio evaluate admission result level new biomarker include neutrophil lymphocyte ratio platelet lymphocyte ratio crp alb ratio systemic immune inflammation index high patient progressive disease stable disease correlation analysis show crp alb ratio strong positive correlation sequential organ failure assessment score length hospital stay survivor multivariate logistic regression analysis show percutaneous oxygen saturation spo d dimer level crp alb ratio risk factor disease progression predict clinical progression area receiver operate characteristic curve alb crp crp alb ratio spo d dimer respectively patient high crp alb ratio markedly high rate clinical deterioration log rank p closely associate high rate hospital mortality icu admission invasive mechanical ventilation long hospital stay conclusion crp alb ratio predict risk progression critical disease death early provide promising prognostic biomarker risk stratification clinical management patient severe covid-
139,background present covid- global pandemic seriously harmful human retrospective study aim investigate interaction cvd covid- method total  patient diagnose covid- yichang central people hospital  january  march  initially include medical history clinical manifestation time admission laboratory test result hospitalization time complication record accord medical history patient assign nonsevere group non cvd n= nonsevere group cvd n= severe group non cvd n= severe group cvd n= result severe group compare non cvd patient cvd patient significantly high incidence fever p compare nonsevere group severe group significantly high proportion patient hypertension type  diabetes mellitus chd hf p patient nonsevere covid- wbc count level il- crp d dimer nt probnp fbg significantly high hb level significantly low cvd patient non cvd patient p patient severe covid- level nt probnp significantly high cvd patient non cvd patient p addition wbc count level il- crp d dimer ckmb alt ast scr nt probnp fbg significantly high hb level significantly low severe group nonsevere group p patient severe covid- incidence acute myocardial injury acute kidney injury arrhythmia sudden death significantly high cvd group non cvd group p result find comparison nonsevere group severe group patient nonsevere covid- cvd mean hospitalization duration sd day cvd mean hospitalization duration sd day difference significant p result find comparison severe group conclusion cvd affect severity covid- covid- increase risk severe cvd
140,exact incidence neurological cognitive sequela covid- long term unknown aim research investigate type neurological cognitive impairment covid- case different severity patient develop covid- examine  month diagnosis mean neurological exam extensive cognitive evaluation investigate general cognition memory verbal fluency visuospatial ability executive function treat intensive care unit icu patient  hospitalize non icu patient neurological deficit find .% non icu .% icu case involve peripheral nervous system icu patient perform significantly bad neuropsychological test show bad age- education correct cognitive impairment cognitive impairment index cii high icu non icu patient median icu  vs p cii significantly correlate age group unrelated length follow- diabetes hypertension icu patients- pao fio icu admission obtain result support great susceptibility covid- patient treat icu develop neurological deficit cognitive impairment month follow compare case mild moderate symptom
141,base recent report cardiovascular event encompass large portion mortality cause covid- pandemic draw cardiologist management admit ill patient give common laboratory value provide key insight illness cause life threaten sars cov- virus helpful screening clinical management time therapeutic strategy commensurate issue review article aim discuss dynamic change common laboratory parameter covid- association cardiovascular disease value change early stage disease consider monitor recovery process time require return biomarker basal level discuss finally particular interest tend abridge late update cardiovascular biomarker prognostic diagnostic criterion determine severity covid-
142,coronavirus disease  covid- disease produce severe acute respiratory syndrome coronavirus  sars cov- currently cause catastrophic pandemic affect human worldwide disease lethal approximately million people world january globally affected country mexico rank death united states america brazil high number deceased people explain social aspect lifestyle custom mexico relationship high proportion death comorbiditie high blood pressure hbp type  diabetes obesity metabolic syndrome official epidemiological figure report mexican government indicate .% population suffer hbp close .% adult suffer type  diabetes approximately .% population suffer obesity disbalance gut microbiota gm associate disease covid- severity presumably inflammatory dysfunction recent datum association gm dysbiosis metabolic disease suggest high level susceptibility sars cov- infection covid- morbidity mexican population primarily prevalence type  diabetes obesity metabolic syndrome
143,risk factor determine severity covid- fully elucidate aim study evaluate role coronary artery calcification cac risk factor death mechanical ventilation mv patient know heart disease infect covid- analyze  consecutive patient acute respiratory symptom chest compute tomography chest ct previous heart disease criterion covid- rt pcr positive and/or typical clinical chest ct finding cac classify number coronary segment affect absent mild severe calcification association cac cac severity death mv severe respiratory failure assess logistic regression mean age year .% man patient cac old likely hypertension likely obese cac present  patient .%  mild calcification  severe calcification associate death or=. ci mv or=. ci adjust multiple confounder significant increase odd ratio severe form cac death or=. ci mv or=. ci conclude cac independent risk factor death mv covid- patient previous heart disease particularly severe calcification cac easily visualize common chest ct widely evaluation moderate severe covid-
144,introduction coronavirus disease  covid- novel disease cause severe acute respiratory syndrome coronavirus  sars cov- lead million death worldwide kidney transplant recipient ktrs fragile population immunosuppressed status limited study available compare population general population clinical symptom laboratory imaging feature disease severity clinical outcome method total  ktr  patient general population control group enrol apply exclusion criterion clinical symptom laboratory value lung involvement pattern high resolution compute tomography hrct compare ktr covid- counterpart general population category disease severity adverse outcome intensive care unit icu admission mechanical ventilation mv mortality rate compare group result hypertension significantly high ktr dyspnea significantly control group p significant difference rest clinical symptom p significant difference ct feature pleural effusion prevalent control group lower absolute lymphocytic count alc platelet count observe ktr renal transplant recipient rtr high elevation creatinine level counterpart icu admission mv duration hospital stay mortality adverse outcome significantly different ktr control group conclusion conclusion significant difference severity risk adverse outcome include mv icu admission mortality ktr chronic immunosuppression control group
145,objective investigate structure postcovid syndrome age gender characteristic course assess effect cytoflavin clinical course neurological disorder patient undergo covid- material method study include  patient average age year statistically man woman duration transfer sars cov- day   day date recovery random sampling patient divide group main group receive cytoflavin tablet course  day  tablet  time day comparison group drug vitamin nootropic drug patient examine day treatment day end therapy status assess asthenia assessment scale mfi- brief mental status assessment scale mmse quality life questionnaire eq d general health assessment scale pittsburgh sleep quality index psqi analysis laboratory parameter carry retrospectively result conclusion postcovid syndrome common man comorbid condition arterial hypertension atherosclerosis prevail neurocognitive autonomic disorder predominate appointment cytoflavin possible achieve pronounce anti asthenic effect correction cognitive impairment reflect significantly significant positive dynamic indicator scale additional effect cytoflavin reveal decrease severity thrombocytopenia observation period patient adverse event effect associate take drug prescription drug require age relate dose adjustment combine basic therapy concomitant pathology
146,background sars cov covid- emerge china cause global pandemic mortality rate report .% patient study determine clinical laboratory parameter covid- relate morbidity mortality hospital objectives investigate relationship demographic clinical laboratory parameter covid related morbidity mortality design retrospective observational study setting tertiary care hospital patient method patient diagnose covid- pneumonia march end december include study main outcome measures relationship demographic clinical laboratory parameter morbidity mortality rate patient diagnose covid- sample size  patient result mortality rate coronary artery disease p. degree c presentation p=. hypertension p positive smoking history p significantly associate mortality patient die old high comorbid disease index pneumonia severity index fast blood glucose baseline serum creatinine d dimer low baseline haemoglobin sao percentage lymphocyte count diastolic blood pressure patient admit icu old high comorbidity disease index pneumonia severity index c reactive protein wbc d dimer creatinine number antibiotic long o support duration low hemoglobin lymphocyte baseline sao conclusion result consistent report datum suggest frequency dosage duration steroid treatment limit limitation low patient number uncertain reason mortality standard treatment regimen limited treatment option like ecmo conflict interest
147,lung primary target severe acute respiratory syndrome coronavirus  sars cov- infection severe hypoxia cause death critical case coronavirus disease  covid- extremely heterogeneous term severity clinical phenotype importantly global distribution majority affected patient recover acute infection continue suffer late sequela affect organ include lung role pulmonary vascular system acute chronic stage covid- adequately study thorough understanding origin dynamic behaviour sars cov- virus potential cause heterogeneity covid- essential anticipate treat disease acute chronic stage include development chronic pulmonary hypertension covid- chronic pulmonary hypertension assume global dimension potential complex interaction review present update origin behaviour sars cov- virus discuss potential cause heterogeneity covid- addition summarize pathobiology covid- emphasis role pulmonary vasculature acute stage term potential develop chronic pulmonary hypertension hope information present review help development strategy prevention treatment continue covid- pandemic
148,background haematological marker absolute lymphopenia associate severe covid- infection literature date cohort describe typically include patient moderate severely unwell pneumonia require intensive care stay uncertain marker apply population severe illness seek describe haematological profile patient mild disease covid- admit single centre singapore method examine  consecutive pcr positive sars cov- patient admit single tertiary healthcare institution feb  april patient blood count obtain  h presentation result patient pneumonia high neutrophil percentage vs .% p low absolute lymphocyte count vs x l p absolute eosinophil count vs x p platelet count  vs  p slightly low group pneumonia demonstrate significant difference neutrophil lymphocyte ratio monocyte lymphocyte ratio platelet lymphocyte ratio patient pneumonia patient .% peripheral eosinophilia common migrant worker live dormitory conclusion neutrophilia lymphopenia find marker associate severe covid- illness find combine haematological parameter neutrophil lymphocyte ratio monocyte lymphocyte ratio platelet lymphocyte ratio association disease severity cohort patient mild moderate disease migrant worker live dormitory eosinophilia reflect concurrent chronic parasitic infection
149,background people infect severe acute respiratory syndrome coronavirus  sars cov- experience wide range clinical manifestation asymptomatic mild illness severe illness death influence age variety comorbiditie neutralize antibody nabs think primary immune defense virus large diverse characterize cohort convalescent individual provide standardized value benchmark nab response past sars cov- infection define potentially protective level immunity method finding analysis comprise observational cohort  hiv seronegative adult united states n peru n convalesce sars cov- infection october mean age  year range  cohort overall hispanic identify white nab titer measure serum sars cov-.dg spike pseudotype virus infection t ace cell multiple linear regression apply define association nab titer demographic variable disease severity time infection disease onset comorbiditie peruvian cohort time nab titer peak   day post diagnosis high participant history severe coronavirus disease  covid- p  year male sex assign birth case body mass index independently associate high nab titer hypertension independently associate low nab titer nab titer differ race underlie pulmonary disease smoking month post enrollment nab id id titer decline overall study limitation observational convalescent cohort include survivorship bias miss early viral load acute immune response correlate convalescent response observe conclusion summary cohort nab titer sars cov- infection peak approximately  month post diagnosis varied age sex assign birth disease severity underlying comorbiditie datum great heterogeneity nab response people recent covid- highlight challenge interpret natural history study gauge response vaccine therapeutic people recent infection observation illuminate potential correlation demographic clinical characteristic nab response key element protection covid- inform development implementation preventative therapeutic strategy globally trial registration clinicaltrials.gov nct
150,background coronavirus disease  covid- pandemic associate heavy burden patient mental physical health regional healthcare resource global economic activity age society japan retirement home long term stay hospital elderly inhabitant covid- pandemic disease cluster identify retirement home long term stay hospital hypothesize additional burden nursing care elderly patient reinforce anxiety exhaustion medical staff healthcare resource age society actual situation understand study aim evaluate current situation countermeasure covid- pandemic age society method covid- patient require hospitalization national hospital organization kyoto medical center -bed capacity hospital locate kyoto japan  april   march assess characteristic covid- patient disease severity duration hospitalization outcome discharge degree activity daily living adls complication unique elderly patient result enrol  patient require hospitalization study period approximately patient aged  year dementia .% prevalent underlying disease follow diabetes mellitus .% chronic kidney disease approximately hospitalize covid- patient impair adl admission covid- patient age  year old require significantly long term hospitalization covid- patient age  year vs. p elderly patient age  year old approximately patient geriatric mental disorder approximately bedridden status feeding difficulty poor adl admission significantly associate covid- mortality odds ratio confidence interval p value conclusion proportion elderly patient age  year old relatively high hospitalization covid- poor adl admission elderly patient significantly associate poor prognosis covid- mind healthcare worker force additional burden nursing care age society covid- pandemic intervention reduce burden urgently require
151,potential relationship diabetes covid- evaluate new knowledge rapidly emerge study systematically relationship viral cell surface receptor ace axl cd dc sign l sign dpp sars cov- infection risk emphasize implication ace sars cov- infection covid- pathogenesis update way interaction diabetes covid- treatment option covid- comorbid patient perspective ace efficacy clinical chemotherapeutic option include anti diabetic drug renin angiotensin aldosterone system inhibitor lipid lower drug anticoagulant glucocorticoid covid- positive diabetic patient discuss significance different form ace mace gender covid- susceptibility severity review summarize covid- pathophysiology good strategy clinical management diabetes patient covid-
152,background absence vaccine global spread covid-  necessitate non pharmaceutical intervention curb rise case purpose article use health belief model novel rapid mobile survey examine correlate report mask wear non pharmaceutical intervention south africa august method way tabulation multivariable analysis logistic regression modeling describe correlation report mask wear factor interest sample  adult period national longitudinal survey national income dynamics study coronavirus rapid mobile survey nids cram result line health belief model result show self efficacy prevalence mask wear district affluence positively associate report mask wear report stay home significantly likely report wear mask little evidence expect severity disease contract affect decision hypertension obesity overweight measure year early significant association mask wear prevalence mask wear increase significantly august  covid- case increase lockdown restriction ease contrary health belief model find despite have high mortality risk elderly significantly low odd mask wear conclusion south africa mask wear adherence increase rapidly concern elderly low odd mask wear examine future research
153,background probable impact maintenance immunosuppressant liver transplant lt recipient coronavirus disease  covid- remain unexplored specific aim approximate prognosis lt recipient covid- standard maintenance method search separate database qualified study december  june ultimately meta analysis carry fix effect random effect model base heterogeneity result total study  lt recipient covid- pool rate severity mortality combined immunosuppressive therapy .% respectively study sufficiently show immunosuppressive therapy lt recipient covid- significantly associate non severe covid- odd ratio ci p duration lt diagnosis covid- primary disease lt obesity significantly associate severity mortality lt recipient covid- immunosuppressive therapy pool analysis find lt recipient covid- comorbiditie severe disease low mortality rate compare covid- comorbiditie conclusion conclusion lt recipient covid- undergo immunosuppressive therapy significantly associate severity mortality take risk organ rejection key consideration complete withdrawal wise mycophenolate mofetil mmf discontinue replace immunosuppressive regimen cnis- mtoris base immunosuppressive therapy select lt recipient covid- depend severity disease
154,currently fourth wave coronavirus disease covid- pandemic create havoc part world vaccination program launch country emerge new strain virus geographical variation lead vary success rate available vaccine presence comorbiditie diabetes cardiovascular disease hypertension responsible increase severity covid- covid- mortality rate angiotensin convert enzyme  ace utilize sars cov- entry host cell widely express lung kidney testis gut adipose tissue brain infection host cell mediate ras overactivation lead decrease ace ace ratio atr atr ratio masr atr ratio imbalance lead development heighten inflammatory response cytokine storm lead post covid- complication mortality association sars cov- infection hypertension remain unclear report provide overview effect sars cov- infection patient hypertension discuss interaction ace sars cov- focus neuronal ace nace shed light possible involvement nace hypertension sars cov- enter brain neuronal ace spread region brain effect viral binding neuronal ace area brain regulate salt water balance blood pressure discuss light neural regulation hypertension covid-
155,objective estimate proportion sars cov- influenza virus coinfection severe acute respiratory infection sari case patient wave covid- pandemic bangladesh design descriptive study setting tertiary level hospital bangladesh participant patient admit sari define case subjective measured fever c degree cough onset  day require hospital admission case patient primary secondary outcome proportion sars cov- influenza virus coinfection proportion mortality sari case patient result enrol  sari case patient median age  year iqr year .% male  .% infect sars cov-  .% infect influenza virus .% coinfecte virus non appearance influenza usual peak season july bangladesh sars cov- infection significantly associate diabetes .% vs .% p hypertension .% vs .% p influenza sari case patient significantly associate diabetes .% vs .% p=. hypertension .% vs .% p=. proportion hospital death sars cov- infected sari case patient high .% n= vs .% n= p sars cov- infection proportion postdischarge death  day high .% n= vs .% n= p=. sars cov- infected sari case patient infection hospital mortality postdischarge mortality register coinfecte sari case patient conclusion finding suggest coinfection sars cov- influenza virus common disease severity consider mortality bangladesh circulate influenza virus influenza peak season covid- pandemic future study warrant exploration
156,ace angiotensin convert enzyme)- target sars cov- negatively regulate renin angiotensin system pathological activation adam disintegrin metalloproteinase- potentiate inflammation diminish ace mediate tissue protection proteolytic shedding contribute sars cov- pathogenesis aim examine plasma soluble ace angiotensin profile relation outcome enrol consecutive patient admit covid- baseline blood collection admission repeat sampling  day primary outcome -day mortality secondary outcome incidence end organ injury overall  patient include median age  year  .% man  .% patient reach primary end point baseline soluble ace elevate covid- associate disease severity mortality contrast upward trajectory soluble ace repeat sampling independently associate elevated risk mortality incidence acute myocardial injury circulatory shock similarly increase soluble tumor necrosis factor receptor level associate adverse outcome plasma ang ang angiotensin level ang -/ang ii angiotensin ii ratio elevate sars cov- infection relate downregulation ace activity baseline patient have upward trajectory soluble ace characterize imbalance ang -/ang ii ratio observed dysregulation ace angiotensin peptide disease progression suggest potential role adam inhibition enhance beneficial ang axis improve outcome sars cov- infection
157,background ongoing outbreak sars cov- represent significant challenge international health report highlight importance ace pathogenesis covid- spike protein sars cov- efficiently bind angiotensin convert enzyme  ace receptor facilitate virus entry host cell present study hypothesize functional insertion deletion polymorphism rs d rs t c ace gene associate sars cov- infection mortality methodology study include  consecutive covid- patient  age match healthy control ace rs d  age match healthy control ace rs t c. mutation specific pcr msp ace rs d genotyping amplification refractory mutation system arms pcr ace rs t c genotyping result result indicate significant difference genotype distribution ace rs d polymorphism p  c covid- patient control p value  c genotype report gender p td p ace cc genotype strongly associate increase covid- mortality ci p ace c allele associate covid- mortality  p conclusion conclude ace dd genotype d allele strongly associate increase covid- patient severity addition ace d polymorphism strongly associate advanced age diabetes ischemic heart disease covid- patient ace ii genotype protective factor development severe covid- ace dd genotype strongly associate increase covid- mortality additionally ace cc ct genotype strongly associate covid- severity study useful identify susceptible population group target intervention make relevant public health policy decision
158,objective aim investigate presence severity depressive symptom coronavirus disease  covid- inpatient possible change discharge subject method collect datum patient admit infectious disease unit sassari italy covid- march  beck depression inventory ii bdi ii perform  week admission t  week discharge t cutoff point choose define clinical significance depressive symptom  moderate result subject include mean age year  .% male frequent comorbiditie cardiovascular disease hypertension (; perform bdi ii t  .% patient report depressive symptom t accord choose cutoff point bdi ii .% patient minimal symptom mild mood disturbance moderate severe depressive symptom find   .%  patient respectively t. comparison bdi ii questionnaire t t show significant improvement total score p   select question interest p univariate analysis show kidney failure death roommate significantly associate severity mood disorder conclusion mood disturbance depressive symptom commonly occur covid- inpatient result covid- inpatient high risk develop depressive reactive disorder benefit early psychological evaluation strategy improve sleep quality
159,background coronavirus disease  covid- suspect mainly deleterious patient underlie cardiovascular disease cvd strong association hypertension covid- severity binding sars cov- angiotensin convert enzyme  ace lead deregulation renin angiotensin aldosterone system raas regulation ace subsequent increment harmful ang ii serum level reduction protective ang-(- angiotensin receptor blocker arb angiotensin convert enzyme inhibitor aceis commonly manage hypertension objective objective illustrate potential link hypertension covid- role angiotensin receptor blocker arb angiotensin convert enzyme inhibitor aceis hypertensive patient covid- method carry comprehensive database search late december  early january  online engine web science research gate scopus google scholar pubmed publish preprinte article result present study finding show hypertension regard independent risk factor covid- severity aceis arb beneficial manage hypertensive patient conclusion study conclude hypertension increase covid- severity underlie endothelial dysfunction coagulopathy covid- augment hypertensive complication regulation ace use aceis arb beneficial management hypertensive patient covid-
160,background covid- pandemic remain emerge public health crisis adverse effect disease cause severe acute respiratory syndrome coronavirus- sars cov-- infection target angiotensin convert enzyme- ace receptor cell entry change renin angiotensin system ras balance alter individual susceptibility covid- infection aim evaluate association agt rs c t ace rs d agtr rs c variant risk covid- infection severity sample southeast iranian population method total  subject include  covid- positive  healthy control recruit genotype ace gene rs agt rs agtr rs polymorphism perform polymerase chain reaction pcr pcr restriction fragment length polymorphism pcr rflp respectively result result show ii genotype ace rs allele decrease risk covid- infection find tc genotype c allele agt rs increase risk covid- infection agtr rs associate covid- infection find association polymorphism severity disease find significantly high age prevalence diabetes hypertension patient severe disease non severe disease conclusion finding suggest ace rs agt rs polymorphisms increase risk covid- infection southeast iranian population
161,background inducible ischaemia strong marker vascular vulnerability know important role vascular tropism covid- explain severity presence prior inducible ischaemia key pathogenetic determinant covid- severity aims investigate prognostic value prior inducible ischaemia stress cardiovascular magnetic resonance cmr predict death patient hospitalize covid- method retrospectively analyse consecutive patient refer stress perfusion cmr //-// later hospitalize covid- primary outcome cause death include hospital post hospitalization death base electronic national death registry result patient refer stress cmr  hospitalize covid- mean age .% male complete follow median interquartile range  day  .% cause death .% occur hospital .% post hospitalization death age male sex hypertension diabetes know coronary artery disease cad presence prior inducible ischaemia number ischaemic segment presence late gadolinium enhancement leave ventricular ejection fraction significantly associate cause death multivariable stepwise cox regression analysis age hazard ratio hr confidence interval ci p=. hypertension hr ci p diabetes hr ci p=. know cad hr ci p=. prior inducible ischaemia hr ci p=. independent predictor cause death conclusion covid- patient prior inducible ischaemia stress cmr year precede covid- pandemic independently associate cause death
162,role vitamin d maintain healthy cardiovascular cv renal system receive increase attention low vitamin d level associate incidence hypertension cardiac remodeling chronic congestive heart failure low vitamin d level influence renal disease progression albuminuria deterioration recent research indicate vitamin d deficiency potential risk factor coronavirus disease- covid- infection poor outcome datum inconclusive supplementation vitamin d agent reduce cv disease risk covid- severity conversely patient kidney disease vitamin d supplementation associate improve kidney function albuminuria narrative review consider recent datum effect vitamin d cv renal system possible role covid- complication
163,purpose assess prognostic value body composition parameter measure ct predict risk hospitalization patient covid- infection method  patient sars cov- infection abdominopelvic ct include retrospective irb approve institution study patient stratify base disease severity outpatient hospital admission patient hospitalize inpatient reader blind clinical outcome segment axial ct image l vertebral body level visceral adipose tissue vat subcutaneous adipose tissue sat muscle adipose tissue mat muscle mass mm vat total adipose tissue ratio vat tat mat mm ratio muscle index mi l compute measure detailed clinical risk factor compare patient stratify severity logistic regression clinical clinical imaging model compare discriminate inpatient outpatient result  outpatient  inpatient male gender p age p hypertension p diabetes p history cardiac disease p vat tat p mat mm p bmi associate hospitalization clinical model age gender bmi auc addition vat tat clinical model improve auc optimal model include gender bmi race black mi vat tat interaction gender vat tat gender mat mm demonstrate high auc conclusion mat mm vat tat provide important prognostic information predict patient covid- likely require hospitalization
164,background well understand impact covid- pandemic hospital healthcare study activity emergency department ed acute medicine department major uk hospital method electronic patient record adult patient attend ed n acute medicine n pandemic prior year analyse compare study parameter include severity primary diagnosis co morbidity admission rate length stay bed occupancy mortality focus non covid- disease result wave pandemic daily ed attendance fall medical admission medical bed occupancy return normal year ed attendance medical admission fall age range great reduction see young adult ed attendance old adult medical admission compare non covid- pandemic admission covid- admission enrich minority ethnic group dementia obesity diabetes low rate malignancy compare pre pandemic period non covid- pandemic admission hypertension cerebrovascular disease liver disease obesity few low severity ed attendance pandemic few medical admission severity category few ed attendance common non respiratory illness include cardiac diagnosis change cardiac arrest covid- common diagnosis medical admission wave few diagnosis pneumonia myocardial infarction heart failure cellulitis chronic obstructive pulmonary disease urinary tract infection sepsis stroke level rebound year later trend high level stroke pandemic pandemic wave -day mortality increase ed attendance non covid- medical admission conclusion reduced ed attendance wave pandemic suggest opportunity reduce low severity presentation ed future raise possibility harm delay miss care reassuringly recent rise attendance admission indicate deterrent effect pandemic attendance diminish
165,background severe coronavirus disease  covid- characterize impaired type interferon activity state hyperinflammation lead acute respiratory distress syndrome complement system recently emerge key player trigger maintain inflammatory state role molecular cascade severe covid- poorly characterize objective aim assess contribution complement pathway protein transcriptomic level method end systematically assess rna level  complement gene circulate blood patient covid- healthy control include gene alternative pathway datum remain scarce result find differential expression gene involve complement system expression pattern patient display moderate disease elevate expression classical pathway gene severe disease associate increase lectin alternative pathway activation correlate inflammation coagulopathy marker additionally properdin pivotal positive regulator alternative pathway show high rna expression find low protein concentration patient severe critical disease suggest deposition site complement activation notably low properdin level significantly associate use mechanical ventilation area curve p conclusion study shed light role alternative pathway severe covid- provide additional rationale testing drug inhibit alternative pathway complement system
166,background liver gastrointestinal involvement occur patient coronavirus disease  covid- variable prevalence study report mild liver function disturbance correlate covid- severity liver failure unusual aim study liver gastrointestinal dysfunction egyptian patient covid- relation disease outcome method multicentre cohort study conduct  egyptian patient april  july consecutive polymerase chain reaction confirm covid- case include quarantine hospital affiliate egyptian ministry health demographic information laboratory characteristic treatment fibrosis- fib- index covid- severity outcome record compare accord degree liver enzyme elevation presence gastrointestinal symptom follow up conduct discharge death regression analysis perform determine independent factor affect mortality result study include  patient  .% die hospitalization  discharge request patient mean age year .% severe critical covid- alanine aminotransferase alt aspartate aminotransferase ast available   patient respectively total patient elevate alt ast respectively significant liver injury alt ast elevation exceed -fold record  .%  patient respectively male gender smoking hypertension chronic hepatitis c lung involvement associate elevated ast alt ast elevate patient -years old fib- significantly high patient admit intensive care unit icu severe covid- non survivor independent variable affect outcome supplementary vitamin c intake g daily capsule odd ratio confidence interval ci lung consolidation ci icu admission ci fib- score ci  .% patient gastrointestinal symptom  .% diarrhoea patient gastrointestinal symptom predominantly female high body mass index  .% patient non severe covid- conclusion egyptian patient covid- develop significant liver injury independent variable affect mortality supplementary vitamin c intake lung consolidation icu admission fib- score
167,hypertension associate severe disease adverse outcome covid- patient recent investigation indicate hypertension independent predictor outcome covid- patient regardless cardiovascular noncardiovascular comorbiditie explore significance coronary calcification  hypertensive patient score covid registry italian multicenter study conduct pandemic wave western world march april total  patient admit rna pcr positive nasopharyngeal swab chest compute tomography ct hospital admission include study clinical outcome cardiovascular calcification analyze independently research core lab hypertensive patient different risk profile nonhypertensive patient cardiovascular comorbiditie deceased hypertensive patient great coronary calcification burden level anterior descend coronary artery hypertension status severity cutoff coronary calcification stratify clinical outcome increase coronary calcium volume hospital mortality hypertensive patient increase regardless sex age diabetes creatinine lung interstitial involvement coronary calcium score contribute stratify risk complication covid- patient cardiovascular calcification appear promising imaging marker provide pathophysiological insight cardiovascular risk factor covid- outcome
168,background coronavirus disease  covid- associate endothelial activation coagulopathy relate pre existing infection induce pro thrombotic autoantibody target angiotensin ii type receptor atr ab method compare prevalence level atr ab covid- case mild severe disease age sex match negative control utilize multivariate logistic quantile regression adjust comorbiditie include hypertension diabetes heart disease result trend increase prevalence vs. p level atr ab median vs. u ml p case versus control consider covid- disease severity trend increase prevalence atr ab vs. p significantly high atr ab level median vs. u ml p individual mild covid- versus match control contrast prevalence vs. p level median u ml p atr ab severe covid- differ match control conclusion finding support association covid- atr ab emphasize vascular pathology present individual mild covid- severe disease
169,objective aim test efficiency chads vasc chads vasc hs rchads vasc score system prediction mortality patient covid- patient method datum collect  hospitalize patient covid- comorbidity feature include coronary artery disease peripheral arterial disease congestive heart failure hypertension atrial fibrillation diabetes mellitus hyperlipidemia smoking chronic obstructive pulmonary disease cerebrovascular event cancer status renal disease record patient divide survive group n= non survivor n= result hospital mortality rate patient covid- factor find associate mortality univariate analysis chads vasc chads vasc hs rchads vasc cancer state atrial fibrillation hemoglobin lymphocyte count crp albumin ferritin model  multivariate cox regression analysis reveal chads vasc hemoglobin crp ferritin level independently associate mortality factor find independently associate hospital mortality model  analysis chads vasc hs rchads vasc hemoglobin crp ferritin hemoglobin model  analysis variable predictive power rchads vasc well chads vasc p=. chads vasc hs p=. determine hospital mortality patient high rchads vasc  point chads vasc hs  point chads vasc  point score exhibit high mortality rate survival analysis kaplan meier long rank test conclusion chads vasc chads vasc hs rchads vasc find independent predictor mortality hospitalize covid- patient current study reveal predictive ability rchads vasc well chads vasc chads vasc hs score
170,background outbreak severe acute respiratory syndrome novel coronavirus  sars cov- spread rapidly worldwide sars cov- find cause multiple organ damage little attention pay damage endocrine system cause virus subsequent impact prognosis research hypothalamic pituitary thyroid hpt axis prognosis coronavirus disease  covid- method retrospective observational study  patient admit hospital laboratory confirm sars cov- infection  january  march clinical characteristic laboratory finding treatment obtain electronic medical record standard data collection form compare patient different thyroid function status result  patient  .% subclinical hypothyroidism  .% severe non thyroidal illness syndrome ntis  .% mild moderate ntis composite endpoint event group include mortality admission icu imv observe compare normal thyroid function hazard ratio hrs composite endpoint event mild moderate ntis severe ntis subclinical hypothyroidism confidence interval ci ci ci .- respectively multivariate adjust hrs acute cardiac injury patient ntf subclinical hypothyroidism severe ntis mild moderate ntis ci ci ci .- respectively conclusion study show suppression hpt axis common complication covid- patient indicator severity prognosis different type thyroid dysfunction covid- mild moderate ntis severe ntis high risk severe outcome compare subclinical hypothyroidism
171,background global pandemic covid- cause new coronavirus sars cov- cause million death date effective direct antiviral vaccine vaccine stage testing overall mortality rate vary country example minimum .% singapore maximum mexico mortality severity covid- high elderly comorbiditie present diabetes hypertension heart disease main text recent evidence show underlie liver disease risk factor sars cov- cause direct indirect damage liver tissue multisystem inflammation generate especially severe stage current pandemic liver dysfunction observe -% patient severe covid- addition drug administer infection additional factor liver damage mechanism cellular penetration virus occur viral entry receptor angiotensin  conversion enzyme ace- host abundantly present type ii pneumocyte heart cell liver cholangiocyte conclusion manuscript describe clinical management aim preserve liver reduce damage cause covid- anti covid- drug treatment
172, novel coronavirus know severe acute respiratory syndrome coronavirus  sars cov- coronavirus disease  covid- cause global pandemic virus primarily affect upper low respiratory tract raise risk variety non pulmonary consequence severe possibly fatal cardiovascular problem datum patient moderate severe form covid- preexisting cardiovascular comorbiditie diabetes mellitus obesity hypertension heart failure coronary artery disease sars cov cause hyper inflammation hypoxia apoptosis renin angiotensin system imbalance variety cell type primarily endothelial cell profound endothelial dysfunction associate covid- cause impaired organ perfusion generate acute myocardial injury renal failure procoagulant state result thromboembolic event discuss recent result involvement endothelial dysfunction pathogenesis covid- patient cardiometabolic disease review provide insight treatment reduce severity viral infection
173,introduction majority patient severe covid- suffer delirium main sign encephalopathy associate viral infection aim study identify early marker development condition material prospective cohort base study include patient community acquire pneumonia confirm pulmonary tissue infiltration base ct datum lesion consist lung main group include patient develop acute encephalopathy patient  woman average age year control group include patient discharge acute encephalopathy patient  woman average age year study collect clinical examination datum comprehensive laboratory datum neurophysiological datum pulse oximetry ct datum identify predictor acute encephalopathy study clinicaltrials.gov identifier nct result data analysis show significant relationship encephalopathy degree lung tissue damage arterial hypertension type  diabetes mellitus d dimer ldh lymphopenia conclusion development encephalopathy secondary severity patient condition severe course coronavirus infection lead hypoxic brain damage
174,background heart damage complication novel coronavirus infection search available predictor hospital death survival determine tactic manage patient covid- challenge present time aim determine role echocardiographic echocg parameter evaluation hospital prognosis patient novel coronavirus infection covid-.material method study include  patient admit covid- echocg perform patient role left ventricular lv ejection fraction ef analyze age group echocg datum compare clinical picture include severity respiratory failure rf blood oxygen saturation ssmall er cyrilliccapital o cyrillic datum compute tomography ct lung blood concentration troponin comorbidity analyze high significance individual pathology determine result lv ef determine bad prognosis patient covid- p&lt include age group old  year small er cyrillic=. lv ef correlate degree lung tissue damage determine ct admission small er cyrillic=. time small er cyrillic=. index determine adverse hospital prognosis considerable degree pericardial effusion p&lt pulmonary hypertension p&lt rv end diastolic dimension lv end diastolic volume determine hospital mortality survival blood serum concentration troponin higher microg l important predictor hospital death high degree significance small er cyrillic&lt th degree rf considerably influence hospital mortality small er cyrillic&lt rf severity associate lv ef small er cyrillic=. spo value determine adverse immediate prognosis high degree significance small er cyrillic=. parameter weakly correlate lv ef r=. p=. patient require artificial ventilation av constitute group bad survival rate small er cyrillic&lt lv ef associate need av high degree significance small er cyrillic=. comorbiditie chronic kidney disease postinfarction cardiosclerosis oncologic disease great extent determine risk fatal outcome conclusion echocg recommend patient covid- hospital stage determine tactic management hospital prognosis
175,study aim evaluate effect non alcoholic fatty liver disease nafld susceptibility consequence coronavirus disease  covid- retrospectively collect datum  adult covid- patient show evidence excessive alcohol consumption undergo abdominal ultrasound examination patient .% patient diagnose nafld indicate high prevalence nafld report general population significantly elevate white blood cell count p alanine aminotransferase p aspartate aminotransferase p c reactive protein p find patient nafld patient significantly high proportion hypertension p diabetes p non nafld case significant difference exist severity mortality viral shed time length hospital stay patient nafld sample population subgroup analysis find patient normal body mass index bmi nafld sufferer likely experience severe event .% vs .% p kaplan meier curve log rank p cox regression hr ci p analysis confirm adjust gender age comorbiditie nafld patient normal bmi high incidence suffer severe event people nafld high proportion covid- nafld correlate severity covid- patient normal bmi group
176,background acute kidney injury aki repeatedly observe ventilate critically ill patient coronavirus disease- covid- pneumonia study aim determine incidence risk factor consequence aki ventilate critically ill adult patient covid- pneumonia method retrospective study include ventilate critically ill adult patient covid- pneumonia march june datum collect electronic medical system aki diagnose kidney disease improve global outcomes  clinical practice definition patient follow  day intensive care unit icu admission time date discharge hospital result aki occur .% patient .% start continuous renal replacement therapy crrt patient aki high comorbidity illness severity score p age vasopressor requirement predictor aki p= p hypertension predict aki p progression p renal recovery rate associate mean arterial pressure icu admission crrt group p hypoxic index crrt group p aki associate high mortality p significantly long icu length stay p additionally aki patient discharge long term skilled nursing facility p conclusion covid associated aki common associate poor outcome specific mechanism main driving factor
177,coronavirus disease covid- patient cardiovascular metabolic disorder find high risk develop severe condition high mortality affect prognosis covid- effect hypertension angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb agent clinical characteristic inflammatory immune response covid- patient undefined study  covid- patient divide hypertension nonhypertension group hypertension group divide control poorly control subgroup base blood pressure level hypertensive patient divide acei arb non acei arb subgroup accord administration acei arb antihypertensive agent clinical characteristic inflammatory immune biomarker level different group covid- patient compare association combine effect hypertension acei arb antihypertensive agent severity covid- examine result show level aminotransferase ast hs ctni high hypertension group compare nonhypertension group long term use acei arb agent patient statistically significantly low ast low density lipoprotein cholesterol ldl c oxygen uptake low white cell count neutrophil count level cd cd crp pct statistical significance addition compare covid- patient hypertension hypertensive patient use acei arb high risk develop severity covid- poorly control patient ci control patient ci hypertension cause organ damage covid- patient long term use acei arb agent beneficial alleviate injury
178,background coronavirus disease  covid- disproportionately affect african americans aa hispanics hsp aim analyze significant effector outcome african american patient population special emphasis gastrointestinal gi symptom laboratory value comorbiditie method retrospectively evaluate medical record  covid- positive patient admit howard university hospital march assess symptom include gi manifestation comorbiditie mortality logistic regression analysis result  covid- positive patient  .% aa  .% hsp  white  aa  .% hsp  white mean age year sd mean age hsp low year vs whites vs  aas mortality rate high aas .% low hsp .% patient shortness breath sob ci elevated ast ci elevate procalcitonin ci ast ci ferritin ci lymphopenia ci high mortality rate cough fever common unrelated outcome hypertension diabetes mellitus common comorbiditie glucocorticoid treatment associate high mortality ci diarrhea prevalent gi symptom affect outcome conclusion african americans study high mortality consist old population comorbiditie age important factor sob determine mortality rate overall elevated liver enzyme ferritin procalcitonin c reactive protein associate poor prognosis gi symptom affect outcome glucocorticoids judiciously consider poor outcome associate attention pay monitor liver function covid- especially aa hsp patient high disease severity
179,background previous study show diabetes mellitus common comorbidity coronavirus disease  covid- effect diabetes anti diabetic medication mortality covid- describe aim investigate outcome different status comorbidity anti diabetic medication use admission diabetic covid- method multicenter retrospective study enrol  consecutive hospitalize patient january march hospital hubei province china primary endpoint hospital mortality epidemiological material demographic information clinical datum laboratory parameter radiographic characteristic treatment outcome extract electronic medical record standardized data collection form laboratory datum fast plasma glucose fpg obtain hospitalization fpg collect day morning major clinical symptom vital sign admission comorbiditie collect treatment datum include covid- diabetes mellitus duration onset symptom admission illness severity intensive care unit icu admission length hospital stay record datum check team sophisticated physician result patient diabetes  year old non diabetic patient vs p /=  hr p vs year hr p survival curve reveal compare diabetes group mortality increase diabetes comorbiditie group p significantly different non comorbidity group p conclusion patient diabetes bad outcome suffer covid- outcome associate diabetes comorbiditie furthermore acarbose reduce mortality diabetic
180,aim perform systematic review meta analysis determine overall effect preadmission prediagnosis use calcium channel blocker ccb clinical outcome hypertensive patient covid- systematic literature search language restriction conduct electronic database july  identify eligible study random effect model estimate pooled summary measure outcome interest preadmission prediagnosis use ccb relative nonuse ccb confidence interval cis meta analysis reveal significant reduction odd cause mortality preadmission prediagnosis use ccb relative nonuse ccb pool ci significant reduction odd severe illness preadmission prediagnosis use ccb relative nonuse ccb pool ci associate adequate evidence reject model hypothesis significant difference current sample size potential protective effect offer ccb hypertensive patient covid- merit large scale prospective investigation
181,obesity prevail worldwide increase effect example american adult consider obese obese individual prone variety complication metabolic disorder include diabetes mellitus hypertension cardiovascular disease chronic kidney disease recent meta analysis clinical study patient cohort ongoing coronavirus disease  covid- pandemic indicate presence obesity relevant disorder link severe prognosis covid- give significance obesity covid- progression provide review host metabolic immune response immunometabolic dysregulation exaggerate obesity viral infection develop severe course covid- sequela study individual  month have covid- high risk metabolic comorbiditie include obesity diabetes kidney disease collectively implicate inter systemic dimension understand association obesity covid- suggest interdisciplinary intervention relief obesity covid- complication phase acute infection
182,background acute kidney injury aki associate poor outcome covid patient difference hospital acquire ha aki community acquire aki aki establish method prospective observational cohort study include  patient hospitalize covid diagnosis level hospital mexico primary outcome cause mortality  day compare covid patient aki ha aki secondary outcome include need krt risk factor associate development aki ha aki result total  patient .% develop aki aki occur  patient .% ha aki occur  .% patient aki significant comorbiditie include diabetes .% vs .% hypertension .% vs .% ckd .% vs .% copd .% vs .% ha aki patient survival aki .% aki ha aki .% log rank test p  year ci p covid severity ci p need mechanical lung ventilation ci p ha aki stage  ci p significant increase mortality presence ckd ci p serum lymphocyte  mul ci p need mechanical lung ventilation ci p aki stage  ci p variable associate krt start conclusion find covid patient complicate aki comorbiditie bad biochemical parameter time hospitalization ha aki patient despite difference probability die similar
183,background acute kidney injury aki potentially fatal complication coronavirus disease- covid- bind severe acute respiratory syndrome coronavirus  sars cov- virus responsible covid- viral receptor angiotensin convert enzyme  ace result viral entry cause aki objectives perform systematic review meta analysis frequency aki renal replacement therapy rrt critically ill covid- patient compare frequency patient infect respiratory virus bind downregulate ace ace associate virus virus bind downregulate ace non ace associate virus design systematic review meta analysis setting observational study covid- respiratory viral infection report aki rrt include exclusion criterion non english article non article review article study include patient age study include few  patient study report aki rrt rate patient adult covid- severe acute respiratory syndrome sars middle east respiratory syndrome mers influenza patient measurement extract follow datum include study year study location age sex race diabetes mellitus hypertension chronic kidney disease shock vasopressor use mortality intensive care unit icu admission icu mortality aki rrt method systematically search pubmed embase article report aki rrt aki define author include study critical illness define icu admission perform random effect meta analysis calculate pooled estimate aki rrt rate virus group random intercept logistic regression model result  hospitalize critically ill covid- patient aki frequency significantly different covid- patient confidence interval ci -% critically ill patient infect ace associated ci -% p non ace associate virus ci -% p pooled rrt rate significantly different critically ill hospitalize patient covid- ci -% ace associate virus ci -% p rrt rate covid- ace associate virus significantly different p non ace associate virus ci -% adjust shock vasopressor use aki rrt rate significantly different group limitations limitation study include heterogeneity definition aki different virus study match severity infection propensity match study include study conduct retrospective fashion include non english publication conclusion finding suggest viral ace association significantly alter rate aki rrt critically ill patient admit icu rate rrt low patient covid- ace associate virus compare patient infect non ace bind virus partly low frequency shock use vasopressor virus group prospective study necessary demonstrate modulation ace axis renin angiotensin system inhibitor impact rate aki beneficial harmful covid- patient
184,background angiotensin convert enzyme  ace report portal severe acute respiratory syndrome coronavirus  sars cov- infection consequently scientific strategy combat coronavirus disease  covid- target arrest sars cov- invasion block ace block ace appear beneficial approach treat covid- clinical concern raise primarily intrinsic role ace neurological function selective report indicate angiotensin receptor blocker arb angiotensin convert enzyme inhibitor aceis upregulate ace level ace metabolize angiotensin ii peptide include apelin- neurotensin kinetensin dynorphin des arg bradykinin lys des arg)-bradykinin elicit neuroprotective effect arb acei upregulate ace hypothesize patient hypertension receive arb acei high expression ace great risk severe disease sars cov- infection recent clinical report indicate beneficial role arb acei reduce covid- severity warrant study effect ace blockade hypertensive patient medicate arb aceis consequential impact neuronal health association blockade neuroinflammation warrant research objective review collate mechanistic insight dichotomous role ace sarscov-  invasion neurometabolic function possible impact ace blockade neuroinflammation conclusion conclude ace blockade impose neuroinflammation
185,background assess prevalence severity mortality covid- people epilepsy pwe evaluate seizure control pwe covid- method retrospective observational multicenter study conduct  hospital medical record randomly select pwe follow neurology outpatient clinic proportion pwe positive test sars cov-  calculate risk factor associate covid- morbimortality evaluate result  pwe include mean age .year .% focal epilepsy drug refractory covid- prevalence pwe spanish population proportion admission hospital icu death pwe .% covid- case spanish population .% .% respectively severe form covid- occur .% dyslipidemia institutionalization long term care facility intellectual disability old age associate risk factor old age hypertension dyslipidemia cardiac disease institutionalization associate mortality covid- seizure control stable .% pwe acute covid- .% report increase seizure frequency post covid- follow .% report seizure control worsen conclusion covid- moderately prevalent pwe  patient require medical attention .% die covid- old age dyslipidemia institutionalization intellectual disability significant risk factor associate severe covid- seizure control remain stable covid- long term follow pwe contract infection
186,severe acute respiratory syndrome coronavirus  sars cov- causative agent coronavirus disease- covid- respiratory disease vary severity mild severe fatal risk factor severe disease identify notably age male sex pre existing condition diabetes obesity hypertension advancement clinical care achieve past year include use corticosteroid e.g. corticosteroid immune modulatory treatment standard care patient acute severe covid- understanding mechanism underlie increase disease severity age improve past month remain incomplete furthermore molecular impact corticosteroid treatment host response acute sars cov- infection investigate study cross sectional longitudinal analysis ab soluble immune mediator transcriptional response young  year diabetic male obesity hospitalize acute severe covid- conduct additionally transcriptional profile sample obtain corticosteroid standard care compare analysis indicate severe covid- characterize robust ab response heighten systemic inflammation increase expression gene relate inflammatory pro apoptotic process reduce expression important adaptive immunity regardless age contrast covid- patient receive steroid high level systemic immune mediator lack transcriptional indicator heightened inflammatory apoptotic response overall datum suggest inflammation cell death key driver severe covid- pathogenesis absence corticosteroid therapy
187,outcome sars cov- infection determine multiple factor include viral host genetic age comorbiditie study investigate association prognostic factor disease outcome patient infect sars cov- multiple s protein mutation covid- patient recruit study genome sequencing  genome sars cov- conduct illumina miseq sequencer patient mild symptom covid- follow moderate .% symptom .% severe critical mortality find .% covid- patient significant difference age hospitalize patient  year age non hospitalize patient p patient hospitalization strongly associate hypertension diabetes anticoagulant strongly significant  ci p ci p ci p respectively patient mortality significantly correlate patient age anticoagulant steroid diabetes ci p ci p ci p ci p respectively study find clade l gh .% gr .% o dg mutation find lf .% va .% sr .% significant association multiple s protein mutation patient hospitalization mortality multivariate analysis reveal hypertension anticoagulant significant factor influence hospitalization mortality patient covid- ci p ci p respectively multiple s protein mutation reach strong association patient hospitalization p conclude hypertension anticoagulant therapy significant impact covid- outcome study suggest multiple s protein mutation impact covid- outcome emphasize significance monitor sars cov- variant genomic surveillance particularly impact covid- outcome
188,manage coronavirus disease  covid- patient radiological imaging complement clinical evaluation laboratory parameter aim assess sensitivity chest radiography finding detect covid- describe finding assess association positive chest radiography finding clinical laboratory finding multicentre cross sectional study conduct involve primary health care corporation register patient patient enrol -month period peak  pandemic wave qatar patient reverse transcription polymerase chain reaction confirm covid- undergo chest radiography  hour swab test positive result reverse transcription polymerase chain reaction gold standard diagnose covid- sensitivity chest radiography calculate airspace opacity distribute peripheral low lung zone patient bilateral involvement pleural effusion detect case risk have positive chest x ray finding increase age southeast asian nationality fever history fever diarrhoea patient cardiac disease obesity hypertension diabetes chronic kidney disease high risk have positive chest x ray finding statistically significant increase mean serum albumin white blood cell count neutrophil count serum c reactive protein hepatic enzyme total bilirubin increase radiographic severity score
189,introduction rapid emergence spread sars cov- late  infect million people worldwide significant morbidity mortality response health authority limit spread virus population wide inoculation prefer currently large variation disparity acquisition development deployment vaccination program country availability vaccine achieve herd immunity guarantee reinfection sars cov- emerge evidence indicate vaccine eliminate infection protect severe disease potential hospitalisation additional strategy strengthen immune system strongly consider assist reduce overall health care burden stem rate infection substantial evidence sars cov- disease severity death link exist comorbiditie cardiovascular disease obesity metabolic disorder purpose review discuss potential medium long term strategy habitual exercise relationship target comorbiditie underlying inflammation protective mechanism sars cov- disease severity conclusion conclude engagement habitual physical activity exercise strategy mitigate development comorbiditie improve response immune system potentially reduce risk symptom life threaten complication infect
190,aim study effect regular drug therapy cardiovascular disease precede covid- infection severity outcome covid- base datum active analysis dynamic comorbiditie patient survive sars cov- infection registry material method active registry create initiative eurasian association therapists registry include  male female patient diagnose covid- treat hospital home protection patient privacy datum nasal throat smear antibody titer typical ct imaging feature register territory include  country russian federation republic armenia republic belarus republic kazakhstan kyrgyz republic republic moldova republic uzbekistan registry design closed multicenter registry nonoverlapping arm outpatient arm patient arm registry schedule  visit  person visit acute period  virtual visit telephone call  mos patient enrollment start june  complete october registry completion schedule october registry id clinicaltrials.gov nct fragment study registry datum work group analyze effect therapy comorbiditie baseline severity outcome novel coronavirus infection study population include patient take medicine regular basis comparison population consist noncompliant patient irregular drug intake take drug despite indication treatment).result analysis active registry database include  patient vast majority patient covid- comorbiditie prevalence cardiovascular disease medicine treatment covid- comorbiditie influence course infectious disease different way low risk fatal outcome associate statin treatment patient ischemic heart disease ihd angiotensin convert enzyme inhibitor acei)/angiotensin receptor antagonist beta blocker patient ihd arterial hypertension chronic heart failure chf atrial fibrillation oral anticoagulant oac primarily direct oac clopidogrel prasugrel ticagrelor patient ihd oral antihyperglycemic therapy patient type  diabetes mellitus dm long act insulin patient type  dm high risk fatal outcome associate spironolactone treatment patient chf inhaled corticosteroid ics patient chronic obstructive pulmonary disease copd).conclusion epoch covid- pandemic low risk severe course coronavirus infection observe patient chronic noninfectious comorbiditie highly compliant base treatment comorbidity
191,background april sars cov- b delta variant rampant worldwide recently variant spread guangzhou china objective characterize clinical feature risk factor severe case delta variant guangzhou method total  patient delta variant enrol datum severe non severe group compare logistic regression method cox multivariate regression analysis investigate risk factor severe case result severity delta variant -year increase age ci p l increase total bilirubin ci p risk factor severe case risk progression severe case increase .-fold age great year hr ci p total bilirubin level great mumol l hr ci p respectively conclusion old age elevated total bilirubin independent risk factor severe case delta variant guangzhou especially age great year total bilirubin level great mumol l.
192,background covid- pandemic rapidly emergence december belong coronavirus family virus strike time history datum base previous research etiology epidemiology virus family help play vital role formulate prevention precaution strategy initial stage pandemic datum relate covid- pakistan initially document large scale addition weak health care system low economic condition pakistan population general suffer comorbiditie severely affect outcome patient infect covid- objective covid- infection couple manifestation notable outcome document characterize clinically aim study examine clinical manifestation serve indicator early detection severity prognosis covid- infection especially high risk group method retrospective observational study involve abstraction demographic feature present symptom adverse clinical outcome  patient covid- conduct patient admit major hospital rawalpindi islamabad region pakistan study conduct february august multivariate regression analysis carry identify significant indicator covid- severity intensive care unit icu admission ventilator aid mortality study relate covid- infection comorbiditie examine related factor age gender result study identify fever .% cough .% shortness breath .% time hospital admission prevalent symptom patient covid- symptom common conclusive outcome infection  patient n= require icu admission n= require ventilator aid point disease progression stay hospital .% n= patient die analysis reveal relationship present symptom comorbiditie progression disease severity patient old adult patient comorbiditie hypertension diabetes chronic kidney disease asthma significantly affect high proportion result requirement icu admission ventilator aid case case mortality conclusion old adult patient comorbiditie hypertension diabetes asthma chronic obstructive pulmonary disorder chronic kidney disease increase risk develop severe covid- infection increased likelihood adverse clinical outcome
193,lipoprotein(a lp(a prothrombotic anti fibrinolytic lipoprotein role clearly define pathogenesis coronavirus disease  covid- prospective observational study serum lp(a outcome measure  covid- patient  match sick control lp(a assess correlation wide panel biomarker serum lp(a significantly differ covid- patient sick control concentration find significantly associate severity covid- illness include acute kidney failure stage r p admission disease severity r p peak severity r p lp(a positively correlate interleukin il)- r p fibrinogen r p creatinine r p negatively correlate adamts activity vwf ag r p il- r p result suggest adverse outcome patient covid- aggravate genetically determined hyper lp(a state inflammation induce elevation
194,covid- febrile infectious illness previously associate telogen effluvium te date study conduct determine incidence te covid- assess frequency te post covid- patient correlation development te severity covid- understand emotional stress medication responsible development te totally  patient history sars cov- infection  month include study diagnosis te history excessive hair shedding hair pull test diffuse bitemporal thinning absence anisotrichosis trichoscopy patient te cause covid- hair loss start covid- consider covid- associate te cate find te  .% case androgenetic alopecia aga  .% case cate present .% case develop average day covid- real time reverse transcription polymerase chain reaction rt pcr positivity proportion patient cate numerically high hospitalize patient compare outpatient .% vs. .% p significantly high woman compare man .% vs. .% p patient hypertension compare hypertension .% vs. .% p patient respiratory symptom compare .% vs. .% p patient cate similar term stress level usage covid- medication patient aga high rate hospitalization .% vs. .% p high incidence fever vs. .% p covid- compare te develop approximately quarter people covid- study detect time onset cate week sars cov- rt pcr positivity different post infectious te patient severe covid- prone develop te presence aga associate severe covid- pandemic clinician consider previous sars cov- infection patient present hair loss
195,purpose consider cross protection report bacillus calmette guerin bcg vaccination viral respiratory infection propose reduce severity coronavirus disease  covid- objective current study investigate association severity covid- prior bcg vaccination adult patient severe acute respiratory syndrome coronavirus  sars cov- infection material method adult patient year positive sars cov- polymerase chain reaction admit july  include cross sectional study patient classify non severe severe critical disease history prior bcg vaccination presence bcg vaccination scar record result  patient  patient prior history bcg vaccination compare  patient bcg vaccination childhood median age  year  year bcg vaccinate non bcg vaccinate patient p value=. male predominance group frequent comorbid illness hypertension diabetes mellitus severe covid- find  patient .% follow non severe disease critical disease i.e.  .%  patient respectively association prior bcg vaccination disease severity covid- find study mortality patient expire  .% prior history bcg vaccination p value=. secondary infection present  patient majority pneumonia conclusion bcg vaccine impact severity covid- protective role low mortality rate infect patient
196,background health condition patient neuromuscular disease nmd great risk develop complication covid- objective study analyze prevalence covid- nmd patient risk factor impact severity wave pandemic clinical datum collect nmd covid- patient march   anonymous survey carry expert physician french health care network filnemus result physician report  patient include  myasthenia gravis  myopathy  neuropathy covid- effect nmd  patient  patient develop low covid- severity covid- cause death  nmd patient diabetic patient great risk die patient diabetes hypertension severe form nmd high risk develop moderate severe form covid- cohort corticosteroid immunosuppressant significantly associate high covid- severity acquire nmd conclusion period small percentage french nmd patient affect covid- compare general french population covid- limited short term effect diabetes hypertension severe degree nmd identify risk factor unfavorable outcome follow covid- conversely cohort patient acquire nmd corticosteroid immunosuppressant appear risk factor severe covid-
197,background purpose coronavirus disease  covid- associate increase risk ischemic stroke present prevalence characteristic stroke patient laboratory confirm severe acute respiratory syndrome coronavirus- infection enrol american heart association covid- cardiovascular disease registry method quality improvement registry study examine demographic baseline clinical characteristic hospital outcome hospitalize covid- patient primary outcome ischemic stroke transient ischemic attack tia hospital death result  patient covid- admit  hospital january november  .% experience acute ischemic stroke tia .% acute stroke  .% type stroke nonischemic stroke  intracerebral hemorrhage  .% subarachnoid hemorrhage  .% epidural subdural hemorrhage  .% cerebral venous sinus thrombose  .% stroke classified asians non hispanic blacks overrepresente ischemic stroke tia patient compare overall representation registry adjust odd stroke vary race median time covid- symptom onset ischemic stroke day interquartile range median national institutes health stroke scale score  interquartile range covid- patient acute ischemic stroke tia high prevalence hypertension diabetes atrial fibrillation compare stroke intensive care unit admission mechanical ventilation associate high odd acute ischemic stroke tia old age predictor adjusted model acute ischemic stroke tia associate hospital mortality conclusion ischemic stroke risk vary race contrast association old age death covid- ischemic stroke risk high middle aged adult adjust comorbiditie illness severity suggest potential mechanism ischemic stroke covid- independent age relate atherosclerotic pathway
198,coronavirus sars cov- cause ongoing covid- pandemic sars cov- infection mild asymptomatic small fraction infected individual develop severe life threaten disease cause uncontrolled immune response result hyperinflammation factor predispose individual severe disease remain poorly understand level cd know mediate immune escape cancer virus infect cell elevate sars cov infect caco- cell calu- cell air liquid interface culture primary human bronchial epithelial cell sars cov- infection increase sirpalpha level bind partner cd primary human monocyte systematic literature search indicate know risk factor old age diabete associate increase cd level high cd level contribute vascular disease vasoconstriction hypertension condition predispose sars cov infect individual covid related complication pulmonary hypertension lung fibrosis myocardial injury stroke acute kidney injury age relate virus induce cd expression candidate mechanism potentially contribute severe covid- therapeutic target address antibody small molecule research need investigate potential involvement cd sirpalpha covid- pathology datum encourage research group consider potential relevance cd/ sirpalpha axis covid- research
199,despite demonstrate efficacy vaccine severe acute respiratory syndrome coronavirus- sars cov- causative agent coronavirus disease- covid- widespread hesitancy vaccination persist improve knowledge frequency severity duration vaccine associate symptom help reduce hesitancy prospective observational study study  healthcare worker receive dose pfizer biontech sars cov- mrna vaccine complete post vaccine symptom survey dose  dose define appreciable post vaccine symptom moderate severity last  day find symptom frequent follow second vaccine dose vs. p symptom resolve  day common symptom injection site pain follow fatigue malaise overall participant experience appreciable symptom dose  dose multivariable analysis female sex associate great odd appreciable symptom dose  ci dose  prior covid- associate appreciable symptom follow dose young age history hypertension associate appreciable symptom dose conclude post vaccine symptom reportedly mild day appreciable post vaccine symptom associate female sex prior covid- young age hypertension information aid clinician advise patient safety expect symptomatology associate vaccination
200,study aim summarize epidemiological clinical characteristic covid- western mexico people retrospective analysis electronic database people visit sentinel center molecular sars cov- confirmatory diagnosis rt pcr april december  carry epidemiological clinical description covid- patient evaluate  .% confirm sars cov- infection mean age female comorbiditie diabetes .% obesity hypertension .% present increase odd ci ci ci respectively viral infection fever headache dry cough frequent symptom infection difference sex find patient year old prone covid- severity ci evaluate number manifest symptom increase age conclusion high sars cov- prevalence find western mexico comorbiditie frequent infected people association disease outcome observe contrast high disease severity risk find old patient continuous monitoring carry comorbiditie report aggravating factor study help health official elaboration planning effort disease management future
201,coronavirus disease  covid- severe acute respiratory syndrome coronavirus  sars cov- cause infectious disease manifest wide range symptom asymptomatic severe illness death severity infection relate risk factor include aging array underlie condition diabetes hypertension chronic obstructive pulmonary disease copd cancer remains poorly understand condition influence severity covid- expansion cd(null senescent t cell population common phenomenon aging chronic inflammatory condition associate high morbidity mortality rate covid- summarize potential mechanism cd(null cell drive adverse outcome disease predispose patient devastating covid- discuss possible treatment individual high count cd(null senescent t cell
202,purpose multiple study worldwide report clinical epidemiological feature coronavirus disease  covid- limited report middle east study describe clinical epidemiological feature covid- case eastern province saudi arabia identify factor associate severity illness patient method observational study  covid- case case report month case country identify clinical demographic datum analyze describe identify effect age sex ethnicity illness severity addition duration viral shedding cycle threshold ct value real time pcr evaluate predictor severity result median age  year male twice likely infect female p  year individual bengali ethnicity patient comorbiditie include diabetes hypertension dyslipidemia p case fatality rate find fatality significantly high male female .% vs .% asians .% arabs africans p association find viral load represent rt pcr cycle threshold ct value severity illness conclusion age sex ethnicity important predictor covid- severity cycle threshold ct sars cov- rt pcr test predictor criticality illness
203,angiotensin convert enzyme  ace essential sars cov- cellular entry study effect common comorbiditie severe covid- ace expression ace level enzyme activity elisa measurement determine human serum heart lung sample patient hypertension n heart transplantation thoracic surgery n healthy individual n represent control serum ace activity increase hypertensive subject substantially elevate end stage heart failure patient show strong negative correlation left ventricular ejection fraction serum ace activity high male overweight obese elderly hypertensive patient primary lung cancer result high circulate ace activity affect ace level surround lung tissue male sex result elevated serum ace activity patient heart transplantation thoracic surgery respectively leave ventricular tissular ace activity unaffected sex low overweight obese old patient end stage heart failure correlation serum tissular leave ventricular lung ace activity serum tissue leave ventricle lung ace level affect ras inhibitory medication abandon acei treatment non compliance result elevated blood pressure effect circulate ace activity ace level associate severity cardiovascular disease suggestive role ace pathomechanism cardiovascular disease provide potential explanation high mortality covid- cardiovascular patient abandon ras inhibitory medication worsen cardiovascular status affect circulate tissue ace level
204,aim patient cardiovascular comorbiditie significantly increase risk critical course covid- sars cov virus enter cell angiotensin convert enzyme receptor ii ace drug interact renin angiotensin aldosterone system raas suspect influence disease severity method result analyze  consecutive patient cardiovascular comorbiditie hypertension enrol large european covid- registry lean european open survey sars cov- leoss registry angiotensin ii receptor blocker intake associate decrease mortality patient covid- ci p effect mainly drive patient present early phase covid- baseline ci p kaplan meier analysis reveal significantly low incidence death patient angiotensin receptor blocker arb n compare patient angiotensin convert enzyme inhibitor acei n patient receive ace inhibitor arb baseline uncomplicated phase n p patient take arb significantly frequently reach mortality predict threshold leukocyte p neutrophil p inflammatory marker crp p procalcitonin p il- p ace expression level human lung sample alter patient take raas modulator conclusion datum suggest beneficial effect arb disease severity patient cardiovascular comorbiditie covid- link dampen systemic inflammatory activity
205,background aim meta analysis aim highlight impact cardio metabolic comorbiditie covid- severity mortality method thorough search major online database study describe clinical outcome covid- patient random effect model compute pool estimate critical fatal disease result total patient  eligible study include maximum risk development critical fatal covid- disease see patient underlie cardiovascular disease ci follow chronic lung disease hypertension diabetes mellitus total case comorbiditie prevalent hypertension pooled prevalence conclusion presence comorbiditie like cardiovascular disease chronic lung disease hypertension diabetes mellitus lead high risk development critical fatal covid- disease maximum risk see underlie cardiovascular disease
206,background host inflammation contribute determine sars cov- infection cause mild life threaten disease tool need early risk assessment method study  covid- patient prospectively follow single reference hospital potential biomarker include alarmin cytokine adipocytokine growth factor humoral innate immune neuroendocrine molecule regulator iron metabolism biomarker hospital admission age degree hypoxia neutrophil lymphocyte ratio nlr lactate dehydrogenase ldh c reactive protein crp creatinine analyse data drive approach classify patient respect survival icu outcome classification regression tree cart model identify prognostic biomarker result potential biomarker classification tree analysis select cxcl hospital admission combination nlr time onset good predictor icu transfer auc ci select predict death auc ci cxcl concentration abate covid- survivor healing discharge hospital conclusion cxcl result data drive analysis account presence confound factor robust predictive biomarker patient outcome covid-
207,coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- initially discover december  china rapidly spread world pandemic common symptom disease fever cough generalized body ache weakness dyspnoea nausea vomiting diarrhea vascular complication covid- venous thrombotic complication like pulmonary embolism low limb deep vein thrombosis uncommon datum arterial thrombotic complication covid- especially carotid thrombosis limited describe case stroke thrombosis right carotid artery patient recover asymptomatic covid- -year old male arterial hypertension present emergency department history repeat collapse dysarthria weakness left extremity drop left angle mouth national institutes health stroke scale nihss]- patient swab covid- negative compute tomography angiography cta obtain show thrombosis branching point brachiocephalic trunk bct continue right subclavian artery sa right common carotid artery cca subtotal occlusion right cca extend internal carotid artery ica apical lung tissue catch ct scan bilateral irregular widespread ground glass opacification consolidation small reticular change see lung typical covid- infection quantitative antibody test covid- infection perform result show strong positivity igg antibody indicate previous covid- infection patient indicate standard carotid thrombectomy perform complication important factor lead formation thrombus carotid artery covid- infection induce inflammation atherosclerotic carotid vessel generalized hypercoagulability hyperviscosity covid- infection independent important risk factor formation arterial thrombus acute illness early post covid- period regardless severity course prophylactic anticoagulation need time acute illness early post covid- time
208,background age implicate main risk factor covid related mortality objective utilize administrative datum build explanatory model accounting geriatric focus indicator predict mortality hospitalize old adult covid- method retrospective cohort study adult age  old n hospitalize covid- great new york metropolitan area datum include patient demographic clinical presentation stepwise logistic regression akaike information criterion minimization result average age sd .% male .% african american .% hispanic multivariable analysis male sex adjust odd ration adjor ci:.- asian race adjor ci:.- history chronic kidney disease adjor ci:.- interstitial lung disease adjor ci:.- low normal body mass index adjor ci:.- high comorbidity index adjor ci:.- admission facility adjor ci:.- mechanical ventilation adjor ci:.- associate mortality age independent predictor mortality increase age center interact hypertension adjor ci:.- reduce factor  year early resuscitate dnr life sustain treatment preference adjor ci:.- reduce factor  year severe illness admission adjor ci:.- reduce factor  year conclusion finding highlight residence prior admission early dnr acute illness severity important predictor mortality hospitalize old adult covid- readily available administrative geriatric focus indicator age utilize consider prognosis
209,microbiota interest development therapeutic strategy sars cov- coronavirus disease  covid- impact host immune system prove communication gut microbiota pulmonary microbiota gut lung axis pathway neural connection gut brain gut brain axis important face pandemic sars cov- show affect organ presence host receptor know angiotensin convert enzyme  ace ace receptor mainly present brush border intestinal enterocyte ciliary cell type ii alveolar epithelial cell lung transport function ace link ecology gut microbe digestive tract suggest covid- relate gut microbiota severity covid- associate number comorbiditie hypertension diabetes obesity and/or old age attention pay multiple morbidity modulation microbiota comorbiditie medication paper review research context state intestinal microbiota impact cell immune system sars cov- pandemic
210,severe acute respiratory syndrome coronavirus- sars cov- responsible coronavirus disease  covid- pandemic affect continue affect million people world patient essential arterial hypertension renal complication particular risk fatal course infection study model select process patient essential hypertension chronic kidney disease ckd suffer covid- emphasize function renin angiotensin aldosterone raa system model build language petri net theory system approach analyze covid- affect study organism check administration select anti hypertensive drug angiotensin convert enzyme inhibitor aceis and/or angiotensin receptor blocker arb impact severity infection assess drug effectively lower blood pressure case sars cov- infection affect essential hypertensive patient research show aceis arb worsen course infection assess treatment hypertension active sars cov- infection observe arb effectively reduce blood pressure slightly opposite effect hand confirm effectiveness arterial hypertension treatment patient receive acei find simultaneous use arb acei average effect take drug lead slight decrease blood pressure way suggest arb hypertensive patient covid- ineffective show research area continue
211,datum repercussion pulmonary function patient severe critical covid- pneumonia objective describe patient pulmonary function establish association severity disease patient severe critical pneumonia presence comorbiditie tomographic involvement persistence dyspnoea patient include  male medium age year old body mass index bmi kg/ m.  comorbidity obesity arterial hypertension diabetes mellitus twentyfive critical pneumonia spirometric alteration suggest restriction  gas exchange defect force volume capacity fvc force expiratory volume second fev carbon monoxide diffusion capacity dlco value significantly low ninety percent present degree involvement chest ct scan ground glass opacity frequent finding moderate negative correlation find severity tomographic involvement dlco level thirty patient refer degree dyspnoea patient symptom dlco kco value dyspnoea vs. p  vs.  p presence abnormal gas exchange main characteristic patient pulmonary sequela covid- study predictor evolution pulmonary sequela association severity disease
212,introduction main purpose study describe chest compute tomography ct finding  patient hospitalize covid- pneumonia wave sars cov- pandemic university clinics kinshasa uck method conduct descriptive study chest ct finding  patient hospitalize coronavirus pneumonia uck -month period march  november hitachi ct scanner  slice patient analyze lesion divide lesion suggestive non suggestive sars cov- infection result average age patient year male sex affected respiratory distress common clinical symptom arterial hypertension renal failure common comorbiditie o% bilateral ground glass opacity predominantly peripheral distribution account .% case follow condensation .% crazy paving severe covid- frequently find distal proximal pulmonary embolism common complication associated disease pleurisy pulmonary pah frequently find majority patient parenchymal lung lesion correspond early stage disease ct conclusion uck wave sars cov- pandemic lesion ct suggestive covid- dominate plaque like ground glass opacity follow nonsystematize parenchymatous condensation crazy paving observed atypical lesion consist unilateral peribronchovascular pseudo nodular condensation infection remodel lung severe covid- common ct finding proximal distal pulmonary embolism common complication study highlight finding consistent report literature
213,background clinical feature outcome sars cov- infection diverge different country aim study describe clinical characteristic outcome cohort patient hospitalize sars cov- argentina method multicenter prospective cohort study /= year old patient confirm sars cov- infection consecutively admit  hospital argentina multivariable logistic regression model identify variable associate -day mortality admission intensive care unit icu result total  patient analyze median age  year male comorbidity common comorbiditie hypertension obesity diabetes disease severity admission classify mild moderate severe critical half patient require supplemental oxygen icu invasive ventilation overall -day mortality factor independently associate icu admission male gender ci hypertension ci obesity ci oxygen saturation year old ci oxygen saturation ci lymphopenia ci conclusion cohort validate crucial clinical datum patient hospitalize sars cov- argentina
214,background angiotensin convert enzyme inhibitor acei angiotensin ii receptor blocker arb widely treatment hypertension ht use drug increase infectivity novel coronavirus result additional risk morbidity mortality covid- matter interest objectives assess effect acei arb compare hypertensive clinical course outcome covid- pneumonia design retrospective setting tertiary care hospital patient method collect datum adult inpatient covid- pneumonia acei arb versus antihypertensive  march  february main outcome measures severity clinical course mortality time pcr negativity patient acei arb antihypertensive sample size  results acei arb  patient .% median age  year  patient .% antihypertensive median age  year p=. vs age acei arb user statistically significant difference acei arb user non user number patient admit intensive care case vs.  case p=. median duration stay hospital day vs. day p=. median duration icu stay day vs.  day mortality rate case vs.  p=. median day transfer icu short ace arbi non user day vs.  day p=. difference important clinically median time pcr negativity similar acei arb user non user day user  day non user p=. conclusion acei arb use probably unrelated poor prognosis covid- pneumonia inpatient acei arb prolong time pcr negativity conclude acei arb probably increase infectivity sars cov- limitation pharmacological therapy discuss detail use corticosteroid affect time pcr negativity analyze effect obesity lack datum conflict interest
215,background seasonality respiratory syncytial virus rsv epidemic disrupt covid- pandemic possibly lockdown social restriction reduce viral transmission give uncertainty severity upcoming rsv bronchiolitis epidemic debate exist palivizumab rsv prophylaxis administer infant congenital diaphragmatic hernia cdh vulnerable lung hypoplasia pulmonary hypertension aim evaluate cdh infant high risk admission rsv bronchiolitis infant general population palivizumab prophylaxis reduce risk method include eligible study examine risk(s rsv positive bronchiolitis require hospital admission cdh infant palivizumab prophylaxis versus infant general population cdh infant prophylaxis versus cdh infant prophylaxis primary outcome evaluate risk admission rsv bronchiolitis datum report descriptively meta analyse appropriate result eligible retrospective cohort study identify study find cdh independent risk factor rsv hospitalisation odd ratio confidence interval ci .- study compare rsv hospitalisation rate cdh patient palivizumab versus pooled risk ratio ci p overall quality evidence consider poor study industry fund conclusion cdh infant particular risk severe bronchiolitis remain unclear evidence current systematic review cdh infant routinely receive palivizumab vaccination prophylaxis
216,background novel coronavirus disease  covid- infect .% world population previous study examine risk factor mortality severity base hospitalize individual population base cohort study call provide evidence extrapolate general population aim examine association comorbiditie mortality disease severity individual covid- diagnose  ontario canada method finding conduct retrospective cohort study individual covid- ontario canada diagnose january  december case link health administrative database maintain ice cover resident ontario primary outcome cause -day mortality covid- diagnosis secondary outcome composite severity index contain death hospitalization examine risk factor outcome employ cox proportional hazard regression model logistic regression model adjust demographic socio economic variable comorbiditie result stratify age group total individual diagnose covid-  include study half .% n comorbidity median follow period  day common comorbiditie hypertension n asthma n diabetes .% n individual comorbidity high risk mortality compare hr ci p risk substantially elevate ci .- ci time number comorbiditie increase significant predictor mortality include comorbiditie solid organ transplant hr ci p dementia hr ci p chronic kidney disease hr ci p severe mental illness hr ci% p cardiovascular disease cvd hr ci .- diabetes hr p chronic obstructive pulmonary disease copd hr ci p cancer hr ci p hypertension hr ci p compare effect old age group comorbiditie associate high risk mortality severity individual  year old individual comorbiditie  year age group ci .- p time high risk mortality compare limitation include datum collect  new variant concern predominant ices database contain detailed individual level socioeconomic racial variable conclusion find solid organ transplant dementia chronic kidney disease severe mental illness cvd hypertension copd cancer diabetes rheumatoid arthritis hiv asthma associate mortality severity study highlight number comorbiditie strong risk factor death severe outcome young individual covid- finding suggest addition prioritize age vaccination priority group include young population multiple comorbiditie
217,kidney function affect covid- kidney modulate immune response hypothesize covid- urine biomarker level assess immune activation vs. clinical trajectory consider kidney critical role modulate immune response seek analyze activation marker patient pre existing dysfunction cross sectional study  patient blood urine collect  h hospital admission h follow  h h seven day h  day h admission serum level ferritin procalcitonin il- assess immune activation overall response viral burden gauge serum level spike protein alphaspike igm igg.  marker correlate highly urine blood age race less extend gender differentiate urine marker burden pre existing condition correlate urine dcn caix ptn inversely il- mcp- high urinary il- low caix ccl il- il- mcp- mcp- muc- pd l tnfrsa tnfrs signify non survivor apache correlate urine tnfrs pgf caix dcn cxcl egf admission urine lag- il- predict death pre exist kidney disease unique pattern urinary inflammatory marker acute kidney injury associate certain degree predict ifng tweak mmp muc- remdesavir profound effect urine biomarker steroid urinary biomarker correlate clinical status kidney function marker immune system activation probability demise covid-
218,background detection severe acute respiratory syndrome coronavirus  sars cov- nucleocapsid antigen blood describe diagnostic prognostic role antigenemia understand study aim determine frequency duration concentration nucleocapsid antigen plasma association coronavirus disease  covid- severity method utilize ultrasensitive electrochemiluminescence immunoassay target sars cov- nucleocapsid antigen evaluate  plasma sample  individual covid- compare plasma antigen respiratory nucleic acid amplification testing naat  individual covid- sample collect day diagnostic respiratory naat  sars cov negative individual kruskal wallis test multivariable logistic regression mix effect model evaluate plasma antigen concentration associate disease severity result plasma antigen ci clinical sensitivity clinical specificity antigen negative plasma sample belong patient later respiratory cycle threshold ct compare antigen positive plasma sample median plasma antigen concentration log fg ml interquartile range outpatient inpatient intensive care unit icu patient model adjust age sex diabetes hypertension plasma antigen concentration diagnosis associate icu admission odd ratio ci p=. non icu hospitalization rate antigen decrease associate disease severity conclusion sars cov- plasma nucleocapsid antigen exhibit comparable diagnostic performance upper respiratory naat especially late respiratory ct addition currently available tool antigenemia facilitate patient triage optimize intensive care utilization
219,objective aim estimate prevalence report symptom comorbiditie investigate factor associate age sars cov- infected patient method perform systematic review meta analysis prospero registration crd database pubmed scopus embase semantic scholar covid- primer search clinical study publish january april initially pooled prevalence symptom comorbidity covid- patient estimate random effect model age -relate factor identify perform multivariate analysis factor analysis result article covid- patient include study altogether find  symptom  comorbiditie frequent  symptom  comorbiditie include meta analysis fever cough dry cough fatigue weakness find prevalent acute respiratory distress syndrome hypertension diabete prevalent comorbid condition factor analysis show positive association cluster symptom comorbiditie patient age symptom comprise fever dyspnea shortness breath nausea vomiting abdominal pain dizziness anorexia pharyngalgia comorbiditie include diabetes hypertension coronary heart disease copd lung disease ards factor positively associate covid- patient age conclusion unique effort study find group symptom fever dyspnea shortness breath nausea vomiting abdominal pain dizziness anorexia pharyngalgia comorbiditie diabetes hypertension coronary heart disease copd lung disease ards associate age covid- infect patient
220,severe acute respiratory syndrome coronavirus- causative virus coronavirus disease- covid- penetrate host tissue binding spike protein angiotensin convert enzyme- ace- receptor activation host protease enzyme prominent effect observe virus bind ace- receptor alveolar epithelium endothelium testosterone exhibit immunosuppressive effect androgen play modulatory role protease enzyme know comorbiditie include obesity pregnancy diabetes mellitus type  type hypertension cancer chronic kidney liver lung disease cerebrovascular disease heart condition human immunodeficiency virus infection immunologic disease immune suppression affect severity covid- infection polycystic ovary syndrome pcos affect reproductive age woman hirsutism observe -% patient increase testosterone level detect woman pcos syndrome associate hyperandrogenism insulin resistance increase renin angiotensin system activity diabetes metabolic syndrome remarkable number case pcos manifest chronic pro inflammatory state hyperandrogenism hyperinsulinemia cause adipocyte hypertrophy dysfunction result increase secretion pro inflammatory adipokine culminate creation chronic inflammatory state light metabolic hormonal change observe woman pcos susceptible severe covid- infection health care giver provide special care detailed counseling service
221,background inadvertent delay access appropriate therapeutic intervention high risk group coronavirus disease  covid- patient contribute mortality patient severe critical disease presentation objective aim study determine effect timely admission hospital mortality patient severe critical covid- secondary aspect study observe efficacy time dependent use corticosteroid mortality critical severe covid- patient method clinical datum  patient severe critical covid- admit major tertiary care hospital islamabad rawalpindi region pakistan retrospectively collect period february august multivariate logistic regression analysis carry determine predictor mortality severe critical covid- patient result total  patient  .% patient die age  year presence hypertension heart disease kidney disease late admission day significant predictor mortality patient severe critical covid- conclusion study highlight importance time provision appropriate medical intervention control covid associate mortality
222,purpose review general population risk severe covid- associate old age male sex hypertension obesity chronic disease chronic lung disease list additional risk factor hospitalization icu admission purpose review define chronic lung disease bronchiectasis interstitial disease represent risk severe sars cov- infection patient affect common variable immunodeficiency cvid common symptomatic primary antibody defect recent finding cvid patient sars cov- infection report beginning pandemic wide range clinical presentation range asymptomatic mild moderate severe covid- meta analysis  cvid case describe large cohort case report demonstrate cvid patient chronic lung involvement increase risk severe covid- comparison cvid lung disease vs. relative risk confidence interval .-- p differently general population age metabolic comorbiditie represent risk factor severe course patient population summary underlie chronic lung disease age represent risk factor severe covid- cvid prompt therapeutic intervention adopt sars cov- positive cvid patient chronic lung disease independently age
223,background objective study assess complex relationship multiple determinant caregiving process caregiver burden depression covid- pandemic serbia method cross sectional study conduct nationally representative sample n covid- pandemic serbia march september section questionnaire design study include characteristic caregiver characteristic care care recipient covid- relate question follow standardized instrument short form health survey fatigue severity scale activities daily living scale instrumental activities daily living scale zarit caregiver burden scale beck depression inventory path analysis simultaneous assessment direct indirect relationship determinant result third .% informal caregiver experience burden quarter .% depression symptomatology self rate physical health need psychosocial support caregiver burden main direct predictor depression multiple determinant caregiving process indirect effect depressive symptomatology caregiver burden mediate factor conclusion subjective burden present significant risk factor depressive symptom caregiver covid- pandemic provision psychosocial support identify important opportunity reduce depressive risk informal caregiver
224,objective compare demographic clinical characteristic severity patient infect different sars cov- variant phase covid- epidemic marseille method single centre retrospective cohort study conduct  patient infect sars cov- nextstrain clade b c phase february pangolin lineage b name marseille- b marseille- variant second phase june december b alpha b beta p. gamma a. marseille- variant phase january -today outcome occurrence clinical failure include hospitalisation transfer intensive care unit death result phase major difference observe regard age gender distribution prevalence chronic disease clinical symptom variant circulate give phase b b variant associate severe outcome infection occur second phase associate high rate death compare infection phase patient second phase likely hospitalise phase patient infect phase frequently obese conclusion large cohort study recommend evaluate transmissibility well characterise clinical severity emerge variant
225,background acute respiratory viral infection result cardiovascular involvement patient have significantly high mortality rate cardiovascular involvement ongoing coronavirus disease  covid- pandemic important determine cardiovascular risk factor associate severity covid- method nationwide datum provide korea disease control prevention agency define patient have critical illness require invasive mechanical ventilation fatal illness die result total patient .% male critical illness rate male female .% fatality rate multivariable analysis show age /= year male sex diabetes mellitus hypertension heart failure chronic kidney disease cancer dementia independent risk factor critical illness risk scoring model show significance multiple risk factor patient risk factor old age /= year male sex hypertension diabetes mellitus  time high risk severe covid- risk factor confidence interval .- critical .- fatal illness conclusion study demonstrate cardiovascular risk factor significant risk factor severe covid- particular patient multiple cardiovascular risk factor likely progress severe covid- early appropriate treatment patient crucial
226,background objective coronavirus disease  covid- public health emergency international concern characteristic hospitalise case include variation symptom radiological laboratory finding describe exact clinical spectrum hospitalise patient covid- oman currently unclear objective paper describe sociodemographic clinical laboratory radiological characteristic treatment clinical outcome confirm case covid- nahdha hospital oman additionally factor associate severity disease identify methodology cross sectional descriptive study hospitalise covid- patient required datum retrieve electronic health information system period rd march th information record bespoke sheet export spss statistics ibm armonk ny analysis result total  admission include study mean age cohort year majority male .% half expatriate diabetes hypertension find .% .% study population respectively common symptom encounter dry cough .% fever .% shortness breath sob radiologically bilateral infiltration present .% patient  case require critical care .% old year male .% non national significant factor associate require critical care symptom sob .% vs .% p=. diabetes .% vs .% or=. p=. chronic artery disease .% vs .% or=. p=. diagnosis acute respiratory distress symptom .% vs .% p additionally mean ferritin level significantly high case require critical care vs p=. depend disease severity treatment include antibacterial antiviral heparin steroid utilisation steroid significantly high case require critical care .% vs .% p=. case require critical care n= die death rate=.% conclusion study provide fundamental information clinical characteristic confirmed covid- case oman include factor associate disease severity result study utilise update covid- management guideline hospitalise patient
227,background fourth wave covid- osaka prefecture japan cause medical crisis aim identify risk factor covid- severity compare patient wave fourth wave method perform observational retrospective study covid- case national hospital organization kinki chuo chest medical center result identify  patient median age year interquartile range  .% mild disease  .% moderate disease  .% severe disease overall mortality rate base multivariate logistic regression analysis cardiovascular disease fever dyspnea inflammatory biomarker independent risk factor moderate severe disease  mg dl increase c reactive protein  iu l increase lactate dehydrogenase  ng ml increase ferritin risk moderate severe disease increase .% .% .% respectively overall disease severity fourth wave high wave significant difference mortality shortage bed  severe patient .% fourth wave transfer advanced hospital conclusion cardiovascular disease fever dyspnea inflammatory biomarker risk factor moderate severe covid- cohort fourth wave covid- severity worsen increase number patient transfer bed severe case result medical crisis osaka
228,coronavirus disease  covid- pandemic cause severe acute respiratory syndrome coronavirus  sars cov- unmask mankind vulnerability biological threat high age major risk factor disease severity covid- predispose risk factor mortality relate low cardiorespiratory metabolic fitness include obesity cardiovascular disease diabetes hypertension reach physical activity pa guideline goal contribute protect numerous immune inflammatory disorder addition multi morbidity mortality elevated level cardiorespiratory fitness non obese regular pa improve immunological function mitigate sustained low grade systemic inflammation age relate deterioration immune system immunosenescence regular pa non obese improve antibody response vaccination review highlight potential physiological cellular molecular mechanism affect regular pa increase host antiviral defense determine course outcome covid- immune system regular pa relation covid- discuss cardiovascular respiratory renal hormonal system skeletal muscle epigenetic mitochondrial function
229,coronavirus disease  commonly know covid- trend global infectious disease month ago affirm global health emergency pandemic emergency committee common symptom manifest pandemic disease high grade fever cough fatigue shortness breath flu like symptom evolve severe respiratory disorder pneumonia acute respiratory distress syndrome ards and/or end organ failure factor contribute severity high mortality rate covid- include old age comorbiditie like hypertension diabetes hyperlipidaemia neutrophilia organ coagulation dysfunction disseminate intravascular coagulation coagulopathie include venous thromboembolism know major contribute factor high mortality rate venous thromboembolism disease combination deep vein thrombosis pulmonary embolism prophylactic anticoagulation patient prone pre existing history venous thromboembolism associate decrease mortality severe covid- pneumonia review article focus covid- increase incidence venous thromboembolism patient infect covid- role high mortality rate covid- patient
230,aim meta analysis aim explore potential risk factor severe covid- method systemically comprehensively retrieve eligible study evaluate clinical difference severe vs non severe covid- main effect size demographic characteristic comorbiditie sign symptom laboratory finding radiological feature chest ct result total  covid- people severe group  non severe group  study eligible meta analysis demonstrate old age male likely severe covid- patient underlie comorbiditie hypertension diabetes heart disease copd significantly susceptible severe covid- patient dyspnoea likely severely ill depressed total lymphocyte observe article reticulation .% intrathoracic lymph node enlargement .% pleural effusion .% relatively infrequent meta analysis reveal patient presentation chest ct associate increase risk severe covid- conclusion significant difference clinical characteristic severe non severe covid- patient factor relate severity disease help clinician differentiate severe patient non severe patient
231,introduction give ongoing coronavirus disease  covid- pandemic consequent global healthcare crisis urgent need well understand risk factor symptom deterioration mortality patient covid- systematic review aim meet need determine predictive value chronic disease covid- severity mortality method search pubmed embase web science cumulative index nursing allied health complete identify study publish december december seventeen observational study  country involve patient include assess risk bias include study perform cumulative meta analysis result find covid- patient hypertension common condition associate high severity intensive care unit icu admission acute respiratory distress syndrome mortality chronic obstructive pulmonary disease strong predictor covid- severity admission icu mortality asthma associate reduce risk covid- mortality patient obesity high risk experience severe symptom covid- mortality patient cerebrovascular disease chronic liver disease chronic renal disease cancer likely severe covid- case great probability mortality conclusion covid- patient chronic disease likely experience severe symptom icu admission face high risk mortality aggressive strategy combat covid- pandemic target patient chronic disease priority
232,background importance clinicolaboratory characteristic covid- report finding alborz province accord late national guideline diagnosis treatment covid- outpatient inpatient trial version  march iran emphasize rrt pcr result clinical feature comorbiditie laboratory finding patient accord severity disease method study  patient include primarily  fulfil inclusion criterion cross sectional center study involve  symptomatic adult hospitalize diagnosis covid- march  april perform analyze frequency rrt pcr result distribution comorbiditie initial clinicolaboratory datum severe non severe case compare compatibility method categorize severity disease result accord finding  patient rrt pcr positive .%  rrt pcr negative indicate significant difference severity group relate date symptom onset admission base national guideline vital sign symptom mean oxygen saturation frequency nausea show significant difference group p significant difference observe comorbiditie curb- group vital sign comorbiditie mean oxygen saturation diabetes hypertension htn hyperlipidemia chronic heart disease chd asthma show significant difference group p significant difference see symptom conclusion study rrt pcr result hospitalize patient covid- relate severity category initial clinical characteristic decrease oxygen saturation appear common abnormality severe non severe category national guideline index comprehensive categorize patient severity group curb- compatibility non severe group national guideline curb- category
233,objective widespread use angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb patient chronic condition raise early concern potential exacerbation covid- severity fatality previous study address question standard method lead biased estimate analyse hospital datum presence compete event event relate dependency investigate association aceis arb use covid- disease outcome time event datum multistate setting account compete event minimise bias setting nationwide surveillance datum  belgian hospital participant medical record  patient hospitalise  march  june  confirm sars cov- infection information aceis arb use primary outcome measure multistate multivariate cox markov model estimate hazard patient transition health state admission discharge death transition probability calculate combine baseline cumulative hazard regression coefficient result account potential confounder discernable association aceis arb use transfer intensive care unit icu contrastingly patient icu transfer aceis arb use associate modest increase recovery hr ci p=. reduction fatality hr ci p=. transition patient transfer icu admission evidence association aceis arb use recovery hr ci p=. hospital death hr ci p=. observe male gender old age significantly associate high risk icu admission death chronic cardiometabolic comorbiditie associate recovery conclusion time multistate model address magnitude direction association aceis arb use covid- progression minimise bias study provide robust indication protective modest association recovery survival
234,immunocompromised status associate severe coronavirus infection give inability immune system combat deadly severe acute respiratory syndrome coronavirus  sars cov- patient multiple comorbiditie diabetes mellitus hypertension chronic kidney disease patient immunosuppressant chemotherapy high risk getting infect ongoing pandemic probability adverse outcome report rare case renal transplant recipient sirolimus contract coronavirus disease covid- immunosuppressant continue manage antiviral steroid low molecular weight heparin patient respond treatment recover completely span week use sirolimus patient renal transplant recipient help prevent intensification severity covid- attribute inhibit effect mammalian target rapamycin mtor post renal transplant prove blessing disguise
235,computed tomography ct chest main diagnositic tool coronavirus disease  covid- infection document chest ct finding patient confirmed covid- association clinical severity search related literature pubmed medline embase web science inception reference list previous systematic review total  case report patient ct finding covid- include common comorbid condition hypertension .% diabetes mellitus common symptom fever .% follow cough .% take average day symptom onset admission common chest ct finding vascular enlargement .% follow ground glass opacity ggo .% air bronchogram .% consolidation lung lesion locate lung periphery .% involve bilateral lung patient show normal range laboratory finding white blood cell count .% lymphocyte compare previous publish meta analysis study summarize different radiologic characteristic chest ct total  covid- patient compile case series study comprehensive diagnostic approach adopt patient know covid- suspect case expose individual
236,introduction computed tomography ct chest screening test diagnosis infection new coronavirus fundamental role assess extent lung involvement complication pleural effusion consider high morbidity mortality elderly patient infection objective study evaluate imaging aspect clinical correlation extreme age /= year confirm diagnosis covid- method retrospective single center cohort study ct scan categorize qualitatively quantitatively case  descriptor describe ct finding compatible finding great specificity covid- opacity attenuation ground glass peripheral bilateral distribution rounded morphology consolidation crazy pavement aspect inverted halo sign organize pneumonia finding doubtful finding specific unusual covid- opacity attenuation ground glass nonrounded morphology central diffuse unilateral distribution consolidation lobar segmental consolidation ground glass opacity small centrilobular nodule appearance tree bud excavation pleural effusion thickening interlobular septum negative absence pneumonia sign quantitative assessment refer extent pulmonary involvement tomographic severity classification grade  lung involvement result total  patient evaluate average age year woman  man mean time interval onset symptom tomography day prevalent comorbidity systemic arterial hypertension .% compatible doubtful negative test  .%  .%  .% respectively compatible exam common finding opacity peripheral ground glass rounded morphology follow crazy paving prevalence pleural effusion consolidation finding influence duration symptom p p respectively exam classify grade grade grade   .%  .%  .% respectively statistically significant association classification tomographic severity outcome invasive ventilation p admission intensive care unit p /= year old present tomographic manifestation similar describe general population ground glass opacity crazy paving extent lung involvement associate need intensive care invasive ventilation death literature describe association stage disease appearance consolidation pleural effusion correlation observe study suggest age group predisposed appearance finding typically describe advanced stage infection
237,introduction mechanism(s mediate critical illness coronavirus disease  covid- remain unclear previous report demonstrate existence endotoxemia viral infection superimpose gram negative bacteremia rate severity endotoxemia critically ill patient covid- require exploration materials method single center cross sectional study  intensive care unit patient diagnose covid- pneumonia endotoxin activity ea measure patient meet follow criterion age /= year multi organ dysfunction score march june result total  patient meet inclusion exclusion criterion measurement ea median age study cohort  year majority male hypertension significant proportion patient exhibit elevated ea intermediate range ea unit high range ea unit nonresponder nr low neutrophil response ea presence gram negative bacteremia patient low ea report patient nrs patient high ea exhibit high acute kidney injury aki compare patient low intermediate ea level .% discussion conclusion elevated ea observe large majority critically ill patient covid- multi organ dysfunction despite low incidence concurrent gram negative bacteremia observe elevated ea nonresponsiveness ea associate aki critically ill patient covid- finding require validation large longitudinal cohort
238,background aim diabetes obesity hypertension common comorbiditie associate increase severity mortality rate corona virus disease covid)- method narrative review pubmed database discuss epidemiological datum pathophysiological link diabetes covid- potential effect glycaemic control antidiabetic drug prevalence outcome covid- role telemedicine diabetes self management post covid- era result diabetes link covid- morbidity mortality research need elucidate association meantime physician aware potential rise prevalence diabetes unhealthy lifestyle change pandemic severity complication focus achieve optimal diabetes prevention management telemedicine diabetes self management help direction dipeptidyl peptidase  dpp inhibitor glucagon like peptide- glp- receptor agonist sodium glucose transporter  sglt inhibitor affect viral entry infection covid- outcome show observational study conclusion diabetes associate covid- development progression certain antidiabetic drug influence covid- prevention management result ongoing randomized clinical trial shed light field
239,march december  autopsy perform semmelweis university budapest hungary chart review patient severe acute respiratory syndrome coronavirus  sars cov- infection demonstrate real time reverse transcription polymerase chain reaction testing mean age year range year  male mean age year  female mean age year classify date death  case pandemic wave march july  second wave august december mortality category define relevance sars cov- infection strong association n= covid- primary responsible death contributive association n= pre existing condition independent covid- primary responsible death albeit substantial covid- co morbidity weak association n= covid- minimally responsible death distribution category differ wave contributive association case dominate strong contributive weak second wave strong association case dominate strong contributive weak chart co morbidity include hypertension cardiovascular disease diabetes cerebrovascular disease chronic respiratory disease malignant tumor renal disease disease central nervous system liver disease autopsy evaluation analyze alteration macroscopy finding microscopy scan score section formalin fix paraffin embed tissue sample block case severity histological abnormality lung differ significantly strong contributive p strong weak category p abnormality include diffuse alveolar damage macrophage infiltration vascular alveolar fibrin aggregate lung macro- microvascular thrombi thromboemboli lung kidney liver conclusion autopsy clarify extent covid- responsible death demonstrate pathological background clinical sign symptom identify organ alteration lead death clinicopathologic correlation conference discussion severity co morbidity direct pathological sign disease permit accurate categorization cause death covid- association strong contributive weak lung involvement reduce ventilatory capacity primary cause death strong contributive category shift distribution category strong association covid- death dominate second wave reflect improve clinical management covid- expertise grow
240,objective scarcity datum reoccurrence sars cov- infection kidney transplant recipient material method conduct retrospective multicenter cohort study identify  kidney transplant recipient living  deceased donor recurrent covid- report demographic immunosuppression regimen clinical profile treatment outcome result covid- second infection rate kidney transplant recipient median age  year median time interval transplant episode covid- diagnosis month interquartile range month common comorbiditie hypertension diabetes fever significantly common recurrent covid- covid- severity range asymptomatic mild moderate infection asymptomatic mild severe second infection  kidney transplant recipient severe second infection die median interval  episode base reverse transcriptase polymerase chain reaction covid positive test  day interquartile range day symptom statistically significant risk factor mortality dyspnea p disease severity p allograft dysfunction p high level neutrophil lymphocyte ratio p intensive care unit ventilator requirement p limited resource allow molecular diagnostic typing suggest second episode reinfection sars cov- conclusion knowledge large study kidney transplant recipient reoccurre sars cov- infection observe mortality
241,coronavirus disease covid- pandemic impose high burden morbidity mortality covid- direct lung parenchymal involvement pulmonary microcirculation dysfunction entail pulmonary hypertension ph ph direct cardiac injury beget right ventricular dysfunction rvd occurrence frequently report covid- patient prevalence rvd impact outcome covid- unclear study aim evaluate prevalence rvd associate outcome patient covid- systematic review meta analysis medline embase systematically search inception th july study report prevalence rvd covid- patient cause death accord rvd status include pooled prevalence rvd odds ratio cause death accord rvd status compute report subgroup analysis meta regression perform  study patient include pool prevalence rvd ci .-.% pi high grade heterogeneity significant difference find geographical location accord risk bias severity covid- associate increase prevalence rvd meta regression presence rvd find associate increased likelihood cause death ci rvd find   covid- patient associate cause mortality rvd represent crucial marker prognostic stratification covid- prospective large need investigate specific management therapeutic approach patient
242,objective role overcrowded multigenerational household risk factor covid- remain unmeasured objective study examine quantify association overcrowded multigenerational household covid- new york city nyc study design cohort study method conduct bayesian ecological time series analysis zip code tabulation area zcta level nyc assess zcta high proportion overcrowded define proportion estimate number housing unit occupant room multigenerational household define estimate percentage residence occupy grandparent grandchild  year age independently associate high suspect covid- case rate nyc department health syndromic surveillance datum march  main measure adjust incidence rate ratio irr suspect covid- case population final model control zcta level sociodemographic factor median income poverty status white race essential worker prevalence clinical condition relate covid- severity obesity hypertension coronary heart disease diabetes asthma smoking status chronic obstructive pulmonary disease spatial clustering result suspect covid- case present emergency department  zcta nyc adjust covid- case rate increase irr ci zcta quartile versus percent overcrowdedness increase irr ci quartile versus percent live multigenerational housing interaction exposure significant betainteraction ci conclusion overcrowdedness multigenerational housing independent risk factor suspected covid- early phase surge covid case social distancing measure increase house bind population inadvertently temporarily increase sars cov- transmission risk covid- disease population
243,lipid profile alteration observe patient coronavirus disease  covid- relation disease severity mortality conduct systematic review meta analysis meta regression study report total hdl ldl cholesterol triglyceride concentration hospitalize patient covid- search pubmed web science scopus january  january study describe lipid concentration covid- severity survival status prospero registration number crd study covid- patient include meta analysis pooled result show hospitalize patient severe disease non survivor status significantly low total cholesterol standardized mean difference smd ci p ldl cholesterol smd ci p hdl cholesterol smd ci p triglyceride smd ci p concentration compare patient mild disease survivor status follow study heterogeneity large extreme sensitivity analysis effect size different lipid fraction affect study turn remove begg egger t test evidence publication bias study investigate ldl cholesterol meta regression significant association observe smd ldl cholesterol age hypertension smd triglyceride study endpoint aspartate aminotransferase systematic review meta analysis low total hdl ldl cholesterol triglyceride concentration significantly associate covid- severity mortality cholesterol concentration useful combination clinical demographic variable risk stratification monitoring group systematic review registration prospero registration number crd
244,objective analyze epidemiological history clinical symptom laboratory testing parameter patient mild severe covid- infection provide reference timely judgment change patient condition formulation epidemic prevention control strategy method retrospective study conduct research total  patient covid- infection receive treatment january  march  ninth people hospital dongguan city select study subject analyze clinical characteristic laboratory confirm patient covid- oversampling method smote solve imbalance category establish lasso logistic regression random forest model result  confirm covid- case  mild  severe average age patient year old include  male  female average age severe patient significantly old mild patient year old vs year old average time illness onset hospital admission day average actual hospital stay day time actor long severe patient mild patient  patient .% family cluster infection similar mild severe patient comorbiditie underlying disease common severe patient include hypertension diabetes disease common symptom cough follow fever headache vomit diarrhea dyspnea .% laboratory finding patient include leukopenia .% lymphopenia .% severe patient low level creatine kinase median high level d dimer median nlr severe patient high mild patient logistic regression show age phosphocreatine kinase procalcitonin lymphocyte count patient admission cough fatigue pharynx dryness independent predictor covid- severity classification random forest predict importance variable display variable importance random forest indicate age d dimer nlr neutrophil lymphocyte ratio rank variable risk factor conclusion clinical symptom covid- patient non specific complicated age time onset admission important factor determine severity patient condition patient mild illness closely monitor identify severe variable age creatine phosphate kinase select logistic regression important indicator assess disease severity covid- patient importance variable random forest complement variable feature information
245,coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- infection continue scale threaten human health public safety essential identify risk factor lead poor prognosis disease predispose host genetic background factor explain interindividual variability covid- severity study rs rs polymorphism angiotensin convert enzyme ace gene key regulator renin aldosterone angiotensin system raas explain different outcome  covid- patient diverse degree severity asymptomatic mildly symptomatic  hospitalize general ward  admit icu find g allele rs rs associate severe covid- hypertensive patient independently gender p g carrier genotype polymorphism associate high mortality p high severity covid- dyslipidemic p type  diabetic patient p association g allele disease severity adjust age sex bmi number comorbiditie suggest metabolic comorbiditie g allele act synergistically covid- outcome find direct association serum ace level covid- severity find high level ace serum patient gg genotype rs rs p explain high susceptibility develop severe form disease patient gg genotype addition hypertension dyslipidemia conclusion preliminary study suggest g contain genotype rs rs confer additional risk adverse covid- prognosis rs rs polymorphism ace predictive marker severity covid- patient hypertension dyslipidemia diabetes knowledge genetic datum contribute precision management sars cov- infected patient admit hospital
246,study try investigate impact oxiris filter clinical laboratory parameter critically ill covid- intensive care unit icu patient receive extracorporeal blood purification clinical setting initiation therapy consecutive sample  icu patient covid- treat oxiris membrane blood purification support renal function acute kidney injury include  non treat icu covid- patient control group chest x ray analyze determine chest ray severity score find significant decrease sofa score respiratory status improve chest ray severity score significantly decrease  h treatment il- significantly decrease  h treatment inflammatory marker respiratory status control group worsen increase sofa score chest x ray severity score survive patient short time onset symptom start extracorporeal blood purification treatment short time vasoactive therapy invasive respiratory support deceased patient critically ill patient covid- treat extracorporeal blood purification survive significantly long icu covid- patient treatment oxiris membrane provide significant reduction il- lead improvement respiratory status chest x ray severity score reduction sofa score severity result suggest icu covid- patient early course disease potentially target group early initiation extracorporeal blood purification
247,background extracorporeal membrane oxygenation ecmo valuable rescue therapy treat refractory hypoxemia cause influenza present meta analysis aim compare clinical characteristic outcome ecmo covid- influenza method search pubmed cochrane library scopus web science database inception include study compare clinical characteristic outcome ecmo adult covid- influenza result study include retrospective cohort involve total  patient covid-  influenza treat ecmo clinical characteristic similar covid- influenza group include body mass index bmi diabetes mellitus hypertension immunocompromised status high proportion patient covid- ecmo male .% vs. .% p difference group term illness severity base sequential organ failure assessment sofa score serum ph. patients covid- long mean duration mechanical ventilation ecmo vs. day p pooled mortality rate mean ecmo duration vs. day p mortality rate .% vs. .% p comparable group conclusion clinical characteristic ecmo duration mortality comparable patient covid- influenza require ecmo treat refractory hypoxemia duration mechanical ventilation ecmo influence outcome patient covid- benefit ecmo salvage therapy similarly influenza
248,background pre exist comorbiditie link sars cov- infection evidence sparse importance pattern multimorbidity condition severity infection indicate hospitalisation mortality aim use multimorbidity index develop specifically covid- investigate association multimorbidity risk severe sars cov- infection method datum uk biobank link laboratory confirm test result sars cov- infection mortality datum public health england march  july review current literature covid- derive multimorbidity index include angina asthma atrial fibrillation cancer chronic kidney disease chronic obstructive pulmonary disease diabetes mellitus heart failure hypertension myocardial infarction peripheral vascular disease stroke adjust logistic regression model assess association multimorbidity risk severe sars cov- infection hospitalisation death potential effect modifier association assess age sex ethnicity deprivation smoking status body mass index air pollution -hydroxyvitamin d cardiorespiratory fitness high sensitivity c reactive protein result participant median age  range year white .%  severe sars cov- infection prevalence multimorbidity double severe sars cov- infection compare cluster multimorbiditie common severe sars cov- infection common cluster severe sars cov- infection stroke hypertension stroke hypertension diabetes hypertension chronic kidney disease hypertension multimorbidity independently associate great risk severe sars cov- infection adjust odd ratio confidence interval compare multimorbidity risk remain consistent potential effect modifier great risk old age high risk severe infection strongly evidence ckd diabetes ci conclusion multimorbidity index help identify individual high risk severe covid- outcome provide guidance tailor effective treatment
249,background case coronavirus disease  covid- report china december cause global pandemic include turkey objective aim study analyse characteristic hospitalise covid- patient assess parameter relate severe pneumonia method include study hospitalise covid- patient positive naso oropharyngeal swab patient demographic admission symptom laboratory radiological finding record retrospectively result  patient  male  female .% mean age half patient comorbiditie common hypertension diabetes mellitus cough .% fatigue .% fever .% common present symptom hospitalise covid- patient .% pneumonia .% typical radiological covid- appearance .% ground glass area common laboratory finding high c reactive protein crp .% lactate dehydrogenase ldh .% level lymphopenia .% severe pneumonia present .% covid- patient multivariate logistic regression analysis indicate advanced age hypotension anaemia elevated crp ldh serum level independent risk factor severity covid- pneumonia p respectively conclusion study multicentre study characteristic covid- turkey guide disease relate parameter severity pneumonia age blood pressure complete blood count routine biochemical test include crp ldh appear important parameter evaluation severity covid- pneumonia
250,coronavirus disease  covid- novel worldwide pandemic cause novel severe acute respiratory syndrome coronavirus  sars cov- covid- pandemic socioeconomic deprivation social isolation reduce physical activity induce heart failure hf destabilization cause complication hf appear potential hazard sars cov- infection chiefly elderly patient underlie comorbiditie reality expression cardiac ace implicate target point sars cov induce acute cardiac injury sars cov- infection like febrile illness high blood viscosity exaggerated pro inflammatory response multisystem inflammatory syndrome endothelial dysfunction induce coagulation disorder increase risk hf development hypoxic respiratory failure pulmonary edema severe acute lung injury ali acute respiratory distress syndrome ards affect heart hemodynamic stability development pulmonary hypertension covid induce hf development cytokine storm characterize high proliferation pro inflammatory cytokine cytokine storm mediate cardiac dysfunction positive correlation level pro inflammatory cytokine myocarditis induce acute cardiac injury biomarker covid induce hf complex related molecular background release pro inflammatory cytokine neuro metabolic derangement affect cardiomyocyte function development hf anti heart failure medication mainly digoxin carvedilol potent anti sars cov- anti inflammatory property mitigate covid- severity development hf conclusion sars cov- infection lead development hf direct acute cardiac injury development cytokine storm depress cardiomyocyte function cardiac contractility anti heart failure drug mainly digoxin carvedilol attenuate severity hf reduce infectivity sars cov- prevent development cytokine storm severely affected covid- patient
251,background prognosis novel coronavirus disease  covid- poor patient end stage kidney disease eskd limited information available clinical characteristic outcome patient arab country present study aim address gap method retrospective cohort study include  patient eskd hospitalize covid-  december  king fahad central hospital single center jazan province saudi arabia chi square test independent sample t test mann whitney u test cox regression perform statistical analysis result  hospitalize covid- patient eskd  patient die patient aged  year significant mortality risk mortality high male patient female patient common comorbiditie hypertension diabetes mellitus heart disease presence diabetes cardiovascular disease eskd increase mortality risk relative risk rr rr respectively frequently report clinical symptom fever shortness breath cough total patient admit intensive care unit require mechanical ventilation patient bilateral lung infiltrate hemoglobin level platelet count significantly low deceased patient survive one compare survive patient high degree lymphocytopenia neutrophilia ferritin d dimer blood urea nitrogen aspartate transaminase detect deceased patient septic shock respiratory failure prevalent complication result death conclusion covid- patient eskd increase risk poor outcome mortality mortality risk increase increase age presence comorbiditie diabetes cardiovascular disease elevated level inflammatory marker correlate disease severity associate hospital mortality population
252,introduction covid- patient categorize clinical severity level care decide base clinical severity apart clinical severity patient need robust predictor feel early categorization accurate prediction final fatal outcome hospitalize patient material method retrospective observational cohort study adult patient admit november month include available datum epidemiological factor inflammatory biomarker ct severity score collect analyze univariate multivariate logistic regression analysis know predictive ability variable receiver operate characteristic analysis compare predictive ability factor final outcome death result analyze record  total patient male .% median iqr age  year diabetes .% hypertension .% common co morbidity univariate multivariate regression analysis find crp d dimer ct severity score level predict final outcome death multivariate regression receiver operative characteristic roc analysis age charlson co morbidity index fail predict hospital mortality crp d dimer admission positively predict final outcome hospital mortality auroc .(p=. ci .- .(p= ci .- respectively ct severity score auroc p= ci .- cut crp  mg l sn sp d dimer  microg l sn sp ct severity score  sn sp conclusion crp level  mg l d dimer level  microg l ct severity level gt time admission add conventional clinical severity algorithm accurately predict final outcome stratify level care offer time admission improve odd survival
253,sars coronavirus- widespread virus globally st century severity ability cause severe pneumonia death vary perform comprehensive systematic review study meet standardised criterion extract datum age symptom different treatment covid- patient prognosis disease follow case study divide accord severity death status meta analyse separately raw mean single proportion method include  complete study include confirm case covid-  study meta analyse symptom clearly emerge escalate manner mild moderate symptom pneumonia severe critical group non survivor hypertension pool proportion pp confident interval ci diabetes pp ci smoke pp ci high pre infection comorbiditie non survivor group acute respiratory distress syndrome pp ci pp ci remain common complication severe death group respectively bilateral ground glass opacification pp ci visible radiological image mortality rate estimate pp ci pp ci pp ci severe critical pneumonia mild moderate group respectively study serve high evidence guideline different clinical presentation covid- grade mild severe special form like pneumonia death group
254,introduction patient clinical condition show associate coronavirus disease covid- severity outcome impact hospital cost know economic evaluation covid- admission aim assess direct fix hospital cost describe particularity different clinical demographic condition outcome large public hospital latin america locate sao paulo brazil institute exclusively dedicate covid- patient response pandemic method partial economic evaluation perform hospital s perspective prospective observational cohort study assess hospitalization cost suspect confirm covid- patient admit march  june hospital das clinicas university sao paulo medical school hcfmusp follow discharge death external transfer micro- macro cost methodology describe analyze total cost associate patient underlie medical condition itinerary outcome cost component different hospital sector result average cost  admission .% involve intensive care unit stay us$ overhead cost main component sex age underlying hypertension us$ diabetes us$ obesity us$ chronic renal failure us$ rheumatic us$ hematologic us$ neurologic us$ disease associate high cost age stratum year reverse transcription polymerase chain reaction rt pcr)-confirmed covid- comorbiditie use mechanical ventilation dialysis surgery outcome remained associate high cost conclusion knowledge covid- hospital cost aid development comprehensive approach decision making planning future risk management
255,respiratory symptom covid- manifestation metalloproteinase mmps essential role lung physiology seek characterize plasmatic level matrix metalloproteinase-  mmp- mmp- patient severe covid- investigate association plasma mmp- mmp- level clinical outcome mortality mmp- mmp- level plasma patient covid- treat icu covid- group control patient measure zymography study group match age sex hypertension diabetes bmi obesity profile mmp- level low mmp- level high covid- group p compare control mmp- level covid- patient affect comorbidity hypertension obesity mmp- level affect hypertension p unaffected obesity status notably hypertensive covid- patient high mmp- level compare non hypertensive covid- group albeit low control p association mmp- mmp- plasmatic level corticosteroid treatment acute kidney injury find covid- patient survival analysis show covid- mortality associate increase mmp- mmp- level age hypertension bmi mmp- mmp- well predictor mortality hospitalization saps sofa score hospital admission conclusion significant association mmp- mmp- level covid- find notably mmp- mmp- level predict risk hospital death suggest possible pathophysiologic prognostic role
256,novel coronavirus relate coronavirus disease  covid- pandemic relentless disrupt overwhelm healthcare world clinical outcome covid- patient chronic comorbiditie especially metabolic syndrome document chronic liver disease cirrhosis patient special sub group management covid- challenge understand pathophysiology covid- patient cirrhosis portal hypertension improve identification risk patient disease progression help compartmentalize generalized specialized treatment option special patient group exhaustive review critically review impact covid- liver chronic liver disease cirrhosis patient discuss common feature associate pathophysiology covid- cirrhosis base renin angiotensin system deliberate current literature guideline treatment covid- extrapolate cirrhosis population provide concise stepwise evidence base management cirrhosis patient severe critical covid- specific management guideline cirrhosis patient covid- current recommendation treatment guideline general population specific issue like avoid corticosteroid decompensated patient variceal bleeding suspect sepsis high grade hepatic encephalopathy acute kidney injury use early mechanical ventilation strategy severe ascite hepatopulmonary syndrome avoidance remdesivir advanced liver disease application liver specific severity score prognostication identification futility need highlight
257,background beta thalassemia prevalent single gene blood disorder assessment susceptibility coronavirus disease  covid- warrant press biomedical priority method study  positive covid- participant unvaccinated severe acute respiratory syndrome coronavirus  sars cov- consecutively recruit trimester patient characteristic include age sex current smoking status atrial fibrillation chronic respiratory disease coronary disease diabetes neoplasia hyperlipidemia hypertension beta thalassemia heterozygosity assess covid- severity length hospitalization intensive care unit icu admission mortality covid- result assess patient characteristic associate clinical symptom icu admission mortality covid- multivariate analysis severe critical covid- strongly associate male sex p increase age p beta thalassemia heterozygosity p requirement icu care multivariate analysis statistically significant association hypertension p beta thalassemia heterozygosity effect p mortality link male sex p increase age p beta thalassemia heterozygosity p multivariate analysis worth note hyperlipidemia reduce mortality covid- p statistically significant association current smoking status patient characteristic study observe conclusion pilot observation indicate enhance mortality beta thalassemia heterozygote covid-
258,endothelial dysfunction characterize aspect call cardiovascular continuum series event range hypertension development atherosclerosis finally coronary heart disease thrombus formation myocardial infarction heart failure endothelial dysfunction main prognostic factor progression vascular disorder respond drug intervention lifestyle change virtually drug prevent cardiovascular disorder long new antilipidemic agent inhibitor angiotensin enzyme acei exert important effect endothelium endothelial dysfunction central feature coronavirus disease covid- clear life risk complication disease prompt alteration endothelium induce viral infection consequence progression covid- bad subject endothelial dysfunction present elderly diabetic obese hypertensive patient importantly circulate biomarker endothelial activation injury predict severity mortality disease evaluate efficacy treatment purpose review provide update endothelial function discuss clinical relevance cardiovascular continuum late insight molecular cellular biology implication clinical practice focus new actor notch signaling emerge therapy cardiovascular disease
259,introduction study aim investigate hsmall o cyrillicssmall er cyrillicitsmall cyrillicl msmall o cyrillicrtsmall cyrilliclity severe small cyrillicsmall es cyrillicute ressmall er cyrillicirsmall cyrillictsmall o cyrillicry syndrsmall o cyrillicme small es cyrillicsmall o cyrillicrsmall o cyrillicnsmall cyrillicvirus  small er cyrillicsmall cyrillictient strsmall cyrillictifie serum ferritin level method patient stratify base ferritin level ferritin level result approximately patient ferritin level  pneumonia hypertension fever .% shortness breath major symptom patient group logistic regression analysis indicate ferritin level odd ratio confidence interval ci p  conclusion study high level serum ferritin find independent predictor hsmall o cyrillicssmall er cyrillicitsmall cyrillicl msmall o cyrillicrtsmall cyrilliclity
260,background blood group consider impact occurrence severity coronavirus disease chinese caucasian blood group o individual group likely severe disease mortality datum south asians available objective study aim find association disease severity blood group coronavirus disease  covid- patient material methodology data collect predesigne questionnaire contain detail patient demographic medical comorbiditie clinical presentation laboratory parameter multiple logistic regression determine association blood group severity coronavirus disease result study participant blood group b high distribution .% follow o .% ab .% fourth .% mild moderate disease .% severe disease age gender hypertension diabetes mellitus hemoglobin level associate disease severity covid- patient univariate analysis p value selection final model show odd disease severity time high male ci time high diabetic patient ci compare female non diabetic respectively significant association find blood group disease severity conclusion blood group role forecast severity coronavirus disease male gender diabetic prone severe disease
261,objective study aim evaluate association monoclonal antibody infusion bamlanivimab reduction -day hospitalization mortality rate patient coronavirus disease  covid- rural community set comorbiditie methodology retrospective data analysis conduct -day period patient visit emergency department community hospital group covid positive patient receive bamlanivimab compare group covid- patient similar characteristic demographic disease severity receive infusion datum -day hospitalization rate analyze odd ratio individual comorbiditie fisher exact test analyze chronic kidney disease ckd mortality logistic regression analysis subsequent odd ratio estimate adjust demographic comorbiditie evaluate association bamlanivimab infusion -day hospitalization rate result total  patient include bamlanivimab group  patient non bamlanivimab group covid- patient analyze comorbidity odd ratio analysis .% diabetic patient .% obese patient hypertensive patient patient ckd require hospitalization  day initial visit bamlanivimab group contrast .% diabetic patient .% obese patient .% hypertensive patient .% patient ckd non bamlanivimab group logistic regression analysis odd ratio estimate show adjust demographic comorbiditie bamlanivimab infusion associate decrease hospitalization p confidence interval ci logistic regression take variable account evaluate comorbiditie hypertension find individually associate decrease hospitalization p ci young age p ci female gender p ci establish mortality benefit subgroup conclusion base result study association bamlanivimab use reduce hospitalization rate covid- patient
262,background hypertension report prevalent comorbidity patient coronavirus disease  covid- retrospective study aim compare clinical characteristic outcome covid- patient hypertension method total  hospitalize patient laboratory confirm covid- include january march information medical record include clinical feature radiographic laboratory result complication treatment clinical outcome extract analysis result total  .% patient comorbidity hypertension covid- patient hypertension coexistence type  diabetes .% vs .% coronary heart disease .% vs .% poststroke syndrome .% vs .% chronic kidney disease .% vs .% significantly high coexistence hepatitis b infection .% vs .% significantly low covid- patient hypertension compute tomography ct chest scan covid- patient hypertension high rate pleural effusion hypertension .% vs .% addition level blood glucose iqr .- vs iqr .- erythrocyte sedimentation rate esr iqr .- vs iqr .- p=. c reactive protein crp iqr .- vs iqr .- p=. serum amyloid saa iqr vs iqr .- p=. covid- patient hypertension significantly high patient hypertension conclusion common patient covid- coexistence hypertension type  diabetes coronary heart disease exacerbate severity covid- optimal management hypertension comorbiditie essential well clinical outcome
263,background ace component non classic renin angiotensin system ras act functional receptor severe acute respiratory syndrome coronavirus  sars cov spike protein enable entry virus host cell non classical ace type ace protective effect vascular respiratory cell ras modulator like angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb line treatment hypertensive patient upregulation ace level ras modulator observe preclinical study raise concern possible increase infectivity patient treat ras modulator method shortlist outcome effect open end english restrict database publish literature clinical study perform utilize ras modulator covid  patient consider conclusion current evidence reveal increased risk covid- infection hypertensive patient aceis arb compare antihypertensive medication study demonstrate detrimental effect ras modulator clinical severity hospital intensive care unit stay ventilation mortality conclude arb aceis treatment cause effect undesirable interaction covid- infect hypertensive patient
264,aim study aim find quantitative association presence co exist diabetes mellitus dm and/or hypertension htn covid- infection severity mortality method total  patient positive covid- include case control design dissect association dm htn covid- severity mortality result accord mohfw guideline  .% patient mild  .% patient moderate  .% patient severe disease outcome include mortality  patient age neutrophil% diabetes status significantly associate severe covid- infection adjust age patient diabetes time likely severe disease chi squared p value time likely fatal outcome chi squared p value find evidence hypertension modify covid- outcome diabetic patient conclusion covid- severity mortality significantly associate status dm risk modify presence htn
265,severe illness poor outcome mainly associate age certain medical comorbiditie especially chronic disease factor unfavorable prognosis describe owe relatively small sample size single center report study aim compare contribution comorbiditie development critical condition coronavirus disease  covid- patient pooled estimate relative risk rrs confidence interval cis calculate conduct meta analysis network meta analysis  study chronic obstructive pulmonary disease copd strongly associate overall critical condition rr ci follow cardiovascular disease cvd rr ci malignancy rr ci cerebrovascular accident cva rr ci diabetes rr ci hypertension rr ci chronic kidney disease rr ci presence comorbiditie chronic liver disease chronic kidney disease significantly increase risk severe infection intensive care unit icu admission cardiac injury subgroup analysis type critical condition preexisting hypertension diabetes additionally increase risk acute respiratory distress syndrome ards comorbiditie copd high probability lead severe covid- icu admission liver injury malignancy likely cause ards cardiac injury summary preexisting copd cvd cva hypertension diabetes malignancy likely worsen progression covid- severe infection icu admission requirement cardiac injury development
266,background systematic analysis concomitant arterial hypertension covid- patient impact angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb study large multicentre cohort conduct subanalysis international hope registry nct compare covid- presence absence arterial hypertension material method  covid- patient  .% patient diagnosis arterial hypertension .% patient treat acei arb clinical outcome present subanalysis include cause mortality  day follow result patient arterial hypertension suffer significantly different complication include respiratory insufficiency .% vs .% heart failure .% vs .% acute kidney injury .% vs .% pneumonia .% vs sepsis .% vs .% bleed event .% vs .% mortality rate patient concomitant arterial hypertension .% arterial hypertension p /= benzodiazepine antidepressant admission elevated ldh creatinine respiratory insufficiency sepsis positive independent predictor mortality antiviral drug interferon treatment acei arb discharge oral anticoagulation discharge independent negative predictor mortality conclusion mortality rate hospital complication increase covid- patient concomitant history arterial hypertension history acei arb treatment impact outcome patient
267,outbreak novel highly infectious severe acute respiratory syndrome coronavirus- sars cov- result hundred million infection million death globally infected individual progress coronavirus disease- covid- experience upper low respiratory complication range severity lead wide spread inflammation generalized hypoxia hypoxemia impact multiple organ system include central peripheral nervous system sars cov- outbreak multiple report continue emerge detail neurological symptom range relatively mild e.g. impaired taste and/or smell severe e.g. stroke suggest sars cov- neurotropic and/or contribute nervous system injury direct and/or indirect mechanism gain insight type neurological complication associate sars cov- infection possible relationship age sex covid- severity comorbiditie perform systematic review case report series publish  april  infected patient neurological manifestation meta analysis conduct individual patient datum report datum extract report neurological injury occur lifespan context infection know comorbiditie disease severity include asymptomatic patient old individual susceptible develop life threaten covid- cerebrovascular disease cvd stroke mild inverse correlation age see cns inflammatory disease encephalitis taste and/or smell disorder report increase age associate comorbid cardiovascular risk factor include hypertension diabetes mellitus lipid disorder obesity obesity correlate development critical covid- discussion potential pathophysiological mechanism neurological symptom arise long term consequence infection nervous system provide
268,aim explore correlation cardiac relate comorbiditie cardiac biomarker acute myocardial injury severity level outcome covid- patient method pubmed web science embase cnki vip wanfang cochrane library database sinomed systemically type clinical research report cardiac relate comorbiditie cardiac biomarker include lactate dehydrogenase ldh troponin tni high sensitivity troponin hs tni creatine kinase ck creatine kinase mb ck mb myoglobin myo n terminal pro b type natriuretic peptide nt probnp acute cardiac injury group severity covid- include outcome measure event total sample size comorbiditie acute cardiac injury laboratory parameter biomarker study perform stata version result seventy study total case identify result show covid- severity relate cardiovascular disease similar odd ratio ors achieve hypertension severe versus critical group ci p relative risk rr acute cardiac injury ci .- non survivor case compare different severity cardiac biomarker pool ck ck mb tni myo ldh ci p ci p ci p ci p ci p critical versus severe group trend similar group standard mean difference smd ck tni critical versus severe group ci p ci p mean difference observe serum level indicator conclusion finding clearly indicate hypertension cardiovascular disease acute cardiac injury related laboratory indicator associate severity covid- need cross national prospectively design observational clinical trial help improve certainty available evidence treatment decision patient
269,background ongoing debate association drug therapy target renin angiotensin aldosterone system raas adverse outcome coronavirus disease  covid- objective study aim examine association medication cardiovascular system risk associate covid- middle aged old adult method total participant aged year uk biobank test sars cov- rna medication include angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb beta blocker calcium channel blocker ccb statin aspirin covid- outcome comprise positive test result severity covid- define mild hospitalization death evaluate risk total participant sub group base sex propensity score matching perform logistic regression model result middle- old aged participant significant association class medication likelihood covid- infection observe acei associate high mortality risk covid- odd ratio confidence interval ci ccb associate low hospitalization risk covid- ci male patient covid- low mortality risk covid- ci .- observe arb female patient covid- conclusion study suggest sex difference risk death covid- use acei arb middle aged old adult sex difference risk hospitalization covid- use ccb observe clinical importance clinician adopt different cvd treatment approach female male patient covid-
270,novel coronavirus disease covid- hit healthcare system worldwide risk severe infection mortality increase advance age especially subject comorbiditie cardiovascular disease hypertension diabetes obesity cancer cardiovascular complication myocardial injury heart failure thromboembolism frequently observe covid- case biomarker troponin ntprobnp d dimer identify prognostic indicator disease severity bad outcome currently specific therapy sars cov- medication investigation aim review explore intertwine relationship covid- disease cardiovascular system focus elderly population available supportive treatment relate concern elderly patient comorbiditie polypharmacotherapy explore
271,background sars cov- spread substantially india multiple wave ongoing covid- pandemic risk factor disease burden associate covid- india remain poorly understand aim assess predictor infection mortality active surveillance study probe completeness case mortality surveillance method prospective active surveillance study datum collect expand programmatic surveillance testing sars cov- district madurai tamil nadu india population  individual prospective testing rt pcr individual fever acute respiratory symptom return traveller frontline worker contact laboratory confirm covid- case resident containment zone patient undergo medical procedure risk group standardised data collection symptom chronic comorbid condition routine intake additionally seroprevalence anti sars cov- immunoglobulin g assess cross sectional survey recruit adult  cluster madurai district oct nov estimate adjusted odd ratio aors positive rt pcr result compare individual age sex comorbid condition aspect clinical presentation estimate case fatality ratio cfr -day period follow rt pcr testing stratify variable adjust hazard ratio ahrs death associate age sex comorbidity estimate infection fatality ratio ifrs basis age specific seroprevalence result oct diagnostic test  inhabitant madurai compare test  inhabitant india total  rt pcr test  sars cov- infection identify  .%  positive individual symptom  .%  positive individual symptom time presentation estimate aors symptomatic rt pcr confirm infection increase continuously factor age year  year old contrast risk asymptomatic rt pcr confirm infection differ age year increase factor age year  year old seroprevalence ci age  year old end study period indicate rt pcr clinical testing surveillance testing identify infection age group rt pcr confirm case old age male sex history cancer diabetes endocrine disorder hypertension chronic circulatory disorder respiratory disorder chronic kidney disease associate elevated risk mortality cfr rt pcr confirm case age standardisation age  year old ifr base report death report death expect count interpretation large scale sars cov- surveillance programme madurai india identify equal risk asymptomatic infection child teenager work age adult increase risk infection death associate old age comorbiditie establish surveillance practice difference infection severity account gap observed expect mortality crucial importance establish burden covid- india funding bill melinda gates foundation national science foundation national institute general medical sciences translation hindi translation abstract supplementary materials section
272,abstract coronavirus disease  covid- lead illness death particularly important predict severity prognosis covid- sequential organ failure assessment sofa score predict clinical outcome patient multiple organ failure require intensive care retrospectively analyze clinical characteristic risk factor relationship sofa score prognosis covid- patient retrospectively include patient year old diagnose covid- laboratory continuously admit jingzhou central hospital january  march demographic clinical manifestation complication laboratory result clinical outcome patient infect severe acute respiratory syndrome coronavirus- collect analyze clinical variable compare patient mild severe covid- univariate multivariate logistic regression analysis perform identify risk factor severe covid- cox proportional hazard model analyze risk factor hospital relate death survival analysis perform kaplan meier method survival difference assess log rank test receiver operate characteristic roc curve sofa score different situation draw area roc curve calculate total  patient confirm diagnosis covid- retrospectively analyze  patient discharge  patient die median age patient year old interquartile range iqr .-  patient comorbiditie hypertension .% frequent comorbiditie follow diabetes .% stroke .% coronary heart disease .% chronic liver disease common symptom admission fever dry cough regression analysis show high sofa score advanced age hypertension associate severe covid- median sofa score patient  iqr patient severe covid- exhibit significantly high sofa score patient mild covid- iqr vs  iqr p /= significantly great risk death low sofa score group sofa score sofa score evaluate severity -day mortality covid- sofa score independent risk factor hospital death
273,background combined marker renal dysfunction inflammation e.g. cystatin c assist risk stratification clinical decision patient coronavirus disease  covid- conduct systematic review meta analysis meta regression serum cystatin c covid- method search pubmed web science scopus january  february study report serum cystatin c concentration measure clinical severity survival outcome hospitalize covid- patient prospero registration number crd result thirteen study  covid- patient  low severity survivor status  high severity non survivor status follow include meta analysis pooled result show serum cystatin c concentration high patient high disease severity non survivor status standard mean deviation smd ci p extreme study heterogeneity observe .% p sensitivity analysis perform sequentially remove study assess pooled estimate show magnitude direction effect size substantially modify begg egger t test publication bias meta regression smd serum cystatin c associate age proportion male c reactive protein neutrophil lymphocyte aspartate aminotransferase alanine aminotransferase albumin creatinine creatine kinase mb lactate dehydrogenase proportion patient diabetes hypertension conclusion high concentration serum cystatin c associate high covid- severity mortality
274,pulmonary manifestation cause severe acute respiratory syndrome sars coronavirus  sars cov- emerge endocrine phenotype heavily impact severity syndrome recently associate coronavirus disease  covid- patient pituitary disease pituitary gland involve covid- clinical presentation and/or severity cause pituitary apoplexy hypopituitarism frequently burden metabolic complication include arterial hypertension hyperglycemia obesity vertebral fracture associate poor outcome increase mortality patient infect sars cov-.this review discuss hypopituitarism condition bidirectional relationship covid- frequent presence metabolic comorbiditie direct indirect pituitary damage se potential risk factor covid- finally address current recommendation clinical management vaccine patient hypopituitarism adrenal insufficiency
275,background primary goal present cross sectional observational study determine clinical demographic risk factor adverse coronavirus disease  covid- outcome pakistani population method examine individual n consult private diagnostic center lahore pakistan covid- testing november attend nurse collect clinical demographic information confirm case covid- define have positive result real time reverse transcriptase polymerase chain reaction rt pcr assay nasopharyngeal swab specimen result rt pcr testing positive  case .% severe .% mild symptom observe strong association covid- severity number type comorbiditie severity disease intensify number comorbiditie increase vulnerable group poor outcome patient diabetes hypertension increase age associate pcr positivity severity disease conclusion case covid- include study develop mild symptom asymptomatic risk factor adverse outcome include old age simultaneous presence comorbiditie
276,introduction covid grip world patient comorbiditie especially kidney ailment high risk develop severe disease kidney disease transplant patient vulnerable group information coronavirus disease  covid- kidney transplant patient limited method observational study conduct  kidney transplant patient test positive severe acute respiratory syndrome coronavirus  sars cov- polymerase chain reaction april june result majority case male median age patient  year interquartile range iqr diabetes hypertension present patient respectively coronary artery disease present patient median time transplant covid- testing  month iqr chronic allograft nephropathy find patient mean baseline creatinine mg dl. common symptom fever acute kidney injury see patient mean creatinine mg dl. base severity patient mild disease moderate disease remain severe disease  patient oral steroid calcineurin inhibitor tacrolimus cyclosporine antimetabolite mycophenolate mofetil azathioprine antimetabolite agent stop patient tacrolimus stop severe case hydroxychloroquine give  patient patient recover die conclusion kidney transplant recipient infect covid- high mortality
277,background acute kidney injury aki common coronavirus disease- covid- severity aki link adverse outcome study investigate factor associate hospital outcome hospitalize patient covid- aki method multicenter retrospective observational study evaluate characteristic hospital renal patient outcome  patient confirmed covid- aki datum collect  hospital turkey march  june aki definition staging base kidney disease improving global outcomes criterion patient end stage kidney disease kidney transplant exclude renal outcome identify discharge patient result median age patient  year .% male frequent comorbid condition hypertension .% diabetes mellitus .% chronic kidney disease ckd .% proportion aki stage  .% .% .% respectively  patient .% admit intensive care unit renal improvement complete .% partial .% patient discharge renal outcome bad patient aki stage  baseline ckd overall hospital mortality patient aki hospital mortality rate different patient preexisting non dialysis ckd compare patient ckd versus .% p multivariate cox regression analysis age hazard ratio hr confidence interval ci p male gender hr ci p diabetes mellitus hr ci p cerebrovascular disease hr ci p serum lactate dehydrogenase great fold increase hr ci p aki stage  hr ci p stage  hr ci p independent predictor hospital mortality conclusion advanced stage aki associate extremely high mortality hospitalize covid- patient age male gender comorbiditie risk factor mortality patient covid- general population relate hospital mortality patient aki preexisting non dialysis ckd increase hospital mortality rate aki patient renal problem continue significant portion patient discharge
278,background novel coronavirus disease covid- declare global pandemic world health organization march constitute health challenge century globally causative organism initially name  novel coronavirus ncov subsequently rename severe acute respiratory syndrome coronavirus  sars cov- pandemic far infect million kill million people worldwide diabetes mellitus dm lead cause morbidity worldwide objective examine critical role diabetes play pathogenesis prognosis covid- assess emerge therapy available fight pandemic method author conduct systematic review literature examine role diabetes comorbidity pathogenesis prognosis covid- result experimental observational datum early  suggest people covid- comorbiditie dominant diabetes cardiovascular disease hypertension empirical evidence indicate diabetic patient infect covid- disease bad outcome concern morbidity mortality conclusion combination underlie chronic condition hypertension obesity cardiovascular disease altered ace receptor expression immune dysregulation cytokine storm alveolar endothelial dysfunction increase systemic coagulation individual diabetes risk covid- severity study need elucidate glucose lower drug modulate host immune response diabetic individual especially follow administration potential covid- vaccine
279,background diabetes commonly report comorbiditie patient infect sars cov- retrospective study patient sars cov- infection conduct evaluate association blood glucose level severity covid- pneumonia patient mortality material methods total  patient confirm sars cov- infection include retrospective study obtain demographic characteristic clinical symptom laboratory datum survival information patient electronic medical record blood glucose measure admission hospital comorbiditie include hypertension diabetes chronic kidney disease chronic liver disease chronic obstructive pulmonary disease cardiovascular disease collect self report medical history result significantly high risk severe covid- find patient blood glucose level range mmol l odd ratio confidence interval ci .- patient blood glucose mmol l ci blood glucose mmol l hr ci estimate -day overall survival rate .% .% .% patient blood glucose mmol l mmol l mmol l respectively conclusion hyperglycemia association severity covid- pneumonia increase patient mortality finding support need blood glucose monitoring control hyperglycemia patient covid- pneumonia
280,background coronavirus disease  covid- cause highly contagious virus call severe acute respiratory syndrome coronavirus  emerge china end  major threat health world health expert learn detailed knowledge natural course severity covid- study aim assess prevalence association severity disease demographic characteristic initial present symptom comorbiditie covid- patient treatment center myanmar method cross sectional study conduct hmawbi indine treatment center yangon region myanmar november december datum collect standardized case report form total  confirm covid- inpatient include study odd ratio confidence interval ci measure association independent associate factor severity disease investigate logistic regression analysis result total .% symptomatic patient common present symptom fever .% loss smell cough .% .% covid- patient comorbiditie common comorbiditie hypertension .% diabetes mellitus .% heart disease respectively severity .% patient sign severe pneumonia associate factor severe pneumonia aged  year old adjust odd ratio aor ci overweight obesity aor ci current smoking aor ci conclusion study fifth patient develop severe pneumonia covid- patient aged  year old overweight obesity current smoker monitor carefully course treatment reduce disease severity
281,background common neurologic symptom report patient affect sars cov- headache dizziness myalgia mental fog anosmia grow basis publish case report stroke setting sars cov- infection literature suggest increased risk cerebrovascular accident cva setting covid- infection method search  database pubmed medline cinahl search term covid- novel coronavirus stroke cerebrovascular accident case series case study present patient positive covid- cva publish january  september include datum collection analysis complete risk bias assess result search identify  study  county comprise  patient patient hospitalize covid- infection cva average age common preexisting condition hypertension diabetes mellitus preexisting condition significantly young average age hospitalize patient covid- cva bimodal association covid- infection severity majority patient classify mild critical covid- infection discussion datum suggest sars cov- risk factor develop stroke particularly patient hypertension diabetes furthermore young average age stroke patient sars cov- particularly patient zero identifiable preexisting condition create high suspicion sars cov- independent risk factor development stroke prove comparable control population datum suggest risk develop cva setting covid- infection dependent severity illness continued study understand epidemiologic factor covid- infection stroke pathophysiology covid associate hypercoagulable state
282,evidence real impact severe acute respiratory syndrome coronavirus  sars cov- infection preterm birth unclear available series report composite pregnancy outcome and/or stratify patient accord disease severity purpose research determine real impact asymptomatic mild sars cov- infection preterm birth maternal respiratory failure case control study involve woman admit sant anna hospital turin delivery  september   january cumulative incidence coronavirus disease- compare preterm birth case group n term delivery control group n woman spontaneous medically indicate preterm birth placental vascular malperfusion pregnancy relate hypertension complication include current past sars cov- infection determine nasopharyngeal swab testing detection igm igg antibody blood sample significant difference cumulative incidence coronavirus disease- case .% control group .% p= observe case group burden high prevalence know risk factor body mass index asthma chronic hypertension severe coronavirus disease- logistic regression analysis show asymptomatic mild sars cov- infection independent predictor spontaneous medically indicate preterm birth pregnancy relate hypertension complication confidence interval pregnant patient comorbiditie need reassure asymptomatic mild sars cov- infection increase risk preterm delivery preterm birth severe coronavirus disease- share common risk factor i.e. body mass index asthma chronic hypertension explain high rate indicate preterm birth maternal condition report literature
283,background covid- newly emerge infectious disease spread globally unpredictable unique pattern extent world health organization announce covid- pandemic couple month study aim describe clinical demographic feature covid- patient influence risk factor severity disease method research retrospective study base saudi arabia ministry health covid- datum analysis rely datum covid- patient record riyadh st march  th july statistical analysis perform investigate effect demographic characteristic clinical presentation comorbiditie infection severity result total number  covid- patient identify base demographic datum follow  case case male  case case saudi patient diagnose mild sign symptom  case  patient case demonstrate moderate sign symptom  case severe  critical febrile illness fever cough sore throat shortness breath common symptom patient covid- study comorbiditie covid- patient diabetes mellitus hypertension prevalent result bivariate logistic regression analysis reveal old age diabetes mellitus asthma smoking fever associate severe critically ill case conclusion finding study old age fever comorbiditie involve diabetes mellitus asthma smoking significantly associate infection severity
284,background aim coronavirus disease  covid- patient severe complication show comorbiditie cardiovascular disease hypertension type  diabetes mellitus clinical disorder share common metabolic alteration insulin resistance dyslipidaemia high triglyceride high density lipoprotein cholesterol tg hdl c ratio associate reduce insulin sensitivity metabolic syndrome adverse cardiovascular event aim study determine association different component lipid profile particularly tg hdl c ratio severe complication like requirement invasive mechanical ventilation covid- patient method collect demographic clinical biochemical datum conduct cohort study  adult patient confirmed covid- diagnosis quantitative polymerase chain reaction qpcr baseline subsequent  day patient subject similar treatment scheme jak/ inhibitor ruxolitinib descriptive statistic variable association logistic regression apply identify predictor disease severity element calculation lipid profile result patient aged   year .% male require hospitalization .% female hospitalize common comorbiditie type  diabetes mellitus hypertension hospitalize critical care patient show low hdl c blood level increase tg hdl c ratio outpatient management mild asymptomatic covid- tg hdl c ratio correlate variable disease severity lactate dehydrogenase ldh level r p tg hdl c ratio predict requirement invasive mechanical ventilation ci p conclusion tg hdlc ratio early biochemical marker covid- severe prognosis requirement invasive mechanical ventilation
285,
286,objective explore longitudinal trend sociodemographic characteristic report symptom laboratory finding pharmacological non pharmacological treatment comorbiditie -day hospital mortality hospitalize patient coronavirus disease  covid- method retrospective cohort study include patient diagnose covid- united states veterans health administration // follow focus analysis patient subsequently hospitalize categorize group base month hospitalization summarize finding descriptive statistic cuzick trend test examine difference distribution study variable month result study period identify patient covid- total patient hospitalize n die  day admission hospitalization increase time proportion patient die consistently decline n march n august patient hospitalize march compare august young average black urban dwell febrile dyspneic high frequency baseline comorbiditie include hypertension diabetes likely present abnormal laboratory finding include low lymphocyte count elevated creatinine lastly decline march august receipt mechanical ventilation .% hydroxychloroquine treatment dexamethasone .% .% remdesivir .% .% increase conclusion hospitalize patient covid- observe trend decrease disease severity mortality time
287,abstract novel coronavirus disease covid- cause severe acute respiratory syndrome coronavirus  sars cov- rapidly evolve global pandemic substantial morbidity mortality associate infection prompt understand potential risk factor predict patient outcome hypertension identify prevalent cardiovascular comorbidity patient infect covid- demonstrably increase risk hospitalization death initial study imply renin angiotensin aldosterone system inhibitor increase risk viral infection aggravate disease severity cause panic give high global prevalence hypertension nonetheless subsequent evidence support administration antihypertensive drug note increase severity covid- infection patient hypertension beneficial effect date precise mechanism hypertension predispose unfavorable outcome patient infect covid- remain unknown mini review elaborate pathology sars cov- infection coexist hypertension summarize potential mechanism focus dual role angiotensin convert enzyme  disorder renin angiotensin aldosterone system covid- hypertension effect proinflammatory factor release immune response gastrointestinal dysfunction covid- discuss
288,background consider widespread risk collider bias confound indication previous research association renin angiotensin aldosterone system raas inhibitor use covid- remain unknown accordingly study test hypothesis raas inhibitor influence summation effect covid- progression severe outcome method results nationwide cohort study compare resident sweden prior cardiovascular disease monotherapy january raas inhibitor calcium channel blocker thiazide diuretic comparative cohort balance machine learn derive propensity score method  people analysis woman  hospitalize die covid- raas inhibitor versus  calcium channel blocker thiazide diuretic cox proportional hazard ratio hr ci outcome assess separately  people hospitalize covid- hr ci .-  die covid- hr ci severity covid- outcome differ raas inhibitor calcium channel blocker thiazide diuretic order logistic regression odd ratio ci conclusion despite potential limitation study good available evidence raas inhibitor use primary prevention increase risk severe covid- outcome present strong datum scientist policy maker alike base great confidence current position safety raas inhibitor covid- pandemic
289,introduction kidney involvement range mild hematuria proteinuria acute kidney injury aki patient coronavirus disease- covid- recent finding incidence rate report hospitalize patient covid- give aki rate associated risk factor lack aki recovery majority patient hospitalize covid- limited datum aki patient covid- iran aim investigate potential risk factor aki development incidence patient hospitalize covid- method retrospective cohort study enrol adult patient refer sina hospital iran february  positive pcr test highly susceptible chest compute tomography feature consistent covid- diagnosis aki define accord kidney disease improve global outcome criterion patient stratify base aki staging evaluate risk indicator associate aki hospitalization hospital outcome recovery rate time discharge result evaluate  patient mean age year male female ratio admit covid- diagnosis aki development observe  patient comprise .% patient stage stage .% stage patient aki occur  .% patient hospital course  .% patient arrive aki admission aki development positively associate hospital outcome include intensive care unit admission need invasive ventilation acute respiratory distress syndrome ards acute cardiac injury acute liver injury multiorgan damage mortality patient stage  aki show significantly high mortality rate ards need invasive ventilation stage multivariable analysis male sex odd ratio chronic kidney disease ckd history hypertension disease severity high urea level admission independent risk indicator aki development  .% patient experience aki survive  .% patient recovery aki  .% patient exhibit recovery time discharge discussion conclusion find male sex history ckd hypertension disease severity high serum urea independent risk factor associate aki patient covid- high stage aki associate increase risk mortality hospital complication result indicate necessity precise care monitoring aki hospitalization patient covid- lack aki recovery time discharge common complication patient
290,background patient underlie heart failure hf setting covid- require admission intensive care unit icu present unique set challenge study aim extensively describe characteristic outcome patient hf admit icu covid- method conduct multicenter retrospective analysis adult patient hf objectively confirm diagnosis covid- admit icu march  august saudi arabia result total  critically ill patient covid- admit icu study period  patient hf  patient hf admission icu patient hf statistically significant comorbiditie include diabetes mellitus hypertension dyslipidemia atrial fibrillation acute coronary syndrome high baseline severity score apache ii sofa score nutritional risk nutric score observe hf patient overall patient hf hospital icu death comparison patient hf .% vs. .% p value .% vs. p value respectively patient hf similar incidence thrombosis icu length stay duration mechanical ventilation hospital length stay compare patient hf conclusion study patient hf hospital icu death patient hf history hf help direct case management hospitalization possibly dictate proactive covid- care
291,background world health organization report  people worldwide infect severe acute respiratory syndrome coronavirus causative agent coronavirus disease  covid- september aim aim investigate long term use renin angiotensin aldosterone system raas inhibitor treatment hypertension aggravate performance covid- patient hypertension method retrospective analysis lung compute tomography ct datum laboratory value covid- patient hypertension admit huoshenshan hospital wuhan hubei province february  march patient divide group group include  people long term user raas inhibitor hypertension group b include  people randomly select database match group age sex basic disease long term use antihypertensive drug patient undergo series ct laboratory test compare severe ct image group laboratory examination result  d correspond ct image result time severe ct image onset covid- d group d group b. difference group significant t p significant difference blood laboratory value c reactive protein marker cardiac injury liver function kidney function group significant difference appearance ct image group semiquantitative score involved lobe group group b. difference significantly different t p conclusion chest ct important imaging tool monitor characteristic covid- degree lung injury chronic use raas inhibitor relate severity covid- worsen clinical process
292,diabetes mellitus dm coronavirus disease  covid- public health issue worldwide comorbiditie trigger progress severe disease death patient globally dm affect estimate adult april world health organization confirm covid- confirm case virus spread droplet aerosol direct touch numerous predictive factor link covid- severity include impaired immune response increase inflammatory response angiotensin receptor blocker angiotensin convert enzyme  identify play boost role susceptibility severity severe acute respiratory syndrome coronavirus  sars cov- specifically dm patient control management pandemic herculean restriction period markedly hamper maintenance mean control glycemia hypertension neuroendocrine kidney disease addition result underlyin cardio metabolic immunological disorder dm patient high risk develop severe form covid- despite comorbiditie hypertension potentially boost development high covid- severity non dm patient sars cov- cause transient hyperglycemia induction insulin resistance and/or pancreatic beta cell injury strict glucose monitoring dm patient covid- mandatory prevent life threaten complication
293,romania officially declare severe acute respiratory syndrome coronavirus- sars cov- case february large coronavirus disease  covid- outbreak romania record suceava north east region country originate suceava regional county hospital follow shelter place measure infection rate decrease rise relaxation measure study describe spread sars cov- suceava part romania analyse mutation association clinical manifestation disease period covid- outbreak sample sequence high throughput platform screen variant select mutation putative biological significance assess effect disease severity phylogenetic analysis conduct romanian genome n sequence originate europe united kingdom africa asia south north america n result indicate multiple introduction event sars cov- suceava mainly italy spain united kingdom russia sequence relate czechia belgium france suceava genome contain mutation common european lineage ag approximately sample miss mutation indicate possible different arrival route overall genome region s orf subject mutation recur mutation av identify mainly present severe form disease non synonymous mutation tn thrasn nspa domain associate change protein responsible decrease viral tethering human host present patient diabetes hypertension exhibit high risk ratio rr acquire severe form disease mainly relate av mutation study identify arrival route sars cov- romania reveal potential association sars cov- genomic organization circulate country clinical manifestation covid- disease
294,aim meta analysis aim analyze association calcium channel blocker ccb use covid- clinical outcome method pubmed proquest science direct scopus database search systematically limited period primary outcome mortality result total patient  eligible study include pooled analysis random effect model reveal ccb associate reduce mortality ci p interestingly subgroup analysis hypertensive patient reveal significantly reduce mortality ci p conclusion ccb usage associate outcome covid- ccb associate decrease mortality rate hypertensive covid- patient
295,importance patient diabetes know increase risk infection include severe coronavirus disease  covid- relationship covid- severity specific pre infection glucose level know objective assess differential effect pre infection glucose level risk severe covid- patient diabetes design population base historical cohort study setting national state mandate hmo patient adult patient positive sars cov test march october exposure recent fast blood glucose fbg glycated hemoglobin hbac age gender body mass index bmi diagnosis diabetes hypertension ischemic heart disease outcome risk severe covid- define result hospitalization day icu admission death result patient positive sars cov test identify  define severe unadjusted risk factor severe disease age year increase ci p male gender ci p bmi  kg m increase ci p control factor find association pre infection fbg risk severe covid- differential effect patient diagnosis diabetes patient diabetes elevate fbg pre diabetes range mg dl associate severe covid- ci p patient diagnosis diabetes find j shape association pre infection glucose control risk severe covid- low risk patient fbg mg dl risk increase high pre infection glucose level strikingly patient low pre infection fbg mg dl hbac .% conclusion relevance elevated pre infection blood glucose risk factor severe covid- non diabetic patient diagnosis diabetes high low pre infection glucose level risk factor severe covid- research require assess association causal believe finding clinical implication covid- risk assessment stratification
296,background coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- spread worldwide objective investigate association hypertension severity mortality hospitalize patient covid- wuhan china method total  patient diagnose covid- seventh hospital wuhan city january  february enrol analyze retrospective single center case study significance level adopt statistical analysis result  patient confirmed diagnosis covid-  .% discharge hospital  patient .% die median age  year range year  patient diagnose hypertension admission median age year range year  .% ci man p=. patient hypertension present significantly high portion severe case .% ci:.%-.% vs.  .% ci severe patient  .% ci:.%-.% vs.  .% ci critical patient p=. high mortality rate .% ci vs.  .% ci p=. hypertensive patient present abnormal level multiple indicator lymphopenia inflammation heart liver kidney lung function admission hypertension group display high level tnt creatinine approach discharge conclusion hypertension strongly associate severity mortality covid- aggressive treatment consider covid- patient hypertension especially cardiac kidney injury
297,analyze datum  confirm patient novel coronavirus  infection covid- early period nationwide lockdown announce india declaration pandemic analyze epidemiological clinical characteristic outcome hospitalization  patient positive result novel corona virus sars cov- rna testing trace basis history travel contact confirm covid- case resident hotspot area presence symptom provide accurate estimate proportion asymptomatic case initial population  patient enrol study asymptomatic symptomatic seventy seven .% male female eighteen .% patient associate comorbiditie prevalent diabetes mellitus hypertension chronic obstructive pulmonary disease copd chronic kidney disease ckd coronary artery disease cad cerebro vascular disease cvd clinical spectrum symptomatic covid- patient varied dry cough fever respiratory failure multi organ failure .% patient keep intensive care unit icu ninety .% patient recover .% die hospital stay majority covid- case india asymptomatic change biochemical inflammatory profile small insignificant asymptomatic patient compare symptomatic patient elevated nlr lymphopenia age presence comorbiditie associate increase severity poor outcome
298,background visceral adipose tissue epicardial adipose tissue eat pro inflammatory property associate coronavirus disease  covid- severity aim investigate association exist eat material method retrospectively measure eat volume compute tomography ct scan semi automatic software inpatient covid- analyze correlation eat volume anthropometric characteristic comorbiditie analyze clinicobiological radiological parameter associate severe covid- o formula text  l min intensive care unit icu admission death ct lung involvement key indicator covid- severity result include  consecutive patient man mean age year obese hypertension diabetes cardiovascular event history severe covid- n associate eat volume  vs   cm p age ferritinemia ct lung involvement icu admission death n associate eat volume  vs   cm p hypertension ct lung involvement association eat volume severe covid- remain adjustment sex bmi ferritinemia lung involvement adjustment age instead association eat volume icu admission death remain adjustment parameter conclusion result suggest measure eat volume chest ct scan hospital admission patient diagnose covid- help assess risk disease aggravation
299,objective describe mortality hospital patient covid- compare risk factor survivor non survivor design prospective cohort adult inpatient set tertiary healthcare teaching hospital guadalajara mexico participant patient confirm covid- hospitalise  march  september  include end study  november primary outcome measures patient survival analyse kaplan meier method comparison factor log rank test mortality risk factor analyse multivariate cox proportional hazard model result thousand patient include  die  alive discharge .% remain hospitalise predominance man high frequency overweight obesity hypertension diabetes lung cardiovascular kidney disease significantly frequent non survivor overweight obesity different group severity disease manchester triage system quick sequential organ failure assessment significantly bad non survivor significantly old vs  year respectively haematological biochemical coagulation inflammatory biomarker altered survivor mortality predictor invasive mechanical ventilation imv p admission intensive care unit icu p age p manchester triage system urgent p=. immediate urgent p=. baseline c reactive protein crp p=. antecedent kidney disease p=. conclusion mortality hospitalise patient covid- emerge country centre high develop country patient display high frequency risk factor poor outcome need imv icu admission old age severe disease admission antecedent kidney disease high crp level significantly predict mortality
300,background understand long term effect coronavirus disease  covid- cognitive function essential monitor cognitive decline elderly population study aim assess current cognitive status longitudinal cognitive decline elderly patient recover covid- method cross sectional study recruit  covid- inpatient aged  year discharge covid designate hospital wuhan china february  april total  uninfected spouse covid- patient select control current cognitive status assess chinese version telephone interview cognitive status- tics- longitudinal cognitive decline assess informant questionnaire cognitive decline elderly iqcode cognitive assessment perform  month patient discharge result compare control covid- patient low tics- score high iqcode score tics- median iqr  vs.  p iqcode median iqr vs. p severe covid- patient low tics- score high iqcode score non severe covid- patient tics- median iqr  vs.  p iqcode median iqr vs. p control tics- median iqr  vs.  p iqcode median iqr vs. p severe covid- patient high proportion case current cognitive impairment longitudinal cognitive decline non severe covid- patient dementia  vs.  p mild cognitive impairment mci  vs.  p control dementia  vs.  p mci  vs.  p covid- severity delirium copd risk factor current cognitive impairment low education level severe covid- delirium hypertension copd risk factor longitudinal cognitive decline conclusion severe acute respiratory syndrome coronavirus  sars cov- infection associate increase risk long term cognitive decline elderly population covid- patient especially severe patient intensively monitor post infection cognitive decline
301,coronavirus disease  covid- pandemic continue ravage world hospital overwhelm large number patient present major outbreak rapid triage covid- patient require hospitalization intensive care urgently need age comorbiditie associate high risk severe covid- sufficient triage patient investigate potential attenuate total reflectance fourier transform infrared atr ftir spectroscopy rapid blood test classification covid- disease severity cohort  covid- patient simple plasma processing atr ftir data acquisition procedure establish ethanol viral inactivation partial square discriminant analysis pls da model develop test datum   patient respectively addition atr ftir spectra clinical parameter age sex diabetes mellitus hypertension increase area roc curve c statistic training test datum set ci respectively independent test set achieve specificity .% sensitivity diabetes mellitus strong predictor model follow ftir region cm(- summary study demonstrate potential atr ftir spectroscopy rapid low cost covid- severity triage tool facilitate covid- patient management outbreak
302,background study report association atherosclerosis relate disease covid- relationship covid- severity atherosclerosis progression remain unclear aim study determine coronary artery calcium score cacs prognostic value patient covid- index deterioration oxygenation ct image chest method single centre retrospective study  consecutive patient covid- narita admit hospital march  august cacs calculate base non gated ct scan chest perform admission day patient divide follow group base cacs group  cacs /= n= group  cacs /= perform reveal unlike cacs /= associate exacerbation oxygenation ct image chest hospitalisation ci furthermore model variable show good calibration hosmer lemeshow p=. conclusion cacs prognosis marker covid- severity coronary artery calcification typically assess pneumonia case provide valuable clinical indicator predict severe covid- outcome
303,background cancer patient high risk infection severity coronavirus disease- covid- management patient infect severe acute respiratory syndrome coronavirus  sars cov- challenge scarce scientific information treatment guideline work present institutional experience  patient oncological malignancy covid- patient method conduct cross sectional study  patient hospitalise instituto nacional de enfermedades neoplasicas lima peru positive sars cov- reverse transcriptase rt)-pcr period  march  june clinicopathological variable oncological disease risk factor management outcome covid- evaluate result mean age year old standard deviation male patient total adult patient bear solid tumour adult haematologic malignancy paediatric patient respectively hypertension frequent comorbidity follow chronic lung disease covid associated symptom include cough fever dyspnoea percent patient asymptomatic nosocomial infection frequent paediatric patient .% adult patient patient uncontrolled oncological disease frequent anaemia present patient lymphopenia ferritin value  mcg l elevate lactate dehydrogenase ldh d dimer  ng ml c reactive protein  mg l. common complication acute respiratory failure overall fatality rate main cause mortality acute respiratory distress syndrome conclusion paediatric patient well outcome adult population high number asymptomatic carrier nosocomial infection early diagnosis recommend consider oncological treatment  day covid- diagnosis datum reveal increase mortality
305,background role angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb address study relate current coronavirus disease- covid- pandemic possible high severity mortality patient hypertension triple blind randomized control trial design evaluate effect medication covid- progression method patient enrol trial april september randomize group dosage aceis arb continue group group aceis arb replace amlodipine carvedilol accord dose equivalent primary outcome length stay hospital intensive care unit outcome include mechanical ventilation non invasive ventilation readmission covid- symptom discharge result randomize  patient covid- group patient aged year old  .%  .% respectively study group nearly similar baseline vital sign characteristic addition significant difference term record systolic diastolic blood pressure measurement group furthermore find significant difference day intensive care unit ward admission discharge rate readmission rate group conclusion randomized triple blind multi centric clinical trial deleterious effect acei arb medication hypertensive covid- patient
306,background statin anti inflammatory immunomodulatory effect reduce severity coronavirus disease  covid- organ dysfunction mediate severe inflammation large study diverse population evaluate statin use outcome covid- lack method result datum patient hospitalize covid- september   hospital enrol american heart association covid- cardiovascular disease cvd registry evaluate association statin use outcome prior admission subject n statin statin statin plus anti hypertensive death discharge hospice occur subject outpatient use statin anti hypertensive associate reduce risk death adjust odd ratio aor ci adjust demographic characteristic insurance status hospital site concurrent medication logistic regression propensity match analysis use statin and/or anti hypertensive associate reduce risk death history cvd and/or hypertension aor ci observed reduction odd death cvd and/or hypertension statistically significant conclusion patient take statin prior hospitalization covid- substantially low odd death primarily individual history cvd and/or hypertension observation support continuation aggressive initiation statin anti hypertensive therapy patient risk covid- treatment indicate base underlie medical condition
307,coronavirus  covid- pandemic present new challenge healthcare community sheer number individual affect range symptom presentation early finding show increase age independent risk factor covid- severity diabetes hypertension find strong independent risk factor severe covid- later discover obesity strong risk factor severe disease possible mechanism increase risk associate metabolic disease include increase prevalence acute respiratory syndrome immune cell dysfunction chronic inflammatory state associate obesity diabetes acknowledge risk factor consequence address vaccination strategy healthcare disparity
308,objective aim study describe main clinical phenotype laboratory finding severity coronavirus disease  covid- patient hospitalize high specialty medical unit  mexican social security institute method prospective observational cohort study total  patient hospitalize severe acute respiratory syndrome coronavirus  sars cov- infection high specialty medical unit  torreon coahuila mexico th august th case confirm covid- positive rt qpcr test clinical phenotype laboratory test evaluate determine degree severity disease frequent comorbiditie result clinical characteristic total  hospitalize patient female  male median age  year confirm covid- diagnosis study severity disease classify moderate grade .% severe grade .% critical grade frequent underlying pathology coexist overweight n .% obesity n .% diabetes n .% hypertension n .% patient present pathology association find diabetes odd ratio confidence interval ci p high level d dimer ci p conclusion retrospective cohort study patient covid- specialty hospital northeast region mexico observe clinical phenotype d dimer elevation compatible inflammatory state degree severity find hospitalize patient underlie chronic medical condition diabetes elevated d dimer level significantly associate increase mortality covid- age sex male factor highly associate mortality
309,introduction covid- pandemic challenge health care world severity disease high mortality rate consequence management patient chronic disease area cover review summarize date publish datum impact covid- management outcome patient chronic noninfectious respiratory illness include obstructive sleep apnea asthma chronic obstructive pulmonary disease bronchiectasis interstitial pulmonary vascular disease lung cancer expert opinion chronic respiratory disease asthma cystic fibrosis associate severe covid- poor outcome mechanism involve identify therapeutic management patient chronic respiratory disease covid- similar patient post recovery course bad population follow development pulmonary fibrosis bronchiectasis pulmonary hypertension pandemic highly impact usual medical activity limit access diagnosis procedure necessity develop new method monitoring disease adapt therapeutic strategy long term consequence change unknown
310,current global pandemic sars cov- infection extend world affect million life date new successful vaccine available promise outcome minimize spread reduce severity disease optimal therapeutic option remain elusive covid- convalescent plasma ccp investigational treatment option study suggest signal efficacy favorable outcome patient treat early course disease benefit use ccp later disease remain highly debate common practice report case severe sars cov- infection young male patient prolonged covid- positivity receive repeat dose ccp treatment later disease temporal clinical improvement patient case highlight need study evaluate efficacy repeat dosing ccp suggest potential successful use ccp later disease select covid- patient
311,report case minimal change disease mcd severe acute kidney injury aki follow injection chadox ncov- azd vaccine oxford astrazeneca coronavirus disease  covid- -year old man history dyslipidemia baseline serum creatinine .mg dl present nephrotic syndrome aki severe hypertension  day receive oxford astrazeneca vaccine refractory hyperkalemia hypervolemia oligoanuria prompt initiation hemodialysis serum albumin dl urinary protein creatinine ratio mg mmol give high suspicion rapidly progressive glomerulonephritis empirical glucocorticoid treatment initiate methylprednisolone pulse follow high dose prednisone kidney biopsy show mcd acute tubular injury kidney function proteinuria subsequently improve hemodialysis discontinue  day start therapy case describe de novo mcd oxford astrazeneca vaccine add publish case report mcd pfizer biontech covid- vaccine report study need elucidate mcd truly associate covid- vaccination
312,coronavirus disease  covid- pandemic cause severe acute respiratory syndrome coronavirus  sars cov- continue spread rapidly unresolved question virus impact autoimmune inflammatory joint disease autoinflammatory disorder main aim paper describe main study focus attention covid- incidence outcome rheumatoid arthritis ra spondylarthritis spa autoinflammatory disease cohort revise possible pathogenic mechanism associate available datum suggest patient ra spa immunosuppressive therapy old age male sex presence comorbiditie hypertension lung disease diabetes cvd chronic renal insufficiency end stage renal disease associate increase risk infection high rate hospitalization study show low odd hospitalization associate bdmard tsdmards monotherapy drive largely anti tnf therapy autoinflammatory disease consider possibility covid- associate cytokine storm syndrome question susceptibility severity sars cov- infection patient display innate immunity disorder raise context datum scarce study available clarify have autoinflammatory disorder risk factor develop severe covid- take observation study likely need fully characterize specific patient group associate sars cov- infection
313,continue rise sars cov infection globally emergence wave different country understand characteristic susceptibility infection clinical severity outcome remain vital retrospective study datum extract patient de identify mount sinai health system covid- database assess risk mortality base presence comorbiditie organ specific sequela cov positive patient prevalence cardiovascular metabolic comorbiditie high sars cov+ individual diabetes obesity coronary artery disease hypertension atrial fibrillation heart failure increase overall mortality risk asthma ethnicity modify risk mortality associate comorbiditie regard secondary complication setting infection individual acute kidney injury acute myocardial injury show increase mortality risk cerebral infarct acute venous thromboembolic event associate increase risk mortality biomarker cardiovascular injury coagulation inflammation compare deceased survive individual find cardiac coagulation biomarker elevate fall normal range deceased patient inflammatory marker evaluate increase deceased patient summary identify comorbiditie sequelae peripheral blood biomarker associate elevated clinical severity poor outcome covid- patient overall finding detail granularity previously report factor impact susceptibility clinical severity mortality course covid- disease
314,background therapeutic targeting host cell factor require sars cov- entry alternative strategy ameliorate covid- severity sars cov- entry lung epithelium require tmprss cell surface protease pre clinical correlative datum human suggest anti androgenic therapy reduce expression tmprss lung epithelium accordingly hypothesize therapeutic targeting androgen receptor signal degarelix luteinizing hormone release hormone lhrh antagonist suppress covid- infection ameliorate symptom severity method randomized phase placebo control double blind clinical trial  patient compare efficacy degarelix plus good supportive care versus placebo plus good supportive care improve clinical outcome male veteran hospitalize covid- enrol patient document infection sars cov- base positive reverse transcriptase polymerase chain reaction result perform nasopharyngeal swab severity illness level hospitalize require invasive mechanical ventilation patient stratify age history hypertension severity centrally randomized degarelix placebo composite primary endpoint mortality ongoing need hospitalization requirement mechanical ventilation  randomization important secondary endpoint include time clinical improvement inpatient mortality length hospitalization duration mechanical ventilation time achieve normal temperature maximum severity covid- illness exploratory analysis aim assess association cytokine viral load comorbiditie outcome addition tmprss expression target tissue development anti viral antibody investigate discussion trial repurpose fda approve lhrh antagonist degarelix commonly prostate cancer suppress tmprss host cell surface protease require sars cov- cell entry objective determine temporary androgen suppression single dose degarelix improve clinical outcome patient hospitalize covid- trial registration clinicaltrials.gov nct register
315,novel severe acute respiratory syndrome sars coronavirus- cause covid- disease result severe morbidity mortality especially vulnerable group pregnancy virtue physiological anatomical adaptation increase risk severe infection especially respiratory tract single strand rna virus transmit droplet soiled fomite degree disease severity- asymptomatic mild moderate severe critical infection pregnancy asymptomatic mildly symptomatic woman consequence mother pregnancy minimal additional risk factor diabetes hypertension cardiorespiratory disease obesity ethnic minority background woman symptom present fever unproductive cough sore throat myalgia nasal congestion loss smell taste associated leukocytosis lymphopenia diagnosis rt pcr nasopharyngeal flock swab saliva pathognomonic feature ground glass appearance pulmonary infiltrate chest x ray ct scan management pregnancy non pregnant woman covid- indication elective delivery assist delivery second stage moderate severe critical disease require shorten stage covid- indication interrupt pregnancy caesarean section perform facilitate ventilation support resuscitation severe disease pain relief labour different regional analgesia prefer operative delivery postpartum thromboprophylaxis consider breast feeding encourage appropriate precaution minimize vertical transmission pregnant lactate woman encourage receive mrna base vaccine evidence adverse outcome
316,objective measure association race ethnicity comorbiditie insurance status need hospitalization symptomatic emergency department patient severe acute respiratory syndrome coronavirus  sars cov- infection method study cohort study symptomatic patient present single emergency department ed laboratory confirm sars cov- infection march -august collect patient level information demographic insurance status comorbiditie level care mortality structured chart review compare characteristic patient categorize home discharge general hospital ward admission intensive care unit icu admission death  day index visit univariate multivariable logistic regression analysis perform report odd ratio confidence interval ci hospital admission versus ed discharge home icu care versus general hospital ward admission result total  patient present ed symptom include analysis  .% patient discharge home  .% patient admit general hospital ward  .% admit icu die patient require admission likely black public insurance medicaid and/or medicare patient admit icu die likely age  year male multivariable logistic regression old age public insurance diabetes hypertension obesity heart failure hyperlipidemia independent predictor hospital admission compare need icu care versus general hospital ward admission univariate logistic regression patient medicaid ci medicare ci medicaid medicare ci history chronic obstructive pulmonary disease ci hypertension ci heart failure ci .- likely admit icu die black ci hispanic latino ci patient likely admit icu association statistically significant multivariable logistic regression old age male sex public insurance heart failure independent predictor icu care death conclusion comorbiditie public insurance predictor severe illness patient sars cov- study suggest disparity severity see covid- black patient attributable low socioeconomic status chronic health condition
317,coronavirus disease  covid- pandemic necessitate scaling hospital care prohibit spread severe acute respiratory syndrome coronavirus- assess patient perception quality care telesurvey cohort write questionnaire cohort analyze trend elective nonelective admission december  february march covid- pandemic austria total  outpatient recruit cohort   patient cohort admission december   division gastroenterology hepatology vienna general hospital analyze total n  cohort  n  cohort  telemedical contact n  n  face face visit total n  need acute medical help health care restriction n  report contact physician covid- difficult impossible patient report satisfaction treatment decrease significantly restriction cohort  visual analog scale vas p insignificantly cohort  vas p despite few hospital admission covid- proportion nonelective admission intensive care unit admission .% increase patient cirrhosis nonelective admission covid- significantly high model end stage liver disease meld vs. interquartile range p deltameld difference meld vs. p require immediate intensive care frequently .% vs. .% p significantly increase -day liver relate mortality .% vs. .% p conclusion covid- pandemic effect quality liver care evident decrease patient satisfaction hospitalization sick patient advanced chronic liver disease increase liver relate mortality strategy improve telemedical liver care preemptive treatment cirrhosis relate complication need counteract covid associated restriction hospital care
318,novel coronavirus begin spread china wuhan gradually spread country lead announcement world health organization march new pandemic important point present world health organization disease well understand risk factor exacerbate course disease worsen prognosis high majority cardio metabolic risk factor like obesity hypertension diabetes dyslipidemia population  year old high cardio metabolic risk factor age people worsen prognosis coronavirus disease  covid- mortality study aim review article beginning pandemic impression cardio metabolic risk factor covid- effectiveness covid- manage disease factor study article include hypertension diabetes mellitus dyslipidemia obesity exacerbate course covid- disease different mechanism inflammatory process cause coronavirus create vicious cycle control disease patient
319,relationship covid- diabetes mellitus complicated bidirectional hand diabetes mellitus consider important risk factor severe course covid- factor present diabetes mellitus likely contribute risk old age proinflammatory hypercoagulable state hyperglycemia underlying comorbiditie hypertension cardiovascular disease chronic kidney disease obesity hand severe covid- infection treatment steroid specific negative impact diabetes lead worsen hyperglycemia increase insulin resistance reduce beta cell secretory function worsen hyperglycemia turn adversely affect course covid- knowledge gradually surface pandemic progress challenge understand interrelationship covid- diabete remain
320,background grip strength main component physical functioning sarcopenia physical frailty objective explore role grip strength measurement admission predict disease severity covid- method demographic datum smoking status comorbiditie covid- related symptom grip strength laboratory compute tomography ct finding admission note smedley hand dynamometer maximum grip strength value kg measurement dominant record low grip strength define standard deviation gender specific peak mean value healthy young adult oxygen saturation /=% extensive lung involvement ct moderate illness group pneumonia ct score mild illness group normal ct finding result study population include  patient f  m distribution mild moderate severe disease group .% .% respectively cough fever dyspnea hypertension obesity cardiovascular disease cvd chronic obstructive pulmonary disease copd frequent c reactive protein crp ferritin d dimer neutrophil level high severe group p absolute grip strength value low frequency have low grip strength high severe group p find significant difference stem severe group combine mild moderate group non severe compare severe vs. non severe group binary logistic regression analysis age gender body mass index smoking status presence comorbiditie low grip strength abnormal laboratory finding take analysis age odd ratio confidence interval ci obesity ci copd ci crp level ci low grip strength ci observe independent predictor severe covid- disease p conclusion addition know independent risk factor i.e. age obesity copd crp level low grip strength independently increase time severity covid-
321,coronavirus disease  covid- turn pandemic short period time high transmissibility causative agent severe acute respiratory syndrome coronavirus report suggest promising link overexpression angiotensin convert enzyme  ace covid- pathogenesis severity covid- pathophysiology greatly depend comorbiditie like hypertension diabetes mellitus dm respiratory cardiovascular disease dm emerge major risk factor current review focus link expression ace use ace inhibitor aceis angiotensin ii type  receptor blocker arb risk covid- pathogenesis dm review emphasize synergistic detrimental effect dm covid- immune system provoke uncontrolled cytokine storm eventually lead lethal consequence finally possible therapeutic strategy highlight reduce excess risk associate covid- people dm
322,aim association cardiovascular disease coronary artery disease hypertension bad outcome covid- patient previously demonstrate effect prior diagnosis heart failure hf reduce preserve leave ventricular ejection fraction covid- outcome establish method result retrospectively study adult patient covid- admit institution march st nd patient group base presence absence hf compete event survival model examine association hf death need intubation need dialysis hospitalization  patient admit covid-  patient .% prior diagnosis hf patient hf old low body mass index significantly high burden co morbidity compare patient hf group present hospital similar clinical severity similar marker systemic inflammation patient hf high cumulative hospital mortality compare patient hf .% vs. .% p remain statistically significant hr p adjustment age body mass index comorbiditie propensity score matching hr p notably difference mortality need mechanical ventilation renal replacement therapy observe hf patient preserve reduce ejection fraction conclusion presence hf risk factor death substantially increase hospital mortality patient admit covid-
323,study aim determine relationship hyperglycemia hg presence type  diabetes td outcome covid- demographic datum blood glucose level bg measure admission hospital outcome covid- patient hospitalize boston university medical center  march  august  extract hospital database hg define bg  mg dl. patient type  diabetes bg  mg dl exclude total  patient td  patient td include study mean sd age   year  female hg occur   patient td respectively overall hospital mortality rate patient td hg statistically significantly associate mortality icu admission intubation acute kidney injury severe sepsis septic shock adjust potential confounder p icu admission acute kidney injury associate hg patient td p  patient hg presence td associate decrease odd mortality icu admission intubation severe sepsis septic shock adjust potential confounder include bg p conclusion hg subset patient td strong indicator high inflammatory burden lead high risk severe covid-
324,introduction severe covid- illness adult link underlie medical condition study identify frequent underlying condition attributable risk severe covid- illness method datum  hospital premier healthcare database special covid- release phd sr describe hospitalize patient age  year old covid- march  march multivariable generalized linear model estimate adjusted risk intensive care unit admission invasive mechanical ventilation death associate frequent condition total number condition result hospitalize adult phd sr .% patient covid- .%  underlie medical condition essential hypertension .% disorder lipid metabolism .% obesity .% common strong risk factor death obesity adjust risk ratio arr ci .- anxiety fear relate disorder arr ci .- diabete complication arr ci .- total number condition arrs death range ci .- patient  condition ci .- patient  condition compare patient condition conclusion certain underlie condition number condition associate severe covid- illness hypertension disorder lipid metabolism frequent obesity diabete complication anxiety disorder strong risk factor severe covid- illness careful evaluation management underlying condition patient covid- help stratify risk severe illness
325,background severe acute respiratory syndrome coronavirus- sars cov- cause covid- pandemic cause increase mortality especially elderly patient severe complication chronic pulmonary obstruction hypertension diabetes cancer nutrition especially micronutrient play important role reduce mortality complication covid- micronutrient strengthen immune system nutritional status important factor affect outcome patient covid- micronutrient selenium important effect intrinsic acquire immunity host selenium deficiency affect viral genome increase virulence virus investigate serum selenium level covid- patient healthy control individual method total  patient covid- infection include study hospitalization  patient die non survivor group  patient recover survivor group assess serum selenium level  covid- patient  healthy individual agilent spectraa- z atomic absorption spectrometer result serum selenium level significantly low covid- patient  mug l compare healthy control individual mug l significant difference survivor non survivor group significant relationship serum selenium level laboratory finding covid- patient conclusion result suggest decrease serum selenium level risk factor covid- infection significant relationship selenium severity mortality covid- disease
326,background comprehensive evidence synthesis association comorbiditie behavioural factor hospitalisation intensive care unit icu admission death covid- require derive national international recommendation primary target non pharmacological intervention npi vaccination strategy method perform rapid systematic review meta analysis study publicly accessible datum quantify association predispose health condition demographic behavioural factor hand hospitalisation icu admission death covid- hand provide range report calculate effect estimate pool relative risk derive meta analysis meta regression result seventy study include qualitative  quantitative synthesis study population range  covid- case risk die covid- significantly associate cerebrovascular pool relative risk rr ci .- cardiovascular rr ci .- disease hypertension rr ci .- renal disease rr ci .- high heterogeneity pooled estimate partly solely explain age study participant comorbiditie meta regression show decrease effect severity disease high median age study population compare death association comorbiditie hospitalisation icu admission pronounce conclusion obtain robust estimate magnitude risk covid- hospitalisation icu admission death associate comorbiditie demographic behavioural risk factor estimate modify age study participant interaction important finding keep mind current vaccination strategy protection individual high risk severe covid- course
327,background systematic review meta analysis aim compare level von willebrand factor vwf antigen patient coronavirus disease  covid- poor outcome compare good outcome explore factor affect difference term vwf antigen group method comprehensive literature search pubmed embase scopus database undertake inception  april primary outcome poor outcome composite mortality severity covid- result study include total  patient include systematic review meta analysis vwf antigen high patient poor outcome standardized mean difference smd p i()=. p subgroup analysis study report vwf antigen level percentage mean difference p i()=. p meta regression show smd poor outcome good outcome affect platelet count coefficient p=. d dimer level coefficient p=. factor viii level coefficient p=. age coefficient p=. gender coefficient p=. obesity coefficient p=. hypertension coefficient p=. diabetes coefficient p=. malignancy coefficient p=. conclusion meta analysis show level vwf antigen significantly high patient covid- poor outcome signal mark endotheliopathy meta regression show difference large platelet count d dimer level factor viii level increase
328,objective coronavirus disease  covid- pandemic raise concern inflammatory bowel disease ibd patient fear increase risk infection poor outcome aim evaluate incidence covid- ibd patient influence disease severity outcome relationship medication use pandemic affect ibd management method anonymous questionnaire post online member israel crohn disease ulcerative colitis foundation november -january questionnaire address course ibd disease covid- infection past year result total  ibd patient complete questionnaire  .% infect covid- significantly low expect infect case israeli population p median age participant  year .% female patient .% comorbiditie ibd correlation find ibd type disease severity covid- infection ibd patient report mild covid- disease regardless type ibd medication multivariable logistic regression analysis reveal young age elevate bmi diabete independent risk factor covid- infection ibd treatment method include -aminosalicylic acid smoking hypertension protective factor total covid- patient discontinue ibd treatment compare .% non covid infected patient ibd flare significantly high discontinue treatment p conclusion ibd patient increase risk covid- regardless ibd activity treatment patient encourage continue effective ibd therapy include biologic steroid minimize active ibd
329,introduction debatable fact estimate risk severity coronavirus disease covid- liver transplant recipient assess impact immunosuppressive therapy clinical course incidence liver failure material method present prospective study liver transplant recipient severe acute respiratory syndrome coronavirus sars cov- infection admit treatment department clinic abdominal surgery military medical academy sofia diagnosis confirm positive reverse transcription polymerase chain reaction rt pcr test sars cov- infection naso pharyngeal swab covid- severity estimate mild oxygen saturation spo room air imaging finding pneumonia moderate spo imaging suggestive pneumonia severe need high flow oxygen supplementation result liver transplant recipient covid- admit treat department male mean age year liver transplantation perform year patient different clinical form disease register mild n= moderate n= severe n= patient severe disease comorbiditie hypertension diabetes obesity patient mild moderate disease receive dual immunosuppressive therapy tacrolimus mycophenolate mofetil severe disease tacrolimus dose reduction tacrolimus undertake follow serum level evaluation change dose mycophenolate mofetil dual therapy patient severe disease die respiratory failure lead case fatality rate .% conclusion early diagnosis hospitalization possible essential prompt initiation treatment prevention complication development severe form covid- liver transplant recipient especially patient comorbiditie hypertension diabetes obesity course treatment dose reduction immunosuppressive therapy discontinuation especially calcineurin inhibitor mono- dual therapy regimen
330,identification high risk patient admit intensive care covid- inform management strategy objective meta analysis determine factor associate mortality adult covid- admit intensive care search database study publish  january   december observational study covid- adult admit critical care include study mixed cohort intensive care cohort restrict specific patient sub group exclude dichotomous variable report pool ci continuous variable pool standardised mean difference smd ci study patient include review increase age smd ci smoking ci hypertension ci diabetes ci cardiovascular disease ci respiratory disease ci renal disease ci malignancy ci .- associate mortality high sequential organ failure assessment score smd ci acute physiology chronic health evaluation- score smd ci low pao fi o smd ci need mechanical ventilation admission ci .- associate mortality high white cell count smd ci neutrophil smd ci d dimer smd ci ferritin smd ci low platelet smd ci lymphocyte count smd ci associate mortality conclusion increase age pre existing comorbiditie severity illness base validate scoring system host response disease associate mortality male sex increase bmi factor prognostic relevance patient admit intensive care covid-
331,purpose review highlight epidemiology pathophysiology hypertension obesity covid- infection recent finding hypertension obesity emerge significant risk factor contract covid- virus subsequent severity illness ace receptor expression dysregulation raas pathway play important role pathophysiology association pro inflammatory state cytokine dysregulation see obesity pattern see historically viral illness understand mechanism association covid- hypertension obesity important develop effective targeted therapy monitor vaccine response efficacy research need apply grow knowledge pathophysiology covid- hypertension obesity prevention treatment intervention focus lifestyle modification manage hypertension obesity potentially positive impact contain pandemic future viral illness outbreak
332,background unclear suggest link covid- pregnancy preeclampsia independent association cause common risk factor objective study aim quantify independent association covid- pregnancy preeclampsia determine effect variable maternal neonatal morbidity mortality study design large longitudinal prospective unmatched diagnose diagnose observational study assess effect covid- pregnancy mother neonate consecutive diagnose woman concomitantly enrol immediately diagnose woman identify stage pregnancy delivery level care minimize bias woman neonate follow hospital discharge standardized intergrowth-(st protocol electronic datum management system total  institution  country contribute study sample independent association  entity quantify risk factor know associate preeclampsia analyze group outcome compare woman covid- preeclampsia condition  condition result enrol  pregnant woman  .% enrol covid- diagnose  .% covid- diagnose group woman  preeclampsia   .% covid- diagnose group   .% diagnose group risk ratio confidence interval adjustment sociodemographic factor condition associate covid- preeclampsia risk ratio preeclampsia remain significant woman risk ratio confidence interval nulliparous woman specifically risk ratio confidence interval trend statistical significance parous woman risk ratio confidence interval risk ratio preterm birth woman diagnose covid- preeclampsia confidence interval confidence interval nulliparous woman compare woman condition diagnose composite adverse perinatal outcome show stepwise increase risk ratio covid- preeclampsia preeclampsia covid- covid- preeclampsia risk ratio confidence interval risk ratio confidence interval risk ratio confidence interval .- respectively similar finding find composite adverse maternal outcome risk ratio confidence interval confidence interval confidence interval association covid- gestational hypertension direction effect preterm birth adverse perinatal maternal outcome similar preeclampsia confine nulliparous woman low risk ratio conclusion covid- pregnancy strongly associate preeclampsia especially nulliparous woman association independent risk factor preexisting condition covid- severity factor association condition associate independently additive fashion preterm birth severe perinatal morbidity mortality adverse maternal outcome woman preeclampsia consider particularly vulnerable group regard risk pose covid-
333,background socio demographic comorbiditie involve determine severity fatality patient covid- suggest study country study bangladesh insufficient aims design study evaluate association sociodemographic comorbiditie prognosis adverse health outcome patient covid- bangladesh method multivariate retrospective cohort study conduct datum  rt pcr positive patient division december february variable include sociodemographic comorbiditie symptom charlson comorbidity index cci access health facility major outcome fatality secondary outcome include hospitalization duration hospital stay requirement mechanical ventilation severity result male .%  predominant mean age year fever dry cough loss test smell frequent patient symptom fatality record .% patient comorbiditie find patient hypertension .% diabetes .% cardiovascular disease .% prevalent age year ci cci ci predictor hospitalization cci aor ci predictor severity age year aor ci symptom aor ci cci vs. cci  symptom increase comorbiditie high cci associate increase hospitalization severity fatality patient covid-
334,objective aim assess prevalence severe acute respiratory syndrome coronavirus  sars cov- factor associate seropositivity asymptomatic coronavirus disease  covid- people hiv pwh method cross sectional study carry cohort spanish hiv research network participant consecutive pwh plasma collect st april th september determine sars cov- antibody abs plasma illness severity nih criterion assess review medical record need participant interview multivariable logistic regression analysis identify predictor seropositivity follow variable sex age country birth education level comorbiditie hypertension chronic heart disease diabetes mellitus non aids relate cancer chronic kidney disease cirrhosis route hiv acquisition prior aids cd+ cell count hiv viral load nucleoside nucleotide reverse transcriptase inhibitor n t]rti backbone type antiretroviral drug month sample collection result  pwh .% male median age  year .% antiretroviral therapy median cd+  cell mm .% undetectable hiv viral load sars cov- abs detect  pwh seroprevalence ci infection .% asymptomatic variable independently associate sars cov- seropositivity birth latin american country versus spain adjust odd ratio aor ci p therapy tenofovir disoproxil fumarate plus emtricitabine tdf ftc versus tenofovir alafenamide taf)/ftc n(t)rti backbone aor ci p conclusion sars cov- infection pwh asymptomatic birth latin american country increase risk sars cov- seropositivity analysis adjust comorbiditie variable suggest tdf ftc prevent sars cov- infection pwh
335,background aim reveal chronic disease age gender affect morbidity mortality patient coronavirus disease  covid- method medical record reverse transcription polymerase chain reaction rt pcr positive covid- patient follow hospital home isolation th mar  th  retrospectively patient kayseri province turkey patient demographic clinical characteristic factor associate morbidity mortality analyze result patient  .% alive  .% die fatality rate difference age group term fatality rate p fatality rate patient age  yr significantly high fatality rate male gender time high p time higher advanced age p time higher patient comorbid disease p hypertension increase mortality time p chronic pulmonary disease time p conclusion advanced age male gender accompany chronic disease adverse effect course severity disease hospitalization increase rate risk mortality
336,covid- calamitous effect global community despite intense study immunologic response infection partially understand addition old age ethnicity patient comorbiditie include obesity diabetes hypertension coronary artery disease malignancy renal pulmonary disease experience severe outcome patient primary immunodeficiency pid secondary immunodeficiency appear increase risk covid- addition vulnerability sars cov- patient pid chronic pulmonary disease respond vaccine exacerbate long term risk patient common variable immunodeficiency disorder frequent symptomatic pid adult child spectrum b- t cell defect possible stratify risk severe covid- base age ethnicity severity t cell defect presence comorbiditie patient common variable immunodeficiency disorder immunodeficiency risk chronic covid- dangerous stalemate suboptimal immune response sars cov- intra host viral evolution result rapid emergence vaccine resistant mutant variant high consequence public health emergency vaccination prevention chronic covid- immunodeficient patient utmost priority have reliable diagnostic assay t cell immunity sars cov- critical evaluate response vaccine patient new treatment sars cov- nzace patari likely particularly beneficial immunodeficient patient especially fail mount robust t cell response covid- vaccine
337,background transmissible variant sars cov- variant concern lineage b emerge uk aim estimate risk critical care admission mortality patient critically ill overall mortality associate lineage b compare non b compare clinical outcome group method observational cohort study link large primary care qresearch national critical care intensive care national audit research centre case mix programme national covid- testing public health england database sars cov- positive sample s gene molecular diagnostic assay failure sgtf proxy presence lineage b extract cohort datum primary care cohort comprise patient primary care positive community covid- test report nov jan know sgtf status critical care cohort comprise patient admit critical care positive community covid- test report nov jan know sgtf status explore association sars cov- infection lineage b admission critical care unit ccu -day mortality -day mortality follow ccu admission royston parmar model adjust age sex geographical region sociodemographic factor deprivation index ethnicity household housing category smoking status primary care cohort ethnicity body mass index deprivation index dependency admission acute hospital ccu cohort comorbiditie asthma chronic obstructive pulmonary disease type   diabetes hypertension primary care cohort cardiovascular disease respiratory disease metastatic disease immunocompromised condition ccu cohort report information type duration organ support b non b group finding primary care cohort include  patient sars cov- infection  lineage b  .% admit ccu  .% die  day critical care cohort include  patient admit ccu  .% lineage b  .% die end critical care primary care cohort estimate adjusted hazard ratio hrs ci .- ccu admission -day mortality patient lineage b compare non b group adjusted hr mortality critical care estimate critical care cohort patient lineage b compare non b infection interpretation patient lineage b increase risk ccu admission -day mortality compare patient non b sars cov- patient receive critical care mortality appear independent virus strain finding emphasise importance measure control exposure infection covid- funding wellcome trust national institute health research oxford biomedical research centre medical sciences division university oxford
338,objective systematic review meta analysis meta regression aim evaluate effect colchicine administration mortality patient coronavirus disease  covid- factor affect association method systematic literature search pubmed scopus embase database perform inception database  march include study fulfill following criterion observational study randomized control trial rct report covid- patient report colchicine use mortality  day restriction age inpatient outpatient set severity disease intervention colchicine administration treatment covid- control receive placebo standard care outcome mortality pool effect estimate report odd ratio random effect restrict maximum likelihood meta regression perform evaluate factor affect pool effect estimate result study comprise  patient include systematic review meta analysis rct observational study pooled analysis show colchicine associate low mortality patient covid- p p meta regression analysis show association colchicine mortality reduce increase age p gender reference male p diabetes p hypertension p cad p conclusion meta analysis indicate colchicine reduce mortality patient covid- meta regression analysis show benefit reduce age increase prospero crd
339,background occurrence covid- world claim nearly million human life world  life ethiopia number death increase variable distribution world despite increase fatality clinical characteristic deceased patient fully know analyze clinical characteristic deceased patient help improve outcome infected patient study aim determine clinical characteristic patient die covid- ethiopia method hospital base multi center cross sectional study conduct chart review deceased patient number covid- relate death limit consecutive covid- relate hospital death analyze datum enter analyze spss version descriptive statistic explain datum collect survey result total  deceased patient chart analyze patient male age range   year mean age  year arrival vital sign .% hypoxia tachycardia patient fever fourth patient comorbidity diabetes mellitus dm common comorbidity accounting .% follow hypertension hiv/ aids conclusion result study show covid- deceased patient present respiratory failure hypoxia patient fever addition presence comorbid illness non covid- disease like aids define illness significant need study identify level contribution increase burden covid- death ethiopia
340,objective study develop validate prediction model identify covid- patient risk require oxygen support base parameter c reactive protein crp hypertension age neutrophil lymphocyte count chanel retrospective cohort study include  consecutive covid- patient patient randomly assign randomly training set test set ratio logistic regression logistic lasso regression random forest support vector machine xgboost analysis perform base age hypertension status serial crp neutrophil lymphocyte count  day hospitalization ability model predict oxygen requirement hospitalization test hospitalization  .% patient training set n  .% test set n require supplementary oxygen support logistic lasso regression model exhibit high auc test set sensitivity specificity online risk calculator oxygen requirement chanel predictor develop chanel prediction model base serial crp neutrophil lymphocyte count  day hospitalization age hypertension status provide reliable estimate risk supplement oxygen requirement patient hospitalize covid-
341,background sars cov- associate severe inflammatory response contribute respiratory systemic manifestation morbidity mortality patient coronavirus disease  covid- method tocilizumab tcz efficacy mortality length hospital stay retrospectively evaluate patient receive tcz compare control similar severity covid- primary endpoint survival probability day secondary endpoint include survival day  length hospital stay result  patient include study  receive tcz standard care  serve control group receive standard care group similar tcz treat patient likely exhibit hypertension .% vs. .% chronic kidney disease .% vs. .% high charlson score vs. p likely receive corticosteroid treatment .% vs. .% tcz associate low mortality day  .% vs. .% p day  .% vs. .% p hospital stay long tcz treat control group vs day p patient .% tcz treat group develop infection conclusion tcz associate low likelihood death despite result high infection rate non significant long hospital stay
343,dysregulation immune response observe covid- patient thymosin alpha  talpha management covid- know restore homeostasis immune system infection cancer aim observe longitudinal change t lymphocyte subset evaluate efficacy talpha covid- retrospective study conduct  covid- patient admit shanghai public health clinical center clinical laboratory characteristic patient different t lymphocyte phenotype treat talpha compare  patient  .% male median age  year interquartile range iqr total  patient receive talpha therapy  patient  patient normal baseline cd count median:/mul iqr  patient .% decrease baseline cd count median:/mul iqr decrease baseline cd count patient old p present critically ill p=. hypertension p=. compare normal cd count statistical difference duration virus shed upper respiratory tract group p=. normal vs p=. decrease baseline cd count group vs p=. duration virus clearance patient talpha therapy significantly long talpha therapy significant difference increase cd+ vs p=. cd+ t cell vs p=. count recovery period group talpha therapy multivariate linear regression analysis show severity illness p talpha therapy p=. associate virus clearance conclusion reduction cd+ t cd+ t cell count observe covid- patient talpha benefit restore cd+ cd+ t cell count virus clearance use talpha covid- need fully investigate
344,objective evidence show angiotensin convert enzyme  ace upregulate angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb treatment play dual role pathogenesis progression coronavirus disease  covid- aim assess association use acei arb outcome covid- patient preexisting hypertension non endemic area method january february  patient hypertension enrol retrospective study covid- patient  center zhejiang jiangsu province composite endpoint consist mechanical ventilation intensive care unit icu admission death cox proportional hazard analysis perform assess association acei arb clinical outcome covid- patient hypertension result main analysis  patient receive acei arb compare  patient receive regimen overall  patient .% endpoint event risk probability crude endpoint acei arb group .% low non acei arb group .% adjust confound factor inverse probability weighting result show use acei arb reduce occurrence end event hazard ratio hr ci similar result obtain multiple sensitivity analysis conclusion retrospective study covid- patient hypertension use acei arb associate increase risk disease severity compare patient acei arb trend beneficial effect acei arb need evaluate randomized clinical trial
345,background coronavirus- covid- declare global pandemic world health organisation severe disease typically present respiratory failure acute kidney injury aki hypercoagulable state occur early report suggest thrombosis link aki study development aki outcome patient covid- take chronic anticoagulation therapy method electronic record adult patient admit manchester university foundation trust hospitals march  april diagnosis covid- patient end stage kidney disease exclude aki classify kdigo criterion result  patient covid- study .% take anticoagulant therapy prior admission similar rate aki anticoagulant anticoagulate .% versus .% difference severity aki requirement renal replacement therapy group versus risk factor aki include hypertension pre existing renal disease male sex high mortality take anticoagulant therapy versus patient take anticoagulant likely admit intensive care unit .% versus receive mechanical ventilation .% versus conclusion patient chronic anticoagulant therapy reduce incidence severity aki suggest aki unlikely thrombotic nature therapeutic anticoagulation currently investigation randomised control study determine potential role covid- treatment
346,increase evidence show coronavirus disease  covid- severity drive dysregulate immunologic response aim assess difference inflammatory cytokine covid- patient compare contemporaneously hospitalize control analyze relationship cytokine development acute respiratory distress syndrome ards acute kidney injury aki mortality cohort study hospitalize patient march  april  quaternary referral center new york city include adult hospitalize patient covid- negative control serum specimen obtain second hospital day cytokine measure luminex autopsy cohort patient examine identify  covid- patient  control analysis  inflammatory cytokine reveal upregulation macrophage induce chemokine t cell relate interleukine stromal cell produce cytokine covid- patient compare control distinctive cytokine signature predict development ards aki mortality covid- patient specifically macrophage associate cytokine predict ards t cell immunity relate cytokine predict aki mortality associate cytokine activate immune pathway il- universally correlate ards aki mortality histopathological examination autopsy show diffuse alveolar damage significant mononuclear inflammatory cell infiltration additionally kidney demonstrate glomerular sclerosis tubulointerstitial lymphocyte infiltration cortical medullary atrophy pattern cytokine expression offer insight pathogenesis covid- disease severity subsequent lung kidney injury suggest targeted treatment strategy
347,objective investigate risk factor contribute severity admission additionally risk factor bad severity fatality study factor compare base point early severity bad severity fatality design observational cohort study datum enter japan nationwide covid- inpatient registry coviregi jp setting  september  case  facility register participate facility cover wide range hospital patient covid- admit japan participant participant positive test result applicable sars cov- diagnostic test admit participate healthcare facility total  case identify  january   case include study primary secondary outcome measure primary outcome severe nonsevere admission determine requirement mechanical ventilation oxygen therapy spo respiratory rate secondary outcome bad severity hospitalisation judge requirement oxygen orinvasive mechanical ventilation extracorporeal membrane oxygenation result risk factor severity admission old age man cardiovascular disease chronic respiratory disease diabetes obesity hypertension cerebrovascular disease liver disease renal disease dialysis solid tumour hyperlipidaemia influence severity admission influence bad severity fatality rate obesity hypertension hyperlipidaemia relatively low conclusion study segregate comorbiditie influence severity death possible risk factor severity admission bad severity fatality consistent propel different factor specifically hypertension hyperlipidaemia obesity major effect bad severity impact mild fatality japanese population study contradict result detailed analysis consider hospital treatment need validation trial registration number umin
348,background current coronavirus health crisis inhale bronchodilators(ib suggest possible treatment patient hospitalize patient evidence covid- pneumonia worldwide prescribe medication therapy disease indication medication ineffective take account pathophysiology mechanism disease progression objective main objective evaluate association ib use length stay primary end point number day patient stay hospital death final event time event analysis pneumonia severity oxygen requirement involve drug comorbidity historical current respiratory diagnosis drug prescribe treat coronavirus pneumonia evaluate method descriptive observational cross sectional study perform tertiary hospital madrid spain datum obtain patient hospitalize covid- exclude intubate primary secondary outcome duration hospitalization death compare patient receive ib patient result  patient evaluate mean age year median length hospitalization stay  day  .% overcome disease remain  die patient receive ib mortality rate odd ratio ci hospitalization period compare patient receive ib odd ratio ci significant association ib use recovery death hypertension diabete common comorbiditie prevalence chronic respiratory disease cohort low anticholinergic ib frequently prescribe covid- pneumonia well response patient treat inhaled corticosteroid observe conclusion label indication inhaled bronchodilator covid- patient common admit patient take account result use ib coronavirus pneumonia apparently associate significantly patient improvement study confirm hypothesis inhale bronchodilator improve clinical outcome reduce risk covid- mortality fact virus mainly affect lung parenchyma pulmonary vasculature probably airway research necessary order fill gap evidence new indication
349,purpose review coronavirus disease  covid- pandemic lead death  million people infect worldwide involvement pulmonary vasculature consider major drive force morbidity mortality set summarize current knowledge acute manifestation pulmonary vascular disease pvd result covid- prioritize long term complication result pulmonary hypertension ph recent finding acute covid- infection result widespread involvement pulmonary vasculature myocardial injury evidence persistent lung disease venous thromboembolism post covid- survivor frequently report ongoing symptom risk spectrum ph include group  pulmonary arterial hypertension group  ph left heart disease group  ph lung disease and/or hypoxia group  chronic thromboembolic ph summary impact covid- pulmonary vasculature central determine disease severity long term pvd manifestation covid- currently uncertain optimize care risk factor ph monitoring development pvd critical reduce long term morbidity improve health survivor
350,background vitamin d deficiency suggest favor poor outcome coronavirus disease- covid- aim assess -hydroxyvitamin d ohd level associate interleukin  il- level disease severity mortality covid- method prospectively study  patient admit northern italian hospital age year  male severely symptomatic covid- subject sars cov- infection mild covid- symptom mildly symptomatic covid- patient  subject sars cov- infection control measure ohd il- level admission focus respiratory outcome hospitalization result severely symptomatic covid- patient low ohd level ng ml mildly symptomatic covid- patient non sars cov infected control ng ml ng ml respectively p comparison ohd il- level respectively low high severely symptomatic covid- patient admit intensive care unit icu ng ml pg ml respectively require icu admission ng ml p pg ml p respectively similar difference find compare covid- patient die hospital ng ml pg ml survivor ng ml p pg ml p respectively ohd level inversely correlate il- level rho p ii subsequent need icu admission relative risk rr confidence interval ci p regardless age gender presence  comorbidity obesity diabetes arterial hypertension creatinine il- lactate dehydrogenase level neutrophil cell lymphocyte platelet count iii mortality rr ci .- p regardless age gender presence diabetes il- c reactive protein lactate dehydrogenase level neutrophil cell lymphocyte platelet count conclusion covid- patient low ohd level inversely correlate high il- level independent predictor covid- severity mortality
352,background sars cov- entry human cell depend angiotensin convert enzyme upregulate inhibitor renin angiotensin system ras aim test hypothesis discontinuation chronic treatment ace inhibitor aceis angiotensin ii receptor blocker arb mitigate course o\f recent onset covid- method acei covid parallel group randomised control open label trial  centre austria germany patient aged  year old enrol present recent symptomatic sars cov- infection chronically treat acei arb patient randomly assign discontinuation continuation ras inhibition  day primary outcome maximum sequential organ failure assessment sofa score  day death score maximum achievable sofa score secondary endpoint area death adjust sofa score aucsofa mean sofa score admission intensive care unit mechanical ventilation death analysis modify intention treat basis trial register clinicaltrials.gov nct finding april jan  patient median age  year iqr female randomly assign discontinue n= continue n= ras inhibition  day  die discontinuation group   patient die continuation group p=. significant difference primary endpoint discontinuation continuation group median iqr maximum sofa score vs p=. discontinuation associate significantly low aucsofa vs p=. mean sofa score vs p=. -day sofa score percentile vs p=.  day  discontinuation group  continuation group sign organ dysfunction sofa score dead p=. significant difference mechanical ventilation vs  p=. admission intensive care unit vs  p=. discontinuation continuation group interpretation discontinuation ras inhibition covid- significant effect maximum severity covid- lead fast well recovery decision continue discontinue individual basis consider risk profile indication ras inhibition availability alternative therapy outpatient monitoring option funding austrian science fund german center cardiovascular research
353,objective review overview pathophysiological effect coronavirus disease  covid- relation hypertension ht focus renin angiotensin aldosterone system raas mas receptor ht multifactorial disease public health burden risk factor disease like stroke coronary artery disease heart failure lead million death yearly blood pressure regulate raas system consist counter regulatory axis ace ang ii r ace ang-(-)/mas main regulatory protein balance raas angiotensin convert enzyme  ace protein function main mediator endocytosis severe acute respiratory syndrome coronavirus  sars cov- host cell sars cov- cause covid- cause worldwide pandemic treatment prophylaxis covid- limited drug vaccine currently test clinical trial approve ema fda ht major risk factor severity fatality covid- raas play important role covid- infection sars cov- lead dysregulation system reduce ace expression exact mechanism ht relation covid- remain uncertain research need elucidation
354,acute kidney injury common complication patient hospitalize sarscov- covid- prior study implicate multiple potential mechanism injury covid- compare respiratory viral illness formal comparison virus kidney health exist retrospective cohort study compare incidence feature outcome acute kidney injury veteran hospitalize covid- influenza adjust baseline condition weighted comparison total  hospitalization covid-  hospitalization influenza admit october    veterans administration hospital nationally study electronic medical record acute kidney injury occur frequently covid- compare influenza .% versus .% weighted analysis severe patient covid- likely require mechanical ventilation vasopressor experience high mortality proteinuria hematuria frequent group common covid- recovery kidney function common patient covid- acute kidney injury similar survivor finding study confirm acute kidney injury common severe patient hospitalize covid- compare influenza finding drive largely illness severity combine impact illness kidney health significant important implication resource allocation
355,objective systematic review meta analysis aim evaluate association prealbumin severity mortality covid- materials method perform systematic literature search pubmed embase scopus database  february primary outcome poor outcome composite mortality severity severe covid- define covid- fulfill criterion severe pneumonia patient acute respiratory distress syndrome disease progression need intensive care unit mechanical ventilation effect estimate mean difference patient poor outcome mg dl odd ratio  mg dl decrease prealbumin level effect estimate report confidence interval ci result study comprise  patient include systematic review meta analysis patient poor outcome low prealbumin level mean difference mg dl ci p  mg dl decrease prealbumin level associate increase poor outcome p=. meta regression analysis show association prealbumin level poor outcome vary gender male coefficient r p age diabetes hypertension chronic kidney disease conclusion low serum prealbumin associate poor outcome patient covid-
356,aim study aim investigate clinical chest compute tomography ct feature associate clinical parameter coronavirus disease covid- capital turkey ankara materials method epidemiological clinical feature laboratory finding radiological characteristic  hospitalise patient covid- ankara collect analyse study risk factor associate disease severity investigate result non severe severe case enrol study compare non severe group severe group significantly old comorbiditie ie hypertension diabetes mellitus cardiovascular disease chronic kidney disease smoking common severe group severe patient high respiratory rate high incidence cough dyspnoea compare non severe patient compare non severe patient severe patient increase c reactive protein crp procalcitonin neutrophil lymphocyte ratio nlr crp albumin ratio decrease albumin occurrence rate consolidation subpleural sparing crazy paving pattern cavity halo sign reverse halo sign air bronchogram pleural thickening micronodule subpleural curvilinear line multilobar bilateral involvement ct finding severe patient significantly high non severe patient conclusion factor relate severity covid- help clinician judge severity patient evaluate prognosis cohort study reveal male sex age /= year patient comorbiditie especially cardiovascular disease dyspnoea increase crp d dimer nlr decrease lymphocyte count ct finding consolidation multilobar involvement predictor severe covid-
357,end  novel coronavirus identify wuhan china disease cause severe acute respiratory distress syndrome coronavirus  sars cov- designate covid- corona virus disease world health organization early patient covid- experience mild symptom severe critical disease occur remain severe disease manifest development pneumonia hypoxia radiographic lung involvement critical disease indicate multiorgan involvement significant respiratory cardiac compromise current estimate case fatality rate covid- approximately epidemiological study show advanced age male gender previous chronic lung disease cardiovascular kidney disease obesity diabete risk factor severity disease course current focused review present overview acute cardiovascular complication covid- detection impact prognosis
358,objective coronavirus disease  covid- novel pandemic considerable difference disease severity mortality rate observe different part world present study investigate characteristic outcome patient hospitalize covid- iran method establish retrospective cohort study hospitalize covid- patient iran epidemiological imaging laboratory clinical characteristic outcome record medical document chi square test t test logistic regression model analyze datum p. mortality show significant relationship body mass index age history hypertension chronic kidney disease ckd ischemic heart disease cerebrovascular accident cva pulmonary disease cancer abnormal high resolution compute tomography hrct finding p cancer high odd ratio conclusion comorbiditie especially cancer ckd cva severe obesity old age abnormal hrct finding affect health outcome patient hospitalize covid-
359,background black individual disproportionately affect coronavirus disease  covid- remain unclear biological factor predispose black patient covid related morbidity mortality objective compare hospital morbidity mortality inflammatory marker level black white hospitalize covid- patient design participant single center retrospective cohort study analyze datum black white patient age /= year hospitalize positive sars cov- pcr test march august main measures exposure self identify race document medical record primary outcome hospital death secondary outcome include intensive care unit admission hospital morbidity inflammatory marker level key result total black white patient identify mean sd age year  .% female  black  .% white patient univariate analysis black patient long hospital stay vs. day p tend high rate hospital death .% vs. .% myocardial infarction .% vs. .% pulmonary embolism pe .% vs. .% acute kidney injury aki .% vs. .% white patient p adjust potential confounder pe adjust odd ratio aor ci aki aor ci .- statistically significantly associate black race comparison white patient black patient statistically significantly high peak plasma d dimer standardize beta erythrocyte sedimentation rate standardize beta ferritin standardize beta lactate dehydrogenase standardize beta adjust potential confounder p conclusion black hospitalize covid- patient increase risk develop pe aki high inflammatory marker level compare white patient observation explain difference prevalence severity underlying comorbiditie unmeasured biologic risk factor black white patient future research need investigate mechanism observe difference outcome severe covid- infection black versus white patient
360,novel coronavirus disease sars cov- virus know covid- emerge major health concern worldwide specific drug treat infection till date sars cov- spread country globe nitric oxide gas serve important signal molecule have vasodilatory effect anti microbial property previous study  sars cov infection demonstrate help reduce respiratory tract infection inactivate virus inhibit replication cycle effective supportive measure treat infection patient pulmonary complication gas inhalation suggest potential therapy manage severe acute respiratory distress syndrome covid- patient view covid- pandemic clinical trial underway examine effect inhalation infected patient previously publish report beneficial effect endogenous inhalation therapy thoroughly search assess potential therapy treat covid- patient present report summarize therapeutic importance reverse pulmonary hypertension restore normal endothelial activity produce anti thrombotic effect addition reduce viral infection inhibit replication entry host cell absence vaccine effective treatment strategy suggest inhalation therapy release food compound consider alternative measure combat covid- infection
361,background pre exist comorbiditie predict severe disease require intensive care unit icu admission covid- case compare comorbiditie clinical feature predictive factor covid- patient require icu admission intubation mechanical ventilation covid- case selangor malaysia method field datum collect covid- outbreak selangor malaysia  april  comprise socio demographic characteristic comorbiditie present symptom covid- case icu admission determine medical record multiple logistic regression analysis perform identify factor associate icu admission require intubation mechanical ventilation covid- case result total  covid positive case include analysis common comorbiditie hypertension .% diabetes case present fever cough  case require intubation mechanical ventilation .% hypertension .% fever .% dyspnoea .% lethargic multivariate regression show case require intubation mechanical ventilation significantly high odd old aged year adjust odd ratio aor have hypertension aor fever aor dyspnoea aor lethargy aor case require intubation mechanical ventilation conclusion covid- case selangor malaysia require intubation mechanical ventilation significantly old high proportion hypertension symptom fever dyspnoea lethargy risk factor report previously severe covid- case highlight role age underlying comorbiditie play severe outcome respiratory disease
362,abrupt change food preference eat habit induce overlook health risk coronavirus disease pandemic covid- emerge evidence point major shift consumption high sodium food pandemic lockdown population different country culture high sodium food sodium content exceed  mg  g process preserve food fall category excessive dietary sodium intake associate chronic disease include hypertension cardiovascular disease kidney disease pose confounding risk pandemic review food category consumer shopping list food parcel deliver people need assistance pandemic freeze meal canned food instant food snack high sodium food gain substantial popularity change consumer behavior drive factor perceive risk viral infection grocery shopping trip limited supply inflate price fresh produce preference food long shelf live emotional eating general low awareness sodium content food contribute increase consumption high sodium food pandemic discuss possible effect covid- infection severity cause excessive sodium intake conclude public educate maintain healthy sodium intake pandemic measure adopt government private donor procure food parcel balanced sodium content lower risk prolonged excessive sodium intake vulnerable population
363,background report effect renin angiotensin aldosterone system raas inhibitor clinical outcome coronavirus disease- covid- conflicting perform meta analysis find conclusive evidence method search publish article pubmed embase  january   august study report clinical outcome patient covid- stratify class antihypertensive include random fix effect model estimate pooled odd ratio result total  study involve patient covid- include overall risk poor patient outcome severe covid- death low patient take raas inhibitor ci compare receive non raas inhibitor antihypertensive sub meta analysis show specific raas inhibitor reduction poor covid- outcome compare class antihypertensive beta blocker bbs example compare calcium channel blocker ccb angiotensin convert enzyme inhibitor aceis ci angiotensin ii receptor blocker arb ci show reduction poor covid- outcome compare bb aceis ci arb ci show apparent decrease poor covid- outcome conclusion raas inhibitor increase risk mortality severity covid- difference covid- clinical outcome different class antihypertensive drug likely underlie comorbiditie antihypertensive drug prescribe adverse effect drug bb exclude
364,background aki complication coronavirus disease  covid- associate high mortality despite document kidney tropism severe acute respiratory syndrome coronavirus  sars cov- consistent report viral detection urine correlation aki covid- severity hypothesize quantification viral load sars cov- urine sediment patient covid- correlate occurrence aki mortality method viral load sars cov- urine sediment u viral load quantify qrt pcr  patient pcr confirm covid- diagnosis hospitalize march  june immunolabele sars cov- protein spike nucleocapsid perform covid- kidney biopsy specimen urine sediment viral infectivity assay perform  urine sediment result total  patient covid- detectable sars cov- u viral load  develop aki average u viral load time high patient covid- aki u viral load high .-fold  week aki diagnosis high u viral load correlate mortality albuminuria aki stage sars cov- protein partially colocalize viral receptor ace kidney biopsy specimen tubule parietal cell urine sediment cell infective sars cov- detect urine sediment conclusion result support sars cov- kidney tropism high sars cov- viral load urine sediment patient covid- correlate increase incidence aki mortality urinary viral detection inform medical care patient covid- kidney injury improve prognosis
365,aim severe acute respiratory syndrome coronavirus  sars cov- bind angiotensin convert enzyme  ace enable entrance virus cell cause infection term coronavirus disease  covid- investigate association plasma ace outcome covid- method result analysis datum large longitudinal study  covid- positive patient  covid- negative patient mgh emergency department covid- cohort comprehensive clinical datum collect cohort include outcome sample run olink(r explore  platform include measurement ace protein high admission plasma ace covid- patient associate increase maximal illness severity  day p plasma ace significantly high covid- patient hypertension compare patient hypertension p circulate ace significantly high covid- patient pre existing heart condition kidney disease compare patient pre existing condition p p respectively conclusion study suggest measure plasma ace potentially valuable predict covid- outcome ace link covid- illness severity establish risk factor hypertension pre existing heart disease pre existing kidney disease
366,introduction coronavirus disease  covid- global threat public health current study investigate alteration biological estimate concern severity recovery mortality assessment treatment base outcome method case series  covid- patient admit omi institute tertiary care hospital conduct august datum demographic characteristic comorbid condition radiographic abnormality biological estimation symptom treatment disease progression complication outcome record structured questionnaire laboratory estimation include complete blood count cbc renal electrolyte profile liver function test lfts hematological index inflammatory marker chest x ray electrocardiogram ecg high resolution compute tomography hrct scan perform datum extract medical record analysis statistical package social sciences spss version result  covid- patient .% recover successfully discharge .% inpatient die patient mean age year male majority common comorbid condition diabetes hypertension fever dry cough frequently report symptom chest imaging finding severe critical covid- patient show extensive bilateral patchy opacity median laboratory investigation include neutrophil lymphocyte ratio nlr c reactive protein crp mg dl lactate dehydrogenase ldh iu l ferritin ml mean oxygen saturation .% significantly alter case increase disease severity expire p proportion acute respiratory distress syndrome ards sepsis development significantly high severe critical covid- patient p treatment tocilizumab remdesivir doxycycline ivermectin enoxaparin sodium steroid deem potentially effective treatment option term reduce covid- severity chance recovery furthermore age p=. presence comorbidity p=. high nlr ldh final outcome p crp level midpoint p=. identify strong predictor death covid- patient conclusion study identify alteration clinical profile covid- patient concern severity hospital stay affect prognosis clinically tocilizumab remdesivir doxycycline ivermectin enoxaparin sodium steroid identify potential therapeutic option covid- ability alter disease associate severity recovery rate
367,importance preventive intervention need protect resident staff skilled nursing assist living facility covid- outbreak facility bamlanivimab neutralize monoclonal antibody sars cov- confer rapid protection sars cov- infection covid- objective determine effect bamlanivimab incidence covid- resident staff skilled nursing assist living facility design setting participant randomized double blind single dose phase  trial enrol resident staff  skilled nursing assist living facility united states  confirm sars cov- index case total  participant enrol study august  november database lock trigger january participant reach study day intervention participant randomize receive single intravenous infusion bamlanivimab  mg n placebo n main outcomes measures primary outcome incidence covid- define detection sars cov- reverse transcriptase polymerase chain reaction mild bad disease severity  day detection  week randomization key secondary outcome include incidence moderate bad covid- severity incidence sars cov- infection result prevention population comprise total  participant staff  resident negative baseline sars cov- infection serology mean age range year  woman bamlanivimab significantly reduce incidence covid- prevention population compare placebo .% vs .% odd ratio ci p absolute risk difference ci percentage point death attribute covid- report day occur placebo group  participant receive study product safety population rate participant adverse event bamlanivimab group .% placebo group common adverse event urinary tract infection report  participant receive bamlanivimab  .% receive placebo hypertension report  participant .% receive bamlanivimab  .% receive placebo conclusion relevance resident staff skilled nursing assist living facility treatment august november  bamlanivimab monotherapy reduce incidence covid- infection research need assess preventive efficacy current pattern viral strain combination monoclonal antibody therapy trial registration clinicaltrials.gov identifier nct
368,objective hypertension think contributor mortality coronavirus disease  patient limited clinical datum outcome covid- patient hypertension available method study design confirm hypertension affect outcome covid- result total  patient covid- female male enrol significantly high odd -day mortality p observe hypertensive group hypertensive group adjustment multivariate analysis subgroup patient  year old old high -day mortality total -day mortality rate age subgroup bothp /= covid- significantly elevate compare group survivor non surviving covid- patient hypertension old basic disease severe clinical condition
369,background development acute kidney injury aki patient coronavirus disease  covid- associate high risk death publish datum demonstrate possibility severe kidney injury patient suffer covid- datum controversial method total patient prove diagnosis covid- include study covid- confirm patient reverse transcriptase polymerase chain reaction test nasopharyngeal swab base typical compute tomography finding demographic datum underlie comorbiditie laboratory blood test assess assess incidence aki associated mortality define survival status discharge result proteinuria identify  patient .% covid- aki identify  patient .% patient .% require dialysis risk factor aki include age  year augmentation c reactive protein ferritin increase value activate partial thromboplastin time overall  hospitalize patient .%   patient .% aki survive hazard ratio hr mortality confidence interval patient aki vs. aki conclusion aki relatively common finding patient covid- risk factor aki covid- include old age inflammatory response severity lung involvement disseminate intravascular coagulation factor addition arterial hypertension find increase risk mortality
370,despite association prevalent health condition coronavirus disease  covid- severity disease modify biomolecule pathogenetic mechanism remain unclear study aim understand influence covid- different comorbiditie vice versa network base gene expression analysis share dysregulate gene identify key genetic determinant signal pathway involve share pathogenesis covid- show significant upregulation  gene downregulation  gene interestingly share   gene diabetes mellitus dm lung cancer lc myocardial infarction hypertension respectively importantly covid- share upregulated gene i.e. mx irf adam dm lc conversely downregulation gene i.e. ppargca mettla find covid- lc share pathway relate inflammatory response furthermore identify potential biomarker important regulatory factor e.g. transcription factor micrornas notable drug candidate include captopril rilonacept canakinumab prognostic analysis suggest concomitant covid- result poor outcome lc patient study provide molecular basis route covid- progression comorbiditie believe finding useful understand intricate association disease therapeutic development
371,ongoing covid- contagious disease characterise different symptom fever cough shortness breath rise concern covid- severely affect healthcare system country covid- outbreak develop rapid rate globe intriguing clinically drug acetazolamide specific inhibitor carbonic anhydrase ec treat high altitude pulmonary oedema hape show high degree clinical similarity pulmonary disease cause covid- context preliminary study aim provide insight factor affect covid- patient hypoxaemia hypoxia blood activity hypothesise patient covid- problem dysregulated acid base status influence activity preliminary result suggest use inhibitor pharmacological treatment covid- beneficial
372,background patient kidney failure increase risk progression severe form coronavirus disease  covid- high mortality current analysis aim assess impact renal failure severity covid- identify risk factor fatal outcome population method analysis include patient sarster database national real world study evaluate treatment covid-  polish center datum complete retrospectively submit online result total  patient include analysis kidney failure diagnose  individual .%  present moderate stage  patient include  dialysis individual present severe renal failure patient kidney failure significantly old demonstrate severe course covid- age baseline spo ordinal scale  neutrophil platelet count estimate glomerular filtration rate c reactive protein concentration malignancy arterial hypertension independent predictor -day mortality logistic regression analysis conclusion underlie kidney disease patient covid- lead factor associate high risk severe clinical presentation increase mortality rate
373,certain underlie disease diabetic mellitus hypertension risk factor severity mortality coronavirus disease covid- patient furthermore angiotensin convert enzyme inhibitor acei angiotensin ii receptor blocker arb controversial role process covid- case aim study investigate underlie disease take acei arb affect duration hospitalization mortality patient confirmed covid- medical usage claim datum past year  corona- international cooperation research project analyze medical insurance claim datum  coronavirus covid- patient confirm rt pcr test nationwide  comorbiditie history hypertension hazard ratio hr confidence interval ci .- diabetes hr ci .- associate significantly mortality furthermore heart failure hr ci .- chronic obstructive pulmonary disease hr ci .- chronic kidney disease hr ci .- mental disorder hr ci .- end stage renal disease hr ci .- associate significantly mortality underlie disease increase risk mortality patient covid- diabetes hypertension cancer chronic kidney disease heart failure mental disorder increase mortality controversial take acei arb benefit covid- patient study patient take acei arb high risk mortality
374,elderly patient comorbiditie experience severe case coronavirus disease  covid- healthy patient underlie medical condition unclear people prone develop alveolar pneumonia rapid exacerbation death hypothesize people comorbiditie genetic predisposition make vulnerable factor example likely severely ill infect severe acute respiratory syndrome coronavirus  sars cov- test hypothesis search literature extensively polymorphism gene encode angiotensin convert enzyme  ace associate numerous comorbiditie cardiovascular disease hypertension diabetes chronic kidney disease obesity potential mechanism explain association e.g. dd type carrier great ace activity patient genetic alpha- anti trypsin aat deficiency lack control inflammatory mediator comorbiditie associate chronic inflammation closely relate renin angiotensin aldosterone system raas individual mild ace ace imbalance viral infection increase risk develop severe case covid- debate association ace d polymorphism comorbiditie good explanation discrepancy d allele dd subtype associate comorbiditie dd genotype exceptionally large effect expect ace d polymorphism intron marker discuss polymorphism aat gene involve comorbiditie severity sars cov- infection presumably combination multiple gene non genetic factor involve establishment comorbiditie aggravation covid-
375,patient covid- require radiological examination chest ct frequent neuro imaging objective identify epidemiological clinical radiological factor consider predictor neurological involvement patient covid- assess neuroimaging describe neuroimaging finding retrospective study perform  consecutive confirm covid- patient radiological unit divide group undergo brain ct mri scan n versus undergo brain ct mri scan undergo chest ct n statistically significant difference association covid- brain scan group admission icu great severity lung injury use mechanical ventilator sepsis statistical tendency find chronic renal failure systemic arterial hypertension percent covid- patient brain scan group abnormal brain ct and/or brain mri .% case bleed microbleeding .% restricted diffusion lesion ischemic stroke case associate irregularity m segment right middle cerebral artery case leave facial nerve palsy enhancement left geniculate ganglion analysis olfactory bulb possible  brain mri enhancement and/or microbleeding conclusion severe covid- disease icu severe form lung disease use mechanical ventilator sepsis associate covid- patient neurological involvement undergo brain scan microvascular phenomenon frequent finding brain olfactory bulb evaluate neuroimaging
376,study examine clinical characteristic outcome type management sars cov- infected patient hospital affiliate west virginia university include patient west virginia sars cov- infection  april  december descriptive analysis perform summarize characteristic patient regression analysis perform assess association baseline characteristic outcome  patient mean age year patient female  patient .% report baseline symptom shortness breath common half comorbidity hypertension common  severe case  patient .% die despite treatment mean overall length hospital stay day age male sex comorbiditie independent predictor outcome study patient sars cov- infection west virginia old patient underlie co morbidity poor outcome hospital mortality similar national average
377,background year coronavirus disease  covid- pandemic analyze blood coagulopathy severe non severe covid- patient link influenza patient comparative study method report  covid- patient  seasonal influenza patient admit separate medical center demographic datum medical history hematological profile coagulation character emphasize compare cohort treatment result  patient include study median age .-  .% male hypertension diabetes cardiovascular disease bronchitis constitute lead comorbiditie hospital admission blood test result differentiate covid- patient influenza case covid- patient leukocytosis neutrophilia lymphocytopenia thrombocytopenia associate disease severity mortality addition covid- cohort demonstrate prolonged prothrombin time pt activate partial thromboplastin time aptt increase inr shorten thrombin time decrease fibrinogen compare influenza cohort leave d dimer level indistinguishably high cohort platelet hyperreactivity covid- evident associate bad hyper inflammatory response refractory coagulopathy severe covid- patient administer anticoagulant bleed incidence substantially high anticoagulant medication conclusion comparison coagulation characteristic covid- influenza infection provide insightful view sars cov- pathogenesis coagulopathic mechanism propose therapeutic improvement
378,background concern safety renin angiotensin aldosterone system raas)-blocke agent include angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb coronavirus disease  covid- pandemic study seek evaluate impact hypertension use acei arb clinical severity patient covid- method total patient age  year old confirm covid- real time reverse transcription polymerase chain reaction identify claim base cohort korea primary study outcome severe clinical event composite intensive care unit admission need ventilator care death result patient hypertension n old high prevalence comorbiditie hypertension risk primary study outcome significantly high hypertension group multivariable adjustment adjust odd ratio aor  confidence interval ci patient hypertensive medical treatment  acei arb acei arb subgroup low risk severe clinical outcome compare acei arb group remain significant multivariable adjustment aor  ci conclusion patient hypertension bad covid- outcome hypertension use raas block agent associate increase risk adverse study outcome use ace inhibitor arb increase risk adverse covid- outcome support current guidance continue medication indicate
379,objective coronavirus disease  covid- know disturb liver function test lfts literature available effect covid- lft patient preexist liver disease study aim find effect covid- patient method single center observational study  patient admit covid- month seven patient exclude presence chronic liver disease result total  patient include study age   year mean  male hypertension present  patient .% diabete present  patient .% fever chief complaint  patient follow dyspnea  patient .% cough  patient elevated aspartate aminotransferase ast see  patient gamma glutamyl transferase ggt  patient alanine transaminase alt  patient alkaline phosphatase  patient bilirubin patient low albumin  patient severe covid- compare mild moderate disease associate elevated ast time upper limit normal uln p ggt uln low albumin p high systemic inflammatory response syndrome sirs raise procalcitonin p high ferritin p low po p high sequential organ failure assessment score sofa p point inflammatory response cause liver injury factor predict mortality covid- assess show direct bilirubin p low albumin p tachypnea leukocytosis independently associate increase covid related mortality conclusion patient suffer covid- evidence liver injury appear secondary inflammatory response correlate severity covid-
380,background hypertension common comorbidity patient coronavirus disease  covid- result case severe symptom high mortality risk factor associate covid- patient hypertension unknown method available confirm patient covid- february  march enrol huoshenshan hospital wuhan china demographic characteristic clinical manifestation laboratory datum radiological assessment treatment admission extract compare univariate multivariate logistic regression method explore risk factor associate covid- patient hypertension severity cohort result total  available patient covid- enrol study include  eligible patient covid- hypertension psm analysis  patient hypertension  case hypertension match compare case hypertension patient hypertension severe vs. .% p=. multivariate analysis find neutrophil count p=. coronary heart disease p=. level k(+ p associate patient hypertension addition percentage pulmonary infection volume large case hypertension vs. p=. high risk factor severe covid- patient hypertension p conclusion admission coronary heart disease neutrophil count level k(+ associate covid- patient hypertension percentage pulmonary infection volume significantly large covid- patient hypertension risk factor covid- severity cohort
381,objective determine association acuity level care alc case fatality length stay patient admit hospital covid- design hospital base observational follow study setting internal medicine service aga khan university hospital pakistan  february   june participant adult patient confirmed covid- aged /= year method alc categorise low intermediate high level patient triage standard emergency severity illness score patient follow end hospital admission outcome case fatality length stay result total  patient covid- admit study period  meet inclusion criterion mean age year male .% triage low .% intermediate .% high acuity care overall case fatality rate .% high high acuity level follow .% intermediate low acuity care acuity level associate case fatality hr ci high versus low acuity care hr intermediate versus low acuity care adjust age sex common comorbiditie include diabetes hypertension ischaemic heart disease chronic lung disease similarly acuity level associate length hospital stay conclusion high intermediate acuity level associate high case fatality rate prolonged length hospital stay patient admit covid- resource limit setting provision high acuity care limited intermediate care acuity serve useful strategy treat relatively critical patient covid-
382,preexisting hypertension know risk factor severe covid- abnormal activation ras upregulate angiotensin ii ang ii contribute severe manifestation covid- ras inhibitor rasi mainstay antihypertensive therapy associate animal study increase angiotensin convert enzyme  ace receptor facilitate cellular entry sars cov- virus nonetheless current medical practice recommend curtail rasi protect hypertensive patient covid contrary clinical evidence support beneficial effect rasi hypertensive patient midst covid- pandemic precise mechanism unclear paper hypothesize rasi reduce severity covid- promote ace atr complex formation cell surface atr mediate major vasopressor effect ang ii furthermore propose interaction ace atr impede binding sars cov- ace allow ace convert ang ii beneficial ang(- vasodilator anti inflammatory activity evidence ace atr complex formation reduce ang ii come receptor colocalization study isolated hek cell confirm cell have endogenous expression ace atr sars cov- virus attack kidney heart lung hypothesis effect rasi covid- test vitro human proximal tubule cell hk- have ace receptor specifically colocalization fluorescent label sars cov- spike protein ace atr hk- cell clarify mechanism rasi action renal lung epithelium lead protocol reduce severity covid- hypertensive normotensive patient
383,background recent study coronavirus disease  covid- demonstrate obesity significantly associate increase disease severity clinical outcome mortality association hepatic steatosis frequently accompany obesity pneumonia severity score pss evaluate compute tomography ct prevalence steatosis patient covid- remain elucidate aim assess frequency hepatic steatosis chest ct covid- patient association pss methods chest ct image  patient admit emergency department suspect covid- retrospectively evaluate patient divide group covid positive ct- reverse transcriptase polymerase chain reaction rt pcr)-positive control ct- rt pcr negative ct image group evaluate pss ratio volume involved lung parenchyma total lung volume hepatic steatosis define liver attenuation value  hounsfield unit hu result  patient n define covid positive group n control group average age covid positive group significantly high control group year vs year p frequency hepatic steatosis positive group significantly high compare control group .% vs .% p average hepatic attenuation value significantly low positive group compare control group hu vs hu p logistic regression analysis show adjust age hypertension diabetes mellitus overweight obesity time great odd hepatic steatosis covid positive group control odd ratio confidence interval p conclusion prevalence hepatic steatosis significantly high covid- patient compare control adjustment age comorbiditie finding easily assess chest ct image
384,introduction severe acute respiratory syndrome coronavirus  sars cov- causative agent coronavirus disease  covid- pandemic remain public health emergency international concern ongoing pandemic result death million people globally half thousand people die illness ethiopia clinical presentation disease vary geography population aim investigate clinical characteristic patient infect sars cov- north east ethiopia method real time polymerase chain reaction pcr conduct individual suspect sars cov- infection june  october woldia university covid- testing center record datum  ethiopians test positive sars cov- infection woldia university covid- testing center retrospectively extract analyze spss v p value consider statistically significant result nearly .% screen participant find positive sars cov- infection fourth sars cov- infected patient male overall median age  year patient asymptomatic common clinical manifestation cough .% follow fever headache .% hypertension .% human immunodeficiency virus hiv .% diabetes mellitus .% chronic respiratory disease .% relatively common comorbiditie note case fatality ratio find .% age underlie comorbiditie statistically significant association severity poor outcome patient p conclusion finding study indicate old age people underlie comorbiditie high risk have severe disease poor outcome appropriate care priority give people decrease morbidity mortality cause illness presence high asymptomatic infection possible indicator potential asymptomatic transmission community highlight need widespread testing contact trace flatten transmission curve
385,background aim coronavirus disease  covid- observe cause high mortality people cardiometabolic disease renin angiotensin aldosterone system raas blocker enhance expression ace bind receptor sars cov- enhance viral infectivity aim provide pool estimate effect raas blocker covid- outcome method literature search perform medline pubmed google scholar server clinical study analyze effect raas blocker clinical outcome covid- patient include study newcastle ottawa scale quality assessment study moose checklist follow mortality severity outcome record pool odd ratio confidence intervals cis level heterogeneity odd mortality primary outcome odd severity hospitalization intensive care unit icu admission mechanical ventilation mv steroid use acute kidney injury secondary outcome severity outcome choose depend definition respective author country specific variation effect individual class raas blocker explore result total  publish study include final analysis total patient  study mortality analysis patient  study severity analysis increase risk mortality pooled severity pooled see raas blocker drug class protective hypertension pool severity covid- outcome high europeans pooled patient pooled nearly  time high risk hospitalization  time high risk icu admission mv observe patient class wise angiotensin receptor blocker use associate time high odd severity mainly europeans conclusion raas blocker associate increase mortality covid- patient continue hypertensive european patient high risk severe outcome pharmacogenetic difference explain ethnicity relate variation plain language summary effect raas block medicine covid- background aim high death observe covid- patient long term disease heart disease diabetes high blood pressure patient prescribe class medicine call raas blocker ramipril telmisartan etc study use medicine worsen course covid- disease patient cause excess death method conduct pool analysis  observational study use raas blocker drug covid- patient result find raas blocker cause excess death patient covid- contrary benefit prescribe high blood pressure find european patient covid- take medicine high disease severity case chinese patient conclusion theremay genetic factor responsible difference ethnicity
386,background define socio demographic factor clinical presentation underlie disease associate covid- severity helpful management study aim clarify determinant clinical risk factor disease severity patient infect covid- method multi centre descriptive study patient diagnose covid- province tehran march  dec  conduct datum socio demographic characteristic clinical presentation comorbiditie health outcome patient examine characteristic study population describe assess association study variable disease severity chi squared test multiple logistic regression model apply result mean age study population year .% woman half patient present low level blood oxygen saturation icu admission rate .% overall mortality rate old age male sex comorbiditie include hypertension cancer chronic respiratory disease asthma chronic liver disease chronic kidney disease chronic neurological disorder hiv aids infection risk marker poor health outcome clinical presentation relate bad prognosis include fever difficulty breathing impaired consciousness cutaneous manifestation conclusion result alert physician pay attention determinant risk factor associate poor prognosis patient covid- addition finding aid decision maker emphasise vulnerable group public health strategy aim prevent spread disease mortality
387,background covid- multisystemic disorder frequently cause acute kidney injury aki precise clinical biochemical variable associate aki progression patient severe covid- remain unclear method perform retrospective study  hospitalize patient admit ward intensive care unit icu covid- march  june university hospital sao paulo brazil patient aged  year covid- confirm rt pcr include aki define accord kidney disease improving global outcomes kdigo criterion evaluate incidence aki clinical variable medicine outcome sub group covid- patient aki cov aki covid- patient aki non aki univariate multivariate analysis perform result elevated incidence aki .% identify distribute different stage kdigo criterion observe high level creatinine c reactive protein crp leukocyte neutrophil monocyte neutrophil lymphocyte ratio nlr cov aki group non aki group hospital admission univariate analysis cov aki associate old age years hypertension crp mcv leucocyte neutrophil nlr combine hydroxychloroquine azithromycin treatment use mechanical ventilation vasoactive drug multivariate analysis show hypertension use vasoactive drug independently associate risk high aki covid- patient finally preferentially find alter erythrocyte leukocyte cellular profile cov aki group compare non aki group hospital discharge conclusion study development aki patient severe covid- relate inflammatory blood marker therapy hydroxychloroquine azithromycin vasopressor requirement hypertension consider potential risk factor attention protocol hypertension blood marker help assist doctor decision making management covid- patient aki
388,introduction world currently face pandemic severe acute respiratory syndrome coronavirus  sars cov- total number case coronavirus disease  covid- rise daily vaccine approve pathophysiology virus study possible risk factor small sample size find material method conduct pooled analysis database medline scopus wangfang web science research square google scholar identify study report severe non severe group covid- patient odd ratio confidence interval hypertension diabetes cerebrovascular disease lead severe covid- calculate r software result article analysis involve confirm case covid- country world odd ratio severe covid- hypertensive patient diabetic patient history cerebrovascular disease confidence interval ci  study ci  study ci  study respectively conclusion analysis confirm patient hypertension diabetes cerebrovascular disease high risk severe outcome covid- vital physician identify main risk factor severe outcome disease
389,introduction coronavirus disease  covid- affect organ responsible numerous complication include cardiovascular problem method analyse consecutive patient n admit cardiology department st october  st january  symptom reflect cardiovascular complication follow covid- collect datum concern clinical characteristic result laboratory test echocardiography -hour ambulatory ecg recording result post covid- complication appear month disease recovery severe cardiovascular complication observe .% hospitalize patient comparison mild complication patient severe complication significantly high prevalence diabetes vs. p decrease ejection fraction vs. p high rest heart rate admission vs.  bpm p high level c reactive protein p troponin t vs. pg ml p dyspnoea exercise intolerance frequent patient severe complication conclusion diabetes elevated level crp troponin heart rate variability parameter worsening leave ventricular ejection fraction relate severity cardiovascular complication follow covid- infection
390,introduction approximately world population infect severe acute respiratory syndrome coronavirus  sars cov- cause coronavirus disease  covid- case rise vaccine begin rollout month away see reduction daily case number hospitalisation mortality urgent need control disease spread repurpose exist therapeutic owe antiviral anti inflammatory immunomodulatory cardioprotective action statin therapy consider plausible approach improve covid- outcome material method carry meta analysis investigate effect statin  covid- outcome intensive care unit icu admission tracheal intubation death systematically search pubmed web science scopus proquest database keyword relate aim november publish observational study randomised clinical trial covid- statin retrieve statistical analysis random effect modelling perform stata software result final select study n  study patient show significant reduction icu admission ci n death ci n outcome significant effect tracheal intubation ci n furthermore subgroup analysis suggest death reduce hospital application stain ci n compare pre hospital use ci n conclusion finding attention need systematic clinical study assess pre- hospital use statin potential mean reduce covid- disease severity particularly term reduction icu admission total mortality reduction
391,background pregnant woman coronavirus disease  covid- increase risk severe illness compare nonpregnant woman datum assess risk factor illness severity pregnant woman covid- limited study aim determine risk factor associate covid- illness severity pregnant woman severe acute respiratory syndrome coronavirus  sars cov- infection method pregnant woman sars cov- infection confirm molecular testing report  march march  surveillance emerging threats mothers babies network set net criterion illness severity asymptomatic mild moderate severe critical adapt national institutes health world health organization criterion crude adjusted risk ratio moderate severe critical covid- illness calculate select demographic clinical characteristic result  pregnant woman sars cov- infection moderate severe critical covid- illness associate age  year old healthcare occupation prepregnancy obesity chronic lung disease chronic hypertension pregestational diabetes mellitus risk moderate severe critical illness increase number underlie medical pregnancy relate condition conclusion old age have underlie medical condition associate increase risk moderate severe critical covid- illness pregnant woman information help pregnant woman understand risk moderate severe critical covid- illness inform target public health messaging
392,background severe acute respiratory syndrome coronavirus  sars cov- involve global outbreak affect million people manifest variety symptom coronavirus disease  covid- cause sars cov- increasingly associate cardiovascular complication require hospitalization mechanism underlie complication remain unknown nitric oxide hydrogen sulfide hs gasotransmitter regulate key cardiovascular function method blood sample obtain  covid- patient  control hs metabolite assess hs level compare case control entire study population subgroup base race availability gasotransmitter examine base severity outcome covid- infection performance hs level predict covid- infection analyze multivariable regression analysis perform identify effect traditional determinant gasotransmitter hs level patient covid- infection result significantly reduce hs level observe caucasian african american covid- patient compare healthy control covid- patient die significantly high hs level compare covid- patient survive receiver operate characteristic analysis hs metabolite study population show free sulfide level highly predictive covid- infection base reduce availability traditional determinant gasotransmitter age race sex diabetes hypertension effect hs level covid- patient conclusion observation provide insight role hs covid- infection low availability result reduce synthesis secondary endotheliitis increase consumption scavenging reactive oxygen specie
393,background uncertainty covid- outcome angiotensin convert enzyme inhibitor acei)/angiotensin receptor blocker arb user continue contradictory finding study aim determine effect acei arb use patient severe covid- method retrospective cohort study saudi public specialty hospital designate covid- referral facility include  patient confirm diagnosis covid- april june  acei arb user  non acei arb user control confounder conduct multivariate logistic regression sensitivity analysis propensity score matching psm inverse propensity score weighting ipsw high risk patient subset result compare non acei arb user acei arb user fold high risk develop critical severe covid- ci nearly high risk intensive care unit icu admission ci nearly high risk require noninvasive ventilation patient diabetes hypertension and/or renal disease fold high risk severe covid- disease result confirm psm ipsw analysis conclusion general especially patient hypertension diabetes and/or renal disease acei arb use associate significantly high risk severe critical covid- disease icu care
394,sex difference anatomy physiology respiratory system widely report intrinsic sex difference show modulate pathophysiology incidence morbidity mortality lung disease life span chapter describe epidemiology sex difference respiratory disease include neonatal lung disease respiratory distress syndrome bronchopulmonary dysplasia pediatric adult disease include asthma cystic fibrosis idiopathic pulmonary fibrosis chronic obstructive pulmonary disease lung cancer lymphangioleiomyomatosis obstructive sleep apnea pulmonary arterial hypertension respiratory viral infection respiratory syncytial virus influenza sars cov- discuss current state research mechanism underlie observe sex difference lung disease susceptibility severity importance consider sex gender variable research study design analysis
395,background infectious agent cause covid- pandemic coronavirus name sars cov- severe acute respiratory syndrome coronavirus end spectrum patient suffering covid- asymptomatic mild symptom end spectrum patient develop numerous life threaten complication way host respond infection sars cov- depend host factor like hypertension old age etc mulbsta scoring system take account clinical laboratory parameter try predict mortality risk patient validation mulbsta score mortality covid- extensively study indian set study aim find association mulbsta score -day mortality risk covid- indian population materials method study include  patient receive treatment sars cov- infection tertiary hospital ranchi jharkhand disease severity icmr guideline mulbsta score disease outcome patient note analyze study result strong association see mulbsta score /= -day mortality risk covid- patient conclusion mulbsta scoring system easy calculate model predict -day mortality risk sars cov- infection help primary care physician stratify refer patient high chance develop severe complication
396,background million contagion  million death little  year covid- change life health management system forever age know significant determinant covid- severity main reason underlie immunosenescence age correlation main covid- comorbiditie hypertension dyslipidaemia study aim obtain cut point laboratory parameter help clinical decision making second analyse effect pandemic lockdown epidemiological clinical laboratory parameter concern severity covid- purpose  sarscov inpatient pandemic confinement include study  case record previously analyse series compare present study datum result concern characteristic lockdown series mild case account .% moderate .% severe .% home contagion .% community transmission .% nursing home contagion .% correspond frontline worker contagion epidemiological feature age  male sex confirm severity determinant equally high severity significantly associate high il crp ferritin ldh leukocyte count low percentage lymphocyte cd cd count compare cohort previous -case series mild case analyse moment pandemic dyslipidaemia frequent il- crp ldh value  pg ml  mg l  u l respectively cd t cell count  cell mul good cut off predict severity parameter offer reliable area curve conclusion age sex select laboratory parameter admission help predict covid- severity clinical resource management decision demographic feature associate lockdown affect homogeneity datum robustness result
397,background aim coronavirus disease  covid- pandemic spread rapidly globe considerable morbidity mortality coexistence comorbiditie covid- consistently report risk factor unfavorable prognosis aim study evaluate impact comorbiditie covid- patient outcome determine predictor prolonged hospital stay requisite icu admission decease method hundred thirty adult patient admit june july assiut aswan university hospitals include study participant diagnose covid- accord egyptian ministry health guidance definite case probable case detection sars cov- rna taqmana cent -ncov control kit v cat supply qiagen germany applied biosystem  fast rt pcr system usa result patient comorbiditie represent .% case constitutional symptom especially myalgia lrt symptom dyspnea significantly high patient comorbiditie p patient comorbiditie significantly bad laboratory parameter icu admission high patient comorbiditie different comorbiditie .% cvd case admit icu follow dm case patient comorbiditie need invasive mechanical ventilation comorbidity vs. .% p significant low frequency recovery find covid- patient comorbiditie vs. p death rate significantly high case comorbiditie p survival rate case pre exist cvd neurological disease low disease p respectively conclusion association cardiovascular comorbid condition include hypertension neurological disease covid- infection carry high risk mortality comorbiditie diabetes mellitus chronic pulmonary kidney disease contribute increase covid- severity
398,background study focus explore clinical characteristic outcome covid- old patient conduct systematic review meta analysis well understanding clinical characteristic old covid- patient method systematic search pubmed scopus perform december  rd observational study include old adult age  year covid- infection report clinical characteristic outcome include primary outcome assess weighted pool prevalence wpp severity outcome secondary outcome clinical feature include comorbiditie need respiratory support result study old patient include severe infection see ci- -% i()-% patient ci- -% i()-% critically ill overall ci- -% i()-% patient die common comorbiditie hypertension ci- i()-% diabetes mellitus ci- -% i()-% cardiovascular disease ci -% i()-% common symptom fever ci- -% i()-% cough ci- -% i()-% dyspnoea ci- -% i()-% overall ci- -% i()-% require oxygen support ci- -% i()-% require mechanical ventilation majority study medium high risk bias overall quality evidence low outcome conclusion approximately half old patient covid- severe infection critically ill die high quality evidence need study outcome vulnerable patient population factor affect outcome
399,coronavirus disease  covid- highly contagious affect world seek investigate clinical laboratory characteristic covid- patient high altitude area sichuan china retrospective cohort study total  patient laboratory confirm sars cov- infection sichuan ngawa tibetan qiang autonomous prefecture include february march clinical characteristic radiological laboratory feature extract .% patient categorize severe case  .% non severe case  .% asymptomatic case total  .% patient associate cluster infection event study common symptom cough sputum production dyspnea fatigue myalgia headache seven .% patient show leucopenia  .% patient show lymphopenia lymphocyte count neutrophil lymphocyte ratio npr different group total  .% patient thrombocytopenia prothrombin time pt fibrinogen level differ group find significant difference sodium chloride calcium level group antiviral therapy lead obvious adverse event shorten duration initial positive subsequent negative nucleus acid test advanced age hypertension high neutrophil count neutrophil lymphocyte ratio fibrinogen lactate dehydrogenase level identify independent risk factor symptomatic case covid- conclusion symptom patient high altitude area mild asymptomatic identify independent risk factor symptomatic case covid-
400,significant controversy arise role renin angiotensin aldosterone system raas covid- pathophysiology prospective observational study evaluate plasma angiotensin convert enzyme ace concentration serum ace activity  adult laboratory confirm sars cov- infection  non covid- sick control significant difference observe ace activity covid- patient versus non covid- sick control interquartile range iqr vs. iqr u l p respectively similarly difference observe ace concentration covid- patient versus non covid- sick control iqr vs. iqr mug l p respectively ace activity p ace concentration p associate covid- severity ace activity ace concentration correlate inflammatory biomarker
401,objective overall death toll covid- africa report low little individual level evidence severity disease study examine clinical spectrum outcome patient monitor covid- care centre cccs west african country method burkina faso guinea set referral cccs hospitalise symptomatic sars cov- carrier regardless severity symptom datum collect hospitalise patient november  present result total patient man median age  year admit covid- symptom last median  day iqr hospitalisation  spo /= year respectively multivariable analysis risk death high man aor ci people age year aor ci chronic hypertension aor ci conclusion covid- severe africa vigilance common risk factor old age hypertension
402,introduction chest x ray cxr initial triage patient suspected covid- study cxr scoring european population find high score male female significantly correlate age study mexican mestizo community aim compare difference cxr score male female correlation age control comorbiditie like diabetes hypertension material method retrospective study  cxr mexican mestizo patient sars cov- infection confirm rt pcr significant difference age age group symptom comorbiditie cxr score male female mann whitney u chi square test chi kruskal wallis test relationship total cxr score age measure spearman rank correlation coefficient rs partial correlation analysis control effect symptom risk factor comorbiditie result total cxr score difference male female group age positive low correlation total cxr score age male r p n female r p n age explain variance cxr severity r decrease magnitude r r lose significance change p value p p control effect hypertension conclusion significant difference cxr score male female mexican mestizo population group age hypertension cancel significance cxr severity age point role pathophysiology covid- research stratified group age gender population need publish
403,background organ transplant recipient comprise immunocompromised vulnerable cohort outcome coronavirus disease  covid- solid organ transplant sot recipient remain understudied method multicenter federated research network compare clinical outcome covid- patient sot propensity match cohort patient sot result identify  sot recipient  nontransplant patient covid- transplant patient likely male individual old body mass index kg m comorbid hypertension diabetes nicotine dependence heart failure ischemic heart disease compare nontransplant group p matching perform diabetes hypertension chronic lung disease race nicotine dependence heart failure ischemic heart disease gender difference composite outcome intubation mechanical ventilation  day risk ratio rr confidence interval ci .-  day rr ci  group hospitalization rate high transplant cohort .% versus .% rr ci difference mortality  day versus .% rr ci  day postdiagnosis rr ci patient sot group develop acute renal injury compare non sot cohort .% versus .% rr ci conclusion patient sot high covid relate mortality propensity match analysis reveal increase risk secondary high burden comorbiditie sot status independently increase risk hospital admission acute kidney injury
404,sars coronavirus  sars cov- novel viral pathogen cause clinical disease call coronavirus disease  covid- covid- case asymptomatic involve mild upper respiratory tract symptom significant number patient develop severe critical disease patient severe covid- commonly present viral pneumonia progress life threaten acute respiratory distress syndrome ards patient covid- predisposed venous arterial thrombose associate poor prognosis present study identify emergence low density inflammatory neutrophil ldn population express intermediate level cd cdint patient covid- cell demonstrate proinflammatory gene signature activate platelet spontaneously form neutrophil extracellular trap enhance phagocytic capacity cytokine production strikingly cdint neutrophil major immune cell bronchoalveolar lavage fluid exhibit increase cxcr loss cd cd expression percentage circulate cdint ldns associate d dimer ferritin systemic il- tnf alpha level change time alter disease status datum suggest cdint ldn subset contribute covid associated coagulopathy systemic inflammation ards frequency ldn subset circulation serve adjunct clinical marker monitor disease status progression
405,rapid outbreak coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- lead infection variable clinical presentation wide clinical spectrum disease report wuhan china  rapidly spread worldwide despite report dynamic change disease progression clinical predictor disease severity difficult identify follow case describe identical twin laboratory confirm covid- different disease course patient reside home share comorbiditie include type  diabetes mellitus hypertension morbid obesity twin  high inflammatory marker white blood cell wbc arguably complicated medical history comparison identical twin patient experience mild short disease course case highlight need identify proper disease marker predictor early clinical course order direct future management guideline timely treatment
406,angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb share target receptor severe acute respiratory syndrome coronavirus  sars cov- use aceis arb cause angiotensin convert enzyme  receptor upregulation facilitate entry sars cov- host cell concern use aceis arb increase risk severe covid- mortality impact discontinue drug patient covid- remain uncertain aim assess association use acei arb risk mortality severe disease patient covid- systematic search perform pubmed embase cochrane library medrxiv.org december june identify additional citation manually search reference list eligible article observational study include participant include find use aceis arb significantly associate reduction relative risk cause mortality odd ratio confidence interval ci p find significant reduction risk severe disease acei subgroup ci p arb subgroup ci p acei arb subgroup ci p seven study show significant difference duration hospitalization group mean difference ci p conclusion use aceis arb appear significant effect mortality disease severity duration hospitalization covid- patient basis finding meta analysis support cessation treatment acei arb patient covid-
407,aim aim study describe clinical characteristic patient respiratory alkalosis analyze relationship respiratory alkalosis outcome adult coronavirus disease  covid- patient method clinical laboratory datum adult covid- patient single center china retrospectively collect analyze kaplan meier km curve cox regression adopt analyze association respiratory alkalosis prognosis covid- patient result  adult covid- patient  patient .% respiratory alkalosis admission  patient median age  year old range year  .% female compare respiratory alkalosis patient respiratory alkalosis significantly old p high proportion female p show high ratio underlie disease include hypertension p cardiovascular disease p demonstrate high proportion severe event p patient respiratory alkalosis high possibility develop severe event compare respiratory alkalosis log rank p adjust gender age comorbiditie patient respiratory alkalosis show significantly elevate risk develop severe case hr ci p cox regression analysis conclusion respiratory alkalosis common acid base disorder covid- patient associate high risk develop severe event
408,background year covid- pandemic start scientific report covid- africa study explore clinical profile factor associate covid- cameroon materials method prospective cohort study follow patient admit suspicion covid- djoungolo hospital st april st july patient categorise age group disease severity mild symptomatic clinical sign pneumonia moderate clinical sign pneumonia respiratory distress severe case clinical sign pneumonia respiratory distress require invasive ventilation demographic information clinical feature summarise multivariable analysis perform predict risk finding total  patient admit study period  confirm case covid- polymerase chain reaction pcr confirm case male group age   year .% predominant disease severity range mild .% n moderate n severe .% n case fatality rate n dysgusia n hyposmia anosmia .% n common feature covid- nearly patient comorbiditie n hypertension common .% n participation mass gathering odds ratio p dysgusia p predictive diagnosis covid- age group   p   p   p male gender p diabetes p hiv infection p lung disease p dyspnoea p fatigue p significantly predict covid- severity conclusion covid- case study benign low fatality age male gender hiv infection lung disease dyspnoea fatigue associate severe covid- finding guide public health decision making
409,objective aim analyze clinical course patient discharge emergency departament ed pneumonia symptom compatible diagnosis covid- material method follow  patient discharge home diagnosis pneumonia compatible covid march  hospital southern autonomous community madrid descriptive statistic median interquartile range frequency appropriate compile main variable treatment prognosis compare kruskal wallis mann whitney test datum undergo logistic regression analysis result patient account .% discharge treat hydroxychloroquine readmission rate ed revisit rate admission associate elevated lactate dehydrogenase ldh level p=. elevated creatine kinase ck p=. lymphopenia p=. hypertension chronic obstructive pulmonary disease relate admission ischemic heart disease associate long duration symptom conclusion lymphopenia elevate ldh ck level predict need hospital admission well traditional biological marker patient mild moderate symptom telephone follow prove useful deal overloading health care service
410,background high income country mortality relate hospitalize patient coronavirus disease  covid- approximately -% datum covid- admission sub saharan africa scanty objective describe clinical profile determinant outcome patient confirm covid- admit hospital ghana method prospective study involve  patient real time polymerase chain reaction confirm covid- admit treatment centre university hospital kwame nkrumah university science technology knust kumasi ghana st june th july manage follow outcome datum analyse descriptively predictor mortality assess multivariate logistic regression modelling result mean age patient year  male main symptom presentation breathlessness follow fever case categorize mild moderate severe critical hypertension common comorbidity present patient medication patient management include dexamethasone azithromycin hydroxychloroquine  case die case fatality ratio increase age high systolic blood pressure associate mortality conclusion case fatality sample hospitalize covid- patient high thorough clinical assessment severity stratification aggressive management underlie co morbidity standardized protocol incountry improve outcome funding declare
411,objective analysis describe clinical feature covid- early phase pandemic ghana method datum extract national covid- treatment center ghana  weeks(from march descriptive inferential statistic perform modify order logistic negative binomial regression analysis apply establish factor associate illness severity non communicable disease ncds count respectively analysis conduct confidence level p value /= stata result  patient average age preponderance male common symptom present cough .% headache .% sore throat .% patient history fever patient asymptomatic approximately underlying co morbid ncd hypertension .% diabetes .% asthma common odd moderate severe mos significantly high unknown exposure similar illness aor(%ci compare non exposure similar illness increased unit ncd count significantly increase odd covid- mos illness cor(%ci adjust age aor(%ci)=.(.- conclusion presence cardiovascular co morbidity dictate frequency report symptom severity covid- infection sample ghanaians physician aware presence co morbid ncd prepare manage effectively covid- patient funding declare
412,complement system hyperactivation propose potential driver adverse outcome severe acute respiratory syndrome coronavirus  infect patient give prior research complement deposit find tissue blood sample evidence clinical improvement anticomplement therapy role augment thrombotic microangiopathy mediate organ damage implicate coronavirus disease  covid- study aim examine association complement parameter progression severe covid- illness correlation system blood sample covid- patient present emergency department ed analyze wide panel complement inflammatory biomarker primary outcome covid- severity index ed visit secondary outcome peak disease severity course illness covid- patient enrol p c ratio p scb-/c ratio p significantly elevate severe disease ed presentation course illness p c ratio p high moderate severity group multivariate regression control confounder complement hyperactivation fail predict progression severe disease c ratio scb-/c ratio correlate positively numerous inflammatory biomarker fibrinogen vwf ag negatively plasminogen adamts activity find evidence complement hyperactivation covid- associate hyperinflammation thrombotic microangiopathy complement inhibition investigate potential benefit patient display hyperinflammatory microangiopathic phenotype
413,coronavirus disease  covid- pandemic continue devastating effect healthcare system crisis call urgent need develop risk stratification tool present chapter aim identify laboratory clinical correlate adverse outcome patient covid- end conduct systematic evaluation study investigate laboratory abnormality patient covid- compare i. patient severe form disease patient non severe form disease ii patient critical condition patient critical condition iii patient survive patient die include  study datum synthesis compare patient non severe form covid- patient severe form disease reveal high value white blood cell wbc polymorphonuclear leukocyte pmn total bilirubin alanine aminotransferase alt creatinine troponin procalcitonin lactate dehydrogenase ldh d dimer contrast platelet count lymphocyte count albumin level decrease patient severe form covid- patient severe phenotype disease likely diabetes chronic heart disease chronic obstructive pulmonary disease copd cerebrovascular disease hypertension chronic kidney disease ckd malignancy compare patient survive patient die high wbc pmn total bilirubin alt procalcitonin il- creatinine pt lymphocyte count platelet count albumin non survivor reveal high prevalence diabetes chronic heart disease copd cerebrovascular disease ckd meta analysis identify laboratory parameter help prediction severe critical lethal phenotype covid- parameter correlate immune system function inflammation coagulation liver kidney function
414,hypertension list case series retrospective cohort potential risk factor incidence severity new coronavirus sars cov-)-associated disease covid- debate noteworthy billion people globe estimate hypertensive disease accord global burden disease study consider sars cov- high infectivity rate possible interaction covid- hypertension worrisome additionally antihypertensive drug especially renin angiotensin aldosterone system raas inhibitor influence natural course covid- infection association hold epidemiologic standpoint mechanistic scenario possibly exist hypertension antihypertensive drug increase expression transmembrane angiotensin convert enzyme ace)- receptor entry target virus facilitate infectivity hand increase ace- protective consider anti inflammatory antithrombotic effect ace angiotensin pathway far little know picture observational study appear indicate twofold increase risk mortality hypertensive patient covid- previous continue use raas inhibitor protective subgroup patient scarcity randomized clinical trial preclude evidence base decision making randomized study non specified sub analysis demonstrate relationship angiotensin convert enzyme inhibitor incidence severity disease reflect mainly observational study international cardiology society guideline state antihypertensive drug particularly raas inhibitor discontinue necessary case case basis
415,objective aim examine comorbiditie associate outcome illness severity death hospitalize patient coronavirus disease  covid- method datum provide national medical center korea disease control prevention agency datum include clinical epidemiological information patient hospitalize covid- discharge april  korea conduct comorbidity network multinomial logistic regression analysis identify risk factor associate covid- disease severity mortality outcome variable clinical severity score css categorize mild oxygen treatment need severe oxygen treatment need death result total patient include fully adjust model chronic kidney disease ckd odd ratio confidence interval ci chronic obstructive pulmonary disease copd ci significantly associate disease severity ckd ci heart failure hf ci malignancy ci dementia ci diabetes mellitus ci associate increase risk death asthma hypertension show statistically insignificant association increase risk death conclusion underlie disease contribute differently severity covid- efficiently allocate limited medical resource underlie comorbiditie closely monitor particularly ckd copd hf
416,objective coronavirus disease- covid- associate clinical manifestation range asymptomatic infection critical illness aim study evaluate clinical laboratory characteristic hospitalise covid- patient construct predictive model discrimination patient risk disease progression method single centre cohort study conduct include consecutively patient covid- demographic clinical laboratory finding prospectively collect admission primary outcome interest intensive care unit admission risk model construct apply cox proportional hazard model elastic net penalty diagnostic performance assess receiver operate characteristic analysis compare conventional pneumonia severity score result total  patient  progress critical illness risk score include patient gender presence hypertension diabetes mellitus fever shortness breath serum glucose aspartate aminotransferase lactate dehydrogenase c reactive protein fibrinogen predictive accuracy estimate high area curve .% perform well curb- crb- psi port score sensitivity specificity estimate .% respectively optimal threshold conclusion variable risk score construct base clinical laboratory characteristic order predict critical illness hospitalise covid- patient achieve well discrimination compare traditional pneumonia severity score propose risk model externally validate independent cohort order ensure prognostic efficacy
417,background host protease suggest crucial dissemination mers sars cov sars cov- coronaviruse relative contribution membrane versus intracellular protease remain controversial transmembrane serine protease  tmprss regard main protease implicate coronavirus s protein priming important step binding s protein angiotensin convert enzyme  ace receptor cell entry method develop cell base assay identify tmprss inhibitor inhibitory activity establish sars cov- viral load system result identify human extracellular serine protease inhibitor serpin alpha  anti trypsin aat novel tmprss inhibitor structural modeling reveal aat dock extracellular domain tmprss conformation suitable catalysis resemble similar serine protease inhibitor complex inhibitory activity aat establish sars cov- viral load system notably plasma aat level associate covid- disease severity conclusion datum support key role extracellular serine protease sars cov- infection indicate treatment serpin particularly fda approve drug aat effective limit sars cov- dissemination affect surface host cell
418,introduction mortality critically ill covid- patient remain relatively high despite different potential therapeutic modality introduce recently treatment critically ill patient challenging task identify credible predictor mortality method perform analysis  consecutive patient confirmed covid- infection admit respiratory intensive care unit june october university hospital center bezanijska kosa belgrade serbia patient invasive noninvasive ventilation high flow oxygen therapy moderate severe ards accord berlin definition ards select study demographic datum past medical history laboratory value ct severity score analyze identify predictor mortality univariate multivariate logistic regression model assess potential predictor mortality critically ill covid- patient result mean patient age year range year predominantly man .%  .% patient invasive mechanical ventilation  .% noninvasive  .% high flow oxygen therapy machine median total number icu day  th th percentile median total number hospital stay  th th percentile mortality rate univariate logistic regression analysis confirm significance age crp lymphocyte admission hospital serum albumin d dimer il- admission icu ct score serum albumin d dimer il- admission icu independently associate mortality final multivariate analysis conclusion present study  consecutive critically ill covid- patient moderate severe ards il- serum albumin d dimer admission icu accompany chest ct severity score mark independent predictor mortality
419,coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- cause ongoing global pandemic manifest wide range complication depend severity infection comorbiditie patient vaccine important measure provide protection covid- report case -year old female past medical history hypertension diabetes mellitus undergo imaging positron emission tomography pet scan imaging staging small cell urinary bladder cancer find hypermetabolic uptake deltoid muscle left shoulder hypermetabolic leave axillary pectoral lymph node mrna bnt b pfizer biontech covid- vaccine vaccine administrate  day ago prior pet scan
420,coronavirus disease  covid- outbreak draw scientific community attention pre existing metabolic condition aggravate infection cause extend viral shedding prolonged hospitalization high death rate metabolic dysfunction associate fatty liver disease mafld emerge surrogate covid- severity constellation metabolic alteration entail review outline impact mafld exert covid- severity obese subject possible mechanistic link poor outcome datum collect show mafld patient poor covid- outcome non mafld obese subject mafld generally accompany impaired glycemic control systemic arterial hypertension decompensate covid- clinical course mafld subject high plasma inflammatory marker concentration non mafld subject relate intensify cytokine storm syndrome frequently associate need mechanical ventilation death conclusion mafld represent high risk obesity covid- severity result poor outcome progression non alcoholic steatohepatitis hepatologist include mafld subject high risk group intensify preventive measurement prioritize vaccination
421,objective previous study unveil relationship severity coronavirus disease  covid- pneumonia obesity aim multicenter retrospective cohort study disentangle association bmi associate metabolic risk factor diabetes hypertension hyperlipidemia current smoking status critically ill patient covid- method patient admit intensive care unit covid-  center europe israel united states enrol study february primary secondary outcome need invasive mechanical ventilation imv -day mortality respectively result total patient enrol median interquartile range age  year .% patient male median bmi kg m total patient .% require imv -day mortality estimate ci adjust mixed logistic regression model show significant linear relationship bmi imv odd ratio ci  kg m adjusted cox proportional hazard regression model show significant association bmi mortality increase obesity class iii /= hazard ratio ci conclusion critically ill covid- patient linear association bmi need imv independent metabolic risk factor nonlinear association bmi mortality risk observe
422,clinical manifestation covid- heterogeneous .% patient admit hospital report comorbidity comorbiditie copd diabetes hypertension malignancy predispose patient covid- adverse clinical outcome alpha -antitrypsin deficiency aatd genetic disorder cause pathological mutation(s serpina gene result imbalance proteinase activity lead premature emphysema copd aim investigate people severe aat deficiency aatd increase risk severe covid- infection collect datum covid- symptom laboratory confirm infection hospitalization treatment mean telephone survey directly administer italian severe aatd subject compare finding datum collect istituto superiore di sanita total population italy period find high frequency sars cov- infection cohort .% compare national datum infection give severe aatd relative risk  ci .- p symptomatic sars cov- infection relative risk rr high aatd patient pre exist lung disease rr ci p similar death rate .% compare general population .% rr preliminary finding highlight importance close surveillance spread covid- patient severe aatd underline need study role antiprotease shield prevent sars cov- infection
423,background subphenotype identify patient sepsis ards associate different outcome response therapy research question unique subphenotype identify critically ill patient covid- study design method datum multicenter cohort study enrol critically ill patient covid-  hospital united states randomly divide center discovery replication cohort latent class analysis independently cohort identify subphenotype base clinical laboratory variable analyze association subphenotype mortality result latent class analysis identify subphenotype sp consistent characteristic discovery center n replication center n cohort sp characterize shock acidemia multiorgan dysfunction include acute kidney injury treat renal replacement therapy sp characterize high c reactive protein early need mechanical ventilation high rate ards sp show high burden chronic disease sp demonstrate limited chronic disease burden mild physiologic abnormality day mortality discovery cohort range sp .% sp mortality subphenotype remain different adjustment demographic comorbiditie organ dysfunction illness severity regional hospital factor compare sp relative risk follow sp ci sp ci sp ci finding similar replication cohort interpretation identify subphenotype covid- critical illness distinct pattern clinical laboratory characteristic comorbidity burden mortality
424,coronavirus disease outbreak  covid- achieve level global pandemic affect  million people continent cause  million death russia needless country affect sars cov- health authority mobilize significant effort resource fight disease paper present result functional analysis  patient moscow region examine central clinical hospital russian academy sciences wave pandemic february july inclusion criterion positive pcr test typical compute tomographic finding viral pneumonia form ground glass opacity clinical correlation analysis perform group patient mechanical ventilation mechanical ventilation subsequently recover die correlation analysis consider confounding comorbiditie diabetes metabolic syndrome hypertension etc immunological status patient examine level immunoglobulin m g class subclass total immunoglobulin level original sars cov- antibody elisa kit elisa kit develop linear s protein rbd sd ntd fragment n protein antigen antigen produce prokaryotic e. coli system recombinant rbd produce eukaryotic cho system rbd cho antigen represent conformational rbd epitope immunoglobulin level find early serological criterion development sars cov- infection yield good sensitivity diagnostic significance elisa compare class m immunoglobulin demonstrate seroconversion rate early n protein specific igm iga antibody comparable antibody specific rbd conformational epitope time seroconversion sars cov- n protein specific class g immunoglobulin significantly fast compare specific antibody finding suggest strong immunogenicity rbd fragment associate conformational epitope linear rbd ntd epitope immunogenicity analysis occurrence rate sars cov specific immunoglobulin different class reveal rbd- n specific antibody evaluate parallel improve sensitivity elisa analysis immunoglobulin subclass distribution sera seropositive patient reveal uniform induction n protein specific igg subclass g g iga subclass group patient vary severity covid- case s protein g g main subclass antibody involve immune response
425,context sars cov- population wide testing implement clinical feature antibody response infect document africa information provide analyze datum population wide testing critical understand infection dynamic devise control strategy describe clinical feature assess antibody response people screen sars cov- infection analyze datum cohort  people molecularly screen sars cov- infection routine activity record people sars cov- diagnosis age gender blood type white blood cell wbc symptom chronic disease status time sars cov- rt pcr conversion positive negative calculate age base distribution sars cov- infection analyze proportion spectrum covid- severity furthermore nested sub study screen  covid- patient  contact case anti sars cov- antibody male female account respectively people screen study population median mean age  year   people .% diagnose sars cov- infection male female represent respectively median mean age sars cov- infected subject   year respectively low rate infection observe elderly aged rate sars cov- infection young year old middle aged adult year old analysis sars cov- infection age distribution show middle aged adult account .% sars cov- positive person follow respectively young adult .% child .% elderly n sars cov- infected person asymptomatic n influenza like symptom n influenza like symptom associate anosmia ageusia n dyspnea n respiratory failure result death datum show sars cov- infected subject chronic disease hypertension diabetes asthma concurrent chronic disease represent respectively record chronic disease half sars cov- rt pcr positive patient cure  day follow initiation anti covid- treatment protocol .% covid- patient sars cov- rt pcr confirm negative contact case positive anti sars cov- antibody patient severe critical illness high leukocyte high neutrophil low lymphocyte count contrarily asymptomatic patient patient mild moderate illness neutrophilic leukopenia prevalent asymptomatic patient patient mild moderate disease  week diagnosis patient severe critical illness neutrophilic leukocytosis neutrophilia lymphocytopenia -% frequent participant blood type o. important note infection rate slightly high b blood type compare type o. african setting young middle aged adult likely drive community transmission covid- rate critical disease relatively low high rate anti sars cov- antibody observe sars cov- rt pcr negative contact case suggest subclinical infection overlook setting
426,introduction coronavirus disease  covid- associate hypercoagulable state increase risk ischemic stroke select case patient anticoagulation therapy example highlight severity covid- hyperthrombotic state raise question optimal stroke prevention patient case report ool male past medical history chronic obstructive pulmonary disease hypertension paroxysmal atrial fibrillation admit respiratory failure secondary covid- pneumonia continue home apixaban  mg twice daily day  admission develop new aphasia right side facial droop computed tomography ct head unreveale ct angiography large vessel occlusion ct perfusion demonstrate left middle cerebral artery ischemic penumbra core eligible thrombolysis thrombectomy intervention later ct head confirm l middle cerebral artery infarct patient d dimer ng ml day  admission increase day hypoxia worsen require intubation transfer icu experience clinical decline eventual demise conclusion ischemic stroke anticoagulated patient covid- previously report case emphasize severity coronavirus virus associate hypercoagulable state majority report case occur patient continue ambulatory therapy overall case likely underreported current trial compare therapeutic versus prophylactic dose anticoagulation patient covid- study specifically address anticoagulation agent failure patient research require area determine optimal therapy patient covid-
427,background coronavirus disease  covid- identify indonesia march number infection grow exponentially situation bad overwhelm intensive care unit icu resource capacity case presentation single center observational case study  confirm covid- patient admit icu march april demographic baseline comorbiditie clinical symptom laboratory test electrocardiogram ecg chest imaging obtain consecutively patient care identify  patient confirm covid- severe infection icu mean standard deviation age patient   year man shortness breath .% common symptom hypertension identify comorbidity .% patient common reason admission icu hypoxemic respiratory failure patient require mechanical ventilation half patient die day  day septic shock primary cause death  survive patient discharge home discharge icu remain hospital ward median length icu stay survivor  day conclusion date known effective antiviral agent specific therapy treat covid- severe systemic inflammatory response multiple organ failure primary cause death supportive care maintain oxygenation hemodynamic stability remain mainstay goal treat critically ill covid- patient
428,meta analysis aim screen risk factor severe illness death provide help early clinical treatment new coronavirus covid- base comprehensive search pubmed embase web science database include study explore cause risk factor severe illness death covid- patient evaluate strength relationship odd ratio ors confidence interval cis total  article include   article china risk factor associate severe illness death age sex multiple comorbiditie advanced age /= year severe illness death male severe illness death chronic respiratory disease severe illness death diabetes severe illness death hypertension severe illness death chronic kidney disease severe illness death cardiovascular disease severe illness death risk factor covid- patient advanced age male patient chronic disease high risk develop severe illness death
429,severe acute respiratory syndrome coronavirus- sars cov- mediate coronavirus disease- covid- affect million individual corner globe symptom severity infection highly contagious virus vary individual disparity number covid related casualty different ethnic group primary receptor sars cov- entry host cell angiotensin convert enzyme  ace certain variant ace know associate covid- comorbiditie hypertension cardiovascular complication diabetes chronic lung disease etc study look geographic distribution disease associate variant ace closely locate pir gene explore possible correlation disparity covid- severity casualty ethnic group frequency ace variant associate covid- comorbiditie high european admix american population variant present strong pairwise linkage disequilibrium ld european admix american population hand variant protective role prevalent east south asian population strong pairwise ld exist activity modifying modifier variant pir ace gene european super population absence pir variant south asian population contribute overall low covid- case fatality rate cfr despite dense population region
430,demonstrate feasibility acute peritoneal dialysis pd acute kidney injury coronavirus disease  covid- pandemic perform multicenter retrospective observational study  patient receive acute pd new york city spring patient comorbiditie severity disease laboratory value kidney replacement therapy patient outcome record mean age   year woman confirm covid- require mechanical ventilation admission compare level prior initiation kidney replacement therapy mean serum potassium level decrease meq l pd day  meq l day  p mean serum bicarbonate increase     meq l pd day  p   meq l day  p median follow  day patient die renal recovery male sex mechanical ventilation admission significant predictor mortality rapid implementation acute pd program feasible despite resource constraint lifesaving crisis covid- pandemic
431,objective aim study assess role midregional proadrenomedullin mr proadm patient covid- method include  patient hospitalize covid- biochemical biomarker include mr proadm measure admission association plasma mr proadm level covid- severity define requirement mechanical ventilation hospital mortality evaluate result patient show increase level mr proadm addition mr proadm high patient die hospitalization patient survive median nmol l interquartile range .- vs median nmol l interquartile range .- p receiver operate characteristic curve analysis show good accuracy mr proadm predict mortality mr proadm value nmol l establish good cutoff value sensitivity specificity p conclusion find mr proadm represent prognostic biomarker covid-
432,endocrine disrupt chemical edcs hormonally active compound environment interfere body endocrine system consequently produce adverse health effect despite persistent public health concern edcs remain important component common consumer product represent ubiquitous contaminant human scientific evidence confirm contribution severity influenza virus hn animal model role susceptibility clinical outcome coronavirus disease covid- underestimate emergence late clinical report covid- confirm severe disease death occur person age /= year underlie comorbiditie major comorbiditie covid- include diabetes obesity cardiovascular disease hypertension cancer kidney liver disease long term exposure edc contribute significantly onset progression comorbid disease edc play vital role disruption body immune system review recent literature role edcs comorbiditie contribute covid- mortality impact edc immune system recent article link edc covid- risk recommend methodology adopt comprehensively study role edcs covid- risk
433,hypercoagulability thrombosis cause coronavirus disease  covid- relate high mortality rate limited datum antiplatelet effect aim evaluate impact aspirin add therapy outcome patient hospitalize severe covid- cohort study patient confirm diagnosis severe covid- admit imam hossein medical center tehran iran march  july  include demographic relate clinical datum hospitalization record mortality rate patient consider primary outcome association aspirin use assess ninety patient include  patient receive aspirin hospitalization  one comorbiditie prevalent patient receive aspirin result multivariate cox proportional model demonstrate significant independent association aspirin use reduction risk hospital mortality p aspirin use hospitalize patient covid- associate significant decrease mortality rate prospective randomized control trial need assess efficacy adverse effect aspirin administration population
434,background covid- respiratory infectious disease cause sars cov- cardiovascular damage commonly observe affected patient seek investigate effect sars cov- infection cardiac injury hypertension current coronavirus pandemic study design method clinical datum  hospitalize covid confirm patient analyze clinical sign laboratory finding extract electronic medical record independent experienced clinician analyze datum result cardiac injury find enrol patient cardiac injury case severe group laboratory finding indicate white blood cell neutrophil procalcitonin c reactive protein lactate lactic dehydrogenase positively associate cardiac injury marker compare healthy control  patient prior hypertension high ang level  .% patient rise blood pressure diagnostic criterion hypertension hospitalization significantly increase level ctni procalcitonin angiotensin ii ang normal blood pressure one multivariate analysis indicate elevated age ctni history hypertension diabete independent predictor illness severity predictive model base parameter gender good ability identify clinical severity covid- hospitalize patient area curve sensitivity .% specificity conclusion hypertension accompany elevated ctni occur covid- patient sequela enhance ang ii signal drive sars cov- infection play important role renin angiotensin system consequently lead development hypertension covid-
435,aim antihypertensive drug implicate coronavirus disease  covid- susceptibility severity estimate association susceptible bias aim evaluate antihypertensive medication covid- diagnosis mortality account healthcare seek behaviour method population base case control study conduct include  covid- case  match control uk clinical practice research datalink evaluate cause mortality covid- case exposure angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb beta blocker b calcium channel blocker c thiazide diuretic d antihypertensive drug o analysis adjust covariate consultation frequency result acei associate low odd covid- diagnosis adjust odd ratio aor confidence interval ci arb aor ci little attenuation adjustment consultation frequency c d associate low odd covid- diagnosis increased odd covid- b aor ci .- attenuate adjustment consultation frequency aor ci patient treat aceis arb similar odd mortality aor ci .- patient treat class b c d o patient receive antihypertensive therapy aor ci conclusion evidence antihypertensive therapy associate increase risk covid- diagnosis mortality class antihypertensive therapy show negative association covid- diagnosis
436,increase clinical evidence show acute kidney injury aki common severe complication critically ill covid- patient old age severity covid- infection ethnicity history smoking diabetes hypertension cardiovascular disease risk factor aki covid- patient inflammation key player pathogenesis aki patient covid- highly possible sars cov- infection trigger activation multiple inflammatory pathway include angiotensin ii cytokine storm interleukin- il- c reactive protein crp tgf beta signaling complement activation lung kidney crosstalk cause aki treatment target inflammatory molecule pathway monoclonal antibody il- tocilizumab c inhibitor amy- anti c antibody anti tgf beta ot- use crrt critically ill patient represent novel specific therapy aki covid- patient
437,background knowledge sars cov- infection pregnancy newborn scarce objective study analyse clinical epidemiological characteristic cohort woman infect sars cov- pregnancy newborn expose sars cov- gestation method multicentric observational study spanish hospital gesneo covd cohort participant reclip spanish network paediatric clinical assays woman confirm sars cov- infection pcr and/or serology pregnancy diagnose deliver period include epidemiological clinical analytical datum collect result total  pregnant woman median year old iqr  newborn include globally pregnant woman covid- symptom treat sars cov- overall .% pregnant woman pneumonia  .% woman admit intensive care unit need invasive mechanical ventilation rate .% caesarean section associate pneumonia pregnancy ci low gestational age delivery ci prevalence preterm birth prematurity associate pneumonia gestation ci% have positive sars cov- pcr delivery ci% nasopharyngeal pcr newborn negative birth positivized  day life newborn die cause relate prematurity unexpected sudden death early skin skin contact delivery conclusion vertical transmission report cohort prognosis newborn worsen sars cov- infection pregnancy covid- pneumonia increase risk caesarean section delivery preterm birth
438,background datum lifestyle change coronavirus disease  covid- pandemic influence clinical feature kidney disease patient remain scarce method study retrospectively analyze clinical variable patient stage g g chronic kidney disease ckd complete incomplete remission proteinuria manage nephrology outpatient clinic university hospital tokyo clinical variable covid- pandemic term june july compare year pandemic term june july urinary protein excretion upe primary outcome measure result study include  patient stage g g ckd mean age year old .% female .% renin angiotensin aldosterone system inhibitor raasis .% maintenance dose immunosuppression therapy evaluate term upe term     mg day median th th percentile respectively value term  low term  p marked difference body weight blood pressure protein intake urinary salt excretion multivariable analysis incomplete remission proteinuria term  odd ratio p raasi use p decrease urinary salt excretion term  vs. term  p identify independent variable associate reduce upe term  vs. term significant interaction variable observe conclusion kidney disease patient receive standard medical care nephrologist upe emergency declaration relation covid- pandemic low declaration upe reduction associate reduce dietary salt intake pandemic patient treat raasi insufficient control proteinuria result support current proposal continue therapeutic approach patient involve raasi therapy optimize dietary habit deal covid- pandemic
439,coronavirus disease  covid- identify end  cluster pneumonia case wuhan china february virus quickly spread global pandemic spectrum symptomatic infection severity range mild severe critical disease correlate comorbiditie establish include smoking socioeconomic background gender male prevalence hypertension obesity cardiovascular disease chronic lung disease diabetes mellitus cancer chronic kidney disease extensive literature search post covid- necrotize staphylococcus aureus pneumonia pneumothorax record present case -year old male present symptom covid- underlying comorbiditie include hypertension hyperlipidemia ventilatory support week hospital receive supplemental oxygenation recover covid- pneumonia nearly month half initial presentation quickly decompensate start supplemental oxygen necessary treatment aid lab work imaging determine develop necrotize staphylococcus aureus pneumonia pneumothorax adequately treat stable discharge home tell continue therapy
440,sars cov entry cell dependent angiotensin convert enzyme  ace angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb increase ace activity safety acei arb usage coronavirus disease  covid- pandemic controversial topic address issue perform meta analysis follow preferred reporting items systematic reviews meta analyses guideline search embase medline pubmed cochrane library database identify  case control study examine effect acei arb incidence covid- severity acei arb usage associate increase risk covid- morbidity odd ratio confidence interval ci p=. general population hypertensive population ci p=. acei arb usage associate increase risk covid- morbidity coefficient ci p=. adjust hypertension general population acei arb usage associate increase risk severe illness ci p=. mortality ci p=. covid- patient meta analysis reveal acei arb usage associate increase risk sars cov infection adverse outcome covid- patient
441,background large airway epithelial barrier provide line defense respiratory virus include sars cov- cause covid- substantial inter individual variability individual disease course hypothesize partially mediate differential regulation gene interact sars cov- virus involve subsequent host response comprehensively investigate non genetic genetic factor influence covid relevant bronchial epithelial gene expression method analyze rna sequence datum bronchial epithelial brushing obtain uninfected individual relate ace gene expression host environmental factor spiromics cohort smoker chronic obstructive pulmonary disease copd replicate association asthma cohort sarp mast identify airway biology ace binding contribute increase susceptibility gene set enrichment analysis determine gene expression change indicative suppress airway immune response observe early sars cov- infection observe association host factor identify host genetic variant affect covid- susceptibility spiromics perform expression quantitative trait eqtl mapping investigate phenotypic association eqtl variant result find ace expression high relation active smoking obesity hypertension know risk factor covid- severity association interferon relate inflammation drive truncated non binding ace isoform discover expression pattern suppress airway immune response early sars cov- infection compare virus similar pattern associate obesity hypertension cardiovascular disease contribute covid susceptible airway environment eqtl mapping identify regulatory variant gene implicate covid- phewas evidence potential role respiratory infection conclusion datum provide evidence clinically relevant variation expression covid related gene associate host factor environmental exposure likely host genetic variation
442,comorbiditie show associate coronavirus disease  covid- related severity mortality considerable variation prevalence estimate comorbiditie effect covid- morbidity mortality observe prior study systematic review meta analysis aim determine geographical age gender relate difference prevalence comorbiditie associated severity mortality rate covid- patient conduct search pubmed scopus embase include covid- study publish january st  july th  reporting comorbiditie severity mortality include study report confirm diagnosis covid- human patient provide information comorbiditie disease outcome dersimonian laird random effect method calculate estimate  study patient prevalent comorbidity hypertension obesity diabetes cardiovascular disease chronic kidney renal disease cerebrovascular accident cardiovascular disease patient covid- severity mortality respectively considerable variation prevalence comorbiditie associated disease severity mortality different geographic region observe high mortality observe study latin american european patient medical condition old adult  year predominantly male patient study observe high prevalence comorbiditie covid- patient severity covid- comorbid condition high asian study mortality high european latin american country risk stratification effective control strategy covid- accord comorbiditie age gender difference specific geographical location
443,background aim reduction atherogenic lipoprotein ultimate goal nutritional intervention complicate give hypolipidemia frequently observe coronavirus disease  covid- patient aim explore association hypolipidemia patient outcome term immunothrombosis multiorgan injury focus specialize apolipoprotein apo apo b. methods lipid profile  covid- patient  sick control present emergency department ed measure prospective observational study primary outcome development severe acute kidney injury aki need hospitalization icu admission secondary outcome lipoprotein analyze independent association serum creatinine scr increase ratio correlate wide panel biomarker result covid- cohort significantly low apo p high apo b apo ratio p patient develop severe aki significantly low ldl c p apo b apo associate .-fold decrease serum scr increase ratio ldl c .% decrease hypolipidemia correlate low plasminogen adamts activity vwf ag high inflammatory biomarker crp il- il- il- plasminogen activator inhibitor- pai- ed creatinine scr increase ratio conclusion favor dietetic finding low ldl c covid- patient alarming light observation low apo b apo ratio ldl c predictive renal deterioration covid- patient low ldl c particular potentially serve indicate covid- relate aki drive disrupt fibrinolysis secondary thrombotic microangiopathy like process
444,background coronavirus disease  covid- spread rapidly multiple country infectious agent severe acute respiratory syndrome coronavirus severity atypical clinical presentation lack specific anti viral treatment pose challenge diagnosis treatment covid- understand epidemiological clinical characteristic covid- case different geographical area essential improve prognosis covid- patient slow spread disease aim investigate epidemiological clinical characteristic main therapeutic strategy confirmed covid- patient hospitalize liaoning province china method adult patient n confirmed covid- enrol retrospective study january  february  liaoning province china pharyngeal swab sputum specimen collect patient detection severe acute respiratory syndrome coronavirus  nucleic acid patient demographic information clinical datum collect medical record base severity covid- patient divide nonsevere severe group patient follow march result mean age  covid- patient year .% man .% severe case  d symptom onset  .% patient live stay wuhan  .% clear history exposure .% patient comorbidity hypertension diabete common comorbiditie compare nonsevere patient severe patient significantly low lymphocyte count median value x interquartile range vs x p elevated level lactate dehydrogenase u l vs  u l p c reactive protein mg l .- vs  mg l .- p prolonged median duration viral shedding d vs d p overall median viral shed time d long  d. severe patient frequently treat lopinavir ritonavir antibiotic glucocorticoid therapy immunoglobulin thymosin oxygen support patient discharge follow treatment quarantine conclusion finding facilitate identification severe case inform clinical treatment quarantine decision covid-
445,severe acute respiratory syndrome coronavirus  sars cov disease covid- novel threat hamper life expectancy especially obese individual association clinically relevant underlie mechanism fully elucidate sars cov enter host cell angiotensin converting enzyme  receptor express adipose tissue adipose tissue source proinflammatory mediator adipokine enhance characteristic covid- cytokine storm chronic low grade inflammatory preconditioning obesity dependent thoracic mechanical constraint incise negatively prognosis obese subject covid- review summarize current body knowledge obesity dependent circumstance trigger increase risk covid- severity clinical relevance
446,sars cov- virus cause infection lead global pandemic  development severe acute respiratory syndrome study aim examine possible role predict severity intrahospital mortality covid- alongside laboratory biochemical procedure clinical sign symptom comorbidity study approve ethical committee clinical center kragujevac design observational prospective cross sectional clinical study conduct  patient diagnose respiratory covid- viral infection april august primary goal determine predictor covid- severity determine predictor negative outcome covid- infection patient divide category patient mild form moderate form severe form covid- infection biochemical laboratory procedure day hospital admission respiratory p heart p rate admission significantly high patient severe form covid- observe hematological inflammatory marker white blood cell count p ldh p significantly high severe covid- group observe severe form sars cov- level superoxide anion radical substantially high group p nitric oxide level significantly low patient severe disease p linear regression model ta anosmia ageusia o duration icu estimate predictor severity sars cov- disease presence dyspnea high heart rate confirm predictor negative fatal outcome result study presence hypertension anosmia ageusia duration icu stay serum level o predictor covid- severity presence dyspnea increase heart rate admission predictor covid- mortality
447,background coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- month declare global pandemic number confirm case  million million death start pandemic count consensus factor predict covid- case progression despite diversity study report sporadic laboratory predictive value predict severe progression review different biomarker systematically analyze value evaluate correlate severity covid- disease ability predictor progression method current meta analysis carry identify relevant article different database value biomarker risk factor significance predict progression mild moderate case severe critical case define eligibility criterion pico model result relevant article select meta analysis follow biomarker c reactive protein interleukin- ldh neutrophil pd- expression d dimer creatinine ast cortisol record high cut value link severe critical case low lymphocyte count low albumin level record meta- analyze age comorbiditie risk factor progression hypertension diabetes chronic obstructive lung disease significantly correlate case progression p conclusion current meta analysis step analyse get cut reference value significance prediction covid- case progression study need patient infect sars cov- large scale establish clear threshold value predict progression mild severe case addition biomarker testing help build scoring system prediction guide proper timely treatment
448,world include united states man bad outcome covid- woman sars cov- causative virus covid- pandemic use angiotensin convert enzyme  ace gain cellular entry ace member renin angiotensin system ras play important role counteract harmful effect mediate angiotensin type  receptor conduct ovid medline embase database search basic science study investigate impact biological variable sex ace expression regulation year ace discover december publication identify  original research article ace conduct primary cell tissue and/or mammal exclude human majority .% study cite sex animal conduct male .% conduct solely female .% compare ace sex .% report sex animal general finding sex difference tissue specific present dependent gonadal state renal cardiac adipose ace increase sex experimental condition model co morbidity associate bad covid- outcome include hypertension obesity renal cardiovascular disease ace protein generally high male study ace knockout mouse indicate ace play great role protect female develop hypertension male study biological variable sex ace research provide opportunity discovery condition involve ras dysfunction shed light sex difference covid- severity
449,background december coronavirus disease  covid- emerge wuhan city spread rapidly china world aim describe clinical feature risk factor predictor hospitalization adult patient treat acute respiratory infection associate coronavirus sars cov- material method descriptive prospective study ambulatory hospitalize adult patient confirm covid- attend april  clinical feature chronic comorbiditie demographic datum record patient follow month outpatient result assess adult age   year man laboratory confirm covid- comorbiditie specially hypertension .% hypothyroidism .% asthma diabetes hospital admission require .% admit critical care unit .% connect mechanical ventilation common symptom include fatigue .% fever .% headache .% anosmia dysgeusia .% dry cough .% dyspnea .% diarrhea patient report persistence symptom month follow specially fatigue cough dyspnea multivariate analysis age fever cough dyspnea immunosuppression associate hospitalization icu admission age male sex moderate severe dyspnea associate requirement mechanical ventilation main predictor prolonged clinical course female sex presence comorbiditie history dyspnea cough myalgia abdominal pain conclusion clinical feature covid- highly unspecific prediction model severity help medical decision making primary care setting
450,aim meta analysis aim assess prognostic value fast hyperglycemia patient covid- method systematic literature search pubmed embase scopus perform february fast hyperglycemia define fast plasma glucose level reference value outcome interest poor outcome composite mortality severe covid- effect estimate odd ratio result  patient  study include systematic review meta analysis prevalence fast hyperglycemia incidence poor outcome fast hyperglycemia associate poor outcome covid- p .% p subgroup analysis patient prior history diabetes show fast hyperglycemia associate poor outcome covid- p p fast hyperglycemia sensitivity specificity plr nlr dor  auc predict poor outcome pool analysis fast hyperglycemia post test probability poor outcome absence fast hyperglycemia confer post test probability meta regression subgroup analysis show sensitivity specificity vary chronic kidney disease age male gender hypertension chronic kidney disease conclusion fast hyperglycemia associate mortality covid- patient diabetes prospero crd
451,objective severity outcome covid- disproportionately high individual obesity smoker patient hypertension kidney disease chronic pulmonary disease coronary heart disease chd and/or type  diabetes td serum level ace cellular entry point coronavirus sars cov- examine high risk group method association ace level smoker patient hypertension td obesity chd copd investigate single center population base study  icelanders age gene environment susceptibility reykjavik study ages rs elderly mean age   year multiple linear regression analysis result serum level ace high smoker individual td and/or obesity unaffected patient group conclusion ace level high patient group comorbiditie link covid- include obesity td emerge role circulate biomarker severity outcome disease
452,background negative impact proton pump inhibitor ppi include risk pneumonia mortality report previously meta analysis aim address current interest administration ppi increase susceptibility risk poor outcome covid- method perform systematic literature search pubmed embase ebscohost europepmc database  december main outcome composite poor outcome comprise mortality severe covid- severe covid- study define patient covid- fulfill criterion severe cap include need intensive unit care mechanical ventilation secondary outcome susceptibility base cohort compare covid- positive covid- negative participant result total patient  study meta analysis ppi use associate increase composite poor outcome p meta regression analysis indicate association vary age p male p hypertension p diabetes p chronic kidney disease p non steroidal anti inflammatory drug use p pre admission hospital ppi use p ppi use associate susceptibility covid- p conclusion meta analysis show potential association ppi use composite poor outcome susceptibility prospero id crd
453,coronavirus disease  covid- primarily affect respiratory tract pathophysiological change cardiovascular system remain elucidate perform retrospective cardiopathological analysis heart vasculature  autopsy covid- patient compare finding control tissue myocardium autopsy covid- patient categorise severe acute respiratory syndrome coronavirus  sars cov- positive n negative n base presence viral rna determine reverse transcriptase polymerase chain reaction rt pcr control tissue select autopsy covid- n similar clinical sequela histological characteristic score ordinal and/or categorical grading rt pcr positive case undergo situ hybridisation ish sars cov- patient lethal covid- infection male high incidence hypertension coronary artery disease diabetes mellitus patient positive myocardial rt pcr die early hospital admission versus  day p patient negative rt pcr increase severity fibrin deposition capillary dilatation microhaemorrhage observe rt pcr positive myocardium negative control positive correlation factor case increase cardioinflammatory infiltrate myocyte necrosis n myocarditis n rt pcr negative ish reveal positivity viral rna interstitial cell myocardial capillary dilatation fibrin deposition microhaemorrhage histomorphological correlate covid associated coagulopathy increased cardioinflammation include case myocarditis detect rt pcr negative heart significantly long hospitalisation time imply secondary immunological response warrant characterisation
454,epidemiological evidence suggest patient hypertension infect severe acute respiratory syndrome coronavirus  sars cov- increase risk acute lung injury clear increase risk relate usage renin angiotensin system ras blocker collect medical record coronavirus disease  covid- patient affiliated hospital zhejiang university school medicine hangzhou china evaluate potential impact angiotensin ii receptor blocker arb clinical outcome covid- patient hypertension total  hypertensive covid- patient enrol  classify non arb group remain  arb group base antihypertensive therapy receive compare non arb group patient arb group low proportion severe case intensive care unit icu admission shorten length hospital stay manifest favorable result laboratory testing viral load arb group low non arb group disease course significant difference time seroconversion antibody level observe group median level soluble angiotensin convert enzyme  sace serum urine sample similar group significant correlation serum sace biomarker disease severity transcriptional analysis show  differentially express gene mainly enrich oxygen transport bicarbonate transport blood coagulation result suggest arb usage associate aggravation covid- finding support maintenance arb treatment hypertensive patient diagnose covid-
455,objective compare clinical paraclinical feature outcome pregnant nonpregnant woman covid- method multicenter retrospective cohort study pregnant nonpregnant woman reproductive age hospitalize march october  tehran iran medical record woman test positive sars cov- rt pcr include extract datum compare logistic regression perform result total  pregnant  nonpregnant covid positive woman include frequency severe disease high nonpregnant woman pregnant woman vs .% p symptom include cough dyspnea chill fatigue headache frequent nonpregnant woman p pregnant woman high oxygen saturation level low lymphocyte count p .% pregnant  .% nonpregnant woman die p significant difference group find icu admission end organ failure significantly nonpregnant woman acute respiratory distress syndrome ards .% vs p univariate regression indicate association hypertension death oxygen saturation ards body mass index icu admission association find pregnancy death icu admission ards conclusion pregnant woman covid- high risk adverse outcome compare nonpregnant woman
456,background globally study show conflicting result association blood group sars cov- infection objective observe association abo blood group presentation outcome confirmed covid- case design setting participant prospective cohort study patient mild moderately severe covid- infection present covid- unit dhaka medical college hospital enrol  june  august patient follow  day disease onset group participant positive negative blood group group participant blood group group ii result cohort include  patient  patient lose follow die  complete study prevalence blood group .% significantly high covid- patient general population p present age mean sd group high group ii p sex p co morbidity hypertension p diabetes p differ patient group ii difference observe important present symptom include fever p cough p respiratory distress p significant difference median duration symptom group day conversion level severity observe  .%  patient .% group ii respectively persistent positivity rt pcr  day initial positivity frequent patient group group ii .% conclusion prevalence blood group high covid- patient abo blood group associate presentation recovery period covid- patient blood group delay seroconversion
457,background coronavirus disease covid- disproportionately affect african americans tend experience severe course adverse outcome simple validated instrument depression screening evaluate incidence severity major depression african american patient  day recovery severe covid associated respiratory failure method african american patient hospitalize treat invasive mechanical ventilation covid associated respiratory failure intensive care unit icu grady memorial hospital atlanta april june screen depression  day hospital discharge validate patient health questionnaire phq- phq- result total  patient complete questionnaire median age year iqr male common comorbiditie hypertension diabetes mellitus percent patient diagnosis major depressive disorder mdd base phq- questionnaire response incidence mdd high female n=/ compare male n=/ patient  year multiple comorbiditie eighteen percent patient moderate depression moderately severe severe depression respectively n=/ eligible patient receive treatment depression time survey conclusion incidence depression cohort african american patient prior psychiatric condition recover severe covid- infection patient receive treatment depression
458,factor link high risk mortality coronavirus disease- covid- include male gender increase age hypertension diabetes mellitus obesity cardiovascular disease chronic obstructive pulmonary disease cancer hyperglycemic covid- patient severe clinical problem increase icu admittance machine drive ventilation substantial rise inflammatory marker patient diabetes hyperglycemia two- fold increase mortality severity covid- diabetes primary cause mortality covid- patient diabetes compromise immune response viral infection increased blood sugar level probably affect intracellular degradation bacteria neutrophil chemotaxis phagocytosis improve viral bind affinity entry decrease virus clearance addition significant effect protein induce glycosylation alter composition complement glycosylation render cell susceptible viral inflammation damage treatment covid- patient diabetes require integrated team approach minimize risk medical complication mortality physician adopt proactive strategy care person comorbiditie strategy help reduce frequency complication mortality patient load healthcare system
459,objective coronavirus disease  covid- considerable global public health threat study seek investigate blood glucose bg level comorbid diabete associate inflammatory status disease severity patient covid- method retrospective cohort study clinical biochemical characteristic covid- patient diabetes compare relationship severity covid- inflammatory status diabetes hyperglycemia analyze severity covid- patient determine accord diagnostic treatment guideline issue chinese national health committee th edition result patient enrol study .% patient diabetes .% patient diabetes hyperglycemia compare patient diabetes n patient diabetes n high leucocyte count neutrophil count neutrophil lymphocyte ratio nlr erythrocyte sedimentation rate esr association severity covid- know diabetes adjust age sex body mass index bmi know hypertension coronary heart disease leucocyte count nlr c reactive protein crp level increase increase bg level hyperglycemia independent predictor critical ci severe ci covid- increase inflammatory level high leucocyte count ci nlr ci crp level ci adjustment age sex bmi severity illness know diabetes conclusion hyperglycemia positively correlate high inflammation level severe illness risk factor increase severity covid- initial measurement plasma glucose level hospitalization help identify subset patient predisposed bad clinical course
460,malnutrition common severe patient coronavirus disease  covid- mainly elderly adult patient comorbiditie associate atypical presentation disease despite possible contribution malnutrition acquisition severity covid- clear nutritional screening measure well diagnose malnutrition patient early stage crucial importance give urgency rapid progression disease vulnerable group accordingly review examine available literature different nutritional screening approach implement covid- patient special focus elderly adult literature search select scrutinize  study assess malnutrition covid- patient nutrition risk screening  nrs- demonstrate superior sensitivity traditional screening measure control nutritional status conut score comprise serum albumin level cholesterol level lymphocyte count combined conut lactate dehydrogenase c reactive protein score express predictive capacity superior nrs- .% .% vs. .% midlife elder covid- patient simple measure base routinely conduct laboratory investigation conut score timely cheap valuable alternative identify covid- patient high nutritional risk mini nutritional assessment mna measure detect residual malnutrition high malnutrition risk remit patient mna score correlate hypoalbuminemia hypercytokinemia weight loss old male severe inflammation gastrointestinal symptom pre existing comorbiditie diabetes obesity hypertension prone malnutrition subsequently poor covid- prognosis acute phase convalescence need frequent nutritional monitoring support detect treat malnutrition general public necessary increase resilience covid-
461,outbreak severe acute respiratory syndrome coronavirus  sars cov- pandemic highlight problem health care system threaten mental physical health patient worldwide goal study assess psychological health insomnia people chronic disease time elevated stress associate pandemic study involve  people zachodniopomorskie province poland participant provide basic demographic datum datum symptom insomnia depression anxiety information concomitant disease hypertension diabetes mellitus coronary heart disease heart failure dyslipidemia chronic obstructive pulmonary disease hashimoto disease smoking cigarette chronic disease include study show strong correlation hashimoto disease increase score accord insomnia severity index isi r p generalized anxiety disorder scale gad- r p patient health questionnaire phq- r p result correct age gender diagnose hypertension dyslipidemia cigarette smoking confirm diagnosis hashimoto disease associate increase risk anxiety odd ratio p depression p insomnia p study show sars cov- pandemic patient hashimoto disease high risk insomnia anxiety depression
462,early month coronavirus disease  covid- pandemic hypothesis emerge suggest pharmacologic inhibitor renin angiotensin system ras increase covid- severity hypothesis base role angiotensin convert enzyme  ace counterregulatory component ras bind site severe acute respiratory syndrome coronavirus  sars cov- allow viral entry host cell extrapolation prior evidence lead speculation upregulation ace ras blockade increase risk adverse outcome covid- counterargument point evidence potential protective effect ace ras blockade regard acute lung injury substantial risk discontinue commonly important medication provide overview classic ras physiology crucial role ace systemic pathway affect covid- additionally critically review physiologic epidemiologic evidence surround interaction ras blockade covid- review recently publish trial evidence propose important future direction improve understanding relationship
463,coronavirus disease  covid- cause novel coronavirus identify wuhan china global number confirm case covid- surpass mortality appear high seasonal influenza covid- patient experience cardiac involvement myocardial infarction patient infect sars cov- bad prognosis furthermore widespread use antiviral drug link worsening heart function arrhythmias hypertension report patient covid- hand previous cardiac disease present patient infect sars cov- uncertainty use ace inhibitor angiotensin ii ang ii antagonist covid- era mechanism action sars cov- elucidate demonstrate angiotensin convert enzyme  ace cellular receptor new coronavirus sars cov- require host cell entry subsequent viral replication effect sars cov- infection downregulation ace contribute severity lung pathology cardiac function ace homolog ace monocarboxypeptidase convert ang ii angiotensin ang vasodilatory antifibrotic antihypertrophic effect counterbalance negative effect ang ii hand angiotensin convert enzyme inhibitor acei atr blocker show upregulate expression ace base mechanism action sars cov- use renin angiotensin system ras inhibitor question scientific society recommend discontinuation clinically recommend brace corona phase randomized study test strategy temporarily stop ace inhibitor angiotensin receptor blocker arb  day versus continue ace inhibitor arb patient take medication chronically hospitalize confirm diagnosis covid- discuss goal review summarize recent laboratory clinical investigation concern use acei arb covid- pandemic available datum base randomized trial suggest acei arb clinically indicate regularly covid- era
464,background adult congenital heart disease chd consider potentially high risk novel coronavirus disease- covid- mortality complication objectives study seek define impact covid- adult chd identify risk factor associate adverse outcome method adult age  year old chd confirm clinically suspect covid- include chd center worldwide data collection include anatomic diagnosis subsequent intervention comorbiditie medication echocardiographic finding present symptom course illness outcome predictor death severe infection determine result  adult chd center study include infected patient age year range   year woman laboratory confirm coronavirus infection cohort include  patient single ventricle and/or fontan physiology  patient cyanosis  patient pulmonary hypertension  covid relate death case fatality .% confidence interval .% factor associate death include male sex diabetes cyanosis pulmonary hypertension renal insufficiency previous hospital admission heart failure bad physiological stage associate mortality p anatomic complexity defect group conclusion covid- mortality adult chd commensurate general population vulnerable patient bad physiological stage cyanosis pulmonary hypertension anatomic complexity appear predict infection severity
465,late december outbreak novel coronavirus cause coronavirus disease  covid- initiate acute kidney injury aki associate high severity mortality covid- aim evaluate effect comorbiditie medication addition determine association aki antibiotic coinfection aac outcome patient conduct retrospective study adult patient hospitalize covid- tertiary center primary outcome incidence rate aki base comorbiditie medication secondary outcome determine mortality intensive care unit icu admission prolonged hospitalization aki aac univariable multivariable logistic regression method explore predictive effect aki aac outcome  include participant  patient develop aki  aac  hypertension diabete common comorbiditie patient develop aki aac lopinavir ritonavir ribavirin angiotensin convert enzyme inhibitor angiotensin ii receptor blocker corticosteroid significant high rate administration patient develop aki aac associate high death odd ratio confidence interval ci icu admission ci aki high prolonged hospitalization ci aki aac associate poor prognosis covid- define strict criterion indication type antibiotic help overcome concomitant infection minimize related adverse event
466,background serial chest compute tomography ct scan detect coronavirus disease  covid- pneumonia monitor disease course study investigate relationship total severity score chest ct outcome coronavirus covid- patient coronary artery disease cad result total  patient history cad mean age=.+/- year male positive real time reverse transcription polymerase chain reaction covid- include outcome define acute respiratory distress syndrome death unadjusted adjust effect ct score outcome report odd ratio confidence interval ci outcome occur  .% patient death ct score directly significantly correlate outcome univariate analysis ci p=. remain significant adjustment diabetes hypertension body mass index serum level highly sensitive c reactive protein ci p=. outcome rate patient ct score conclusion chest ct score robust predictor adverse event confirmed covid- patient coronary artery disease
467,importance chronic receipt angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb assume exacerbate complication associate covid- produce bad clinical outcome objective conduct update comprehensive systematic review meta analysis compare mortality severe adverse event aes associate receipt vs nonreceipt aceis arb patient covid- data sources pubmed embase database systematically search december september study selection meta analysis include study design exception narrative review opinion base article covid- diagnose laboratory radiological test result clinical outcome unadjusted adjust associate covid- assess adult patient /= year receive acei arb data extraction synthesis author independently extract datum mortality severe aes associate covid- severe aes define intensive care unit admission need assisted ventilation outcome random effect model compare odd ratio patient receive acei arb vs receive acei arb main outcomes measures unadjusted adjust or mortality severe aes associate covid- result total  record pubmed embase database identify removal duplicate  record screen  article undergo text evaluation clinical datum pool  eligible study cohort study  case series  case control study  randomized clinical trial  cross sectional study enrol  total patient  .% receive acei arb adjust covariate significant reduction risk death adjust aor ci p severe aes aor ci p find unadjusted adjust analysis subgroup patient hypertension indicate decrease risk death unadjusted ci p aor ci p severe aes unadjusted ci p aor ci p conclusion relevance systematic review meta analysis receipt aceis arb associate high risk multivariable adjust mortality severe aes patient covid- hypertension multiple comorbiditie support recommendation medical society contrary aceis arb associate protective benefit particularly patient hypertension future randomized clinical trial warrant establish causality
468,importance unknown adult susceptible severe complication covid- recognize susceptibility modify behavior reduce exposure objective determine adult risk factor covid- complication perceive elevated chance complication undertake few high infection risk behavior design setting participant cross sectional analysis adjust sociodemographic characteristic include civilian noninstitutionalize adult wave  understanding america study collect november  december exposure centers disease control prevention identify medical risk factor covid- complication old age main outcomes measures primary outcome perceive percentage chance infection hospitalization death infect  potentially high infection risk activity undertake past week mask wear mask wear past week attitude  aspect mask wear result understand america study wave  n  participant nonmisse datum mean age  year woman response rate adult   medical risk factor aged  year old report high perceive chance complication infect adjust mean perceive chance hospitalization infect range ci .%-.% high blood pressure ci .%-.% chronic lung disease associate number medical risk factor ci ci .%-.% adult  vs  medical risk factor respectively few potentially high infection risk activity undertake adult  vs  risk factor ci .- vs ci wear mask week nearly universal  specific activity visit grocery store pharmacy half wear mask  activity visit grocery store pharmacy mask wear common adult  vs  condition conclusion relevance cross sectional survey study adult risk factor covid- complication report higher perceive susceptibility complication common activity include visit friend majority adult include highly susceptible consistently wear mask
469,objective assess medium term organ impairment symptomatic individual follow recovery acute sars cov- infection design baseline finding prospective observational cohort study setting community base individual uk centre  april  september participant individual year persistent symptom follow recovery acute sars cov- infection age match healthy control intervention assessment symptom standardised questionnaire eq d l dyspnoea- organ specific metric biochemical assessment quantitative mri main outcome measures severe post covid- syndrome define ongoing respiratory symptom and/or moderate functional impairment activity daily living single organ multiorgan impairment heart lung kidney liver pancreas spleen consensus definition baseline investigation result  individual mean age range year female white healthcare worker complete baseline assessment median  day follow sars cov- infection iqr study population low risk covid- mortality obesity hypertension type  diabetes heart disease hospitalise covid- individual  symptom severe post covid- syndrome fatigue muscle ache breathlessness headache frequently report mild organ impairment present heart lung kidney liver pancreas spleen single organ multiorgan impairment respectively hospitalisation associate old age p=. non white ethnicity p=. increase liver volume p pancreatic inflammation p fat accumulation liver p pancreas p severe post covid- syndrome associate radiological evidence cardiac damage myocarditis p conclusion individual low risk covid- mortality ongoing symptom impairment organ  month initial covid- symptom implication healthcare public health assume low risk young people comorbiditie trial registration number nct pre result
470,severe acute respiratory syndrome coronavirus  sars cov- infection present increase disease severity poor clinical outcome diabetic patient compare nondiabetic counterpart diabetes hyperglycemia trigger endothelial dysfunction hyperactive inflammatory immune response correlate twofold threefold higher intensive care hospitalization twice mortality diabetic coronavirus disease  covid- patient comorbiditie obesity cardiovascular disease hypertension worsen prognosis diabetic covid- patient covid- infection associate new onset diabetes severe metabolic complication increase thrombotic event backdrop aberrant endothelial function antidiabetic medication manage blood glucose level discuss multifaceted ability metformin control blood glucose level possibly attenuate endothelial dysfunction inhibit viral entry infection modify inflammatory immune response sars cov- infection action metformin viable candidate drug consider repurpose gain ground sars cov induce tsunami diabetic covid- patient
471,year pass report case severe acute respiratory syndrome coronavirus  sars cov infection city wuhan china hubei province antiviral medication e.g. remdesivir drug target inflammatory complication associate sars cov infection consider safe public health authority end november crisis lead million death reveal high susceptibility people pre existing comorbiditie e.g. obesity diabetes coronary heart disease hypertension suffer severe form disease elderly people find highly susceptible sars cov infection morbidity gastrointestinal manifestation gut microbial alteration observe sars cov infect hospitalize patient raise awareness potential role intestinal mechanism increase severity disease critically important find alternative complementary approach prevent treat disease reduce grow societal economic burden review explore potential nutritional strategy implicate use polyphenol probiotic vitamin d omega- fatty acid focus gut microbiome lead concrete recommendation easily applicable vulnerable people pre existing metabolic comorbiditie elderly general population
472,background objectives aki coronavirus disease  covid- associate high morbidity mortality objective study identify kidney histopathologic characteristic deceased patient diagnosis covid- evaluate association biopsy finding clinical variable include aki severity design setting participant measurement multicenter observational study deceased patient covid- level center mexico city evaluate postmortem kidney biopsy light electron microscopy analysis case descriptive association statistic perform clinical histologic variable result total  patient include median age  year man body mass index  kg m history diabetes history hypertension receive anticoagulation steroid receive potential nephrotoxic medication severe aki present patient biopsy finding include fsgs diabetic nephropathy arteriosclerosis acute tubular injury grade observe histopathologic characteristic associate severe aki pigment cast biopsy associate significantly low probability kidney function recovery odd ratio confidence interval use aminoglycoside colistin level c reactive protein serum albumin previous use angiotensin convert enzyme inhibitor angiotensin ii receptor blocker antiviral nonsteroid anti inflammatory drug anticoagulant associate specific histopathologic finding conclusion high prevalence chronic comorbiditie find kidney biopsy nonrecovery severe aki associate presence pigmented cast inflammatory marker medication associate specific histopathologic finding patient die covid-
473,thomson timothy m. fresia casas harold andre guerrero romulo figueroa mujica francisco c. villafuerte claudia machicado potential protective effect covid- confer altitude longitudinal analysis peru lockdown high alt med biol background covid- pandemic delay onset america despite time advantage implementation preventative measure contain spread pandemic follow growth rate parallel observe europe objective analyze temporal geographical distribution covid- pandemic district level peru lockdown period method analysis publicly available data set stratify altitude geographical localization correlation test covid- case death rate population prevalence comorbiditie result observe strong protective effect altitude covid- mortality population locate m. provide evidence internal migration specific land route significant factor progressively override protection covid- afford high altitude protection independent poverty index inversely correlate prevalence hypertension hypercholesterolemia discussion long term adaptation residency high altitude general protective factor covid- severity death young age female sex multisystemic adaptive trait acclimatization process response chronic hypobaric hypoxia explain apparent protective effect high altitude covid- death
474,background novel coronavirus disease  covid- spread worldwide beginning place heavy burden health system world population particularly affect pandemic group patient suffer diabetes mellitus having take public health consideration decide perform systematic review meta analysis diabetes mellitus hospital mortality patient covid- method systematic literature review medline embase web science scopus cochrane include publish clinical trial observational study publish till december perform follow term diabetes mellitus diabetes dm survival mortality sars cov- covid- result nineteen study include  initially identify study mortality dm patient vs non dm patient versus .% respectively ci p severe disease dm non dm group vary amount .% versus ci p dm group complication observe far compare non dm group acute respiratory distress vs. .% ci p acute cardiac injury .% vs. .% ci p acute kidney injury vs. .% ci p conclusion base finding shall conclude diabetes independent risk factor severity covid- hospital setting patient diabetes shall aim reduce exposure potential infection covid-
475,ongoing coronavirus disease  covid- pandemic cause novel severe acute respiratory syndrome coronavirus  sars cov- global public health challenge patient experience severe complication approximately patient progress acute respiratory distress syndrome ards mortality rate approximately -% clinical finding determine risk factor severe complication mortality covid- patient advanced age smoking obesity chronic disease obesity common health problem worldwide initiate cascade disorder include hypertension cardiovascular disease cvd diabetes mellitus chronic kidney disease ckd presence disorder link severe course covid- give epidemic obesity worldwide importance obesity progression covid- investigate mechanism obesity increase susceptibility severity covid- support selection appropriate therapy individual obesity
476,background purpose coronavirus disease  co vid- infection ongoing pandemic worldwide health emergency cause important change healthcare system previous study report increase risk thromboembolic event include stroke systematic review aim describe clinical feature etiological characteristic ischemic stroke patient co vid- infection method literature search perform principal database study case report contain datum concern risk factor clinical feature etiological characteristic patient infect covid- suffer stroke descriptive analytical statistic apply result overall  article include total  patient median age  iqr year prevalence male stroke occur median  day covid- infection diagnosis median national institute health stroke scale nihss score cryptogenic cry stroke frequent follow cardioembolic etiology occur long time covid- diagnosis compare large artery atherosclerosis stroke ptrend clinical severity stroke significantly associate severity grade covid- infection ptrend conclusion ischemic stroke covid infected patient clinically severe affect young patient mainly cry cardioembolic etiology multicenter prospective registry need well describe causal association effect covid- infection stroke
477,covid- infection predominantly affect respiratory system system organ affect kidney organ commonly affect sars cov- report predictor increase severity need intensive care icu admission death present case covid- associate co morbidity include diabetes mellitus systemic hypertension impaired kidney function relationship multiple co morbidity particularly impaired kidney function outcome covid- infection challenge offer dialysis patient covid- infection kidney failure discuss case present highlight state preparedness management covid- complication co morbidity particularly kidney failure tertiary hospital nigeria onset covid- outbreak
478,test pregnant non pregnant woman differ covid- symptom profile severity extend previous investigation hospitalize pregnant woman require hospitalization female community base cohort year provide longitudinal smartphone application n n  pregnant test positive cross sectional web base survey n n  pregnant test positive datum prospectively collect self participatory citizen surveillance uk sweden usa pregnant non pregnant compare frequency event include sars cov- testing symptom hospitalization rate multivariable regression investigate symptom severity comorbidity effect pregnant non pregnant woman positive sars cov- infection different syndromic severity gastrointestinal symptom pregnant likely receive testing despite report few symptom pre exist lung disease closely associate syndromic severity pregnant hospitalize heart kidney disease diabete increase risk frequent symptom non hospitalize woman anosmia pregnant non pregnant headache cardiopulmonary symptom include persistent cough chest pain frequent pregnant hospitalize consistent observation non pregnant population lung disease diabete associate increase risk severe sars cov- infection pregnancy
479,background observational study consistently describe poor clinical outcome increase icu mortality patient severe coronavirus disease  covid- require mechanical ventilation mv study describe clinical characteristic outcome patient severe covid- admit icu large health care system state florida united states method retrospective cohort study patient admit icu severe covid- adventhealth health system orlando florida march th th patient characterize base demographic baseline comorbiditie severity illness medical management include experimental therapy laboratory marker ventilator parameter major clinical outcome analyze end study period hospital icu length stay mv relate mortality overall hospital mortality icu patient result total  patient covid-  .% meet criterion icu admission median age  year interquartile range iqr .- .% female common comorbiditie hypertension diabetes (;  icu patient  .% require mv  .% receive ecmo low positive end expiratory pressure peep observe survivor vs non survivor p compare non survivor survivor long mv length stay los iqr vs iqr p hospital los iqr vs  p icu los iqr vs iqr p overall hospital mortality mv relate mortality .% respectively exclusion hospitalize patient hospital mv relate mortality rate .% respectively conclusion study demonstrate important improvement mortality patient severe covid- require icu admission mv comparison previous observational report emphasize importance standard care measure management covid-
480,introduction coronavirus disease  covid- multiorgan involvement severity vary presence pre existing risk factor like cardiovascular disease cvd hypertension htn important evaluate effect outcome covid- patient objective meta analysis meta regression evaluate outcome covid- patient cvd htn method english text observational study have datum epidemiological characteristic patient covid- identify search pubmed december july follow meta analysis observational studies epidemiology moose protocol study have pre exist cvd htn datum describe outcome include mortality invasive mechanical ventilation imv utilization select random effect model risk composite poor outcome meta analysis isolate mortality imv utilization meta regression evaluate pooled prevalence cvd htn correlation coefficient r odd ratio estimate forest plot correlation plot create random effect model result  study n= meet criterion   study datum cvd htn respectively pooled prevalence cvd .% htn meta analysis cvd ci htn ci associate composite poor outcome age adjust meta regression pre exist cvd have significantly high correlation imv utilization r ci have association mortality r ci covid- hospitalization htn correlate high imv utilization r ci correlate high mortality r ci conclusion age adjust analysis identify pre exist cvd risk factor high utilization mechanical ventilation pre exist cvd htn independent role increase mortality
481,current time rise demand hospital bed important triage covid- patient accord treatment need hospitalization need oxygen therapy important factor determine hospital admission patient retrospective study design identify risk factor associate progression oxygen requirement covid- patient total  patient laboratory confirm covid- admit hospital february august exclude asymptomatic non japanese pediatric pregnant patient need oxygen immediately admission datum remain  patient analyze patient separate require oxygen admission characteristic compare age body mass index bmi lymphocyte count c reactive protein crp lactate dehydrogenase estimate glomerular filtration rate glucose intolerance hypertension dyslipidemia significantly different group multivariate analysis identify significant independent risk factor oxygen requirement include advanced age obesity glucose intolerance lymphocytopenia divide patient subgroup accord number risk factor find patient indicate need oxygen increase high number risk factor individual result suggest presence high number risk factor covid- patient associate future oxygen requirement index potentially useful triage covid- patient stay home context need hospitalization
482,background ongoing outbreak pneumonia associate severe acute respiratory coronavirus sars cov- emerge december  wuhan china epidemiologic evidence suggest patient comorbiditie novel coronavirus disease  covid- infection poor survival outcome risk coexist medical condition severe non severe case systematically report purpose present study aim estimate association chronic comorbiditie severe non severe case method literature search conduct database pubmed embase china national knowledge infrastructure cnki wanfang database chinese scientific journals text database cqvip inception date april identify cohort study assess comorbidity risk adverse outcome fixed- random effect model calculate overall combine risk estimate result total  study involve  patient laboratory confirm covid- include analysis overall compare patient non severe case pool odd ratio ors hypertension diabetes mellitus cardiovascular cerebrovascular respiratory disease patient severe case confidence interval ci ci ci ci ci respectively conclusion meta analysis support finding chronic comorbiditie contribute severe outcome patient covid- accord finding present study old age  comorbiditie significantly impactful covid- outcome hospitalize patient china
483,background solid organ transplant sot recipient complex immunocompromised population great coronavirus disease  covid- mortality report compare general population method examine retrospective cohort  sot recipient wave covid- compare patient severe nonsevere illness additionally sot recipient compare general patient wave covid- result organ transplant include  kidney  liver  heart  pancreas average sot recipient age year male .% african american .% white comorbiditie include hypertension chronic kidney disease diabetes mellitus coronary artery disease chronic obstructive pulmonary disease patient severe covid- .%  nonsevere disease severe disease common old sot recipient comorbiditie associate cough dyspnea pneumonia c reactive protein mg l platelet count sex race body mass index time transplant baseline immunosuppression diagnosis month differ severe nonsevere covid- seventy percent sot recipient hospitalize vs .% general patient covid- inpatient sot recipient high mechanical ventilation rate trend long length stay higher intensive care unit admission great inpatient mortality observe .% vs .% difference significant conclusion severe acute respiratory syndrome coronavirus  greatly impact sot recipient sot recipient see wave severe illness associated standard risk factor poor outcome compare general wave patient sot recipient hospitalize inpatient covid- mortality significantly differ
484,angiotensin convert enzyme  ace protect organ damage hypertension cardiovascular disease counter regulate renin angiotensin system ras ace receptor severe acute respiratory syndrome coronavirus  sars cov- base claim ras inhibitor rasis cause ace overexpression animal experiment concern arise rasis aggravate sars cov- infection coronavirus disease- severity rasi treat patient achieve comprehensive review systematic search medline pubmed conduct effect rasis tissue ace mrna protein expression healthy animal animal model human disease identify  eligible article involve  experiment heart kidney lung organ  experiment involve healthy animal show ace expression great twice control overexpression  disease model experiment baseline ace overexpresse  model experiment half control level repression  model experiment  experiment rasis change ace level baseline level disease model rasis cause ace overexpression compare control level seven experiment unsupported experiment similar condition  experiment rasis reverse prevent disease induce ace repression yield marginal change ace overexpression appear rare common consequence rasi treatment healthy animal disease model future study clarify pathophysiological significance rasi induce reversal prevention ace repression disease model
485,introduction corona virus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- global pandemic aim study investigate impact angiotensin convert enzyme inhibitors acei and/or angiotensin receptor blockers arb hospital admission following covid- outcome disease severity icu admission mortality method chart patient consecutively diagnose covid- th february th june year  jaber ahmed sabah hospital kuwait check relate patient information clinical datum retrieve hospital electronic medical record system primary outcome covid- disease severity define need intensive care unit icu admission secondary outcome mortality result total covid- patient include  patient .% acei arb user acei arb find significantly old vs. year acei arb user find co morbidity diabetes vs. hypertension vs. .% acei arb use find significantly associate great risk icu admission unadjusted analysis ci p adjustment age gender nationality coronary artery disease diabetes hypertension icu admission find inversely associate acei use ci p inversely associate mortality ci p conclusion current evidence literature support continuation acei arb medication patient co morbidity acquire covid- infection protective effect medication covid- disease severity mortality remain unclear finding present study support use acei arb medication
486,aim respiratory infectious disease obesity associate poor outcome coronavirus disease  covid- association obesity severity prognosis require analysis method retrospective single center study hospitalize patient recruit renmin hospital wuhan university january  february datum body mass index bmi obtain follow survive patient accord bmi normal weight define .- kg m overweight .- kg m obesity kg m result total  patient enrol  .% patient normal weight group  .% overweight group  .% obesity group compare normal group obese patient likely high heart rate low finger oxygen saturation high level white blood cell neutrophil count basophil count intravenous glucose triacylglycerol uric acid alanine aminotransferase creatine kinase mb cd+ cell count percentage low level monocyte percentage high density lipoprotein cd+ cell percentage addition proportion hypertension .% vs. .% severe+critical illness vs. significantly high obesity group normal group significant difference observe normal obesity group critical illness organ damage define endpoint mechanical ventilation intensive care unit multiple logistic regression show obesity increase risk develop severe+critical illness odd ratio ci p=. patient covid- affect risk critical illness organ damage endpoint overweight affect risk severity organ damage endpoint patient covid- conclusion obesity risk factor develop severity patient covid-
487,background gender relate factor affect vulnerability covid- aim study describe role gender clinical feature -day mortality covid- patient method observational study covid- patient hospitalize bergamo italy week outbreak medical record clinical radiological laboratory finding admission treatment collect primary outcome -day mortality hospitalization result  consecutive adult patient admit female patient  .% mean age year vs male p previous history myocardial infarction vasculopathy smoking habit common male time admission pao fio similar man woman iqr vs  mmhg p continuous positive airway pressure cpap assistance need  h frequently male patient .% vs .% p overall -day mortality woman .% man p gender result independent predictor death parameter relate disease severity presentation include multivariable analysis p accordingly kaplan meier survival analysis female male patient require cpap non invasive ventilation  h find significant difference p conclusion hospitalized woman likely die covid- severe disease occur risk die similar man study need well investigate role gender clinical course outcome covid-
488,coronavirus disease  covid- break december high morbility mortality necessary summarize clinical characteristic covid- patient provide theoretical basis future treatment current study conduct retrospective analysis clinical characteristic covid- patient explore risk factor severity illness total  covid- patient hospitalize leishenshan hospital wuhan china classify sub type moderate n severe n critical n clinical datum collect electronic medical record show  covid- patient median age  year iqr  .% patient accompany hypertension  .%  .% patient suffer diabetes heart disease respectively complication patient wuhan definite history exposure epidemic area multivariate logistic regression analysis reveal old age diabetes chronic liver disease percentage neutrophil n% crp  mg l d dimer mg l il r  u ml il-  pg ml il- pg ml independent variable associate severe covid- conclusion identify independent risk factor severity covid- pneumonia include old age diabetes chronic liver disease high level n% crp d dimer il r il- il- provide evidence accurate risk prediction
489,renin aldosterone angiotensin system raas play important role pathogenesis coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- angiotensin convert enzyme  ace cellular receptor sars cov- host expression membrane bind protein affect susceptibility infection raas important regulator cardiovascular physiology ace essential role people hypertension trait show imbalance ace ace level reduce level ace enhance risk adverse outcome patient covid- hypothesise raas mediate interplay cardiovascular disease covid- severity evidence show antihypertensive drug target raa significant effect risk infection disease outcome variation raas gene associate risk develop hypertension cardiovascular disease partly explain heterogenous response sars cov- infection article explore interplay raas covid- emphasis possible relationship genetic variation disease severity
490,aim investigate impact comorbidity burden mortality patient coronavirus disease covid- analyze covid- datum nationwide health insurance claim south korea datum demographic characteristic comorbiditie mortality record patient covid- extract database odd ratio mortality accord comorbiditie patient adjustment age sex calculate predictive value original charlson comorbidity index cci age adjust cci acci mortality patient investigate receiver operate characteristic roc curve analysis  patient  .% die age sex adjustment hypertension diabetes mellitus congestive heart failure dementia chronic pulmonary disease liver disease renal disease cancer significant risk factor mortality roc curve analysis show acci threshold yield good cut point predict mortality area roc confidence interval .- study reveal multiple risk factor mortality patient covid- high predictive power acci mortality result support importance old age comorbiditie severity covid-
491,background number study report association use angiotensin convert enzyme inhibitor acei angiotensin ii receptor blocker arb medication occurrence severity coronavirus disease  covid- publish result inconclusive possibly difference participant comorbiditie sociodemographic background acei arb frequently anti hypertension medication aim determine use acei arb associate occurrence severity covid- large study veterans hypertension method datum collect department veterans affairs va national corporate data warehouse va covid- shared data resource february  august datum veteran history hypertension receive covid- testing va investigate use acei arb year prior index date associate increase odd positive covid- test severe outcome hospitalization mortality use intensive care unit icu and/or mechanical ventilation covid positive patient logistic regression propensity score weighting psw estimate odd ratio confidence interval ci association acei arb use positive covid- test result association medication use covid- outcome severity examine multinomial logistic regression compare participant hospitalize participant hospitalize admit icu mechanical ventilator die model adjust relevant covariate include demographic age sex race ethnicity select comorbiditie charlson comorbidity index cci result use acei significantly decrease odd positive covid- test veteran hypertension psw use acei arb associate significantly increase odd mechanical ventilator psw covid- inpatient compare outpatient conclusion study veteran hypertension acei significantly associate decrease odd testing positive covid- exception association acei small non clinically important increase odd mechanical ventilator acei arb find associate clinical severity mortality covid positive veteran result study need corroboration validation cohort sample outside va
492,introduction increase virulence severity illness mortality hypothesize respect angiotensin convert enzyme inhibitor acei)/angiotensin receptor blocker arb use coronavirus disease  covid- infection study aim assess acei arb use patient covid- confer worsen severity illness increase mortality additionally explore possibility unearth protective benefit interruption ras signal pathway observe cardiovascular disease method cochrane library medline embase search study relevant covid- severity mortality inflammation context acei arb use study include total patient .% take acei arb study population female average age study study choose sample size  patient result mortality outcome assess study show significant difference mortality acei arb control group odd ratio ci seven study assess severity covid- show statistically significant difference disease severity compare acei arb group control group odd ratio ci study report length stay significant difference acei arb group compare non user study include inflammatory marker c reactive protein crp d dimer note consistently low acei arb group compare control group statistically significant conclusion study find significant difference mortality severity illness length stay acei arb user non user covid- infection result support continuation acei arb setting covid- advise american college cardiology acc)/american heart association aha decrease crp d dimer suggest possible protective effect relate acei arb use covid- study large sample size need establish effect
493,objective explore modify ct scoring system feasibility disease severity evaluation predictive value coronavirus disease  covid- patient method study multi center retrospective cohort study patient confirm covid- recruit medical center locate beijing wuhan nanchang january  march demographic clinical datum ct image collect ct analyze emergency physician year work experience independently modify scoring system final score determine average score reviewer consensus reach lung divide  zone upper middle low side level trachea carina level low pulmonary vein target lesion type include ground glass opacity ggo consolidation overall lung involvement crazy paving pattern bronchiectasis cavity pleural effusion etc include ct reading analysis low incidence reviewer evaluate extent target pattern ggo consolidation overall affected lung parenchyma zone likert scale range (= absent ggo score consolidation score overall lung involvement score sum  zone range crazy paving pattern code absent present zone range result total  patient  medical center  ct scan enter final analysis median age patient  year .% male patient hypertension .% patient diabetes mellitus  patient classify moderate case  severe case  critical case initial symptom dry cough occur  patient  patient fever  patient dyspnea reparatory rate oxygen saturation lymphocyte count curb  score admission day varied patient different disease severity scale  patient suffer deterioration hospital stay median time consume ct clinician second cronbach alpha ggo consolidation crazy paving pattern overall lung involvement clinician respectively show good excellent inter rater correlation  .% patient ggo  .% consolidation .% crazy paving pattern clinical course bilateral lung involvement observe patient median time interval ct scan study  day clinical course divide stage week analysis second week ct score type lesion severe critically patient high moderate case fifth week course disease enter recovery period ct score upper lung zone low zone moderate severe case similar distribution observe critical patient moderate case ground glass opacity score second week predictive value escalation severity classification hospitalization area receiver operate characteristic curve good cut value  point sensitivity .% specificity .% conclusion feasible clinician use modify semi quantitative ct scoring system evaluate patient covid- severe critical patient high score ground glass opacity consolidation crazy paving pattern overall lung involvement moderate case ground glass opacity score second week optimal predictive value escalation disease severity hospitalization moderate patient admission frequency ct scan reduce enter recovery stage
494,background datum comorbiditie result negative outcome people covid- currently scarce african population study identify comorbiditie predict death large sample covid- patient nigeria method retrospective analysis medical record  laboratory confirm case covid- lagos southwest nigeria extract datum include age sex severity condition presentation self report comorbiditie outcome interest death discharge facility result case male .% median age  year iqr ninety patient .% comorbidity common hypertension .% diabetes mortality rate .% significantly high proportion patient comorbiditie die compare comorbiditie predict death hypertension ci diabetes ci renal disease ci cancer ci hiv conclusion comorbiditie prevalent associated risk death high covid- patient lagos nigeria public enlightenment early identification target care covid- case comorbiditie recommend pandemic evolve
495,december coronavirus disease- covid- keep world suspense prove risk factor severe course covid- common disease like diabetes hypertension cardiovascular respiratory disorder today little know psychological burden individual suffer high risk disease regard covid- aim study define impact coronavirus pandemic behavior mental health individual high risk develop severe covid- course item assess generalized anxiety gad- covid relate fear adherent dysfunctional safety behavior subjective risk perception symptom have severe course die covid- datum compare participant high risk disease individual disease respondent complete study generalized anxiety covid relate fear adherent dysfunctional safety behavior subjective risk perception elevate participant high risk disease increased covid relate fear functional concern conclusion increase risk severe course functionality fear reflect people increase need security include increase adherent dysfunctional safety behavior underline need psychological support strategy
496,elderly people people co morbidity emerge vulnerable group risk develop complication succumb novel coronavirus covid- infection record baseline demographic profile baseline clinical laboratory parameter prevalence co morbidity effect prognosis covid- case conduct prospective observational study analyze baseline clinical laboratory parameter co morbidity effect severity mortality  covid- case seven patient laboratory confirm covid- recruit th march st august mean age .year total  .% patient male overall mean length hospital stay day total  patients(.% mild moderate case require initial icu care .% case require initial intensive care unit care admit patient succumb illness diabetes mellitus hypertension increase risk death covid- patient irrespective age increase age co morbidity adversely affect prognosis patient covid- diabetes mellitus hypertension increase risk death covid- patient negate incremental effect age death patient
497,background obesity associate co morbidity worsen effect severe acute respiratory syndrome coronavirus  sars cov- study demonstrate severe form coronavirus disease covid- occur elderly patient patient co morbidity diabetes hypertension cardiovascular disease objective study investigate impact obesity covid- severity irrespective individual factor method retrospective observational study include adult patient confirmed covid- infection admit sheikh khalifa ibn zaid international university hospital march  compare patient obesity term demographic characteristic co morbidity clinical symptom outcome logistic regression model analyze association obesity intensive care unit icu admission examine association obesity icu admission consistent overweight patient result study population include  patient confirmed covid- infection obese patient admit icu patient obesity p value adjust risk factor icu admission find obesity independent risk factor icu admission ci examine association obesity overweight icu admission find obesity significantly associate icu admission ci conclusion study find obesity strongly associate severity covid- risk icu admission great presence obesity physician award need specific early management obese patient covid- disease
498,background effectively efficiently diagnose patient covid- accurate clinical type disease essential achieve optimal outcome patient reduce risk overload health care system currently severe nonsevere covid- type differentiate feature comprehensively characterize complicated pathological physiological immunological response sars cov- infection different disease type addition type define feature readily testable time diagnosis objective study aim use machine learning approach understand covid- comprehensively accurately differentiate severe nonsevere covid- clinical type base multiple medical feature provide reliable prediction clinical type disease method study recruit  confirm patient nonsevere covid-  patient severe covid- clinical characteristic feature laboratory test result feature admission acquire input modality exploratory analysis demonstrate feature differ substantially clinical type machine learn random forest model base feature modality  feature modality combine develop validate differentiate covid- clinical type result clinical laboratory result independently input random forest model achieve predictive accuracy respectively importance score input feature evaluate  feature modality identify age hypertension cardiovascular disease gender diabete clinical feature modality dimerize plasmin fragment d high sensitivity troponin absolute neutrophil count interleukin lactate dehydrogenase laboratory testing modality descend order  multimodal feature input instead  feature combine random forest model able achieve predictive accuracy conclusion finding shed light human body react sars cov- infection unit provide insight effectively evaluate disease severity patient covid- base common medical feature gold standard feature available suggest clinical information initial screening tool self evaluation triage laboratory test result apply accuracy priority
499,background coronavirus disease  covid- report cause bad outcome patient underlie cardiovascular disease especially patient acute cardiac injury determine elevated level high sensitivity troponin paucity datum impact congestive heart failure chf outcome covid- patient method conduct literature search pubmed medline embase google scholar database till // identify relevant study report cardiovascular comorbiditie cardiac biomarker disease severity survival pooled datum select study metanalysis identify impact risk factor cardiac biomarker elevation disease severity and/or mortality result collect pooled datum  covid- patient  individual study find non survivor severe disease increase risk acute cardiac injury cardiac arrhythmia pool relative risk rr ci p ci p respectively mean difference level troponin ck mb nt probnp high deceased severely infected patient rr hospital mortality ci p ci p patient pre exist chf hypertension respectively conclusion cardiac involvement covid- infection appear significantly adversely impact patient prognosis survival pre existence chf high cardiac biomarker like nt pro bnp ck mb level covid- patient correlate bad outcome
500,coronavirus disease  covid- vaccine platform available promising strategy curb spread sars cov- infection numerous uncertainty exist pro con vaccination especially patient immune mediate kidney disease immunosuppressive drug member immunonephrology working group iwg european renal association european dialysis transplant association era edta discuss thirteen frequently ask question safety efficacy promising vaccine candidate post marketing surveillance perform estimate rate vaccine response humoral cellular different vaccine platform surveillance disease activity follow administration covid- vaccine candidate induce signal pathway promote autoimmune kidney disease e.g. type interferon systemic lupus erythematosus efficacy estimate far favor use select covid- vaccine bntb mrna- gam covid vac humoral immune response vaccination monitor appropriate assay absence neutralize antibody patient protect sufficient cellular immune response capable reduce severity covid- reduced vaccine response use cd deplete agent anticipate particularly important discuss strategy improve vaccine response patient distance shielding measure remain important vaccine fully protect coronavirus infection depth information press vaccine question essential reduce vaccine hesitancy patient
501,background aim study identify predictor hospitalization old /= year patient coronavirus disease- covid- saudi arabia method patient randomly select covid- database maintain ministry health saudi arabia patient aged /= year reverse transcriptase polymerase chain reaction rt pcr)-confirmed covid- register database march  july medical sociodemographic characteristic retrieve database additional datum collect telephone interview conduct train health professional descriptive statistic multiple logistic regression analysis analyze relationship patient characteristic risk hospitalization result  include patient .% female half .%   year age hospitalize independent predictor hospitalization include age year ci p have comorbidity ci p diabetes mellitus ci p hypertension ci p chronic kidney disease ci p history hospital admission precede year ci p risk hospitalization low male ci p patient co live health care worker ci p conclusion factor associate high risk covid associate hospitalization prioritize old adult admission future study robust design conduct examine risk covid associated illness severity mortality
502,importance acute kidney injury aki occur half patient hospitalize coronavirus disease  covid- longitudinal effect covid associated aki kidney function remain unknown objective compare rate change estimate glomerular filtration rate egfr hospital discharge patient covid- experience hospital aki design setting participant retrospective cohort study conduct  hospital connecticut rhode island march  august patient test covid- develop aki screen survive past discharge require dialysis  day discharge  outpatient creatinine level measurement follow discharge include exposure diagnosis covid- main outcomes measures mixed effect model assess association covid associated aki egfr slope discharge secondary outcome time aki recovery subgroup patient kidney function return baseline level discharge result total  patient covid associated aki  patient aki associate covid- include population include  woman .% median age year interquartile range year patient covid associate aki likely black vs  hispanic vs  few comorbiditie covid- similar rate preexist chronic kidney disease hypertension patient covid associated aki great decrease egfr unadjusted model ci ml min/. m y p adjust baseline comorbiditie ci ml min/. m y p fully adjust model control comorbiditie peak creatinine level hospital dialysis requirement egfr slope difference persist ci ml min/. m y p subgroup patient achieve aki recovery discharge n covid associated aki associate decrease kidney recovery outpatient follow adjust hazard ratio ci conclusion relevance cohort study patient experience hospital aki covid associated aki associate great rate egfr decrease discharge compare aki patient covid- independent underlying comorbiditie aki severity egfr trajectory reinforce importance monitor kidney function aki study intervention limit kidney disease covid associated aki
503,background clinical datum patient admit hospital coronavirus disease  covid- provide clinician public health official information guide practice policy aim study describe patient covid- admit hospital intensive care investigate predictor outcome characterize severe acute respiratory infection method observational cohort study canadian datum  select hospital include global multisite cohort jan.  july adult pediatric patient confirm diagnosis covid- receive care intensive care unit icu sampling  patient receive care hospital ward include perform descriptive analysis characteristic intervention outcome primary analysis examine hospital mortality secondary analysis length hospital icu stay result january july  patient admit hospital diagnosis covid- median age  interquartile range iqr year  .% man  .% health care worker  .% pregnant  .% young  year  .% young  year median time symptom onset hospital admission  iqr day common symptom admission fever shortness breath cough malaise diabetes hypertension cardiac kidney respiratory disease common comorbiditie patient  receive care icu admit median  iqr day hospital admission critically ill patient receive treatment invasive mechanical ventilation .% renal replacement therapy .% extracorporeal membrane oxygenation .% die receive mechanical ventilation .% die age influential predictor mortality odd ratio additional year life confidence interval .- interpretation patient admit hospital covid- commonly fever respiratory symptom comorbid condition increase age associate development critical illness death critically ill patient canada include require mechanical ventilation survive discharge hospital
504,patient rheumatic disease susceptible different bacteria virus immune impairment clear high risk infection course disease novel coronavirus sars cov- perform systematic review meta analysis assess risk clinical outcome covid- patient rheumatic disease compare general population search pubmed embase scopus web science database january  october  determine epidemiological information relate patient rheumatic disease covid- include clear risk estimate datum convert extract include  observational study total  patient rheumatic disease infect covid- meta analysis show risk covid- infection rheumatic patient significantly high general population ci p term hospitalization severe clinical outcome associate covid- find rheumatic patient show similar result reference population hospitalization ci p admit icu ci p death ci p presence comorbiditie hypertension lung disease significantly associate increase risk covid relate hospitalization rheumatic patient anti tnf drug associate low hospitalization risk old age relate severe covid- meta analysis indicate rheumatic patient high risk covid- infection lead disease process
505,coronavirus disease  covid- cause acute respiratory distress syndrome ards multiple organ damage failure require intensive care lead death male sex advanced age chronic lung disease chronic kidney disease cardiovascular disease hypertension diabetes obesity identify risk factor covid- severity presumably cardiovascular risk factor associate high prevalence multiorgan damage present focus clinical review discuss cardiovascular complication covid- include acute cardiovascular syndrome acute cardiac injury covid cardiomyopathy thromboembolic complication arrhythmia post covid- sequelae preliminary data show cause acute cardiovascular syndrome multifactorial involve direct viral invasion heart vascular system immune inflammation mediate systemic cytokine storm covid- survivor persistently elevate blood pressure sinus tachycardia rest furthermore poor diabetic control persistent renal damage cerebral sequelae persistent cognitive neuropsychiatric alteration frequently report particular attention pay cardiovascular protection covid- patient develop acute cardiovascular syndrome hospitalization and/or permanent semipermanent sequela recovery covid- condition require careful clinical assessment treatment close follow avoid short term long term complication
506,introduction analysis pathogenesis coronavirus infection cause sars cov- indicate significant impact hemorheological disorder course outcome know chronic cardiovascular disease associate risk severe course lethal outcome covid- infectious disease case necessary study interaction mutual influence different component treatment program prescribe patient purpose work evaluate effect coagulation activity course novel coronavirus infection covid- justify management comorbid patient having receive novel oral anticoagulant noacs previously select dose accord indication concomitant somatic disease material method total  case confirm coronavirus infection patient receive initial therapy outpatient basis analyze  patient receive noacs rivaroxaban apixaban dabigatran main group  comparison control group patient administer drug affect blood clotting episode covid- patient prescribe therapy follow provisional guideline result discussion number hospitalization significantly few group patient receive noac vs. control group death case severe respiratory and/or renal failure observe main group adverse outcome note patient administer drug conclusion take noac reduce probability severe course adverse outcome development coronavirus infection cause sars cov- indicate significant contribution coagulation mechanism pathogenesis covid- indication drug replacement correction anticoagulant therapy regimen patient receive adequate therapy oral anticoagulant treat non severe form coronavirus infection ambulatory patient setting
507,coronavirus disease  covid- worldwide pandemic responsible million death world hypertension identify common comorbiditie risk factor severity adverse outcome patient recent investigation raise question hypertension represent predictor outcome covid- patient independently common comorbiditie diabetes obesity cardiovascular disease chronic kidney liver pulmonary disease impact chronic newly diagnose hypertension covid- patient insufficiently investigate true relationship blood pressure level outcome covid- patient long discussion impact angiotensin convert enzyme inhibitor acei blocker angiotensin receptor arb severity outcome covid- approach end large number original study meta analysis discard initial finding high prevalence acei arb use patient unfavorable outcome controversy relationship hypertension covid- aim review article provide clinical overview currently available evidence predictive value hypertension effect blood pressure level impact previously know newly diagnose hypertension effect antihypertensive therapy severity outcome covid- patient
508,unclear patient hypertension likely infect severe acute respiratory syndrome coronavirus  sars cov- general population difference severity coronavirus disease covid- pneumonia patient take acei arb drug compare observational study include datum patient clinically confirm covid- admit hankou hospital wuhan china january  march datum extract clinical laboratory record follow cut march total  patient  hypertension  hypertension include analysis compare patient hypertension patient hypertension old likely preexisting comorbiditie include chronic renal insufficiency cardiovascular disease diabetes mellitus cerebrovascular disease patient hypertension tend high positive rate sars cov- pcr detection multivariate logistic regression analysis show age p gender p independent risk factor associate severity pneumonia patient admission acei arb treatment p patient covid- hypertension significantly old likely underlying comorbiditie include chronic renal insufficiency cardiovascular disease diabetes mellitus cerebrovascular disease acei arb drug influence severity pneumonia patient sars cov- future study large sample size multi center clinical datum need support conclusion
509,severe acute respiratory syndrome corona virus- sars cov- emerge china december  cause coronavirus induce disease  covid- researcher worldwide struggle detect possible pathogenesis disease covid- show wide range clinical behavior asymptomatic severe acute respiratory disease syndrome etiology susceptibility severe lung injury fully understand angiotensin convert enzyme ace convert angiotensin angiotensin ii metabolize ace  ace bind ace receptor sars cov- facilitate enter host cell interaction imbalance ace ace play crucial role pathogenesis lung injury aim study investigate association ace d polymorphism severity covid- study include rt pcr confirm  case covid- case genotype ace d polymorphism polymerase chain reaction follow statistical analysis spss version find ace dd genotype frequency d allele old age /= year unmarried status presence diabetes hypertension significantly high severe covid- patient ace id genotype significantly independently associate high socio economic covid- patient ci datum suggest ace genotype impact incidence clinical outcome covid- serve predictive marker covid- risk severity
510,purpose paper intend describe characteristic coronavirus disease  covid- patient know chronic kidney disease ckd history method clinical information  covid- pneumonia patient ckd history diagnose january th march st  collect tongji hospital wuhan list clinical baseline datum laboratory finding chest compute tomography ct change process short period follow  patient result base estimate glomerular filtration rate egfr admission  patient classify stage  ckd   b    respectively covid- patient ckd history eld hypertension common comorbidity cough fever account infectious case lymphopenia increase d dimer elevate infectious indication hypersensitive c response protein hscrp interleukin- il- tumor necrosis factor alpha tnf alpha common patient ground glass opacity ggo consolidation major manifestation ct scan  patient die  patient undergo acute kidney injury aki observation  discharge patient  stable renal function  deteriorate renal function compare admission conclusion compare general population infect sars cov- covid- patient ckd history preference develop severity high fatality rate
511,background aim creatine kinase ck marker muscle damage potentially associate severe covid- systematic review meta analysis aim evaluate association elevated ck severity mortality covid- method perform systematic literature search pubmed scopus embase january main outcome poor outcome composite mortality severe covid- result  patient  study include systematic review meta analysis incidence elevated ck pooled analysis incidence poor outcome pooled analysis elevated ck associate poor outcome patient covid- p ): effect estimate vary age p male p hypertension p diabetes p elevated ck sensitivity specificity plr nlr dor  auc predict poor outcome patient covid- pooled analysis elevate ck confer probability poor outcome non elevated ck confer probability subgroup analysis univariate meta regression indicate sensitivity specificity vary age male hypertension diabete conclusion elevated ck associate increase mortality severity patient covid- prospero crd
512,individual feature metabolic syndrome particularly susceptible severe acute respiratory syndrome coronavirus  sars cov- novel coronavirus associate severe respiratory disease coronavirus disease  covid- despite considerable attention dedicate covid- link metabolic syndrome sars cov- infection remain unclear datum uk biobank investigate relationship severity covid- metabolic syndrome relate serum biomarker measure prior sars cov- infection logistic regression analysis test biomarker level biomarker associate genetic variant sars cov related outcome sars cov positive case negative control  mg dl increase serum hdl cholesterol apolipoprotein level associate approximately reduce risk sars cov- infection adjustment age sex obesity hypertension type  diabetes coronary artery disease evaluation know genetic variant hdl cholesterol reveal individual homozygous apolipoprotein e allele approximately high risk sars cov- infection mortality covid- compare apolipoprotein e homozygote adjustment hdl cholesterol level cumulative effect evaluate hdl cholesterol raise allele mendelian randomization analysis reveal association genetically high hdl cholesterol level decrease risk sars cov- infection result implicate serum hdl cholesterol apolipoprotein level measure prior sar cov- exposure clinical risk factor severe covid- infection provide evidence genetically elevated hdl cholesterol level associate sar cov- infection
513,december novel sars cov- severe acute respiratory syndrome coronavirus- emerge infectious disease pathogen lead global pandemic  million case report worldwide million global death  oct  commonly know coronavirus disease  covid- pathogen present broad spectrum disease progression manifestation symptom acute respiratory distress syndrome lead severe complication death multiple publication report risk disease co morbidity include select underlying medical condition risk old age /= year hypertension htn cardiovascular disease smoking chronic respiratory disease cancer diabetes dm obesity bmi  kg m male sex study researcher find severe obesity bmi  kg m associate intensive care unit icu admission nonetheless risk factor severity disease determine pathogen host environment
514,objective determine incidence risk factor acute cardiac injury aci acute kidney injury aki investigate effect severity mortality patient covid- patient method total  patient covid- include retrospective study predictor aci aki investigate multivariable logistic regression model determine association aci aki severity mortality result median age patient  year .% male aci aki observe  .%  .% patient respectively patient age  year chronic heart disease decrease lymphocyte increase crp pct esr hospital admission lopinavir ritonavir use show high odd aci patient age  year male obesity hypertension chronic kidney disease decrease lymphocyte increase crp pct esr hospital admission show high odd aki increased hs ctni  ng l pro bnp  pg ml decrease e gfr  ml min reveal high adjust mortality conclusion aci aki common covid- patient shanghai china patient aci aki high severity rate mortality rate compare aci aki
515,novel corona virus  covid- outbreak start hubei province china spread corner earth pandemic start later africa find african country vary degree think prevalence severity disease influence number non communicable disease ncd increasingly prevalent sub saharan africa ssa addition ssa bear major burden human immunodeficiency virus hiv tuberculosis tb infection datum europe united states child spare severe disease uncertain hold true ssa child suffer sickle cell disease malnutrition addition infectious disease limited datum africa effect condition covid- review discuss epidemiology condition africa possible pathogenesis interaction covid-
516,objective systematically collect clinical datum patient prove covid- infection netherlands design datum  patient covid- admit  dutch center period february july  describe clinical datum base covid case record form crf supplement patient characteristic recently association disease severity report method survival analysis perform primary statistical analysis kaplan meier curve time early death week determine pre morbid patient characteristic clinical radiological laboratory datum hospital admission result total hospital mortality  week ci .% .% hospital mortality  day significantly high elderly patient  year ci .% patient die  day admit intensive care ci .% .% apart dutch population risk early death patient co morbidity chronic neurological nephrological cardiac disorder hypertension patient home medication increase urea creatinine level conclusion early death covid- infection netherlands appear associate demographic variable e.g. age comorbidity e.g. cardiovascular disease disease char acteristic admission
517,background study incidence severity coronavirus disease  covid- child significantly low adult datum effect covid- child congenital heart disease chd limited good knowledge study report mortality child chd acquire covid- case summary -month old boy present emergency department shortness breath fever cough poor oral intake test positive severe acute respiratory syndrome coronavirus  sars cov- require mechanical ventilation rapidly progress respiratory failure patient large mid muscular ventricular septal defect vsd close percutaneously age  month follow hospital sequelae admission death discussion child multiple risk factor include malnutrition persistent pulmonary hypertension ph late closure vsd pre exist ph aggravate lung condition associate covid- respiratory failure trigger sars cov- infection patient present ventricular systolic dysfunction elevated troponin serum level newly develop trifascicular block indicative myocardial injury elevated inflammatory marker multi organ dysfunction corroborate multisystem inflammatory syndrome child describe recently paediatric patient covid-
518,background objective study investigate location extension type novel coronavirus induce disease  covid- infection involvement hepatic steatosis initial chest compute tomography ct relationship fatty liver severity disease investigate measure liver attenuation index lai method study evaluate chest ct image  patient male mean age year confirm covid- nasopharyngeal swab chest ct analyze laterality number involved lobe diffuseness number lesion lesion type ct attenuation value liver spleen measure lai calculate detection hepatic steatosis univariate multivariate logistic regression analysis identify independent early predictor severe covid- result significant difference gender term clinical course liver density lai significantly low intensive care unit icu patient prevalence severe disease high patient hepatic steatosis non steatotic group odd ratio confidence interval ci p adjust age comorbiditie include hypertension diabetes mellitus coronary artery disease chronic obstructive pulmonary disease chronic kidney disease multivariate logistic regression analysis show non alcoholic fatty liver disease nafld independent risk factor covid- severity ci p optimal cut value lai calculate predict patient require icu treatment conclusion initial chest ct image covid- patient presence fatty liver strong predictor severe disease
519,background coronavirus disease  covid- associate cardiac arrhythmia hospitalize patient datum icu setting limited aim describe epidemiology cardiac arrhythmia icu patient covid- method conduct multicenter retrospective cohort study include icu patient airway sample positive severe acute respiratory syndrome corona virus  march st june st capital region denmark million inhabitant register cardiac arrhythmia icu potential risk factor intervention icu outcome result seven icu include  patient covid- incidence cardiac arrhythmia icu confidence interval patient new onset arrhythmia previous history tachyarrhythmias high disease severity icu admission associate cardiac arrhythmia adjust analysis  patient supraventricular origin arrhythmia receive intervention arrhythmia eg amiodarone iv fluid magnesium recurrent episode arrhythmia icu patient arrhythmia icu high mortality compare arrhythmias conclusion new onset supraventricular arrhythmia frequent icu patient covid- relate previous history tachyarrhythmias severity acute disease mortality high patient despite frequent use intervention arrhythmias
520,purpose review analyze impact sodium retention state course covid- propose possible intervention curb disease progression recent finding numerous datum confirm positive association non communicable disease age sodium retain state include iatrogenic one severe fatal clinical course covid- reason effect include increase angiotensin signal atr receptor endothelial glycocalyx play important role infection lead vicious cycle inflammation tissue sodium retention damage ras inhibitor help restore glycocalyx function prevent severe organ damage anticoagulant especially heparin therapeutic application antithrombotic anti inflammatory glycocalyx repair antialdosteronic property ambiguous influence diuretic sodium balance discuss abnormal sodium storage increase angiotensin convert enzyme activity relate severity covid- induce sodium removal reduce intake improve outcome
521,background recent study show obesity associate severity coronavirus disease covid- clinical study clarify obesity relationship covid- severity comorbiditie discuss possible mechanism materials method electronic database include web science pubmed scopus google scholar search study conduct covid- obesity study independently screen reviewer base title abstract result relevant article select text obesity affect respiratory immune system mechanism cytokine adipokine secretion adipose tissue lead pro inflammatory state obese patient predispose thrombosis incoordination innate adaptive immune response inadequate antibody response cytokine storm obese patient long virus shedding obesity associate comorbiditie hypertension cardiovascular disease diabetes mellitus vitamin d deficiency hospitalization intensive care unit admission mechanical ventilation mortality obese patient high normal weight patient obesity alter direction severe covid- symptom young individual reduce physical activity unhealthy eating habit stress fear experience covid- pandemic result weight gain obesity conclusion obesity consider independent risk factor severity covid- pay attention prevent weight gain obese patient covid- infection early level disease crucial pandemic
522,severe case covid- observe healthy -year old man take oxandrolone  mg day anabolic steroid patient take oxandrolone enhanced bodybuilding  day prior present outpatient clinic covid- symptom patient report symptom rapidly worsen course  day prior present clinic experimental antiandrogen treatment hyperandrogenic man suffer covid- administer single  mg dose novel antiandrogen proxalutamide hour administration dose mark improvement symptom marker disease severity observe knowledge case potentially link anabolic steroid use covid- disease severity
523,background rvef right ventricular ejection fraction measure dimensional echocardiography de evaluate right ventricular rv function provide useful prognostic information cardiovascular disease prognostic value d rvef coronavirus disease  covid- remain unknown aim investigate d rvef predict mortality covid- patient method cohort  covid confirm patient undergo echocardiography study thirty healthy volunteer enrol control covid- patient divide subgroup general severe critical accord covid- severity illness conventional rv structure function parameter rv free wall longitudinal strain fwls d rvef acquire rvfwls measure dimensional speckle tracking echocardiography rvef acquire de result compare control d rvfwls d rvef significantly decrease covid- patient vs. .% p .% vs. .% p critical patient likely high incidence acute cardiac injury acute respiratory distress syndrome ards bad prognosis general severe patient critical patient exhibit large right heart chamber bad rv fractional area change rvfac d rvfwls d rvef high proportion pulmonary hypertension general severe patient eighteen patient die median follow  day multivariate cox regression analysis reveal acute cardiac injury ards rvfac rvfwls d rvef independent predictor death d rvef chi square improve p rvfac chi square improve p d rvfwls chi square improve p provide additional prognostic value high mortality clinical risk factor incremental predictive value d rvef significantly p high rvfac rvfwls conclusion d rvef robust independent predictor mortality covid- patient provide high predictive value conventional rv function parameter rvfwls helpful identify covid- patient high risk death
524,objective study aim investigate ferritin level predict severity coronavirus disease  covid- background covid- pandemic challenge patient caregiver laboratory marker well understand cause poor outcome improve management covid- patient method total  patient positive polymerase chain reaction test result severe acute respiratory syndrome coronavirus  sars cov- include study demographic feature comorbiditie clinical laboratory finding obtain hospital database retrospectively patient divide group accord disease severity follow mild group n severe group n result median age study population .% male patient patient severe group significantly old show high frequency hypertension diabetes mellitus coronary artery disease heart failure comparison mild group addition gamma glutamyl transferase c reactive protein ferritin interleukin- procalcitonin neutrophil lymphocyte ratio high albumin level low patient severe group linear regression analysis demonstrate ferritin level significant predictor disease severity beta t p receiver operator characteristic curve analysis ferritin level ng ml predict severe covid- sensitivity .% specificity .% conclusion early analysis ferritin level patient covid- effectively predict disease severity
525,report december  wuhan china novel coronavirus disease  covid- rapidly spread world lack effective therapy available covid- patient identification risk factor severe course disease matter urgency aim review report evidence base risk factor affect severity prognosis covid- search pubmed database current literature identify relevant publication concern risk factor covid- severity demographic social factor age gender race center community nursing home clinical factor smoking hypertension obesity diabetes chronic lung disease cardiovascular disease cvd chronic kidney disease ckd malignancy dementia cardiomyopathy immunocompromised state laboratory marker c reactive protein crp leukocytosis ferritin interleukin il)- d dimer lactate dehydrogenase ldh aspartate aminotransferase ast procalcitonin creatinine lymphopenia il- il- il- granulocyte colony stimulate factor g csf know colony stimulating factor  csf interferon gamma inducible protein- ip- monocyte chemoattractant protein- mcp- macrophage inflammatory protein alpha mipa tumor necrosis factor alpha tnf alpha genetic factor relate virus host discuss identification potential risk factor affect severity prognosis covid- provide chance early effective management covid-
526,background covid- consider widespread concern global public health diagnosis covid- case necessary severe prognosis study epidemiology clinical demographic characteristic patient covid- study taleghani hospital urmia iran method descriptive analytical cross sectional study carry  patient covid- march april approve covid- case consider person positive respiratory sample perform rt pcr method genetic sequencing anova repeat measure independent t test logistic regression p  high spo increase chance recovery unit reduction kidney involvement increase chance death ci odd ratio spo recovery covid- ci p kaletra odd ratio high effect recovery follow covid- p conclusion covid- involve different organ body different severity meantime smoking risk factor virus associate severe manifestation disease patient high creatinine cpk pulmonary involvement hypoxemia high mortality rate increase spo improve patient result indicate kaletra high effect improvement follow covid-
527,introduction coronavirus disease  covid- case increase rapidly worldwide similar middle east respiratory syndrome cardiovascular disease present nearly case increase presence cardiovascular comorbiditie remain true covid- mechanism association remain unclear time available literature try find probable association cardiovascular disease disease severity mortality covid- patient method search medline pubmed cochrane central register controlled trials article publish sept nineteen article include involve covid- patient result random effect meta analysis show cardiovascular disease significantly associate severity mortality covid- odd ratio confidence interval ci severity ci mortality respectively risk covid- severity high patient have diabetes hypertension chronic obstructive pulmonary disease malignancy cerebrovascular disease chronic kidney disease similarly patient diabetes hypertension chronic liver disease cerebrovascular disease chronic kidney disease high risk mortality conclusion finding show cardiovascular disease negative effect health status covid- patient large prevalence study demonstrate consequence comorbid cardiovascular disease urgently need understand extent concern comorbiditie
529,introduction date effective treatment decrease hospitalization coronavirus disease  covid- infection suggest influenza vaccine attenuate severity covid- method retrospective single center cohort review de identify database  patient age  university florida health care system test positive covid- comorbiditie influenza vaccination status examine primary outcome severity disease reflect hospitalization intensive care unit icu admission logistic regression perform examine relationship influenza status hospitalization result covid positive patient receive influenza vaccination year ci great odd hospitalization ci great odd icu admission compare vaccinate result control account age race gender hypertension diabetes chronic obstructive pulmonary disease obesity coronary artery disease congestive heart failure discussion analysis suggest influenza vaccination potentially protective moderate severe case covid- infection protective effect hold regardless comorbidity literature point potential mechanism natural killer cell activation datum potentially limit generalizability vaccination rate low hold significant relevance give upcoming influenza season simply encourage influenza vaccination decrease morbidity mortality flu help flatten curve covid- pandemic encourage study finding
530,coronavirus disease  covid- outbreak necessary rationalize health care resource little publish datum moment ambulatory management patient covid- pneumonia objective study evaluate performance protocol ambulatory management patient covid- pneumonia readmission admission intensive care unit icu death identify unfavorable prognostic factor increase risk readmission prospective cohort study patient covid- pneumonia discharge emergency ward infanta cristina hospital madrid spain meet criterion hospital protocol outpatient management describe outcome patient compare need readmission versus use logistic regression explore factor associate readmission total  patient include  .% need readmission need icu admission die comorbidity present .% patient hypertension leukopenia lymphocytopenia increase lactate dehydrogenase ldh increase aminotransferase associate high risk readmission clinical course  day long absolute eosinophil count /microl associate low risk multivariate analysis hypertension ci .- temperature  degree c emergency ward ci .- leukopenia ci .- increase ldh ci .- remain significantly associate readmission outpatient management patient low risk covid- pneumonia safe adequately select protocol present allow avoid admission covid- pneumonia hospital low readmission rate mortality
531,introduction highly infectious coronavirus disease  covid- rapidly spread world meta analysis strictly focus influence smoking history severe critical outcome people covid- pneumonia method systematic literature search conduct online database  february study meet selection criterion include evaluate stata software analyze datum result total  article involve patient include meta analysis statistically significant association discover smoking history covid- severity pool ci smoking significantly associate risk admission intensive care unit icu or=. ci increase mortality or=. ci critical disease composite endpoint or=. ci relationship mechanical ventilation pooled prevalence smoking random effect model rem ci meta regression analysis show age p=. hypertension p=. diabetes p=. chronic obstructive pulmonary disease copd p=. covariate affect association conclusion smoking associate severe critical outcome increase risk admission icu mortality covid- patient associate mechanical ventilation association significant smoker current smoker current smoker high risk develop severe covid- compare non smoker detailed datum representative country need confirm preliminary finding
532,new coronavirus sars cov- disease cause covid- involve respiratory system damage lead disorder central peripheral nervous system muscular system article present publish datum observation course neurological disorder covid- patient relationship severity covid- severity frequency neurological manifestation severe neurological disorder see severe case covid- include acute cerebrovascular accident acva acute necrotize encephalopathy guillain barre syndrome factor potentially complicate course covid- increase development neurological complication include arterial hypertension diabetes mellitus chronic cardiac respiratory system disease question possible effect human coronaviruse course chronic progressive neurological disease address multiple sclerosis ms example discuss management patient acva ms depend risk develop coronavirus infection
533,background coronavirus disease  covid- infectious disease characterize cough fever fatigue case develop severe condition result acute lung injury manifestation acute respiratory distress syndrome ards account mortality currently report comorbiditie link increase rate severity mortality covid- patient assess role comorbidity covid- progression perform systematic review meta analysis relationship covid- severity  different underlie disease method pubmed web science cnki search article investigate prevalence comorbiditie severe non severe covid- patient total  study comprise patient include result prevalence commodity low general population hypertension vs .% diabetes vs .% chronic kidney disease ckd vs .% chronic liver disease cld vs .% chronic obstructive pulmonary disease copd vs .% include cancer vs .% cardiovascular disease vs .% cerebrovascular disease vs .% exhibit great percentage covid- cerebrovascular disease ci .- find strong risk factor disease exacerbation follow ckd ci copd ci cardiovascular disease ci malignancy ci diabetes ci hypertension ci find correlation cld increase disease severity ci conclusion impact underlie disease covid- deterioration high patient outside hubei base different comorbiditie covid- patient tend risk develop poor outcome vary degree tailored infection prevention monitoring treatment strategy target high risk subgroup improve prognosis covid- pandemic
534,purpose article discern examine causative factor likely influence high consequence health disparity experience pregnant postpartum african american woman covid- understudied pregnancy presence covid- increase risk illness severity datum suggest pregnant woman covid- likely hospitalize admit intensive care unit require life support similarly covid- pose significant challenge maternal obstetric care postpartum recovery period african- american woman bear disproportionately high morbidity mortality burden disease diabetes obesity hypertension pre exist chronic health condition place pregnant postpartum woman high risk develop severe health consequence covid- delivery addition social determinant health hypothesize modulate deleterious impact covid- pregnant postpartum african american woman
535,objective study aim compare severity outcome hypertensive patient present coronavirus disease  covid- take angiotensin convert enzyme inhibitor aceis)/angiotensin receptor blocker arb antihypertensive drug method retrospective cohort study involve  hypertensive patient present covid- infection study population comprise  patient take acei arb group  patient take antihypertensive drug beta blocker bbs calcium channel blocker ccb thiazide group b patient provide type treatment management covid- record datum relate demographic anthropometric variable clinical symptom treatment period disease severity hospital mortality primary study endpoint result significant difference covid related outcome group severity lung infiltration chest x ray  patient have lung infiltration group  .% group b p value severe disease diagnose  .% patient group compare  patient group b p value hospital mortality note  .% patient group  .% patient group b p value conclusion base result find significant association use acei arb severity covid- infection necessitate admission icu hospital mortality
536,current pandemic coronavirus disease  covid- global issue cause severe acute respiratory syndrome coronavirus  sars cov- study reveal virus result poor consequence high rate mortality old adult comorbiditie cardiovascular disease hypertension diabetes prolonged respiratory illness review discuss detail potential group risk covid- outline future recommendation mitigate community transmission covid- rate covid- high healthcare worker smoker old adult traveller pregnant woman furthermore patient severe medical complication heart disease hypertension respiratory illness diabetes mellitus cancer high risk disease severity mortality special effort devotion need diminish threat sars cov- infection proper vaccination use sanitizer handwashing complete lockdown recommend mitigate chain covid- transmission
537,beginning infection cause severe acute respiratory syndrome coronavirus  sars cov- rapidly evolve emergent worldwide pandemic outbreak unprecedented consequence highlight exist flaw public healthcare system world coronavirus disease  covid- bestow broad spectrum clinical manifestation involve vital organ respiratory system transpire main route entry sars cov- lung primary target infect require hospitalization account severity majority patient asymptomatic exhibit mild symptom exacerbation disease severity complication covid- infection associate multiple comorbiditie include hypertension diabetes mellitus cardiovascular disorder cancer chronic lung disease interestingly recent body evidence indicate pulmonary gut microbiome potential modulator alter course covid- potentially microbiome immune system axis relative concordance microbe immunity fully elucidate regard covid- present overview current understanding covid microbiome immune cross talk discuss potential contribution microbiome relate immunity sars cov- pathogenesis covid- disease progression
538,rationale objective assess effect compute tomography ct)-base residual lung volume rlv mortality patient coronavirus disease  covid- materials method single center retrospective study prospectively maintain database perform total  patient covid- enrol baseline chest ct scan perform patient ct base automate semi automate lung segmentation perform alma medical workstation calculate normal lung volume lung opacity volume total lung volume rlv primary end point study mortality univariate multivariate analysis perform determine independent predictor mortality result overall  man  woman mean age year y include study overall mortality rate patient median time  day interquartile range   d univariate analysis demonstrate age hypertension diabete associate death p similarly patient die low normal lung volume rlv patient survive p multivariate analysis demonstrate low rlv independent predictor death odd ratio confidence interval furthermore receiver operate characteristic curve analysis demonstrate rlv significantly increase risk death odd ratio confidence interval conclusion overall mortality patient covid- reach univariate multivariate analysis demonstrate reduced rlv principal independent predictor death furthermore rlv associate -fold increase risk death
539,objective therapy patient respiratory failure coronavirus disease  urgently need early implementation prone positioning ventilation improve survival patient acute respiratory distress syndrome study examine effect prone survival patient coronavirus disease  lack objective estimate effect early proning initiation survival patient coronavirus disease -associate respiratory failure design datum derive study treatment outcomes critically ill patients coronavirus disease multicenter cohort study critically ill adult coronavirus disease  admit  u.s. hospital datum emulate target trial prone positioning ventilation categorize mechanically ventilate hypoxemic ratio pao correspond fio  mm hg patient having initiate proning  day icu admission fit inverse probability weight cox model estimate mortality hazard ratio early proning versus early proning patient follow death hospital discharge end follow setting icu  u.s. site patient critically ill adult laboratory confirm coronavirus disease  receive invasive mechanical ventilation ratio pao correspond fio equal  mm hg intervention measurement main result eligible patient  .% prone  day icu admission inverse probability weighting baseline severity illness characteristic balanced group total .% patient discharge alive .% die  .% hospitalize follow patient prone  day icu admission low adjust risk death compare nonproned patient hazard ratio ci conclusion hospital mortality low mechanically ventilate hypoxemic patient coronavirus disease  treat early proning compare patient treatment include early proning
540,infection cause novel coronavirus declare pandemic spread  country territory world severe implication present paper try review relationship sars cov- infection ace expression gene polymorphism cardiovascular malfunction hypertension type- diabetes paper highlight fact ace gene polymorphism tend population specific screening ace polymorphism diverse population group geography beneficial evaluate severity sars cov- infection
541,background novel coronavirus name severe acute respiratory syndrome relate coronavirus  sars cov- associate development acute respiratory distress syndrome ards require mechanical ventilation high percentage critically ill patient recent study highlight state hypercoagulability patient sars cov- lead increase risk deep venous thrombosis dvt pulmonary embolism pe low proportion pe associate dvt covid- patient suggest pulmonary thrombosis embolism guideline recommendation treatment massive pe covid- patient suffer ards cardiogenic shock case summary describe series seven sars cov- patient diagnose pe institution undergo use systemic thrombolysis recombinant tissue plasminogen activator accord standard protocol  mg  min  mg  min discussion accord european society cardiology esc severity scale patient high risk pe intermediate high risk pe systemic thrombolysis find associate reduction brescia covid respiratory severity scale patient record reduction   patient   patient furthermore patient initial improvement alveolar partial pressure oxygen pao)/fraction inspire oxygen fio ratio range patient improvement patient associate decrease right ventricular rv dysfunction rv leave ventricular ratio  h later major bleed event occur thrombolysis overall mortality perform systemic thrombolysis patient conclusion despite low level knowledge underlie pathophysiology covid- ards venous thromboembolic event microvascular thrombosis finding suggest treatment pe rv failure patient covid- suffering ards cardiogenic shock systemic thrombolysis consider
542,objective coronavirus disease  covid- bad pandemic clinical characteristic vary asymptomatic fatal study aim examine association body mass index bmi level severity covid- method study design cohort study include  adult patient confirmed covid- categorize  group bmi level admission kg m obese rate pneumonia severe pneumonia acute kidney injury aki icu stay hospitalization bmi group determine logistic regression analysis determine association bmi severe pneumonia result total patient have bmi kg m .% .% .% respectively rate pneumonia severe pneumonia tend high patient high bmi rate aki icu stay high patient bmi /=  kg m compare patient normal bmi control age sex diabetes hypertension dyslipidemia logistic regression analysis have bmi kg m associate high risk severe pneumonia ci p compare have bmi .- kg m. admission elevated hemoglobin alanine aminotransferase level day   illness associate high bmi level contrast rise serum creatinine level observe underweight patient day   illness conclusion obesity patient covid- associate severe pneumonia adverse outcome aki transaminitis icu stay underweight patient closely monitor aki study body composition warrant explore link adiposity covid- pathogenesis
543,objective hypercoagulability key mechanism acute organ injury death patient severe coronavirus disease relationship elevated plasma level d dimer biomarker coagulation activation mortality rigorously study examine independent association d dimer death critically ill patient coronavirus disease design multicenter cohort study setting icu  hospital united states patient critically ill adult coronavirus disease  admit icu march measure d dimer concentration icu day  intervention measurement main result primary exposure high normalize d dimer level assess category x upper limit normal icu day  primary endpoint -day mortality multivariable logistic regression adjust confounder patient .% male median age  yr interquartile range yr .% d dimer concentration upper limit normal total patient .% die  day patient high compare low d dimer category .-fold high odd death ci univariate analysis decrease .-fold increase odd death ci multivariable adjustment demographic comorbiditie illness severity adjustment therapeutic anticoagulation meaningfully attenuate relationship odd ratio ci conclusion large multicenter cohort study critically ill patient coronavirus disease high d dimer level independently associate great risk death
544,objective novel coronavirus severe acute respiratory syndrome coronavirus  sars cov- cause worldwide coronavirus disease  covid- outbreak high mortality unique finding covid- patient decline eosinophil level eosinopenia result previous study relationship eosinopenia disease severity inconsistent objective study determine relationship eosinopenia covid- mortality clinical condition potentially lead mortality method ninety patient diagnose moderate severe critical covid- hospital admission enrol datum collect patient medical record second day hospital admission include medical history clinical symptom chest image compute tomography ct laboratory examination outcome result eosinophil level significantly low patient critical disease compare moderate severe disease control confound factor ie age gender hypertension coronary heart disease diabetes chronic lung disease progressive decline eosinophil level independently associate mortality eosinophil level significantly positively correlate platelet d dimer level significantly inversely correlate serum level urea creatinine aspartate aminotransferase lactate dehydrogenase creatine kinase conclusion eosinopenia progressively worsen indicate covid- patient progress critical disease significantly high chance mortality additionally eosinopenia correlate biomarker coagulation disorder tissue damage kidney liver tissue
545,introduction development acute respiratory distress syndrome indicate form covid- study prognostic factor severe form study conduct burkina faso method retrospective cohort study conduct march  june  ouagadougou burkina faso involve  patient covid- result nearly quarter patient .% present acute respiratory distress .% die  year old hr ci have hypertension hr ci independently associate risk mortality adjustment age  year hr ci risk factor death survival rate patient   day .%  day conclusion acute respiratory distress lead death mainly find old people covid- close monitoring high risk patient reduce risk death
546,background hypertension common comorbid condition patient coronavirus disease  covid- korea lack study investigate risk factor covid- patient hypertension korea study aim examine effect risk factor hypertensive korean covid- patient method select patient database project opendatacovid information link historical healthcare datum severity disease classify level cluster level grade result risk factor associate covid- severity old age diabetes mellitus cerebrovascular disease chronic obstructive pulmonary disease copd malignancy renal replacement therapy use angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb diagnosis covid- associate covid- severity multivariate analysis reveal old age male sex diabetes mellitus renal replacement therapy risk factor severe covid- conclusion result suggest hypertensive patient covid- old age male sex diagnosis diabetes mellitus renal replacement therapy risk factor severe clinical course addition use arb acei covid- infection affect patient risk contract covid- contribute bad prognosis disease result highlight precaution consider hypertensive patient risk factor support discontinuation arb acei covid- pandemic
547,study severe fatal covid- risk routine hospitalisation datum detailed pre morbid characterisation community base uk biobank cohort investigate risk factor covid- mortality comparison non covid- mortality investigate demographic social education income housing employment lifestyle smoking drinking body mass index biological lipid cystatin c vitamin d medical comorbiditie medication environmental air pollution datum uk biobank n relation  covid-  non covid- death  september univariate multivariable penalise regression model age s.d. year p x male sex p x black versus white ethnicity p x independently associate jointly explanatory area receiver operate characteristic curve auc increase risk covid- mortality multivariable regression alongside demographic covariate healthcare worker current smoker have cardiovascular disease hypertension diabetes autoimmune disease oral steroid use enrolment independently associate covid- mortality penalise regression model select income cardiovascular disease hypertension diabetes cystatin c oral steroid use jointly contribute covid- mortality risk black ethnicity hypertension oral steroid use contribute covid- non covid- mortality age male sex black ethnicity comorbiditie oral steroid use enrolment associate increase risk covid- death result suggest previously report association covid- mortality body mass index low vitamin d air pollutant renin angiotensin aldosterone system inhibitor explain aforementioned factor
548,outbreak coronavirus disease  covid- cause novel coronavirus severe acute respiratory syndrome coronavirus  sars cov- pandemic cellular receptor sars cov- entry angiotensin convert enzyme membrane bind homolog angiotensin convert enzyme henceforth bring attention scientific community study interaction covid- renin angiotensin system ras ras inhibitor inhibitor commonly treat hypertension chronic kidney disorder diabete obesity know risk factor heart disease diabetes hypertension diabetes hypertension indirectly relate effect obesity furthermore people hypertension obesity diabetes relate complication like cardiovascular kidney disease high risk severe covid- infection general population usually exhibit poor prognosis severity systemic inflammation compromise immune response ras associate comorbid condition urgent need develop evidence base treatment method affect severity covid- infection effectively manage chronic disease people covid-
549,background people previous diagnosis non communicable disease ncd likely develop form covid- die mexico country fourth high fatality rate sars cov- high mortality young adult objective describe characterize association ncd case fatality rate cfr adjust age sex mexican adult positive diagnosis sars cov- method study mexican adult age year test positive sars cov- period  february  july cfr calculate association history ncd number disease combination severity indicator type institution treat patient explore relative risk rr death estimate poisson model cfr adjust logistic model result analyse  sars cov positive adult cfr .% man .% woman cfr positively associate age number ncd p trend number ncd increase risk death young adult present ncd compare ncd rr confidence interval ci woman rr ci man lastly great heterogeneity cfr institution .% private institution .% public institution conclusion young adult high cfr associate total number ncd combination type  diabetes chronic kidney disease chronic obstructive pulmonary disease cardiovascular disease
550,objective evaluate difference thromboinflammatory biomarker patient severe coronavirus disease  covid- infection death mild infection patient method medline cochrane central register controlled trials embase ebsco web science cinahl database search study compare thromboinflammatory biomarker covid- patient severe covid- disease death severe nonsurvivor nonsevere disease survivor nonsevere survivor january july inclusion criterion hospitalize patient  year old compare severe nonsurvivor vs nonsevere survivor biomarker inflammation and/or thrombosis random effect model estimate weighted mean difference wmd  group covid- severity result include  study patient severe nonsurvivor group old great proportion man high prevalence hypertension diabetes cardiac cerebrovascular disease chronic kidney disease malignancy chronic obstructive pulmonary disease thromboinflammatory biomarker significantly high patient severe disease include d dimer wmd ci fibrinogen wmd ci p subanalysis base disease severity mortality geographic region study reveal similar inference conclusion thromboinflammatory biomarker d dimer fibrinogen crp high sensitivity crp ferritin interleukin marker end organ damage high sensitivity troponin associate increase severity mortality covid- infection
551,severe respiratory systemic disease name coronavirus disease- covid- cause severe acute respiratory syndrome coronavirus  sars cov- currently covid- pandemic present huge social health challenge worldwide different risk factor associate disease severity systemic arterial hypertension diabetes mellitus obesity old age co infection respiratory disease chronic obstructive pulmonary disease copd smoking common comorbiditie worldwide previous investigation identify covid- patient smoker copd patient recent investigation question high risk population previous report fail isolate smoker copd patient comorbiditie perform longitudinal evaluation disease course smoker smoker copd patient covid- comorbiditie hospitalization hospital discharge difference group observe hospital admission smoker copd patient present increase covid associate inflammatory marker disease course comparison non smoker smoker result demonstrate smoking copd risk factor severe covid- possible implication ongoing pandemic
552,objective systematic review meta analysis aim evaluate dyslipidemia affect mortality severity covid- aim evaluate comorbiditie influence association method systematic literature search pubmed embase europepmc perform  october study main outcome poor composite outcome comprise mortality severe covid- result  study patient prevalence dyslipidemia pooled analysis -% dyslipidemia associate increase composite poor outcome rr p=. .% p=. subgroup analysis show dyslipidemia associate severe covid- rr p=. .% p=. meta regression show association dyslipidemia poor outcome vary age coefficient p=. male gender coefficient p=. hypertension coefficient p=. diabetes coefficient p=. cardiovascular disease coefficient p=. inverted funnel plot relatively symmetrical egger test indicate pool analysis statistically significant small study effect p=. conclusion dyslipidemia potentially increase mortality severity covid- association strong patient old age male hypertension prospero registration number crd
553,objective datum effect angiotensin convert enzyme inhibitor aceis)/angiotensin receptor blocker arb lung involvement patient covid- pneumonia hypertension ht aim compare lung involvement ht patient hospitalize covid- acei arb patient take anti ht medication method patient diagnosis ht patient treat laboratory confirm covid-  march    include study patient divide aceis arb group n non aceis arb group n accord anti ht drug chest ct involvement area group evaluate quantitatively observer include lobe total severity score tss calculate tss value compare drug group clinical group result clinical classification  asymptomatic  .% mild type  .% common type  .% severe type  .% critical type patient acei arb group tss mean+/-sd statistically high anti ht medication group mean+/-sd p likewise severe critical clinical type tss mean+/-sd statistically high common type mean+/-sd p excellent agreement establish blind observer tss measurement conclusion quantitative evaluation ct tss score idea clinical classification patient tss high acei arb group non aceis arb group
554,background inflammation facilitate development coronavirus disease  covid- cardiac injury associate bad clinical outcome datum relatively scarce association hyper inflammatory response cardiac injury covid- patient method study design base severe critically ill patient covid- information clinical characteristic laboratory examination collect electronic medical record analyze result n= patient cardiac injury median age  year n= patient man hypertension common  patient follow diabetes .% n= coronary heart disease .% n= compare case cardiac injury cardiac injury old high proportion coronary heart disease leukocyte count significantly elevated concentration n terminal pro b type natriuretic peptide high sensitivity c reactive protein hs crp tumor necrosis factor tnf)-alpha interleukin- receptor il r il- il- low lymphocyte count significant positive correlation observe high sensitivity troponin inflammatory cytokine logistic regression analysis show hs crp tnf alpha il- independent risk factor cardiac injury conclusion cardiac injury associate elevated level inflammatory cytokine severe critically ill patient covid- suggest hyper inflammatory response involve cardiac injury
555,objective identify describe mechanism lifestyle characteristic obesity dm hypertension physical inactivity lead severity illness individual covid- data source scoping review conduct search electronic database pubmed scopus december  august inclusion exclusion criterion inclusion criterion study explicitly describe mechanism covid- relationship hypertension type  diabetes mellitus type  dm obesity and/or physical inactivity study epidemiological background descriptive survey interventional study exclude data extraction study characteristic tabulate accord purpose type non communicable disease ncds hypothesis mechanism infestation moi conclusion data synthesis ncd categorize accord type hypothesis mechanism infestation interplay covid- type ncd moi lead severity disease appraise result study identify  unique record study postulate mechanism infestation interaction covid  illness severity obesity  study describe covid- dm study highlight interaction covid- hypertension  study show physical activity restriction suppress immunity conclusion current review identify explicitly describe mechanism lifestyle characteristic increase severity illness people covid-
556,background identification patient admission hospital coronavirus infectious disease  covid- pneumonia develop poor outcome comprehensively assess objective compare severity score community acquire pneumonia identify high risk patient covid- pneumonia design psi curb- qsofa mulbsta new score viral pneumonia calculate admission hospital identify high risk patient hospital mortality admission intensive care unit icu use mechanical ventilation area receiver operating characteristic curve auroc sensitivity specificity score determine auroc compare participant patient covid- pneumonia include semi covid- network key result examine patient covid- mean age patient year .% male common comorbiditie follow hypertension .% diabetes .% chronic obstructive pulmonary disease .% acute respiratory distress syndrome .% acute kidney injury .% common complication hospital mortality psi curb- show high auroc respectively mulbsta low auroc respectively qsofa specific score specificity albeit sensitivity psi high sensitivity .% specificity .% conclusion psi curb- specific severity score pneumonia well qsofa mulbsta predict mortality patient covid- pneumonia additionally qsofa simple score perform specific albeit sensitive
557,background limited evidence clinical characteristic sars cov- infection latin america present finding nationwide study argentina research question disease severity measure risk factor associate admission intensive care unit mortality study design method datum extract covid- database integrated argentina health information system encompass period march rd october nd standardized case report form include information contact history clinical sign symptom clinical diagnosis information collect initial site care follow conduct call regional healthcare authority confirm case covid- define have positive result sequencing real time reverse transcriptase polymerase chain reaction rt pcr assay nasal pharyngeal swab specimen result rt pcr testing positive case complete dataset available analysis case mean age year .% male frequent co existing condition include hypertension .% diabetes .% asthma obesity common symptom include fever .% cough .% headache .% sore throat death icu admission independently associate old age male coma dyspnea tachypnea seizure underlie co morbidity immunodeficiency chronic renal failure liver disease show strong effect interpretation case covid- diagnose argentina mild favorable outcome fatality rate relatively elevated risk factor adverse outcome include old age male sex coma seizure concurrent presence morbidity datum useful healthcare provider healthcare policy maker low middle income latin american country guide decision optimize care pandemic
558,aim identify predictor outcome survival patient live  major metropolitan area sickle cell disease scd covid- inform good approach prevention care datum collect baseline clinical course scd patient diagnose covid- covid- epicenter patient follow posthospital discharge  month scd patient covid- patient require hospitalization seven die patient preexisting kidney disease chronic kidney disease likely hospitalize common present symptom vaso occlusive pain acute chest syndrome occur   hospitalize patient die old age history pulmonary hypertension congestive heart failure chronic kidney disease stroke prevalent patient die high creatinine lactate dehydrogenase d dimer level anticoagulation use inpatient twice common patient die death occur individual take hydroxyurea scd modify therapy patient scd covid- exhibit broad range disease severity definitively state overall mortality high patient scd case fatality rate approximately compare approximately general population despite median age  year individual scd age year preexist cardiopulmonary renal disease and/or stroke receive hydroxyurea present high serum creatinine lactate dehydrogenase d dimer level high risk death irrespective genotype sex
559,background limited number study controversial finding association anemia admission coronavirus disease  covid- outcome research aim investigate prospective association anemia covid- outcome hospitalize patient iran method prospective study datum  consecutive patient hospitalize covid- statistically analyze biomarker include hemoglobin high sensitivity c reactive protein hs crp level measure standard method anemia define hemoglobin hb concentration  g dl  g dl male female respectively assess association anemia covid- survival hospitalize patient primary endpoint result mean age participant year  .% anemic subject patient anemia significantly old p high frequency cardiovascular disease hypertension kidney disease diabetes cancer p frequency death anemic .% vs. nonanemic .% icu admission anemic .% vs. nonanemic:.% ventilator requirement anemic .% vs. nonanemic .% significantly high anemic patient nonanemic patient p accord result regression analysis adjust significant covariate univariable model anemia independently associate mortality ci p ventilator requirement ci p risk icu admission ci p conclusion prevalence anemia hospitalize patient covid- high associate poor outcome covid-
560,article propose difference covid- morbidity associate transient receptor potential ankyrin  trpa and/or transient receptor potential vanilloid  trpv activation desensitization trpa trpv induce inflammation play key role physiology organ augment sensory vagal nerve discharge evoke pain symptom covid- include cough nasal obstruction vomiting diarrhea partly sudden severe loss smell taste trpa activate reactive oxygen specie regulate covid- trpa trpv channel activate pungent compound include nuclear factor erythroid derive nrf)-interacte food lead channel desensitization interaction nrf associate nutrient trpa trpv partly responsible severity covid- symptom regulation nrf trpa trpv unclear suggest limited clinical evidence covid- propose rapid desensitization trap trpv ingredient food reduce symptom severity provide new therapeutic strategy
561,cellular humoral immunity sars cov- critical control primary infection correlate severity disease role sars cov specific t cell immunity relationship antibody pre existing immunity endemic coronaviruse hucov hypothesize protective investigate  healthy donor hds  recover rcs  active covid- patient acs ac high amount anti sars cov- nucleocapsid spike igg lymphopenia overall reduce antiviral t cell response inflammatory milieu expression inhibitory molecule pd- tim- effector caspase- activity t cell sars cov specific t cell immunity confer polyfunctional mainly interferon gamma secrete cd(+ t cell remain stable convalescence humoral response decline immune response hucov rc mild disease strong cellular sars cov- t cell reactivity imply protective role pre existing immunity hucov.
562,background covid- pandemic significant public health crisis hit hard people health freedom movement affect global economy scientist worldwide compete develop therapeutic vaccine currently drug vaccine candidate give emergency authorization use question efficacy regard specific subgroup patient vaccine scalability general public circumstance understand covid- symptom vital initial triage crucial distinguish severity case effective management treatment study aim discover symptom pattern overall symptom rule include rule disaggregate age sex chronic condition mortality status covid- patient method study retrospective analysis covid- patient datum available online wolfram data repository apply widely rule base machine learning technique call association rule mining identify frequent symptom define pattern rule discover result total patient covid- include study median age  year frequently occur symptom fever follow cough malaise body soreness pneumonia sore throat myocardial infarction heart failure renal disease present patient significant symptom rule  generate show cough septic shock respiratory distress syndrome frequent consequent patient breathing problem sputum production high confidence patient have cough cardiac disease renal disease pneumonia present high confidence septic shock respiratory distress syndrome symptom rule differ young old patient male female patient patient chronic condition die covid- severe symptom rule patient chronic condition survive covid- concern chronic condition rule  patient patient diabetes prerenal azotemia coronary bypass surgery certainty hypertension conclusion frequently report symptom patient covid- fever cough pneumonia sore throat severe symptom septic shock respiratory distress syndrome respiratory failure symptom rule differ age sex patient chronic disease patient die covid- severe symptom rule specifically cardiovascular relate symptom accompany pneumonia fever cough consequent
563,objective describe coronavirus disease  covid- severity pregnant patient evaluate association disease severity perinatal outcome method conduct observational cohort study pregnant patient singleton gestation positive test result severe acute respiratory syndrome coronavirus  sars cov- deliver   u.s. hospital  state march  july disease severity classify national institutes health criterion maternal fetal neonatal outcome abstract centrally train certify perinatal research staff evaluate trend maternal characteristic outcome covid- severity class association severity outcome multivariable modeling result total patient include asymptomatic mild moderate severe critical overall hispanic trend race ethnicity distribution disease severity severe illness old mean age high median body mass index pre existing medical comorbiditie maternal death .% attribute covid- frequency perinatal death positive neonatal sars cov- test result differ severity adverse perinatal outcome frequent patient severe illness include ci -% incidence venous thromboembolism severe critical illness compare .% mild moderate asymptomatic p trend severity adjusted analysis severe critical covid- associate increase risk cesarean birth .% vs .% adjust relative risk arr ci hypertensive disorder pregnancy .% vs .% arr ci preterm birth .% vs .% arr ci compare asymptomatic patient mild moderate covid- associate adverse perinatal outcome compare asymptomatic patient conclusion compare pregnant patient sars cov- infection symptom severe critical covid- mild moderate covid- increase risk perinatal complication
564,background aim liver chemistry abnormality lca common patient coronavirus disease  covid- cause clinical impact adequately study assess association lca clinical characteristic inflammatory serum marker hospital mortality method thousand adult patient covid- hospitalize  hospital new york march  april analyze retrospectively abnormality liver chemistry aspartate aminotransferase ast alanine aminotransferase alkaline phosphatase total bilirubin define absent mild moderate value time elevated severe result lca mild moderate .% severe admission risk factor severe lca male sex chronic liver disease conversely hypertension diabetes mellitus likely associate severe lca ast elevation correlate weakly modestly inflammatory marker adjusted analysis hospital mortality time time increase patient mild moderate severe lca respectively diabetes hypertension male sex age great  year associate incremental risk mortality increase severity lca especially week hospitalization htn associate increase hospital mortality lca present conclusion increase severity lca hospital admission predict early hospital mortality covid- patient mortality associate know risk factor hypertension diabetes male sex old age accentuate presence lca ast correlate modestly inflammatory marker
565,objective severe coronavirus disease  covid- associate dysregulated immune state research focus hyperinflammation little research perform compensatory anti inflammatory response aim study evaluate anti inflammatory cytokine response covid- assess interleukin- il- il-/lymphocyte count ratio association outcome method adult patient present emergency department ed laboratory confirm covid- recruit primary endpoint maximum covid- severity  day index ed visit result total  covid- patient enrol il- il-/lymphocyte count significantly high patient severe disease p develop severe acute kidney injury aki new positive bacterial culture p</=. multivariable analysis unit increase il- il-/lymphocyte count associate p=. p=. increase odd respectively severe covid- standardize unit standard deviation scale increase il- strong predictor maximum -day severity severe aki increase il- il- conclusion hyperinflammatory response covid- accompany simultaneous anti inflammatory response associate poor outcome increase risk new positive bacterial culture il- il-/lymphocyte count ed presentation independent predictor covid- severity elevated il- strongly associate outcome pro inflammatory il- il- anti inflammatory response covid- require investigation enable precise immunomodulatory therapy sars cov-
566,aim report hypertension play important role adverse outcome coronavirus disease- covid- confounding factor aim study explore hypertension independent risk factor critical covid- mortality data synthesis medline pubmed embase web science database systematically search november combined odd ratio ors confidence interval cis calculate random effect model effect covariate analyze subgroup analysis meta regression analysis total  observational study covid- patient include meta analysis proportion hypertension critical covid- ci compare ci noncritical covid- patient die ci compare ci survivor pooled result base adjust show patient hypertension .-fold high risk critical covid- aor ci p .-fold high risk covid- mortality aor ci p  year associate significantly increase risk covid- mortality ci p meta regression analysis result show age coef p significant influence association hypertension covid- mortality conclusion evidence meta analysis suggest hypertension independently associate significantly increase risk critical covid- inhospital mortality covid-
567,background coronavirus disease  covid- emerge pandemic global public health concern aim summarize characteristic covid- patient early stage pandemic explore risk factor disease progression method conduct systematic review meta analysis search database study publish january march random effect model calculate confidence interval pool estimate prevalence odd ratio severe nonsevere case result ninety study involve covid- patient include hypertension .% diabetes .% common comorbiditie prevalent clinical symptom fever .% cough .% fatigue increased serum ferritin .% high c reactive protein .% high erythrocyte sedimentation rate esr .% frequently report laboratory abnormality patient bilateral lung involvement show peripheral subpleural .% distribution multifocal involvement common ct feature vascular enlargement .% ground glass opacity ggo .% thicken interlobular septum .% respiratory failure common complication overall case fatality rate cfr male history smoking comorbiditie influence prognosis clinical symptom fever high fever cough sputum production fatigue shortness breath dyspnoea abdominal pain link severity disease specific laboratory indicator imply deterioration disease leucocytosis lymphopenia platelet alanine aminotransferase alt aspartate aminotransferase ast albumin creatinine creatine kinase ck lactic dehydrogenase ldh c reactive protein procalcitonin pct d dimer risk bilateral pneumonia consolidation pleural effusion enlarge mediastinal node high severe case conclusion covid- patient fever cough lymphopenia increase inflammatory index main ct feature ggo involve bilateral lung patient comorbiditie bad clinical symptom laboratory characteristic ct finding tend poor disease progression
568,covid- pandemic lead worldwide socio economic depression high health impact geriatric population elderly population reason low immunity pre existing co morbidity hypertension cardiovascular disease diabetes obviously predisposed develop severe infection exhibit high mortality rate reason include atypical presentation geriatric population lead diagnostic delay guideline perform rt pcr symptomatic individual small portion individual test leave fraction population undiagnosed remain chance asymptomatic individual caregiver healthcare professional family member undiagnosed carry virus geriatric patient country prepared handle burden healthcare system include sudden increase demand icu bed mechanical ventilation etc result decision admit atypical presentation geriatric population include afebrile low grade fever absence cough malaise muscle pain dyspnoea etc geriatric population show severe type pneumonia significantly high number neutrophil c reactive protein lymphocyte high proportion multiple lobe involvement extreme social suppression covid- pandemic increase risk mental physical adverse effect old adult vulnerable depression anxiety
569,identification factor predispose severe covid- young adult remain partially characterize low birth weight lbw alter cardiovascular lung development predispose adult disease hypothesize lbw risk factor severe covid- non elderly subject analyze prospective cohort  patient year laboratory confirm sars cov- infection attend tertiary hospital require admission intensive care unit icu perinatal current potentially predictive variable obtain patient lbw define birth weight g. age adjust aor p male sex aor p hypertension aor p lbw aor p independently predict admission icu area receiver operate characteristic curve auc model ci positive negative predictive value .% .% respectively result reproduce independent cohort web base survey  subject self report laboratory positive sars cov- infection  patient .% need icu admission auc ci lbw independent risk factor severe covid- non elderly adult improve performance risk stratification algorithm
570,covid- newly emerge infectious disease generally susceptible human being cause huge loss people health acute respiratory distress syndrome ards common clinical manifestation severe covid- responsible current shortage ventilator worldwide study aim analyze clinical characteristic covid- ards patient establish diagnostic system base artificial intelligence ai method predict probability ards covid- patient collect clinical datum  covid- patient  region china clinical characteristic ards group ards group covid- patient elaborately compare traditional machine learning algorithm deep learning base method build prediction model result indicate median age ards patient year old significantly old non ards year male patient bmi  likely develop ards clinical feature ards patient include cough .% polypnea .% lung consolidation .% secondary bacterial infection .% comorbiditie hypertension .% abnormal biochemical indicator lymphocyte count ck nlr ast ldh crp strongly relate aggravation ards furthermore ai method modeling prediction effect evaluation base risk factor decision tree achieve good auc accuracy sensitivity specificity identify mild patient easy develop ards undoubtedly help deliver proper care optimize use limited resource
571,objective aim identify country level determinant severity wave covid- pandemic design ecological study publicly available datum country report covid- relate death  june  include outcome log mean mortality rate covid- estimate country level daily increase report death ascend phase epidemic curve potential determinant assess recently publish demographic parameter population population density percentage population live urban area population year average body mass index smoking prevalence economic parameter gross domestic product capita environmental parameter pollution level mean temperature january comorbiditie prevalence diabetes hypertension cancer health system parameter health index hospital bed  population international arrival stringency index measure country level response covid- bcg vaccination coverage uv radiation exposure testing capacity multivariable linear regression analyse datum primary outcome country level mean mortality rate mean slope covid- mortality curve ascend phase participant thirty seven country include algeria argentina austria belgium brazil canada chile colombia dominican republic ecuador egypt finland france germany hungary india indonesia ireland italy japan mexico netherlands peru philippines poland portugal romania russian federation saudi arabia south africa spain sweden switzerland turkey ukraine uk usa result country level determinant include multivariable model total number international arrival beta ci bcg vaccination coverage ci significantly associate natural logarithm mean death rate conclusion international travel directly associate mortality slope potentially spread covid- early restriction international travel consider control covid- outbreak prevent related death
572,background severe acute respiratory syndrome coronavirus  sars cov- pandemic remain latin america mexico country high death rate worldwide datum hospital mortality risk factor impact hospital overcrowding latin america thoroughly explore method finding prospective cohort study enrol consecutive adult patient hospitalize severe confirm covid- pneumonia sars cov- referral center mexico city february th june th total  patient admit confirmed diagnosis mean age year male obese overweight hypertension type  diabetes  recover .%  die survivor  receive invasive mechanical ventilation imv  manage outside intensive care unit icu mortality icu non survivor n receive support lack icu bed availability subgroup main cause death acute respiratory distress syndrome ards case non survivor receive n support main cause death septic shock follow ards main risk factor associate hospital death male sex rr ci obesity rr ci particular morbid obesity rr ci oxygen saturation admission rr ci conclusion study find similar hospital icu mortality risk factor mortality compare previous report patient survive justified admission icu receive imv icu care unavailability icu bed furthermore mortality rate time mainly availability icu bed indirectly suggest overcrowding main factor contribute hospital mortality
573,aging obesity relate condition worsen effect coronavirus disease  covid- study assess possible role metabolic obesity phenotype vitamin d status increase great severity covid- study uk biobank participant england mean age year metabolic obesity phenotype define combination metabolic component hypertension high cholesterol diabetes obesity multivariate logistic regression analysis perform test addition metabolic disorder vitamin d insufficiency increase obesity association covid- hospitalization confirm covid- severe covid- metabolically unhealthy obesity muho represent .% total analytic sample .% .% .% include subpopulation covid- hospitalization confirm covid- severe covid- respectively vitamin d insufficiency phenotype represent .% total analytic sample .% .% .% include subpopulation covid- hospitalization confirm covid- severe covid- respectively multivariate logistic regression muho vitamin d insufficiency combination significantly associate covid- illness severity odd ratio covid- hospitalization confidence interval ci .- confirmed covid- ci severe covid- ci elderly man prone high risk covid- woman finding show muho vitamin d insufficiency associate significantly increase risk covid- severity especially adult  year old susceptible individual aware condition avoid contact new coronavirus
574,aim study report accompaniment severe covid- comorbiditie systematic evaluation aspect association meta analysis aim assess association underlie comorbiditie covid- infection severity method electronic literature search perform scientific search engine removal duplicate selection article interest  study include fix effect model heterogeneity high random effect model apply combine datum result total individual assess severe non severe patient median age  confidence interval ci  ci year severe non severe group respectively patient comorbiditie severity high patient history cerebrovascular disease ci odd severe group increase ci history cardiovascular disease cvd ci chronic lung disease ci cancer odd ratio diabetes hypertension ci ci respectively conclusion presence comorbiditie associate severity covid- infection strong association observe cerebrovascular disease follow cvd chronic lung disease cancer diabetes hypertension
575,report clinical profile patient sars cov- infection genome sequence wgs seven virus isolate report case india international travel history comorbiditie diabetes hypertension cardiovascular disease frequently associate severity disease wbc neutrophil count show increase lymphocyte count decrease patient severe infection suggest possible neutrophil mediate organ damage immune activity diminish decrease lymphocyte lead disease severity increase sgot sgpt blood urea suggest functional deficiency liver heart kidney patient succumb disease compare group recover patient wgs analysis show isolate classify clade ai aa accord gisaid o l gr gh wgs phylogeny travel history indicate possible transmission middle east europe s protein variant wuhan reference dg yh identify predict possess different bind affinity host ace
576,background covid- necessitate implementation innovative health care model preparation influx patient virtual ward model deliver clinical care remotely patient isolation report australian cohort patient covid- treat virtual ward objective aim study describe evaluate safety efficacy virtual ward model care australian cohort patient covid- method retrospective clinical assessment perform  patient confirm covid- treat virtual ward brisbane australia march  statistical analysis perform variable associate length stay hospitalization result  patient  recover need escalation hospital care median length stay virtual ward  day range day total  patient refer hospital  .% discharge assessment emergency department furthermore  .% patient admit hospital  .% require supplemental oxygen  .% require mechanical ventilation death record factor associate escalation hospital care follow hypertension odd ratio ci p=. sputum production ci p=. arthralgia ci p=. illness onset polymerase chain reaction cycle threshold diagnostic nasopharyngeal swab ci p=. conclusion result suggest virtual ward model care treat patient covid- safe efficacious small number patient potentially require escalation hospital care study require validate model care
577, coronavirus disease covid- present newly recognize pneumonia bring global pandemic increasingly consider systemic illness investigate clinical laboratory feature recovered covid- patient pre existing hematologic disease wuhan  hospital male  female chinese patient include median age  year present study eosinopenia .% monocytosis .% lymphocytopenia .% anemia .% common hematologic finding cohort particularly severe critically ill covid- level change leukocyte neutrophil lymphocyte monocyte eosinophil basophils platelet hemoglobin level mean corpuscular volume mcv mean cell hemoglobin concentration mchc overall associate lung involvement oxygen demand disease activity change eosinophil end hospitalization baseline coefficient ci p basophils max min coefficient ci p independent predictor delay recovery hospital multivariate analysis recovered population variety hematologic change associate severity clinical outcome recovered covid- patient warrant exploration underlie mechanism
578,course coronavirus  covid- determine certain comorbiditie e.g. diabetes hypertension cardiovascular disease advanced age impact immunosuppression disease severity entirely clear management patient immunosuppressive treatment remain controversial case inflammatory bowel disease ibd patient covid- immunosuppressive medication present aim study describe patient clinical manifestation chronologic development virus specific antibody severe acute respiratory syndrome coronavirus  sars cov- infection restart immunosuppressive biological therapy indicator specific immune response patient test presence sars cov rna pcr clinical remission prior covid- patient continue immunosuppressive treatment covid- infection initial symptom covid- pyrexia diarrhea cephalea dysgeusia anosmia patient need admission hospital icu sars cov- antibody development describe late patient late antibody development frequent old patient patient combine immunosuppressive treatment scenario sars cov- antibody testing useful prior restart immunosuppressive therapy
579,january confirm epidemic outbreak sars cov- health emergency international concern aim meta meta analysis quantify meta analytic finding association cardiovascular disease cvd comorbiditie covid- severity finding suggest chance get severe covid- disease patient cvd great cvd prevalence cvd patent covid- ci indicate odd get severe covid-  time high cvd prevalence hypertension patient covid- ci indicate odd get severe covid- case high blood pressure time high hypertension rational suppose person coronary artery disease prone severe viral infection guideline direct diagnosis medical therapy vital cvd patient
580,background evidence accumulate coronavirus disease  increase risk hospitalization mechanical ventilation pregnant patient preterm delivery impact maternal mortality morbidity differentially affect disease severity delivery trimester infection unknown objective study aim describe disease severity outcome severe acute respiratory syndrome coronavirus  infection pregnancy washington state include pregnancy complication outcome hospitalization case fatality study design pregnant patient polymerase chain reaction confirm severe acute respiratory syndrome coronavirus  infection march june identify multicenter retrospective cohort study  site washington state site capture annual state delivery case fatality rate pregnancy compare coronavirus disease  fatality rate similarly aged adult washington state rate ratio rate difference maternal neonatal outcome compare trimester infection disease severity time delivery result principal study finding follow  pregnant patient washington state severe acute respiratory syndrome coronavirus  infection   develop severe critical disease   hospitalize coronavirus disease   die coronavirus disease -associate hospitalization rate high similarly aged adult washington state .% vs .% rate ratio confidence interval pregnant patient hospitalize respiratory concern likely comorbidity underlying condition include asthma hypertension type  diabetes mellitus autoimmune disease class iii obesity  maternal death .% attribute coronavirus disease  maternal mortality rate  pregnancy confidence interval coronavirus disease  case fatality pregnancy significant confidence interval high pregnant patient similarly age individual washington state absolute difference mortality rate confidence interval preterm birth significantly high woman severe critical coronavirus disease  delivery woman recover coronavirus disease  .% severe critical coronavirus disease  vs .% mild coronavirus disease p conclusion coronavirus disease  hospitalization case fatality rate pregnant patient significantly high similarly aged adult washington state datum indicate pregnant patient risk severe critical disease mortality compare nonpregnant adult risk preterm birth
581,background despite grow number study coronavirus disease- covid- little know association menopausal status covid- outcome material method retrospective study include  covid- inpatient february  april  taikang tongji hospital wuhan china electronic medical record include patient demographic laboratory result chest compute tomography ct image result total  patient complete clinical outcome include analysis mean age year patient woman n .% patient present comorbiditie hypertension common comorbidity propensity score matching result show man significantly high odd premenopausal woman develop severe disease type .% vs. ci p bilateral lung infiltration .% vs. .% ci p mortality .% vs. ci p non significant difference observe man postmenopausal woman percentage severe disease type .% vs. .% ci p bilateral lung infiltration .% vs. .% ci p mortality .% vs. .% ci p conclusion man high disease severity premenopausal woman difference disappear postmenopausal woman man finding support aggressive treatment poor prognosis postmenopausal woman clinical practice
582,background objective new type coronavirus -ncov epidemic spread rapidly cause  thousand death worldwide virus appear sign pneumonia later call sars cov- severe acute respiratory syndrome world health organization sars cov- virus trigger bind angiotensin convert enzyme  ace inhibitor vital cardiovascular disease immune system especially condition cerebrovascular hypertension diabete study aim evaluate prediction performance death status base demographic clinical factor include covid- severity datum mining method method dataset consist  sars cov- patient  variable obtain open source web address current dataset contain age gender chronic disease hypertension diabetes renal cardiovascular etc enzyme ace angiotensin ii receptor blocker covid- severity predict death status deep learning machine learning approach random forest k near neighbor extreme gradient boost xgboost grid search algorithm tune hyperparameter model prediction assess performance metric step knowledge discovery database apply obtain relevant information result accuracy rate deep learning .% successful accuracy rate base classical machine learning .% rf .% k nn ensemble classifier xgboost method give high accuracy covid- severity age calculate xgboost important factor associate death status determine variable death status estimate deep learning covid- severity hypertension conclusion propose model xgboost achieve good prediction death status base factor compare algorithm result study guide patient certain variable early measure access preventive health care service infect virus
583,constantly grow number covid- infection death attempt undertake find drug anti sars cov- activity one approve pathology framework attempt number vitro vivo model show hydroxychloroquine hcq effect sars cov- clinical datum support use hcq country include russia include hcq treatment protocol infected patient prophylaxis current non randomized observational study evaluate sars cov- rna nasopharynx swab infected patient day post symptom clinically mild disease compare viral rna load dynamic patient receive hcq mg twice day accord ministry health russian federation treatment instruction n control group antiviral pharmacological therapy n find statistically significant relationship maximal rna quantity deterioration patient medical condition confirm arterial hypertension risk factor people covid- show dose study hcq therapy shorten viral shedding period reduce virus rna load
584,objective aim study evaluate clinical feature severity mortality coronavirus disease- covid- hospitalize middle aged old woman risk factor associate severity mortality woman method retrospective study conduct hospitalize patient covid- clinical feature severity mortality covid- middle aged old woman age  year old compare young woman age year odd ratio confidence interval .- p imv requirement odd ratio confidence interval .- p predict mortality conclusion severity mortality high middle aged old woman covid- compare young woman
585,purpose coronavirus disease  covid- present spectrum disease severity case require intensive care echocardiography line tool evaluate cardiovascular complication covid- intensive care unit icu analyze transthoracic echocardiogram obtain patient population state art ultrasound technology method patient covid- require icu admission transthoracic echocardiogram obtain include study focus transthoracic protocol perform experienced sonographer echocardiographic variable include speckle track echocardiography collect analyze clinical information obtain electronic medical record patient follow discharge result  total patient mean age year .% male  know prior cardiac disease cardiac complication identify echocardiography prevalent occur .% patient patient know prior cardiac disease likely new worsen leave ventricular dysfunction right ventricular dysfunction common abnormality assess qualitatively  case advanced echocardiographic method  case know prior cardiac disease right ventricular enlargement pulmonary hypertension significantly associate morbidity mortality conclusion patient require intensive care covid- face significant morbidity mortality cardiac complication occur majority patient admit icu covid- know prior cardiac disease fare worse echocardiographic finding right ventricular enlargement pulmonary hypertension associate bad outcome state art echocardiography perform experienced sonographer critical identify cardiac complication guide icu strategy
586,background large inter individual inter population difference susceptibility outcome severe acute respiratory syndrome coronavirus  coronavirus disease  covid- note understand difference influence vulnerability infection disease severity critical public health intervention aim analyze compare profile covid- case china north america region differ environmental host healthcare factor relate disease risk method conduct meta analysis examine compare demographic information clinical symptom comorbiditie disease severity level disease biomarker covid- case clinical study datum china study north america study result covid- patient north america old chinese counterpart high male female ratio fever cough fatigue dyspnea common clinical symptom study region present case region meta analysis prevalence comorbiditie obesity hypertension diabetes cardiovascular disease chronic obstructive pulmonary disease cancer chronic kidney disease covid- patient significantly prevalent north america compare china comorbiditie positively correlate age significantly young age range china compare north american prevalent infection outcome acute respiratory distress syndrome frequent north america china level c reactive protein .-fold high north american case case china conclusion difference profile covid- case china north america relate difference environmental- host- healthcare relate factor region inter population difference intra population variability underline need characterize effect health inequity inequality public health response covid- assist prepare emergence epidemic
587,global spread sars cov- million people affect lead declaration coronavirus disease  covid- pandemic study link severity covid- case increase fatality patient obesity comorbid condition diabetes cardiovascular disease hypertension kidney disease obesity metabolically deranged condition establish low grade chronic inflammation body affect different organ promote development disease way sars cov- infection aggravate overload body organ inflammation vice versa perplex researcher result intensify search clear cut mechanism understand link obesity increase severity covid- obese patient article discuss mechanism link obesity inflammation covid- enhance understanding disease process help clinician scientist develop potential cellular molecular metabolic target clinical intervention management covid- severity obese patient
588,systematic review meta analysis aim evaluate thrombocytopenia prognostic biomarker patient coronavirus disease  covid- perform systematic literature search pubmed embase europepmc main outcome composite poor outcome composite mortality severity need intensive care unit care invasive mechanical ventilation  patient  study thrombocytopenia occur patient male gender p significantly reduce incidence thrombocytopenia associate composite poor outcome rr p subgroup analysis show thrombocytopenia associate mortality rr p severity rr p subgroup analysis cut x show rr p thrombocytopenia sensitivity specificity positive likelihood ratio negative likelihood ratio diagnostic odd ratio  area curve composite poor outcome meta regression analysis show association thrombocytopenia poor outcome vary significantly age male lymphocyte d dimer hypertension diabetes ckd fagan nomogram show posterior probability poor outcome patient thrombocytopenia thrombocytopenia deek funnel plot relatively symmetrical quantitative asymmetry test non significant p study indicate thrombocytopenia associate poor outcome patient covid-.prospero id crd
589,report highlight contribution host factor age gender co morbidity diabetes hypertension coronary heart disease determine covid- disease severity inspite initial effort understand contribution sars cov- variant unable delineate causality study visit contribution different clade virus g gr gh attribute explain disparity mortality rate country total high quality sars cov- sequence include g s dg variant find linkage disequilibrium c u rdrp pl linear regression analysis reveal increase age odd ratio p value high frequency clade g virus odd ratio value explain difference mortality rate  country multiple r squared machine learn algorithm logitboost adaboostm apply determine country belong high low mortality group classify attribute accurate classification achieve .% .% country respectively evolutionary analysis indian viral population n carry allele frequency spectrum nucleotide diversity pi value negative tajima d value orf indicative population expansion network analysis reveal presence major cluster viral haplotype clade g variant clade l lv have rdrp av amino acid change clade g genome find evolve rapidly find high proportion state high mortality rate gujarat madhya pradesh west bengal finding study result vitro study highlight role variant increase transmissibility alter response antiviral reflect role viral factor disease prognosis
590,introduction patient diagnose covid- present emergency department eds worldwide wide range symptom study report clinical laboratory radiological feature case diagnose covid- method single center retrospective descriptive observational study patient admit ed march   diagnose covid- infection result  male  female patient covid- polymerase chain reaction pcr positive test include study average age study group calculate year .% patient asymptomatic common symptom identify cough .% follow dyspnea .% fever compute tomography ct severity score prove significantly high patient hypertension coronary artery disease cad disease p p respectively moderate positive correlation serum ferritin level ct severity score finding worth note rho p similar vein high level d dimer ct positive group positive moderate correlation ct severity rho p conclusion study serum ferritin d dimer level observe high ct positive group moderate positive correlation ct severity argue d dimer ferritin level measure time admission ed take consideration predict radiological severity
591,background paucity information coronavirus disease  covid- outcome asthmatic objective identify risk factor associate admission subsequent mortality covid infected asthmatic method adult institution positive polymerase chain reaction covid- march  april retrospectively identify comorbiditie laboratory result mortality rate hospitalization record result total   .% asthma patient covid- see emergency department ed .% ed patient admit individual previously measure mean absolute eosinophil count aec /= cell mul likely admit odd ratio confidence interval ci p concomitant heart failure chf chronic kidney disease ckd chronic obstructive pulmonary disease copd risk factor admission hospitalize patient asthma peak hospital measure aec /= cell mul n likely die compare aec remain cell mul protective covid associated admission development eosinophilia aec /= cell mul hospitalization associate decrease mortality preadmission aec influence aec trend hospitalization have th asthma phenotype important predictor reduced covid- morbidity mortality explore prospective mechanistic study
592,background investigate effect angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb administration hypertension patient coronavirus disease  covid- induce pneumonia method record recovery status  inpatient hypertension covid- induce pneumonia raytheon mountain hospital wuhan february  march patient treat acei arb categorize group n patient administer acei arb categorize group b n comparative analysis parameter pneumonia progression length stay hospital level alanine aminotransferase alt serum creatinine cr creatine kinase ck day patient admit hospital day treatment end result  hypertension case count .% total covid- patient significant difference usage drug treatment covid- group b p treatment  case group  case group b progress mild pneumonia severe pneumonia eventually patient cure discharge treatment recurrence covid- induce pneumonia occur discharge length stay short group compare group b significant difference p significant difference general parameter patient group b day admission hospital p alt ck cr level significantly differ group b day admission day discharge p conclusion treat hypertension patient covid- cause pneumonia anti hypertensive drug ace arb accord relative guideline treatment regimen drug need alter covid- patient
593,background coronavirus disease  covid- clinical expression pleiomorphic severity relate age comorbiditie diabetes hypertension pathophysiology involve aberrant immune activation lymphopenia wonder myeloid compartment affect covid- monocyte macrophage infect severe acute respiratory syndrome coronavirus  sars cov- method monocyte monocyte derive macrophage mdm covid- patient control infect sars cov- extensively investigate immunofluorescence viral rna extraction quantification total rna extraction follow reverse transcription quantitative polymerase chain reaction specific primer supernatant cytokine interleukin beta interferon beta transform growth factor beta tumor necrosis factor alpha flow cytometry effect m- vs m type polarization prior infection assess result sars cov- efficiently infect monocyte mdm infection abortive infection associate immunoregulatory cytokine secretion induction macrophagic specific transcriptional program characterize upregulation m type molecule vitro polarization account permissivity sars cov- m- m type mdm similarly infect covid- patient monocyte exhibit low count affect subset decrease expression hla dr increase expression cd irrespective severity conclusion sars cov- drive monocyte macrophage induce host immunoparalysis benefit covid- progression sars cov- infection macrophage induce specific m transcriptional program covid- patient monocyte subset decrease associate expression immunoregulatory molecule cd suggest sars cov- drive immune system benefit covid- disease progression
594,objective date study investigate neurocognitive deficit covid- publish case series address cognition post covid- patient describe patient acute rehabilitation inform model cognitive sequela covid- method english speak inpatient severe symptom long term intensive care unit icu treatment describe patient premorbid history hypertension hyperlipidemia experience delirium hypoxemia hospitalize patient  -year old male  year education additional history obstructive sleep apnea type  diabetes patient  -year old female  year education premorbid medical history alcohol use disorder guillain barre syndrome patient  -year old male  year education patient premorbid psychiatric history result patient demonstrate deficit formal neuropsychological testing particularly encoding verbal fluency memory measure improve structured story memory task compare structured verbal list learn task suggest executive dysfunction impact learn patient demonstrate rapid forgetting information patient endorse new depressive and/or anxiety symptom conclusion result suggest evidence neurocognitive deficit severe covid- infection particularly encoding verbal fluency result interpret caution give limited number patient telephone base battery specific mechanism cause cognitive deficit individual remain unclear propose stage model cognitive dysfunction describe help guide future research
596,background limited datum impact coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- people multiple sclerosis ms objective well understand sars cov- infection ocrelizumab treat people ms methods internal roche genentech datum source case covid- ongoing roche genentech clinical trial post marketing use ocrelizumab july  identify assess descriptive statistic external real world datum rwd source ms covid- cohort ocrelizumab treat ms covid- cohort identify assess optum de identify covid- electronic health record ehr database result roche genentech clinical trial datum  .% suspect confirm case covid- identify patient ongoing  roche genentech clinical trial  confirm covid-  suspect covid- sixteen .% patient hospitalize covid- severity mild moderate patient .% .% patient severe disease .% fatal case patient .% recover recover association apparent duration exposure ocrelizumab covid- covid- patient previous serum immunoglobulin status .% igg level normal range roche genentech post marketing safety database datum  post marketing case covid- roche genentech global safety database  .% confirm  .% suspect covid-  .% patient hospitalize covid- asymptomatic mild moderate  patient severe  patient critical  patient  .% fatal case information severity report  .% case patient .% recover recover time report external rwd datum source july optum database include ehrs million patient suspected covid- meet criterion confirm clinically diagnose covid- total  patient ms confirmed covid- identify .% treat ocrelizumab  .% hospitalize die similar rate hospitalization invasive ventilation death observe ocrelizumab treat non ocrelizumab treat ms cohort roche genentech rwd source assess age male sex presence comorbiditie hypertension associate severe disease course covid- high number comorbiditie present hospitalize versus non hospitalize patient conclusion assessment provide evidence covid- ocrelizumab treat people ms predominantly mild moderate severity patient require hospitalization line datum report general population ms dataset risk factor know associate severe covid- outcome general population appear influence covid- severity ocrelizumab treat people ms case fatality rate ocrelizumab treat people ms publish range general population ms cohort
597,coronavirus disease covid- priority health problem objective evaluate clinical characteristic evolution severity covid- level hospital province buenos aires argentina conduct retrospective cohort  patient covid- march  june patient divide accord presence absence pneumonia severity disease median age  year woman common symptom fever cough dyspnea fever associate presence pneumonia prevalent comorbiditie hypertension obesity cardiovascular disease chronic respiratory disease presence comorbidity hypertension common severe case frequent laboratory finding lymphopenia elevated d dimer thrombocytopenia severe disease level c reactive protein d dimer high patient pneumonia healthcare worker diagnosis reverse transcriptase polymerase chain reaction rt pcr sample need case moderate high value pneumonia severity index psi prevalent severe mild pneumonia vs. p mortality register ci clinical characteristic severity prognosis similar describe worldwide highlight high proportion healthcare worker sars cov- positive false negative rate rt pcr usefulness psi discriminate severity pneumonia
598,rationale severe coronavirus disease covid- significant risk factor development invasive fungal superinfection great medical interest remain open question objective aim assess occurrence invasive fungal respiratory superinfection patient severe covid-.method conduct study patient severe acute respiratory syndrome coronavirus  sars cov-)-related pneumonia admit icu france respiratory serum sampling perform specific screening fungal complication measurement main results study population include total  patient median age  year old male n overweight n hypertension n diabetes n patient present preexisting host risk factor invasive fungal infection n global severity high patient invasive mechanical ventilation half n extracorporeal membrane oxygenation support mycological analysis include mycological test culture galactomannan beta glucan pcr perform  respiratory sample  sera probable putative invasive pulmonary mold infection diagnose  patient link high mortality multivariate analysis indicate significantly high risk solid organ transplant recipient odd ratio interquartile range .- p false positive fungal test clinically irrelevant colonization require initiation antifungal treatment observe  patient patient underlie immunosuppression severe sars cov related pneumonia low risk invasive fungal secondary infection especially aspergillosis
599,pandemic novel coronavirus disease  covid- trigger international crisis result excess morbidity mortality adverse societal economic geopolitical consequence like disease state patient characteristic impact clinical risk determine spectrum severity obesity adiposity base chronic disease emerge important risk factor morbidity mortality covid- imperative stratify risk patient obesity determine optimal mitigation therapeutic preparedness strategy suspect insulin resistance important pathophysiologic cause poor outcome patient obesity covid- independent body mass index explain association type  diabetes mellitus tdm hypertension htn cardiovascular disease poor outcome insulin resistance main driver dysglycemia base chronic disease cardiometabolic base chronic disease end stage disease manifestation stage severity adiposity relate disease complication centric manner htn dyslipidemia metabolic syndrome tdm obstructive sleep apnea etc different ethnic group patient covid- help predict adverse risk adiposity patient health pragmatic actionable manner pandemic
600,coronavirus disease  covid- high mortality elderly patient pre existing cardiovascular disease cellular receptor severe acute respiratory syndrome coronavirus  sars cov- angiotensin convert enzyme  ace implicate link cardiovascular disease sars cov- susceptibility aortic stenosis represent chronic inflammatory state severe cardiovascular complication elderly prime condition covid- mortality circulate ace level measure  patient severe compare patient hypertension healthy individual  time high circulate ace activity find patient severe hypertensive healthy individual n n mu l n respectively patient severe old patient hypertension  year vs.   year p serum ace activity correlate negatively left ventricular ejection fraction aortic root area tapse positively right ventricular systolic pressure cardiac diameter patient contrast circulate ace activity independent blood pressure peak flow velocity aortic root kidney function gfr inflammatory state crp find effect raas inhibitory drug serum ace activity group patient result illustrate circulate ace potential interface chronic inflammation cardiovascular disease covid- susceptibility elderly patient markedly elevate ace level altered left right ventricular function pose high risk covid- clinical datum support role raas inhibitor regulate circulate ace level
601,foremost mortality cause symptom associate covid- acute respiratory distress syndrome ards significant correlation identify deficiency vitamin d risk develop ards suggest reduce modify ards covid- patient significantly reduce severity covid- symptom associate mortality rate increase mortality dark skin people reduce uv absorption capacity consistent diminished vitamin d status factor associate covid- mortality old age ethnicity obesity hypertension cardiovascular disease diabetes find link vitamin d deficiency base review precautionary measure suggest adoption appropriate safe solar exposure vitamin d enrich food supplement consider reduce possible severity covid- symptom safe sun exposure deem beneficial globally specifically low middle income country cost involve note improve solar exposure vitamin d level reduce impact disease assist maintain general human
602,coronavirus disease  covid- reach pandemic proportion affect million people worldwide severe acute respiratory syndrome coronavirus- sars cov- causative agent covid- epidemiological report show severity sars cov- infection associate preexisting comorbiditie hypertension diabetes mellitus cardiovascular disease chronic kidney disease risk factor acute kidney injury aki kidney emerge key organ affect sars cov- aki associate increase morbidity mortality patient covid- male sex independent predictor aki increase death rate report male patient covid- worldwide mechanism(s mediate sex discrepancy mortality covid- remain(s unknown angiotensin convert enzyme ace receptor sars cov- alteration ace ace ratio implicate renal disease perspective aim discuss datum suggest androgen alteration intrarenal renin angiotensin system impair renal hemodynamic predispose patient aki covid- infection explain high mortality observe man covid- clinician ensure early effective cardiometabolic control patient ameliorate compensatory elevation ace alteration ace ace ratio well understanding role androgen sars cov associate aki mortality imperative kidney constitute key organ explain sex disparity high mortality bad outcome associate covid- man
603,coronavirus disease  covid- pandemic cause severe acute respiratory syndrome coronavirus  sars cov- rapidly evolve important cardiovascular consideration presence underlie cardiovascular risk factor establish cardiovascular disease cvd affect severity clinical management patient covid- conduct review literature summarize cardiovascular pathophysiology risk factor clinical presentation treatment consideration covid- patient underlie cvd angiotensin convert enzyme  ace identify functional receptor sars cov- virus associate cardiovascular system hypertension diabetes cvd common comorbiditie covid- patient factor associate progression severity covid- elderly population develop severe covid- complication naturally expose comorbiditie underscore possible confounding age observational datum support international cardiovascular society recommendation discontinue ace inhibitor angiotensin receptor blocker therapy patient guideline indication fear increase risk sars cov- infection severe disease death addition cardiotoxicity experimental antiviral potential interaction experimental therapy cardiovascular drug strategy cardiovascular protection recommend covid- patient underlie cvd troponin elevation associate increase risk hospital mortality adverse outcome patient covid- cardiovascular care team high index suspicion fulminant myocarditis like presentation sars cov- positive remain vigilant cardiovascular complication covid- patient
604,background hypertension common comorbidity coronavirus disease  covid- patient accompany bad clinical outcome lack evidence prognostic factor covid- patient hypertension come prognostic factor predict severity covid- hypertensive patient addition epidemiologic clinical laboratory difference covid- patient underlie hypertension evaluate method medical profile  covid- case analyze patient divide comparative group accord positive negative history hypertension epidemiologic clinical laboratory radiological feature clinical outcome compare result  .% patient underlying hypertension diabetes significantly high hypertensive group .% vs  p value cardiovascular renal disorder significantly high hypertensive patient p value respectively covid- patient hypertension severe critical type significantly high .% vs. .% p value logistic regression model body mass index  oradj ci p value age  oradj ci p value increase hospitalization period oradj ci p value type  diabetes oradj ci p value chronic kidney disease oradj ci p value relate progression covid- conclusion hypertensive patient age -year old bmi  kg m cvd diabetes chronic kidney disease associate poor outcome covid- infection
605,december pneumonia case infect  novel coronavirus appear pose critical threat global health study perform meta analysis discover different clinical characteristic severe non severe patient covid- find potential risk factor predictor disease severity serve guidance subsequent epidemic prevention control work pubmed cochrane library medline embase database search collect study difference clinical characteristic severe non severe patient meta analysis perform revman software funnel plot evaluate publication bias p mean statistical significance furthermore meta regression analysis perform stata find potential factor high degree heterogeneity i()>% sixteen study include severe patient non severe patient compare non severe patient severe patient likely symptom dyspnea hemoptysis complication ards shock secondary infection acute kidney injury acute cardiac injury interestingly smoker prevalent severe case compare non severe case difference group current smoker chronic liver disease chronic kidney disease underlie comorbiditie hypertension diabetes cardiovascular disease chronic obstructive pulmonary disease copd malignancy cerebrovascular disease hiv disease bad term laboratory indicator decrease lymphocyte platelet count increase level white blood cell wbc d dimer creatine kinase lactate dehydrogenase procalcitonin alanine aminotransferase aspartate aminotransferase c reactive protein prevalent severe patient meta regression analysis show patient age gender proportion severe case significantly impact outcome clinical index show high degree heterogeneity meta analysis conclusion severity covid- evaluate radiologic finding symptom like dyspnea hemoptysis laboratory indicator smoking history especially ex smoker compare non severe patient severe patient likely complication comorbiditie include hypertension cardiovascular disease etc risk factor disease severe chronic liver disease chronic kidney disease associate severity covid- china
606,aim process datum wave covid- cause severe acute respiratory syndrome coronavirus  sars cov- collect infectious diseases clinic idc faculty medicine central military hospital prague analyse clinical diagnostic therapeutic aspect covid- context czech republic compare datum recent literature patient method retrospective study analyse datum patient admit idc  march   study cohort include  patient covid-  female  male average age  year parameter analyse clinical symptom average length hospital stay complication death additional datum concern age weight smoking habit history comorbiditie select laboratory result datum compare group patient differ severity course covid- finally imaging finding serology result therapy outcome study statistical analysis perform sigmastat software result .% patient mild course disease  .% patient moderate course  .% patient severe course .% patient critical course study patient present follow clinical symptom fever .% case cough .% case difficulty breathe .% case diarrhoea .% case chest pain .% case anosmia .% case average length hospital stay day common complication bacterial superinfection report  .% study patient overall case fatality rate covid- study average age study cohort  year patient severe course disease old average age severe course disease p lt predominant comorbiditie hypertension diabetes mellitus analysis baseline laboratory datum show significant difference group patient differ severity course covid- crp procalcitonin d dimer lymphocyte count high resolution compute tomography hrct scan lung perform  patient  typical finding covid- average mulbsta score covid- pneumonia severity study cohort point associate severity course disease serology test perform  study patient  .% turn positive test .% testing positive reteste hydroxychloroquine hcq give experimentally monotherapy combination azithromycin azi  patient patient hcq therapy receive inosinum pranobexum isoprinosine severe lymphopenia patient receive convalescent plasma patient give azi patient treat inosinum pranobexum altogether .% study patient prescribe antibiotic confirmed suspect bacterial superinfection standard clinical pharmaceutical care provide patient particular focus safety label drug use hcq draw patient prolonged correct qt interval qtc conclusion wave sars cov- epidemic study patient show comorbiditie risk factor consistent international literature course disease moderate severe low proportion critically ill patient fatal outcome soon new information available new diagnostic therapeutic option introduce routine practice base experience prepared possible second wave sars cov- term diagnostic therapeutic option remain limited
607,background unpredictability progression coronavirus disease  covid- attribute low precision tool predict prognosis disease objective identify predictor associate poor clinical outcome patient covid- method relevant article pubmed embase cochrane web science search april quality include paper appraise newcastle ottawa scale nos datum interest collect evaluate compatibility meta analysis cumulative calculation determine correlation effect estimate perform z test result total  paper recording mild severe case covid- include base initial evaluation  potential risk factor identify meta analysis comorbiditie include chronic respiratory disease cardiovascular disease diabetes mellitus hypertension observe frequent patient severe covid- mild one compare mild form severe covid- associate symptom dyspnea anorexia fatigue increase respiratory rate high systolic blood pressure low level lymphocyte hemoglobin elevated level leukocyte aspartate aminotransferase alanine aminotransferase blood creatinine blood urea nitrogen high sensitivity troponin creatine kinase high sensitivity c reactive protein interleukin d dimer ferritin lactate dehydrogenase procalcitonin high erythrocyte sedimentation rate associate severe covid- conclusion  risk factor associate high risk severe covid- serve useful baseline parameter development prediction tool covid- prognosis
608,coronavirus disease  covid- pandemic threat report different presentation complication old age comorbiditie diabetes hypertension cardiac disease increase risk factor covid- severity death n engl j med lancet respir med  propose cancer patient significantly high incidence severe incident include admission intensive care unit necessity assist ventilation death catch virus compare non cancer patient lancet oncol describe cancer patient appear twice likely contract infection severe acute respiratory syndrome coronavirus- sars cov- jama oncol hairy cell leukemia hcl rare b cell lymphoproliferative disorder patient typically present cytopenias mark splenomegaly -% patient circulate leukemia cell bone marrow infiltration presence braf ve somatic mutation indian j hematol blood transfus suppl leukemic cell classically central nucleus abundant cytoplasm hairy like projection express cdc cd cd cd indian j hematol blood transfus suppl loss cd hcl rarely report literature j hematol describe unique case covid positive male present severe respiratory symptom deteriorate quickly intubate workup severe progressive pancytopenia bone marrow examination reveal hcl splenomegaly atypical unusual loss cd knowledge case cd negative hcl splenomegaly associate covid- infection initial presentation
609,background december coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- emerge wuhan hubei china global pandemic great value describe clinical symptom covid- patient detail look marker significant predict prognosis covid- patient method multicenter retrospective study  patient covid- enrol consecutive series screening total  patient include study cause death primary endpoint patient follow admission till discharge death result main symptom observe study include fever admission cough fatigue shortness breath common comorbiditie hypertension diabetes mellitus patient low cd(+)t cell level old male compare high cd(+)t cell level reduce cd(+)t cell level indicator severity covid- decrease cd(+)t hr ci cd(+)t hr ci cell level associate hospital death covid- patient decrease cd(+)t cell level independent predictor hospital death covid- patient conclusion reduction lymphocyte lymphocyte subset common covid- patient especially severe case covid- cd(+)t cell level cd(+)t cell level reflect severity patient disease reduce cd(+)t cell level independently associate increase hospital death covid- patient trial registration prognostic factors patients covid- nct register  march retrospectively register
610,background coronavirus covid- infection represent medical condition associate cardiovascular complication pulmonary hypertension ph right ventricle dysfunction rvd aim study mean transthoracic echocardiography tte presence increase estimate systolic pressure pulmonary artery espap alter right ventricular global longitudinal strain rv gls patient history ph method group  patient age  year hospitalize moderate covid- infection thorough cardiologic tte examination perform month discharge initial thorax computer tomography tct image laboratory datum access electronic datum base hospital result observe increase prevalence ph .% rvd .% significantly correlate initial level tct score inflammatory factor p borderline change observe patient multivariate regression analysis show factor rv gls explain .% elevated espap conclusion covid- infection ph rvd common complication encounter recovery moderate case appear connection severity extent initial pulmonary injury inflammatory response
611,background old population especially affect severe acute respiratory syndrome coronavirus  pandemic covid- objective aim study explore incidence severity mortality rate clinical feature risk factor symptom covid- home dwell old people association type residence cognitive deterioration neurodegenerative disease method datum symptom covid- collect telephone survey cohort  old volunteer vallecas project aged year home dwell madrid spain association demographic anthropometric measure genetic polymorphism comorbiditie life habit type residence frailty surrogate explore potential risk factor incidence severity mortality covid- old population finding case report symptom compatible covid-  die  home  nursing home moderate severe case significantly old frequently male apoe epsilon allele associate presence symptom covid- high systolic blood pressure intense smoking habit alcohol intake low consumption coffee tea cognitive impairment associate disease severity conclusion estimate incidence symptomatic covid- old cohort madrid .% overall mortality rate .% .% live nursing home fatality rate .% exploratory study indicate life habit clinical condition epsilon variant apoe gene associate presence clinical severity coronavirus infection
612,background biological consideration suggest renin angiotensin system inhibitor influence severity covid- aim evaluate continue versus discontinue renin angiotensin system inhibitor angiotensin convert enzyme inhibitor angiotensin receptor blocker affect outcome patient admit hospital covid- method replace covid trial prospective randomised open label trial  large referral hospital seven country worldwide eligible participant aged  year old admit hospital covid- receive renin angiotensin system inhibitor admission individual contraindication continuation discontinuation renin angiotensin system inhibitor therapy exclude participant randomly assign continuation discontinuation renin angiotensin system inhibitor permute block randomisation allocation conceal secure web base randomisation system primary outcome global rank score participant rank hierarchical tier incorporate time death duration mechanical ventilation time renal replacement vasopressor therapy multiorgan dysfunction hospitalisation primary analysis intention treat population replace covid trial register clinicaltrials.gov nct finding march  aug  participant enrol randomly assign continue discontinue renin angiotensin system inhibitor therapy continuation group discontinuation group mean age participant  year sd  female mean body mass index  kg m sd  diabetes compare discontinuation renin angiotensin system inhibitor continuation effect global rank score median rank  iqr continuation vs  discontinuation beta coefficient  ci   participant continuation arm versus   discontinuation arm require intensive care unit admission invasive mechanical ventilation   participant continuation group versus  discontinuation group die  participant continuation group  participant discontinuation group adverse event chi test adverse event treatment group p=. difference blood pressure serum potassium creatinine follow group interpretation consistent international society recommendation renin angiotensin system inhibitor safely continue patient admit hospital covid- funding replace covid investigators replace covid trial social fundraising campaign fastgrants
613, october  confirm covid- infection  death worldwide include  infection  death uk acute respiratory distress syndrome occur patient secondary haemophagocytic lymphohistiocytosis hyperinflammatory syndrome characterise surge cytokine include interleukin  il- describe case patient severe covid- pneumonia successfully treat tocilizumab humanised monoclonal antibody il- receptor uk early treatment day onset symptom tocilizumab reduce risk require non invasive invasive ventilation offer chance survival people fit escalation refuse ventilate potentially increase chance survival patient ventilate fail improve supportive treatment
614,pre exist health condition exacerbate severity coronavirus disease  covid- aim estimate case fatality rate cfr rate ratio rr patient hypertension hbp diabetes mellitus dm new york state obtain age specific number covid- confirm case death public report provide new york state department health age specific prevalence hbp dm behavioral risk factor surveillance system calculate cfr rr covid- patient hbp dm base report number death comorbidity divide expect number covid- case comorbidity perform subgroup analysis age calculate cfr rr age year respectively find old population high cfr elevated rr associate comorbiditie pronounced young population finding suggest elderly young population comorbidity consider vulnerable group
615,coronavirus situation covid- continue evolve question concern factor relate diffusion severity disease remain unanswered whilst opinion weight evidence risk factor study publish far inconclusive offer contrast result role comorbiditie risk adverse outcome patient affect covid- appear evident outset hypertension diabetes obesity discussion important factor affect severity disease air pollution consider play role diffusion virus propagation contagion severity symptom poor prognosis accumulate evidence support hypothesis environmental particulate matter pm trigger inflammatory response molecular cellular organ level sustain respiratory cardiovascular dysmetabolic disease well understand intricate relationship pre existing condition pm viral infection examine response molecular level td human breast adenocarcinoma cell expose different fraction pm td cell express receptor include aryl hydrocarbon receptor ahr ace main receptor sars cov- entry pm sample collect urban background site locate northern area city bologna emilia romagna region northern italy winter td cell expose organic aqueous inorganic extract final concentration  m -hour duration concentration exposure time choose resemble average outdoor exposure rna extract cell purify hybridise k microarray slide agilent list differentially express gene pm organic extract evaluate metacore enrichment analysis perform identify pathway map process network disease biomarker alter td treatment analysis modulate gene give evidence involvement pm dysmetabolic disease include diabetes obesity hypertension activation aryl hydrocarbon receptor ahr canonical pathway basis current knowledge exist datum exploratory experimental evidence tease likely molecular interplay ultimately tip disease outcome severity look ace additional key marker identify disruption target worsen pre existing condition and/or exacerbate adverse effect induce sars cov- infection whilst appropriately design epidemiological study need investigate association base hypothesis investigation review recent experimental epidemiological evidence speculate provide new insight possible role environmental pollution exacerbation effect sars cov- respiratory virus work intend assist development appropriate investigative approach protect public health
616,coronavirus disease  covid- rapidly expand worldwide short period relationship chronic comorbiditie unclear aim determine effect chronic comorbiditie clinical outcome patient covid- analysis patient suspicion viral respiratory disease sars cov- positive sars cov- negative january   national administrative healthcare open datum mexico sars cov- infection confirm reverse transcriptase polymerase chain reaction general characteristic chronic comorbiditie explore clinical outcome interest hospital admission pneumonia intensive care unit admission endotracheal intubation mortality prevalence chronic comorbiditie multivariate logistic regression analysis show effect age male sex bronchial asthma diabetes mellitus chronic kidney disease clinical outcome similar sars cov- positive negative patient adverse clinical outcome associate time symptom onset medical contact chronic obstructive pulmonary disease hypertension obesity sars cov- positive patient cardiovascular disease sars cov- negative patient p value comparison chronic comorbiditie commonly find patient suspicion viral respiratory disease knowledge impact comorbiditie adverse clinical outcome well define covid- patient high risk different impact specific type chronic comorbidity clinical outcome patient sars cov- infection require research finding need confirmation datum source
617,objective appraise effective predictor covid- mortality retrospective cohort study method total  covid- patient include  admit sino french new city branch training internal validation set randomly split ratio  admit optical valley branch external validation set wuhan tongji hospital include study clinical laboratory feature screen lasso method multi tree extreme gradient boost xgboost machine learning base model rank importance feature select lasso subsequently construct death risk prediction model simple tree xgboost model performance model evaluate auc prediction accuracy precision f score result feature include disease severity age level high sensitivity c reactive protein hs crp lactate dehydrogenase ldh ferritin interleukin- il- select predictor covid- mortality simple tree xgboost model conduct feature predict death risk accurately precision sensitivity f score training validation set conclusion propose disease severity age serum level hs crp ldh ferritin il- significant predictor death risk covid- help identify high risk covid- case key message machine learning method build death risk model covid- patient disease severity age hs crp ldh ferritin il- death risk factor finding help identify high risk covid- case
618,sars cov- cause lethal disease covid- public health emergency  global pandemic outbreak fast spread sars cov- high morbidity mortality specifically eld patient chronic disease diabetes mellitus arterial hypertension chronic kidney disease organ transplant patient immunosuppressive therapy preliminary result support different treatment chloroquine convalescent plasma infusion severe case good outcome hand efficacy supplementation active vitamin d immunomodulator hormone antiinflammatory antimicrobial effect unproven recent study report vitamin d attain antiviral effect block viral replication directly sars cov- primarily use immune evasion process infection envelope spike glycoprotein follow cytokine storm cause severe acute respiratory disease syndrome death sars cov- know angiotensin convert enzyme  protein spike host receptor enter alveolar myocardial renal epithelial cell disrupt vitamin d. correlation vitamin d level covid- death previous study insignificant retrospective study demonstrate correlation vitamin d status covid- severity mortality study find correlation study show vitamin d reduce risk acute viral respiratory tract infection pneumonia direct inhibition viral replication antiinflammatory immunomodulatory effect datum available today beneficial protective effect vitamin d unclear conflicting result large randomized control trial necessary test hypothesis review explain cross talk active vitamin d angiotensin convert enzyme summarize datum literature
619,worldwide coronavirus disease  covid- pandemic progress remain unknown disease article review association hypertension renin angiotensin system ras covid- correlation electrolyte disorder disease severity underlying hypertension likely associate severe critical covid- relationship clear owe confound factor angiotensin convert enzyme  ace play important role non classical ras pathway bind receptor bind domain severe acute respiratory syndrome coronavirus  sars cov- ras blockade know increase ace level controversy remain effect ras blockade therapy course covid- report indicate protective effect ras blockade covid- report association ras blockade therapy occurrence severe complication acute kidney injury admission intensive care unit electrolyte disorder uncommon patient covid- severe covid- frequently show hypokalemia hyponatremia hypocalcemia electrolyte imbalance cause alteration ras gastrointestinal loss effect proinflammatory cytokine renal tubular dysfunction invasion sars cov-
620,objective aim test hypothesis traditional japanese kampo medicine hochuekkito hochu ekki het preventive effect symptom covid- trial design study design multi center interventional parallel group randomized (: ratio investigator sponsor arm study participant thousand participant recruit healthy hospital worker  japanese university hospitals inclusion criteria age   year old time registration asymptomatic body temperature  degree c time registration capable eat orally exclusion criterion previous upper respiratory inflammation viral infection include suspect covid- take immunosuppressant allergic kampo medicine study history hypokalaemia severe hypertension severe liver dysfunction interstitial pneumonia regularly take kampo medicine pregnant possibly pregnant participate research judge unsuitable study doctor charge intervention comparator kampo group participant receive het  tablet  time day  week control group participant receive placebo dosage intervention group  tablet  time day  week placebo tablet identical appearance package het taste placebo different het ohsugi pharmaceutical co. ltd osaka japan manufacture placebo het main outcomes primary outcome number patient sars cov- rna ploymerase chain reaction pcr positive result symptom fever cough sputum malaise shortness breath -week study period include -week observation period oral administration secondary outcomes period infection onset period appearance symptom disappearance pcr positive number day appearance improvement symptom severe stage presence hospitalization shock stage icu management require mechanical ventilation shock vital failure organ(s lung safety endpoint include numbness hand and/or foot edema skin rash allergic symptom gastric discomfort randomisation patient randomized (: ratio group minimization implement electric data capture system datatrak enterprise cloud balancing arm age range  year age have history risk factor covid- cardiovascular disease hypertension diabetes respiratory disease blind masking participant randomized number randomised sample size main research hypothesis study kampo medicine significantly prevent onset covid- assume infection rate administration drug consideration incidence covid- -% symptom covid- assume pharmaceutical effect drug effective patient incidence rate placebo drug group respectively placebo calculate study drug frequency verification low number case large set total  analysis interim analysis final analysis number case time final analysis condition alpha power peto method set  case interim analysis estimate dropout rate .% finally total number case set placebo group het group trial status protocol version october rd recruitment start expect december st recruitment finish expect december st trial registration trial register japan registry clinical trials jrct jrcts  october protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
621,objective aim investigate clinical characteristic risk factor severe case coronavirus disease  covid- comparison non severe patient method search pubmed embase web science cnki collect relevant study publish july total  paper include meta analysis result severe covid- patient ci male ci  year old ci obese ci comorbiditie prevalent comorbiditie hypertension ci diabetes ci cardiovascular disease cvd ci common blood test abnormality elevate c reactive protein crp -% decrease lymphocyte count -% increase lactate dehydrogenase ci addition abnormal laboratory finding reveal organ dysfunction frequently observe severe case include decrease albumin ci increase aspartate aminotransferase ci alanine aminotransferase ci troponin troponin t tni tnt ci serum cr scr ci conclusion male elderly obese patient comorbiditie especially hypertension diabetes cvd likely develop severe case association hypertension diabetes cvd severity covid- decline increase age significant elevation cardiac tni tnt hepatic enzyme scr reduction lymphocyte elevated crp important marker severity specific attention give elderly male obese patient indication severe immune injury combination bacterial infection indication multi organ dysfunction damage
622,role antihypertensive especially renin angiotensin aldosterone system inhibitor debatable covid related severity outcome search global analysis antihypertensive medication relation sas cov- severity prescription datum worldwide association percentage use different type antihypertensive medication mortality rate sars cov- infection  week pandemic analyze random effect linear regression model  country worldwide high percentage prescribe angiotensin receptor blocker arb beta confidence interval ci p calcium channel blocker ccb beta ci p associate low -week sars cov relate death rate high percentage prescribe angiotensin convert enzyme inhibitor aceis beta ci p associate high -week death rate adjust age metformin use association prescribe beta blocker bbs diuretic diu -week death rate analyze combination drug antihypertensive user different country country low -week death rate angiotensin receptor blocker prescribe antihypertensive medication arb ccb beta ci p arb bb beta ci p finally country prescribe high potency arb low -week arb conclusion arb ccb protective effect death sars cov- infection
623,background coronavirus disease  covid- outbreak start february  control end march  daegu epicenter coronavirus outbreak korea aim study describe clinical course outcome patient covid- daegu method collaboration daegu metropolitan city korean center diseases control conduct retrospective multicenter cohort study demographic clinical treatment laboratory datum include viral rna detection obtain electronic medical record cohort database compare survivor non survivor univariate multi variable logistic regression method cox regression model perform kaplan meier analysis determine risk factor associate -day mortality release isolation patient result study laboratory confirm patient covid- total cohort diagnose february  july  include total cohort asymptomatic mild patient .% asymptomatic .% mild .%  moderate .%  severe  critical mortality patient cox regression hazard model patient available clinical information core cohort n show risk factor -day mortality age  hazard ratio hr p need o supply admission hr p fever degree c hr p diabetes hr p cancer hr p dementia hr p neurological disease hr p heart failure hr p hypertension hr p median duration release isolation  day interquartile range .- survivor cox proportional hazard model long duration isolation include severity age dementia conclusion overall asymptomatic mild patient approximately total cohort asymptomatic .% case fatality rate risk factor include old age need o supply dementia neurological disorder admission help clinician identify covid- patient poor prognosis early stage
624,objective study investigate quantify severity covid- infection high resolution compute tomography ct chest determine relationship clinical parameter study aim ct change clinical recovery progression disease cross sectional study perform july  august chest hrct clinical feature include laboratory confirm covid-  patient attend depertment radiology imaging bangabandhu sheikh mujib medical university bsmmu dhaka bangladesh study include clinical symptom comorbiditie patient hrct chest characteristic ct severity score collection require datum careful medical chest review clinical datum laboratory confirm patient compile tabulate study group  patient patient th th dacade mean age year study  patient male female average sex ratio male female prevalance clinical presentation study sample population distribute fever cough .% shortness breath sore throat common clinical manifestation patient .% symptom like headache chest tightne anosmia diarrhoea major comorbid condition diabet mellitus hypertension bronchial asthma chronic kidney disease ckd patient comorbid disease especially multiple high symptomatic presentation  patient patient co morbidity .% ptaient co existing disease accord hrct imaging severity score lung pathological change evaluate typical covid finding intermediate atypical normal chest ct finding patient symptomatic presentation find high .% ct severity index sympotomatic presentation less .% ct severity index ct severity index see patient .% patient .% patient .% patient positive ct finding prominent symptomatic co morbid patient hrct chest covid- patient major diagnostic prognostic importance clinical symptom patient directly correlate ct severity score ct imaging find useful predict clinical recovery patient progression disease
625,hypertension represent common pre existing condition comorbiditie coronavirus disease  covid- patient explore hypertension serve risk factor disease severity multi centre retrospective study conduct covid- patient total  consecutively hospitalise patient lab confirm covid- china enrol cohort logistic regression assess association hypertension likelihood severe illness adjustment confounder observe enrol patient exhibit pre existing hypertension admission severe covid- case occur individual hypertension hypertension vs. p hypertension associate increase risk severe illness modify demographic factor age sex hospital geological location blood pressure level admission attention treatment offer patient underlying hypertension usually old comorbiditie susceptible cardiac complication
626,objective conestat alfa recombinant human c esterase inhibitor multi target inhibitor inflammatory cascade include complement kinin kallikrein contact activation system study objective investigate efficacy safety conestat alfa improve disease severity short term outcome covid- patient pulmonary disease trial design study investigator initiate randomized (: ratio open label parallel group control multi center phase clinical trial participant trial conduct  hospital switzerland  hospital brazil  hospital mexico academic non academic patient confirm sars cov- infection require hospitalization  calendar day severe covid- screen study eligibility inclusion criteria sign informed consent age year evidence pulmonary involvement ct scan x ray chest duration symptom associate covid- /=  year obesity bmi  kg m history cardiovascular disease chronic pulmonary disease chronic renal disease c reactive protein mg l oxygen saturation rest breathe ambient air exclusion criterion incapacity inability provide informed consent contraindication class drug investigation c esterase inhibitor treatment tocilizumab il r il- inhibitor enrolment history suspicion allergy rabbit pregnancy breast feeding active anticipate treatment complement inhibitor liver cirrhosis child pugh score admission icu day anticipate  hour enrolment invasive non invasive ventilation participation study investigational drug  day prior enrolment enrolment study investigator family member employee closely relate dependent person intervention comparator patient randomize experimental arm receive conestat alfa addition standard care soc conestat alfa u follow  u  hour administer slow intravenous injection minute period i.e.  administration total conestat alfa treatment administer day enrolment control group receive soc soc treatment administer accord local institutional guideline include supplemental oxygen antibiotic corticosteroid remdesivir anticoagulation main outcomes primary endpoint trial disease severity day  enrolment assess adapt ordinal scale clinical improvement score  omit score   combine  limitation activity  death secondary outcome include time clinical improvement time randomization improvement point ordinal scale discharge hospital  day enrolment ii proportion participant alive having require invasive non invasive ventilation  day enrolment iii proportion subject acute lung injury define pao fio ratio  day enrolment exploratory outcome include virological clearance c esterase inhibitor pharmacokinetic change routine laboratory parameter inflammatory protein randomisation subject randomise ratio treatment conestat alfa addition soc soc randomization perform interactive web response system secutrial(r blind masking open label trial participant caregiver outcome assessor blind group assignment number randomised sample size randomise approximately  individual active treatment arm  soc group interim analysis   patient plan accord pocock adjusted level alphap result interim analysis allow adjustment sample size lehmacher wassmer trial status protect covid- protocol version july  participant recruitment start july  center basel switzerland participant include august  study center patient actively recruit participation fifth study center mexico anticipate mid december completion trial recruitment depend development sars cov- pandemic trial registration clinicaltrials.gov number nct register  june  protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
627,background aim covid  pneumonia commonly lead ards occurrence ards covid  patient think occur secondary exaggerated immunologic response meta analysis aim comprehensively study level immunological parameter patient covid material method perform systematic literature search pubmed europepmc scopus cochrane central database search term covid- interleukin outcome interest prognosis covid  patient result perform meta analysis  study high count cd cd lower levels tnf ilr il il observe patient good prognosis compare patient poor prognosis pg ml p p u ml p p pg ml p p pg ml p p pg ml p p respectively meta regression show age hypertension coefficient p significantly influence association il- poor outcome conclusion elevated immune response coronavirus occur covid  patient high count cd cd see patient good prognosis compare patient poor prognosis low level tnf ilr il il observe patient good prognosis compare patient poor prognosis
628,purpose recent outbreak covid- rapidly spread worldwide comorbid disease determinant severity covid- infection mortality aim study explore potential association chronic kidney disease ckd severity covid- infection method study include  consecutive adult patient male .% mean age year hospitalize diagnosis covid- tertiary level hospital datum collect electronic health record hospital patient separate group group include covid positive patient ckd stage group ii include covid positive ckd stage relationship examine ckd stage laboratory parameter mortality result significant difference determine group respect inflammation parameter parameter prognosis group ii statistically significantly high rate determine comorbid disease hypertension p diabetes mellitus p acute kidney injury aki find associate mortality p mortality p multivariate regression analysis ckd stage aki male gender hypertension dm malignancy find significant independent variable increase mortality conclusion prevelance ckd stage admission associate high risk hospital mortality patient covid- close follow recommend patient reduce glomerular filtration rate gfr
629,coronavirus disease  covid- pandemic challenge healthcare system time excellent catalyzer promoter successful translational research covid- simple viral infection bronchial system pandemic hyperinflammatory multiorgan disease cardiovascular system play causal role context severe acute respiratory syndrome coronavirus  sars cov- invade host cell angiotensin convert enzyme  ace- enzyme renin angiotensin system furthermore cardiovascular comorbiditie risk factor hypertension diabetes obesity play important role severity course disease additional risk factor gender age genetic air pollution modulate severity sars cov infection cardiovascular disease sequelae covid- increase thrombosis myocardial infarction myocardial inflammation vasculitis occur directly damage cardiovascular system substantially contribute high morbidity mortality knowledge gain study course disease patient infect sars cov lead improve treatment possibility second wave partly standardized particular adapt complication cardiovascular system review provide short overview pathophysiology sars cov general specifically cardiovascular system furthermore summarize current treatment approach pathophysiological principle status november
630,severe coronavirus disease  covid- characterize systemic hyper inflammation acute respiratory distress syndrome multiple organ failure cytokine storm refer set clinical condition cause excessive immune reaction recognize lead cause severe covid- comparison covid- cytokine storm kind cytokine storm hemophagocytic lymphohistiocytosis cytokine release syndrome pathogenesis cytokine storm clearly elucidate recent study show impaired response type- ifns early stage covid- infection play major role development cytokine storm cytokine il- il- involve severe covid- furthermore clinical evidence indicate importance anti inflammatory therapy severe covid- approach currently treat observe cytokine storm associate covid- expectation especially high new cytokine target therapy tocilizumab anakinra baricitinib number study conduct anti inflammatory treatment severe covid- specific recommendation drug patient review provide overview cytokine storm covid- treatment currently address addition discuss potential therapeutic role extracorporeal cytokine removal treat cytokine storm associate covid-
631,coronavirus disease  covid- emerge mid december  rapidly spread worldwide conduct retrospective analysis datum patient covid- construct simple risk prediction score implement prehospital setting patient classify critical non critical group base disease severity hospitalization multivariate analysis perform identify independent risk factor develop risk prediction score total  patient include study median age critical group significantly old non critical group year respectively percentage male critical group high non critical group .% .% respectively multivariate analysis reveal factor age  year male sex comorbiditie hypertension cancer have fever dyspnea admission independently associate critical covid- infection critical event note patient total risk factor score /=  likely critical covid- infection risk prediction score useful identify critical covid- infection
632,disease covid- novel coronavirus pandemic far infect million result death million people oct infect covid- mild symptom rest infected case severe symptom result significant mortality age emerge major factor predict severity disease mortality rate significantly high elderly patient patient underlying condition like type  diabetes cardiovascular disease hypertension cancer increase risk severe disease death covid- infection obesity emerge novel risk factor hospitalization death covid- independent study observe people obesity great risk severe disease death covid- review publish datum relate obesity overweight assess possible risk outcome covid- patient base body weight explore obese host provide unique microenvironment disease pathogenesis result increase severity disease poor outcome
633,background limited information association upper respiratory tract urt viral load host factor disease severity sars cov infected patient method study  patient mean age  year diagnose polymerase chain reaction pcr urt viral load measure pcr cycle threshold categorize high moderate low result  patient comorbiditie  patient .% high  moderate  .% low viral load univariate analysis compare patient moderate low viral load patient high viral load old comorbiditie develop symptomatic disease covid- intubate die patient high viral load long stay intensive care unit long intubation compare patient low viral load p value comparison patient chronic cardiovascular disease hypertension chronic pulmonary disease immunosuppression obesity chronic neurological disease high viral load p value comparison multivariate analysis high viral load associate covid- level viral load associate outcome conclusion urt viral load identify patient high risk morbidity severe outcome
634,background coronavirus disease  covid- infection cause alteration coagulation mechanism conditioning thrombotic phenomenon acute limb ischemia ali manifestation infection aim study describe clinical surgical characteristic group patient infect severe acute respiratory syndrome coronavirus  present ali context covid- pandemic lima peru method multicenter observational retrospective study perform general hospital march july variable consider pathological history associated habit laboratory test severity covid- infection ali anatomic location lesion treatment evolution discharge condition result thirty patient ali infect covid- evaluate mean age   year condition frequent man main comorbiditie arterial hypertension .% obesity diabetes mellitus  .% asymptomatic patient manifestation ali rutherford iia iib stage include .% patient frequent location thrombosis low limb vs. .% thrombectomy perform .% patient amputation primary secondary perform patient mortality rate acute respiratory distress syndrome conclusion ali vascular pathology associate embolic thrombotic process covid- infection cause severe alteration coagulation mechanism lead patient present severe acute arterial complication thrombosis associate manifestation report young cohort describe study high frequency amputation despite adequate surgical treatment
636,background angiotensin convert enzyme  ace identify entry receptor coronaviruse human cell include severe acute respiratory syndrome coronavirus  sars cov- cause coronavirus disease  covid- hypertension ht lead comorbidity non survivor covid- test association ace gene ht interaction specific pre existing condition know associate covid- severity method genetic analysis ace gene conduct french canadian fc british population result fc individual t allele single nucleotide polymorphism rs ace gene risk factor ht adult obese male odd ratio confidence interval ci obese male smoke ci lean male non smoker male female t allele significantly associate severity ht early penetrance ht obese smoking male significant interaction t allele obesity present sex association ace rs genotype blood pressure see adolescent interaction obesity present female variant ace gene find associate ht obese smoke male british individual uk biobank addition observe severe outcome covid- association ace risk allele obese smoke male conclusion report ace variant associate early penetrance severe ht severe outcome covid- obese smoking male
637,background coronavirus disease  covid- pandemic disease spread world arouse global concern increase mortality reveal severity important distinguish severe patient provide appropriate treatment care prevent damage diabetes report common comorbidity covid- patient associate high mortality attempt clarify relationship diabetes covid- patient severity aim determine role type  diabetes covid- patient method study relationship diabetes covid- retrospectively collect  patient datum tertiary medical center wuhan patient diagnose laboratory confirm covid- admit center february  march patient age sex laboratory test chest compute tomography finding capillary blood glucose bg treatment collect analyze fisher exact test categorical datum univariate multivariate logistic regression explore relationship clinical characteristic patient severity result  patient comorbidity type  diabetes hypertension heart disease .% respectively diabetic group relate invasive treatment p severe status p univariate logistic regression history diabetes p hypertension p hepatic dysfunction p predictor patient severity heart disease p large lung involvement p slightly exacerbate patient condition multivariate analysis diabetes p hepatic dysfunction p risk factor severe patient diabetic patient show elevate bg .% preprandial test .% postprandial test reveal limited control glycemia covid- patient conclusion history type  diabetes correlate invasive treatment severe status suboptimal glycemic control hepatic dysfunction negative effect severity status lead exacerbation covid- patient
638,background severe acute respiratory syndrome coronavirus  sars cov- cycle threshold ct suggest approximate measure initial viral burden utility cycle threshold admission predictor disease severity thoroughly investigate method finding conduct retrospective study sars cov- positive hospitalize patient // // sars cov- ct datum  hour admission n patient complete survival datum discharge n die hospital n include analysis laboratory demographic clinical datum extract electronic medical record multivariable logistic regression apply examine relationship patient mortality ct value adjust establish risk factor ct analyze continuous variable subdivide quartile well illustrate relationship outcome cumulative incidence curve create assess survival difference setting compete risk death versus patient discharge mean ct admission high survivor sd compare non survivor sd p hospital mortality significantly differ p ct quartile adjust age gender bmi hypertension diabetes increase cycle threshold associate decrease odd hospital mortality ci p compare th quartile patient ct value st quartile ct nd quartile ct .- adjust odd ratio hospital mortality respectively p discriminative ability ct predict inpatient mortality find limit possess area curve auc ci conclusion sars cov- ct find independent predictor patient mortality study need well clinically utilize information give result variation specimen quality phase disease limited discriminative ability test
639,covid- study africa understand clinical profile management covid- help plan well prevention treatment strategy take local context consideration study describe clinical profile treatment outcome covid- patient covid- treatment center ethiopia boru meda hospital institution base retrospective cross sectional study carry medical record covid- patient admit boru meda hospital positive reverse transcription rt)-pcr result  september patient positive rt pcr admit hospital regardless symptom severity status total  covid- patient include final analysis median age patient  year interquartile range majority .% male quarter n .% patient symptomatic cough n .% fever n .% common symptom symptomatic patient  .% mild .% moderate  .% severe .% critical case fatality rate .% hypertension age old  year hiv aids significantly associate symptomatic infection study covid- patient asymptomatic proportion severe critical patient symptom high study need assess effect hiv aids severity mortality covid-
640,introduction determine profile covid- patient low pulse hemoglobin saturation oxygen spo help clinician identify poor prognosis aim identify compare clinical biological radiological datum algerian patient hospitalize covid- divide accord spo measure admission rest ambient air method prospective study carry algerian patient hospitalize covid- period march  april general characteristic patient clinical biological radiological datum determine result  patient include study g spo g spo  year vs. .% p=. have arterial hypertension vs. .% p=. cancer vs. .% p=. anemia vs. .% p=. leukocytosis vs. .% p=. biological inflammatory syndrome vs. p=. hyper uremia vs. .% p=. hyper creatininaemia vs. .% p=. tissue damage vs. .% p=. diffuse ground glass opacity vs. .% p=. band condensation vs. .% p=. severe extension vs. .% p=. include few patient complain diarrhea vs. .% p=. have nodular ground glass vs. .% p=. slight extension vs. .% p=. conclusion criterion associate low spo hospitalize covid- patient advanced age history arterial hypertension cancer high frequency certain biological abnormality radiological sign diarrhea symptom radiological appearance nodular ground glass slight extension radiological lesion appear protective element
641,retrospective match cohort study describe  solid organ transplant sot patient coronavirus disease  covid- match  non sot patient control group base age body mass index bmi comorbiditie hypertension diabetes mellitus hemoglobin ac .% sot group high proportion cardiovascular disease p index hospitalization significant difference regard disease severity critical care need mechanical intubation vasopressor renal replacement therapy  day  patient die sot group  patient die control group p nineteen patient receive tocilizumab sot group compare  patient control group patient interleukin- il- soluble interleukin- receptor level increase tocilizumab interleukin- il- level decrease tocilizumab overall sot patient comparable mortality non sot patient numerically sot patient receive tocilizumab vs steroid vs large multi center study need ascertain finding lastly complex cytokine release syndrome covid- remain area intense research analysis key interleukin level il- il- silr study contribute understanding process
642,introduction coronavirus infectious disease  covid- currently important public health crisis affect global human population continue spread widely world lack specific treatment vaccine virus scenario covid- yemen obscure lack adequate datum develop electronic questionnaire distribute online yemeni people aim study understand covid- epidemiological situation yemen well currently limited publish datum limited availability covid- testing methodology -question web base survey distribute social medium outlet target people yemen datum aggregation analysis visualization perform tableau microsoft excel result individual report symptom concern covid- infection .% report chronic medical condition diabetes hypertension asthma immune deficiency associate increase severity disease obesity cardiovascular disease kidney disease liver disease  individual .% confirmatory covid- pcr test presence high fever dyspnea chest pain dysphagia symptom tend correlate bad clinical outcome conclusion study provide important information early overspread covid- yemeni community june july show online questionnaire help collect datum pandemic resource limit country testing availability limited
643,objective recently influential article report association hydroxy)chloroquine angiotensin convert enzyme ace inhibitor coronavirus disease  covid- mortality retract significant methodological issue aim analyze clinical issue improved research method find difference retract paper systematically pre existing literature compare result retract paper gain novel insight materials method extract common risk factor identify retract paper conduct relevant publication search june  pubmed analyze risk factor covid- mortality compare retract paper result systematic review demonstrate demographic clinical risk factor covid- mortality similar retract paper retract paper indicate hydroxy)chloroquine monotherapy combination therapy macrolide associate high risk mortality study show combination therapy hydroxychloroquine macrolide associate high risk mortality odd ratio confidence interval .- addition study demonstrate use ace inhibitor angiotensin receptor blocker arb associate reduce risk mortality conclusion analyze clinical issue retract paper systematic review randomized control trial relevant cohort study find hydroxy)chloroquine monotherapy associate high risk mortality use ace inhibitor arb associate reduce risk mortality covid- patient
644,background vitamin k concentration inversely associate clinical severity covid- objective cohort study determine regular use vitamin k antagonist vka prior covid- associate short term mortality frail old adult hospitalize covid- method eighty patient consecutively hospitalize covid- geriatric acute care unit include association regular use vka prior covid- survival  day covid- examine propensity score weight cox proportional hazard model accounting age sex severe undernutrition diabetes mellitus hypertension prior myocardial infarction congestive heart failure prior stroke and/or transient ischemic attack chads vasc score bled score egfr result  patient mean sd age year woman  survive covid- day   die group difference baseline despite trend frequent use vka survive day  versus .% p consider vka reference hazard ratio hr hr -day mortality regularly vka ci consistently covid- patient vka regular basis short survival time p conclusion regular use vka associate increase mortality day  hospitalize frail elderly patient covid-
645,introduction obesity diabetes hypertension age point factor influence progression covid- evidence condition inconclusive objective identify clinical characteristic relate covid- severity determine age act modifier relationship cardio metabolic comorbiditie cmc covid- progression method datum -year old confirm case n analyze hospitalization development pneumonia intubation requirement intensive care unit admission death dependent variable poisson regression model estimation interaction age different cmc independent variable result have cmcs comorbiditie directly relate covid- progression chronic obstructive pulmonary disease relate increase risk die risk covid- severity low age advanced asthma smoking risk factor progression covid- conclusion mexican population risk covid- progression associate comorbiditie high young adult
646,objective investigate potential influence racial difference outcome patient infect coronavirus disease patient require intensive care urban hospital design retrospective cohort study setting henry ford health system multidisciplinary icu total  bed spread hospital detroit mi patient obtain datum electronic medical record adult severe acute respiratory syndrome coronavirus positive patient manage icu henry ford hospital detroit mi march july include patient divide group people color include black asian hispanic latino arab white intervention measurement main result total  patient evaluate  black .%  white .% asian .% hispanic latino .% seven arab .% people color young vs p equal distribution sex people color coronary artery disease vs  p self report use regular alcohol consumption vs  p whites difference diabetes vs  p hypertension vs  p congestive heart failure vs  p chronic kidney disease vs  p difference icu length stay people color d ci d whites d ci d p frequency .% vs .% p ns median time mechanical ventilation people color d ci d whites d ci d p different overall  patient die hospital -day mortality low people color .% versus whites .% adjust odd ratio p increase median survival time people color d versus whites d hazard ratio p inhospital mortality low people color versus white difference statistically significant vs  respectively p finally significant difference day symptom prior admission frequency present symptom frequency severity acute respiratory distress syndrome group conclusion critically ill patient infect coronavirus disease people color low -day mortality whites difference hospital mortality icu length stay rate intubation finding contrary previously hold belief surround pandemic
647,objective intend identify probable risk factor responsible severity covid- meta analysis method literature exploration last  april  pubmed google scholar embase cochrane library identify  pertinent publication paraphrase outcome autonomous research perform random effect meta analysis result total  patient information extract select literature find gender male risk ratio rr confidence interval ci hypertension rr ci diabetes rr ci fatigue myalgia rr ci smoking history rr ci potential risk factor severity covid- find fever rr ci cough ci diarrhoea rr ci insignificant risk factor covid- severity conclusion finding research beneficial identify patient high risk provide additional medical attention beginning treatment
648,covid- virus name severe acute respiratory syndrome coronavirus  sars-- cov- pandemic disease characterize respiratory infection cause coronavirus spread worldwide outbreak begin wuhan china december sars cov- infect  million people globally disease severity mortality increase patient heart relate comorbiditie cardiovascular disease patient susceptible infect sars cov- early screening management patient prevent ameliorate adverse outcome treatment combat effect previously see mers sars review cover association cardiovascular disease covid show cardiovascular disease common patient covid- increased attention highlight gap pay care unique group patient
649,widely recognize hypertension major risk factor disease severity mortality patient coronavirus disease  covid- type  diabetes mellitus tdm hypertension frequent comorbid condition complicate assessment hypertension individual contribution risk aim study evaluate contribution hypertension tdm combination risk death acute respiratory distress syndrome ards)/respiratory failure severe covid- infection additionally assess risk associate elevated blood pressure fast blood glucose clinical outcome multivariate logistic model analysis  patient .% survive .% die compare patient have hypertension tdm n risk mortality significantly high patient tdm n ci tdm combination hypertension n ci similarly tdm risk factor development ards respiratory failure severe infection hypertension n confer additional risk development severe infection ci conclusion hypertension elevated blood pressure independent risk factor death ards respiratory failure hypertension marginally increase risk severe covid- infection risk associate hypertension accentuate confounding effect tdm
651,diagnosis severe acute respiratory syndrome coronavirus  sars cov- case base count real time reverse transcription plymerase chain reaction rt pcr positive people viral load real time rt pcr suggest biomarker sars cov- infection association viral load severity disease resolve nasopharyngeal sample  patient test rt pcr sars cov- diagnosis relative quantitation comparative threshold cycle deltadeltact formula orfab viral rnase p housekeeping gene absolute viral load calculate reference positive control prevalent clinical sign cough .% myalgia .% fever hypertension .% neurological disease .% asthma hypothyroidism .% frequent comorbiditie fever exclusive symptom combine associate high viral load  c t range .- log rna copy test week onset symptom mild patient  year old detect peak viral load child  year old high viral load  day postinfection sharp decline case   year old show low moderate viral load  day postinfection range patient  year old high viral load second week onset symptom range .- indicate long presence virus finding suggest viral load nasopharyngeal swab help monitor sars cov- infection mild coronavirus disease  case
652,discover entry receptor severe acute respiratory syndrome coronavirus sars cov protein call angiotensin convert enzyme  ace protein present number cell type include respiratory tract soon emergence sars cov- responsible disease covid- scientist find ace new coronavirus infect cell open interesting possibility explain striking variation risk catch die covid- well recognise high risk illness old young people man woman pre existing comorbiditie hypertension cardiovascular disease way ace protein contribute variation obvious ace entry point virus infect cell e.g. old people man evidence small partly easy obtain representative healthy tissue alternatively relate ace membership family protein end protein anchor inside cell protein protrude outside cell shed cleave protease cell membrane review current evidence theory ace role sars cov- infectivity covid- severity
653,introduction covid- present benign form young patient frequently present anosmia infant rarely infect severe form occur patient  year age comorbiditie include hypertension diabetes lymphopenia eosinopenia thrombopenia increase lactate dehydrogenase troponin c reactive protein d dimer low zinc level associate severity area cover author review literature provide overview current state knowledge natural history therapeutic option covid- expert opinion diagnosis rely pcr clinical presumption discrepancy clinical symptom oxygen saturation radiological sign ct scan pulse oximetry radiological investigation systematic disease evolve successive phase acute virological phase patient cytokine storm phase uncontrolled coagulopathy acute respiratory distress syndrome therapeutic option include antiviral oxygen therapy immunomodulator anticoagulant prolonged mechanical treatment early diagnosis care implementation antiviral treatment use immunomodulator later stage quality intensive care critical mortality rate high mortality observe western country remain unexplained pulmonary fibrosis occur patient future unpredictable
654,large country variation covid- death rate partly explain diet country low covid- death rate common feature eat large quantity fermented vegetable cabbage continent spice fermented vegetable spice agonist antioxidant transcription factor nuclear factor erythroid derive  nrf spice transient receptor potential ankyrin  vanillin  trpa v agonist mechanism explain covid- symptom severity appear synergy nrf trpa v food explain role diet covid- mechanism covid- appear oxygen specie ros)-mediate process synergy trp channel modulate nrf pathway spicy food likely desensitize trp channel act synergy exogenous antioxidant activate nrf pathway
655,background scarcity datum consequence coronavirus disease- covid- infection kidney transplant recipient ktrs emerge country method present cohort study  transplant center india include  ktr living  deceased donor polymerase chain reaction confirm covid- positivity march september detail demographic immunosuppression regimen clinical profile treatment outcome result median age transplant recipient  year recipient present median year transplant common comorbiditie include arterial hypertension diabetes present symptom time covid- include fever cough sputum production clinical severity range asymptomatic mild moderate severe strategy modify immunosuppressant include discontinuation antimetabolite change calcineurin inhibitor steroid risk factor mortality include old age dyspnea severe disease obesity allograft dysfunction covid- infection acute kidney injury high level inflammatory marker include c reactive protein interleukin- level procalcitonin chest x ray abnormality intensive care unit ventilator requirement overall patient mortality .% hospitalize patient intensive care unit patient .% patient require ventilation ktr mild covid- symptom n manage outpatient optimize utilization scarce resource covid- pandemic conclusion mortality rate covid positive ktr appear high nonimmunosuppressed patient high mortality note require intensive care ventilator
656,background prognosis patient covid- infection uncertain derive validate new risk model predict progression disease severity hospitalization admission intensive care unit icu mortality patient covid- infection gal covid- score method retrospective cohort study patient covid- infection confirm reverse transcription polymerase chain reaction rt pcr galicia spain datum extract electronic health record patient include age sex comorbiditie accord international classification primary care code icpc- logistic regression model estimate probability disease severity calibration discrimination evaluate assess model performance result incidence infection  patient total  patient .% require hospitalization  .% admit icu  .% die variable include model predict severity include age gender chronic comorbiditie cardiovascular disease diabetes obesity hypertension chronic obstructive pulmonary disease asthma liver disease chronic kidney disease haematological cancer model demonstrate fair good fit predict hospitalization auc area receiver operating characteristic roc curve confidence interval ci admission icu auc ci death auc ci conclusion gal covid- score provide risk estimate predict severity covid- patient ability predict disease severity help clinician prioritize high risk patient facilitate decision making health authority
657,purpose severe acute respiratory coronavirus  sars cov- case overgrow globally pandemic meta analysis conduct evaluate impact age sex comorbiditie clinical characteristic severity covid- help diagnose evaluate current outbreak clinical decision making method pubmed sciencedirect bmc search collect datum demographic clinical characteristic comorbiditie covid- patient meta analysis conduct review manager publication bias assess egger test begg mazumdar rank correlation result study include meta analysis include  patient sars cov- infection male case case age year p /= year associate p severity covid- presence comorbidity hypertension diabetes cerebrovascular disease cardiovascular disease respiratory disease malignancy chronic kidney disease chronic liver disease individually increase severity covid- case significantly p  publication bias find case age /= year age>/= year comorbiditie clinical manifestation conclusion male patient elderly old patient age /= year high risk develop severity comorbiditie clinical manifestation significantly affect prognosis severity covid-
658,severe acute respiratory syndrome coronavirus  sars cov- infection able produce excessive host immune reaction lead severe disease- life threaten condition occur patient suffer comorbiditie hypertension diabetes obesity infection human corona virus highly depend host microrna mir involve regulation host innate immune response inflammation modulatory mir mirs induce immune reaction virus recent analysis show mir- predict target sars cov- genome dominant regulator toll like receptor tlrs downstream signal mir limit excessive inflammatory response virus downregulation circulate mir find diabetes obesity hypertension reflect enhanced inflammation fibrosis systemic effect accompany severe covid- hypothesize mir deficiency contribute severe covid- state observe diabetes obesity hypertension investigation need
659,aim meta analysis provide summary odd ratio estimate association treatment vs. renin angiotensin system blocker risk severe acute respiratory syndrome coronavirus- sars cov- infection coronavirus disease  covid- severity include case fatality patient hypertension patient irrespective hypertension method result pubmed embase web science google scholar ssrn search   august non randomized observational covid- study event patient number extract compare angiotensin convert enzyme ace inhibitor angiotensin receptor blocker arb treatment separately treatment drug outcome likelihood sars cov- infection ii covid- severity include hospitalization intensive therapy unit itu ventilation iii case fatality risk bias assess robins random effect meta analysis estimate pool eighty study include  patient  hypertension analyse patient hypertension ace inhibitor arb treatment associate great likelihood sars cov- infection  patient ci hospitalization  patient .- itu  patient .- ventilation itu ventilation death  patient case fatality  patient  death conclusion angiotensin convert enzyme inhibitor arb appear safe context sars cov- infection discontinue prospero registration number crd
660,objective emergence coronavirus disease covid- death toll increase daily risk factor associate high mortality rate covid- establishment common pathway risk factor improve understanding covid- severity mortality review aim establish common pathway possible effect covid- mortality material method current review execute consecutive stage start determine risk factor covid- mortality try find common pathway depend available literature follow propose mechanism explain common pathway increase mortality finally potential role manage covid- propose result review identify common pathway low baseline reduce glutathione i.e. gsh level particular review provide depth discussion pathophysiology covid- lead gsh depletion tissue damage acute respiratory distress syndrome addition current review demonstrate gsh depletion result failure immune system render end organ vulnerable damage oxidative stress conclusion preclinical study show gsh depletion central role covid- mortality pathophysiology elevate gsh level tissue decrease severity mortality rate covid-
661,-year old male history primary hypertension present emergency department tertiary care hospital pakistan complaint fever cough shortness breath test positive severe acute respiratory syndrome coronavirus  sars cov- polymerase chain reaction bilateral infiltrate find chest x ray admission oxygen saturation room air immediately non invasive ventilation laboratory investigation reveal elevate d dimer international normalize ratio total leukocyte count c reactive protein markedly elevate mg l indicate state cytokine release syndrome crs treatment start antibiotic prophylactic enoxaparin -mg subcutaneous daily methyl prednisone  mg bd multivitamin intravenous tocilizumab tcz  mg kg start day  address crs day complain pain right low limb sign hypothermia numbness slight blackening right foot peripheral pulse palpable vascular ultrasound show vascular flow popliteal anterior posterior tibial dorsalis pedis artery vascular surgery department declare limb unsalvageable right limb knee amputation day right foot blacken atrophy extend knee knee amputation discharge rivaroxaban  hour observation conclude heparin effective treat coronavirus disease -associate coagulopathy tcz simultaneously decrease severity crs case suggest concomitant use tcz anticoagulation therapy beneficial patient present arterial venous thrombosis
662,objective analyze association d dimer level inflammatory indicator cytokine abnormality disease severity covid- severe critical type patient method medical record  patient collect single center wuhan february  march patient divide severe type group patient critical type group patient level d dimer wbc anc pct hscrp il r il- il- tnf alpha compare patient different clinical type covid- infection change cytokine analyze patient different d dimer level level d dimer il r il- il- tnf alpha anticoagulant therapy assess statistical analysis perform student t test mann whitney u test chi square test result  patient  man .%  woman .% median patient age  y. age critical type patient .+/- y high severe type patient .+/- y difference significant t=- p=. proportion critical type patient chronic disease especially hypertension cardiovascular disease cerebrovascular disease high compare severe type patient difference significant p prevalence dyspnea sweat fatigue symptom critical type patient high severe type disease difference significant chi()=. p level d dimer wbc anc pct hscrp il- critical type patient high severe type patient difference significant p level il r il- tnf alpha patient abnormal d dimer high compare patient normal d dimer level difference significant p patient treat prophylactic anticoagulation level d dimer il r il- il- anticoagulant therapy low treatment conclusion covid- critical type patient coagulation immune dysfunction dynamic monitoring d dimer cytokine level help identify critical type patient early possible anticoagulant therapy improve patient condition correct coagulation immune dysfunction
663,covid- public health emergency international concern million confirm case globally include indonesia thousand confirm case date covid- covid- wide clinical manifestation range asymptomatic acute respiratory illness respiratory failure necessitate mechanical ventilation support icu mods comorbiditie demonstrate associate development severe outcome covid- infection hypertension diabetes cardiovascular disease dyslipidemia thyroid disease pulmonary disease severe covid- associate increase plasma concentration il- result cytokine storm tocilizumab interleukin- inhibitor alleviate cytokine storm prevent significant lung organ damage improve clinical outcome tocilizumab promising therapy severe covid- limited study efficacy covid- patient especially control group like report experience tocilizumab treatment severe covid- patient indonesia indonesia good knowledge
664,objective measure association race ethnicity comorbiditie insurance status need hospitalization symptomatic emergency department ed patient severe acute respiratory syndrome coronavirus  sars cov- infection method study retrospective case series symptomatic patient present single ed laboratory confirm sars cov- infection march -august collect patient level information demographic public insurance status medicare medicaid comorbiditie level care mortality structured chart review compare demographic comorbiditie patient able convalesce home require admission general medical service require admission intensive care unit icu die  day index visit multivariable logistic regression analysis perform report adjusted odd ratio aor associated confidence interval ci hospital admission versus ed discharge home result total  patient present ed symptom include analysis  .% patient require hospital admission  patient require icu care patient require admission likely black african american hispanic latino public insurance medicaid medicare multivariable logistic regression analysis compare patient require hospital admission african american race aor ci hispanic ethnicity aor ci .- associate need admission public insurance medicaid aor ci medicare aor ci medicaid medicare aor ci presence hypertension aor ci diabetes aor ci obesity aor ci heart failure aor ci hyperlipidemia aor ci .- identify independent predictor hospital admission conclusion comorbiditie public insurance predictor severe illness patient sars cov- study suggest disparity severity see covid- african americans hispanics likely closely relate low socioeconomic status chronic health condition reflect independent predisposition disease severity
665,south korea confirm case coronavirus  covid- detect january month number confirm case surge community transmission occur local hospital experience severe shortage medical resource mechanical ventilator extracorporeal membrane oxygenation ecmo equipment medical claim datum covid- confirm patient study examine demand major medical resource medication change outbreak subsequent stabilization period covid- south korea aim investigate underlie disease demographic factor affect disease severity finding reveal risk treat mechanical ventilator ecmo critical condition twice high man previous history hypertension diabetes psychiatric disease increase risk progress critical condition odds ratio ci respectively chronic pulmonary disease significantly increase risk severity illness patient charlson comorbidity index score /= treat outbreak area increase risk develop critical condition respectively result help clinician predict demand medical resource spread covid- infection identify patient likely develop severe disease
666,objective aim describe epidemiological clinical characteristic patient covid- saudi arabia severity group method datum  patient extract medical record infectious disease center prince mohammed bin abdul aziz hospital riyadh patient basic information laboratory test result sign symptom medication prescribe comorbiditie outcome datum collect analyze descriptive datum report examine distribution study variable severe severe group result  include patient  .% classify severe  .% severe .% patient aged   year patient severe condition non saudi chronic condition history tend chronic condition compare severe disease diabetes hypertension thyroid disease significantly high patient severe disease death report .% severe patient  .% patient remain hospital severe group conclusion severe case likely comorbiditie diabetes hypertension thyroid disorder common compare non severe case
667,coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- represent public health crisis major proportion advanced age male gender presence comorbiditie emerge risk factor severe illness death covid- observation study hypertension common comorbiditie patient covid- hypertension show associate increase risk mortality acute respiratory distress syndrome need intensive care unit admission disease progression covid- patient present time precise mechanism hypertension lead severe manifestation disease patient covid- remain unknown review aim present biological plausibility link hypertension high risk covid- severity emphasis give role renin angiotensin system inhibitor give crucial role system play viral transmissibility pathophysiology arterial hypertension describe importance immune system dysregulate hypertension sars cov- infection potential involvement multifunctional enzyme dipeptidyl peptidase  dpp addition angiotensin convert enzyme  ace contribute sars cov- entrance target cell role hemodynamic change hypertension aggravate myocardial injury setting covid- include endothelial dysfunction arterial stiffness leave ventricle hypertrophy discuss
668,objective study describe clinical characteristic outcome adult coronavirus disease  covid- patient admit pediatric intensive care unit picu assessment respiratory clinical severity outcome care pediatric intensivist utilize specific care process conduct retrospective cohort study adult patient admit -bed picu quaternary referral center covid- surge boston april june total  adult admit  test covid- positive  test covid- negative covid positive patient  male  .% identify hispanic latino comorbiditie patient include diabetes mellitus .% hyperlipidemia .% hypertension .% .% require mechanical ventilation low median ratio arterial oxygen partial pressure fractional inspired pressure median peak positive end expiratory pressure peep  cmho  .% undergo optimal peep maneuver patient prone median day  patient extubate  require reintubation tracheostomy perform  patient  extubation failure  prolonged mechanical ventilation weakness renal replacement therapy require  patient  mortality report detailed clinical outcome adult patient care intact pediatric critical care team covid- pandemic good clinical outcome support adult critical care colleague dedicated operational process possible
669,hypertension identify risk factor coronavirus disease  covid- associate adverse outcome study examine association preinfection blood pressure bp control covid- outcome datum  general practice england eligible patient adult hypertension test diagnose covid- bp control define recent bp reading  month index date january bp define control mm hg primary outcome death  day covid- diagnosis secondary outcome covid- diagnosis covid relate hospital admission multivariable logistic regression examine association bp control outcome  patient mean age  year .% male include  .% control bp patient old comorbiditie diagnose hypertension long total  patient .% diagnose covid-  die  day individual stage  uncontrolled bp low odd covid- death odd ratio ci compare patient control bp association bp control covid- diagnosis hospitalization finding suggest bp control associate bad covid- outcome possibly patient have advanced atherosclerosis target organ damage patient need consider adhere strict social distancing limit impact covid- future wave pandemic occur
670,objective association angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb use coronavirus disease  covid- remain controversial aim investigate impact acei arb use cause mortality severe covid- patient hypertension method enrol  covid- patient changsha wuhan city  january   march demographic clinical characteristic outcome collect multivariable analysis propensity score matching perform assess impact acei arb therapy mortality result  patient  severe covid- concomitant hypertension analyze average age  year  .% man  acei arb user  hospital death mortality rate .% male sex odd ratio confidence interval ci acei arb use ci independent risk factor mortality severe covid- patient hypertension propensity score matching  severe covid- patient include significant correlation use acei arb mortality observe conclusion significant association acei arb use mortality severe covid- patient hypertension finding support continuation acei arb therapy patient
671,background aim aim investigate factor affect mortality patient age  year old hospitalize diagnosis new coronavirus pneumonia covid- material method retrospective study patient  year old old covid- hospitalize istanbul university cerrahpasa cerrahpasa medical faculty hospital march  demographic clinical treatment laboratory datum extract electronic medical record univariate multivariate logistic regression method explore risk factor hospital death result total  patient man  woman include  discharge  die hospital univariate analysis clinical feature laboratory variable find significantly different i.e. p multivariate logistic regression analysis following independently associate mortality present malignancy odd ratio confidence interval ci p dyspnea ci p neutrophil lymphocyte ratio nlr ci p high value c reactive protein crp ci p lactate dehydrogenase ldh ci p creatinine level ci p oxygen saturation spo value admission ci p azithromycin use ci p conclusion presence malignancy symptom dyspnea high nlr high crp ldh creatinine level low spo admission predict mortality hand azithromycin use find protective mortality know cause predict mortality important treat future case successfully
672,witness unparalleled pandemic cause novel severe acute respiratory syndrome coronavirus  sars cov- associate coronavirus disease  covid- current datum sars cov- result mild flu like symptom majority healthy young patient affect severity covid- respiratory syndrome risk adverse catastrophic outcome increase patient pre existing cardiovascular disease patient adult congenital heart disease achd)-by definition underlying cardiovascular disease patient achd afflict residual haemodynamic lesion valve dysfunction diminish ventricular function arrhythmias cyanosis extracardiac comorbiditie face additional challenge pregnancy currently emerge datum effect covid- achd patient aspect especially risk stratification treatment consideration remain unclear article aim discuss broad impact covid- achd patient focus specifically pathophysiology risk stratification work self isolation hospitalization impact pregnancy psychosocial health long term implication provision achd care
673,coronavirus disease covid- cause sars cov- virus result respiratory illness pneumonia lead respiratory failure report wuhan hubei china december  rapidly spread globally pandemic march comorbiditie observe sars cov- positive patient hypertension .% type -diabetes .% frequent condition symptom highly heterogeneous range absence symptom severe acute respiratory failure patient metabolic associate disease experience bad covid- outcome review investigate association metabolic disorder covid- severity explore molecular mechanism potentially underlie relationship responsible severe covid- outcome addition role main biological process connect metabolic alteration sars cov- infection hyperglycemia immune system deregulation ace- receptor modulation inflammatory response describe impact metabolic disorder prognosis covid- major implication public health especially country affect high incidence metabolic disease
674,acute kidney injury aki common hospitalize patient coronavirus infectious disease  covid- occurrence aki range .% variability occurrence aki attribute difference geographic location race ethnicity severity illness aki hospitalize patient associate increase length stay hospital death patient aki survive hospital discharge risk develop chronic kidney disease end stage kidney disease improved knowledge pathophysiology aki covid- crucial mitigate manage aki improve survival patient develop aki covid- goal article provide current understanding etiology pathophysiology aki setting covid-
675,evidence relation sars cov- mortality underlie medical condition scarce conduct observational retrospective study base romanian official datum location age gender comorbiditie covid- fatality finding indicate male hypertension diabetes obesity chronic kidney disease frequent covid- fatality burden disease low prognosis survival probability high sample evidence show age dependent pair comorbiditie negative prognosis factor severity disease sars cov  infection
676,background severe acute respiratory syndrome coronavirus  sars cov- infection sweep wuhan spread china overseas begin december identify predictor associate disease progression evaluate clinical risk factor exacerbation sars cov- infection method retrospective analysis pcr confirm covid- coronavirus disease -diagnose hospitalize case january february zhejiang china systematically analyse clinical characteristic patient predictor clinical deterioration result patient covid- median age  year include  patient severe critical disease age vs p sex vs .% p body mass index bmi vs p hypertension .% vs .% p il- vs p il- vs p t lymphocyte count vs p b lymphocyte count vs p white blood cell count vs p d dimer vs p pct vs p crp vs p ast vs p artificial liver therapy vs .% p glucocorticoid therapy .% vs p associate severity disease age weight independent risk factor disease severity conclusion deterioration covid infected patient occur rapidly hospital admission cohort find multiple factor associate severity covid early detection monitoring indicator reduce progression disease remove factor halt progression disease addition oxygen support early treatment low dose glucocorticoid artificial liver therapy necessary help reduce mortality critically ill patient
677,novel coronavirus cov severe acute respiratory syndrome sars)-cov- outbreak begin end  wuhan china spread  country multicenter retrospective study identify  adult patient admit laboratory confirm covid- participate center multivariate logistic regression conduct patient comorbid hypertension examine potential association clinical outcome disease severity clinical characteristic use acei arb calcium channel blocker ccb beta blocker bb thiazide diuretic clinical outcome dyspnea fatigue significantly improve patient especially elderly patient old  year take arb drug prior hospitalization compare patient take drug reduction disease severity elderly covid- patient associate ccb acei user clinical index include crp lymphocyte count procalcitonin d dimer hemoglobin significantly improve elderly arb user addition clinical outcome statistically significantly improve patient take antihypertension drug arb bb ccb statistical adjustment age gender baseline blood pressure coexist medical condition datum indicate hypertension drug arb acei ccb bb beneficial covid- patient
678,background identify risk factor severe novel coronavirus disease covid- useful ascertain patient benefit advanced supportive care study offer description covid- patient admit general ward non critical clinical picture aim analyse difference transfer intensive icu and/or sub intensive care sicu unit method observational retrospective study include covid- patient admit infectious diseases unit clinical laboratory radiological treatment datum collect primary outcome composite need transfer icu and/or sicu hospitalization patient require transfer define group patient transfer icu and/or sicu define group demographic clinical characteristic laboratory finding st rd measurement compare group result  include median age  year  patient .% meet primary outcome define group overall fatality rate group  patient predominantly male .% vs. .% p high fatality rate .% vs. .% p hypertension .% vs. p diabetes .% vs. p likely present dry cough .% vs. .% p overall chest x ray admission show finding suggestive pneumonia .% group  likely develop pathological finding hospitalization .% vs. .% p admission group  present significantly high neutrophil count aspartate transaminase c reactive protein rd measurement group  present persistently high neutrophil count hepatic inflammation marker c reactive protein group  present short duration admission negativization follow swab vs.  day p conclusion presence comorbiditie persistent observation abnormal laboratory finding regard predispose factor clinical worsening
679,background rapid spread coronavirus disease  covid- reveal significant constraint critical care capacity anticipation subsequent wave reliable prediction disease severity essential critical care capacity management enable early target intervention improve patient outcome purpose study develop externally validate prognostic model clinical tool predict covid- critical disease presentation medical care method retrospective study prognostic model prediction covid- critical disease critical disease define icu admission ventilation and/or death derivation cohort develop multivariable logistic regression model covariate include patient comorbiditie present vital sign laboratory value model performance assess validation cohort concordance statistic model develop consecutive patient covid- present university california irvine medical center orange county california external validation perform random sample patient covid- emory healthcare atlanta georgia result total  patient test derivation cohort positive covid- clinical datum include past medical history present laboratory value available patient median age  year range year male common comorbiditie include obesity hypertension diabetes critical disease present backward stepwise selection follow factor associate great increase risk critical disease number comorbiditie body mass index respiratory rate white blood cell count lymphocyte serum creatinine lactate dehydrogenase high sensitivity troponin ferritin procalcitonin c reactive protein total  patient validation cohort median age  year range year male critical disease present model discrimination validation cohort high concordance statistic confidence interval .- web base tool develop enable clinician input patient datum view likelihood critical disease conclusion relevance present model accurately predict covid- critical disease risk comorbiditie present vital sign laboratory value derivation validation cohort different institution validate additional cohort patient model clinical tool provide useful prognostication critical care need
680,background study evaluate tpeak tend tpe interval tpe qt ratio tpe qtc ratio assess cardiac arrhythmia patient covid- objective aim examine change qt qtc tpe interval tpe qt ratio tpe qtc ratio patient covid- method study include  patient covid- infection  age sex match healthy control qt qtc tpe interval tpe qt ratio tpe qtc ratio measure participant include study divide follow  group healthy control group patient covid- pneumonia group ii patient covid- mild pneumonia group iii patient covid- severe pneumonia group iv statistical significance set p result find baseline heart rate presence hypertension diabetes white blood cell count blood urea nitrogen creatinine potassium aspartate aminotransferase alanine aminotransferase nt probnp high sensitive c reactive protein d dimer hs ctni tpe tpe qt tpe qtc increase group group iv significantly high patient group iv p systolic diastolic blood pressure hemoglobin calcium level find low group iv significantly low group qt qtc interval similar group determine increase heart rate calcium d dimer nt probnp hs crp level significantly relate tpe tpe qt tpe qtc conclusion patient covid- severe pneumonia tpe tpe qt ratio tpe qtc ratio ventricular repolarization parameter find increase prolonged qt qtc interval study definitively conclude ecg change observe directly relate covid- infection inflammation associate severe covid- scenario involve cause inflammation comorbiditie arq bras cardiol
681,introduction covid- epidemic grow clinical trial antiviral opportunity complement trial investigation angiotensin ii type  receptor blocker arb arb losartan effective murine influenza pneumonia method analysis innovative design include arb alignment ordinal scale primary endpoint align covid- trial joint longitudinal analysis predictive biomarker angiotensin ii ace ace hypothesis arb decrease need hospitalisation severity need ventilation vasopressor extracorporeal membrane oxygenation renal replacement therapy mortality hospitalise covid- infected adult pronged multicentre pragmatic observational cohort study examine safety effectiveness arb hospitalise adult patient covid- patient arb primary outcome evaluate ordinal logistic regression main secondary outcome joint longitudinal modelling analysis compare rate hospitalisation arb expose versus arb expose patient determine continue arb decrease primary outcome base publish covid- cohort assume patient arb expose total sample size  patient detect proportional alpha=. power compare scale arb expose versus non arb expose patient ethics dissemination study core institution approval ubc providence healthcare research ethics board site institution approval health research ethics board university alberta comite d'etique de la recerche chu sainte justine mcgill university university sherbrook conjoint health research ethics board university calgary queen university health sciences affiliated hospitals research ethics board research ethics board sunnybrook health sciences centre veritas independent research board humber river hospital mount sinai hospital research ethics board unity health toronto research ethics board st. michael hospital result disseminate review publication social medium release trial registration number nct
682,immunosuppression comorbiditie place solid organ transplant sot recipient high risk covid- suggest recent case series compare  sot vs.  non sot patient admit covid- health care system march  august evaluate hospital length stay inpatient mortality compete risk regression compare trajectory covid- severity scale mix effect ordinal logistic regression adjust severity score admission sot non sot patient comparable age sex race sot recipient likely diabetes vs. p hypertension vs. p hiv vs. .% p peripheral vascular disorder vs. p statistically significant difference sot non sot maximum illness severity score p length stay shr p mortality shr p severity score admission slightly low sot median iqr  non sot median iqr  p despite high risk profile sot recipient fast decline disease severity time p compare non sot patient finding implication transplant decision making covid- pandemic insight impact sars cov- immunosuppressed patient
683,background recent study show diabetes major risk factor contribute severity covid- result mortality poor glycemic control associate poor patient outcome eg hospitalization death objective study aim describe clinical characteristic outcome patient diabetes admit hospital covid- treatment method cross sectional observational study comprise patient diabetes admit covid- mediclinic parkview hospital dubai united arab emirates march  june study difference characteristic length hospital stay diabetes status comorbiditie treatment outcome patient result cohort patient coexistent diabetes prediabete patient represent  different ethnicity asian country arab country mean patient age  sd year patient male patient know diabete prior admission newly diagnose diabetes prediabete admission cohort patient type  diabetes prediabete patient type  diabetes furthermore patient demonstrate evidence suggest good glycemic control week prior admission define arbitrarily admission hemoglobin ac level .% patient comorbiditie include hypertension ischemic heart disease dyslipidemia laboratory datum mean sd value admission patient need ward base care versus need intensive care follow fibrinogen sd mg dl vs sd mg dl d dimer sd microg ml vs sd microg ml ferritin sd mg dl vs sd mg dl c reactive protein sd mg l vs sd mg l. laboratory datum significantly high patient intensive care unit subcohort p average length hospital stay day patient patient require intensive care die hospitalization intensive care unit conclusion majority patient diabetes prediabete covid- notable comorbiditie  patient test negative covid- rt pcr show pathognomonic change covid- radiologically laboratory analysis reveal distinct abnormal pattern biomarker associate poor prognosis fibrinogen d dimer ferritin c reactive protein level significantly high admission patient subsequently need intensive care need ward base care study large sample size need compare datum covid- patient admit diabete uae region
684,coronavirus disease covid- associate pulmonary hypertension pulmonary embolism affect subsequent outcome definitive diagnosis pulmonary hypertension difficult risk spread infection assess utility plane compute tomography noninvasively predict clinical severity covid-
685,objective beginning severe acute respiratory syndrome coronavirus  pandemic discussion severity coronavirus disease- covid- comparison infection seasonal influenza objective study compare clinical demographic characteristic german patient hospitalize infection sars cov- influenza method study anonymize german healthcare claim datum patient confirm covid- influenza diagnosis complete hospital course available i.e. patient discharge die hospital include datum set include detailed information patient characteristic hospital treatment patient group accord transfer intensive care unit icu receive mechanical ventilation mv severe course disease sd charlson comorbidity index quarter prior hospitalization secondary diagnosis hospitalization analyze result total  hospitalize patient covid-  hospitalize patient influenza include percent patient male patient man twice frequent covid- severe group disease patient year account quarter hospital case hypertension diabetes mellitus chronic kidney disease chronic obstructive pulmonary disease common comorbiditie proportion case icu mv sd substantially high patient covid- icu+  vs.  mv+  vs. sd+  vs. overall inhospital mortality fold higher covid- vs. influenza vs. length ventilation hospitalization proportion patient diagnose acute respiratory distress syndrome systemic inflammatory response syndrome acute kidney injury considerably high patient covid- conclusion covid- result high inhospital mortality bad clinical outcome influenza attributable demographic characteristic preexist comorbiditie patient triage german healthcare system reach limit pandemic discussion suggest covid- seasonal influenza similar severity base clinical evidence
686,covid- pandemic affect  million people worldwide mortality exceed patient risk factor associate severe disease mortality include advanced age hypertension diabetes obesity risk factor pathologically disrupt lipidome include immunomodulatory eicosanoid docosanoid lipid mediator lms hypothesize dysregulation lms define feature severity covid- examine lms polyunsaturated fatty acid precursor lipid serum hospitalize covid- patient demonstrate moderate severe disease separate specific difference abundance immune regulatory proinflammatory lms difference lm balance correspond decrease lm product alox cox increase lms product alox cytochrome p. give important immune regulatory role lms datum provide mechanistic insight immuno lipidomic imbalance severe covid-
687,introduction severe covid- compound prothrombotic state associate poor outcome investigation aim evaluate adamts activity von willebrand factor level vwf ag corresponding adamts activity vwf ag ratio patient covid- association disease progression acute kidney injury aki method patient present emergency department ed covid- enrol prospective observational study adamts activity vwf ag measure index ed visit primary endpoint severe aki define kdigo stage   criterion secondary endpoint peak -day covid- severity result total  adult covid- patient enrol overall observe .% cohort relative deficiency adamts activity .% elevate vwf ag adamts activity vwf ag ratio significantly low patient severe aki p develop severe form covid- p adamts activity vwf ag ratio negatively correlate age p ldh p positively correlate hemoglobin p control confounder unit increase adamts vwf ag ratio associate decrease odd severe aki conclusion low adamts activity vwf ag ratio ed presentation associate progression severe covid- disease severe aki pattern suggestive secondary microangiopathy interventional study conduct assess restoration adamts vwf ag ratio hospitalize patient covid-
688,objective quantify contextualize risk coronavirus disease  covid-)-relate hospitalization illness severity type  diabetes research design method conduct prospective cohort study identify case subject covid- regional health care network  service location electronic health record query chart review patient contact identify clinical factor influence illness severity result identify covid-  patient diabetes type  type  diabetes respectively compare have diabetes people type  diabetes adjust odd ratio ci .- hospitalization ci .- great illness severity similar risk type  diabetes patient type  diabetes glycosylated hemoglobin hbac hypertension race recent diabetic ketoacidosis health insurance status diabetes technology use significantly associate illness severity conclusion diabetes status type  type independently increase adverse impact covid- potentially modifiable factor e.g. hbac significant modest impact compare comparatively static factor e.g. race insurance type  diabetes indicate urgent continue need mitigate severe acute respiratory syndrome coronavirus  infection risk community
689,background incidence outcome coronavirus disease  covid-)-induce kidney injury variably describe aim describe clinical characteristic correlate outcome critically ill patient severe covid- complicated acute kidney injury aki method perform multicenter retrospective cohort study  critically ill adult laboratory confirm covid-  hospital china january  february datum capture demographic comorbiditie symptom acute physiology laboratory parameter intervention outcome primary exposure icu admission confirmed covid- related critically illness primary outcome -day mortality secondary outcome include factor associate aki organ dysfunction treatment intensity health service use measurement main result  severe covid- patient median iqr  year male sex n hypertension n apache ii score  develop aki patient aki old great marker inflammation coagulation activation great acuity organ dysfunction presentation despite similar treatment antiviral patient aki low viral conversion negative rate aki -day mortality high aki patient patient aki vs. increase -day mortality accord severity aki non survivor likely receive antiviral therapy vs.  compare survivor low viral negative conversion rate vs.  conclusion acute kidney injury common severe covid- pneumonia associate high mortality
690,background scant datum currently available potential link comorbid chronic lung disease cld risk severity coronavirus disease  covid- infection method describe clinical characteristic outcome patient covid- infection include patient comorbid respiratory disease primarily hospitalize pulmonology department strasbourg university hospital france retrospective single center study include confirm case covid- march  april compare symptom biological radiological finding outcome patient cld result  patient enrol median age  year  patient male overall patient n= preexisting cld include chronic obstructive pulmonary disease copd n= asthma n= patient transfer intensive care unit icu patient die unit cld predictive icu hospitalization significantly high total mortality observe vs. .% p patient conclusion result suggest lack representation cld covid- represent patient cohort pulmonology department cld risk factor icu management tendency high global mortality observe covid- patient cld study warrant determine risk covid- patient comorbid cld
691,study compare risk severe covid- related mortality transplant recipient nontransplant patient enrol group patient hospitalize covid- kidney transplant recipient ktr french registry solid organ transplant n single center cohort nontransplant patient n analysis perform subgroup match age risk factor severe covid- mortality severe covid- define admission transfer intensive care unit need mechanical ventilation death transplant recipient young comorbiditie compare nontransplant patient present high creatinine level develop episode acute kidney injury matching cumulative incidence severe covid- differ ktr nontransplant patient -day covid relate mortality significantly high ktr .% vs .% respectively p age year cardiovascular disease dyspnea fever lymphopenia c reactive protein crp associate severe covid- univariate analysis transplant status serum creatinine level age year hypertension cardiovascular disease diabetes crp mg l lymphopenia kidney transplant status hr creatinine level micromol l hr associate covid relate mortality univariate analysis multivariable analysis cardiovascular disease dyspnea fever associate severe disease age year cardiovascular disease dyspnea fever creatinine level micromol l retain independent association mortality ktr high covid relate mortality compare nontransplant hospitalize patient
692,emergence sars cov- virus subsequent covid- pandemic initiate intense research mechanism action virus quickly note covid- present seriously conjunction human disease condition hypertension diabetes lung disease conduct bioinformatics analysis covid- comorbidity associate gene set identify gene pathway share comorbiditie evaluate current knowledge gene pathway relate current information sars cov- infection perform analysis geneweaver gw reactome biomedical ontology represent compare common covid- comorbiditie phenotypic analysis share gene reveal significant enrichment immune system phenotype cardiovascular relate phenotype point allele phenotype mouse model evaluate clue covid- severity pathway analysis identify enriched pathway share comorbidity dataset dataset associate sars cov- infection
693,introduction coronavirus disease covid- infection cause novel severe acute respiratory syndrome coronavirus- sars cov- primarily affect lung tobacco relate illness include asthma chronic obstructive pulmonary disease copd coronary artery disease know reduce lung capacity impair immune system body greatly influence ability fight novel coronavirus purpose state art literature review summarize evidence association tobacco use severity covid- manifestation method article describe association tobacco use severity covid- manifestation search pubmed medline google review cover relevant study subject publish january  september result tobacco use form smoking chewing significantly associate severe covid- outcome pre exist comorbiditie tobacco user cardiovascular disease diabetes respiratory disease hypertension find aggravate disease manifestation make treatment covid- patient challenging rapid clinical deterioration conclusion current review indicate nicotine exposure link cardiopulmonary vulnerability covid- tobacco use potential risk factor get viral infection severe manifestation current pandemic provide teachable moment break cycle nicotine addiction accelerate national tobacco control program achieve tobacco free world
694,ministry ayush recommend use decoction mixture ocimum tenuiflorum cinnamomum verum piper nigrum zingiber officinale vitis vinifera preventive measure boost immunity severity infection cause novel coronavirus covid- present study aim identify probable modulate pathway combine action ayush recommend herbal tea golden milk formulation immune booster covid- report phytoconstituent medicinal plant retrieve chebi database target predict digep pred string database cytoscape predict protein protein interaction construct network respectively likewise molsoft admet sar predict druglikeness score admet profile phytoconstituent study identify modulation hif- p pik akt mapk camp ras wnt nf kappa b il- tnf cgmp pkg signal pathway boost immune system multiple pathway identify involve regulation pathogenesis multiple infection non infectious disease low immune system result indicate recommend herbal formulation modulate pathway involve boost immunity modulate multiple pathway contribute progression multiple disease pathogenesis add beneficial effect co morbid patient hypertension diabetes study provide scientific documentation role ayurvedic formulation combat covid-
695,background previous study focus clinical characteristic hospitalize patient novel  coronavirus disease covid- limited datum available convalescent patient study aim evaluate clinical characteristic discharge covid- patient method retrospective study extract datum  convalescent patient covid- guizhou provincial staff hospital february  march case analyze basis demographic clinical laboratory datum radiological feature result  convalescent patient covid-  .% severe case  .% non severe case median patient age  year iqr cohort include  man  woman compare non severe case severe patient old chronic comorbiditie especially hypertension diabetes thyroid disease p leukopenia present .% convalescent patient lymphocytopenia present .% common severe patient  .% discharge patient elevate level alanine aminotransferase common adult child .% vs .% p normal chest ct find  .% patient rehabilitation severe patient ground glass opacity bilateral patchy shadowing fibrosis significant difference observe positive rate igg and/or igm antibody severe non severe patient conclusion leukopenia lymphopenia ground glass opacity fibrosis common discharge severe covid- patient liver injury common discharge adult patient suggest physician develop follow treatment plan base different clinical characteristic convalescent patient
696,sars cov- infection risk develop life threaten covid- disease age hypertension chronic inflammatory condition risk factor underlying host factor marker disease severity e.g. require intensive care unit icu treatment remain poorly define end longitudinally profile blood inflammation marker antibody  plasma protein hospitalize covid- patient require icu admission essentially patient display sars cov specific antibody virus neutralization capacity day rapid transient upregulation selective inflammatory marker include il- cxcl cxcl ifngamma il- monocyte attract ccl ccl ccl particularly evident icu patient addition consistent sustained upregulation apoptosis associate protein casp tnfsf hgf tgfb hgf discriminate icu non icu cohort covid- associate selective inflammatory milieu apoptotic pathway cardinal feature potential aid risk base patient stratification
697,background explore clinical significance serum angiotensin convert enzyme ace activity coronavirus disease  covid- method retrospective study total  consecutive patient confirmed covid- recruit demographic clinical datum record serum ace activity measure baseline recovery phase relationship clinical condition analyze result  patient confirmed covid-  severe patient old high body mass index bmi proportion hypertension  nonsevere patient comparison normal control baseline serum ace activity subject severe group nonsevere group decrease low level severe group serum ace activity increase recovery phase significant difference severe group nonsevere group normal control group conclusion serum ace activity marker reflect clinical condition covid- low activity associate severity covid- baseline activity increase remission disease
698,march world health organization declare coronavirus disease  covid- pandemic reality situation finally catch widespread reach disease presentation disease highly variable range asymptomatic carrier critical covid- availability angiotensin convert enzyme  ace receptor reportedly increase susceptibility and/or disease progression covid- comorbiditie risk factor note increase covid- susceptibility paper review evidence pertain ace relationship common comorbiditie risk factor therapy associate susceptibility severity covid- highlight gap knowledge require investigation primary comorbiditie respiratory disease cardiovascular disease renal disease diabetes obesity hypertension strong evidence secondary risk factor age sex race genetic limit moderate evidence tertiary factor ace inhibitor angiotensin ii receptor blocker limit moderate evidence ibuprofen thiazolidinedione limit evidence
699,despite pandemic status covid- limited information host risk factor treatment supportive care immunoglobulin g igg potential treatment target aim determine incidence igg deficiency associated risk factor cohort  critically ill patient covid- admit german icu .% male median age  yr thirteen .% patient display igg deficiency igg  g l baseline predominant igg igg igg subclass patient igg deficient bad measure clinical disease severity normal igg level short duration disease onset icu admission low ratio formula text formula text high sequential organ failure assessment score high level ferritin neutrophil lymphocyte ratio serum creatinine patient igg deficient likely sustain low level lymphocyte count high level ferritin hospital stay furthermore patient igg deficient compare normal igg level display high rate acute kidney injury .% vs. .% p death vs. .% p long icu vs.  day p hospital length stay vs.  day p univariable logistic regression show increase odd -day overall mortality associate igg deficiency odd ratio confidence interval .- p igg deficiency common patient covid- critically ill warrant investigation marker disease severity potential therapeutic target
700,objective vitamin d deficiency previously correlate incidence severity coronavirus disease  covid- investigate association serum d oh)d level admission radiologic stage outcome covid- pneumonia method retrospective observational trial  severe acute respiratory syndrome coronavirus  sars cov-)-infected individual hospitalize march april combine chest compute tomography ct oh)d measurement admission multivariate regression analysis perform study vitamin d deficiency oh)d ng ml correlate survival independently confound comorbiditie result patient covid- vitamin d deficient admission female male particular male patient covid- show progressively low oh)d advance radiologic stage deficiency rate increase stage  stage vitamin d deficiency admission confound age ethnicity chronic lung disease coronary artery disease hypertension diabetes associate mortality odd ratio confidence interval ci .- independent age ci .- chronic lung disease ci .- extent lung damage express chest ct severity score ci conclusion low oh)d level admission associate covid- disease stage mortality
701,background pandemic covid- pose challenge global healthcare mortality rate severe case range .% particularly important identify risk factor aggravate disease method perform systematic review literature meta analysis  database identify study report clinical characteristic comorbiditie complication severe non severe patient covid- observational study include perform random fix effect model meta analysis calculate pool proportion confidence interval ci measure heterogeneity estimate cochran q statistic index p value result total  case  study relate covid- include prevalent comorbidity hypertension severe .% ci non severe ci follow diabetes severe .% ci non severe .% ci prevalence acute respiratory distress syndrome acute kidney injury shock high severe case ci ci ci ci ci ci non severe patient respectively death rate high severe case .% ci non severe case .% ci conclusion hypertension diabetes cardiovascular disease risk factor severe covid-
702,covid- exhibit variability rapid progression particularly patient comorbiditie diabetes hypertension cancer determine underlying disorder exacerbate pneumonia covid- evaluate  patient severe covid- group accord comorbiditie clinical information laboratory examination immunological function treatment outcome retrospectively analyze study reveal severe covid- patient comorbiditie high level inflammatory index include blood interferon gamma interleukin il)- c reactive protein level erythrocyte sedimentation rate accompany lymphopenia hypokalemia hypoalbuminemia decrease cd+ t cell lymphocyte count coagulation disorder closely relate poor prognosis patient comorbiditie long disease remission time day comorbiditie day cox multivariate analysis indicate glucocorticoid therapy il- independent prognostic factor finding suggest coexist comorbiditie aggravate covid- excessive release inflammatory factor glucocorticoid therapy beneficial
703,background speculation treatment angiotensin convert enzyme inhibitor ace angiotensin ii receptor blocker arb predispose severe coronavirus disease  covid- worsen outcome study assess association ace arb therapy development severe covid- method multi center prospective study enrol patient hospitalize covid- receive antihypertensive agent manage hypertension cardiovascular disease ace arb therapy association severe covid- day hospitalization intensive care unit icu admission mechanical ventilation hospital death follow test multivariate logistic regression model adjust age obesity chronic illness composite outcome mechanical ventilation death examine adjust cox multivariate regression model result  enrol patient  .% ace arb day hospital admission  continue ace arb therapy hospitalization ninety patient severe covid- significantly associate use ace arb ci p prehospitalization ace arb therapy associate icu admission mechanical ventilation hospital death continue ace arb therapy hospitalization associate decrease mortality ci p ace arb use associate develop composite outcome mechanical ventilation hospital death hr ci p versus ace arb conclusion patient hypertension cardiovascular disease receive ace arb therapy increase risk severe covid- admission hospital icu admission mechanical ventilation mortality associate ace arb therapy maintain ace arb therapy hospitalization covid- lower likelihood death clinical trial registration clinicaltrials.gov nct
704,investigate effect renin angiotensin aldosterone system raas inhibitor prognosis patient coronavirus disease  covid- meta analysis perform systematically search pubmed cochrane library web science embase database october primary secondary outcome mortality severe covid- respectively include  study covid- patient compare outcome patient receive angiotensin convert enzyme inhibitor angiotensin receptor blocker aceis arb use aceis arb associate high risk severe disease odd ratio confidence interval ci mechanical ventilation ci dialysis ci length hospital stay smd ci covid- patient effect estimate show overall protective effect acei arb mortality ci severity mortality ci transfer intensive care unit covid- patient hypertension ci hospitalization ci acute respiratory distress syndrome ci use raas inhibitor associate increase mortality disease severity covid- patient study support current guideline discourage discontinuation raas inhibitor covid- patient
705,sars cov- induce novel coronavirus disease covid- outbreak significant medical challenge century covid- associate notable increase morbidity death worldwide preexisting condition like cardiovascular disease cvd diabetes hypertension obesity correlate high severity significant increase fatality rate covid- covid- induce multiple cardiovascular complexity cardiac arrest myocarditis acute myocardial injury stress induce cardiomyopathy cardiogenic shock arrhythmias subsequently heart failure hf precise mechanism sars cov- cause myocardial complication clearly understand propose mechanism myocardial injury base current knowledge direct viral entry virus damage myocardium systemic inflammation hypoxia cytokine storm interferon mediate immune response plaque destabilization virus enter cell angiotensin convert enzyme- ace receptor play central function virus pathogenesis systematic understanding cardiovascular effect sars cov need develop novel therapeutic tool target virus induce cardiac damage potential strategy minimize permanent damage cardiovascular system reduce morbidity review discuss current understanding covid- mediate damage cardiovascular system
706,background cardiac injury patient coronavirus disease  covid- report recent study report risk factor cardiac injury prognostic value limited result total .% case define cardiac injury study patient severe covid- significantly associate old age high respiratory rate sequential organ failure assessment sofa score cardiac injury biomarker pao fio ratio male patient chest distress dyspnea likely severe disease patient cardiac injury significantly likely severe condition outcome death significant difference find respiratory rate dyspnea pao fio ratio patient cardiac injury logistic regression model pre existing hypertension high sofa score independent risk factor patient covid- develop cardiac injury conclusion study reveal cardiac injury important predictor patient have severe fatal outcome patient pre existing hypertension high sofa score admission likely develop cardiac injury pulmonary ventilation dysfunction oxygen inhalation insufficiency main cause cardiac injury patient covid- method total  confirm case include study severe patient define accord american thoracic society guideline community acquire pneumonia cardiac injury define serum ctni th)-percentile upper reference limit patient characteristic clinical laboratory datum treatment detail collect analyze risk factor patient cardiac injury analyze
707,kidney transplant kt recipient increase risk severe covid- immunosuppressed state -year old kt patient diagnose covid- month kt despite lymphopenia risk factor mild disease course nasopharyngeal real time reverse transcriptase polymerase chain reaction sars cov- negative  day detection sars cov- igg antibody negative day ttv dna load increase onset covid- reduce resolution report ttv dna load measure course covid-
708,background current surge coronavirus  covid- case certain part country burden healthcare system limit access tertiary center result covid positive solid organ transplant sot recipient increasingly manage local healthcare provider crucial community provider understand disease severity know covid impact sot recipient different clinical course compare covid negative sot recipient similar presentation method conduct retrospective analysis sot recipient suspect covid- infection test march -april patient follow time testing result sot recipient undergo testing  covid- positive  covid- negative covid positive patient likely rapid progression symptom median  vs  d p great hospitalization vs p need intensive care unit care vs p severe covid- infection observe patient belatacept immunosuppression vs p covid-  positive patient intensive care unit likely multifocal opacity radiological imaging comparison admit medical floor vs survival probability similar cohort conclusion covid infected sot recipient propensity rapid clinical decompensation local provider need work closely transplant center appropriately triage manage covid- sot recipient community
709,recent study show comorbiditie diabetes hypertension obesity contribute severe bad outcome coronavirus disease  covid- suggest metabolic syndrome component associate severity covid- systematically possible association metabolic syndrome susceptibility severe acute respiratory syndrome coronavirus  sars cov- infection severity covid- literature search population base study uk biobank study show patient metabolic syndrome highly susceptible sars cov- infection recent meta analysis show metabolic syndrome significantly associate development severe covid- angiotensin convert enzyme ace  cellular entry receptor sars cov- enhanced ace expression pre existing endothelial dysfunction procoagulant state induce adipocytokine dysregulation metabolic syndrome play crucial role development severe covid-
710,background combination therapy hydroxychloroquine darunavir ritonavir lopinavir ritonavir suggest approach improve outcome patient moderate severe covid- infection objective examine safety combination therapy hydroxychloroquine darunavir ritonavir lopinavir ritonavir method observational cohort study patient hospitalize covid- pneumonia treat hydroxychloroquine darunavir ritonavir lopinavir ritonavir clinical evaluation electrocardiogram pharmacokinetic hydroxychloroquine darunavir lopinavir examine accord clinical practice guideline result patient receive hydroxychloroquine lopinavir ritonavir median age  year  male  receive hydroxychloroquine darunavir ritonavir median age  year  male treatment patient .% develop ecg abnormality patient discontinue treatment include seven ecg abnormality median  range day start treatment ecg abnormality reverse day interrupt treatment patient die  day ecg abnormality significantly associate age  year coexist condition hypertension chronic cardiovascular disease kidney failure initial potential drug interaction hydroxychloroquine concentration conclusion patient covid- receive hydroxychloroquine lopinavir darunavir ecg abnormality mainly relate age history cardiovascular disease
711,background march community spread severe acute respiratory syndrome coronavirus  increasingly prevalent pregnant woman equally susceptible develop coronavirus disease disease course usually appear mild severe critical case coronavirus disease  lead substantial morbidity include intensive care unit admission prolonged hospital stay intubation mechanical ventilation death recent report impact coronavirus disease  pregnancy lack information severity coronavirus disease  pregnant vs nonpregnant woman objective aim describe outcome severe critical case coronavirus disease  pregnant vs nonpregnant reproductive aged woman study design multicenter retrospective case control study woman laboratory confirm severe acute respiratory syndrome coronavirus  infection hospitalize severe critical coronavirus disease   academic medical center new york city  philadelphia march case consist pregnant woman admit specifically severe critical coronavirus disease  obstetrical indication control consist reproductive aged nonpregnant woman admit severe critical coronavirus disease primary outcome composite morbidity include follow death need intubation extracorporeal membrane oxygenation noninvasive positive pressure ventilation need high flow nasal cannula o supplementation secondary outcome include intensive care unit admission length stay need discharge long term acute care facility discharge home o requirement result total  pregnant woman severe acute respiratory syndrome coronavirus  polymerase chain reaction confirm infection admit  institution specifically coronavirus disease  .% meet criterion severe disease status  .% meet criterion critical disease status mean age body mass index markedly high nonpregnant control group nonpregnant cohort increase frequency preexisting medical comorbiditie include diabetes hypertension coronary artery disease pregnant woman likely experience primary outcome compare nonpregnant control group .% vs .% p=. adjust odd ratio confidence interval pregnant patient experience high rate intensive care unit admission .% vs .% p adjusted odd ratio confidence interval pregnant woman undergo delivery .% occur cesarean delivery mean gestational age delivery week patient severe disease status week patient critical coronavirus disease  status conclusion pregnant woman severe critical coronavirus disease  increase risk certain morbidity compare nonpregnant control despite high comorbiditie diabetes hypertension nonpregnant control pregnant case increase risk composite morbidity intubation mechanical ventilation intensive care unit admission finding suggest pregnancy associate bad outcome woman severe critical case coronavirus disease study suggest similar viral infection severe acute respiratory syndrome coronavirus middle east respiratory syndrome coronavirus pregnant woman risk great morbidity disease severity
712,remain uncertain hypertension ht medication angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb mitigate exacerbate sars cov- infection evaluate association acei arb severe coronavirus disease  covid- define hospitalization mortality individual diagnose covid- investigate association modify age simultaneous use diuretic thiazide health condition associate medication use observational study utilize datum massachusetts group medical practice identify  patient covid- diagnosis study pre infection comorbiditie include ht cardiovascular disease diabete associate increase risk severe covid- risk elevate patient age  comorbiditie cancer percent severe covid- compare severe covid- acei respectively arb propensity score match analysis use acei ci arb ci associate increase risk severe covid- thiazide use modify relationship beta blocker calcium channel blocker anticoagulant medication associate covid- severity conclusion cardiovascular relate comorbiditie associate severe covid- outcome especially patient age find substantial increase risk severe covid- patient take antihypertensive medication finding support recommendation discontinue use renin angiotensin system ras inhibitor prevent severe covid-
713,objective getafix trial test hypothesis favipiravir effective treatment covid- infection patient early stage disease compare current standard care study provide important opportunity investigate safety tolerability favipiravir pharmacokinetic pharmacodynamic profile drug mechanism resistance context covid- infection effect favipiravir hospitalisation duration post covid- health psycho social wellbeing patient recruit study trial design getafix open label parallel group arm phase ii iii randomised trial treatment allocation ratio patient randomised arm primary endpoint assess superiority favipiravir plus standard treatment compare standard treatment participant trial recruit adult patient confirm positive valid covid- test pregnant breastfeed prior major co morbidity multi centre trial patient recruit patient outpatient glasgow hospital royal alexandra hospital queen elizabeth university hospital glasgow royal infirmary patient meet following criterion age  time consent exhibit symptom associate covid- positive sars cov- valid covid- test point  covid- ordinal severity scale time randomisation asymptomatic positive valid covid- test symptomatic independent symptomatic assistance need hospitalize oxygen therapy risk death admit hospital define isaricc risk index  able provide write informed consent negative pregnancy test woman childbeare potential able swallow oral medication patient exclude trial meet following criterion renal impairment require likely require dialysis haemofiltration pregnant breastfeed child bear potential woman female partner child bear potential man agree use adequate contraceptive measure duration study  month completion study treatment history hereditary xanthinuria patient judge unsuitable principal investigator sub investigator know hypersensitivity favipiravir metabolite excipient severe co morbidity include patient severe hepatic impairment define great child pugh grade ast alt  x uln ast alt x uln total bilirubin xuln  hour positive covid- test sample take unable discontinue contra indicate concomitant medication multi centre trial patient recruit patient outpatient glasgow hospital royal alexandra hospital queen elizabeth university hospital glasgow royal infirmary intervention comparator patient randomised experimental arm getafix receive standard treatment covid- discretion treat clinician plus favipiravir patient receive loading dose favipiravir day  mg mg  hour apart day patient experimental arm receive maintenance dose favipiravir mg  hour apart total  dose patient randomise control arm getafix trial receive standard treatment covid- discretion treat clinician main outcome primary outcome assess getafix trial efficacy favipiravir addition standard treatment patient covid- reduce severity disease compare standard treatment disease severity assess covid  point ordinal severity scale day   hour randomised participant follow death  day post randomisation whichever soon randomisation patient randomise experimental versus control arm computer generate random sequence allocation minimisation algorithm incorporate random component allocate patient factor minimisation site age -/-/+ history hypertension currently obsess bmi obesity clinically evident yes  day duration symptom yes unknown sex male female covid- ordinal severity score baseline blind masking blinding getafix trial participant assess outcome aware treatment allocation number randomised sample size total  patient randomised getafix trial  control arm  experimental arm optional consent form patient want contribute frequent pk pd sampling maximum number patient undergo testing sixteen male female option offer patient treat hospital time take informed consent patient experimental arm trial able undergo testing trial status current getafix protocol version th september getafix open recruitment th october  recruit patient period approximately month trial registration getafix register european union drug regulating authorities clinical trials eudract database th april reference number  getafix register isrctn th september reference number isrctn  protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol study protocol report accordance standard protocol items recommendation clinical interventional trials spirit guideline additional file
714,diabetes important comorbiditie link severity infection cause severe acute respiratory syndrome coronavirus sars cov- prevalence diabetic patient hospitalize intensive care unit covid- threefold high observe non diabetic patient risk progress critical fatal disease increase factor   patient diabetes multiple mechanism link diabetes risk factor severe covid- include diabetes related hyperglycaemia diabetes associated immune dysfunction obesity hypertension component optimise glycaemic control reduce risk severe covid- appear important challenging good choice antidiabetic treatment remain establish early introduction insulin type  diabetes patient covid- encourage admission hospital future investigation necessary improve management prognosis high risk patient
715,diabetes consider risk factor complication covid- order clarify association explore characteristic clinical sign outcome death diabetic patient covid- retrospective observational study evaluate demographic characteristic comorbiditie patient clinical sign infection sign clinical severity biological assessment admission treatment outcome death  patient covid-  diabetes compare covid- patient diabetes patient diabetes old high blood pressure cardio vascular disease severe form present diabetic patient versus .% weight loss high diabetic patient kg versus kg biologically diabetic patient high level c reactive protein versus l procalcitonin versus ng l ferritin versus ng ml lactic dehydrogenase versus iu l d. dimer versus mug l diabetic patient require oxygen therapy versus .% mechanical ventilation versus .% frequent admission intensive care unit versus present thromboembolic complication versus significant difference outcome death rate excess morbidity mortality diabetes fully clarify role demographic factor interaction mediation ace- receptor role co morbidity need study order identify patient risk profile i.e. develop severe form disease outcome early identification possible hyper inflammation valuable attention pay patient covid- diabetes high risk complication
717,background understand factor associate disease severity mortality coronavirus disease covid- imperative effectively triage patient perform systematic review determine demographic clinical laboratory radiological factor associate severity mortality covid- method search pubmed embase database english language article inception include observational study direct comparison clinical characteristic patient die survive b patient severe disease severe disease datum extraction quality assessment perform author independently result  article literature search  article include analysis risk mortality high patient increase age male gender rr ci dyspnea rr ci diabetes rr ci hypertension rr ci congestive heart failure ci hilar lymphadenopathy ci bilateral lung involvement ci reticular pattern ci .- associate severe disease clinically relevant cut off leukocytosis l lymphopenia(mg l ldh(>u l d dimer(>mg l high odd severe disease great risk mortality conclusion knowledge factor associate disease severity mortality identify study assist clinical decision making critical care resource allocation patient covid-
718,novel coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus- sars cov- declare pandemic  march pandemic associate markedly elevate blood glucose level remarkable degree insulin resistance suggest pancreatic islet beta cell dysfunction apoptosis insulin inability dispose glucose cellular tissue diabetes know pre existing co morbidity associate severity covid- hypertension cardiocerebrovascular disease advanced age male gender recently obesity review focus covid- responsible accelerate development type  diabetes mellitus tdm acute suspect long term complication observation implicate active role metabolic syndrome systemic tissue islet renin angiotensin aldosterone system redox stress inflammation islet fibrosis amyloid deposition beta cell dysfunction apoptosis develop tdm utilize light electron microscopy preclinical rodent model human islet help well understand covid- accelerate islet beta cell injury remodeling result long term complication tdm
719,background purpose objective systematic review identify prognostic factor decision making relate care patient infect covid- data source conduct highly sensitive search pubmed medline cochrane central register controlled trials central embase search cover period inception date database april study design publication status language restriction apply study selection data extraction include study assess patient confirm suspect sars cov- infectious disease examine prognostic factor mortality disease severity reviewer work pair independently screen study eligibility extract datum assess risk bias perform meta analysis grade assess certainty evidence prognostic factor outcome result include  study find high moderate certainty follow  variable provide valuable prognostic information mortality and/or severe disease patient covid- infectious disease demographic factor age male sex smoking patient history factor comorbiditie cerebrovascular disease chronic obstructive pulmonary disease chronic kidney disease cardiovascular disease cardiac arrhythmia arterial hypertension diabetes dementia cancer dyslipidemia physical examination factor respiratory failure low blood pressure hypoxemia tachycardia dyspnea anorexia tachypnea haemoptysis abdominal pain fatigue fever myalgia arthralgia laboratory factor high blood procalcitonin myocardial injury marker high blood white blood cell count wbc high blood lactate low blood platelet count plasma creatinine increase high blood d dimer high blood lactate dehydrogenase ldh high blood c reactive protein crp decrease lymphocyte count high blood aspartate aminotransferase ast decrease blood albumin high blood interleukin- il- high blood neutrophil count high blood b type natriuretic peptide bnp high blood urea nitrogen bun high blood creatine kinase ck high blood bilirubin high erythrocyte sedimentation rate esr radiological factor consolidative infiltrate pleural effusion high sofa score sequential organ failure assessment score conclusion identify prognostic factor help clinician policy maker tailor management strategy patient covid- infectious disease researcher utilise finding develop multivariable prognostic model eventually facilitate decision making improve patient important outcome systematic review registration prospero registration number crd protocol available
720,background coronavirus disease  covid- pandemic expose longstanding racial ethnic inequity health risk outcome united states aim identify racial ethnic difference presentation outcome patient hospitalize covid- method american heart association covid- cardiovascular disease registry retrospective observational registry capture consecutive patient hospitalize covid- present datum  patient race ethnicity treat  hospital united states january july primary outcome hospital mortality secondary outcome include major adverse cardiovascular event death myocardial infarction stroke heart failure covid- cardiorespiratory ordinal severity score bad good death cardiac arrest mechanical ventilation mechanical circulatory support mechanical ventilation vasopressor inotrope support mechanical ventilation hemodynamic support hospitalization multivariable logistic regression analysis perform assess relationship race ethnicity outcome adjust difference sociodemographic clinical presentation feature account clustering hospital result  patient hospitalize covid- .% hispanic .% non hispanic black .% asian .% non hispanic white hispanic black patient young non hispanic white asian patient likely uninsured black patient high prevalence obesity hypertension diabete black patient high rate mechanical ventilation .% renal replacement therapy .% low rate remdesivir use overall mortality death occur black hispanic patient adjusted odd ratio mortality ci .- black patient ci .- hispanic patient ci .- asian patient compare non hispanic white patient median odd ratio hospital ci result similar major adverse cardiovascular event asian patient high covid- cardiorespiratory severity presentation adjust odd ratio ci conclusion hospital mortality major adverse cardiovascular event differ race ethnicity adjustment black hispanic patient bear great burden mortality morbidity disproportionate representation covid- hospitalization
721,introdution covid- infection predispose venous arterial thromboembolism excessive inflammation hypoxia immobilization disseminate intravascular coagulation report low limb ischemia main manifestation disease presentation case male patient  year old asthmatic ex smoker bearer systemic arterial hypertension admit emergency department sudden onset pain right low limb rll associate cyanosis reduce temperature limb test covid- positive result igg igm compute tomography angiography angioct perform show sign arterial embolization limb right internal iliac artery superior mesenteric artery face threat limb loss absence sign symptom visceral ischemia patient undergo anticoagulation rll thromboembolectomy tricompartmental fasciotomy discharge  day hospitalization demonstrate sign symptom covid- follow outpatient follow discussion covid- associate high risk thrombotic complication relate clinical severity patient study symptom sudden pain low limb complaint conclusion individual infect covid- risk arterial thromboembolic event knowledge case essential order create specific protocol prophylaxis thrombotic event patient addition increase suspicion infection individual acute arterial occlusion pandemic time
722,examine effect coronary heart disease chd hypertension diabetes development severe covid- perform comprehensive systematic literature search study publish december  july  database prevalence severe covid- patient chd hypertension diabete evaluate meta analysis thirty article patient include available study case series pooled odd ratio development severe covid- patient chd fix effect model ci patient hypertension random effect model ci patient diabetes random effect model ci heterogeneity study moderate effect chd covid- severity high effect diabetes hypertension funnel plot egger test reveal publication bias chd hypertension analysis suggest publication bias diabetes analysis bias correct trim fill method ultimately find effect result finding suggest patient chd hypertension diabete great risk develop severe covid- condition
723,background objectives coronavirus disease  covid- associate high risk aki aim describe rate characterize predictor health outcome associate aki national cohort veteran hospitalize covid- design setting participant measurement cohort  veteran hospitalize covid- identify july describe change serum creatinine examine predictor aki association aki health resource utilization death utilize logistic regression characterize geographic temporal variation aki rate estimate variance explain key variable utilize poisson regression result total  participant aki    meet kidney disease improving global outcomes definition stage  aki respectively  receive krt percent participant aki  day hospitalization recover baseline serum creatinine discharge old age black race male gender obesity diabetes hypertension lower egfr significant predictor aki hospitalization covid- aki associate high mechanical ventilation use odd ratio confidence interval long hospital stay additional day confidence interval aki associate high risk death odd ratio confidence interval association strong blacks p value interaction hospital level rate aki exhibit substantial geographic variability range march july aki rate decline proportion aki stage  aki require krt decrease geographic temporal variability predominately explain percentage blacks respectively conclusion aki common hospitalization covid- associate high risk health care resource utilization death nearly half patient aki recover baseline discharge substantial geographic variation temporal decline rate severity aki observe podcast article contain podcast
724,aim study investigate clinical characteristic fatal outcome hypertension role angiotensin convert enzyme inhibitor angiotensin receptor blocker acei arb use patient severe coronavirus disease  covid- total  female patient severe covid- include mean age include patient year  .% patient history hypertension  patient receive acei arb therapy patient hypertension old comorbiditie likely suffer severe inflammatory response acute cardiac injury patient hypertension associate significantly high risk hospital mortality patient hypertension adjustment potential confounder independent correlation observe addition acei arb user associate low level high sensitivity cardiac troponin creatinine kinase myocardial band low risk acute cardiac injury acei arb non user conclusion patient hypertension likely suffer severe inflammatory response acute cardiac injury high risk hospital mortality severe covid- use acei arb protect patient covid- acute cardiac injury
725,background seek assess impact predictor coronavirus disease  covid- infection severity cohort patient congenital heart disease chd large chd center new york city method results perform retrospective review individual chd follow columbia university irving medical center diagnose covid- march  july primary end point moderate severe response covid- infection define death covid- infection need hospitalization and/or respiratory support secondary covid- infection  covid positive patient chd  year age median age  year age thirty complex congenital anatomy include  fontan repair genetic syndrome  pulmonary hypertension  obese adult  physiologic class c d. entire cohort  moderate severe infection include  death correct multiple comparison presence genetic syndrome odd ratio p=. adult physiological stage c d p=. significantly associate moderate severe infection conclusion chd center number symptomatic patient covid- relatively low patient chd genetic syndrome adult advanced physiological stage high risk moderate severe infection
726,coronavirus disease- covid- global pandemic cause thousand death worldwide far study suggest medication helpful effective treatment covid- critical find important risk factor affect recovery severity covid- guide treatment severe acute respiratory syndrome coronavirus  sars cov- infection study recruit discharge patient covid- hospital collect clinical datum analyze time disease onset positive negative transmission tpnt nucleic acid test related clinical variable tpnt consider important indicator recovery covid- patient sars cov- infection covid- patient divide short tpnt group long tpnt group significant difference hypertension abidol treatment serum alanine aminotransferase alt lymphocyte count serum triglyceride tg group p patient low tpnt group high serum triglyceride proportion hypertension logistic regression analysis show tpnt highly associate serum tg level hypertension relate expression ace target protein invasion sars cov- finding demonstrate serum triglyceride level hypertension important influence factor recovery sars cov- infection diet change antihypertensive medication translational treatment covid- promote recovery covid- patient
728,background high level serum interleukin- il- correlate disease severity covid- hypothesize tocilizumab recombinant humanized anti il- receptor improve outcome select patient severe worsen covid- pneumonia high inflammatory parameter method tocicovid study include prospective cohort patient age year severe require  l min oxygen therapy obtain sp rapidly deteriorate increase  l min oxygen flow previous  h covid- pneumonia  day symptom c reactive protein level  mg l. enter compassionate use program treatment intravenous tocilizumab mg kg maximum  mg infusion need second infusion   h later control group retrospectively select inclusion criterion outcome assess d inverse probability treatment weighted iptw methodology result  patient include male mean sd age  year underlying condition baseline disease severity concomitant medication broadly similar tocilizumab n control n group iptw analysis treatment tocilizumab associate reduce need overall ventilatory support vs. whr p albeit lack statistical significance substantial trend reduction mechanical ventilation vs. whr p tocilizumab improve overall survival whr p  patient alive d patient treat tocilizumab high rate oxygen withdrawal vs. .% whr p short delay wean oxygen therapy mean  vs.  day p d rate patient discharge hospital high tocilizumab group vs. whr p level crp fibrinogen post therapy p variable significantly low tocilizumab group interaction test mixed model rate neutropenia vs. p high tocilizumab group rate infection vs. p include ventilator acquire pneumonia vs. p high control group conclusion datum helpful design future trial aim counter covid induce inflammation especially patient require admission intensive care unit
729,pandemic coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- cause unprecedented global social economic impact high number death risk factor identify progression covid- severe critical stage include old age male gender underlie comorbiditie hypertension diabetes obesity chronic lung disease heart liver kidney disease tumor clinically apparent immunodeficiency local immunodeficiency early type interferon secretion capacity pregnancy possible complication include acute kidney injury coagulation disorder thoromboembolism development lymphopenia eosinopenia laboratory indicator covid- laboratory parameter monitor disease progression include lactate dehydrogenase procalcitonin high sensitivity c reactive protein proinflammatory cytokine interleukin il)- il beta krebs von den lungen- kl- ferritin development cytokine storm extensive chest compute tomography imaging pattern indicator severe disease addition socioeconomic status diet lifestyle geographical difference ethnicity expose viral load day initiation treatment quality health care report influence individual outcome review highlight scientific evidence risk factor severity covid-
730,background aim verify prevalence hypovitaminosis d obesity elderly patient infect new coronavirus patient develop severe symptom admit intensive care unit icu receive invasive ventilation diagnosis acute respiratory distress syndrome ards method cross sectional descriptive study compose elderly age  year admit icu collect demographic sex age anthropometric datum presence comorbiditie hypertension diabetes heart disease lung neurological oncological disease severity score icu saps iii pao fio ratio analysis c reactive protein crp serum dosage -hydroxy vitamin d ohd day hospitalization identify elderly hypovitaminosis d low value  kg m result total  elderly meet inclusion criterion elderly man mean age year median bmi kg m .% have nutritional diagnosis obesity .% bmi  kg m prevalent comorbiditie hypertension .% diabetes prevalence hypovitaminosis d value  ohd ng ml  ng ml ng ml .% .% respectively prevalence hypovitaminosis d ng ml obese elderly negative significant bivariate correlation bmi level  ohd r p conclusion hypovitaminosis d obesity elderly high prevalence critically ill patient icu infect new coronavirus laboratory investigation vitamin d important especially obese elderly patient
731,global covid- coronavirus disease pandemic complex problem overlap grow public health problem obesity obesity alter different component innate adaptive immune response create chronic low grade state inflammation nutritional status closely relate well bad prognosis viral infection excess weight recognise risk factor covid- complication addition direct risk obesity trigger disease diabetes hypertension increase risk severe covid- present review explain diet induce obesity importance different food process review tissue disruption obesity lead impaired immune response possible mechanism obesity co morbidities increase covid- morbidity mortality nutritional strategy support immune system patient obesity covid- discuss light available datum consider severity infection discussion hold contribute combat global emergency plan specific public health policy
732,background coronavirus disease  covid- quickly spread country world break wuhan china outbreak start january fujian province control number indigenous case increase march aim describe clinical characteristic patient covid- fujian province china method retrospective multicenter study collect analyze epidemiological clinical laboratory datum case confirm nucleic acid test designate hospital fujian province january  february patient follow discharge covid- severity classify mild moderate severe critical result  discharge patient covid-  patient male median age year  patient severe  patient critical admission hypertension diabete common comorbiditie symptom illness onset mainly fever .% cough .% myalgia fatigue total .% patient abnormal imaging finding chest compute tomography lymphopenia .% hypoxemia .% observe acute respiratory distress syndrome respiratory failure occur  patient .%  patient respectively patient die cure discharge median hospital stay  day old age negatively correlate lymphocyte count r p  year hypertension diabetes lymphopenia correlate severity covid- conclusion patient fujian province nonsevere case mild moderate symptom low mortality patient wuhan old age hypertension diabetes lymphopenia risk factor severity covid-
733,background coronavirus diseases  covid- cause unique threat great challenge chronic disease patient apart severity community chronic disease patient highly vulnerable current covid- pandemic study aim assess preparedness response covid- chronic disease patient follow healthcare facility method institutional base cross sectional study conduct north shoa zone june pre tested semi structured questionnaire collect datum study participant select simple random sampling technique datum enter epi datum export spss cleaning analysis bivariable multivariable logistic regression identify factor associate covid- preparedness response result total  patient respond face face interview administer questionnaire nearly third respondent good knowledge prepared good response covid- pandemic male participant news medium tv radio social medium tuberculosis hypertension diabetes mellitus significantly associate good preparedness informal education news medium tv radio have hypertension significantly associate good response covid- pandemic conclusion prevalence preparedness response covid- pandemic chronic disease patient low male participant source information educational status have chronic disease significantly associate covid- prevention preparedness response continue provide awareness creation chronic patient news medium tv radio social medium increase preparedness response covid- pandemic
734,objective study aim assess relation anxiety depression level hypertension covid- outbreak analysis association select socio demographic clinical parameter presence severity psychological distress perform method study involve  patient apply medical history supportive covid- infection accord hospitalization criterion diagnostic result sars cov- nucleic acid test certainty disease group create patient positive sars cov- nucleic acid test result consist  hospitalize subject assess applicant psychological state specially develop questionnaire presence severity symptom assess beck depression inventory bdi beck anxiety inventory bai result statistically significantly high average level depression high incidence anxiety demonstrate applicant covid- pandemic  high level anxiety demonstrate hospitalize patient compare outpatient group different presence depression symptom presence anxiety symptom associate independently hypertension study group ci p conclusion aftermath covid- outbreak anxiety depression common psychological disorder different symptom depression symptom anxiety associate independently hypertension describe socio demographic parameter clinical characteristic impact symptom depression anxiety irrespective hospitalize status investigate group
735,pandemic covid- emerge health crisis globally india extensively affect active case report till date present study focus demographic clinical laboratory profile patient tertiary level non covid respiratory care hospital retrospective observational study seventy seven sick patient fulfil covid suspect criterion admit isolation area rt pcr test designated laboratory  confirm covid- patient detailed demographic clinical laboratory profile covid- patient study mean age year male predominance majority case symptomatic common symptom cough follow breathlessness fever nineteen .% patient co morbidity  .% chronic lung disease comorbiditie nearly half patient require supplementary oxygen presentation patient invasive mechanical ventilation  patient require non invasive ventilation shift covid hospital conclude covid- patient chronic respiratory disease manifest high prevalence symptom high severity disease symptomatology covid- closely mimic acute exacerbation chronic lung disease cautious screening testing especially pulmonary department
736,covid- pandemic  million case worldwide disease impose huge burden health resource evaluation clinical epidemiological profile patient help understanding manage outbreak efficiently study prospective observational analysis  diagnose covid- patient admit tertiary care center th march th patient positive covid- oro nasopharyngeal swab rtpcr base testing analysis demographic factor clinical characteristic comorbiditie laboratory parameter outcome perform mean age population  year slight male predominance patient majority patient symptomatic fever common symptom .% follow cough .% old age presence symptom duration leukocytosis high quick sofa score high modify sofa score need ventilator support ast level  time upper limit normal uln serum creatinine level  mg dl great significantly high risk icu admission mortality presence diabetes mellitus ast time uln serum creatinine  mg dl high qsofa score  high associate significantly great odd critical care requirement triage severity assessment help decide requirement hospital stay icu admission covid- easily clinical laboratory parameter mild moderate severe category approach define criterion treatment guideline help judicious utilization health care resource especially develop country like india member safdarjung hospital covid- work group balvinder singh microbiology mk sen pulmonary medicine shibdas chakrabarti pulmonary medicine nk gupta pulmonary medicine aj mahendran pulmonary medicine ramesh meena medicine g usha anaesthesiology santvana kohli anaesthesiology sahil diwan anaesthesiology rushika saksena microbiology vikramjeet dutta microbiology anupam kr anveshi microbiology
737,background association antihypertensive drug risk severity covid- remain unknown method result systematically search pubmed medline cochrane library cochrane central register controlled trials central clinicaltrials.gov publication july cohort study case control study contain information association antihypertensive agent include angiotensin convert enzyme inhibitor aceis angiotensin ii receptor blocker arb calcium channel blocker ccb beta blocker diuretic risk severity covid- select random fix effect model pool odd ratio confidence interval ci outcome literature search yield  study satisfy inclusion criterion comprise  cohort study  case control study study include total participant observe association prior usage antihypertensive medication include aceis arb ccb beta blocker diuretic risk severity covid- additionally hypertensive patient include severity mortality low prior usage aceis arb overall ci p overall ci p conclusion take usage antihypertensive drug associate risk severity covid- base current available literature recommend abstain usage drug covid- patient registration meta analysis register osf
738,background coronavirus disease  covid- global pandemic study show covid- affect lung organ study aim explore cardiac damage patient covid- method collect datum  patient diagnose severe type covid- february  april include demographic illness history physical examination laboratory test treatment hospital mortality observe cardiac damage define plasma hypersensitive troponin hstni pg ml and/or n terminal pro brain natriuretic peptide ntprobnp  pg ml age result median age patient year old  .% comorbiditie mainly present hypertension diabetes cardiovascular disease fever .% cough chest distress .% fatigue .% common initial symptom cardiac damage occur  patient subgroup hstni significantly high eld patient  year young median iqr vs. p high man woman vs. p prevalence increase ntprobnp significantly high man woman .% vs. .% p similar eld young patient .% vs. .% p multivariable analysis male hypertension risk factor cardiac damage mortality conclusion cardiac damage exist patient severe type covid- especially male patient hypertension clinician pay attention cardiac damage
739,background study aim assess efficacy safety tocilizumab tcz investigate factor relate progress mortality patient secondary cytokine release syndrome cause sars cov- method retrospective descriptive observational study hospitalise patient positive polymerase chain reaction pcr result sars cov- clinical evolution require administration dose tcz conduct demographic variable clinical evolution radiologic progress analytical parameter analyse day   administration dose tcz result total  patient clinical history accurate respiratory distress syndrome ards analyse  mild ards .%  moderate ards .%  severe ards .% lymphocytopenia high level pcr d dimer il- observe patient treatment tcz associate reduction lymphocytopenia c reactive protein crp level severe ards case fever well evolution pao fio observe patient receive dose tcz increase mortality .% icu admission -day mortality rate ci hypertension high initial d dimer level icu admission predictive factor find conclusion base result treatment tcz associate fever swell ventilator support improvement evidence administration dose tcz relate mortality decrease
741,onset human disease infection sars cov- cause covid- reveal risk factor disease severity identify factor high risk infection and/or mortality create disparity age co morbidity race ethnicity gender datum indicate old person and/or presence obesity diabetes cardiovascular disease chronic kidney disease place high risk covid- united states specific race ethnicity particularly african americans native americans strong covid- risk component male gender emerge severity risk factor age racial ethnicity accumulation health co morbidity common precipitate mechanism particular underlie socio economic structure united states likely drive development co morbidity put affected population high risk severe covid- sudden cardiac death trigger common sodium channel variant african americans covid- evaluate cause racial disparity evidence racial ethnic difference covid- cause abo blood group use angiotensin convert enzyme ace inhibitor amino acid substitution sars cov- spike protein grow evidence androgen enable expression ace receptor serine protease tmprss permissive element engage sars cov- spike protein infection contribute severe covid- man overall covid- generate disparity infect severity infection understand mechanism disparity help nullify difference risk covid-
742,objective systematically review literature estimate risk chloroquine cq hydroxychloroquine hcq cardiac toxicity patient coronavirus disease  covid- method search multiple datum source include pubmed medline ovid embase ovid ebm reviews scopus web science medrxiv.org november  include study enrol patient covid- treat cq hcq azithromycin report cardiac toxic effect perform meta analysis arcsine transformation different incidence result total  study total  patient include pool incidence torsade de pointe arrhythmia ventricular tachycardia cardiac arrest   ci  study  patient  study  patient pool incidence discontinuation cq hcq prolong qtc arrhythmia ci pool incidence change qtc baseline  millisecond qtc  millisecond ci mean median age coronary artery disease hypertension diabetes concomitant qt prolong medication intensive care unit admission severity illness study population explain study heterogeneity conclusion treatment patient covid- cq hcq associate important risk drug induce qt prolongation relatively high incidence torsade de pointe ventricular tachycardia cardiac arrest agent routinely management covid- disease patient covid- treat antimalarial indication adequately monitor
743,covid- disease cause coronavirus name sars cov- pandemic contagious nature majority patient asymptomatic have mild flu like symptom need hospitalisation severe acute respiratory infection sari co morbidity like diabetes hypertension renal failure etc associate severe covid- cause death publish case report monoclonal gammopathy unknown significance mgus patient covid- disease cytokine storm observe severe covid- cytokine include il- activate plasma cell increase blood condition present case severe covid- patient bioclonal gammopathy know diabetic hypertensive treatment develop sari cytokine storm septicaemia treat antibiotic enoxaparin hydroxychloroquine insulin anti hypertensive ventilator subsequently develop septicaemia multi organ failure die m band serum capillary electrophoresis presence igg kappa m band indicate biclonal gammopathy unknown significance patient conclude like mgus early stage biclonal gammopathy rare gets manifest m band plasma protein electrophoresis probably high level il- associate cytokine storm severe covid- stimulate early stage dyscratic plasma cell biclonal gammopathy risk factor severe covid- associated mortality
744,context objective covid- relevant medical issue globally despite study investigate clinical characteristic covid- patient datum report prevalence vertebral fracture vfs vfs influence cardiorespiratory function disease outcome aim study assess vfs prevalence clinical impact covid- design patient retrospective cohort study perform san raffaele hospital tertiary health care hospital italy include covid- patient lateral chest x ray emergency department available vfs detect semiquantitative evaluation vertebral shape chest x ray result total  patient include study thoracic vfs detect  patient patient vfs old frequently affect hypertension coronary artery disease p p p respectively thirty patient vfs+ group compare  vfs- group hospitalize p patient vfs frequently require noninvasive mechanical ventilation compare vfs p mortality vfs+ group vfs- group p particular mortality high patient severe vf compare moderate mild vf p conclusion vfs integrate cardiorespiratory risk covid- patient useful easy measure clinical marker fragility poor prognosis suggest morphometric thoracic vertebral evaluation perform suspect covid- patient undergo chest x ray
745,background role vitamin d status covid- patient matter debate objective assess serum -hydroxyvitamin d ohd level hospitalize patient covid- analyze possible influence vitamin d status disease severity method retrospective case control study  covid- patient  population base control serum ohd level measure group association serum ohd level covid- severity admission intensive care unit requirement mechanical ventilation mortality evaluate result  patient  vitamin d supplement analyze separately covid- patient mean standard deviation ohd level ng ml compare ng ml control p /= ng ml. causal relationship find vitamin d deficiency covid- severity combined endpoint separate component conclusion ohd level low hospitalize covid- patient population base control patient high prevalence deficiency find relationship vitamin d concentration vitamin deficiency severity disease
746,emergence new coronavirus severe acute respiratory syndrome coronavirus  sars cov- result global pandemic associated coronavirus disease  covid- result high number death worldwide observational study case report provide insight old age presence chronic disease frequently associate high covid- severity individual high risk mortality covid- review provide insight impact chronic disease associate cardiovascular system obesity diabetes mellitus hypertension cardiovascular disease sars cov- infection covid- additionally review recommendation guidance international scientific association discuss key learning importance future
747,sars cov infection covid- create panic world origin december  wuhan city china covid- pandemic infect million people death immune system play crucial role severity covid- development pneumonia induce acute lung injury ali acute respiratory distress syndrome ards provide protection innate t cell base adaptive immune response dysregulate severe sars cov infection dysregulation pronounced old population patient comorbiditie diabetes hypertension obesity pulmonary autoimmune disease covid- patient develop protective antibody abs sars cov long induction immune response pathogen require metabolic energy generate process immunometabolism change metabolic stage immune cell homeostasis inflammatory infectious environment call immunometabolic reprogramming article describe cellular immunology macrophage t cell b cell dendritic cell nk cell pulmonary epithelial cell pec vascular endothelial cell associated immune response covid- immunometabolism serve cell specific therapeutic approach target covid-
748,objective study aim discuss unique clinical feature patient zhengzhou city provide reference clinical diagnosis treatment patient method seventeen patient zhengzhou people hospital february march  collect epidemiology clinical symptom laboratory examination chest ct image  patient aged year average age  year consist  male .%  female patient history live travel wuhan  patient attack locally  remain patient unknown incidence reason result average incubation period  day average time course disease  day participant  patient fever symptom  patient normal body temperature patient symptom free carrier patient symptom patient develop mild symptom severe symptom  patient mild symptom  patient complication cardiovascular cerebrovascular disease hypertension  patient advanced stage squamous cell lung carcinoma  patient diabetes mellitus renal failure late stage uremia accord novel coronavirus nucleic acid test  patient positive account .% patient negative novel coronavirus igm antibody test negative common respiratory pathogen detection  patient ground glass like high density shadow strip high density shadow lung ct image accompany affected lesion lung average stay hospital  day average time course disease  day hospitalization  patient discharge hospital recovery  patient transfer superior hospital continuous treatment  patient die patient zhengzhou people hospital mainly attack local area mild symptom positive rate nucleic acid test conclusion main clinical characteristic increase neutrophil granulocyte increase c reactive protein decrease lymphocyte ground glass like strip lesion lung ct image common complication cardiovascular cerebrovascular disease favorable prognosis
749,novel coronavirus disease  covid- worldwide pandemic place significant burden hospital healthcare provider immune response disease think lead aberrant inflammatory response cytokine storm contribute severity illness urgent need confirm use tocilizumab provide benefit individual covid- single center propensity score match cohort study include consecutive covid- patient admit medical center discharge medical center expire march perform patient stratify accord receipt tocilizumab cytokine storm match control propensity score primary outcome hospital mortality total  patient meet inclusion exclusion criterion identify  patient include match dataset tocilizumab tocilizumab approximately patient male hypertension diabetes mellitus chronic pulmonary disease common comorbiditie present  death .% tocilizumab group  death .% tocilizumab group odd ratio confidence interval p advanced age history myocardial infarction dementia chronic pulmonary disease heart failure malignancy significantly common patient die current analysis support use tocilizumab management cytokine storm patient covid- use therapeutic agent limit context clinical trial evidence available
750,background association severity coronavirus disease  covid- presence certain chronic condition suggest unlike influenza virus disease burden covid- patient asthma evident objective understand impact covid- patient asthma method big data analytic artificial intelligence savana manager clinical platform analyse clinical datum patient asthma january  result  patient asthma  .% suffer covid- compare asthmatic individual covid- patient asthma covid- significantly old versus  year predominantly female versus smoke frequently high prevalence hypertension dyslipidaemia diabetes obesity allergy relate factor rhinitis eczema common asthmatic patient covid- p addition high prevalence comorbiditie observe patient covid- require hospital admission use inhale corticosteroid ics low patient require hospitalisation covid- compare non hospitalise patient versus .% ci patient treat biologic n= .% show increase severity comorbiditie ear nose throat level covid relate hospitalisation patient relatively low conclusion patient asthma covid- old increase risk comorbidity relate factor ics biologic generally safe associate protective effect severe covid- infection
751,background new coronavirus covid- rapidly result pandemic report characteristic patient severe critical severe acute respiratory syndrome coronavirus  sars cov- infection wuhan city china risk factor relate infection severity death method extract demographic clinical datum  patient severe covid- infection designate wuhan hospital  february factor associate covid- critical illness mortality analyse logistic- cox regression analysis result study  patient severe covid- illness  critically ill patient median iqr age  year .% male .% retiree .% self report history chronic disease end study  patient .% recover discharge  .% die remainder receive treatment number daily confirm critical case peak  january  february patient advanced age odd ratio confidence interval cis .- male sex ci pre existing diabetes hypertension cardiovascular disease respiratory disease likely critically ill compare recover discharge patient die old hazard ratio hr ci likely male hr ci likely hypertension hr cardiovascular disease hr diabetes hr conclusion advanced age male sex history chronic disease associate covid- critical illness death identify risk factor help clinical monitoring susceptible population
752,background cardiovascular disease cvd traditional risk factor predict severe coronavirus disease  covid- uncertain potential confound age sex method perform systematic review study explore pre exist cvd traditional risk factor risk factor severe covid- define death acute respiratory distress syndrome mechanical ventilation intensive care unit admission search pubmed embase paper english original datum /= case severe covid- random effect model pool relative risk rr estimate conduct meta regression analysis result  publication identify search  paper meet inclusion criterion covid- patient include severe case old age consistently associate severe covid- eligible study rr versus year study show change rr age adjust covariate(s univariate analysis factor robustly associate severe covid- male sex study pool rr ci hypertension study diabetes study cvd study rr male sex likely independent age factor meta regression analysis suggest confound age study report multivariable analysis show adjust rr hypertension diabetes cvd study explore renin angiotensin system inhibitor risk factor severe covid- conclusion despite potential confound result suggest hypertension diabetes cvd independently associate severe covid- age male sex informative predict risk severe covid-
753,objective purpose assess ability low dose ct ldct determine lung involvement sars cov- pneumonia describe covid ldct severity score material method patient sars cov- infection confirm rt pcr retrospectively analyse clinical datum national early warning score news imaging feature record lung feature include ground glass opacity ggo area consolidation crazy paving pattern covid ldct score calculate sum score segment  involvement  severe impairment univariate analysis perform explore predictive factor high covid ldct score nonparametric mann whitney test compare group spearman correlation p significance result eighty patient positive rt pcr analyse mean age  year /-  male frequent symptom fever cough mean news ldct analyse normal major imaging finding ggo  case covid ldct score mean value correlate news r p symptom risk factor pulmonary involvement univariate analysis show dyspnea high respiratory rate hypertension diabete associate covid ldct score superior conclusion covid ldct score correlate news significantly different clinical low risk high risk group work need validate covid ldct score patient prognosis
754,aim assess impact liver function test lft abnormality prognosis patient coronavirus disease  covid- french cohort hospitalize patient patient method march  april collect computerized anonymize database medical record laboratory datum clinical outcome patient hospitalize confirmed case covid- infection rt pcr and/or ct scan patient follow april  death discharge consider statistical analysis lft abnormality level great time upper limit normal composite endpoint include admission icu mechanical ventilation severe radiologic injury death define disease severity result  patient median age  year covid-  .% abnormal lft hypertension .% diabetes .% main comorbiditie .% take liver toxic drug admission .% give drug know induce hepatic cytolysis hospitalization patient elevated level alt ast significantly severe high rate admission icu .% vs .% p global mortality .% vs .% p= multivariate analysis obesity cytolytic profil associate composite endpoint respectively p= confidence interval p value conclusion liver injury mild transient covid- lft abnormality associate poor prognosis relevant biomarker early detection severe infection
755,aim investigate clinical characteristic identify risk factor severity coronavirus disease  covid- pneumonia outside wuhan china materials method include  patient confirmed covid- discharge die  march retrospectively collect epidemiological clinical laboratory compute tomography imaging outcome datum clinical characteristic describe relative risk factor compare result clinical characteristic study similar study wuhan low mortality rate mild severity median time onset symptom confirmation hospitalization   day respectively median virus clearance shed time   day respectively severe critical group compare mild moderate group significant risk factor include old age dyspnea hypertension poor appetite fatigue high white cell count neutrophil count prothrombin time creatine kinase creatine kinase mb d dimer alanine aminotransferase alt aspartate aminotransferase ast lactate dehydrogenase ldh c reactive protein low lymphocyte count albumin p intensive care unit icu group compare non icu group risk factor include old age chronic obstructive pulmonary disease copd dyspnea poor appetite high white cell count d dimer alt ast ldh low lymphocyte count albumin p independent risk factor associate severe critical group dyspnea odd ratio alt albumin independent risk factor associate icu group dyspnea copd d dimer alt ldh p conclusion severity covid- outside wuhan china mild wuhan clinical infective period long long virus shed time  day important risk factor dyspnea copd d dimer alt ldh albumin review paper available supplemental material section
756,covid- recently emerge infectious disease cause novel severe acute respiratory syndrome coronavirus sars cov. sars cov differ previous coronavirus infection sars mers high infectivity reproduction value r typically pre- asymptomatic transmission property contribute current global covid- pandemic identify risk factor disease severity death sars cov infection include old age male sex diabetes obesity hypertension reason association largely obscure evidence emerge sars cov infection exacerbate underlie pathophysiology hyperglycemia people diabetes discuss potential mechanism diabetes affect risk severe outcome covid- additionally diabetic emergency long term pathology aggravate infection virus consider role immune system observed phenomenon microangiopathy severe covid- infection potential direct viral toxicity metabolically relevant tissue include pancreatic beta cell target insulin action
757,objective evaluate acute cardiac injury covid- patient association adverse outcome include mortality united arab emirates uae population method retrospective study conduct february june  dubai uae laboratory confirm coronavirus disease- patient demographic clinical laboratory radiological clinical outcome compare patient acute cardiac injury result study period  patient include  .% evidence acute cardiac injury compare patient acute cardiac injury patient acute cardiac injury old shortness breath diabetes hypertension bilateral airspace shadow admission chest radiography patient high neutrophil count c reactive protein procalcitonin ferritin d dimer lactate dehydrogenase low lymphocyte count outcome patient high intensive care admission high rate complication include acute kidney liver injury acidosis septic shock acute respiratory distress syndrome need mechanical ventilation significantly high risk death conclusion acute cardiac injury common coronavirus disease- patient patient present high comorbiditie high inflammatory marker great risk hospital multi organ damage need mechanical ventilation death prompt assessment intervention recommend
758,objective determine association comorbiditie severity disease covid- patient method search cochrane medline trip embase database review include available study covid- patient publish english language study clinical characteristic comorbiditie disease outcome beginning pandemic author extract study characteristic risk bias odd ratio analyze datum confidence interval ci result review include covid- patient  observational study degree bias risk substantial heterogeneity significant association record covid- severity follow variable male or= ci= current smoker or=. ci= presence comorbiditie include hypertension or=. ci= diabetes or=. ci= coronary heart disease or=. ci= chronic kidney disease or=. ci= cancer or=. ci= conclusion comorbiditie covid- patient contribute increase susceptibility severe illness identification potential risk factor help reduce mortality identify patient poor prognosis early stage
759,background prediction covid- disease behavior early phase infection challenge urgently need mulbsta score scoring system predict mortality viral pneumonia induce variety virus include coronavirus scoring system verify novel coronavirus pneumonia aim study validate scoring system estimate risk disease worsen patient covid- method study include patient treat april  st march  th patient classify mild moderate severe group accord extent respiratory failure mulbsta score apply estimate risk disease worsen severity group validate utility scoring system result total  patient analyze  patient mild disease  show disease progression moderate severe disease admission model show sensitivity specificity .% cut value  point  patient mild moderate disease  deteriorate severe disease model show sensitivity .% specificity .% cut value  point conclusion study show mulbsta score potentially useful tool predict covid- disease behavior scoring system criterion identify high risk patient worsen life threaten status
760,background coagulation abnormality frequently encounter patient coronavirus disease  covid- especially severe disease hematologic abnormality suspect occur context underlying immune dysregulation endothelial dysfunction elevated d dimer level covid associated coagulopathy cac disseminate intravascular coagulation dic positive lupus anticoagulant common finding date current guideline suggest patient covid- receive pharmacologic thromboprophylaxis case report -year old man medical history hypertension type  diabetes advanced prostate cancer remission present generalized weakness center reverse transcription polymerase chain reaction test positive severe acute respiratory syndrome coronavirus patient symptom covid- find prolong activate partial thromboplastin time secondary high titer factor viii inhibitor lupus anticoagulant eventually develop respiratory compromise disease manifest bleeding prothrombotic state conclusion report highlight importance comprehensive evaluation prolonged partial thromboplastin time make assumption base positive lupus anticoagulant result case present concomitant factor viii inhibitor cause patient great bleeding tendency imperative physician balance risk bleed clotting patient covid- patient vary presentation base disease severity level immune dysregulation
761,background coronavirus disease  covid- show affect organ body clear thyroid gland impair covid- patient euthyroid sick syndrome ess usually associate disease severity deterioration prognosis critical illness study thyroid function covid- patient assess factor associate outcome analyze determine potential predictive value ess method clinical laboratory datum covid- patient ess changsha china collect analyze admission kaplan meier curve cox regression model utilize determine correlation ess endpoint subsequently receiver operate characteristic roc curve plot evaluate predictive performance ft c reactive protein crp disease severity result .% case covid- patient diagnose ess ess patient high proportion fever shortness breath hypertension diabetes severe event non ess patient level erythrocyte sedimentation rate c reactive protein positive rate procalcitonin significantly high lymphocyte count apparently low ess patient non ess patient regression analysis show ess significantly associate disease severity covid- hr ci p area curve aucs predict severe disease ci p ci p ft crp respectively conclusion ess significantly associate disease severity inflammatory parameter covid- patient
762,background emerge severe acute respiratory syndrome coronavirus  sars cov- result worldwide devastating effect diagnostic challenge identify risk factor severity aid assessment need early hospitalization aim demonstrate time clinical laboratory radiological characteristic coronavirus disease  covid- patient identify predictor severity describe antimicrobial resistance profile patient upper egypt materials method demographic character clinical presentation laboratory radiological datum record analyze presence respiratory microorganism sensitivity pattern identify vitek system resistance associate gene test pcr result study include  covid- patient majority male .% age   year hypertension diabetes ischemic heart disease common comorbiditie main clinical manifestation fever .% cough .% dyspnea fatigue accord severity .% moderate mild severe critical lymphopenia elevated crp ferritin d dimer occur patient significantly high value severe group age year elevated ferritin /= ng ml significant risk factor severity .% covid- patient show bacterial and/or fungal infection klebsiella pneumoniae acinetobacter baumannii staphylococcus aureus predominant isolated bacteria candida albican candida glabrata predominant isolate fungus staphylococci methicillin resistant carry meca gene gram negative isolate multidrug resistant carry different resistance associate gene include ndm- kpc tem ctx m shv conclusion old age elevated serum ferritin significant risk factor severe covid- bacterial co infection multidrug resistance patient covid- upper egypt common test presence co infect agent consider prompt treatment carry accord antimicrobial sensitivity report
763,objective investigate laboratory marker covid- progression patient different medical condition method perform multicenter retrospective study  case hubei avoid collinearity indicator principal component analysis pca follow partial square discriminant analysis pls da perform obtain overview laboratory assessment multivariable logistic regression analysis multivariable cox proportional hazard regression analysis respectively explore risk factor associate disease severity mortality survival analysis perform patient common comorbiditie result lactate dehydrogenase ldh prealbumin associate disease severity patient comorbiditie indicate pca pls da multivariable logistic regression analysis mortality risk associate age ldh c reactive protein crp d dimer lymphopenia patient comorbiditie crp risk factor associate short term mortality patient hypertension liver disease additionally d dimer risk factor death patient liver disease conclusion lactate dehydrogenase reliable predictor associate covid- severity mortality patient different medical condition laboratory biomarker mortality risk identical patient comorbiditie suggest multiple pathophysiological mechanism follow covid- infection
764,background emergent fulminant infectious disease corona virus disease  covid- cause worldwide pandemic early identification timely treatment severe patient crucial reduce mortality covid- study aim investigate clinical characteristic early predictor severe covid- establish prediction model identification triage severe patient method confirm patient covid- admit second affiliated hospital air force medical university enrol retrospective non interventional study patient divide mild group severe group clinical datum compare group univariate multivariate analysis identify independent early predictor severe covid- prediction model construct multivariate logistic regression analysis receiver operate characteristic roc curve evaluate predictive value prediction model early predictor result total  patient enrol study  mild  severe proportion patient venerable age year old comorbiditie hypertension severe patient high mild p duration fever respiratory symptom interval illness onset viral clearance long severe patient p patient receive form oxygen treatment severe patient require mechanical ventilation p univariate multivariate analysis show venerable age hypertension lymphopenia hypoalbuminemia elevate neutrophil lymphocyte ratio nlr independent high risk factor severe covid- roc curve demonstrate significant predictive value age lymphocyte count albumin nlr severe covid- sensitivity specificity newly construct prediction model predict severe covid- .% respectively positive predictive value negative predictive value crude agreement conclusion severe covid- risk model help clinician quickly identify severe patient early stage timely optimal therapeutic schedule
765,coronaviruse rna virus cause disease upper low respiratory tract human animal lately new coronavirus cause pneumonia case detect wuhan china december soon virus identify severe acute respiratory syndrome world health organization name disease coronavirus disease- covid- country case begin appear second week march study aim investigate demographic characteristic risk factor patient diagnosis covid- total  patient female  male include study patient include study randomly select registration system information evaluate retrospectively mean age patient age range= risk factor catch disease evaluate determine risk factor  patient  patient close contact covid- patient social environment  patient travel history outside city  day common symptom patient cough fever dyspnea weakness sore throat diarrhea headache sputum common comorbid condition patient detect hypertension diabetes mellitus dm congestive heart failure allergic asthma chronic obstructive pulmonary disease rheumatoid arthritis coronary artery disease solid organ tumour depression epilepsy mean age  patient monitor intensive care unit  y mean age  patient follow service difference statistically significant p= group compare term comorbid disease presence dm high n= intensive care patient difference statistically significant p= addition majority patient patient hospitalize intensive care unit male p= smoking evaluate risk factor illness   patient intensive care unit smoking history patient die covid- smoking history finding suggest smoking increase severity covid- disease result knowledge disease increase rapidly share study risk factor transmission route clinical feature covid- infection affect world
766,background -day readmission rate important indicator patient safety hospital quality performance study aim find -day readmission rate mild moderate severity coronavirus disease  covid- patient discharge tertiary care university hospital demonstrate possible factor associate readmission method observational single center study epidemiological clinical datum patient hospitalize diagnosis covid- retrieve research database patient information record prospectively readmission datum seek hospital information management system national health information system detect patient readmitte hospital  day discharge adult patient year old hospitalize covid- ward diagnosis mild moderate covid-  march  case admit hospital  april  include result  march   mild moderate severity non critical covid- patient discharge covid- ward  .% readmitte median time readmission day interquartile range iqr patient .% categorize mild disease remain  .% moderate disease patient  year age metastatic cancer hypertension develop sepsis die hospital readmission episode malignancy .% vs. .% p hypertension .% vs. p common readmitte conclusion study report -day readmission rate covid- literature comprehensive study need reveal cause predictor covid- readmission
767,aim study aim assess body mass index bmi fast plasma glucose fpg level blood pressure bp kidney function associate risk severe disease death patient covid- method datum candidate risk factor extract patient checkup record propensity score match cohort construct logistic regression model adjust age sex comorbiditie primary outcome death severe covid- define require supplementary oxygen high ventilatory support result patient confirmed covid- .% receive checkup severe covid- occur  patient bmi .- associate outcome woman aor ci patient age year aor ci fpg  mg dl associate poor outcome woman aor ci man similarly estimate glomerular filtration rate egfr  ml min/. m risk factor woman aor ci patient age  year conclusion effect bmi fpg egfr outcome associate covid- prominent woman man
768,introduction underlie disease critical role vulnerability population great morbidity mortality suffer covid- aim current study evaluate prevalence underlie disease die people covid- method current study conduct accord prisma guideline international database include pubmed scopus web science cochrane google scholar search relevant study  june relevant article report underlying disease die case covid- include analysis result screen exclude duplicate irrelevant study  article include analysis prevalent comorbiditie hypertension diabetes cardiovascular disease liver disease lung disease malignancy cerebrovascular disease copd asthma report underlying disease high low prevalence relate hypertension asthma estimate respectively conclusion summary underlie disease critical role poor outcome severity disease high mortality rate covid- case patient hypertension cardiovascular disease diabetes carefully monitor aware health protocol
769,renin angiotensin aldosterone system raas inhibitor include angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb prescribed antihypertensive medication previous study show raas inhibitor increase expression ace cellular receptor severe acute respiratory syndrome coronavirus  sars cov- provoke concern use acei arb hypertensive individual lead increase mortality severity coronavirus disease  covid- investigate effect acei arb covid- patient systematically relevant study meet predetermined inclusion criterion search pubmed embase cochrane library database search strategy include clinical datum publish october study involve  hypertensive patient acei arb treat group  hypertensive patient non acei arb treat group analyze random effect meta analysis show acei arb treatment significantly associate low risk mortality hypertensive covid- patient odd ratio confidence interval ci p meta regression analysis show age gender study site newcastle ottawa scale score comorbiditie diabetes coronary artery disease chronic kidney disease cancer significant modulating effect acei arb treatment mortality hypertensive covid- patient p addition acei arb treatment associate low risk ventilatory support ci p conclusion result suggest acei arb medication discontinue hypertensive patient context covid- pandemic
770,objective limited datum outcome hospital cardiac arrest coronavirus disease  patient study report outcome hospital cardiac arrest coronavirus disease  patient united states describe characteristic outcome hospital cardiac arrest coronavirus disease  patient rural southwest georgia design retrospective cohort study setting single center multihospital patient consecutive coronavirus disease  patient experience hospital cardiac arrest attempt resuscitation intervention attempt resuscitation advanced cardiac life support measurement main result patient hospitalize coronavirus disease  study period  patient suffer hospital cardiac arrest attempt resuscitation include study median age  year .% male majority patient african americans common comorbiditie hypertension .% obesity .% diabetes .% chronic kidney disease .% eighteen patient .% charlson comorbidity index common present symptom shortness breath .% fever .% cough median duration symptom prior admission  day hospital course .% patient develop septic shock .% acute respiratory distress syndrome prior hospital cardiac arrest ventilator .% vasopressor .% dialysis majority hospital cardiac arrest .% occur icu time initiation advanced cardiac life support protocol  minute hospital cardiac arrest icu  minute remain patient common initial rhythm pulseless electrical activity asystole return spontaneous circulation achieve patient brief hospital mortality conclusion study coronavirus disease  patient suffer hospital cardiac arrest hospital mortality regardless baseline comorbiditie present illness severity location arrest
771,coronavirus disease infectious disease cause severe acute respiratory syndrome coronavirus- result global pandemic unprecedented health societal economic impact disease manifest flu like symptom dominate pulmonary complication widely diverse clinical manifestation involve multiple organ system result posit viral tropism aberrant host immune response mediate protean finding severity disease general extrapulmonary manifestation harbinger contemporaneously associate disease progression case extrapulmonary finding gastrointestinal dermatologic track mild disease precise underlying pathophysiological mechanism remain incompletely elucidate additional immune phenotyping study warrant reveal early correlate disease outcome novel therapeutic target
772,background aim coronavirus disease  covid- global pandemic spectrum disease asymptomatic mild disease severe case require intensive care unit icu admission india start mild presentation affect young population later increase disease severity observe involve old age group paucity publish datum patient require icu care india case series describe initial experience icu india epidemiological profile clinical course outcome critically ill covid- patient method case series include  consecutive laboratory confirm covid- patient admit tertiary care icu  day period follow till discharge icu demographic clinical datum include laboratory radiological finding compile special attention co morbidity patient management patient institutional protocol critically ill covid- patient result median age patient  year difference gender comorbid condition see patient diabetes .% hypertension .% common condition median duration symptom admission  day fever common clinical symptom presentation chest roentogram show bilateral lung infiltrate .% patient mild moderate severe hypoxia observe  patient respectively patient manage oxygen therapy seventeen patient .% require ventilatory support mortality rate patient admit icu conclusion case series show middle aged patient comorbid disease present severe covid- disease poor outcome
773,recent coronavirus disease  covid- pandemic show different severity disease male female man severely ill high rate woman datum age dependent disease susceptibility mortality elderly suggest sex hormone main factor determine clinical course infection difference age male versus female role sex hormone key phenotype covid- infection describe review recommendation base dimorphic approach male female suggest sex specific management disease
774,importance therapy improve survival critically ill patient coronavirus disease  covid- need tocilizumab monoclonal antibody interleukin  receptor counteract inflammatory cytokine release syndrome patient severe covid- illness objective test tocilizumab decrease mortality population design setting participant datum study derive multicenter cohort study  adult covid- admit participate intensive care unit icu  hospital march  critically ill adult covid- categorize accord receive receive tocilizumab  day admission icu datum collect retrospectively june cox regression model inverse probability weighting adjust confound exposure treatment tocilizumab  day icu admission main outcomes measures time death compare hazard ratio hrs -day mortality compare risk difference result  patient include analysis male median age  interquartile range iqr year  .% receive tocilizumab  day icu admission patient treat tocilizumab young median age  iqr vs  iqr year high prevalence hypoxemia icu admission  vs   .% mechanical ventilation ratio partial pressure arterial oxygen fraction inspire oxygen mm hg patient treat tocilizumab apply inverse probability weighting baseline severity illness characteristic balanced group total  patient .% die include  .% treat tocilizumab  .% treat tocilizumab primary analysis median follow  iqr day patient treat tocilizumab low risk death compare treat tocilizumab hr ci estimate -day mortality ci .%-.% tocilizumab treat patient ci .%-.% non tocilizumab treat patient risk difference ci .%-.% conclusion relevance critically ill patient covid- cohort study risk hospital mortality study low patient treat tocilizumab  day icu admission compare patient treatment include early use tocilizumab finding susceptible unmeasured confound research randomized clinical trial need
775,coronavirus disease  covid- pandemic strain healthcare system particularly patient severe outcome require admittance intensive care unit icu study investigate potential association obesity diabete covid- severe outcome assess icu admittance medical history demographic patient characteristic retrospective cohort patient hospitalize covid- analyse single centre kuwait univariate multivariate analysis perform explore association different variable icu admittance  hospitalize patient  diabetes  hypertension  require admittance icu patient available measurement  body mass index bmi kg m univariate analysis show overweight obesity class morbid obesity associate icu admittance patient diabetes likely admit icu model multivariate regression analysis assess bmi diabete icu outcome bmi model class morbid obesity associate icu admittance diabetes model diabetes associate increase icu admittance hypertension protective effect icu admittance cohort overweight obesity diabetes patient covid- associate icu admittance increase risk poor outcome
776,argument angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb treatment alter risk coronavirus disease  covid- susceptibility disease severity identify total  eligible study systematic review  study adjust confounder include meta analysis find association prior acei arb use risk severe acute respiratory syndrome coronavirus  sars cov- infection general population adjust odd ratio aor confidence interval ci .- risk mortality aor ci severe outcome aor ci .- unchanged covid- patient take acei arb finding remain consistent subgroup analysis stratify population drug exposure secondary outcome systematic review provide evidence base support current medical guideline position statement aceis arb discontinue additionally evidence initiate acei arb regimen prevention treatment covid-
777,background cytokine storm marker coronavirus disease  covid- illness severity increase mortality immunomodulatory treatment repurpose improve mortality outcome research question immunomodulatory therapy improve survival patient covid- cytokine storm ccs study design method conduct retrospective analysis electronic health record northwell health system covid- patient hospitalize march april include ccs define inflammatory marker ferritin  ng ml c reactive protein crp  mg dl lactate dehydrogenase ldh  u l. patients subdivide group immunomodulatory treatment standard care group receive corticosteroid anti il- antibody tocilizumab anti il- therapy anakinra combination corticosteroid primary outcome hospital mortality result thousand seven seventy patient meet inclusion criterion common comorbiditie hypertension -% diabetes -% cardiovascular disease -% patient frequently meet criterion high ldh .% combination follow ferritin .% crp .% patient show elevated d dimer patient treat corticosteroid tocilizumab combination show low mortality compare patient receive standard care soc treatment hazard ratio hr ci p patient treat corticosteroid hr ci p combination anakinra hr ci p corticosteroid administer hr ci p combination tocilizumab hr ci p anakinra hr ci p improve hospital survival compare soc treatment interpretation combination corticosteroid tocilizumab show superior survival outcome compare soc treatment treatment corticosteroid combination anakinra furthermore corticosteroid use combination tocilizumab anakinra associate reduce hospital mortality patient ccs compare patient receive soc treatment
778,background comorbiditie associate increase risk severity mortality coronavirus disease  covid- include hypertension diabetes cerebrovascular disease chronic kidney disease chronic obstructive pulmonary disease purpose systematic review meta analysis attempt investigate association heart failure hf poor outcome patient covid- method perform systematic literature search pubmed europepmc scopus cochrane central database search term heart failure covid- outcome interest mortality poor prognosis define incidence severe covid- infection admission icu use ventilator patient preexist heart failure coronavirus disease result identify  potential article search  duplicate remove screen title abstract remain  article identify  potentially relevant article exclude  study following reason study systematic review study meta analysis article literature review  article report outcome interest finally include remain  study qualitative synthesis meta analysis patient  study hf associate hospitalization covid hr p high heterogeneity p hf associate poor outcome demonstrate p high heterogeneity p patient preexisting hf associate high mortality p moderately high heterogeneity p conclusion patient heart failure increase risk hospitalization poor outcome death covid- significant difference mortality patient heart failure observe patient heart failure have high mortality
779,emergence novel  coronavirus disease p. r. china highly contagious disease currently spread country worldwide novel  coronavirus disease middle east respiratory syndrome severe acute respiratory syndrome report cause high risk severe infection patient chronic comorbiditie hypertension diabetes severe infection contribute high rate morbidity mortality patient present review discuss role underlying mechanism common chronic disease type- diabetes mellitus hypertension clinical manifestation disease severity novel  coronavirus disease middle east respiratory syndrome severe acute respiratory syndrome hope provide evidence well decision making treatment vulnerable population
780,background coronavirus disease  covid- pandemic place unprecedented burden delivery intensive care service worldwide research question global point estimate death risk factor patient admit icu severe covid- study design method systematic review meta analysis medline embase cochrane library search august pooled prevalence participant characteristic clinical feature outcome datum calculate use random effect model subgroup analysis base geographic distribution study type quality assessment sample size end date patient disposition study report hospital mortality rate adult patient age year confirm covid- admit icu meet study eligibility criterion critical evaluation perform newcastle ottawa scale nonrandomized study result study patient  country continent include patient covid- admit icu mean age year ci common comorbiditie include hypertension .% ci diabetes mellitus .% ci quarter case experience development ards .% ci invasive mechanical ventilation require ci .- case vasopressor support ci .- case renal replacement therapy ci .- case extracorporeal membrane oxygenation ci .- case duration icu hospital admission day ci day ci .- respectively hospital mortality rate ci significant subgroup effect observe interpretation critically ill patient covid- admit icu require substantial organ support prolong icu hospital level care pooled estimate global death severe covid-
781,december coronavirus disease  covid- emerge global pandemic aim investigate clinical characteristic analyze risk factor prolonged viral rna shed retrospectively collect datum  hospitalize covid- patient single center wuhan china factor associate prolonged viral rna shed /= day investigate .% patient prolong viral rna shed patient prolonged viral shedding old high rate hypertension proinflammatory cytokine include interleukin r il r tumor necrosis factor alpha tnf alpha significantly elevate patient prolonged viral shedding multivariate analysis reveal hypertension old age lymphopenia elevate serum il r independent risk factor prolonged viral shedding comprehensive investigation reveal distinct characteristic patient prolonged viral rna shed hypertension old age lymphopenia high level proinflammatory cytokine correlate prolonged viral shedding
782,high prevalence thrombotic event severely ill covid- patient report pulmonary embolism microembolization vital organ individual direct cause death identification patient high risk develop thrombosis lead target effective prophylactic treatment primary aim study test rotational thromboelastometry rotem admission indicate hypercoagulopathy predict disease severity assess care level covid- patient study design prospective observational study covid- patient  year admit hospital eligible inclusion patient divide group depend care level regular ward ward specialized ventilation support conventional coagulation test blood type rotem take admission  patient include age  median man comorbiditie e.g. hypertension diabetes rotem variable maximum clot firmness extem-/fibtem mcf high covid- patient compare healthy control p high severely ill patient compare patient regular ward p result suggest hypercoagulopathy present early patient mild moderate disease pronounced severe covid- pneumonia non o blood type overrepresente covid- positive patient rotem variable show hypercoagulopathy admission pattern pronounced patient increase disease severity feature predict risk thromboembolic complication study warrant
783,aim study assess prognostic value baseline clinical high resolution ct hrct finding patient severe covid- retrospective center study include group inpatient severe covid- discharge die jin yin tan hospital wuhan union hospital january february case confirm real time polymerase chain reaction demographic clinical laboratory datum hrct imaging collect compare discharge deceased patient univariable multivariable logistic regression model assess predictor mortality risk patient  patient include study  discharge  die hospital mean age year  .% man  patient hypertension .% cardiovascular disease .% diabetes .% chronic pulmonary disease .% common coexist condition multivariable regression analysis show old age ci p acute respiratory distress syndrome ards ci p reduce lymphocyte count ci p elevate hrct score ci p independent predictor mortality risk admission severe covid- patient finding important clinical implication decision making base risk stratification severe covid- patient
784,background aki common sequela coronavirus disease  covid- study focus aki treat rrt aki rrt method conduct multicenter cohort study  critically ill adult covid- admit intensive care unit icu  hospital united states multivariable logistic regression identify patient hospital level risk factor aki rrt examine risk factor -day mortality patient result total   patient .% develop aki rrt  day icu admission  .% die  day icu admission patient level risk factor aki rrt include ckd man non white race hypertension diabetes mellitus high body mass index high d dimer great severity hypoxemia icu admission predictor -day mortality patient aki rrt old age severe oliguria admission hospital few icu bed great regional density covid- end median follow  day range day   patient .% aki rrt die  .% discharge  .% remained hospitalize  patient discharge  .% remain rrt dependent discharge  .% remain rrt dependent  day icu admission conclusion aki rrt common critically ill patient covid- associate hospital mortality rate survive discharge depend rrt discharge remain rrt dependent  day icu admission
785,infection severe acute respiratory syndrome sars coronavirus- sars cov- causative agent new disease covid- risk severe covid- increase certain underlie comorbiditie include asthma cancer cardiovascular disease hypertension diabetes obesity notably exposure hormonally active chemical call endocrine disrupt chemical edcs promote cardio metabolic disease endocrine relate cancer immune system dysregulation link high risk severe covid- bisphenol bpa common edc exert effect receptor widely distribute human tissue include nuclear oestrogen receptor eralpha erbeta membrane bind oestrogen receptor g protein couple receptor gpr human nuclear receptor oestrogen relate receptor gamma paper focus potential role bpa promote comorbiditie associate severe covid- potential bpa induce effect key sars cov- infection mediator angiotensin convert enzyme  ace transmembrane serine protease  tmprss interestingly gpr appear exhibit great co localisation tmprss key tissue like lung prostate suggest bpa exposure impact local expression sars cov- infection mediator overall potential role bpa risk severity covid- merit investigation
786,background liberal administration hydroxychloroquine sulphate hcq covid- patient raise concern risk qtc prolongation cardiac arrhythmia particularly prescribe azithromycin evaluate incidence qtc prolongation moderately severely ill covid- patient treat hcq existence concomitant alternative cause method covid- patient treat hcq mar  apr tertiary medical centre include clinical characteristic relevant risk factor collect electronic medical record individual patient qtc interval determine treatment hcq primary outcome measure seek composite end point comprise increase millisecond ms qtc interval compare pre treatment qtc and/or maximal qtc interval ms results ninety patient include median age  year iqr  male thirty patient severely critically ill hypertension obesity common n  qtc prolongation evolve  patient age year congestive heart failure severity disease c reactive protein level hypokalaemia furosemide treatment associate qtc prolongation adjust analysis show qtc prolongation time likely hypokalaemia ci time likely furosemide treatment  ci .- conclusion patient treat hcq qtc prolongation associate presence traditional risk factor hypokalaemia furosemide treatment
787,severe acute respiratory syndrome coronavirus  sars cov- virus lead global public health emergency cause coronavirus disease  covid- initially identify wuhan china cause significant respiratory illness respiratory symptom common present symptom recognize covid- encompass multiple organ system include cardiovascular system acute myocardial injury st elevation myocardial infarction stemi associate covid- covid- patient cardiovascular manifestation risk increase severity illness present case young -year old patient past history hypertension coronary artery disease risk factor coronary artery disease obesity develop stemi hospital
788,change immune coagulation system possible viral spread blood brain barrier describe sars cov- infection study evaluate possible retinal involvement ocular finding severe covid- pneumonia patient cross sectional study conduct  patient affect severe covid- hospitalize intensive care unit icu infectious disease ward include bedside eye screening corneal sensitivity assessment retinography total  sars cov positive pneumonia patient affect covid- pneumonia include include  male  female median age  year iqr patient unilateral posterior chorioretinitis opportunistic origin aqueous tap negative sars cov- retinal manifestation relate covid- infection find cohort find  patient bilateral conjunctivitis pcr analysis conjunctival swab provide negative result sars cov- alteration corneal sensitivity find demonstrate absence retinal involvement sars cov- pneumonia patient ophthalmologic evaluation covid- particularly patient hospitalize icu setting useful reveal systemic co infection opportunistic pathogen
789,objective acute myocardial damage detect significant portion patient coronavirus  disease covid- infection report prevalence -% aim study investigate relationship electrocardiographic finding indicator severity covid- detect electrocardiography ecg method total  patient hospitalize covid- april   enrol study patient divide group accord severity covid- infection severe n non severe n ecg finding time admission record patient clinical characteristic laboratory finding retrieve electronic medical record result mean age year severe group year non severe group st depression vs. t wave inversion vs. st t change vs. presence fragmented qrs fqrs vs. frequent severe group compare non severe group multivariate analysis reveal hypertension odd ratio confidence interval ci]:.- p severity covid- infection ci p presence cardiac injury ci p d dimer ci p independent predictor st t change ecg conclusion st depression t wave inversion st t change presence fqrs admission ecg closely associate severity covid- infection
790,background despite th month pandemic knowledge respect viral dynamic infectivity rt pcr positivity continue evolve aim analyse sars cov- nucleic acid rt pcr profile covid- patient design retrospective observational study conduct covid facility aiims new delhi method patient admit laboratory confirm covid- eligible enrolment patient incomplete detail single pcr test exclude datum demographic detail comorbiditie treatment receive result sars cov- rt pcr perform nasopharyngeal oropharyngeal swab collect different time point retrieve hospital record result total  patient include majority male .% mean age year year mean duration symptom onset positive rt pcr day sd symptom onset positive test day sd proportion positive rt pcr test .% .% st nd rd th week illness total  symptomatic patient prolong positive test result  week symptom onset age  year associate prolonged rt pcr positivity statistically significant conclusion study show average period pcr positivity  week covid- patient elderly patient prolong duration rt pcr positivity require follow
791,host protease suggest crucial dissemination mers sars cov sars cov- coronaviruse relative contribution membrane versus intracellular protease remain controversial transmembrane serine protease  tmprss regard main protease implicate coronavirus s protein priming important step binding s protein angiotensin convert enzyme  ace receptor cell entry main cellular location sars cov- s protein priming occur remain debatable hamper development target treatment identify human extracellular serine protease inhibitor serpin alpha  antitrypsin aat novel tmprss inhibitor structural modeling reveal aat dock extracellular domain tmprss conformation suitable catalysis resemble similar serine protease inhibitor complex inhibitory activity aat establish sars cov- viral load system notably plasma aat level associate covid- disease severity datum support key role extracellular serine protease sars cov- infection indicate treatment serpin particularly fda approve drug aat effective limit sars cov- dissemination affect surface host cell summary delivery extracellular serine protease inhibitor serpin aat capacity reduce sars cov- dissemination bind inhibit extracellular protease host cell inhibit step sars cov- cell cycle i.e. cell entry
792,outbreak coronavirus disease  covid- world wide emergency severity covid- highly correlate mortality rate aim disclose clinical characteristic prognostic factor covid- patient develop severe covid- study enrol case no= mild moderate type covid- fangcang shelter hospital jianghan total  patient progress mild moderate severe absolute shrinkage selection operator regression model select prognostic factor model case severity rate shelter hospital symptomatic admission fever cough fatigue common symptom hypertension diabetes coronary heart disease common co morbidity predictor contain prediction nomogram include fever distribution peak temperature degree c myalgia arthralgia distribution c reactive protein /= mg l distribution peak temperature degree c set myalgia arthralgia c reactive protein /= mg l prognostic factor identify progression covid- patient mild moderate type early attention risk factor help alleviate progress covid-
793,introduction severity coronavirus disease covid- japanese patient unreported retrospectively examine significant factor associate disease severity symptomatic covid- patient covid pts admit institution february  april method patient diagnose base genetic detection severe acute respiratory syndrome coronavirus information initial symptom laboratory datum compute tomography ct image hospitalization collect patient record covid pts categorize critical severe illness pts csi moderate mild illness pt mmi statistical analysis perform r software result datum  patient pt csi  pt mmi include  japanese east asians analyze pt csi significantly old hypertension diabetes pt mmi p respectively serum albumin level significantly low pt csi pt mmi p neutrophil lymphocyte ratio c reactive protein level significantly high pt csi pt mmi p p respectively ct image  patient bilateral lung lesion frequently observe pt csi pt mmi p  pt csi  receive antiviral therapy  receive tocilizumab undergo methylprednisolone treatment receive mechanical ventilation die conclusion illness severity japanese covid pts associate old age hypertension and/or diabetes low serum albumin high neutrophil lymphocyte ratio c reactive protein
794,background angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb increase risk coronavirus disease  covid- infection affect disease severity prior study examine risk medication dose method retrospective cohort study include people age /= year enrol integrate healthcare system  month current acei arb use identify pharmacy datum estimate daily dose calculate standardize medication covid- infection hospitalization identify laboratory hospitalization datum logistic regression estimate odd ratio ors confidence interval cis adjust race ethnicity obesity covariate result individual  develop covid- infection people acei arb develop covid- individual compare acei arb use yield adjust ci use /= ddds ci similar acei arb subgroup age sex people covid- infection hospitalize adjust hospitalization relation acei arb use ci association dose conclusion finding support current recommendation individual medication continue use
795,purpose coronavirus disease- covid- firstly report december  wuhan china soon number case increase rapidly worldwide confirm case report world macao  confirm covid- case material method study summarize radiological feature case analyze relationship clinical characteristic radiological finding retrospectively analyze imaging manifestation  case covid- macao focus identify characterize common radiological finding covid- retrospectively analyze relationship clinical feature radiological finding covid- pneumonia result study show chest ct manifestation covid- multiple ground glass density lung dominate bilateral peripheral subpleural distribution accompany consolidation interlobular septum thickening adjacent pleura thickening disease progress manifest consolidation lung ct scan find age smoking hypertension risk factor predict severity covid- radiology conclusion covid- diagnose base clinical feature ncov pcr test radiological manifestation main manifestation covid- peripheral ground glass opacity age smoking hypertension predict severity covid- chest ct important radiological method screen detect covid- patient
796,emergence novel severe acute respiratory syndrome coronavirus  sars cov- cause coronavirus disease  covid- result pandemic sars cov- highly contagious severity highly variable fatality rate unpredictable amplify factor include advance age atherosclerotic cardiovascular disease diabetes mellitus hypertension obesity large proportion patient condition treat lipid lower medication question safety continue lipid lower medication patient infect covid- arise suggest exacerbate condition important consider know interaction lipid lower agent specific therapy covid- statement aim collate current evidence surround safety lipid lower medication patient covid- offer consensus view base current knowledge rate strength level evidence recommendation pubmed google scholar web science search extensively article search term sars cov- covid- coronavirus lipid statin fibrates ezetimibe pcsk monoclonal antibody nicotinic acid bile acid sequestrant nutraceutical red yeast rice omega fatty acid lomitapide hypercholesterolaemia dyslipidaemia volanesorsen evidence currently lipid lower therapy unsafe patient covid- infection lipid lower therapy interrupt pandemic patient increase risk covid- infection patient confirmed covid- care take avoid drug interaction lipid lower medication drug treat covid- especially patient abnormality liver function test
797,introduction coronavirus disease  covid- present range symptom mild critical low pulmonary involvement include pneumonia associate severe critical case understand baseline characteristic patient hospitalize covid- illness essential effectively target clinical care allocate resource study aim describe baseline demographic clinical characteristic patient hospitalize covid- pulmonary involvement method patient covid- pulmonary involvement inpatient admission december identify ibm explorys((r electronic health record database baseline  month prior covid- hospitalization demographic clinical characteristic preadmission day  day prior admission pulmonary diagnosis assess patient stratify sex age race geographic region result overall  patient hospitalize covid- pulmonary involvement include mean sd age year .% patient female african american south .% midwest common comorbiditie include hypertension .% diabetes .% hyperlipidemia .% obesity cough .% dyspnea .% common preadmission pulmonary symptom african american patient young mean sd vs. high mean sd body mass index vs. prevalence diabetes .% vs. .% low prevalence chronic obstructive pulmonary disease .% vs. .% smoke tobacco use .% vs. .% white patient conclusion patient primarily south midwest hospitalize covid- pulmonary involvement common comorbiditie hypertension diabetes hyperlipidemia obesity difference observe african american white patient consider context complex factor underlie racial disparity covid-
798,purpose come attention specific vascular change vcs appear frequently chest compute tomography ct patient coronavirus disease  covid- study aim investigate specific vcs chest ct correlate clinical severity disease method ct image  patient undergo low dose noncontrast chest ct covid-  march   april  evaluate retrospectively patient divide group base presence vcs ct image vcs chest ct patient covid- define follow descriptor decrease lumen caliber vascular wall irregularity angulation course vessel vascular disruption and/or interruption relationship vcs disease symptom fever cough shortness breath comorbid condition diabetes hypertension asthma smoking habit disease specific laboratory change white blood cell lymphocyte count neutrophil lymphocyte ratio c reactive protein crp d dimer lactate dehydrogenase ldh ferritin procalcitonin lung parenchymal infiltration pattern ground glass opacity crazy paving pattern consolidation distribution peripheral central mixed upper lobe low lobe right middle lobe ct investigate comparison variable patient vcs chest ct result vcs observe   patient typical parenchymal involvement covid- significant difference term age sex find irregularity wall vascular structure distal branch decrease lumen caliber vessel relate ground glass opacity  patient concentric luminal narrowing annular form  patient angulation traction springiness vascular structure active lesion  patient interruption vascular course  patient vcs significantly correlate fever .% shortness breath change significantly remarkable common disease involve upper low lobe case substantial increase crp mean .+/- mg dl ldh value compare vcs conclusion result study suggest specific vcs observe chest ct predict disease severity case covid- pneumonia change relate respiratory distress disease
799,objective describe ischemic stroke subtype relate coronavirus disease  covid- cohort new york city hospital explore etiopathogenesis background neurological manifestation non focal report characteristic ischemic stroke investigate pathophysiology method datum collect prospectively april -april  center new york city review possible ischemic stroke type see covid positive patient patient presentation demographic relate vascular risk factor associated laboratory marker imaging outcome collect result age patient range   year approximately patient know vascular risk factor common hypertension follow diabetes coronary disease atrial fibrillation patient present large vessel occlusion lvo median age  year male patient present non lvo syndrome median age year female group african americans south asian group similar d dimer level acute phase reactant disease severity marker ferritin crp procalcitonin high lvo group lvo group significantly high mortality compare non lvo group common etiology cryptogenic patient follow small vessel occlusion patient undetermined unclassified patient remain  patient  identify cardioembolic  large artery atherosclerosis conclusion covid relate ischemic event present small vessel occlusion branch emboli large vessel occlusion common etiology cryptogenic patient lvo syndrome tend young male elevate acute inflammatory marker
802,objective aim study determine clinical outcome old patient coronavirus covid- receive combination vitamin d magnesium vitamin b dmb compare hypothesize few patient administer combination require oxygen therapy intensive care support combination method cohort observational study consecutive hospitalize patient y age covid- tertiary academic hospital april patient receive dmb combination date patient administer  iu d oral vitamin d  mg d oral magnesium  mcg d oral vitamin b admission require oxygen therapy primary outcome deterioration lead form oxygen therapy intensive care support result january  april identify  consecutive patient y age covid- seventeen patient receive dmb onset primary outcome  patient baseline demographic characteristic group significantly different age univariate analysis age hypertension significant influence outcome adjust age hypertension separately multivariate analysis intervention group retain protective significance few treat patient control require initiation oxygen therapy hospitalization vs .% p dmb exposure associate odd ratio confidence interval ci .- ci .- oxygen therapy intensive care support univariate multivariate analysis respectively conclusion vitamin d magnesium vitamin b combination old covid- patient associate significant reduction proportion patient clinical deterioration require oxygen support intensive care support study support large randomized control trial ascertain benefit combination ameliorate severity covid-
803,background covid- cause sars cov- lead myriad range organ involvement include liver dysfunction aim analyse liver function patient covid- association respect age sex severity disease clinical feature material method study cross sectional study rajendra institute medical sciences ranchi  patient admit confirm sars cov- infection include study divide asymptomatic mild moderate severe group liver function test compare different severity group result  patient covid-  .% abnormal liver function aspartate transaminase ast alanine transaminase alt alkaline phosphatase alp total bilirubin level x uln .% .% .% case x uln .% .%  .% case respectively mean ast alp level different severity group covid- statistically significant p  statistical difference male female regard abnormal liver function liver injury see .% case hypertension .% case diabetes fever myalgia headache breathlessness find correlate significantly severity disease conclusion liver injury common sars cov- infection prevalent severe disease group aspartate transaminase alkaline phosphatase well indicator covid- induce liver injury alanine transaminase total bilirubin
804,background aim angiotensin convert enzyme ace type  receptor sarscov- cell entry lung cell ace- modulate ace inhibitor aceis angiotensin ii receptor blocker arb concern patient treat aceis arb high risk covid- infection severity study seek analyse association severe form covid- mortality hypertension previous treatment acei arb method prospective follow  consecutive patient hospitalise covid- pneumonia confirm pcr highly probable clinical biological radiological finding include covhyp study mortality severe covid- criterion death intensive care unit hospitalisation day compare patient receive aceis arb follow hospital discharge .% month result age year female follow mean days  patient severity criterion death  intensive care unit hospital stay day hypertension .% vs .% p antihypertensive treatment associate severe covid- mortality association acei arb treatment covid- severity criterion find univariate analysis odds ratio ci p=. confirm adjust age gender hypertension adjust p=. diabetes hypothyroidism associate severe covid- history asthma conclusion study suggest previous treatment acei arb associate hospital mortality -month mortality severity criterion patient hospitalise covid- protective effect acei arb severe pneumonia relate covid- demonstrate
805,objective investigate effect ginger compare usual therapeutic regimen clinical manifestation paraclinical feature patient confirmed covid- moderately ill trial design single center randomized double blind placebo control clinical trial parallel group design participant inclusion criterion patient admit severe acute respiratory syndrome sars departments shahid mohammadi hospital bandar abbas iran age year weight kg hospitalize /= hour confirmed sars cov- diagnosis positive polymerase chain reaction pcr moderate pneumonia lung involvement imaging sign informed consent willingness study participant accept randomization assign treatment arm exclusion criterion underlie disease include heart disease chronic hypertension severe renal failure severe liver failure thyroid disorder use warfarin selective serotonin reuptake inhibitor ssris monoamine oxidase inhibitor maois diuretic corticosteroid antiarrhythmic drug severe critical pneumonia history know allergy ginger pregnancy breastfeed intervention comparator intervention group standard treatment regimen covid- ginger base herbal tablet vomigone r dineh pharmaceutical company iran dose  mg time day period seven day control group standard treatment covid- base iranian ministry health medical education protocol vomigone like placebo tablet dineh pharmaceutical company iran dose tablet time day period seven day main outcome primary outcome recovery rate clinical symptom include fever dry cough tiredness gi symptom paraclinical feature include thrombocytopenia lymphocytopenia c reactive protein seven day randomization time improvement clinical paraclinical feature incidence adverse event secondary outcome seven day randomization randomization interactive web base system allocate eligible participant base inclusion exclusion criterion study arm ratio block randomization blinding masking study participant research coordinator clinician nurse investigator blind group assignment number randomized sample size total  participant randomize group  patient trial status protocol version recruitment begin july anticipate complete october trial registration clinical trial register iranian registry clinical trials irct registration number irctn registration date  protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
806,coronavirus disease  covid- cause highly transmissible severe acute respiratory syndrome coronavirus  sars cov- affect global population despite socioeconomic status amazed surveillance agency incidence mortality recovery rate covid- affect age group suggest progress severe disease cause mortality confirm case depend individual characteristic affected population big unanswered question individual develop severe stage disease current datum indicate critically ill elderly comorbiditie hypertension diabetes asthma note population severe disease observe young individual -year old report underlying medical condition certainly factor contribute disease severity include intrinsic host factor genetic variant expression level tissue protein consider aspect review aim discuss expression level tissue protease different profile immune response influence susceptibility covid- disease severity outcome
807,background anosmia common coronavirus disease impact prognosis unknown analyse anosmia predict hospital mortality patient anosmia different clinical presentation inflammatory response disease severity method retrospective cohort study include consecutive hospitalize patient confirm covid- march th april th determine cause mortality need intensive care unit icu admission register bad laboratory parameter statistical analysis multivariate logistic linear regression result include  patient .% female aged year mean anosmia present  patient patient anosmia frequently female young disabled frequently hypertension diabetes smoking habit cardiac neurological comorbiditie anosmia independently associate low mortality ci icu admission ci p multivariate analysis patient anosmia high frequency cough ci headache ci myalgia ci high adjust value hemoglobin ci lymphocyte ci glomerular filtration rate ci low d dimer ci -.-(- c reactive protein ci -.-(- conclusion hospitalized covid- patient anosmia low adjust mortality rate severe course disease relate distinct clinical presentation different inflammatory response
808,background morocco affect country coronavirus disease  covid- pandemic risk factor covid- severity describe datum infected patient north africa limited aim explore predictive factor disease severity covid- patient tertiary hospital casablanca method single center retrospective observational study include adult patient confirm severe acute respiratory syndrome coronavirus  sars cov- infection admit sheikh khalifa international university hospital casablanca march  patient separate group non severe patient mild moderate form covid- severe patient admit intensive care unit icu follow sign respiratory rate  breath min oxygen saturation  mg l ci p lymphopenia lower x()/l ci p conclusion clinicians consider old male patient comorbiditie lymphopenia high crp rate factor predict severe form covid- early high severity infected patient cluster confirm epidemiological genetic study
810,objective define epidemiological curve covid- qatar determine factor associate severe critical illness design case series  covid- case qatar setting participant confirm covid- case state qatar  february  april main outcome measures number total daily new covid- infection demographic characteristic comorbidity burden severity infection factor associate severe critical illness result  february  april  case covid- identify median age  iqr year .% male .% qatari national overall .% concomitant comorbidity .% comorbiditie overwhelming majority .% asymptomatic minimal symptom .% have severe critical illness seven death observe time interval study presence hypertension diabetes associate high risk severe critical illness age epidemiological curve indicate distinct pattern infection large cluster expatriate craft manual worker small qatari national return abroad epidemic conclusion covid- infection qatar start distinct cluster widespread population community transmission infection asymptomatic minimal symptom associate low mortality severe critical illness associate presence hypertension diabetes increase age
811,mozambique locate east coast africa country affect covid- case report  march  case increase gradually country worldwide environmental population characteristic analyze worldwide understand possible association covid- article seek highlight evolution possible contribution risk factor covid- severity accord available datum mozambique available datum highlight covid- severity magnify mainly hypertension obesity cancer asthma hiv sida malnutrition condition buffer age youthful population covid- epidemic evolution particularly cabo delgado need increase laboratory diagnosis capacity monitor compliance preventive measure particular attention give cabo delgado include isolation province overcome local transmission spread sars cov-
812,backgroud association underlying comorbiditie cardiac injury prognosis coronavirus disease  covid- patient assess study hypothesis underlie comorbiditie cardiac injury associate prognosis covid- patient method systematic search conduct pubmed embase web science cochrane library december  july odd ratio confidence interval ci estimate probability comorbiditie cardiac injury covid- patient severe type survivor vs nonsurvivor covid- patient result total  study include analysis high risk severity observe covid- patient comorbiditie pooled result patient hypertension ci diabetes ci cardiovascular disease ci chronic obstractive pulmonary disease ci chronic kidney disease ci cancer ci respectively comorbiditie present high risk mortality prevalence acute cardiac injury high severe group nonsevere group acute cardiac injury associate increase risk hospital mortality conclusion comorbiditie acute cardiac injury closely associate poor prognosis covid- patient necessary continuously monitor related clinical indicator organ injury concern comorbiditie covid- patient
813,background global rate intensive care unit icu admission covid- pandemic vary country main challenge health care system worldwide conflicting result report response coronavirus infection covid- outcome man woman understand predictor intensive care unit admission help future planning management disease method finding design cross sectional observational multicenter nationwide survey italy understand gender relate clinical predictor icu admission patient covid- analyze information  chart italian patient certify covid- admit  hospital ninety patient .% require icu admission covid infection frequently man high prevalence comorbiditie /- vs p multivariable regression model main predictor admission icu male gender ci p presence obesity ci p chronic kidney disease p hypertension p gender specific analysis obesity chronic kidney disease hypertension associate high rate admission icu man woman obesity ci p heart failure ci associate high rate icu admission conclusion study demonstrate gender primary determinant disease severity covid- obesity condition observe admit icu gender trial registration clinicaltrials.gov nct
814,objective role renin angiotensin aldosterone system raas blocker coronavirus disease  covid- pandemic matter controversy study base hospital exposure suggest beneficial effect drug unlike base chronic exposure aim analyse raas blocker prescription hospital stay patient covid- correspond outcome explain discrepant result method retrospective cohort study conduct  patient hospitalize covid- bichat hospital paris france  january- april raas blocker exposure timing reason treatment modification collect association exposure mortality  day hospital admission analyse logistic regression analysis adjust age sex comorbiditie result median age  interquartile range year  male  history treat hypertension  receive raas blocker prior hospitalization raas blocker discontinue  day hospital admission previously treat patient drive severity disease corresponding mortality rate mortality treatment maintain introduce patient expose adjust odd ratio association exposure mortality confidence interval .- base chronic exposure base hospital exposure conclusion healthy user sick stopper bias influence raas blocker prescription hospital admission covid- explain seemingly favourable outcome associate hospital treatment
815,objective determine age specific clinical presentation incidence adverse outcome patient covid- jiangsu china design setting retrospective multicentre cohort study perform  hospital jiangsu china participant  patient covid- enrol  january  march result  patient median age  year  .% man  .% child year young  young adult year  .% middle aged adult year  elderly adult year old incidence hypertension coronary heart disease chronic obstructive pulmonary disease diabetes comorbiditie increase age trend test p/= year patient covid- high risk severe critical illness intensive care use respiratory failure long hospital stay partly have high incidence comorbiditie poor immune response covid-
816,man consistently overrepresente severe acute respiratory syndrome coronavirus  sars cov- infection coronavirus disease  covid- severe outcome include high fatality rate difference likely gender specific behavior genetic hormonal factor sex difference biological pathway relate sars cov- infection social behavioral comorbid factor implicate generally bad outcome man compare woman underlie biological sex difference effect covid- outcome receive attention present review summarize available literature propose molecular cellular marker covid- infection association health outcome reported modification sex biological sex difference characterize biomarker exist healthy population differ age- sex specific condition pregnancy menopause context covid- descriptive biomarker level report sex datum pertain effect patient sex relationship biomarker covid- disease severity outcome scarce biomarker offer plausible explanation bad covid- outcome see man need large study sex specific reporting robust analysis elucidate sex modify cellular molecular pathway associate sars cov- improve interpretation biomarker clinical management covid- patient facilitate personalize medical approach risk stratification prevention treatment
817,background aim corona virus disease  covid- pandemic spread rapidly grow evidence overweight obesity extent nearly world population associate severe covid- study aim explore association risk increase bmi obesity composite poor outcome covid- adult patient method conduct systematic literature search pubmed embase database include original research article covid- adult patient obesity base classification body mass index bmi composite poor outcome consist icu admission ards severe covid- use mechanical ventilation hospital admission mortality result sixteen study include meta analysis  study present bmi continuous outcome  study present bmi dichotomous outcome cut kg m covid- patient composite poor outcome high bmi mean difference ci .- p obesity associate composite poor outcome odd ratio ci .- p multivariate meta regression show association bmi obesity composite poor outcome affect age gender dm type hypertension conclusion obesity risk factor composite poor outcome covid- hand covid- patient composite poor outcome high bmi bmi important routine procedure assess management covid- patient special attention give patient obesity
818,hypertension prove associate severity mortality coronavirus disease  covid- little know effect pre admission and/or hospital antihypertension treatment clinical outcome study aim investigate association hospital blood pressure bp control covid related outcome compare effect different antihypertension treatment study include  covid- patient  hypertensive patient group accord bp hospitalization record medication application patient high bp show bad cardiac renal function clinical outcome adjustment subject pre admission usage renin angiotensin aldosterone system raas inhibitor hr ci p low risk adverse clinical outcome include death acute respiratory distress syndrome respiratory failure septic shock mechanical ventilation intensive care unit admission particularly hypertension patient receive raas inhibitor treatment hr ci p hr ci p admission show significantly low risk adverse clinical outcome receive application antihypertensive medicine furthermore consecutive application raas inhibitor covid- patient hypertension show well clinical outcome hr ci p non raas inhibitor user reveal covid- patient poor bp control hospitalization bad clinical outcome compare antihypertension medicine raas inhibitor beneficial improve clinical outcome covid- patient hypertension finding provide direct evidence support administration raas inhibitor covid- patient hypertension admission
819,objective aim study evaluate association chronic kidney disease ckd new onset renal replacement therapy rrt outcome coronavirus disease  covid- patient methodology systematic literature search database perform study assess ckd use rrt outcome covid- composite poor outcome consist mortality severe covid- acute respiratory distress syndrome ards need intensive care use mechanical ventilator result nineteen study total  patient include ckd associate increase composite poor outcome rr p p subgroup consist mortality rr p p severe covid- rr p p rrt associate increase composite poor outcome rr p p include mortality rr p p severe covid- rr p p intensive care ic rr p p use mechanical ventilator rr p conclusion ckd new onset rrt associate poor outcome patient covid-
820,novel coronavirus sars cov- identify causative agent series atypical respiratory disease hubei province wuhan china december disease sars cov- term covid- officially declare pandemic world health organization march sars cov- contain single strand positive sense rna genome surround extracellular membrane contain series spike glycoprotein resemble crown covid- infection result diverse symptom morbidity depend individual genetic ethnicity age geographic location severe case covid- pathophysiology include destruction lung epithelial cell thrombosis hypercoagulation vascular leak lead sepsis event lead acute respiratory distress syndrome ards subsequent pulmonary fibrosis patient covid- risk factor include cardiovascular disease hypertension diabetes highly prevalent united states population upregulation angiotensin convert enzyme- ace receptor exploit covid- route entry infection viral envelope protein bind degrade ace receptor prevent normal ace function covid- infection cause imbalance ace induce inflammatory immune response know cytokine storm amplify comorbiditie host discuss genetic pathogenesis possible therapeutic covid- infection secondary complication associate disease progression include ards pulmonary fibrosis understand mechanism covid- infection allow development vaccine novel therapeutic approach prevent transmission reduce severity infection
821,contributor consequence disordered health increasingly complex sociodemographic ecological economic food system change opportunity adversity mitigate advance understanding human especially nutritional ecobiology accessible affordable evaluation monitoring viral pandemic rise climate change loss ecosystem threaten human civilisation planetary habitability human security dependent sustainable livelihood food water system vital socioecological being depend health biodiversity food diversity ensure connectedness communication difficult pandemic rapid accessible point care poc tool available compliment selfmonitore network approach checklist questionnaire physical chemical biological healthcare nutritional health provide information complimentary interdependent health index facilitate personal group community action management plan apply index communicable non communicable disease problem separately compromise health prospect index include one physical mental activity dietary pattern metabolite blood pressure presence severity virus like covid-.of imminent relevance promise optically- readable biosensor base strip nasal pharyngeal salivary sample check viral presence finger prick blood immunoglobulin interleukin allow socially prohibitive measure curb viral transmission promote personal societal wellbeing
822,aim aim study explain demographic datum comorbidity laboratory finding case covid- pneumonia country method gather datum covid- pneumonia participant electronic medical system include daily medical knowledge laboratory radiological microbiological result march  april result totally  patient finding compatible covid- include study  patient exclude study distribution gender  female  male average age hypertension  year age diabetes mellitus  year age common comorbiditie neutrophils/ lymphocyte percent(% nlr note  patient average  range statistically significant positive relationship d dimer c reactive protein crp ferritin conclusion detect comorbiditie see covid- disease differ accord patient age d dimer ferritin crp outcome particularly high significant correlation covid- severity tab ref text pdf  keywords covid- prognosis acute phase reactan
823,purpose study relationship osa risk covid- infection disease severity identify need hospitalization progression respiratory failure method query electronic medical record system integrate health system  hospital chicago metropolitan area identify case covid- comorbiditie outcome ascertain icd cm code medical record datum evaluate risk covid- diagnosis hospitalization respiratory failure associate osa univariate test logistic regression adjust diabetes hypertension bmi account potential confound association osa covid- hospitalization progression respiratory failure result identify  covid- infection  hospitalize  diagnose respiratory failure osa prevalent patient require hospitalization versus .% p ci progress respiratory failure versus .% p ci adjustment diabetes hypertension bmi osa associate increase risk hospitalization ci respiratory failure ci conclusion patient osa experience approximately great risk covid- infection compare similar age population receive care large racially socioeconomically diverse healthcare system patient covid- infection osa associate increase risk hospitalization approximately double risk develop respiratory failure
824,severe form covid- mark abnormal exacerbate immunological host response favor poor outcome significant number patient especially obesity diabetes hypertension atherosclerosis chronic inflammatory process find cardiometabolic comorbiditie mark overexpression pro inflammatory cytokine interleukin- il- tumoral necrosis factor alpha tnf alpha product toll like receptor  tlr pathway sars cov- initially infect cell upper respiratory tract patient spread quickly need respiratory support systemically cause collateral damage tissue hypothesize happen sars cov- spike protein interact strongly tlr cause intensely exacerbate immune response host lung culminate cytokine storm accumulate secretion hinder blood oxygenation immune system attack body lead multiple organ failure
825,coronavirus disease  covid- cause global pandemic early infectious disorder heterogeneous course range asymptomatic disorder critical situation need intensive care current study present report affected patient admit single hospital iran eighty hospitalize patient covid- assess demographic clinical paraclinical parameter gather statistically analyze median age iqr patient year primary evaluation fever present .% affect individual common clinical symptom dyspnea .% cough totally  .%  .% patient low high wbc count respectively lymphopenia detect  .% patient  .% patient lymphocytosis high level il- detect  .% patient crp level elevate  .% patient median iqr hospitalization  day totally  patient hospitalize icu patient discharge good health condition patient die current study show heterogeneous clinical manifestation paraclinical parameter covid- patient
826,background coronavirus disease  covid- associate microvascular alteration screen fundus patient covid- detect alteration retina vasculature assess possible correlation clinical parameter method cross sectional study presence retinal alteration patient covid- subject unexposed virus assess fundus photograph prevalence compare mean artery diameter mad mean vein diameter mvd compare patient unexposed subject multiple linear regression include age sex ethnicity body mass index smoking alcohol consumption hypertension hyperlipidaemia diabetes covariate influence clinical lab parameter retinal finding test covid- patient finding  patient  unexposed subject enrol retinal finding covid- include haemorrhage .% cotton wool spot .% dilated vein .% tortuous vessel mad mvd high covid- patient compare unexposed subject microm vs microm p microm vs microm p respectively multiple regression account covariate mvd positively associate covid- severe coefficient ci% .- non severe coefficient ci% .- case compare unexposed subject covid- patient mvd negatively correlate time symptom onset coefficient ci positively correlate disease severity coefficient ci interpretation covid- affect retina retinal vein diameter directly correlate disease severity assessment possible application management covid- funding
827,right heart catheterization essential diagnostic modality evaluation pulmonary hypertension coronavirus disease  pandemic result deferral elective procedure include right heart catheterization benefit proceed right heart catheterization characterization hemodynamic subtype severity pulmonary hypertension initiation target pulmonary arterial hypertension therapy hemodynamic testing need carefully balanced risk potentially expose patient health care personnel coronavirus disease  infection review article aim provide good clinical practice safely perform right heart catheterization pulmonary hypertension patient coronavirus disease  pandemic
828,background critical hypoxia covid- pandemic result high mortality economic loss worldwide initially disease pathophysiology poorly understand interpret sars severe acute respiratory syndrome pneumonia severe atypical lung cat scan image alert country include poor purchase lack sophisticated ventilator patient ventilator lose life suggest covid- similar high altitude pulmonary edema hape new observation pathological finding gradually clarify disease method high altitude medicine hypoxia physiology specialist work live highland  year perform perspective analysis hypoxic disease treat high altitude compare covid- oxygen transport physiology sars cov- characteristic transmission lung imaging covid- hape cause clinical sign symptom discuss result high altitude oxygen transport physiology systematically ignore covid- sign symptom indicate progressive irreversible failure oxygen transport system secondary pneumolysis produce sars cov- alveolar capillary membrane attack hape pulmonary compromise treatable reversible covid- associate disease different individual outcome different country different altitude conclusion pathophysiology high altitude illness help explain covid- pathophysiology severity management early diagnosis use epo acetylsalicylic acid anti inflammatorie oxygen therapy antitussive antibiotic use earth open circuit- astronaut resemble suit return daily activity consider ventilator use counterproductive immunity development feasible long term survival tool
829,coronavirus disease  covid- pandemic disease originate wuhan city china cause severe acute respiratory syndrome corona virus  sars cov- biology poorly understand currently vaccine drug agent reduce severity new disease recent datum suggest patient age relate comorbiditie include cardiovascular disease diabetes obesity hypertension chronic kidney disease dementia highly susceptible severe respiratory illness coronavirus infection recent research reveal aged individual elevated baseline inflammation cause defect t b cell lead decrease body immune response viral infection current article discuss effect sars cov- age relate chronic disease diabetes obesity alzheimer disease article highlight interaction coronavirus immune cell covid- alter mitochondrial activity host cell base new compelling evidence propose mitochondrial fission inhibit fusion promote cause mitochondrial elongation provide receptive intracellular environment viral replication infected cell research need understand cross talk viral replication mitochondria disease progression patient covid-
830,ace angiotensin convert enzyme key component renin angiotensin aldosterone system little know clinical biologic correlate circulate ace level human assess clinical proteomic correlate plasma soluble ace protein level human heart failure measure plasma ace modify aptamer assay phfs penn heart failure study participant n= perform association study ace approximately  plasma protein measure somascan platform plasma ace associate ace inhibitor angiotensin receptor blocker use plasma ace associate old age male sex diabetes mellitus lower estimate glomerular filtration rate bad new york heart association class history coronary artery bypass surgery high pro bnp pro b type natriuretic peptide level plasma ace exhibit association  plasma protein pathway overrepresentation analysis canonical pathway associate plasma ace include clathrin mediate endocytosis signaling actin cytoskeleton signal mechanism viral exit host cell eif eukaryotic initiation factor signal protein ubiquitination pathway conclusion human heart failure plasma ace associate clinical factor know associate severe coronavirus disease  covid- include old age male sex diabetes mellitus associate ace inhibitor angiotensin receptor blocker use plasma ace protein level prominently associate multiple cellular pathway involve cellular endocytosis exocytosis intracellular protein trafficking causal relationship ace relevant novel coronavirus- infection remain assess future study
831,-year old man long history severe haemophilia treat prophylactically efmoroctocog alpha iu twice weekly diagnose covid- infection multiple risk factor covid- severity include obesity diabetes mellitus hypertension require prolonged intensive care unit icu stay severity respiratory failure death day icu stay receive continuous infusion efmoroctocog alpha order maintain factor viii activity  therapeutic dose low molecular weight heparin target anti xa activity iu mol tolerate numerous invasive procedure bleed post mortem examination evidence thrombosis haemorrhage different organ
832,aim describe epidemiological clinical characteristic outcome hospitalize coronavirus disease  covid- patient diabetes method retrospective single center study include  consecutive hospitalize patient confirmed covid- baqiyatallah hospital tehran iran february  march demographic datum clinical laboratory radiological finding collect compare patient base diabetes status complication clinical outcome follow april result  hospitalize patient covid- median age  year  .% male common symptom include fever dry cough .% dyspnea total  patient .% diabetes compare patient diabetes patient comorbiditie eg hypertension .% vs. .% p high level white blood cell count neutrophil count c reactive protein erythrocyte sedimentation rate blood urea nitrogen high proportion patchy ground glass opacity chest compute tomography finding .% vs. .% p significantly patient diabetes complication need respiratory support diabetes p end follow treatment failure death significantly high patient diabetes compare diabetes .% vs. .% p conclusion covid- patient diabetes high risk complication high hospital mortality hospitalization diabetes status covid- patient frequent monitoring glycemia helpful prevent deteriorate clinical condition
834,coronavirus disease  covid- emerge disease reach pandemic status rapidly spread worldwide elderly individual patient comorbiditie obesity diabetes hypertension high risk hospitalization severe disease mortality acute respiratory syndrome coronavirus  sars cov- infection patient frequently exacerbate secretion proinflammatory cytokine associate overreaction immune system call cytokine storm host nutritional status play pivotal role outcome variety different infectious disease know immune system highly affect malnutrition lead decrease immune response consequent augment risk infection disease severity body composition especially low lean mass high adiposity consistently link worsen prognosis different disease review evidence concern impact nutritional status viral infection outcome discuss
835,background aim elucidate clinical feature covid- patient type  diabetes td hospitalization home isolation condition method retrospective study conduct  patient covid- td seek treatment prince sultan military medical city riyadh saudi arabia  july patient datum extract electronic medical record result total  covid- patient td .% require hospitalization .% undergo home isolation study population report hypertension chronic pulmonary disease cpd thyroid disorder celiac disease  study patient report normal chronic kidney disease ckd ii end stage renal failure common symptom observe hospitalize patient nausea vomit .% follow fever .% cough .% sore throat .% abdominal pain .% dyspnea .% common reason hospitalization diabetic ketoacidosis .% follow bacterial pneumonia .% fever .% sore throat .% severe hyperglycemia .% covid- pneumonia .% severity covid- p demographic clinical parameter indicate statistically significant difference patient require hospitalization home isolation conclusion majority covid- patient td recover conservative treatment home diabetic ketoacidosis common reason hospitalization
836,importance identify independent risk factor adverse outcome patient infect severe acute respiratory syndrome coronavirus  sars cov- support prognostication resource utilization treatment objective identify excess risk risk factor associate hospitalization mechanical ventilation mortality patient sars cov- infection design setting participant longitudinal cohort study include  patient test sars cov- nucleic acid polymerase chain reaction feburary  follow june department veterans affairs va national health care system include  patient .% test positive exposure sociodemographic characteristic comorbid condition symptom laboratory test result main outcomes measures risk hospitalization mechanical ventilation death estimate time event analysis cox proportional hazard model result  veteran sars cov- predominantly male .% diverse race ethnicity white  black  hispanic mean sd age year compare patient test negative sars cov- test positive high rate -day hospitalization .% vs .% adjust hazard ratio ahr ci .- mechanical ventilation .% vs .% ahr ci .- death .% vs .% ahr ci patient test positive sars cov- characteristic significantly associate mortality include old age eg year vs /= vs /= vs ahr ci .- fever ahr ci .- dyspnea ahr ci .- abnormality certain blood test exhibit dose response association mortality include aspartate aminotransferase u l vs mg dl vs mg dl ahr ci .- neutrophil lymphocyte ratio vs /= vs .- ahr ci .- black race ahr ci .- hispanic ethnicity ahr ci .- chronic obstructive pulmonary disease ahr ci .- hypertension ahr ci .- smoking eg current vs ahr ci death cohort occur patient age  year old .% male sex .% charlson comorbidity index score  .% conclusion relevance national cohort va patient sars cov- death associate old age male sex comorbidity burden factor previously report associate mortality small study confirm obesity black race hispanic ethnicity chronic obstructive pulmonary disease hypertension smoking
837,background detection severe acute respiratory syndrome coronavirus  sars cov- rna blood know rnaemia report prognostic implication poorly understand study aim determine frequency sars cov- rna plasma association coronavirus disease  covid- clinical severity method analytical cross sectional study perform single center tertiary care institution include consecutive inpatient outpatient confirmed covid- prevalence sars cov- rnaemia strength association clinical severity variable examine include intensive care unit icu admission invasive mechanical ventilation -day cause mortality result pair nasopharyngeal plasma sample include  patient median age  year individual rnaemia old undetectable sars cov- rna plasma vs  year p comorbiditie frequent include obesity .% hypertension .% diabetes mellitus rnaemia detect .% patient include .% require hospitalization model adjust age rnaemia detect frequently individual develop severe disease include icu admission vs .% p invasive mechanical ventilation .% vs .% p  death occur individual detectable rnaemia additional  plasma sample  individual rnaemia assess longitudinally rna detect maximum duration  day conclusion study demonstrate high proportion sars cov- rnaemia association rnaemia clinical severity suggest potential utility plasma viral testing prognostic indicator covid-
838,background recent study demonstrate evidence coagulation dysfunction hospitalize patient severe coronavirus disease  covid- excessive inflammation hypoxia platelet activation endothelial dysfunction stasis effective anticoagulation therapy play dominant role management severe covid- case case report -year old man -day history fever degree c dyspnea cough fatigue diagnose covid- past medical history significant hypertension coronary artery bypass grafting day hospital admission patient develop acute respiratory failure require intubation mechanical ventilation transfer intensive care unit icu receive treatment include antibiotic hydroxychloroquine tocilizumab vasopressor prone positioning anticoagulation enoxaparin prophylactic dose -day icu stay patient hemodynamically stable hypoxemic transthoracic echocardiogram time follow transesophageal echocardiogram well evaluation reveal presence right atrium thrombus sign acute right ventricular dilatation impaired systolic function patient hemodynamically stable decide treat conventional anticoagulation close monitoring sign hemodynamic deterioration prophylactic dose enoxaparin replace therapeutic dosing key component patient successful outcome day show significant clinical improvement follow transesophageal echocardiogram  week effective therapeutic anticoagulation reveal sign right heart thrombus conclusion present covid- case report case evidence right heart thrombus transesophageal echocardiography highlight central role diagnostic imaging strategy importance adequate anticoagulation therapy management severe covid- case icu
839,review focus hypothetical mechanism enhance vulnerability african americans sars cov- infection covid- severity increase death disproportionately high number african americans afflict autoimmune inflammatory disease e.g. diabetes hypertension obesity sars cov- help expose health disparity factor include socioeconomic status inferior health care work circumstance contribute disparity identify potential inflammatory biomarker decrease basal level high risk individual comorbiditie preventive measure critical immune cell particularly neutrophils protect pathogen bacteria fungus virus increase generation free radical oxidant neutrophil extracellular trap net ensnare pathogen kill extracellularly continue generation net couple lack prompt removal pose danger host cell net level increase pro inflammatory disease covid- patient exhibit elevate net level depend disease severity conceivably high risk individual elevated basal net level exhibit hyper inflammation infect sars cov- amplify disease severity death drug inhibit oxidant formation vitamin supplement decrease net formation mouse model inflammation conceivable preventive treatment lower net level inflammation high risk individual mitigate sars cov induce complication decrease mortality
840,rationale objective outcome patient hospitalize coronavirus disease  covid- acute kidney injury aki understand goal study investigate survival kidney outcome patient study design retrospective cohort study setting participant patient aged>/= year hospitalize covid-  hospital metropolitan new york march april follow hospital discharge exposure aki outcomes primary outcome hospital death secondary outcomes require dialysis discharge recovery kidney function analytical approach univariable multivariable time event analysis logistic regression result patient admit covid- aki incidence rate patient day incidence rate hospital death patient aki aki require dialysis aki stage aki receive dialysis aki d patient day respectively take aki reference group observe great risk hospital death patient aki aki d hrs ci ci respectively adjust demographic comorbid condition illness severity risk death remain high aki adjusted hr ci aki d adjust hr ci compare aki patient aki survive .% achieve kidney recovery time discharge aki d survive .% remain dialysis discharge prehospitalization chronic kidney disease independent risk factor associate need dialysis discharge adjust ci limitations observational retrospective study limit ny metropolitan area peak covid- pandemic conclusion aki hospitalize patient covid- associate significant risk death
841,background kingdom saudi arabia ksa report case  death covid- case emerge country march  june objective report describe characteristic outcome observe  hospitalize covid- patient large academic hospital ksa assess co infection middle east respiratory syndrome coronavirus mers cov method single center case series datum include select epidemiological clinical radiological feature laboratory finding confirm hospitalize case covid- king saud university medical city ksumc riyadh ksa march  follow june conduct retrospective analysis list datum  hospitalize patient present characteristic factor associate severity percentage univariate odd ratio case confirm nasopharyngeal throat swab real time reverse transcriptase polymerase chain reaction rt pcr severe acute respiratory syndrome coronavirus  sars cov- mers cov rt pcr result  hospitalize covid- patient include analysis constitute  positive sars cov-  person test ksumc positivity rate .% mers cov pcr negative  patient test majority  hospitalize patient male mean age  year range quarter .% health care worker patient comorbid condition account .% patient include .% asymptomatic diabetes mellitus frequent .% follow hypertension .% common present symptom fever .% cough .% dyspnea .% upper respiratory symptom .% fatigue .% diarrhea .% loss smell clinical condition  patient include upper respiratory tract infection .% abnormal chest x ray lymphopenia high inflammatory marker fifth patient moderate pneumonia severe pneumonia .% require admission intensive care unit .% die late presentation severe disease abnormal chest x ray lymphopenia high inflammatory marker c reactive protein ferritin procalcitonin end organ damage high creatinine high aspartate aminotransferase predictor admission critical care unit die conclusion observe mers cov co infection early cohort hospitalize covid- patient relatively young half comorbid condition present fever and/or cough abnormal chest x ray lymphopenia high inflammatory marker give mers cov endemicity country co monitoring mers cov sars cov- coinfection critical
843,coronavirus disease  covid- global public health concern classify mild moderate severe critical base disease severity identification critical patient crucial develop effective management strategy evaluate clinical characteristic laboratory datum treatment provide oxygenation identify potential predictor mortality critical covid- pneumonia patient retrospectively utilize datum seven critical patient admit hospital april  require mechanical ventilation primary endpoint clarify potential predictor mortality patient old  year man hypertension ultimately die compare survivor non survivor tend smoker pack year vs.  pack year p high body mass index kg m vs. kg m p require early tracheal intubation symptom onset day vs. day p few lymphocyte admission /mul vs.  p week tracheal intubation non survivor display low value minimum ratio partial pressure oxygen fractional inspiratory oxygen concentration p f ratio mmhg vs.  mmhg p poor response intensive therapy compare survivor summary obesity lymphopenia predict severity covid- pneumonia trend low p f ratio week mechanical ventilation provide useful prognostic information
844,severe acute respiratory syndrome coronavirus  sars cov- virus responsible coronavirus disease  covid- associate high incidence multiorgan dysfunction death angiotensin convert enzyme  ace facilitate sars cov- host cell entry impact angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb commonly antihypertensive class multicenter international randomized control trial begin enrollment march participant randomized continuation vs withdrawal long term outpatient acei arb hospitalization covid- primary outcome hierarchical global rank score incorporate time death duration mechanical ventilation duration renal replacement vasopressor therapy multiorgan dysfunction severity approval study obtain institutional review board participate institution participant provide informed consent data safety monitoring board assemble provide independent oversight project
845,importance role angiotensin convert enzyme inhibitor acei angiotensin ii receptor blocker arb setting coronavirus disease  covid- pandemic hotly debate recommendation discontinue medication essential treatment chronic disease condition absence clinical evidence professional society advocate continue use objective study association use acei arb likelihood test positive covid- study outcome datum subset patient take acei arb test positive severity clinical outcome covid- eg hospitalization intensive care unit admission requirement mechanical ventilation design setting participant retrospective cohort study overlap propensity score weighting conduct cleveland clinic health system ohio florida patient test covid- march  april include exposure history take acei arb time covid- testing main outcomes measures result covid- testing entire cohort number patient require hospitalization intensive care unit admission mechanical ventilation test positive result total  patient test covid- mean sd age  year  male  white  patient undergo covid- testing  .% take aceis arb positive covid- test result observe   patient patient test positive  .% admit hospital  .% admit intensive care unit  .% require mechanical ventilation overlap propensity score weighting show significant association acei and/or arb use covid- test positivity overlap propensity score weight odd ratio ci conclusion relevance study find association acei arb use covid- test positivity clinical datum support current professional society guideline discontinue acei arb setting covid- pandemic study large number hospitalize patient receive acei arb therapy need determine association clinical measure covid- severity
846,objective investigate effect licorice glycyrrhiza glabra l. root extract anti inflammatory natural medicine compare usual therapeutic regimen clinical symptom laboratory sign patient confirmed covid- moderately ill trial design single center open label randomized clinical trial parallel group design study conduct shahid mohammadi hospital bandar abbas iran participant male female patient year age  kg weight admit shahid mohammadi hospital hormozgan university medical sciences bandar abbas treatment screen following criterion inclusion criterion confirm diagnosis sars cov- infection polymerase chain reaction pcr and/or antibody test present moderate covid- pneumonia chest compute tomography ct and/or x ray require hospitalization hospitalize /= hour sign informed consent willingness study participant accept randomization assign treatment arm exclusion criterion underlie disease include chronic heart disease chronic hypertension severe renal failure severe liver failure thyroid disorder severe critical covid- pneumonia use warfarin selective serotonin reuptake inhibitor ssris monoamine oxidase inhibitor maois diuretic corticosteroid antiarrhythmic drug treatment investigational antiviral therapy clinical study month randomization history allergy licorice pregnancy breastfeeding intervention comparator intervention group standard treatment regimen covid- licorice base herbal preparation d reglis r irandarouk pharmaceutical company iran dose  mg time day period seven day control group standard treatment covid- base iranian ministry health medical education protocol period seven day main outcome recovery rate clinical symptom include fever dry cough tiredness paraclinical feature include thrombocytopenia lymphocytopenia c reactive protein evaluate primary outcome seven day randomization time improvement clinical paraclinical feature length stay hospital incidence adverse reaction evaluate secondary outcome seven day randomization randomization electronic table random number allocate include participant control intervention group ratio simple randomization method blinding masking open label trial blind placebo control number randomized sample size total  participant randomize patient allocate intervention group  patient allocate control group trial status protocol version recruitment begin july anticipate complete october trial registration clinical trial register iranian registry clinical trials irct registration number irctn  registration date  protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
847,wide range neurological complication coronavirus disease  covid- increasingly recognise majority remain ischaemic haemorrhagic event disorder report particular case diffuse acute leukoencephalopathy observe critically ill patient covid- disease report case -year old man multiple comorbiditie severe covid- pneumonia develop diffuse leukoencephalopathy microhaemorrhage extensive associate white matter necrosis document case extensive covid associate white matter necrosis highlight relatively constant feature injury similar previously report case include symmetrical involvement supratentorial white matter sparing peripheral subcortical region precentral gyri frequently associate microhaemorrhage relative sparing deep gray matter structure infratentorial structure lack enhancement
848,background conduct systematic review meta analysis evaluate late evidence association cerebrovascular cardiovascular disease poor outcome patient coronavirus disease  covid- pneumonia method comprehensive systematic literature search perform pubmed scopus europepmc cochrane central database outcome interest composite poor outcome comprise mortality severe covid- result total  patient obtain  study cerebrovascular disease associate increase composite poor outcome rr p subgroup analysis reveal cerebrovascular disease associate mortality rr p show borderline significance severe covid- rr p=. cardiovascular disease associate increase composite poor outcome rr p mortality rr p severe covid- rr p meta regression demonstrate association influence gender age hypertension diabetes respiratory comorbiditie furthermore association cerebrovascular disease poor outcome affect cardiovascular disease vice versa conclusion cerebrovascular cardiovascular disease associate increase risk poor outcome patient covid-
849,background coronavirus disease  covid- typically present respiratory illness range severity neurological complication disease remain largely unknown discuss case woman diagnose covid- meningitis follow positive cerebrospinal fluid csf rt pcr assay highlight importance recognize neurological manifestation disease case report patient -year old woman history hypertension present non specific symptom fever headache malaise nausea vomiting chest compute tomography ct reveal lack pulmonary involvement oropharyngeal nasopharyngeal rt pcr negative covid- lumbar puncture perform day admission csf analysis elucidate viral pattern csf bacterial culture rt pcr assay herpes simplex virus negative surprisingly csf rt pcr covid- positive diagnosis covid- meningitis patient treat solely kaletra((r second csf analysis confirm unique finding  week later patient clinical characteristic improve progressively discharge excellent general condition  day conclusion contrast originally believe sars cov- cause meningitis isolation cross blood brain barrier essential physician maintain high index suspicion neurological involvement covid- patient early csf analysis brain imaging indicate
850,covid- epidemic initially start wuhan china december  sars cov- sars cov- genetically similar bat beta coronavirus genus novel specie genus infect human common clinical feature covid- fever cough myalgia fatigue expectoration dyspnea primary report mortality rate china reach patient underlie cardiovascular disease primary epidemiological investigation show high prevalence underlie cardiovascular disease infected patient high prevalence hypertension ischemic heart disease diabete report deceased patient italy previous experiment different pandemic situation show cardiovascular system affect way previous study sars cov mers cov report cardiovascular co morbidity direct correlation risk infection severity disease mortality rate brief available protocol control negative effect novel respiratory infection cardiovascular system especially high risk population underlie cardiovascular condition concern healthcare provider aim review available datum cardiac manifestation covid- describe useful map well treatment covid- infection patient underlie cardiovascular condition high risk group patient
851,background scarcity datum effect type  diabetes mellitus tdm associate comorbiditie clinical presentation outcome symptomatic patient -covid- infection comparison non diabetic patient aim study describe compare clinical presentation radiological hematological datum cohort symptomatic covid positive tdm diabetic patient n versus cohort non diabetic symptomatic covid positive patient n =) diagnose time january  associated comorbiditie -assesse charlson comorbidity index calculate outcome include duration hospitalization duration intensive care unit icu stay duration mechanical ventilation duration o -supplementation assess result prevalence tdm symptomatic covid positive patient (= diabetic patient high prevalence hypertension chronic kidney disease ckd cardiac dysfunction coronary heart disease chd congestive heart failure chf charlson comorbidity score significantly high tdm patient .+/- versus non diabetic -patient p clinically radiologically tdm patient significantly high percentage pneumonia severe pneumonia ards versus non diabetic patient hematologically diabetic patient significantly high c reactive protein crp high absolute neutrophilic count anc low count lymphocyte eosinophil compare non diabetic patient significantly high systolic diastolic blood pressure long duration hospitalization icu stay mechanical ventilation oxygen therapy crp correlate significantly duration stay icu duration oxygen supplementation r respectively p conclusion tdm patient show high inflammatory response covid  high absolute neutrophilic count anc crp low lymphocytic eosinophilic count diabetic patient comorbiditie aggressive course disease high rate icu admission long need hospitalization oxygen use
852,telemedicine allow remote exchange medical datum patient healthcare professional increase patient access care provide effective healthcare service distance recent coronavirus disease  covid- pandemic telemedicine thrive emerge worldwide indispensable resource improve management isolated patient lockdown shielding include hypertension well propose healthcare model telemedicine hypertension management include remote monitoring transmission vital sign notably blood pressure medication adherence plus education lifestyle risk factor video consultation option use mixed automate feedback service supervision multidisciplinary clinical team physician nurse pharmacist ideal approach indication include screen suspect hypertension management old adult medically underserved people high risk hypertensive patient patient multiple disease isolate pandemic national emergency
853,objective information critically ill coronavirus disease  covid- patient limited case come health system approach different national public system exist country europe patient follow remain incomplete publication aim characterize acute respiratory distress syndrome ards patient admit medical critical care unit mccu referral hospital spain design retrospective case series consecutive ards covid- patient admit treat mccu setting mccu referral tertiary hospital patient participant sars cov- infection confirm real time reverse transcriptase polymerase chain reaction rt pcr assay nasal pharyngeal swab intervention main variables interest demographic clinical datum collect include datum clinical management respiratory failure patient mortality result ards covid- patient include study median age year patient male hypertension dyslipidemia frequent co morbidity .% respectively steroid mg kg day tocilizumab administer patient .% .% patient need invasive mechanical ventilation median  day prone position ventilation perform  patient median  session patient nosocomial infection diagnose  patient .% tracheostomy perform patient study close patient discharge ccu .% remain hospital ward mccu length stay  day mortality study closing n .% ventilate patient conclusion seven week period mccu exclusively dedicate covid- patient challenge despite severity patient high need invasive mechanical ventilation mortality
854,background covid- disease cause severe acute respiratory syndrome coronavirus  sars cov- study aim describe clinical characteristic covid- patient admit hospital tengku ampuan afzan htaa pahang malaysia identify clinical laboratory marker severe disease complication virologic clearance accord clinical staging method single centre retrospective descriptive study covid- patient admit htaa march  april include study patient categorise accord clinical staging datum obtain medical report include baseline characteristic patient comorbiditie present symptom laboratory finding treatment complication outcome result total  patient hospitalise majority consist clinical stage  stage  disease old patient diabetes mellitus hypertension cardiovascular disease chronic kidney disease find common patient severe disease fever uncommon majority normal haemoglobin level white cell count platelet count c reactive protein crp find statistically significant predict pneumonia hypoxia cut value mg l sensitivity .% specificity mg l sensitivity specificity respectively pneumonia diagnose radiologically chest radiography especially clinical stage acute kidney injury aki significant complication clinical stage  developed aki require haemodialysis median virologic clearance time  day onset illness asymptomatic patient long clearance time conclusion covid- present wide spectrum clinical pattern crp valuable predictor severe disease study risk severity acute kidney injury find high long duration virologic clearance observe asymptomatic patient
855,background clinical presentation covid- range mild self limit disease multiple organ failure death severe covid- case present low lymphocyte count high leukocyte count accumulate evidence suggest subgroup patient present severe covid- hyperinflammatory response drive severe hypercytokinaemia signal presence underlying endothelial dysfunction context available datum suggest prognostic role neutrophil lymphocyte ratio nlr inflammatory disease oncological process follow rationale hypothesize nlr marker endothelial dysfunction useful identify patient poor prognosis hospitalize covid- case design retrospective observational study perform hospital universitario hm puerta del sur madrid spain include  patient covid-  march  march patient categorize accord r&d expert group result .% patient experience severe acute respiratory failure require respiratory support seven .% patient die bad outcome old p present significantly high nlr admission p great increase peak nlr p high increase speed nlr p compare follow patient multivariable logistic regression age cardiovascular disease c reactive protein admission peak nlr significantly associate death conclusion nlr easily measurable available cost effective reliable parameter continuous monitoring useful diagnosis treatment covid-
856,introduction use renin angiotensin system ras inhibitor include angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb allege cause severe course novel coronavirus disease  covid- method systematically publish study assess association ras inhibitor mortality disease severity covid- patient systematic literature search perform retrieve relevant original study investigate mortality severity severe critical disease covid- patient exposure ras inhibitor result total  original study include qualitative synthesis study report adjusted effect size study report mortality outcome  study report disease severity outcome conduct ras inhibitor expose unexposed group pool random effect model estimate overall risk quality assessment study reveal study include fair quality use acei arb covid- patient significantly associate low odd odd ratio confidence interval ci n hazard hazard ratio hr ci n mortality compare non use acei arb use acei arb non significantly associate low odd ci n hazard hr ci n develop severe critical disease compare non use acei arb discussion increased risk harm use ras inhibitor hypertension establish clinical indication maintain covid- patient
857,study aim investigate specific medication treatment chronic disease affect development and/ severity coronavirus disease  covid- cohort  covid- case population base control zhejiang china cohort  covid- case population base control zhejiang china test role usage cardiovascular antidiabetic medication risk severity covid- analysis adjust age sex body mass index presence relevant comorbiditie individual hypertension take calcium channel blocker significantly increase risk odd ratio confidence interval ci manifest symptom covid- take angiotensin receptor blocker diuretic significantly low disease risk ci ci respectively type  diabetes dipeptidyl peptidase- inhibitor ci insulin ci .- glucosidase inhibitor prevalent ci patient covid- drug treatment hypertension diabetes influence risk development covid- severity
858,coronavirus disease  covid- find associate comorbiditie include cardiovascular disease hypertension diabete impaired regulation renin angiotensin aldosterone system raas see covid- patient raas inhibitor angiotensin convert enzyme inhibitor aceis angiotensin ii type  receptor blocker arb responsible worsen clinical condition remain unknown review role angiotensin convert enzyme  ace expression disease progression association comorbiditie covid- summarize clinical evidence potential direction future research work aceis arb covid- patient
859,objective describe clinical manifestation outcome covid- explore risk factor deterioration death disease method retrospective study collect datum  covid- case confirm rt pcr generation sequencing renmin hospital wuhan university january march conduct statistical analysis result total  patient include study median age  year iqr year .% case man case  .% case progress severe  .% die overall common manifestation fever respiratory symptom .% neurological symptom find .% patient .% case comorbiditie include hypertension .% diabetes admission case usually elevated level neutrophil .% d dimer .% interleukin- .% interleukin- .% high sensitivity c reactive protein .% lactate dehydrogenase .% decrease level lymphocyte .% cd cell .% cd cell proportional hazard cox model show risk factor severity progression death include comorbiditie hr ci hr ci leukocytosis hr ci hr ci neutrophilia hr ci hr ci elevate ldh hr ci hr ci elevated d dimer hr ci il- hr ci il- level hr ci risk factor progression disease severity lymphopenia wake immune response e.g. low cd cd cd count hr associate disease deterioration death conclusion severe case death covid- associate old age comorbiditie organ dysfunction lymphopenia high cytokine weak immune response
860,coronavirus disease  covid- cause sars cov associate comorbiditie cardiovascular disease hypertension diabetes liver lung disease neurological ailment majority dysfunction mention associate endothelial deterioration indicate endothelium target sars cov. study exclusive observational study quantitatively analyse covid- relate comorbiditie retrieve datum population covid- hospitalize deceased patient associate comorbiditie publicly accessible portal european country tailed t test enable determine significant proportion death compare hospitalize patient associate comorbidity study reveal death associate cardiovascular disease diabete highly significant p compare hospitalize country like italy france spain unlike netherlands death kidney disease italy- p sweden- p netherlands- p france- p neurological ailment france- p netherlands- p significantly high total hospitalize patient affect particular comorbidity note death liver disease associate covid- comorbiditie intriguingly immunodeficiency show mixed outcome death proportion compare hospital admit individual treatment regime involve drug like losartan ace inhibitor angiotensin receptor blocker remdesivir chloroquine hydroxychloroquine etc modulate severity comorbiditie comorbiditie create chaos exist healthcare system worsen disease outcome
861,objective describe dietary characteristic participant nutrinet brasil cohort immediately covid- pandemic method datum stem adult cohort create prospectively investigate relationship diet morbidity mortality chronic non communicable disease brazil study select participant n answer twice simplified questionnaire diet day time enter study january  february second  questionnaire inquirie consumption healthy vegetable fruit legume unhealthy ultra process food eat marker comparison indicator base consumption marker pandemic present study population accord gender age group macro region residence schooling chi square test t test compare proportion mean respectively adopt p identify significant difference result participant find modest statistically significant increase consumption healthy eating marker stability consumption unhealthy food marker favorable pattern dietary change pandemic occur sociodemographic stratum observe favorable change pattern tendency increase consumption healthy unhealthy food marker northeast north macro region people schooling suggest social inequality response pandemic conclusion confirm trend increase consumption ultra process food underdeveloped region people schooling concern eat food increase risk obesity hypertension diabetes presence increase severity lethality covid-
862,rationale detailed datum characteristic outcome patient covid- sub saharan africa limited objective determine clinical characteristic treatment outcome patient diagnose covid- uganda measurement  total  case confirm report  patient  receive hydroxychloroquine hcq  endpoint include admission intensive care mechanical ventilation death hospitalisation main result median age year .% male .% .% .% blood pressure bp mm hg .% bp mm hg laboratory derangement leucopenia .% lymphopenia .% thrombocytopenia .% abnormal chest x ray observe .% patient reach primary endpoint time clinical recovery short patient receive hcq difference reach statistical significance conclusion patient covid- present mild disease exhibit clinical trajectory similar country outcome differ hcq treatment status line conclude study benefit hcq treatment covid-
863,coronavirus disease  covid- usually severe associate bad outcome individual pre existing cardiovascular pathology include hypertension atherothrombosis severe acute respiratory syndrome coronavirus- sars cov- differentially infect multiple tissue i.e. lung vessel heart liver different stage disease age- sex dependent manner particular cardiovascular cv cell e.g. endothelial cell cardiomyocyte directly infect indirectly disturb systemic alteration lead hyperinflammatory apoptotic thrombotic vasoconstrictive response hundred clinical trial test antiviral immunomodulator decrease sars cov- infection related systemic anomaly new therapy target cv system reduce severity lethality disease line activation non canonical pathway renin angiotensin aldosterone system raas improve cv homeostasis covid- particular treatment angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb help reduce hyperinflammation viral propagation infusion soluble ace trap plasma viral particle increase cardioprotective ang-(- ang-(- peptide association specific ace polymorphism increase susceptibility infection related cv pathology suggest potential genetic therapy specific agonist ang-(- receptor counter regulate hypertensive hyperinflammatory hypercoagulable response interestingly sex hormone regulate raas component wait efficient vaccine suggest investigation non canonical raas pathway reduce cardiovascular damage mortality covid- patient
864,importance host genetic demography coronavirus disease  covid- crucial aspect infection prognosis associated case fatality rate individual genetic landscape contribute understand severe acute respiratory syndrome coronavirus  sars cov- burden information fight virus spread associated severe acute respiratory distress syndrome ards spread pathogenicity virus pandemic specific geographic area ethnicity interestingly sars cov- firstly emerge east asia europe cause high morbidity mortality peculiar feature sars cov- different past global viral infection i.e. sars- mers share previous pandemic strong age- sex dependent gap disease outcome observation severe covid- patient likely history hypertension diabetes and/or cardiovascular disease receive renin angiotensin system ras inhibitor treatment raise hypothesis ras unbalancing crucial role accordingly recently publish genetic hypothesis role ras pathway gene ace rs rs rs rs ace rs rs rs abo locus rs rs covid- prognosis suspect inherit genetic predisposition predictive covid- severity addition recently genome wide association studies gwas find covid association signal locus p. rs comprise solute carrier slca cl- couple transporter family locus q. rs coincident abo blood group rs rs rs interestingly loci associate ras pathway finally ace ace haplotype provide plausible explanation sars cov- affect heavily ethnic group people european ancestry asians
865,purpose tmprss host co receptor cell entry sars cov- prior report suggest use androgen deprivation therapy downregulate tmprss protect man prostate cancer infection material method cohort study prospective registry patient test sars cov- march  june  complete followup disease recovery death main exposure examine use androgen deprivation therapy outcome measure rate sars cov- positivity disease severity function androgen deprivation therapy use result study cohort consist man prostate cancer total test population .% positive sars cov- prostate cancer  .% sars cov- positive  .% androgen deprivation therapy androgen deprivation therapy positive compare .% androgen deprivation therapy man androgen deprivation therapy slightly old vs year p=. likely smoke .% vs .% p=. likely report take steroid .% vs .% p factor know increase risk infection disease severity equally distribute asthma diabetes mellitus hypertension coronary artery disease heart failure immune suppressive disease multivariable analysis indicate difference infection risk prostate cancer androgen deprivation therapy ci p=. conclusion androgen deprivation therapy appear protective sars cov- infection
866,background acute kidney injury aki affect hospitalize patient coronavirus disease  covid- estimate range .% perform systematic review meta analysis study report incidence mortality risk factor aki hospitalize covid- patient method systematically search  electronic database   study english report original datum aki kidney replacement therapy krt hospitalize covid- patient incidence aki krt risk ratio mortality associate aki pool generalized linear mixed random effect model potential risk factor aki assess meta regression incidence stratify geographic location disease severity result total  article identify  study include  hospitalize covid- patient include  aki event risk bias include study generally low pool incidence aki confidence interval ci hospitalize covid- patient usa europe study ci .- patient china study pool incidence krt ci  study ci  study respectively patient admit intensive care unit incidence krt ci  study meta regression analysis show age male sex cardiovascular disease diabetes mellitus hypertension chronic kidney disease associate occurrence aki aki associate increase risk mortality pooled risk ratio ci conclusion aki krt common event hospitalize covid- patient estimate vary geographic location additional study need well understand underlie mechanism optimal treatment aki patient
867,peripheral blood lymphocyte count show decrease patient covid- early stage disease degree lymphocyte count reduction relate covid- severity indicator reflect disease severity aim investigate value lymphocyte count determine covid- severity estimate time sars cov- nucleic acid test result turn negative retrospectively analyze clinical datum  patient severe critical covid- patient admit west campus union hospital tongji medical college huazhong university science technology datum include age gender chronic disease lymphocyte count sars cov- nucleic acid test result age patient critically ill group high severely ill group p lymphocyte count critically ill patient low severely ill patient cutoff value lymphocyte count distinguish critically ill severely ill x p cutoff value lymphocyte count sars cov- nucleic acid test result turn negative severely critically ill patient chronic disease hypertension diabetes coronary heart disease x p cutoff value lymphocyte count sars cov- nucleic acid test result turn negative severely critically ill male patient x p lymphocyte count effective indicator predict covid- severity useful determine time nucleic acid test result turn negative covid- patient underlie chronic disease male covid- patient severe critical condition
868,-kda heat shock protein hsp chaperone essential mitochondrial proteostasis ensure sufficient aerobic energy production pathological condition hsp translocate mitochondria excrete cell turn extracellular hsp strong ability trigger enhance inflammatory response marked proinflammatory cytokine induction mainly mediate toll like receptor bind previous study find increase circulate level hsp hypertensive patient enhance hsp expression membrane translocation hypertrophic myocardium observation particular interest provide possible pathophysiological explanation severe course bad outcome severe acute respiratory syndrome coronavirus  infection hypertensive patient repeatedly report recent coronavirus disease  covid- pandemic relate hyperinflammatory response cytokine storm development phase disease regard pharmacological inhibition hsp attract attention potentially ameliorate inappropriate inflammatory reaction severe covid- patient hsp antagonize drug mizoribine intriguing clinically approve exert antiviral activity topic require scrutinize
869,angiotensin system implicate pathogenesis covid- ace cellular receptor sars cov- expression ace gene regulate individual susceptibility infection addition balance ace ace activity implicate pathogenesis respiratory disease play role severity covid- functional ace ace gene polymorphism associate risk cardiovascular pulmonary disease contribute outcome covid- study  covid- patient non severe  severe icu case  age match control ace insertion deletion ace rs polymorphism determine variable frequency compare group logistic regression sequence ace code nucleotide group patient severe covid- associate hypertension male gender p hypertension p hypercholesterolaemia p ace dd genotype p multiple logistic regression hypertension p ci male gender p ci remain independent significant predictor severity ace polymorphism associate disease outcome ace sequencing show code sequence variant explain increased risk develop covid- conclusion adverse outcome covid- associate male gender hypertension hypercholesterolemia ace genotype work suggest ace d influence covid- severity effect dependent hypertensive status result require validation large cohort
870,background identification vulnerable subgroup risk factor associate susceptibility severe acute respiratory syndrome coronavirus  sars cov- infection coronavirus disease  covid- utmost importance pandemic scenario potential interaction renin angiotensin system ras immune marker covid- play role disease outcome specific group patient objective review aim describe particularity ras immune system profile particular subgroup patient method non systematic review summarize evidence sars cov- infection specific subgroup patient possible relationship immune system ras pathophysiology covid- result ras immune system exert role pathogenesis prognosis covid- mainly case hypertension diabetes obesity chronic disease overactivation ace ang ii atr axis enhancement inflammation contribute deleterious effect covid- likewise pregnant woman elderly patient usually display immune response effective withstand exposition virus child relatively protect severe complication covid- woman conversely exhibit strong antiviral response sensitive effect increase ang ii future perspectives recognition vulnerable subgroup risk factor disease severity essential well understand pandemic precision medicine tool include proteomic metabolomics approach identify metabolic pattern severe form disease alternative diagnose evaluate predict prognosis efficiency therapy
872,objective investigate clinical characteristic risk factor severe event coronavirus disease  covid- elderly patient method retrospective analysis perform clinical datum elderly covid-  patient treat changsha public health treatment center january  march include basic disease symptom test result clinical characteristic prognostic indicator severity illness length hospital stay virus shed time mortality rate difference clinical characteristic prognostic indicator elderly middle aged young covid- patient analyze logistic regression model conduct univariate multivariate analysis risk factor develop severe event elderly covid- patient receiver operate characteristic roc curve analysis evaluate prediction efficacy result  covid- adult patient  young patient .%  middle aged patient .%  elderly  elderly patient  male  female .% medium age  year old common symptom fever .% cough .% fatigue c reactive protein crp increase significantly proportion severe case mortality median length hospitalization median virus shed time day  day respectively compare young middle aged patient elderly high proportion hypertension diabetes cardiovascular disease common shortness breath high proportion pneumonia severe case p decrease lymphocyte count lymphocyte percentage p high crp erythrocyte sedimentation rate esr level p compare non severe case severe elderly patient demonstrate high crp aspartate aminotransferase ast level p reduce lymphocyte count p prolonged length hospitalization virus shed duration p univariate logistic regression analysis indicate lymphocyte proportion crp ast level significantly correlate risk develop severe event elderly covid- patient p multivariate logistic regression find severe event elderly patient covid- significantly correlate crp level or=. p=. roc curve analysis reveal area curve auc crp diagnose severe event elderly covid  patient conclusion proportion severe case elderly covid- patient high young middle aged patient crp level good predictive value possibility severe event elderly covid- patient
873,objective outbreak coronavirus disease  covid- spread rapidly china country rapid increase number case cause widespread panic people main public health problem world severe patient difficult breathing and/or hypoxemia  week onset critically ill patient rapidly develop acute respiratory distress syndrome cause coagulopathy multiple organ failure heart liver kidney death article analyze predictive role clinical feature patient covid- severe disease help doctor monitor severity relate feature restrain disease progress provide reference improvement medical treatment method clinical datum  patient covid- isolate treat changsha public health treatment center january  march  collect patient mild ordinary adult patient admission include  male  female   median age year old accord program diagnosis treatment novel coronavirus covid- infect pneumonia trial version issue general office national health committee office state administration traditional chinese medicine diagnostic typing criterion accord progression mild severe disease hospitalization patient divide mild group n= severe transformation group n= clinical feature age underlie disease blood routine coagulation function blood biochemistry oxygenation index analyze laboratory test include white blood cell wbc lymphocyte lym neutrophil neu hemoglobin hb platelet plt prothrombin time pt plasma fibrinogen fib activate partial prothrombin time aptt thrombin time tt d dimer total bilirubin tbil albumin alb alanine aminotransferase alt aspartate aminotransferase ast blood urea nitrogen bun serum creatinine cr creatine kinase ck creatine kinase isoenzyme mb ck mb lactate dehydrogenase ldh c reactive protein crp oxygen partial pressure arterial blood partial pressure oxygen arterial blood fractional concentration inspiratory oxygen pao fio calculate variable statistical significance analyze logistic regression analysis result patient severe transformation group combine underlie disease mild group p perspective disease distribution patient severe transformation group combine hypertension p severe transformation group pt significantly long level fib alt ast ck ldh crp significantly high mild group p p lym alb pao fio significantly low mild group p p logistic regression analysis perform clinical feature statistically significant difference combine hypertension lym pt fib alb alt ast ck ldh crp independent variable have severe disease dependent variable result combine hypertension decrease lym long pt increase ck level independent risk factor affect severity covid- p conclusion patient mild covid- apt develop severe disease relate combined hypertension decrease lym long pt increase ck level mild patient clinical feature early intervention effectively prevent progression severe disease
874,order describe manifestation patient coronavirus disease  covid- sociodemographic variable previous medical history clinical radiological manifestation treatment evolution patient evaluate take place march th th edgardo rebagliati martins national hospital lima seventeen patient register male average age year range .% return abroad .% refer health facility .% admit mechanical ventilation .% patient die risk factor detect advanced age arterial hypertension obesity main symptom detect cough fever dyspnea frequent laboratory finding elevated c reactive protein lymphopenia predominant radiological presentation bilateral interstitial lung infiltrate experience management patient diagnose severe covid- peru report
875,background aims onset coronavirus disease  covid- pandemic concern association exposure renin angiotensin aldosterone system raas inhibitor risk severity covid- method perform case control study utilize date datum south korean population provide korean national health insurance system patient hypertension heart failure test covid- .% confirm case case control matching multivariable adjust conditional logistic regression analysis perform result comparison patient expose raas inhibitor expose raas inhibitor reveal adjust odd ratio confidence interval ci covid- infection death ci ci respectively subgroup analysis major confounder age region diagnosis result ci ci respectively conclusion present study demonstrate evidence association raas inhibitor exposure risk severity covid-
876,background aims concern use renin angiotensin system ras blocker increase risk infect severe acute respiratory syndrome coronavirus  sars cov- progress severe clinical course infection study aim investigate influence ras blocker risk severity sars cov- infection method conduct retrospective cohort study analyze nationwide claim datum adult undergo sars cov- test south korea sars cov- positive rate clinical outcome evaluate accord use ras blocker patient hypertension n result total patient hypertension ras blocker sars cov- positive rate significantly high ras blocker group control group adjustment adjust odd ratio confidence interval ci p match propensity score adjust ci p sars cov positive patient hypertension use ras blocker associate poor outcome mortality adjust ci p composite admission intensive care unit mortality adjust ci p analysis propensity scorematched population show consistent result conclusion korean nationwide claim dataset use ras blocker associate high risk sars cov- infection high mortality severe clinical course
877,objective vitamin d endocrine system variety action cell tissue involve covid- progression especially decrease acute respiratory distress syndrome calcifediol rapidly increase serum ohd concentration evaluate effect calcifediol treatment intensive care unit admission mortality rate spanish patient hospitalize covid- design parallel pilot randomize open label double mask clinical trial setting university hospital setting reina sofia university hospital cordoba spain participant  consecutive patient hospitalize covid- infection clinical picture acute respiratory infection confirm radiographic pattern viral pneumonia positive sars cov- pcr curb severity scale recommend hospital admission case total score procedure hospitalize patient receive good available therapy standard care hospital protocol combination hydroxychloroquine mg  h day  mg  h follow  day azithromycin mg orally  day eligible patient allocate  calcifediol calcifediol ratio electronic randomization day admission oral calcifediol mg patient calcifediol treatment group continue oral calcifediol mg day  weekly discharge icu admission outcome effectiveness include rate icu admission death result  patient treat calcifediol require admission icu  untreated patient  require admission p value x fischer test p univariate risk estimate odds ratio icu patient calcifediol treatment versus calcifediol treatment ci multivariate risk estimate odds ratio icu patient calcifediol treatment vs calcifediol treatment icu adjust hypertension tdm ci patient treat calcifediol die discharge complication  patient treat calcifediol admit icu discharge  patient admit icu die remain  discharge conclusion pilot study demonstrate administration high dose calcifediol -hydroxyvitamin d main metabolite vitamin d endocrine system significantly reduce need icu treatment patient require hospitalization prove covid- calcifediol able reduce severity disease large trial group properly match require definitive answer
878,viral spike coat protein severe acute respiratory syndrome coronavirus  sars cov- engage human ace angiotensin convert enzyme  cell surface receptor infect host cell concern arise theoretically high risk coronavirus disease- covid- patient take ace inhibitor angiotensin ii type  receptor antagonist angiotensin receptor blocker arb systematically assess case population cohort study medline ovid cochrane database systematic reviews pubmed embase world health organization database covid- publication clinicaltrials.gov june plan ongoing surveillance rate certainty evidence accord cochrane method grading recommendations assessment development evaluation approach pool adjust odd ratio include study significant increase note risk sars cov- infection use ace inhibitor adjust odd ratio ci arb adjust odd ratio ci random effect meta regression reveal age modify sars cov- infection risk subject use arb coefficient ci use arb oppose ace inhibitor specifically augment risk sars cov- infection young subject year old use ace inhibitor increase susceptibility sars cov- infection severity disease mortality case population cohort study additionally discover time use arb oppose ace inhibitor specifically augment risk sars cov- infection young subject obvious effect covid- outcome
879,background high burden severe disease death coronavirus disease  covid- consistently observe old patient especially pre existing medical co morbidity global pandemic lockdown isolate patient chronic illness routine medical care narrative review article analyse multitude issue face individual underlie medical condition covid- pandemic method source publication identify search pubmed article publish st december  th june combination search term guideline update reputable agency consult article publish english language include result volume literature covid- continue expand article index pubmed th june  deem particularly relevant subject matter review old patient likely progress severe covid- disease require intensive care unit icu admission patient pre existing cardiovascular disease especially hypertension coronary heart disease greatly increase risk develop severe fatal covid- disease controversial aspect management covid- disease use angiotensin convert enzyme inhibitor angiotensin receptor blocker obese covid- patient likely require complex icu management putative mechanism increase covid- disease severity diabetes include hyperglycaemia alter immune function sub optimal glycaemic control hospitalisation pro thrombotic pro inflammatory state patient mental health disorder particularly vulnerable social isolation compound suspension non emergency care hospital world make difficult patient chronic mental illness attend outpatient appointment conclusion global pandemic covid- disease disproportionately negative impact patient live chronic medical illness future research direct effort protect vulnerable patient possible wave covid- minimise negative impact pandemic mitigation strategy individual
880,aim coronavirus disease  covid- recently encounter disease declare pandemic obesity component metabolic syndrome aggravate severity covid- nonalcoholic fatty liver disease nafld represent hepatic manifestation metabolic syndrome aim study investigate possible association mafld covid- severity method perform retrospective case control study enrol  consecutive covid- patient divide group accord presence absence fatty liver compute tomography scan medical record eligible patient include demographic clinical laboratory parameter datum presence nafld covid- severity result nafld identify study group thirteen suffer severe covid- nafld patient severe covid- compare non nafld subject .% vs. p respectively multiple logistic regression analysis show nafld subject likely severe covid- disease odd ratio confidence interval p conclusion nafld represent high risk severe covid- irrespective gender independent metabolic syndrome specifically male gender obesity hypertension metabolic syndrome significantly associate severe covid-
881,coronavirus disease  covid- pandemic infectious disease cause novel coronavirus severe acute respiratory syndrome coronavirus  sars cov- old age presence comorbiditie include diabetes show associate severe course high fatality rate study affected country include china united states italy indicate prevalence diabetes patient affect covid- high observe general population suggest diabetes risk factor sars cov- infection large body evidence demonstrate diabetes risk factor disease progression critical illness development acute respiratory distress syndrome need mechanical ventilation admission intensive care unit ultimately death mechanism underlie relationship covid- diabete remain elucidate particular unresolved diabetes se especially poorly control comorbiditie complication associate predispose patient covid- bad prognosis fact condition cluster diabetes context metabolic syndrome obesity hypertension complicate chronic hyperglycemia cardiovascular disease chronic kidney disease associate poor prognosis individual available study consistently show diabetes predict disease severity independently
882,background histomorphological change lung damage severe coronavirus disease  covid- adequately characterize article describe sequence pathological change covid- discuss implication approach treatment method standardized autopsy perform thirteen patient die covid- finding analyze clinical datum patient medical record result deceased patient man median age death  year range major pre exist chronic disease commonly arterial hypertension autopsy reveal characteristic covid induce pathological change lung regard cause death patient main histological finding sequential alveolar damage apparently large measure focal capillary microthrombus formation alveolar damage lead death patient directly induction pulmonary parenchymal fibrosis diffuse lung damage see exclusively invasively ventilate patient conclusion autopsy crucial systematic assessment new disease covid- provide basis investigation disease mechanism devising potentially effective mode treatment autopsy finding suggest focal damage microvascular pulmonary circulation main mechanism lethal lung disease sars cov- virus cause persistent lung damage patient recover severe covid-
883,introduction particulate matter exposure associate appearance severity disease include viral infection aim study investigate coronavirus disease  covid- case death italian region province march  link past exposure fine coarse particulate matter pm pm respectively material method geographical distribution covid- case death respectively st march pm pm exposure demographic characteristic extract publicly accessible database adjust regression model perform test association particulate matter exposure different italian region province covid- incidence proportion death rate result heterogeneous distribution covid- case death particulate matter exposure observe italy high number northern italy region province independent association regional pm./pm exposure covid- incidence proportion death rate observe covid- incidence proportion beta p beta p respectively covid- death rate beta p beta p respectively similarly pm./pm exposure independently associate covid- incidence proportion beta p beta p respectively provincial level number day exceed provincial limit value exposure pm microg m independently associate covid- incidence proportion beta p conclusion exposure pm pm associate covid- case death suggest particulate matter pollution play role covid- outbreak explain heterogeneous distribution covid- italian region province
884,severe acute respiratory syndrome coronavirus responsible current coronavirus disease  pandemic use angiotensin convert enzyme  gateway host cell review summarise biology enzyme play key role cardiovascular homeostasis blocker renin angiotensin system modify expression activity angiotensin convert enzyme  different way effect angiotensin convert enzyme inhibitor angiotensin receptor blocker expression enzyme activity angiotensin convert enzyme  consequence treatment severity coronavirus disease  infection discuss
885,modified chadsvasc m chadsvasc risk score include prognostic risk factor covid- assume predict hospital mortality identify high risk patient early stage compare troponin increase neutrophil lymphocyte ratio nlr aim investigate m chadsvasc rs independent predictor mortality patient hospitalize covid- compare discriminative ability troponin increase nlr term predict mortality total  patient retrospectively analyze divide  group accord m chadsvasc rs simply create change gender criterion chadsvasc rs female male group score n= group score n= group score n= adverse clinical event define hospital mortality admission intensive care unit need high flow oxygen and/or intubation m chadsvasc rs increase adverse clinical outcome significantly increase group .% group .% group .% p hospital mortality multivariate logistic regression analysis show m chadsvasc rs troponin increase neutrophil lymphocyte ratio independent predictor hospital mortality p=. odd ratio scale m chadsvasc rs receiver operate characteristic analysis comparative discriminative ability m chadsvasc rs superior chadsvasc rs score area curve auc value hospital mortality respectively aucm chads vasc vs. aucchads vasc z test=. p conclusion admission m chadsvasc rs useful tool predict hospital mortality patient covid-
886,background systematically review clinical biochemical characteristic associate severity novel severe acute respiratory syndrome coronavirus  sars cov-)-related disease covid- materials method systematic review observational study pubmed isi web science scopus cochrane database include people affect covid- report datum accord severity disease datum combine odd ratio metanalyse severe covid- define acute respiratory distress syndrome intensive care unit admission death result include  study  patient  .% severe disease slightly high age find severe vs non severe disease find prevalent cerebrovascular disease odd ratio confidence interval ci chronic obstructive pulmonary disease ci prevalent cardiovascular disease ci diabetes ci hypertension ci smoking ci male sex ci .- associate severe disease furthermore increase procalcitonin ci increase d dimer ci thrombocytopenia ci predict severe infection conclusion characteristic associate severity sars cov- infection allow early identification management patient poor outcome
887,purpose covid- global threat push health care limit vaccine drug covid- people increase risk severe fatal course disease particularly need protection furthermore factor increase risk interest search potential treatment systematic literature review risk factor severe fatal covid- course present method review carry pubmed publicly available dataset analysis risk factor categorize information study study size location extract result compare risk factor list public authority different country result  record include preprint indicate condition comorbiditie connect poor state health high age obesity diabetes hypertension risk factor severe fatal disease course furthermore severe fatal course associate organ damage mainly affect heart liver kidney coagulation dysfunction play critical role organ damaging time hospital admission tuberculosis inflammation disorder coagulation dysfunction identify risk factor find review mention public authority conclusion factor associate increase risk severe fatal disease course identify include condition connect poor state health organ damage coagulation dysfunction result facilitate upcoming covid- research
888,aim poor outcome coronavirus disease  covid- link diabetes relation pre infection glycaemic control unclear materials method address question report association pre infection haemoglobin ac hbac level covid- severity assess need hospitalization cohort  patient diabetes test covid- leumit health services lhss israel  february  april lhs integrate electronic medical record system able collect large clinical information include age sex socio economic status weight height body mass index hbac prior diagnosis ischaemic heart disease depression anxiety schizophrenia dementia hypertension cerebrovascular accident congestive heart failure smoking chronic lung disease result patient include cohort  .% diagnose covid-  admit hospital hospitalize patient female come high socio economic background high baseline hbac prior diagnosis cerebrovascular accident chronic lung disease confer increase risk hospitalization obesity smoking status multivariate analysis control multiple prior clinical condition parameter associate significantly increase risk hospitalization hbac conclusion pre infection glycaemic control datum identify hbac clear predictor covid- severity pre infection risk stratification crucial successfully manage disease efficiently allocate resource minimize economic social burden associate undiscriminating approach
889,present covid- rage world comorbiditie diabetes mellitus ci hypertension ci show worsen patient condition cardio cerebrovascular disease affect covid- remain unclear meta analysis collect study pubmed d science cnki chinese july report covid- patient cardio cerebrovascular disease severity mortality random effect model meta analysis analyze overall odd ratio ci funnel plot begg egger test assess publication bias thirty study patient finally include meta analysis result show ci covid- severity ci covid- mortality compare cardiovascular disease subgroup analysis indicate cerebrovascular disease likely increase severity ci mortality ci covid- infer cardio cerebrovascular disease associate increase risk severe illness death covid- patient meta analysis show cardio cerebrovascular disease significant relation severe death outcome covid- nurse pay special attention covid- patient cardio cerebrovascular disease
890,novel coronavirus disease covid- global health crisis appearance wuhan china current epidemiological study suggest covid- affect old patient multiple comorbiditie hypertension obesity chronic lung disease difference incidence severity covid- likely multifaceted depend biological social economical factor specifically socioeconomic difference psychological impact covid- affect male female essential pandemic mitigation preparedness previous clinical study show female susceptible acquire viral infection reduce cytokine production female patient high macrophage neutrophil activity antibody production response furthermore vivo study angiotensin convert enzyme  ace show high expression kidney male female patient explain difference susceptibility progression covid- male female patient remain unknown expression ace differ lung male female patient disparity healthcare access socioeconomic status ethnic group influence covid- rate ethnic group high level medical comorbiditie low socioeconomic status increase risk contract covid- weak cell mediate immunity article examine current literature gender racial difference covid- patient examine possible biological mechanism underlie difference
891,background multicentre cohort investigation patient coronavirus disease  covid- limit investigate clinical chest compute tomography characteristic patient covid- peak epidemic multiple centre china method retrospectively analyse epidemiologic clinical laboratory radiological characteristic  patient confirmed covid- admit seven hospital chinese province  january   february result mean patient age  year .% man /= co existing medical condition fever cough fatigue myalgia diarrhoea headache common symptom onset hypertension common co morbidity common clinical sign include dyspnoea hypoxia leukopenia lymphocytopenia neutropenia lesion exhibit subpleural distribution common radiological manifestation mixed ground glass opacity consolidation mggo c patient grid like shadow show pave stone patient hypertension dyspnoea hypoxia exhibit severe lobe involvement diffusely distribute lesion patient severely affected area exhibit high body temperature fatigue dyspnoea manifestation multiple lesion lobe involvement mggo c. wuhan lockdown period cough nausea dyspnoea alleviate patient newly confirm covid- lobe involvement improve conclusion patient covid- hospitalise peak epidemic china fever cough dyspnoea main symptom initial diagnosis accompany lymphocytopenia hypoxaemia patient severe disease show severe lobe involvement diffuse pulmonary lesion distribution
892,invasive mechanical associate high mortality covid- alternative therapy high flow nasal therapy hfnt greatly debate world use covid- pandemic concern increase healthcare worker transmission retrospective analysis consecutive patient admit temple university hospital philadelphia pennsylvania  march   april  moderate severe respiratory failure treat hfnt primary outcome prevention intubation  patient covid-  meet inclusion criterion average age year  female  .% african american  hispanic patient .% smoker saturation fraction ratio chest x ray score statistically significant improvement day  day   .% able avoid invasive mechanical ventilation cohort incidence hospital associate ventilator associate pneumonia overall mortality n= cohort  .% progress intubation group  .% non intubation group mortality incidence pneumonia statistically high progress intubation group conclusion hfnt use associate reduction rate invasive mechanical ventilation overall mortality patient covid- infection
893,sars cov- pandemic currently affect entire world show especially dangerous elderly /= year smoker notably strong comorbidity patient suffer chronic disease type  diabetes cancer chronic respiratory disease obesity hypertension inflammation lung main factor lead respiratory distress patient chronic respiratory disease patient severe covid- study show inflammation lung general type  diabetes accompany degradation glycosaminoglycan gags especially heparan sulfate hs study show importance counter degradation hs lung infection type  diabetes d xylose initiate element different sulfate gag chain especially hs show regeneration property gag d xylose xylitol demonstrate anti inflammatory antiglycemic antiviral antibacterial property lung infection combination antibiotic consider exist research covid- relate d xylose xylitol review offer perspective association d xylose antibiotic contribute significantly reduce duration treatment covid- patient anti inflammatory drug increase severity covid- strong correlation scurvy base gender age ethnicity smoking status obesity status relate effect treatment plant artemisia address chemical compound d xylose xylitol l ascorbic acid d glucuronic acid n acetylglucosamine d n acetylglucosamine n acetylgalactosamine galactose
894,background new virus break wuhan hubei china later name severe acute respiratory syndrome coronavirus  sars cov- clinical characteristic severe pneumonia cause sars cov- clear objective aim study explore clinical characteristic risk factor severe pneumonia cause sars cov- wuhan china method study include patient hospitalize central hospital wuhan diagnose covid- clinical feature chronic comorbiditie demographic datum laboratory examination chest compute tomography ct scan electronic medical record spss data analysis explore clinical characteristic risk factor patient severe pneumonia cause sars cov- result total  patient diagnose covid- include study include  severe pneumonia  nonsevere pneumonia statistical analysis show advanced age increase d dimer decrease lymphocyte characteristic patient severe pneumonia early stage disease chest ct scan patient severe pneumonia show illness progress rapidly conclusion advanced age decrease lymphocyte d dimer elevation important characteristic patient severe covid- clinician focus characteristic identify high risk patient early stage
895,background ferocious global assault covid- continue critically ill patient witness significantly high mortality severe moderate one aim comprehensively delineate clinical feature covid- explore risk factor develop critical disease method mini national multicenter retrospective cohort study involve consecutive covid- inpatient undergo discharge death january  march quality control covid- inpatient enrol electronic medical record collect identify risk factor develop critical covid- finding severity covid- climb straightly age critical group characterize high proportion dyspnea systemic organ damage long last inflammatory storm cause mortality critical group contrast severe group moderate group logistic regression reveal sex effect modifier hypertension coronary heart disease chd hypertension chd risk factor solely male multivariable regression show increase odd critical illness associate hypertension chd tumor age  year male chronic obstructive pulmonary disease copd chronic kidney disease ckd tumor age  year female interpretation provide comprehensive line information different severity covid- insight different risk factor associate critical covid- sex result highlight significance divide risk factor sex clinical epidemiologic work covid- coronavirus appear future funding national science foundation china
896,aim study investigate possible relationship bad clinical outcome use angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb hospitalize covid- patient total  adult patient male  female mean age year hospitalize covid- confirm polymerase chain reaction pcr retrospectively demographic clinical characteristic laboratory parameter analyze statistical modeling primary outcome define need intensive care unit icu mechanical ventilation occurrence death patient  treat icu high flow oxygen noninvasive mechanical ventilation nimv n mechanical ventilation n median length icu stay  range day mortality see icu patient patient follow covid- service median  day significant correlation primary outcome use acei arb frequentist confidence interval ci p bayesian posterior median ci presence hypertension frequentist ci p bayesian posterior median ci neutrophil lymphocyte ratio nlr d dimer level strongly associate primary outcome conclusion presence hypertension use acei arb significantly associate poor primary clinical outcome nlr d dimer level strong predictor clinical worsening
897,impact statement close relationship periodontal disease pds severity covid- infection relationship cause galectin mediate increase immune response increase viral attachment keep pd control maintain rigorous oral hygiene troubled covid- pandemic period important patient old age pre existing condition like cardiovascular disease hypertension diabetes obesity high risk group develop severe covid- infection inflammatory pathway involve condition pathway periodontal disease pds raise significant question pd pre existing condition increase risk develop severe covid- infection study show galectin play key role homeostasis immune cell recently relationship find covid- galectin- gal-).it determine important area spike protein coronavirus- exactly morphology gal- spike protein critical entry virus host cell suspect evidence support close relationship pds severity covid- infection accumulate evidence suggest relationship severity pd risk infection covid- require investigation relationship cause gal mediate increase immune response increase viral attachment context want emphasize importance keep pd control maintain rigorous oral hygiene troubled covid- pandemic period like point possibility have pd pre disposition develop severe covid- infection
899,introduction coronavirus disease  covid- represent threat patient maintenance dialysis clinical setting mortality rate prognostic factor patient establish method include dialyze patient covid- refer dialysis center march  april datum obtain review medical record censor time data cutoff result patient maintenance dialysis covid- refer dialysis unit covid- epidemic median age  year interquartile range iqr .% man comorbiditie include hypertension .% diabetes mellitus chronic cardiac .% respiratory .% disease initial symptom fever .% shortness breath .% cough .% diarrhea profile severity distinguish base world health organization progression scale .% hospitalize  maintain outpatient hemodialysis thirty patient require oxygen therapy include  .% refer intensive care unit overall .% patient die .% discharge hospital include  .% admit intensive care unit multivariate analysis cough thrombopenia  mg l significantly associate death conclusion major outbreak covid- occur paris region spread dialyzed patient study underscore severity covid- patient identify prognostic marker
900,introduction life threaten respiratory disease coronavirus  covid- spread globe december prognostic factor forward predict risk death outcome current study evaluate survival rate hypertensive non hypertensive infected patient method patient include study admit  february  march  fars southwest iran province hospital datum collect electronic base registry contain demographic information medical symptom sign underlie disease ct scan result final outcome result  positive case  .% know hypertension ant group significantly old non hypertensive patient year v year p accord kaplan meier survival curve log rank test see hypertensive patient deteriorate rapidly non hypertensive group p hiv cardiovascular kidney disease diagnose factor increase risk death hypertensive patient conclusion current study survival rate covid- patient show hypertensive patent danger disease severity relate age probability complication like diabetes smoking asthma kidney cardiovascular disease infection hiv condition complicate need consideration prevent noxious outcome
901,ace play critical role sars cov- infection cause covid- sars cov- spike protein bind ace probably functionally inhibit ace aggravate underlie disease covid- important factor affect severity fatality covid- include patient underlie disease age particular care patient underlie disease need treatment covid- patient
902,severe acute respiratory syndrome coronavirus  sars cov- cause great worldwide pandemic  flu consequence coronavirus disease  covid- devastating represent current major public health issue globe onset sars cov- primarily attack respiratory system represent main point entry host affect multiple organ patient present symptom mildly symptomatic people infect sars cov- experience severe multiorgan dysfunction severity covid- typically combine set comorbiditie hypertension diabetes obesity and/or advanced age seriously exacerbate consequence infection sars cov- cause gastrointestinal symptom vomiting diarrhea abdominal pain early phase disease intestinal dysfunction induce change intestinal microbe increase inflammatory cytokine diagnose gastrointestinal symptom precede respiratory problem covid- necessary improve early detection treatment uncover composition microbiota metabolic product context covid- help determine novel biomarker disease help identify new therapeutic target elucidate change microbiome reliable biomarker context covid- represent overlook piece disease puzzle require investigation
903,previous evidence demonstrate red blood cell distribution width rdw useful prognostic parameter critical illness infectious disease investigate utility rdw monitor patient coronavirus disease  covid- study population consist  covid- patient include  .% severe illness  .% severe acute kidney injury aki  .% require renal replacement therapy rrt predictive value blood test perform emergency department evaluation address progressive increase rdw observe advance covid- severity area curve auc rdw predict severe illness severe aki rrt respectively multivariate analysis elevate rdw associate -fold -fold increase odd severe covid- aki respectively result study suggest rdw routine laboratory assessment monitoring covid-
904,increased age appear strong risk factor covid- severe outcome study sufficiently consider age dependency important factor influence course disease aim review quantify isolated effect age severe covid- outcome search pubmed find relevant study publish independent reviewer evaluate predefined inclusion exclusion criterion extract result assess seven domain bias study adjust important age relate risk factor isolated effect age estimate meta regression study meet inclusion criterion study covid- disease severity seven mortality admission icu crude effect age .% high risk disease severity death age year respectively substantially decrease adjust important age dependent risk factor diabetes hypertension coronary heart disease cerebrovascular disease compromise immunity previous respiratory disease renal disease adjust comorbiditie indicate .% risk increase disease severity study additional risk death year age study indication weak influence age covid- disease severity adjustment important age dependent risk factor take consideration implement age relate preventative measure e.g. age dependent work restriction
905,beginning coronavirus disease  covid- outbreak initiate diamond princess cruise ship yokohama harbor february good treat covid- patient animal experiment angiotensin convert enzyme inhibitor aceis angiotensin ii type- receptor blocker arb report suppress downregulation angiotensin convert enzyme  ace inhibit worsening pathological condition aim examine precede use acei arb affect clinical manifestation prognosis covid- patient consecutive patient mean age   year polymerase chain reaction prove severe acute respiratory syndrome coronavirus  sars cov- infection admit hospital kanagawa prefecture japan analyze multicenter retrospective observational study covid- patient multiple regression analysis old age age  year significantly associate primary composite outcome odd ratio confidence interval ci p consist hospital death ii extracorporeal membrane oxygenation iii mechanical ventilation include invasive noninvasive method iv admission intensive care unit covid- patient hypertension precede acei arb use significantly associate low occurrence new onset worsen mental confusion ci p define confusion criterion include mild disorientation hallucination estimation medical history mental status adjustment age sex diabete conclusion old age significant contributor bad prognosis covid- patient aceis arb beneficial prevention confusion covid- patient hypertension
906,background impact country bacillus calmette guerin bcg vaccination policy course coronavirus disease covid- outbreak curiosity study relationship bcg vaccination status severity covid- pneumonia factor affect disease severity investigate method retrospective cross sectional study conduct march june  patient diagnose covid- pneumonia confirm severe acute respiratory syndrome coronavirus- polymerase chain reaction positivity nasopharyngeal sample pulmonary infiltrate compute chest tomography state hospital istanbul turkey socio demographic feature body mass index smoking status concomitant disease income rate bcg vaccination status subject analyze result study population comprise  adult covid- pneumonia mean age year standard deviation year  .% male rate case vaccinate bcg low versus .% p mean age year versus year p diabetes versus .% p low income versus .% p high patient severe disease compare mild disease accord multivariate analysis increase age odd ratio confidence interval ci p low income ci p associate severe disease covid- pneumonia conclusion study reveal bcg vaccination associate disease severity covid- pneumonia age low income main determinant severe covid- pneumonia
907,background confirm case novel coronavirus -ncov infection united states report state washington january march new york city epicenter outbreak united states method track patient confirmed coronavirus- covid- infection admit intensive care unit icu montefiore medical center bronx ny datum obtain manual review electronic medical record patient  day follow result  icu patient admit march  april majority .% patient man acute respiratory distress syndrome ards document .% patient .% require mechanical ventilation prone positioning employ patient neuromuscular blockade .% mechanically ventilate patient intervention associate decrease mortality vasopressor require .% patient acute kidney injury aki present admission .% patient develop subsequently .% .% patient aki receive renal replacement therapy rrt overall -day mortality rate patient receive mechanical ventilation univariate analysis high mortality rate associate increase age male sex hypertension obesity smoking number comorbiditie aki presentation need vasopressor support representative multivariable model -day mortality present contain patient age gender body mass index aki admission  patient .% remained hospitalize conclusion mortality critical illness associate covid- high majority patient develop ards require mechanical ventilation vasopressor dependent shock aki variation mortality rate report date likely reflect difference severity illness evaluate population
908,background objectives study describe epidemiological datum comorbiditie clinical symptom severity illness early outcome patient coronavirus disease  covid- tertiary care teaching hospital new delhi india method preliminary analysis prospective observational study adult patient admit screen intensive care unit icu institute fulfil case definition covid- confirm sars cov- infection reverse transcription polymerase chain reaction include demographic clinical datum  h outcome assess result preliminary analysis  patient reveal mean age yr cent male fever .% cough .% shortness breath .% common present symptom hypertension .% diabetes mellitus .% common associate comorbid illness patient mild moderate severe critical illness cent respectively time icu admission proportion confidence interval patient require form oxygen therapy oxygen therapy high flow nasal cannula invasive mechanical ventilation cent respectively  h hospital admission  h icu mortality cent non survivor high respiratory rate p n= low baseline oxyhaemoglobin saturation p n= presentation high baseline serum lactate p n= total leucocyte count p n= absolute neutrophil count p n= prothrombin time p n= inr p n= compare survivor interpretation conclusion nearly half patient present severe critical disease require high flow nasal oxygen invasive mechanical ventilation admission severity present respiratory illness haematological parameter lactate age presence comorbidity predict early death  h.
909,covid- pandemic start december  present result death globally approximately death report africa despite high prevalence covid- risk factor hypertension diabetes chronic pulmonary disease cardiovascular disease cvds rheumatic heart disease compromise immunity obesity low case fatality rate record part africa far covid- severity previously show bad patient cvd hypertension observe severity covid- mortality rate africa compare outcome prevalence establish risk factor hypertension cvd stratify datum united nations  african subregion north african country positive association risk factor mortality rate covid- observe discordant pattern relationship covid- cvd hypertension sub saharan african country paper review pathogenesis sars cov- infection worsen cvd postulate difference modulation renin angiotensin aldosterone system raas axis control angiotensin convert enzyme ace)/ace balance important determinant covid- outcome africa
910,background increase study demonstrate cardiac involvement relate coronavirus disease  covid- investigate clinical characteristic patient covid- determine risk factor cardiac involvement method results analyze datum  consecutive laboratory confirm hospitalize patient covid- woman aged year epidemiologic demographic characteristic clinical feature routine laboratory test include cardiac injury biomarker echocardiography electrocardiography chest imaging finding management method clinical outcome collect patient divide acute cardiac injury cardiac marker abnormitie group accord different level cardiac marker research cardiac involvement find   .% patient tachycardia n= electrocardiography abnormality n= echocardiography abnormality n= elevate myocardial enzyme n= acute cardiac injury n= patient acute cardiac injury aged year seven underlie comorbiditie hypertension diabetes mellitus cardiovascular disease chronic obstructive pulmonary disease chronic kidney disease novel coronavirus pneumonia severe patient acute cardiac injury patient nondefinite acute cardiac injury p multivariate analysis show crp c reactive protein level old age novel coronavirus pneumonia severity underlying comorbiditie risk factor cardiac abnormality patient covid- conclusion cardiac involvement common patient covid- elevated crp level old age underlie comorbiditie novel coronavirus pneumonia severity main risk factor cardiac involvement patient covid- attention give cardiovascular protection covid- treatment mortality reduction registration url  unique identifier chictr
911,medical personnel contact patient infect sars cov- especially high risk adverse psychological effect aim study assess mental health factor healthcare worker quantify severity anxiety depression sleep disorder current sars cov- pandemic take account coexist disease study involve  healthcare professional include  healthcare worker emergency ward infectious ward intensive care unit control group consist  healthcare worker work ward individual study group work regression adjust age gender occurrence hypertension diabetes mellitus dyslipidemia asthma autoimmune disease cigarette smoking show elevated risk anxiety generalized anxiety disorder gad- scale p depression patient health questionnaire phq- scale p sleep disorder insomnia severity index isi scale p study show healthcare worker expose sars cov infect patient emergency ward infectious ward intensive care unit high risk show symptom anxiety depression sleep disorder healthcare worker work ward
912,background sars cov- infection widely spread great public health challenge date covid- pandemic different fatality rate country probably non standardized record carry local health authority spanish case fatality rate .% far high report asia european country multicentre retrospective study demographic clinical laboratory immunological feature  spanish covid- hospitalize patient outcome perform use renin angiotensin system blocker analyse risk factor result study .% case present mild course moderate .% case course severe age range   average  .% patient male interleukin  high severity increase hand cd lymphocyte count significantly low severity grow subpopulation cd cd cd nk show concordant lowering trend severity relate natural killer percent descent evidence aged case significant severity relate decrease cd lymphocyte find male use angiotensin convert enzyme inhibitor associate well prognosis angiotensin ii receptor blocker use associate severe course conclusion age age relate comorbiditie dyslipidaemia hypertension diabetes determine frequent severe form disease study previous literature cohort case old far report clinical course disease find impair age immunosenescence suitable explanation hampering immune system effector adaptive immunity exhausted strong ineffective deleterious innate response account covid- severity angiotensin convert enzyme inhibitor hypertensive patient protective effect regard covid- severity series conversely patient angiotensin ii receptor blocker show severe disease
913,pulmonary embolism pes coronavirus disease  covid- increasingly report observational study limited information describe clinical characteristic outcome exist study aim describe clinical feature risk stratification strategy hospitalize covid- patient pe retrospectively analyze  hospitalize patient covid- infection acute pe clinical outcome measure intensive care unit admission mechanical ventilation bleeding transfusion event acute kidney injury aki mortality pulmonary severity index pesi score risk stratification common comorbiditie hypertension obesity hyperlipidemia cohort baseline d dimer abnormality note admission -fold increase time pe diagnosis p portend bad prognosis high mortality rate length stay conclusion study provide characteristic early outcome hospitalize patient covid- acute pulmonary embolism pesi score utilize risk stratify clinical outcome result serve alert medical community heighted vigilance vte complication associate covid- infection
914,"purpose study pattern severe covid- reduce morbidity mortality method observational cohort study comprehensive clinical analysis critically ill covid- patient dedicated covid public hospital result total .% patient critically ill male .% female include  pregnant death occur patient mean parameter associate critical covid illness have significant difference dead recover age spo blood sugar(.,p= il-(.,p=. d dimer(.,p= patient give oxygen non invasive technique .% intubation invasive ventilation require use hydroxychloroquin .% p=.,or.,%ci .- lopinavir/ ritonavir .% p=.e-,or ci.- tocilizumab patient p=.e ci.- associate recovery factor influence mortality presence co morbidity p=.,or.,%ci.- hypertension(p=.,or.,% ci low spo p=.e-,or.,%ci.- high blood sugar(p=.e-,or.,%ci .- high ldh(p=.,or ci.- high ferritin(p=.,or.,%ci .- high d dimer(p=.e-,or.,%ci .- low pfr(p=.e- endotracheal intubation(p=.e-,or.,%ci.- binary logistic regression elevated il- low pfr endotracheal intubation(.e- statistically significant predictor death conclusion happy hypoxia hyperglycemia high inflammatory marker il- ferritin ards hallmark critical covid- early detection factor associate severity mortality start multipronged management oxygen prone position hydroxychloroquin antiviral methylprednisolone anticoagulant tocilizumab early help halt worsening covid reduce morbidity mortality"
915,objective impact inflammatory rheumatic disease covid- severity poorly know compare outcome cohort patient rheumatic disease match control cohort identify potential risk factor severe illness method comparative cohort study identify hospital pcr+covid- rheumatic patient chronic inflammatory arthritis ia connective tissue disease ctds non rheumatic control randomly sample match age sex pcr date main outcome severe covid- define death invasive ventilation intensive care unit admission complication assess association outcome potential prognostic variable adjust covid- treatment logistic regression result cohort compose  rheumatic non rheumatic patient equal number mean age  iqr year male sex cohort rheumatic disease ia ctd patient hospitalise risk severe covid- rheumatic .% non rheumatic cohort age male sex previous comorbidity obesity diabetes hypertension cardiovascular lung disease increase risk rheumatic cohort bivariate analysis logistic regression analysis independent factor associate severe covid- increase age ci male sex ci have ctd ci conclusion hospitalise patient chronic inflammatory rheumatic disease have ctd ia previous immunosuppressive therapy associate severe covid-
916,sars cov- pandemic result million infection role host immune response early covid- pathogenesis remain unclear investigate  acute  convalescent patient find acute sars cov- infection result broad immune cell reduction include t natural killer monocyte dendritic cell dcs dcs significantly reduce functional impairment ratio conventional dc plasmacytoid dcs increase acute severe patient lymphocytopenia neutralize antibody rapidly abundantly generate patient delay receptor bind domain rbd)- nucleocapsid protein np)-specific t cell response  week symptom onset acute rbd- np specific t cell response include relatively cd t cell cd t cell finding provide evidence impaired dc timely inverted strong antibody weak cd t cell response contribute acute covid- pathogenesis implication vaccine development
917,coronavirus disease  covid- pandemic report characteristic outcome vary greatly study determine pooled estimate clinical characteristic outcome covid- patient include subgroup disease severity base world health organization interim guidance report infectious disease society america american thoracic society criterion country region search pubmed embase scopus cochrane chinese medical journal database  january   april study laboratory confirm covid- patient relevant datum include reviewer independently perform study selection data extraction  article  study  country region involve  individual analyze overall mean age year .% male .% severe disease mortality .% underlie immunosuppression diabetes malignancy strongly associate severe covid- coefficient respectively p old age male gender diabetes hypertension associate high mortality coefficient year respectively p gastrointestinal nausea vomiting abdominal pain respiratory symptom shortness breath chest pain associate severe covid- pneumonia end organ failure associate mortality covid- associate severe disease course mortality infected person individual comorbiditie clinical feature associate severity monitor closely preventive effort especially target diabetes malignancy immunosuppression
918,background aim outbreak coronavirus disease  covid- quickly turn pandemic aim clarify clinical characteristic relationship feature disease severity method retrospective single center study demographic clinical laboratory datum collect analyze moderate severe critically ill group patient result  hospitalization patient confirm covid- enrol study average age patient year sd  patient median body mass index bmi iqr .- range median duration disease onset hospital admission  day iqr .% patient comorbiditie hypertension common .% follow diabetes mellitus .% coronary atherosclerotic heart disease cad .% common symptom onset disease fever .% cough .% dyspnea .% fatigue  patient divide moderate .% severe .% critically ill .% group compare severe moderate patient lymphocytopenia occur critically ill patient serum il r il- il- tnf alpha ldh ctni increase .% .% .% .% .% critically ill patient analysis age comorbiditie lymphocyte count eosinophil count ferritin crp ldh pt inflammatory cytokine statistically significant disease severity conclusion find clinical characteristic inflammatory cytokine reveal severity covid- outbreak phage research assist clinician recognize severe critically ill patient timely focus expectant treatment patient
919,case covid- appear wuhan china end disease quickly pandemic seriously affect economic health system  country territory world patient mild symptom asymptomatic patient develop complication acute respiratory distress syndrome venous thromboembolism require mechanical ventilation intensive care important identify patient high risk complication timely manner objective paper review hematological laboratory parameter consistently alter covid- identify relationship severity disease accord  select report frequency patient age  year high subject severely affect deceased likewise male predominantly suffer comorbiditie hypertension diabetes obesity retrospective study identify alteration hematological inflammatory parameter host response infection secondary increase risk different thrombotic event alter parameter d dimer c reactive protein interleukin- test prognostic biomarker close relationship severity disease actually reliably indicate use antithrombotic therapy prophylactic therapeutic dose mainly d dimer establish patient individualized assessment appear high risk thrombotic event
920,-year old pregnant woman hospitalise fever cough myalgia dyspnoea week gestation wg development acute respiratory distress syndrome ards mandate invasive mechanical ventilation nasopharyngeal swab prove positive severe acute respiratory syndrome coronavirus  reverse transcription pcr patient develop hypertension biological disorder suggest pre eclampsia hellp haemolysis elevate liver enzyme level low platelet level syndrome pre eclampsia subsequently rule low ratio serum soluble fms like tyrosine kinase- placental growth factor give severity ards delivery caesarean section contemplate ratio normal patient respiratory condition stabilise delivery postpone recover  day mechanical ventilation spontaneously deliver healthy boy wg clinical laboratory manifestation covid- infection mimic hellp syndrome fetal extraction systematic absence fetal distress intractable maternal disease successful evolution result multidisciplinary teamwork
921,-year old man medical history hypertension atrial fibrillation chronic kidney disease metastatic castration resistant prostate cancer crpc progress line therapy crpc abiraterone plus androgen deprivation therapy adt second line therapy treat docetaxel biochemical progression prostate specific antigen measurement admit hospital april middle coronavirus disease  covid- pandemic painful bone lesion deterioration renal function
922,barely month pandemic know covid- spread  country affect  million people cause  death elderly people patient previous comorbiditie hypertension diabete increase risk suffer poor prognosis severe acute respiratory syndrome coronavirus  sars cov- infection expect patient chronic obstructive pulmonary disease copd current epidemiological datum conflicting lead reduction precautionary measure patient context particularly complex global health crisis copd patient long history smoking exposure harmful particle gas capable impair pulmonary defence year absence exposure copd characterize ongoing immune dysfunction affect pulmonary systemic cellular molecular inflammatory mediator consequently increase susceptibility viral respiratory infection report copd worsen bacterial co infection lead clinical outcome present paper date review discuss available research implication coronavirus infection copd validation large study need copd likely increase sars cov- susceptibility increase covid- severity specific mechanism monitor assess copd patient address current pandemic
923,purpose coronavirus disease  covid- create unprecedented healthcare crisis understand determinant mortality crucial optimise intensive care unit icu resource use identify target improve survival method multicentre retrospective study include  covid- patient admit icu  february  april  categorise accord time disease onset icu admission cox proportional hazard model identify factor associate mortality result median age  year  man main comorbiditie include obesity overweight hypertension .% diabetes median time disease onset i.e. viral symptom icu admission  day miss  .% patient admit week disease onset  .%   day  .%  day disease onset day  mortality decrease time disease onset icu admission increase  respectively patient admit week high sofa score thrombocytopenia acute kidney injury limited radiographic involvement significantly high blood il- level age copd immunocompromised status time disease onset troponin concentration acute kidney injury independently associate mortality conclusion excess mortality patient admit week disease onset reflect great non respiratory severity therapeutic intervention sars cov- impact different clinical endpoint accord time disease onset
924,coronavirus disease  covid- high morbidity mortality associate age male gender comorbiditie chronic lung disease cardiovascular pathology hypertension kidney disease diabetes mellitus obesity condition characterize increase sympathetic discharge exert significant detrimental effect covid- patient action lung heart blood vessel kidney metabolism and/or immune system furthermore covid- increase sympathetic discharge change blood gas chronic intermittent hypoxia hyperpnea angiotensin convert enzyme ace)/ace imbalance immune inflammatory factor emotional distress potential role sympathetic nervous system consider pathophysiology covid- opinion sympathetic overactivation represent far undervalued mechanism vicious circle covid- comorbiditie
925,introduction retrospectively analyze epidemiological clinical hematological characteristic covid- patient method demographic symptom physiological parameter  patient collect analyze performance complete blood count cbc index monitor predict severity covid- patient evaluate analyze compare cbc result different covid- patient group result white blood cell wbcs neutrophil percentage neu% absolute neutrophil count neu neutrophil lymphocyte ratio nlr significantly high critical group group p lymphocyte percentage lym% monocyte percentage mon% lymphocyte count lym lymphocyte monocyte ratio lmr significantly low critical group group p wbcs neu% neu nlr neutrophil monocyte ratio nmr significantly high severe group mild moderate group p lym% significantly low severe group mild moderate group p mon% lym lmr significantly low severe group moderate group p receiver operate characteristic roc curve analysis differentiate severe nonsevere patient area curve aucs nlr neu% lym% respectively differentiate critical patient noncritical patient auc nlr neu% lym% conclusion nlr valuable differentiate predict patient critical  week onset covid-
926,coronavirus disease  covid- cause devastating global pandemic continue overwhelm health care facility shatter economy country worldwide primarily affect lung share strong interplay cardiovascular system presence underlie cardiovascular disease risk factor diabetes hypertension predispose patient increase severity mortality associate covid- hand covid- lead cardiovascular complication increase associated morbidity mortality affected patient prudent review rapidly evolve datum field understand mechanism cardiovascular involvement lethal disease
927,study aim evaluate onset characteristic patient uremia undergo maintenance hemodialysis complicate covid- improve understanding diagnosis treatment case confirm case covid- confirm patient covid- undergo maintenance hemodialysis blood purification center recruit general datum patient include age sex duration dialysis basic disease analyze clinical feature include fever respiratory symptom gastrointestinal symptom item laboratory test include blood routine examination liver function c reactive protein procalcitonin creatine kinase creatine kinase mb marker myocardial injury b type natriuretic peptide d dimer forth imaging examination refer mainly compute tomography imaging finding lung case complicate chronic basic disease hypertension diabetes term clinical manifestation  case fever close number case fever case respiratory symptom include dry cough case shortness breath case fatigue case forth  patient hypoxemia indicate severe patient sore throat case significant patient report gastrointestinal symptom case result blood routine examination show decrease absolute lymphocyte count x  approximately low hemoglobin level  g l normal absolute neutrophil count  approximately inflammatory index procalcitonin ng ml c reactive protein mg l high normal blood biochemistry reveal low albumin level g l high troponin ng ml myoglobin level ng ml suggest myocardial injury patient uremia confirm covid- undergo maintenance hemodialysis common male proportion fever patient proportion hypoxemia patient high poor cardiac function prone respiratory failure complicate heart failure accord onset characteristic population early diagnosis treatment help reduce risk develop critical illness control spread covid- epidemic
928,objective identify factor contribute increase susceptibility severity covid- obese child adolescent health consequence source study publish   pubmed medline scopus scielo cochrane database summary findings obesity highly prevalent comorbidity severe case covid- child adolescent social isolation lead increase fat accumulation excessive adipose tissue deficit lean mass insulin resistance dyslipidemia hypertension high level proinflammatory cytokine low intake essential nutrient factor compromise functioning organ system obese individual factor associate damage immune cardiovascular respiratory urinary system modification intestinal microbiota dysbiosis severe acute respiratory syndrome coronavirus  infection organic change obesity increase need ventilatory assistance risk thromboembolism reduce glomerular filtration rate change innate adaptive immune response perpetuation chronic inflammatory response conclusion need social isolation effect cause worsen obesity comorbiditie pediatrician need aware issue face child suspect confirm covid- health professional diagnose excess weight advise health care time isolation screen comorbiditie ensure treatment interrupt measure level immunonutrient guide family understand specific situation refer unit qualified care obese child adolescent necessary
929,introduction severe acute respiratory syndrome coronavirus  sars cov- cause pandemic coronavirus disease  covid- global health crisis possible pancreatic involvement recently observe patient significance unclear aim study evaluate association significantly elevated lipase disease outcome method datum demographic symptom laboratory value clinical outcome collect consecutive patient test positive covid- elevated lipase define great  time upper limit normal x uln baseline characteristic patient elevated lipase compare fisher exact test student t test categorical numerical variable respectively logistic regression evaluate association lipase level primary clinical outcome intensive care unit admission intubation adjust age sex body mass index history diabetes hypertension result patient covid-  available lipase level admit hospital  .% elevate lipase x uln associate high rate leukocytosis p abnormal liver enzyme p compare low lipase level x uln patient elevated lipase high rate icu admission .% vs .% p intubation .% vs .% p multivariable adjust model high lipase level significantly associate admission icu rate intubation discussion lipase elevation see covid- associate bad disease outcome
930,background coronavirus disease- covid- pandemic major health event endanger people health china world understand factor associate covid- disease severity support early identification patient high risk disease progression inform prevention control activity potentially reduce mortality study aim describe characteristic patient covid- factor associate severe critically ill presentation jiangsu province china method multicentre retrospective cohort study individual confirm severe acute respiratory syndrome coronavirus- sars cov- infection diagnose  covid designate hospital jiangsu province th january th march demographic clinical laboratory radiological datum collect hospital admission datum disease severity collect follow patient categorise asymptomatic mild moderate severe critically ill accord bad level covid- record hospitalisation result total  patient  .% severe critically ill  .% asymptomatic mild moderate patient discharge patient die patient severe critically ill covid- likely old single onset i.e. belong cluster case family community etc medical history hypertension diabetes high temperature fast respiratory rate low peripheral capillary oxygen saturation spo high computer tomography ct image quadrant score pulmonary opacity percentage increase c reactive protein fibrinogen d dimer admission low white blood cell lymphocyte platelet count albumin admission asymptomatic mild moderate case multivariable regression show odd severe critically ill case associate age year ci lymphocyte count ci pulmonary opacity ct admission ci conclusion severe critically ill patient covid- tenth patient jiangsu age lymphocyte count pulmonary opacity ct admission associate risk severe critically ill covid-
931,background coronavirus disease  covid- rapidly spread global pandemic clinical characteristic covid- report limited research investigate clinical characteristic covid- middle east study aim investigate clinical radiological therapeutic characteristic patient diagnose covid saudi arabia method study retrospective single centre case series study extract datum patient admit noor specialist hospital pcr confirm sars cov- th st march descriptive statistic describe patient characteristic continuous datum report mean sd chi squared test fisher test appropriate compare proportion categorical variable result total  patient hospitalise covid- study period mean age year sd year common comorbiditie hypertension .% n diabetes mellitus .% n severity hospitalise patient  patient .% mild  .% moderate  patient .% severe require icu care conclusion case series provide clinical radiological therapeutic characteristic hospitalise patient confirmed covid- saudi arabia
932,advanced age presence multiple comorbiditie major contributor increase risk severe disease fatal outcome severe acute respiratory syndrome coronavirus  sars cov- disease covid- emerge evidence overweight obesity predispose severe symptom negative prognosis remarkably severity covid- appear rise increase body mass index bmi association covid- outcome overweight obesity biological physiological plausibility potential pathophysiological mechanism explain strong association include chronic pro inflammatory state excessive oxidative stress response impaired immunity commonly report individual role cytokine mammalian target rapamycin mtor alter natural killer cell polarization dangerous liaison covid- obesity discuss pathway favor accelerate deleterious downstream cellular effect sars cov- obesity known associate reduce lung function poor response mechanical ventilation place individual high risk severe illness mortality covid- furthermore obesity lead complication renal failure cardiovascular dysfunction hypertension vascular damage turn accelerate negative clinical outcome covid- obese individual shield potential viral exposure sars cov- consequential consideration compulsory protection device social distancing health care provider aware obesity predispose severe symptom negative prognosis covid- patient
933,pandemic coronavirus disease- commonly know covid- cause severe acute respiratory syndrome coronavirus- sars cov- highly contagious disease high mortality rate comorbiditie associated symptom accompany sars cov- infection comorbiditie like hypertension cardiovascular disease chronic obstructive pulmonary disease diabetes consider critical comorbidity affect survival infected patient severity covid- disease intensify patient elevated glucose level probably amplify pro inflammatory cytokine response poor innate immunity downregulate angiotensin convert enzyme use ace inhibitor angiotensin receptor blocker worsen glucose level patient suffer novel coronavirus infection observe direct beta cell damage cause virus hypokalemia cytokine fetuin mediate increase insulin resistance deteriorate diabetic condition covid- patient review highlight current scenario coronavirus disease pre existing diabetic patient epidemiology molecular perception investigation treatment management covid- disease patient pre existing diabete discuss unexplored therapy future perspective coronavirus infection
934,association use angiotensin convert enzyme ace inhibitor angiotensin receptor blocker arb clinical outcome coronavirus disease  covid- unclear pubmed embase search relevant study assess association application acei arb risk covid- inflammation level severity covid- infection death patient covid- study include  patient acei arb therapy associate reduce inflammatory factor interleukin- elevated immune cell count cd cd meta analysis show significant increase risk covid- infection odd ratio ci patient receive acei arb therapy acei arb therapy associate decrease risk severe covid- ci mortality ci subgroup analysis show general population acei arb therapy associate reduce severe covid- infection ci cause mortality ci covid- infection ci increase patient hypertension use acei arb associate low severity covid- ci low mortality ci evidence increase risk covid- infection basis available evidence acei arb therapy continue patient risk covid- general population hypertension patient result need interpret caution consider potential residual confounder design study control clinical confounder necessary confirm finding
935,background anecdotal report suggest few patient stroke symptom present hospital coronavirus disease  covid- pandemic quantify trend stroke code call treatment  connecticut hospital local emergence covid- examine patient characteristic stroke process measure comprehensive stroke center csc pandemic method stroke code activity analyze january  april corresponding date piecewise linear regression spline model identify stroke code  begin decline fall  level patient level datum analyze february versus march april  csc identify difference patient characteristic pandemic result total  stroke code activate  hospital january  april number stroke code wk decrease february  march  p=. nadir .% expect stroke code call march   decrease total stroke code pandemic week  versus commensurate increase network telestroke utilization compare pandemic n= pandemic epoch stroke code patient csc n= likely history hypertension dyslipidemia coronary artery disease substance abuse public health insurance low median household income live csc city p difference age sex race ethnicity stroke severity time presentation door needle door reperfusion time discharge modify rankin scale conclusion hospital presentation stroke like symptom decrease covid- pandemic difference stroke severity early outcome individual live outside csc city likely present stroke code csc pandemic public health initiative increase awareness present non covid- medical emergency stroke pandemic critical
936,coronavirus disease  covid- suppose global health emergency affect million people particular severity elderly patient previous comorbiditie especially cardiovascular disease patient pulmonary arterial hypertension pah chronic thromboembolic pulmonary hypertension cteph represent especially vulnerable population high mortality rate report respiratory infection number covid- case report pah cteph patient surprisingly low furthermore clinical picture describe patient far severity expert expect endothelial dysfunction common feature patient pah cteph covid- lead ventilation perfusion mismatch vasoconstriction thrombosis inflammation picture angiotensin convert enzyme  play essential role directly involve pathophysiology clinical entity common characteristic explain good adaptation pah cteph patient covid- obtain benefit disease specific treatment anticoagulant pulmonary vasodilator probably protective effect endothelium additionally common feature lead pah cteph potential sequela covid- comprehensive review describe similarity difference condition possible pathophysiological therapeutic base mechanism lead low incidence severity covid- report pah cteph patient date international registry look carefully population well understanding management
937,understand pathophysiology sars cov- infection critical therapeutic public health strategy viral host interaction guide discovery disease regulator protein structure function analysis point immune pathway include complement coagulation target coronaviruse determine condition associate dysregulated complement coagulation system impact disease perform retrospective observational study find history macular degeneration proxy complement activation disorder history coagulation disorder thrombocytopenia thrombosis hemorrhage risk factor sars cov associate morbidity mortality effect independent age sex history smoking transcriptional profiling nasopharyngeal swab demonstrate addition type interferon interleukin dependent inflammatory response infection result robust engagement complement coagulation pathway finally candidate drive genetic association study severe sars cov- disease identify putative complement coagulation associate loci include missense eqtl sqtl variant critical complement coagulation regulator addition provide evidence complement function modulate sars cov- infection outcome data point putative transcriptional genetic marker susceptibility result highlight value multimodal analytical approach reveal determinant predictor immunity susceptibility clinical outcome associate infection
938,background population mexico high prevalence rate noncommunicable disease ncds hospitalization death covid- patient country affect pandemic associate chronic comorbiditie objective describe prevalence ncd patient covid- mexico analyze increase risk comorbiditie risk factor hospitalization utilization intensive care unit death method cross sectional study perform confirm covid- case report ministry health june odd ratio perform logistic regression model result .% patient covid- diagnosis report comorbidity hypertension frequent report ncd significantly increase risk death respect patient diagnosis chronic kidney disease increase risk death follow diabetes immunosuppression obesity hypertension chronic obstructive pulmonary disease comorbiditie increase risk icu intubation diabetes immunosuppression obesity conclusion ncd comorbiditie increase severity covid- infection give high ncd prevalence rate mexican population pandemic pose special threat health system society special prevention measure need strengthen person ncd diagnosis short term mid term disease control strategy need improve protect patient covid- severity
939,introduction objective recent outbreak coronavirus disease  covid- occur worldwide angiotensin convert enzyme  ace mediate coronavirus entry host cell renin angiotensin system inhibitor rasi suspect contribute increase coronavirus infection aim analyze effect rasi covid- patient hypertension patient method retrospective single center study  covid- patient hypertension admit shanghai public health clinical center january  january analyze clinical feature laboratory parameter medication length stay patient give antiviral antihypertension treatment  patient treat rasi  patient rasi result compare group find statistically significant difference clinical symptom laboratory test furthermore cough aggravate conclusion analysis small sample rasi deem safe effective control high blood pressure covid- patient analysis large sampling size require explore underlie mechanism
940,present case detail seven patient diagnose severe novel coronavirus disease  -ncov covid- hepatic injury patient elderly hypertension diabetes mellitus coronary heart disease underlie health condition prior admission covid- liver injury occur seven case course disease serum alanine aminotransferase alt aspartate aminotransferase ast level initially increase .-time normal value respectively second week liver function recover patient week conventional liver protection treatment elevated serum transaminase level patient covid- infection relate systemic immune response cause cytokine storm syndrome css hepatocyte damage cause ischemia hypoxia covid- highly infectious mainly affect lung case especially patient severe disease type covid- cause liver injury liver function patient severe covid- carefully monitor especially patient elderly underlying comorbiditie
941,objective primary objective study determine effect baseline use angiotensin convert enzyme inhibitor ace i)/at blocker arb mortality hospitalize coronavirus disease  covid- african american patient secondary objective determine effect baseline use ace arb need mechanical ventilation new dialysis icu care composite mention outcome cohort method retrospective study analyze datum electronic medical record hospitalize covid- african american patient die hospital survive discharge  march  patient divide group ace arb baseline pearson chi square test categorical variable student t test continuous variable perform multiple logistic regression test primary secondary objective sas result  patient include analysis  ace arb baseline patient ace arb group old vs.  year p high prevalence hypertension vs. .% p diabetes mellitus vs. .% p difference sex bmi comorbiditie present illness severity group adjustment multiple covariate difference outcome group include mortality need mechanical ventilation new dialysis icu care composite outcome conclusion baseline use ace arb worsen outcome hospitalize covid- african american patient
942,coronavirus disease  covid- infection reach pandemic state affect million patient worldwide predictor disease outcome patient need urgently assess decrease morbidity societal burden lactate dehydrogenase ldh associate bad outcome patient viral infection pool analysis  publish study n  covid- patient evaluate association elevated ldh level measure early time point hospitalization disease outcome patient covid- elevated ldh level associate ~-fold increase odd develop severe disease ~-fold increase odd mortality patient covid- large study need confirm finding
943,role renin angiotensin aldosterone system severe acute respiratory syndrome coronavirus- infection development coronavirus disease- disease generate remarkable concern physician patient suggestive pathophysiological link renin angiotensin aldosterone system virus propose pathogenic role remain difficult define coronavirus disease- target preferentially old people high prevalence hypertension extensive use renin angiotensin aldosterone system inhibitor independent role hypertension therapy define article scrutinize evidence representative available study potential role renin angiotensin system inhibitor specifically angiotensin convert enzyme inhibitor angiotensin receptor blocker evaluate coronavirus disease- disease course regard severity disease mortality conclude time overall available evidence fail support pathogenetic speak harmful role renin angiotensin aldosterone system inhibitor coronavirus disease- consequently conclude treatment renin angiotensin aldosterone system inhibitor discontinue therapy interrupt
944,background uncertainty association angiotensive enzyme ace inhibitor angiotensin receptor blocker arb drug covid- disease study patient prescribe drug alter risk contract severe covid- disease receive associate intensive care unit icu admission method prospective cohort study routinely collect datum  general practice england million participant aged year cox proportional hazard model derive adjust hrs exposure ace inhibitor arb drug adjust sociodemographic factor concurrent medication geographical region primary outcome covid- rt pcr diagnose disease b covid- disease result icu care finding  patient covid- disease  receive icu care ace inhibitor associate significantly reduce risk covid- disease adjust hr ci increase risk icu care adjust hr ci adjust wide range confounder adjust hrs arb ci covid- disease ci icu care significant interaction ethnicity ace inhibitor arb covid- disease risk covid- disease associate ace inhibitor high caribbean adjust hr ci black african adjust hr ci group white group adjust hr ci high risk covid- arb see black african adjust hr ci white adjust hr ci group interpretation ace inhibitor arb associate reduce risk covid- disease adjust wide range variable ace inhibitor arb associate significantly increase risk receive icu care variation different ethnic group raise possibility ethnic specific effect ace inhibitor arb covid- disease susceptibility severity deserve study
945,objective determine specific intervention reduce composite progression patient covid related disease organ failure death measure time incidence follow death invasive mechanical ventilation ecmo cardiovascular organ support inotrope balloon pump renal failure estimate cockcroft gault creatinine clearance  risk count include radiographic severity score risk count calculate following feature admission point radiographic severity score male gender non white ethnicity diabetes hypertension neutrophil x()/l age year crp mg l. patients consider appropriate subject intervention immunomodulatory disease modify agent opinion investigator able swallow capsule tablet complete inclusion exclusion criterion detail additional file  fulfil drug specific inclusion exclusion criterion apply active arm patient enrol prior need invasive mechanical ventilation cardiac renal support participant recruit multiple centre uk include initially cambridge university hospitals nhs foundation trust st george university nhs foundation trust centre approach internationally view evolve pandemic intervention comparator increase evidence role immunomodulation alter course covid- additionally group demonstrate presence pulmonary shunting patient covid- cardiovascular complication tactic e assess efficacy novel immunomodulatory agent edp versus approve cardio pulmonary drug dapagliflozin combination ambrisentan versus prevail standard care edp give  capsule twice daily x cell  day option extend  day discretion principal investigator delegate patient feel clinically respond treatment tolerate treatment judge likely benefit long treatment course ambrisentan mg dapagliflozin mg give combination daily orally maximum  day patient randomise ratio treatment active arm compare standard care additional arm add trial progress comparison active arm platform trial main outcome primary outcome incidence baseline day occurrence following event death invasive mechanical ventilation extra corporeal membrane oxygenation cardiovascular organ support inotrope balloon pump renal failure estimate cockcroft gault creatinine clearance ml min randomisation eligible patient randomise central web base randomisation service sealed envelope ratio stratify site treatment arm standard care blinding masking open label trial datum analysis blind number randomised sample size fix sample size study early biomarker base futility analysis perform point study biomarker futility analysis conclusive second futility analysis base clinical endpoint perform approximately  patient recruit arm provisionally analysis clinical endpoint perform  patient active arm later  patient arm recruit additional analysis trigger independent datum monitoring committee trial status tactic e protocol version number date th recruitment start rd july end trial date  month patient visit accurately predict time trial registration register eu clinical trials register eudract number register  june trial register clinicaltrials.gov nct  protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
946,objective compare effect treatment coronavirus disease  covid- design live systematic review network meta analysis datum source covid- database comprehensive multilingual source global covid- literature  march  additional chinese database  february study identify  february  include analysis study selection randomised clinical trial people suspect probable confirm covid- randomised drug treatment standard care placebo pair reviewer independently screen potentially eligible article method duplicate data abstraction bayesian network meta analysis conduct risk bias include study assess modification cochrane risk bias tool certainty evidence grading recommendation assessment development evaluation grade approach outcome intervention classify group beneficial harmful follow grade guidance result  trial enrol  patient include  .% trial  patient new previous iteration  .% trial evaluate treatment  patient  event meet threshold inclusion analysis compare standard care corticosteroid probably reduce death risk difference  few  patient credible interval  few  few moderate certainty mechanical ventilation few  few  few moderate certainty increase number day free mechanical ventilation moderate certainty interleukin- inhibitor probably reduce mechanical ventilation few  few  few moderate certainty reduce length hospital stay day few few few low certainty reduce mortality uncertain few  few  low certainty janus kinase inhibitor reduce mortality few  few difference low certainty mechanical ventilation few  few  few low certainty duration mechanical ventilation day few few few moderate certainty impact remdesivir mortality outcome uncertain effect ivermectin rate low certainty critical outcome include mortality patient non severe disease colchicine reduce mortality few  few  few low certainty mechanical ventilation few  few  low certainty azithromycin hydroxychloroquine lopinavir ritonavir interferon beta appear reduce risk death effect patient important outcome certainty effect intervention low low conclusion corticosteroid interleukin- inhibitor probably confer important benefit patient severe covid- janus kinase inhibitor appear promise benefit certainty low azithromycin hydroxychloroquine lopinavir ritonavir interferon beta appear important benefit remdesivir ivermectin drug confer patient important benefit remain uncertain systematic review registration review register protocol publicly available supplementary material readers note article living systematic review update reflect emerge evidence update occur year date original publication fourth version original article publish  july  bmj m previous version find data supplement cite paper consider add version number date access clarity
947,importance covid- cause sars cov- betacoronavirus use angiotensin convert enzyme relate carboxypeptidase ace receptor gain entry cell ace receptor widely express multiple organ include retina extension central nervous system ace receptor involve diabetic hypertensive retinopathy additionally coronaviruse cause ocular infection animal include retinitis optic neuritis objective assess retinal disease associate covid- design evaluate  asymptomatic subject retinal fundoscopic optical coherence tomography oct oct angiography fourteen day hospital discharge covid- bilateral pneumonia result cotton wool exudate evident  patient evaluate cotton wool exudate marker vascular disease severity medical context diabetes hypertension associate increase risk acute vascular event antiaggregation therapy play role fundoscopic select patient covid- require prospective trial
948,background use corticosteroid critical coronavirus infection include severe acute respiratory syndrome sars middle east respiratory syndrome mers coronavirus disease  covid- controversial meta analysis efficacy steroid treat coronavirus infection lack purpose assess methodological criticism quality previous publish meta analysis risk mislead conclusion important therapeutic consequence examine evidence efficacy corticosteroid reduce mortality sars mers covid- method pubmed medline embase web science identify study publish  april report association steroid use mortality treat sars mers covid- investigator screen extract datum independently search restrict study human article report exact number patient group datum mortality exclude calculate odd ratio ors hazard ratio hrs fixed- random effect model result article patient eligible inclusion select study  patient diagnose sars  patient mers  covid- .% patient administer steroid meta analysis include study show difference overall term mortality ci random effect model p conclusion bias study patient steroid group severe symptom control group contrast meta analysis perform restrict study appropriate adjustment e.g. time disease severity significant difference group hr ci random effect model p difference mortality steroid severe case difference group underlying disease ci p conclusion knowledge study comprehensive systematic review meta analysis provide accurate evidence effect steroid coronavirus infection contraindicate absence effect use steroid consider coronavirus infection include covid-
949,background identification reliable outcome predictor coronavirus disease  covid- paramount importance improve patient management method systematic review literature conduct  april  article  study select pool assessment cumulative statistic age sex retrieve   case endpoint define composite outcome include death severe presentation hospitalization intensive care unit icu and/or mechanical ventilation b hospital mortality extract numeric datum patient characteristic case adverse outcome employ inverse variance random effect model derive pooled estimate result identify   factor associate composite endpoint death respectively history cvd odd ratio confidence interval cis acute cardiac kidney injury increase procalcitonin d dimer thrombocytopenia .- convey high odd adverse composite endpoint advanced age male sex cardiovascular comorbiditie acute cardiac kidney injury lymphocytopenia d dimer confer increase risk hospital death respect treatment acute phase therapy steroid associate adverse composite endpoint ci mortality conclusion advanced age comorbiditie abnormal inflammatory organ injury circulate biomarker capture patient adverse clinical outcome clinical history laboratory profile help identify patient high risk hospital mortality
950,new  coronavirus disease covid- accord world health organization characterize pandemic discover virus aim report finding complete blood count cbc covid- patient serve provide physician important knowledge change expect cbc mild normal covid- patient total  mild common patient admit dongnan hospital locate city xiaogan hubei china cbc patient follow confirm diagnosis covid- retrospectively analyze significant p find statistical analysis conduct statistical package social sciences ibm spss cbc analysis reveal change level red blood cell rbcs hemoglobin hgb hematocrit hct mean corpuscular volume mcv c reactive protein crp clinician expect similar finding deal new covid-
951,coronavirus disease- covid- manifest fever cough shortness breath cause severe acute respiratory syndrome coronavirus- sars cov- occasionally patient present diabetic ketoacidosis dka patient comorbiditie diabetes mellitus hypertension old age group know severe disease progression poor prognosis review article attempt well understand disease process diabetic discuss potential mechanism diabetes play role disease severity include effect diabetes immune response immune dysregulation role diabetes mellitus molecular process include augment angiotensin convert enzyme  ace level discuss potential mechanism explain grave prognosis see patient
952,objective exist finding relationship comorbiditie severity coronavirus disease  covid- inconsistent insufficient aim study evaluate association different comorbiditie severity covid- method pubmed embase cochrane library database search identify study report rate comorbiditie covid- patient severe fatal outcome subgroup analysis conduct accord disease severity country residence odd ratio confidence interval ci pool random effect model result total  eligible study identify patient severe fatal covid- prevalent chronic comorbiditie obesity ci -% hypertension ci -% follow diabetes ci -% cardiovascular disease ci -% respiratory disease ci -% cerebrovascular disease ci -% malignancy ci -% kidney disease ci -% liver disease ci order prediction pool or comorbiditie patient severe fatal covid- compare patient non severe fatal covid- follow chronic respiratory disease ci hypertension ci cardiovascular disease ci kidney disease ci cerebrovascular disease ci malignancy ci diabetes ci obesity ci correlation observe liver disease covid- aggravation ci conclusion chronic comorbiditie include obesity hypertension diabetes cardiovascular disease cerebrovascular disease respiratory disease kidney disease malignancy clinical risk factor severe fatal outcome associate covid- obesity prevalent respiratory disease strongly predictive knowledge risk factor help clinician well identify manage high risk population
953,background month april spain european country confirmed case covid- infection surpass italy april nd community castile leon spain affected covid- infection province leon total  case  death far rheumatic patient give special attention covid- infection immunocompromised state result underlying immune condition use target immune modulate therapy study epidemiological clinical characteristic patient rheumatic disease infect sars cov pivotal clarify determinant covid- disease severity patient underlie rheumatic disease objective describe epidemiological characteristic patient rheumatic disease hospitalize covid- determine risk factor associate mortality level hospital set leon spain method perform prospective observational study st march  st june include adult rheumatic disease hospitalize covid- perform univariate multivariate logistic regression model estimate or ci mortality age sex comorbiditie rheumatic disease diagnosis treatment disease activity prior infection radiographic laboratorial result arrival analyse result study period  patient covid- admit hospital  rheumatic musculoskeletal disease percent woman mean age hospital admission iqr year median length stay  day total  patient die hospital admission patient die covid- old median age iqr survive covid- median age iqr likely arterial hypertension vs  patient  ci .- p dyslipidaemia vs   ci p diabetes vs  patient p interstitial lung disease vs  ci p cardiovascular disease vs  ic .- p moderate high index rheumatic disease activity vs p univariate analysis find patient die covid- high hyperinflammation marker patient survive c reactive protein iqr vs iqr p lactate dehydrogenase iqr .- vs  iqr p serum ferritin iqr .- vs iqr p d dimer iqr .- vs iqr p difference sex radiological abnormality rheumatological disease background therapy symptom admission deceased patient survivor find multivariate analysis follow risk factor associate mortality rheumatic disease activity p dyslipidaemia p cardiovascular disease p interstitial lung disease p age hypertension diabete significant predictor univariate multivariate analysis rheumatic disease activity significantly associate fever p interstitial lung disease p cardiovascular disease p dyslipidaemia p conclusion result suggest comorbiditie rheumatic disease activity laboratorial abnormality c reactive protein crp d dimer lactate dehydrogenase ldh serum ferritin elevation significantly associate mortality previous use rheumatic medication inflammation closely relate severity covid- key points patient recover covid- use dmard corticosteroid biologic agent increase odd mortality study rheumatic disease activity associate mortality
954,patient severe complication covid- underlying condition obesity diabetes hypertension parallel grow evidence link periodontitis non oral systemic disease oral cavity reservoir respiratory pathogen patient periodontal disease likely develop hospital acquire pneumonia healthy individual hypothesize improve oral health decrease severity covid- symptom reduce associate morbidity
955,background acute kidney injury common complication patient infect sars cov- occur case increase patient treat intensive care unit icu objective report describe clinical case patient infect sars cov- develop acute renal injury probably secondary infection case report  april -year old woman present emergency service national institute respiratory diseases mexico city -day history dry cough subjective fever finally follow diagnosis integrate acute renal injury etiology determine acute chronic kidney disease secondary tdm vs. acute renal injury sars cov- covid- patient typical presentation severe covid- evidence risk severity factor disease admit hospital show evidence acute renal injury renal injury microangiopathic damage cause chronic hypertension diabetes imperative consider possibility exacerbation contribute sars cov- infection synergy multiple factor conclusion aspect pandemic remain unclear formulation hypothesis explain physiopathological mechanism new virus cause mortality infected patient help reduce mortality rate control pandemic
956,globally obesity underweight severe health risk disease current study systematically examine emerge evidence identify association body mass index bmi covid- disease outcome online literature database e.g. google scholar pubmed medline embase scopus medrixv biorixv screen follow standard search strategy have appropriate keyword obesity underweight bmi body mass index -ncov covid- novel coronavirus coronavirus disease study publish till th april  include language restriction study include case report case series cohort report bmi overweight obesity underweight complication covid- disease study observe covid- infection bmi  kg m result current study bmi play significant role covid- severity age group especially old individual panel doctor nursing staff review covid- patient high bmi co morbidity diabetes hypertension give increase vigilance priority testing treatment control associated co morbidity covid- patient illness enter day age  year elevate crp level give additional medical consideration finding show population patient high bmi moderate high risk medical complication covid- health status monitor frequently include monitoring blood pressure blood glucose
957,introduction covid- viral respiratory disease global threat public health specific subset population vulnerable chronic disease aim estimate share portuguese population high risk complication follow covid- infection old age specific comorbiditie material method sample include people age  year man  woman participate fifth portuguese national health interview survey conduct order project potential population high risk covid- late available official demographic estimate national institute statistics ine restrictive definition risk combine old age criterion follow chronic condition potential risk factor covid- accord available literature hypertension diabetes chronic obstructive pulmonary disease cardio- cerebrovascular disease result estimate n  portuguese population increase risk complication covid- old age exist chronic condition estimate vary country .% azores .% northern portugal northern portugal high prevalence select morbidity .% mainland portugal large population risk covid- n  follow lisbon tagus valley region n  central portugal n  discussion result encourage authority continue protect vulnerable pandemic threat particularly area country likely affect conclusion project considerable number portuguese people high risk severe covid- disease old age pre existing chronic condition estimate vary country
958,covid- pandemic cause severe acute respiratory syndrome coronavirus- use ace receptor drug raise serum tissue ace level include ace inhibitor aceis angiotensin ii receptor blocker arb commonly patient hypertension cardiovascular disease and/or diabetes comorbiditie adverse outcome covid- patient result pharmacotherapy increase ace potentially increase risk infection severity mortality covid- protective form angiotensin-(- exhibit anti inflammatory anti oxidative effect prevent diabetes- and/or hypertension induce end organ damage exist clinical uncertainty review study implicate  class drug increase ace level vivo available literature clinical safety drug covid- patient analysis clinical datum meta analysis  study aceis arb usage associate increase risk cause mortality literature suggest aceis arb usage generally appear clinically safe use severe covid- patient increase risk acute renal injury definitive clarity clinical mechanistic study need assess safety class ace raise medication
959,background objective covid- highly disseminate viral disease impart severe acute respiratory syndrome coronavirus  sars cov- declare global pandemic world health organization study aim describe clinical characteristic  hospitalize patient confirm covid- develop country material method study include admit patient n have covid- polymerase chain reaction pcr positive evaluate clinical profile characteristic patient link disease severity result  patient  ward  icu  recover  death report mean age frequent comorbiditie diabetes hypertension frequent symptom fever dry cough bilateral low zone patchy infiltrate frequent chest radiographic finding patient admit icu significant difference total leukocyte count p neutrophil lymphocyte p monocyte p urea p creatinine p neutrophil lymphocyte ratio nlr platelet lymphocyte ratio plr increase disease severity lymphocyte monocyte ratio lmr lymphocyte c reactive protein ratio lcr decrease mortality gamma glutamyl transferase ggt follow aspartate aminotransferase ast frequent hepatic derangement c reactive protein crp level predict icu admission area curve auc positive predictive value ppv .% lactate dehydrogenase ldh predict mortality auc ppv .% nlr auc ppv .% mortality neutrophil auc ppv .% icu patient conclusion number factor link disease severity mortality dynamic change laboratory investigation hospital stay affect prognosis
960,objective coronavirus disease  covid- raise concern world epidemic pandemic datum covid- grow clear old adult disproportionately high rate death covid- study describe early clinical characteristic covid- patient  year age method epidemiological clinical laboratory radiological treatment datum  patient diagnose covid- january  february  collect analyze retrospectively treatment outcome subgroup patient non severe severe symptom covid- compare result  hospitalize patient covid- median age year interquartile range year range year  .% man age distribution patient significantly different non severe group severe group patient chronic pre existing condition hypertension cardiovascular disease common chronic condition subgroup common symptom onset covid- fever n .% fatigue n .% cough n .% lymphopenia observe patient lymphopenia significantly severe severe group non severe group x vs x p level serum creatinine high severe group non severe group mumol l vs mumol l p common feature chest compute tomography image nodular foci  patient pleural thickening  .% patient patient receive antiviral therapy patient receive intravenous antibiotic therapy .% chinese medicinal preparation therapy lianhuaqingwen capsule .% corticosteroid .% immunoglobin patient .% transfer intensive care unit complication patient .% receive intranasal oxygen  .% receive non invasive mechanical ventilation  .% receive high flow oxygen june  .% patient discharge  .% cohort .% severe patient die conclusion mortality patient age  year old severe covid- symptom high lymphopenia characteristic laboratory result patient severity lymphopenia indicative severity covid- majority patient covid- age cohort atypical symptom early diagnosis depend prompt use viral nucleic acid test
961,objective describe clinical characteristic predictor major outcome patient treat tocilizumab tcz severe covid- pneumonia patient method case series sequential patient severe covid- pneumonia treat tcz academic spanish hospital march  clinical outcome death length hospital stay early clinical response tcz h administration assess variation respiratory function marker brescia covid respiratory severity scale bcrss inflammatory parameter patient physician opinion association test multiple logistic regression result cohort  patient  patient treat tcz include median age  year iqr .- .% male .% charlson index /= hypertension .% obesity diabetes median follow day patient readmitte icu admission require  .% invasive mechanical ventilation  .%  patient die .% global .% icu admit multivariate adjustment tcz response bcrss p charlson index p identify independent factor associate mortality median hospital stay day bcrss physician subjective d dimer response associate short hospitalization stay conclusion mediterranean cohort use tocilizumab severe covid- mortality early tcz response bcrss low comorbidity associate increase survival early tcz response relate short median hospital stay
962,background abnormality hematologic biochemical immunologic biomarker show associate severity mortality coronavirus disease  covid- early evaluation monitoring liver kidney function hematologic parameter pivotal forecast progression covid- objective study perform systematic review meta analysis investigate association complication include acute kidney injury aki acute liver injury ali coagulopathy poor outcome covid- design systematic review meta analysis setting observational study report aki ali coagulopathy outcome clinically validate death severe covid- intensive care unit icu care include study exclusion criterion abstract publication review article commentary letter case report non english language article study report key exposure outcome interest patient adult patient diagnose covid- measurement datum extract include year study design age sex cardiovascular disease hypertension diabetes mellitus respiratory comorbiditie chronic kidney disease mortality severe covid- need icu care method perform systematic literature search pubmed scopus europepmc cochrane central database aki ali follow definition include study coagulopathy refer coagulopathy disseminate intravascular coagulation define include study outcome interest composite mortality need icu care severe covid- random effect model regardless heterogeneity calculate risk ratio rrs dichotomous variable heterogeneity assess random effect meta regression conduct comorbiditie analysis perform covariate time result  patient  study mean newcastle ottawa scale include study aki associate increase composite outcome rr p subgroup analysis show aki associate increase mortality rr p severe covid- rr p need icu care rr p ali associate increase mortality rr p covid- mortality high covid- coagulopathy rr p aki associate composite outcome influence age p sex p hypertension p cardiovascular disease p diabetes p respiratory comorbidity p chronic kidney disease p limitation limitation study study define extent aki grade affect outcome acute liver injury coagulopathy define study definition severe covid- differ study article include study publish server study china patient overlap report include study retrospective design conclusion meta analysis show presence aki ali coagulopathy associate poor outcome patient covid-
963,background aim morbidity mortality coronavirus disease  covid- high people diabetes mellitus dm hypertension cardiovascular disease cvd statin majority people dm cvd mini review discuss current understanding benefit risk ratio use statin covid- method search pubmed database specific keyword relate aim till june text relevant article publish english language retrieve result statin immunomodulatory anti inflammatory anti thrombotic anti oxidant property potential reduce severity lung injury mortality severe acute respiratory syndrome coronavirus  sars cov infection statin induce upregulation angiotensin convert enzyme- ace potential reduce lung injury excess angiotensin ii disrupt lipid raft statin potential reduce viral entry cell benefit risk ratio complex interaction myd gene expression outcome covid- putative role low serum ldl cholesterol increase severity sars cov infection need clarification conclusion people covid- statin underlying co morbid condition continue specific contraindication de novo use statin people covid- underlie co morbidity beneficial await substantiation clinical trial till time de novo use statin covid  limit clinical trial setting
964,aim aim study investigate association type- diabetes mellitus underlie disease obesity outcome critically ill covid- patient greece method retrospective observational multi centre study datum outcome  rna confirm critically ill patient  hospital greece analyse report information stand april th results median age patient iqr majority male obesity present .% patient prevalent young  year hypertension prevail comorbidity follow cardiovascular disease .% type- diabetes admission common symptom duration median  iqr day .% patient discharge .% icu .% deceased hospitalise few day survivor iqr vs.  iqr respectively age risk factor diabetes deteriorate outcome obesity pose suggestive burden notable deceased versus survivor conclusion type  diabetes obesity contribute disease severity mortality covid- critically ill patient greece
965,novel coronavirus sars cov- covid- affect respiratory system lead central peripheral nervous system disorder cause muscular symptom author review literature clinical case respect nervous system involvement covid- patient correlation severity covid- severity frequency neurologic complication severe neurologic symptom primarily observe patient severe covid- neurologic associate symptom include stroke acute necrotizing encephalopathy guillen barre syndrome disease potentially aggravate covid- increase risk neurologic complication include arterial hypertension diabetes chronic disease heart respiratory system probable impact human coronaviruse chronic progressive disease nervous system particular respect multiple sclerosis triage plan stroke ms patient covid- pandemic depend risk coronavirus infection present
966,objective assess prevalence characteristic prognostic value pulmonary hypertension ph right ventricular dysfunction rvd hospitalise non intensive care unit icu patient coronavirus disease  covid- method single centre observational cross sectional study include  patient covid- admit non icu department undergo single transthoracic echocardiography tte patient poor acoustic window n= exclude clinical imaging laboratory tte finding compare patient versus ph estimate systolic pulmonary artery pressure mm hg versus rvd tricuspid annular plane systolic excursion mm s wave cm s primary endpoint hospital death icu admission result total  patient include final analysis median age  iqr year .% man prevalence ph rvd respectively patient ph old high burden pre existing cardiac comorbiditie sign severe severe acute respiratory syndrome coronavirus  sars cov- infection radiological lung involvement laboratory finding oxygenation status compare ph conversely patient rvd high burden pre existing cardiac comorbiditie evidence severe sars cov- infection compare rvd presence ph associate high rate hospital death icu admission vs .% p presence rvd vs .% p=. conclusion hospitalise non icu patient covid- ph rvd associate sign severe covid- bad hospital clinical outcome trial registration number nct
967,objective angiotensin convert enzyme inhibitor acei angiotensin ii receptor blocker arb hmg coa reductase inhibitor statin hypothesize affect covid- severity study investigate association conduct vulnerable affected population group ie old adult reside nursing home objective study explore association acei arb and/or statin clinical manifestation covid infect old adult reside nursing home design undertake retrospective multicenter cohort study analyze association acei arb and/or statin use clinical outcome covid- outcome covid- define long stay hospital admission death  day disease onset asymptomatic ie disease symptom study period diagnose polymerase chain reaction setting participant total  covid positive subject identify reside   belgian nursing home experience similar covid- outbreak measures logistic regression model apply age sex functional status diabetes hypertension covariate result find statistically significant association statin intake absence symptom covid- odd ratio confidence interval ci remain statistically significant adjust covariate ci effect statin intake clinical outcome beneficial direction statistically significant ci statistically significant association acei arb asymptomatic status ci clinical outcome ci conclusion implication datum indicate statin intake old frail adult associate considerable beneficial effect covid- clinical symptom role statin renin angiotensin system drug need explore large observational study randomized clinical trial
968,coronavirus disease  covid- recent pandemic cause severe acute respiratory syndrome coronavirus  sars cov- novel coronavirus diabetes type  diabetes mellitus tdm hyperglycemia major comorbiditie patient covid- lead poor outcome report patient diabetes covid- increase risk develop severe complication include acute respiratory distress syndrome multi organ failure death explore potential mechanistic link explain observe high morbidity mortality patient population patient tdm underlying increase level inflammation associate obesity insulin resistance addition comorbiditie include hypertension obesity cardiovascular disease dyslipidemia old review evidence tdm hyperglycemia factor lead elevated expression angiotensin convert enzyme  ace lung tissue ace cellular receptor port viral entry preexist chronic inflammation augment inflammatory response infection increase viral load lead extreme systemic immune response cytokine storm strongly associate increase severity covid- base available evidence recommend panel expert safe stringent control blood glucose blood pressure lipid carry patient tdm measure potentially serve decrease severity covid- patient contract viral infection infection occur attention direct proper glycemic control use insulin frequent monitoring blood glucose level
969,background aim undertake review critical appraisal publish report offer method determine effect hypertension diabetes stroke cancer kidney issue high cholesterol covid- disease severity method search conduct author independently freely available covid- open research dataset cord- develop automate search engine screen total article second filtering article undertake keyword question e.g. effect diabetes covid normal coronavirus sars cov-/ncov covid- disease severity mortality search term repeat comorbiditie consider paper additional article retrieve search google scholar pubmed finding total  article consider review observe diabetes hypertension cholesterol level possess apparent relation covid- severity comorbiditie cancer kidney disease stroke evaluate determine strong relationship virus conclusion report associate cancer kidney disease stroke covid- carefully interpret size sample patient old history smoking clinical condition suggest factor associate poor covid- outcome comorbidity research relationship clinical management warrant
970,purpose compare analyze clinical ct feature coronavirus disease  covid- different age group method  patient male  female mean age chest ct examination positive reverse transcriptase polymerase chain reaction test rt pcr january  february  retrospectively study patient divide age group child year young adult year middle age year senior  year accord age diagnosis base pcr test clinical symptom result comorbiditie hypertension diabetes mellitus heart disease common senior group cluster onset confirmed case small area common child group senior group old patient find high incidence high clinical classification severe critical group senior patient high incidence large multiple ground glass opacity ggo child patient negative chest ct involvement lobe lung old patient high incidence involvement lung lobe frequency lobe involvement find significant difference age group conclusion clinical imaging feature patient different age group find significantly different well understanding age difference comorbiditie cluster onset high clinical classification large multiple ggo number lobe affect frequency lobe involvement useful diagnosis covid- patient different age
971,background coronavirus disease  covid- pandemic drastically affect global health despite study dearth datum mechanism cardiac injury clinical presentation risk factor treatment covid associate cardiovascular disease systematic review meta analysis aim define clinical electrocardiographic pathologic spectrum cardiovascular disease cvd frequency elevated cardiac inflammatory biomarker frequency relationship severity disease mortality covid- patient develop triage risk stratification tool trst serve guide timely recognition high risk patient mechanism target therapy conduct online search database pubmed embase identify relevant study datum selection concordance prisma guideline result present pool frequency odd ratio standardized mean difference smd forest funnel plot result gather total  study include  meta analysis acute cardiac injury occur case mortality  time high admission intensive care unit increase time hypertension common pre exist comorbidity frequency .% follow diabetes mellitus deceased group patient high cardiac inflammatory biomarker statistically significant smd compare survivor pediatric patient predominantly mildly affected frequently presentation similar kawasaki disease kawasaki shock syndrome presentation hass call multisystem inflammatory syndrome child mis c conclusion wide spectrum cardiac involvement covid- patient triage risk stratification tool serve guide timely recognition high risk patient mechanism target therapy
972,introduction february  designate covid- disease cause severe acute respiratory syndrome coronavirus sars cov- novel virus quickly turn global pandemic risk associate acquire virus find significantly vary age presence underlie comorbidity rapid literature review explore prevalence comorbiditie associate adverse outcome individual covid- summarize finding base information available method comprehensive systematic search perform pubmed medline scopus embase google scholar find article publish relevant article provide information pcr test covid- positive patient population clinical characteristic epidemiological information select review analysis result total  article consist patient case major epicenter worldwide include study major comorbiditie see overall population cvd .% htn .% diabetes .% copd .% cancer .% ckd .% major comorbidity specific country include study china htn south korea cvd .% italy htn usa htn mexico .% uk htn iran diabetes fatal case estimate .% presence comorbidity subgroup analysis fatality association have comorbidity estimate ci p conclusion base finding hypertension follow diabetes cardiovascular disease common comorbidity see covid- positive patient major epicenters world wide have comorbidity link increase disease severity clear association find have risk factor increase risk fatality
973,december new coronavirus identify cause outbreak pneumonia respiratory distress wuhan china declare pandemic march important know predictor poor outcome order optimize strategy care newly diagnose patient neutrophil lymphocyte ratio nlr constitute novel prognostic marker oncologic cardiovascular infectious disease aim assess prognostic value covid- evaluate retrospective cohort  patient covid- march analyze association nlr  severe covid- baseline characteristic population mortality rate median age  year man  patient present criterion severe disease  require mechanical ventilation nlr  find severe patient mild patient ci p age hypertension associate severe disease mortality rate obtain seven  patient die present nlr significant association mortality nlr  p nlr conjunction predictor early prognostic marker covid- give accessibility low cost
974,objective identify biomarker perform emergency analysis help stratify covid- patient accord mortality risk method observational descriptive cross sectional study perform datum collect patient suspected covid- emergency department february  march univariate multivariate study perform find independent mortality marker calculate risk build severity score result total  patient include  die  positive covid- pcr test obtain possible factor conform mortality risk score age  year adjust ci p total leukocyte cell mm adjust ci p glucose  mg dl adjust ci p creatinine mg dl adjust ci p score call coveb covid age basic analytical profile auc ci p cut point  sensitivity ci .% -.% specificity ci .% -.% score negative predictive value ci positive predictive value ci .% -.% conclusion clinical severity scale kidney function biomarker white blood cell count parameter total neutrophils total lymphocyte ratio procalcitonin early risk factor mortality variable age glucose creatinine total leukocyte stand good predictor mortality coveb score indicate probability patient suspect covid- die  day
976,objective describe clinical respiratory characteristic cohort  patient covid- evolutive period  day design prospective single center observational study carry setting intensive care patient patient admit covid- respiratory failure intervention variable automatic recording demographic variable severity parameter laboratory datum assist ventilation hfo high flow oxygen therapy imv invasive mechanical ventilation oxygenation pao pao fio complication patient divide group survivor g deceased g patient remain admission g chi squared test fisher exact test categorical variable mann whitney u test wilcoxon test analyze difference median statistical significance consider p result total  patient include g= g= g= mean age  year range male apache ii  sofa  arterial hypertension .% obesity .% frequent comorbiditie high flow oxygen therapy .% patient failure turn patient require imv receive ventilation prone decubitus general population initial pao fio improve  day vs. p=. way g vs.  p=. g vs.  bacterial coinfection observe incidence imv associate pneumonia high episodes/ day imv conclusion patient covid- require early imv high frequency ventilation prone decubitus high incidence fail hfo lack improvement pao fio  day prognostic marker
977,severe acute respiratory syndrome coronavirus  know infect host cell interact ace angiotensin convert enzyme express respiratory epithelium concern alteration ace expression renin angiotensin aldosterone system raas inhibitor contribute infectivity severity coronavirus disease  covid- perform case control study investigate association raas inhibitor risk severity covid- infection south korea population base datum provide korean national health insurance system  subject hypertension  .% confirm covid- case case control matching multivariable adjust conditional logistic regression analysis perform adjusted odd ratio ci covid- infection long term hospitalization compare exposure raas inhibitor nonexposure raas inhibitor respectively compare exposure raas inhibitor nonexposure raas inhibitor intensive care unit admission high flow oxygen therapy death adjust odd ratio cis respectively analysis p value significant p present study demonstrate absence identifiable association exposure raas inhibitor risk severity covid- infection support current medical guideline recommendation patient discontinue raas inhibitor concern increase risk infection severe illness covid-
978,solid organ transplant recipient sotr coronavirus disease  covid- expect poor outcome compare nontransplant patient immunosuppression comorbiditie clinical characteristic  sotr kidney  nonkidney organ compare  consecutive hospitalize nontransplant control  sotr manage outpatient subsequently exclude outcome analysis avoid potential selection bias chronic kidney disease vs p diabetes vs p hypertension vs p common  hospitalize sotr compare control diarrhea vs p frequent sotr primary composite outcome escalation intensive care unit mechanical ventilation hospital cause mortality comparable sotr control vs odd ratio confidence interval ci p despite comorbiditie sotr acute kidney injury require renal replacement therapy occur sotr compare control  ci p multivariate analysis demonstrate increase age clinical severity associate mortality transplant status associate mortality
979,background outbreak coronavirus disease covid- lead major concern cause pandemic globally goal study clarify clinical characteristic recovery death patient severe critical covid- materials method retrospective single center study clinical datum collect  severe critical covid- patient wuhan fourth hospital jan. th feb. th patient divide recovery group death group accord clinical outcome difference group compare result  patient enrol study  .% severe case  .% critical case .% patient recover  .% die compare recovery patient patient death group old high incidence hypertension coronary disease dyspnea admission laboratory test lactate dehydrogenase creatine kinase myoglobin brain natriuretic peptide d dimer indicate high level death group pao fio ratio minimum spo low death group high proportion patient receive noninvasive mechanical ventilation invasive mechanical ventilation extracorporeal membrane oxygenation treatment conclusion elderly patient comorbiditie high risk severe covid- death patient low blood gas index poor coagulation function admission high mortality rate patient comprehensive treatment perform soon possible improve prognosis reduce mortality
980,recent report show proportion patient coronavirus disease  covid- present elevated leukocyte count clinical datum patient scarce aim evaluate clinical finding patient covid- increase leukocyte admission retrospectively collect clinical datum  patient increase leukocyte count admission  patient confirmed covid- pneumonia abnormal feature chest ct scan renmin hospital wuhan university wuhan china february  march mean age  patient increase leukocyte count sd year  .% man  .% fever compare patient non increased leukocyte count patient increase leukocyte count significantly old p likely underlying chronic disease p likely develop critically illness p likely admit icu p likely receive mechanical ventilation p high rate death p blood level neutrophil count serum concentration crp il- significantly increase p old patient covid- underlying chronic disorder likely develop leukocytosis patient likely develop critical illness high admission icu high mortality rate
981,"background elucidate role t cell response covid- utmost importance understand clearance sars cov- infection method  hospitalize covid- patient  age- gender match healthy control hc participate study comprehensive flow cytometric panel conform good laboratory practice approve clinical diagnostic finding absolute number lymphocyte subset differentially decrease covid- patient accord clinical severity severe disease sd patient lymphocyte subset reduce whilst mild disease md nk nkt gammadelta t cell level hc additionally provide evidence t cell activation md sd compare hc follow sample reveal marked increase effector t cell memory subset convalesce non convalescing patient interpretation datum suggest activation expansion innate adaptive lymphocyte play major role covid- additionally recovery associate formation t cell memory suggest miss formation effector central memory t cell sd md understand t cell response context clinical severity serve foundation overcome lack effective anti viral immune response severely affected covid- patient offer prognostic value biomarker disease outcome control funding fund state lower saxony grant german research foundation excellence strategy exc""resist""-project id dfg sfb/-project id grant sfb b sfb b."
982,world currently embroil pandemic coronavirus disease  covid- respiratory illness cause novel betacoronavirus severe acute respiratory syndrome coronavirus  sars cov- severity covid- disease range asymptomatic fatal acute respiratory distress syndrome patient disease undergo phenotypic differentiation   day acute illness result recovery symptom escalation mechanism variation clear fact suggest patient immune status comorbiditie systemic effect viral infection potentially depend sars cov- strain involve play key role subsequently patient severe symptom tend poor outcome manifest severe hypoxia possess elevate level pro inflammatory cytokine include il beta il- ifn gamma tnf alpha elevated level anti inflammatory cytokine il- mark lymphopenia elevate neutrophil lymphocyte ratio base available evidence propose mechanism sars cov- infection induce direct organ damage fuel il mediate cytokine release syndrome crs hypoxia result escalate systemic inflammation multi organ damage end organ failure elevated il- hypoxia predispose patient pulmonary hypertension presence asymptomatic hypoxia covid- compound problem similar downstream mediator discuss potential synergistic effect systemic ramification sars cov- influenza virus co infection phenomenon term covi flu additionally difference crs cytokine storm highlight finally novel management approach clinical trial therapeutic strategy sars cov- covi flu infection discuss highlight host response optimization systemic inflammation reduction
983,objective aim study explore effectiveness safety oral corticosteroid prednisone treatment early stage sars cov- pneumonia patient meet hospital admission criterion trial design randomized clinical trial control open parallel group evaluate effectiveness steroid adult patient confirmed covid- incipient pulmonary involvement hospital admission criterion patient stratify presence radiological datum pneumonia participant include patient early stage sars cov- pneumonia meet hospital admission criterion reference hospital hospital universitario de burgos region castilla y leon spain patient follow specialist physician primary health care professional inclusion criteria man woman age   year old diagnose sars cov- infection pcr and/or igm+ antibody test and/or antigen test clinical diagnosis lung involvement respiratory symptom pathological auscultation o desaturation chest x ray mild moderate alteration normal patient verbal informed consent witness reflect patient medical record exclusion criterion oxygen desaturation p moderate severe dyspnea significant respiratory general deterioration make admission advisable chest x ray multifocal infiltrate insulin dependent diabete poor control glycaemia emergency room test great  mg ml fast significant comorbiditie severe renal failure creatinine clearance  ml min cirrhosis chronic liver disease poorly control hypertension heart rhythm disturbance include prolonged qt severe immunosuppression hiv infection long term use immunosuppressive agent cancer pregnant breast feed woman patient use glucocorticoid disease history allergy intolerance drug study prednisone azithromycin hydroxychloroquine patient take study drug  day prior study inclusion patient take non suppressible drug risk qt prolongation significant interaction patient unwilling unable participate study completion participation study intervention comparator eligible patient randomize receive standard outpatient treatment group standard outpatient treatment plus prednisone group group paracetamol  g/ h demand hydroxychloroquine  mg h day  mg/ h  day azithromycin  mg h  day group paracetamol  g/ h demand hydroxychloroquine  mg h day  mg/ h  day azithromycin  mg h  day prednisone  mg  h  day  mg  h  day  mg  h  day main outcome patient require ambulatory observation accord protocol establish respect emergency department meet criterion inclusion exclusion datum take person responsible datum collection sheet main result admission  day secondary outcome -day icu admission hospital stay safety variable occurrence clinical symptom delirium relate steroid possible decompensation diabetes measure test intention treat basis randomisation treatment assign accord stratified randomization presence absence radiological datum lung involvement previously perform random sequence generate epidat keep hide opaque sealed envelope open inclusion basal measurement blind masking participant caregiver personnel responsible outcome measurement blind group assignment patient include basal measurement perform protocol design number randomised sample size percentage patient incipient lung involvement unknown give pulmonary involvement exist estimate consider intervention reduce percentage necessary sample size  subject group power estimate loss percentage trial status protocol code tac covid- version date april  approve spanish drug agency aemps local ethics committee trial recruitment phase recruitment begin  april  anticipate complete april trial registration trial register title outpatient treatment early pulmonary covid corticosteroids opportunity modify course disease eudract number register  april protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
984,background information risk factor associate severe coronavirus disease covid- limited study aim develop model predict covid- severity method overall  patient confirmed covid- recruit  january  march  hospital honghu nanchang finally  patient assess datum categorise training test set develop validate model respectively finding predictive hnc ll hypertension neutrophil count c reactive protein lymphocyte count lactate dehydrogenase score establish multivariate logistic regression analysis hnc ll score accurately predict disease severity honghu training cohort area curve auc]=. confidence interval ci p/= year score model mulbsta multilobular infiltration hypo lymphocytosis bacterial coinfection smoking history hypertension age score model neutrophil lymphocyte ratio model clinical significance hnc ll accurately predict risk future development severe covid- confirm interpretation develop accurate tool predict disease severity covid- patient model potentially identify patient risk develop severe disease early stage guide treatment decision funding work support national nature science foundation china grant guangdong province universities colleges pearl river scholar fund scheme
985,objective datum serial liver biochemistry patient infect different human coronaviruse hcovs lack impact liver injury adverse clinical outcome coronavirus disease  covid- patient remain unclear design retrospective cohort study datum territory wide database hong kong covid- severe acute respiratory syndrome sars hcov patient identify diagnosis code and/or virological result alanine aminotransferase alt)/aspartate aminotransferase ast elevation define alt ast x upper limit normal ie  u l primary end point composite intensive care unit icu admission use invasive mechanical ventilation and/or death result identify  covid- patient mean age  year man  sars patient mean age  year man  hcov patient mean age  year man alt ast elevation occur sars patient covid- patient hcov patient covid- patient  .% admit icu  .% receive invasive mechanical ventilation  .% die alt ast elevation independently associate primary end point adjust aor ci p adjust albumin diabetes hypertension use lopinavir ritonavir interferon beta aor ci p=. corticosteroid aor ci p independently associate alt ast elevation conclusion alt ast elevation common independently associate adverse clinical outcome covid- patient use lopinavir ritonavir ribavirin interferon beta and/or corticosteroid independently associate alt ast elevation
986,december case severe coronavirus  covid- infection rapidly progress acute respiratory failure study aim assess association neutrophil lymphocyte ratio nlr incidence severe covid- infection retrospective cohort study conduct  patient covid- infection admit central hospital wuhan  january   march peripheral blood sample collect examine lymphocyte subset flow cytometry association tertile nlr incidence severe illness analyse logistic regression  patient covid-  diagnose severe case mean nlr severe group high mild group vs. p high tertile nlr exhibit ci .- increase incidence severity relative low tertile adjustment age diabetes hypertension confounder number t cell significantly decrease severe group vs. p covid- mainly act lymphocyte particularly t lymphocyte nlr identify early risk factor severe covid- illness patient increase nlr admit isolation ward respiratory monitoring supportive care
987,objective determine specific immunomodulatory intervention reduce progression covid related disease organ failure death compare standard care soc trial design randomised parallel -arm (: ratio open label phase iv platform trial immunomodulatory therapy patient late stage  stage  covid related disease diagnosis base positive assay high suspicion covid- infection clinical and/or radiological assessment participant patient aged  clinical picture strongly suggestive covid related disease positive covid- test risk count define risk count include radiographic severity score risk count calculate following feature admission point radiographic severity score male gender non white ethnicity diabetes hypertension neutrophil x()/l age year crp mg l. patients consider appropriate subject intervention immunomodulatory therapy opinion investigator able maintain venous thromboembolism prophylaxis inpatient dosing period accord local guideline complete inclusion exclusion criterion detail additional file  fulfil patient enrol prior need invasive mechanical ventilation cardiac renal support participant recruit multiple centre include initially cambridge university hospitals nhs foundation trust king college hospital nhs foundation trust guy st thomas nhs foundation trust university hospital wales gloucestershire royal hospitals nhs foundation trust royal wolverhampton nhs trust intervention comparator active comparator arm compare standard care soc immunomodulatory drug select panel licenced candidate drug evaluation committee consider potential efficacy potential toxicity scalability novelty strategy initial active arm comprise baricitinib ravulizumab baricitinib give  mg orally daily od day day discharge dose reduce  mg od patient age  year estimated cockcroft gault creatinine clearance ml min ravulizumab administer intravenously accord licensed weight base dosing regimen additional file active arm compare standard care comparison active arm platform trial main outcome primary outcome incidence baseline day event whichever come death invasive mechanical ventilation extra corporeal membrane oxygenation cardiovascular organ support inotrope balloon pump renal failure estimate cockcroft gault creatinine clearance ml min randomisation eligible patient randomise central web base randomisation service sealed envelope ratio stratify site treatment arm soc. blinding masking open label trial datum analysis blind number randomised sample size fix sample size study serial interim analysis trigger independent data monitoring committee idmc include analysis  patient recruit arm  total assume  arm additional interim analysis project  patient arm potentially  arm additional analysis trigger idmc trial status tactic r protocol version number date recruitment begin  end trial date  month patient visit recruitment end date accurately predict trial registration register eu clinical trials register eudract number register   register clinicaltrials.gov nct isrctn isrctn protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
988,background outbreak coronavirus disease  covid- enormous threat public health clinical spectrum covid- extensive critical case rapid disease progression high mortality aim study summarize characteristic different subtype explore risk factor illness severity early identification prompt treatment method retrospective study collect datum patient confirm covid- zhejiang province  january  february accord definition clinical classification divide confirm case type summarize epidemiological clinical characteristic laboratory radiograph finding treatment outcome respectively univariate multivariate ordinal logistic regression model explore risk factor severity illness patient covid- result total  patient enrol study  case .% mild type  case .% common type  case .% severe type  case .% critical type multivariate ordinal logistic regression demonstrate increase odd severity illness patient covid- associate male odd ratio confidence interval ci p fever ci p /=  year ci p conclusion clinician pay close attention feature patient covid- include old age male fever cough hemoptysis gastrointestinal symptom hypertension identify severity illness early possible
989,march world health organization declare sars cov  covid- outbreak global pandemic document community scale transmission region include latin america risk factor associate severity disease include old age diabetes hypertension cardiovascular lung disease immune suppression additional evidence strongly suggest obesity risk factor severe form covid- disease type malnutrition increase risk hospitalization influenza like disease regardless causative agent illness detailed datum available impact nutrition evolution covid- give know inflammatory response cause condition reasonable expect suboptimal immune response high risk severity find obesity
990,background incidence elevated liver chemistry presence pre exist chronic liver disease cld variably report covid- aim assess prevalence cld incidence elevated liver chemistry outcome patient underlie cld elevate liver chemistry covid- method comprehensive search electronic database  december   april  include study report underlie cld elevate liver chemistry patient outcome covid- result  article n  patient include systematic review pooled prevalence underlie cld ci  covid- patient pool incidence elevated liver chemistry covid- initial presentation additionally .% develop elevated liver chemistry illness pool incidence drug induce liver injury pooled prevalence cld  severely infect patient -.% odd develop severe covid- cld patient p compare non cld patient covid- patient elevated liver chemistry increase risk mortality or- p severe disease or- ci .- p compare patient elevated liver chemistry conclusion elevated liver chemistry common presentation covid- severity elevated liver chemistry correlate outcome covid- presence cld alter outcome covid- study need analyse outcome compensated decompensate liver disease
991,continue coronavirus disease  covid- pandemic couple phase reopening critical identify risk factor associate susceptibility severity disease diverse population help shape government policy guide clinical decision making prioritize future covid- research retrospective case control study de identify electronic health record ehr university california los angeles ucla health system march th  june th  identify risk factor covid- susceptibility severe acute respiratory distress syndrome coronavirus  sars cov- pcr test positive inpatient admission severe outcome treatment intensive care unit intubation individual test pcr sars cov-  covid- positive .% tested  admit hospital covid- positive  severe outcome inpatient consistent previous study male individual old  year old increase risk inpatient admission notably individual self identify hispanic latino constitute increase percentage covid- patient disease severity escalate comprise testing positive severe outcome disparity remain correct medical comorbiditie cardiovascular disease hypertension renal disease premorbid risk factor present sars cov- pcr testing associate covid- susceptibility establish risk factor covid- susceptibility include pre existing dementia odd ratio p=. x mental health condition depression p=. x vitamin d deficiency p=. x renal disease include end stage renal disease anemia chronic renal disease predominant premorbid risk factor covid- inpatient admission establish risk factor covid- inpatient admission include previous renal transplant p=.x(- disorder immune system p=.x(- prior use oral steroid medication associate decrease covid- positive testing risk p=.x(- increase inpatient admission risk p=.x(- observe prior use angiotensin convert enzyme inhibitor angiotensin receptor blocker increase risk test positive sars cov- admit hospital have severe outcome study involve direct ehr extraction identify know establish demographic prior diagnosis medication risk factor covid- susceptibility inpatient admission knowledge risk factor include mark ethnic disparity observe disease severity guide government policy identify risk population inform clinical decision making prioritize future covid- research
992,severe acute respiratory syndrome coronavirus  sars cov- outbreak public health emergency affect different region world lung damage presence sars cov- bind receptor ace epithelial alveolar cell severity infection vary complete absence symptomatology aggressive symptom characterize sudden acute respiratory distress syndrome ards multiorgan failure sepsis require treatment intensive care unit icu clear immune system able efficiently suppress viral replication small percentage patient document pathological condition affect cardiovascular system strongly associate atherosclerotic progression heart failure hf coronary heart disease chd hypertension htn diabetes mellitus dm serve predictive factor severity susceptibility sars cov- infection atherosclerotic progression chronic inflammation process characterize immune system dysregulation lead pro inflammatory pattern include interleukin  il- tumor necrosis factor alpha tnf alpha il beta review immune system inflammation profile atherosclerosis laboratory result report severe covid- infection hypothesize pathogenetic correlation atherosclerosis ideal pathogenetic substrate high viral replication ability lead adverse outcome report patient cardiovascular factor level atherosclerotic progression affect different degree severe infection vicious circle feed sars cov- exacerbate atherosclerotic evolution excessive aberrant plasmatic concentration cytokine
993,background objective male sex associate severe coronavirus disease  covid- infection examine association male sex severe covid- infection increase risk remain adjustment age comorbiditie method nationwide register base follow study covid- patient denmark  average risk ratio compare composite outcome cause death severe covid- diagnosis intensive care unit icu admission man versus woman standardize age comorbidity distribution patient derive multivariable cox regression include covariate age hypertension diagnosis include obesity alcohol sleep apnea diabetes chronic obstructive pulmonary disease previous myocardial infarction mi ischemic heart disease ihd heart failure hf atrial fibrillation af stroke peripheral artery disease cancer liver rheumatic chronic kidney disease ckd result  covid- patient  .% man median age  -% man versus  woman p  fully adjust average risk ratio ci conclusion man covid- infection high risk cause death severe covid- infection icu admission woman excess risk explain age comorbiditie
994,covid- outbreak declare pandemic march patient sars cov- infection underlie chronic medical condition diabetes cardiovascular disease cvd hypertension patient relate outcome bad associate comorbiditie evidence appropriate management patient diabetes covid- infection insulin resistance cvd increase inflammatory state body contribute mediate increase covid- severity addition management dysglycemia cvd risk factor target explore possible pathophysiologic link diabetes covid- discuss option treat dysglycemia hypertension dyslipidemia era covid-
995,corona virus disease  covid- present unprecedented challenge health care system world current study aim identify determinant illness severity covid- base ordinal response retrospective cohort covid- patient hospital province china establish  patient include  january  march divide moderate severe critical illness group relative variable retrieve electronic medical record univariate multivariate ordinal logistic regression model fit identify independent predictor illness severity cohort include  .% moderate case  .% severe  .% critical case  die hospitalisation  april patient age group year ci age year ci hypertension ci alt mu l ci ctni ng ml ci myohaemoglobin ng ml ci great risk develop bad severity illness interval illness onset diagnosis ci interval illness onset admission ci independent significant predictor illness severity patient critical illness suffer inferior survival compare patient severe group hr ci moderate group hr ci finding highlight identify determinant help predict risk develop severe illness covid- patient contribute optimise arrangement health resource
996,background previous study show coronavirus disease  covid- patient underlie comorbiditie bad outcome effect hypertension outcome covid- patient remain unclear research question aim study explore effect hypertension outcome patient covid- propensity score match psm analysis study design method participant enrol study patient covid- hospitalize central hospital wuhan china chronic comorbiditie laboratory radiological datum patient outcome length stay obtain discharge record cox proportional hazard model cphm analyze effect hypertension patient outcome psm analysis validate abovementioned effect result total  patient covid- enrol study  survive  die proportion patient hypertension non survivor high survivor .% vs. .% p result obtain cphm show hypertension increase risk mortality covid- patient hazard ratio ci p increased d dimer level high ratio neutrophil lymphocyte n l find increase patient mortality risk match propensity score come similar conclusion apply method critically ill patient find hypertension increase risk death patient severe covid- conclusion hypertension increase d dimer ratio neutrophil lymphocyte increase mortality patient covid- hypertension particular
997,objective coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- renin angiotensin aldosterone system raas inhibitor increase expression angiotensin convert enzyme receptor sarscov- spike protein consequence angiotensin convert enzyme inhibitor acei angiotensin receptor blocker arb covid- pandemic unknown method retrospective cohort study aim identify odd severe disease define hospitalization /= day admission intensive care unit death associate exposure acei arb conduct adult patient age /= year covid- admit istanbul faculty medicine corona center march  include chronic user acei arb antihypertensive drug match accord age sex sick day hospitalization comorbiditie smoking number antihypertensive regimen doxazosin use furosemide use serum creatinine level odd ratio have severe disease calculate result total  patient admit covid- confirm reverse transcriptase polymerase chain reaction compute tomography ct  male age range   year average age year  participant severe disease death case fatality rate hypertension n= arb exposure compatible decrease odd or=. ci p=. severe disease statistically significant acei exposure significantly reduce risk severe disease or=. ci p=. acei exposure associate mild infiltration see baseline ct low c reactive protein ferritin high monocyte short hospitalization requirement specific empirical treatment favipiravir meropenem conclusion datum suggest exposure acei drug favorable effect context covid- pneumonia
998,patient coronavirus disease  covid- develop severe respiratory distress think mediate cytokine release elevated proinflammatory marker associate disease severity tocilizumab interleukin- receptor antagonist beneficial severe covid- cytokine storm suspect retrospective single center analysis record patient diagnose covid- receive tocilizumab outcome include clinical improvement mortality change oxygen support  hour  day post tocilizumab report patient evaluate baseline pre tocilizumab oxygenation status change proinflammatory marker  day post tocilizumab report patient receive tocilizumab mean dose  mg mg kg day admission baseline patient ventilation support elevate proinflammatory marker include c reactive protein crp common comorbiditie diabetes mellitus hypertension patient receive concomitant glucocorticoid hydroxychloroquine seven day tocilizumab patient .% clinical improvement oxygenation status decrease crp  day treatment patient clinical improvement minimal improvement worsen die transfer outside hospital ultimately patient receive tocilizumab expire discharge study find limited clinical improvement patient receive tocilizumab setting severe covid- clinical trial ongoing evaluate tocilizumab benefit patient population
999,coronavirus disease- covid- designate highly contagious infectious disease cause severe acute respiratory syndrome coronavirus- sars cov- december outbreak pneumonia case emerge wuhan china covid- pandemic lead global health crisis devastate social economic political aspect life clinician health professional scientist organization government actively defeat covid- share experience sars cov. diabetes major risk factor fatal outcome covid- patient diabetes vulnerable infection hyperglycemia impaired immune function vascular complication comorbiditie hypertension dyslipidemia cardiovascular disease addition angiotensin convert enzyme  ace receptor sars cov- human body use angiotensin direct medication patient diabetes require attention severity mortality covid- significantly high patient diabetes patient diabetes precaution covid- pandemic review current knowledge covid- include global regional epidemiology virology impact diabetes covid- treatment covid- standard care management diabetes critical period
1000,aim novel coronavirus infection covid- worldwide public health concern associate varied fatality patient chronic underlie condition like diabete hypertension show bad outcome understanding association helpful early vigilant monitoring well management covid- patient high risk aim meta analysis assess association diabetes hypertension severity disease method literature search conduct database pubmed cochrane march seven study include meta- analysis include  covid- patient result diabetes low survivor ci p ): non severe ci p ): patient association diabetes find icu care hypertension positively associate death ci p ): icu care ci p ): severity ci p ): conclusion finding suggest diabete hypertension negative effect health status covid- patient large prevalence study demonstrate consequence comorbid diabete hypertension urgently need understand magnitude vexatious comorbiditie
1001,possible effect angiotensin convert enzyme inhibitor aceis angiotensin ii receptor blocker arb covid- disease severity generate considerable debate perform single center retrospective analysis hospitalize adult covid- patient wuhan china definite clinical outcome dead discharge february patient anti hypertensive treatment acei arb compare clinical characteristic outcome medical record  patient screen  patient history hypertension take anti hypertensive medication  patient receive acei arb regimen  patient antihypertensive medication acei arb observe statistically significant difference percentage hospital mortality vs. p icu admission vs. p invasive mechanical ventilation vs. p patient acei arb treatment multivariable adjustment age gender provide evidence significant association acei arb treatment severe covid- outcome finding confirm lack association chronic receipt renin angiotensin system antagonist severe outcome covid- patient continue previous anti hypertensive therapy evidence available
1002,limited information describe characteristic clinical outcome patient infect coronavirus disease  covid- especially underserved urban area minority population united states retrospective single center study patient admit covid- infection datum collection  march  april demographic clinical laboratory treatment datum present descriptive statistic frequency chi test multivariate logistic regression determine association risk factor clinical outcome total  inpatient include mean age  /-standard deviation total female african american comorbiditie include hypertension diabetes mellitus copd asthma old age associate high risk inpatient death odd ratio confidence interval ci p inpatient mortality occur need mechanical ventilation ci p require continuous renal replacement therapy hemodialysis crrt hd ci p need vasopressor ci p biomarker disease severity baseline crp level  mg l associate mortality ci p majority hospitalize patient hypertension diabetes old age independent risk factor inpatient mortality requirement mechanical ventilation vasopressor use crrt hd associate significantly inpatient mortality high baseline crp significantly associate inpatient death
1003,background aim investigate association use angiotensin convert enzyme inhibitor acei)/angiotensin receptor blocker arb outcome hypertensive covid- patient systematic review meta analysis perform method systematically search pubmed europepmc proquest cochrane central databases term covid- sars cov- angiotensin convert enzyme angiotensin receptor blocker primary second outcome mortality non survivor severe covid- respectively result totally  patient include  study pooled analysis show use acei arb associate mortality p severity p pool adjust show risk benefit associate acei arb use term mortality p subgroup analysis show use arb associate reduce mortality p acei subgroup p meta regression show association acei arb use mortality patient covid- vary gender p grade show low certainty evidence effect acei arb mortality severity certainty evidence low acei arb subgroup conclusion administration renin angiotensin system ras inhibitor associate increase mortality severity covid- patient hypertension specifically arb acei use associate low mortality
1004,background sars cov- coronavirus infection range asymptomatic fatal covid- characterize cytokine storm lung failure vitamin d deficiency postulate determinant severity objective review evidence relevant vitamin d covid- method narrative review result regression modelling show northerly country northern hemisphere currently show relatively high covid- mortality estimate .% increase mortality  degree latitude north  degree north p adjustment age population support role ultraviolet b acting vitamin d synthesis factor associate bad covid- prognosis include old age ethnicity male sex obesity diabetes hypertension associate deficiency vitamin d response vitamin d deficiency link severity childhood respiratory illness experimentally vitamin d increase ratio angiotensin convert enzyme  ace ace increase angiotensin ii hydrolysis reduce subsequent inflammatory cytokine response pathogen lung injury conclusion substantial evidence support link vitamin d deficiency covid- severity indirect community base placebo control trial vitamin d supplementation difficult evidence come study covid- outcome large cohort information prescribe datum vitamin d supplementation assay serum unbound oh vitamin d level vitamin d supplementation strongly advise people likely deficient
1005,nowadays coronavirus disease  covid- increase mortality world mercilessly learn day new symptom mutate quickly disease tie desperate death rate disease increase patient pre existing medical condition especially cardiovascular one eliminate angiotensin convert enzyme ace)- receptor lung ace angiotensin receptor blocker arb stimulate ace expression bad prognosis intravenous infusion acei arb experimental animal increase number ace receptor reason covid- infect cell patient treat hypertension congress cardiology recommend discontinue anti hypertensive drug brief report evaluate covid- view cardiovascular disease take account current report suggest possible solution virus control
1006,objective study aim explore association obesity type  diabetes hypertension severe coronavirus disease  covid- admission method present study total patient sample evaluate laboratory mexican institute epidemiological diagnosis reference negative covid- positive covid- positive respiratory virus severe type respiratory disease define presence pneumonia organ failure require intensive care multivariable logistic regression model explore factor associate severe covid- admission result patient test positive covid- high proportion obesity .% diabetes .% hypertension .% compare confirm diagnosis compare patient obesity obesity show .-fold high odd develop severe covid- admission subject diabetes hypertension show .-fold high odd develop severe covid- admission respectively conclusion obesity diabetes hypertension significantly associate severe covid- admission association obesity strong patient  year age
1007,myopericarditis remain prominent infectious inflammatory disorder patient lifetime viral pathogen prove lead contributor myopericarditis pediatric adult population despite current comprehensive knowledge myocardial injury viral post viral myopericarditis cellular molecular mechanism sars cov induce myopericarditis poorly understand report present case coronavirus covid- fulminant myopericarditis acute respiratory distress syndrome ards middle aged male patient -year old man history hypertension arrive emergency department dry cough fatigue dyspnea fever real time reverse transcriptase polymerase chain reaction rt pcr assay confirm diagnosis covid- infection result patient admission airborne isolation unit clinical observation condition begin deteriorate patient transfer cardiac care unit electrocardiography detect cardiac injury demonstrate diffuse st segment elevation laboratory evaluation reveal elevate troponin t bnp echocardiogram indicate global left ventricular hypokinesia reduce ejection fraction patient treat hydroxychloroquine azithromycin dobutamine remdesivir ventilatory support specific case highlight severity complication arise direct result covid- infection
1008,ongoing coronavirus disease  covid- pandemic cause novel coronavirus severe acute respiratory syndrome coronavirus  sars cov- individual metabolic syndrome increase risk poor disease outcome mortality covid- pathophysiologic mechanism observation fully elucidate critical interaction sars cov- angiotensin convert enzyme  ace facilitate viral entry host cell ace express pancreatic islet vascular endothelium adipose tissue sars cov- -ace interaction tissue factor govern spectrum severity clinical manifestation covid- patient metabolic syndrome pro inflammatory milieu observe patient metabolic syndrome contribute covid mediate host immune dysregulation include suboptimal immune response hyperinflammation microvascular dysfunction thrombosis review describe spectrum clinical feature likely pathophysiologic mechanism potential implication management metabolic syndrome covid- patient
1009,whilst covid- infection generally run mild course affect number pre existing co morbidity determine severity infection outcome individual patient important co morbidity consistently emerge study globe patient age sex important co morbidity adversely affect outcome include pre existing diabetes obesity hypertension chronic lung disease malignancy comprehensive review discuss impact co morbidity role laboratory predictor poor patient outcome
1010,purpose present study undertake investigate quantify severity covid- infection high resolution chest compute tomography ct determine relationship clinical parameter study aim ct change clinical recovery progression disease materials method attempt provide extensive information pertain clinical radiological characteristic covid- present study undertake  hospitalize patient patient covid- confirm positive genomic analysis rt pcr tertiary care center jaipur initially patient evaluate clinical parameter correlate hrct chest hospitalization ct finding correlate duration disease assess progress recovery result total  patient laboratory confirm covid- test rt pcr sms hospitals jaipur assess confirm case patient young adult fifth sixth decade age group mean age year male preponderance male female total analyze patient  patient .% symptomatic fever .% cough .% shortness breath sore throat .% common present clinical manifestation patient .% symptom like headache chest pain pain abdomen alter sensorium etc patient underlying co morbid disease sample population prevalent comorbiditie diabetes mellitus hypertension .% copd k chest cad .% like hypothyroidism anemia cva etc lung pathological change evaluate hrct imaging assign ct severity score find typical covid finding patient indeterminate atypical patient negative ct chest covid clinical status patient correlate ct severity score mild case show score .% patient ct feature vary duration course disease proportional ggo high early phase low later stage disease conclusion varied spectra covid- presentation include fever cough shortness breath sore throat etc diabetes mellitus hypertension copd k chest cad find major comorbid condition symptomatic presentation covid- observe high patient co morbid disease especially multiple hrct chest covid- patient major diagnostic prognostic importance positive ct finding prominent symptomatic patient co morbid patient clinical symptom patient directly correlate ct severity index ct imaging find useful predict clinical recovery patient progression disease
1011,background coronavirus disease  covid- disease cause severe acute respiratory syndrome coronavirus  sars cov- despite international aggressive extension significant morbidity mortality impact renal function prognosis uncertain method analysis international hope registry nct objective evaluate association kidney failure severity admission mortality patient sars cov- infection patient categorize  group accord estimate glomerular filtration rate admission egfr  ml min/. m egfr ml min/. m egfr  vs egfr vs egfr .% vs .% vs .% p multivariate analysis age hypertension renal function saturation lactate dehydrogenase elevation admission independently predict cause mortality conclusion renal failure admission patient sars cov- infection frequent associate great number complication hospital mortality datum come multicenter registry allow precise mortality risk assessment study need confirm finding
1012,present recent experience -month old infant personal history short bowel syndrome present fever cyanosis cardiogenic shock secondary severe pulmonary hypertension right ventricular failure pulmonary thromboembolism present sign toxin mediate disease kawasaki disease finally diagnose sars cov- infection presentation confirm future research severe cardiovascular impairment child covid- attributable primary pulmonary infection multisystem inflammatory syndrome child heart disease
1013,background coronavirus disease  covid- pandemic emerge threat worldwide remain unclear comorbiditie affect risk infection severity covid- method nationwide retrospective case control study individual aged  year old medical cost covid- testing claim covid- diagnosis infection severity identify reimbursement datum diagnosis code basis respiratory support use respectively odd ratio ors estimate multiple logistic regression adjust age sex region healthcare utilization insurance status result covid- group young high proportion female overall case severe severe covid- group old patient proportion male ratio non severe group diabetes odd ratio range orr .- osteoporosis orr .- rheumatoid arthritis orr .- substance use orr .- schizophrenia orr .- show significant association covid- term severity diabetes confidential interval hypertension orr .- chronic low respiratory disease orr .- chronic renal failure end stage renal disease orr .- associate severe covid- conclusion identify comorbiditie associate covid- health care worker careful diagnose treat covid- patient abovementioned comorbiditie
1014,presence cardiovascular co morbidity know effect coronaviruse cardiovascular system call attention potential implication patient cardiovascular risk factor evidence base viewpoint address question individual underlie cardiovascular risk factor e.g. high blood pressure diabetes overt disease e.g. coronary heart disease heart failure kidney disease likely develop severe covid- die underlie condition b regular use angiotensin convert enzyme inhibitor ace angiotensin receptor blocker arb patient likely infect die covid- necessary cautionary note evidence link covid- cardiovascular disease accrue fast pace date conclude great susceptibility individual underlie cardiovascular condition develop severe covid- high mortality rate likely confound age type co morbidity patient heart failure chronic kidney disease excess risk b ace arb associate great risk sars cov infection severity risk death patient covid- patient drug stop strict medical supervision addition suitable replacement medicine
1015,objective aim determine clinical characteristic covid- patient sars cov- virus continue circulate population method retrospective multicentre cohort study adult covid- case hospital zhejiang enrol cluster group base epidemiological history generation patient travel history hubei  day disease onset second generation patient contact history generation patient generation patient contact history second generation patient demographic clinical characteristic clinical outcome duration viral shedding analyse result total  patient enrol   patient first- second- generation respectively compare second generation generation patient old vs. year p /= .% vs. .% .% p proportion generation patient develop severe illness .% vs. .% .% p critical illness .% vs. .% .% p receive endotracheal intubation .% vs. .% .% p high group discussion generation patient old underlying comorbiditie high proportion severe critical illness first- second generation patient
1017,coronavirus disease covid- pandemic far involved  country million patient worldwide past month attribute death death united states pulmonary manifestation predominant identify cardiac involvement common acute cardiac injury common cardiac manifestation disease see patient prior cardiac comorbiditie establish cardiovascular risk factor diabetes mellitus hypertension coronary artery disease predispose cardiac injury severity illness mortality non ischemic myocardial injury secondary cytokine storm think predominant mechanism acute cardiac injury associate covid- multiple mechanism process contribute cardiac injury result poor outcome clearly understand clinical diagnostic detail cardiovascular involvement patient limit biochemical marker multiple therapeutic agent try questionable efficacy clinical evidence interaction comorbiditie cardiovascular drug cardiac effect therapeutic agent illness continue investigation increase number patient new promising therapy ongoing clinical trial exact mechanism extent risk factor contribute outcome clear future
1018, january world health organisation identify covid- cause virus sars cov- global emergency risk factor identify develop complication covid- infection age gender comorbiditie diabetes hypertension obesity cardiovascular disease risk factor account death arise covid- seemingly healthy individual paper investigate potential link sars cov- bacterial load question bacteria play role bacterial superinfection complication pneumonia acute respiratory distress syndrome sepsis connection covid- complication oral health periodontal disease examine comorbiditie high risk covid- complication cause imbalance oral microbiome increase risk periodontal disease explore connection high bacterial load mouth post viral complication improve oral health reduce risk complication covid-
1019,study design investigate change index patient different type coronavirus disease  covid- seventy patient covid- collect affiliated hospital zhejiang university school medicine classify moderate severe critically severe type accord disease severity basic information blood routine pneumonia relate blood index immune relate index liver kidney myocardial index patient different type analyze analysis immune relate index show proportion critically severe patient abnormal interleukin- il- il- high severe moderate patient addition proportion patient abnormal total cholesterol increase severity disease increase proportion critically severe patient significantly high moderate patient patient severe covid- old likely history hypertension progression covid- abnormal proportion total white blood cell neutrophil lymphocyte il- il- total cholesterol increase change index patient different covid- type provide reference disease severity identification diagnosis covid- addition change total cholesterol level suggest covid- induce liver function damage patient
1020,background despite report characteristic coronavirus disease  covid- wuhan china relatively little know transmission feature covid- outside wuhan especially provincial level method collect epidemiological demographic clinical laboratory radiological occupation information contact history  patient laboratory confirm covid- report january  february henan province china describe characteristic case compare diagnostic accuracy feature blood testing compute tomography ct scan x ray analyse sars cov- transmission source patient occupation henan province result mean age patient case series  year .% male .% coexist medical disorder death rate fourteen patient symptom lymphocyte percentage associate disease severity chi p large variation sample group mean time illness onset diagnosis day total  patient live visit wuhan  contact confirm case  hospital  wet market  patient traceable transmission source .% farmer .% workman conclusion lymphocyte percentage sign severe covid- general good diagnostic index long time illness onset diagnosis associate high covid- severity old age high likelihood having coexist cardiovascular disease include hypertension male farming find high risk occupation henan province china
1021,background january coronavirus disease  covid- rapidly spread world early assessment illness severity important stratification patient analyse predictive value national early warning score  news intensive care unit admission icu patient severe acute respiratory syndrome- coronavirus- sars cov- infection method datum  patient sars cov- admit  march  april clinic infectious diseases perugia hospital italy retrospectively news hospital admission demographic comorbidity clinical datum collect univariate multivariate analysis perform establish correlation variable icu admission result  patient include analysis  admit icu news hospital admission good predictor icu admission show area receiver operate characteristic curve analysis standard error confidence interval .- multivariate logistic regression analysis news significantly relate icu admission threshold  clinical variable include model significantly correlate icu admission news threshold  high sensitivity threshold  high specificity positive likelihood ratio positive predictive value find threshold  threshold news hospital admission good predictor icu admission patient severe covid- correctly rapidly stratified
1022,aim nowadays ongoing pandemic covid- cause novel coronavirus syndrome coronavirus- sars cov- emerge rapidly evolve situation complication hypertension diabetes copd cardiovascular disease cerebrovascular disease major risk factor patient covid- method meta analysis explore diabetes relate mortality patient covid- meta analysis aim explore possible clinical mortality diabetes covid- analyze diabetes patient infect sars cov- expose bad clinical prognostic risk evaluate reliability evidence result result show close relationship diabetes mortality covid- pool ci p pooled datum calculate fix effect model fem heterogeneity appear study sensitivity analysis show omit single study convert random effect model fem main result hold conclusion meta analysis show diabetes increase mortality patient covid- result indicate disturbance blood glucose covid- patient importantly meta analysis grade reliability evidence basic clinical research diabetes dysfunction covid- patient
1023,coronavirus disease  covid- show wide variation expression severity symptom mild symptom flu like symptom severe case pneumonia acute respiratory distress syndrome death large difference outcome observe male female cause variability likely multifactorial include genetic sars cov- virus responsible infection depend human gene human receptor angiotensin convert enzyme  ace cell invasion serine protease tmprss s protein priming genetic variation gene modulate individual genetic predisposition infection virus clearance genetic datum covid- patient gather carry phenome wide association scan phewas investigate role gene human phenotype general population examine  quantitative phenotype include cytokine cardio metabolic biomarker usage  medication volunteer lifelines population cohort relation genetic variant locate near ace tmprss reach threshold significance observe interesting suggestive association example single nucleotide polymorphism snp near tmprss gene associate thrombocyte count p x snp ace gene associate use angiotensin ii receptor blocker arb combination therapy p x association significantly strong female p dif f use non steroid anti inflammatory antirheumatic product p x association need confirm large sample size suggest variant play role disease thrombocytopenia hypertension chronic inflammation observe severe covid- case investigation genetic variant context covid- promise well understanding disease variability result available
1024,severe acute respiratory syndrome coronavirus  sars cov- outbreak begin  spread rapidly globe observe cause acute lung injury multiorgan system failure common symptom flu like population observe decompensate alarmingly rapid rate severe hypoxia sars cov- infect host cell target angiotensin convert enzyme  ace receptor present endothelial cell lung heart kidney gastrointestinal tissue pathophysiology acute respiratory distress syndrome ards sars cov- infection component lung perfusion dysregulation describe cytokine storm cause increase vascular permeability disease severity old adult comorbid condition particularly hypertension diabetes history ischemic heart disease especially vulnerable high risk population angiotensin modulate therapy theorize increase ace expressivity current evidence discontinuation equivocal standard sars cov- testing reverse transcription polymerase chain reaction present problem low sensitivity possible co infection pathogen treatment ards setting sars cov- follow pre establish goal care wish patient family member caregiver consider high risk polypharmacy cognitive decline malnutrition depression particularly old adult treatment recommendation outline ventilation goal minimize lung injury compassionate use pharmacologic therapy remdesivir show promise clinical trial anticytokine agent underway
1025,aim retrospective case control study aim identify potential independent predictor severe lethal covid- include treatment angiotensin convert enzyme inhibitor acei and/or angiotensin ii receptor blockers arb method result adult sars cov- infection italian province follow median  day arb and/or acei treatment hypertension diabetes cancer copd renal major cardiovascular disease cvd extract clinical chart electronic health record year infection sample consist  subject mean age .% male  .% severe symptom  severe lethal disease death mean age year .% hypertensive .% cvd youngest deceased person age  year hypertensive subject n proportion treat arb acei .% patient mild severe severe lethal disease respectively multivariate analysis association observe therapy disease severity adjust severe lethal covid- ci significant predictor severe disease old age aor largely increase  year age male gender aor .- diabetes aor .- cvd aor copd aor gender age diabetes predict severe lethal disease conclusion association find covid- severity treatment arb and/or acei support recommendation continue medication patient advise physician
1026,importance new york city global epicenter sars cov- outbreak significant number individual infect virus patient multiple myeloma compromise immune system disease anti myeloma therapy particularly susceptible coronavirus disease  covid- limited information guide clinical management objective assess risk factor outcome covid- patient multiple myeloma design case series setting large academic center new york city participant patient multiple myeloma related plasma cell disorder diagnose covid- march th  april th exposure clinical feature risk factor analyze relation severity covid- main outcomes measures descriptive statistic logistic regression estimate disease severity reflect hospital admission intensive care unit icu admission need mechanical ventilation death result  multiple myeloma patient male median age range diagnose covid-  admit  patient place mechanical ventilation  patient expire study risk factor significantly associate p adverse outcome icu admission mechanical ventilation death hypertension n= odd ratio confidence interval ci diabetes n= ci age year n= ci high dose melphalan autologous stem cell transplant month n= ci igg mg dl n= or=. ci entire series  patient plasma cell disorder hypertension significantly associate combine end point ci conclusion relevance multiple myeloma patient compromise immune system disease therapy large disease specific cohort date patient multiple myeloma covid- compare general population find risk factor adverse outcome share mortality rate high range officially report mortality rate
1027,aim estimate prevalence cardiometabolic co morbidity patient covid- estimate increase risk severity disease mortality people co morbidity materials method medline scopus world health organization website search global research covid- conduct january   april study inclusion restrict english language publication original article report prevalence co morbidity individual covid- case series include  patient eighteen study select inclusion datum analyse random effect meta analysis model result eighteen study total  individual identify pooled prevalence co morbidity patient covid- disease ci hypertension diabetes .% cardiovascular disease cvd chronic obstructive pulmonary disease copd chronic kidney disease ckd cerebrovascular disease cancer pool prevalence exception cerebrovascular disease co morbidity present significantly increase risk have severe covid- addition risk mortality significantly increase individual cvd copd ckd cerebrovascular disease cancer conclusion individual covid- presence co morbidity cardiometabolic associate high risk severe covid- mortality finding important implication public health regard risk stratification future planning
1028,sars cov- cause worldwide pandemic begin outbreak pneumonia case hubei province china knowledge risk integral treatment guideline implementation resource allocation conduct systematic review meta analysis evaluate comorbiditie associate severe fatal case covid- search conduct pubmed embase  april pooled estimate collect random effect model thirty study include systematic review meta analysis total case ci .% .% comorbiditie fatal case ci .% .% hypertension prevalent severe ci .% .% fatal ci .% .% case compare total case ci .% .% diabetes prevalent fatal case ci .% .% compare total case ci .% .% respiratory disease high prevalence fatal case ci .% .% comparison total case ci .% .% study assess mechanism account association severe case hypertension diabetes respiratory disease crucial understand new disease manage patient risk develop policy guideline reduce future risk severe covid- disease
1029,objective knowledge severe acute respiratory syndrome coronavirus  sars cov- infection liver transplant recipient lack particularly term severity disease aim study describe demographic baseline clinical characteristic early outcome european cohort liver transplant recipient sars cov- infection design conduct international prospective study europe liver transplant recipient sars cov- infection confirm microbiological assay outbreak covid- pandemic baseline characteristic clinical presentation management immunosuppressive therapy outcome collect result  patient include male median iqr age diagnosis  year    patient cardiovascular disease arterial hypertension diabetes mellitus respectively common symptom fever cough dyspnoea fatigue myalgia gi symptom immunosuppression reduce  recipient discontinue  regard impact outcome observe subject hospitalise  develop acute respiratory distress syndrome overall estimate case fatality rate ci increase ci hospitalise patient seven patient die history cancer conclusion european multicentre prospective study liver transplant recipient covid- associate overall hospital fatality rate ci ci respectively history cancer frequent patient poor outcome
1030,current datum suggest infection severe acute respiratory syndrome coronavirus  sars cov- cause corona virus disease- covid- follow severe clinical course patient cardiovascular disease cvd hypertension overweight obesity appear lipid lower pharmacological intervention particular statin reduce risk cardiovascular complication cause covid- potentially additional antiviral activity show high cholesterol level associate lipid raft subdomain plasma membrane harbour angiotensin convert enzyme  ace receptor s protein sars cov- evidence importance cholesterol viral entry host cell suggest role cholesterol lower therapy reduce viral infectivity addition lipid lowering plaque stabilisation effect statin possess pleiotropic effect include anti inflammatory immunomodulatory antithrombotic activity low rate mortality intubation report study investigate statin therapy influenza infection statin therapy show increase viral clearance blood chronic hepatitis c infection statin serve potential sars cov- main protease inhibitor contribute control viral infection review elaborate role cholesterol level process coronavirus infection provide critical appraisal potential statin reduce severity duration complication covid-
1031,covid- pandemic cause severe acute respiratory syndrome coronavirus  sars cov- overwhelm healthcare system require rapid development treatment reduce covid- severity drug repurposing offer fast track discuss potential beneficial effect statin covid- patient base evidence target virus receptor replication degradation downstream response infected cell address basic research epidemiological information briefly statin modulate virus entry act sars cov- receptor ace cd and/or lipid raft engagement statin induce autophagy activation regulate virus replication degradation exert protective effect know anti inflammatory property statin block molecular mechanism include nf kappab nlrp inflammasome limit cytokine storm severe covid- patient link fatal outcome finally statin moderation coagulation response activation contribute improve covid- outcome linked article article themed issue pharmacology covid- view article section visit
1032,background examine great severity coronavirus disease  covid- man black asian minority ethnic bame individual explain cardiometabolic socio economic behavioural factor method study  uk biobank participant test covid- positive n multivariate logistic regression model include age sex ethnicity test addition cardiometabolic factor diabetes hypertension high cholesterol prior myocardial infarction smoking body mass index bmi oh)-vitamin d poor diet townsend deprivation score housing home type overcrowding behavioural factor sociability risk taking attenuate sex ethnicity association covid- status result representation man bame ethnicity covid- positive group bame individual average poor cardiometabolic profile low oh)-vitamin d great material deprivation likely live large household flat apartment male sex bame ethnicity high bmi high townsend deprivation score household overcrowding independently associate significantly great odd covid- pattern association consistent man woman cardiometabolic socio demographic behavioural factor attenuate sex ethnicity association conclusion study sex ethnicity differential pattern covid- adequately explain variation cardiometabolic factor oh)-vitamin d level socio economic factor factor underlie ethnic difference covid- easily capture investigation alternative biological genetic susceptibility comprehensive assessment complex economic social behavioural difference prioritise
1033,context individual diabetes appear similar risk sars cov- infection diabetes likely suffer severe consequence include death diabetic ketoacidosis dka common potentially lethal acute complication diabetes arise relative insulin deficiency occur type  diabetes setting moderate severe illness early report indicate patient pre existing diabete dka common complication severe covid- poor prognostic sign case description clinical perspective explore key element care individual dka covid- pandemic  case topic address include diagnosis triage fundamental principle treatment focus importance characterize dka severity medical complexity determine good approach conclusion discuss tenet dka management require flexibility setting covid- important public health goal prevent transmission high risk individual reduce healthcare worker exposure infected patient preserve personal protective equipment evidence alternative treatment strategy explore special attention place treatment option relevant pandemic include use subcutaneous insulin therapy finally dka preventable condition include evidence base strategy guidance design empower clinician patient avoid complication possible
1034,background datum nonrandomized study suggest hydroxychloroquine effective therapeutic agent coronavirus disease  covid- method conduct observational retrospective cohort study involve hospitalize adult patient confirm mild severe covid- french university hospital patient receive hydroxychloroquine mg  time daily dosage  day compassionate basis addition standard care soc compare patient contraindication hydroxychloroquine receive soc propensity score weighted analysis perform control confounder age sex time symptom onset admission  day charlson comorbidity index medical history arterial hypertension obesity national early warning score  news score admission pneumonia severity primary endpoint time unfavorable outcome define death admission intensive care unit decision withdraw withhold life sustain treatment whichever come result datum  patient laboratory confirm covid- analyze  consider primary analysis  patient treat hydroxychloroquine  patient treat soc admission mean age patient  year median charlson comorbidity index median news severity score propensity score weighting treatment hydroxychloroquine associate significantly reduce risk unfavorable outcome hazard ratio confidence interval p overall survival significantly different  group hazard ratio p conclusion hospitalize adult covid- significant reduction risk unfavorable outcome observe hydroxychloroquine comparison soc unmeasured confounder persist despite careful propensity weight analysis study underpowered ongoing control trial patient vary degree initial severity large scale help determine place hydroxychloroquine treatment covid- hospitalize adult covid- significant reduction risk unfavorable outcome observe hydroxychloroquine comparison soc
1035,renin angiotensin system ras long appreciate major regulator blood pressure recently recognize mechanism modulate inflammation concern covid- patient use drug target system ras explore fully druggable target abbreviated description ras suggest dysregulation center covid-
1036,outbreak coronavirus disease covid- wuhan affect  country region worldwide clinical study focus wuhan little know disease outside wuhan china retrospective cohort study report early clinical feature  patient covid- admit hospital beijing result  .% patient severe illness .% patient admit icu  .% patient die percent patient history living travel wuhan patient severe- illness significantly old average age  year old vs  year old high incidence expectoration .% vs .% shortness breath .% vs .% anorexia .% vs .% confusion(.% vs compare nonsevere patient systolic blood pressure median  mmhg vs  mmhg high oxygen saturation median .% vs .% significantly low severe patient nonsevere patient addition myoglobin median ng ml vs ng ml troponin median pg ml vs pg ml c reactive protein median mg l vs mg l neutrophil median l vs .x l significantly increase lymphocyte median l vs .x l albumin mean g l vs g l creatinine clearance rate median vs ml min/.m significantly decrease severe patient study reveal old patient high level c reactive protein myoglobin troponin neutrophil high systolic blood pressure low level lymphocyte albumin low creatinine clearance rate oxygen saturation likely severe disease
1037,background centers disease control prevention advise patient moderate severe asthma belong high risk group susceptible severe coronavirus disease  covid- association asthma covid- establish objective primary objective determine prevalence asthma patient covid- major health system assess clinical characteristic comorbiditie asthmatic nonasthmatic patient covid- determine risk hospitalization associate asthma and/or inhale corticosteroid use method medical record patient covid- search computer algorithm march  april chart review validate diagnosis asthma medication prescribe asthma patient pcr confirm covid- demographic clinical feature characterize regression model assess association asthma corticosteroid use risk covid related hospitalization result  patient identify covid-  classify have asthma asthma associate increase risk hospitalization relative risk ci adjust age sex comorbiditie ongoing use inhale corticosteroid increase risk hospitalization similar adjust model relative risk ci conclusion despite substantial prevalence asthma covid- cohort asthma associate increase risk hospitalization similarly use inhale corticosteroid systemic corticosteroid associate covid related hospitalization
1038,current coronavirus disease  covid- pandemic cause severe acute respiratory syndrome coronavirus- sars cov- major public health crisis past month overall case fatality rate range -% rate high elderly underlying comorbiditie like diabetes hypertension heart disease recent report show -% patient covid- underlying chronic liver disease previous sars epidemic patient report develop degree liver damage current pandemic hepatic dysfunction see -% patient covid- particularly severe disease case acute liver injury report associate high mortality hepatic involvement covid- relate direct cytopathic effect virus uncontrolled immune reaction sepsis drug induce liver injury postulated mechanism viral entry host angiotensin convert enzyme  ace receptor abundantly present type  alveolar cell interestingly ace receptor express gastrointestinal tract vascular endothelium cholangiocyte liver effect covid- underlie chronic liver disease require detailed evaluation datum currently lack research warrant area
1039, coronavirus disease covid- pandemic disrupt social economical medical system worldwide strictly infectious disease intricate bidirectional relationship non communicable metabolic disease endocrinological factor observe diabetes hypertension obesity find independent risk factor covid- disease severity mortality inclination sedentary lifestyle psychosocial stress critical time harbinger metabolic syndrome endocrinologist great opportunity play role combat pandemic paper examine endocrinological disorder influence dynamic covid- vice versa intend review clinical guideline adopt practice endocrinology try time
1041,background outbreak severe acute respiratory syndrome coronavirus  sars cov- cause coronavirus disease covid- declare global pandemic identify individual infection potentially severe critical control case fatality rate covid- knowledge symptom prognostic covid- severity lack objective objective study identify symptom prognostic covid- infection severity method analyze document symptom include fever cough fatigue expectoration sore throat chest distress headache diarrhea rhinorrhea stuff nose nausea vomiting muscle joint ache shortness breath association disease severity case series include  confirm case january  february  henan province china analyze influence individual characteristic include age gender comorbiditie symptom prognostic value result fatigue ci p expectoration ci p stuff nose ci p=. identify prognostic symptom covid- patient multivariate analysis fever occur .% patient associate disease severity fatigue account .% patient linearly associate infection severity statistical significance expectoration occur .% patient cohort sole prognostic factor patient cardiovascular complication include hypertension shortness breath chest distress muscle joint ache dry cough occur   .%  .%  .%  patient respectively significantly enrich patient classify severe stuffed nose nausea associate favorable disease severity especially male patient female male patient document have muscle joint ache headache enrich patent age   year follow age   year statistical significance conclusion fatigue expectoration sign severe covid- infection shortness breath chest distress muscle joint ache dry cough prevalent severe patient expectoration commonly present old individual patient cardiovascular disorder include hypertension shortness breath prognostic severe infection male patient stuffed nose nausea favorable prognostic factor severe infection especially male patient
1042,background midst coronavirus disease pandemic emerge clinical datum world equip frontline health care worker policy maker researcher well understand combat illness objective aim study report correlation clinical laboratory parameter patient require mechanical ventilation mortality patient infect severe acute respiratory syndrome coronavirus  sars cov- method review patient sars cov- confirmed infection admit manage institution month patient group intubate nonintubate subgroupe alive deceased comprehensive analysis follow parameter perform age sex ethnicity bmi comorbiditie inflammatory marker laboratory value cardiac renal function electrocardiogram ekg chest x ray finding temperature treatment group hospital acquire patient sars cov- result total  patient include study age range year mean year include  female .%  male .% mean bmi  african americans .%  hispanics .%  asians .%  caucasian .% mean comorbiditie overall mortality rate n= .% n= patient require mechanical ventilation n= hospital acquire sars cov- infection pertinent statistically significant result find intubate versus nonintubated patient confirm sars cov- follow parameter age p=. bmi p=. african american ethnicity p hispanic ethnicity p=. diabetes mellitus p=. creatinine p=. blood urea nitrogen bun p=. procalcitonin p=. c reactive protein crp p=. lactate dehydrogenase ldh p=. glucose p=. temperature p=. bilateral pulmonary infiltrate chest x ray p bilateral patchy opacity p=. result live deceased subgroup patient confirm sars cov- link mortality bmi p=. length stay p hypertension p=. multiple comorbidity p=. bun p=. ekg finding arrhythmia block p=. conclusion arrive follow conclusion base comprehensive review study group data collection statistical analysis parameter strongly correlate need mechanical ventilation young age group overweight hispanic ethnicity high core body temperature ekg finding sinus tachycardia bilateral diffuse pulmonary infiltrate chest x ray intubate exhibit increased disease severity significantly elevate level serum procalcitonin crp ldh mean glucose creatinine bun mortality strongly correlate bmi african american ethnicity hypertension presence multiple comorbiditie mean worsen renal function acute kidney injury acute chronic kidney injury ekg finding arrhythmia heart block
1043,background aim liver involvement common covid- elevated aspartate alanine amino transaminase ast alt borderline increase serum bilirubin serum alkaline phosphatase alp common finding patient associated co morbid condition like obesity cardiovascular disease renal disease malignancy hypertension old age prone develop severe disease limited datum available patient covid- metabolic dysfunction associate fatty liver disease mafld).the aim review analyse effect mafld severity covid- method systematically search pubmed database till  retrieve article publish covid- fatty liver mafld nafld result limited study show fold high risk severe covid- patient mafld patient mafld associated obesity severe fibrosis age yr prone develop severe covid- conclusion mafld associate fold increase severity covid- compare non mafld patient physician hepatologist follow patient cautiously preventive measure take strictly high risk patient
1044,objective aim investigate relationship clinical characteristic outcome severity severe acute respiratory syndrome coronavirus  pneumonia method perform systematic review meta analysis pubmed embase cochrane library database assess clinical characteristic outcome confirmed covid- case compare severe icu nonsevere non icu group result include  cohort study include patient covid- compare nonsevere non icu patient severe icu disease associate smoking history p=. comorbiditie include chronic obstructive pulmonary disease or=. p diabetes or=. p hypertension or=. p coronary heart disease or=. p cerebrovascular disease or=. p=. malignancy or=. p=. find significant difference  group fever dyspnea decrease lymphocyte platelet count increase leukocyte count c creative protein procalcitonin lactose dehydrogenase aspartate aminotransferase alanine aminotransferase creatinine kinase creatinine level p significant difference observe multiple treatment p patient severe icu group likely complication high mortality rate low discharge rate nonsevere non icu disease p conclusion investigation clinical characteristic outcome severe case covid- contribute early prediction accurate diagnosis treatment improve prognosis patient severe illness
1045,current coronavirus disease- covid- pandemic present huge challenge health care system worldwide different risk factor associate disease severity old age diabetes hypertension recently obesity incidence obesity rise past  year reach  billion people world obesity consider pandemic review summarize aspect involve obesity change immune response nutritional factor physiological factor gut lung axis impact viral response covid- prognosis
1046,report angiotensin convert enzyme  ace transmembrane serine protease  tmprss main cell entry protein severe acute respiratory syndrome coronavirus  sars cov- play critical role cause coronavirus disease  covid- investigate expression level sars cov- host cell entry gene lung airway public gene expression dataset find differential expression ace tmprss nasal bronchial airway relative age disease status child find significantly low expression covid- receptor upper low airway nasal bronchial lung airway expression ace tmprss find significantly upregulate smoker compare non smoker patient chronic obstructive pulmonary disease copd compare healthy subject difference observe blood expression level ace tmprss child adult copd diabetic patient significant increase blood expression level gene observe patient essential hypertension ace upregulate blood asthmatic result suggest observed difference covid- severity child adult attribute difference ace tmprss airways tissue expression level
1047,background investigate effect cardiovascular disease cvd global pandemic coronavirus disease  covid- analyze case laboratory confirm covid- patient wuhan method results datum extract medical record sars cov- rna confirm rt pcr total  .%  case cvd high prevalence severe covid- compare non cvd patient p=. median age patient year old coronary artery disease .% hypertension .% common coexist cvds covid- patient high sensitivity cardiac troponin hs ctni creatinine high density lipoprotein cholesterol interleukin- c reactive protein prothrombin time d dimer level severe covid- cvd group high non severe covid- cvd group p patient chest compute tomography ct show ground glass opacity .% local .% bilateral .% interstitial abnormality covid- patient cvd  .% cure discharge  .% remain hospital include  patient require intubation mechanical ventilation hs ctni level remain hospitalize patient high discharge patient p=. conclusion cvds play vital role disease severity covid- covid- result myocardial injury affect prognosis covid-
1048,comorbiditie associate severe coronavirus disease covid- unclear increase susceptibility covid- case control mexican study find obesity represent strong predictor covid- follow diabetes hypertension sex chronic renal failure female active smoking associate decrease odd covid- finding indicate comorbiditie associate severity disease predispose get covid- future research need establish mechanism involve comorbidity apparent protective effect cigarette smoking
1049,background national health system hospital lombardy face heavy burden admission acute respiratory distress syndrome associate coronavirus disease covid- datum patient european origin affect covid- limited method consecutive patient age /= year come north east milan province admit san raffaele hospital covid- february th march th report patient follow month clinical radiological feature admission predictor clinical outcome evaluate result  patient admit emergency unit  patient hospitalize analyze median age  iqr year majority patient male median iqr day covid- symptom onset  day hospital admission fever degree c present .% patient median oxygen saturation spo range median pao fio ratio  iqr median radiographic assessment lung edema rale score  iqr half patient .% comorbiditie hypertension coronary heart disease diabetes chronic kidney failure common probability overall survival day  multivariable analysis show old age coronary artery disease cancer low lymphocyte count high rale score factor independently associate increase risk mortality conclusion large cohort covid- patient european origin main risk factor mortality old age comorbiditie low lymphocyte count high rale
1051,background  million people carry diagnosis asthma datum suggest high risk infection adverse outcome severe acute respiratory syndrome coronavirus asthma remarkably heterogeneous currently unclear patient intrinsic factor relate coronavirus disease objective seek identify characterize subset patient asthma increase risk severe acute respiratory syndrome coronavirus  infection method participant  large asthma cohort stratify clinically relevant parameter identify factor relate angiotensin convert enzyme- ace expression bronchial epithelium ace correlate gene signature interrogate publicly available database identify upstream signal event novel therapeutic target result stratify type  inflammatory biomarker identify subject demonstrate low peripheral blood eosinophil accompany increase expression severe acute respiratory syndrome coronavirus  receptor ace bronchial epithelium gene highly correlate ace overlap type   ifn signature normally induce viral infection t cell recruitment activation bronchoalveolar lavage cell ace high subject reciprocally increase patient demonstrate characteristic correspond risk factor severe coronavirus disease include male sex history hypertension low peripheral blood elevate bronchoalveolar lavage lymphocyte conclusion ace expression link upregulation viral response gene subset type -low patient asthma characteristic resemble know risk factor severe coronavirus disease therapy target ifn family t cell activate factor benefit subset patient
1052,patient die covid- comorbiditie hypertension diabetes chronic obstructive lung disease angiotensin convert enzyme  ace crucial sars cov- bind enter host cell study systematically assess ace expression lung patient disease analyze  lung transcriptome sample patient comorbiditie associate severe covid- find ace highly express patient compare control individual finding suggest patient comorbiditie high chance develop severe covid- correlation network analysis reveal potential regulator ace human lung include gene relate histone modification hat hdac kdmb system biology approach offer possible explanation increase covid- severity patient certain comorbiditie
1054,covid- pandemic decree world health organization march  wreak havoc globally true economic social health challenge clinical manifestation covid- respiratory symptom patient cardiological symptom patient cardiological condition represent group high risk fact particularly vulnerable group high risk contagion great severity case acquire disease heart failure hf include heart transplant ct ventricular assist patient pulmonary arterial hypertension pah hf main chronic cardiovascular disease patient group vulnerable development clinical symptom suffer infection great extent case advanced hf fact hf frequent complication patient covid- likewise transplant patient require immunosuppressant avoid graft rejection constitute population especially susceptible infection develop process situation national association cardiologists mexico ancam mexican society cardiology smc respective chapter prepare follow recommendation medical personnel participate care special group patient different clinical setting suffer covid-
1056,background degree myocardial injury reflect troponin elevation associate outcome u.s. hospitalize patient coronavirus disease- covid- unknown objective purpose study describe degree myocardial injury associate outcome large hospitalize cohort laboratory confirm covid- method patient covid- admit   mount sinai health system hospital new york city february april troponin normal value ng ml n .% significantly associate death adjust hazard ratio ci p ng dl n .% significantly associate high risk adjust hr ci p conclusion myocardial injury prevalent patient hospitalize covid- troponin concentration generally present low level patient cvd likely myocardial injury patient cvd troponin elevation patient hospitalize covid- associate high risk mortality
1057,objective primary objective determine efficacy single dose ivermectin administer low risk non severe covid- patient  hour symptom onset reduce proportion patient detectable sars cov- rna polymerase chain reaction pcr test nasopharyngeal swab day  post treatment secondary objective assess efficacy ivermectin reduce sars cov- viral load nasopharyngeal swab day  post treatment assess efficacy ivermectin improve symptom progression treat patient assess proportion seroconversion treat patient day assess safety ivermectin propose dose determine magnitude immune response sars cov- assess early kinetic immunity sars cov- trial design saint single centre double blind randomized placebo control superiority trial parallel arm participant randomize receive single dose  mug kg ivermectin placebo number patient treatment placebo group (: ratio participant population study patient positive nasopharyngeal swab pcr test sars cov- non severe covid- disease risk factor progression severity vulnerable population pregnant woman minor i.e.  year old senior i.e.  year old exclude inclusion criterion patient diagnose covid- emergency room clinica universidad de navarra cun positive sars cov- pcr resident pamplona basin cuenca de pamplona patient age   year age negative pregnancy test woman child bear age patient representative give informed consent participate study patient pi opinion able comply requirement clinical trial include home follow isolation exclusion criterion know history ivermectin allergy hypersensitivity component ivermectin covid- pneumonia diagnose attend physician identify chest x ray fever cough present  hour positive igg sars cov- rapid diagnostic test age   year follow co morbidity disease interfere study eye pi immunosuppression chronic obstructive pulmonary disease diabetes hypertension obesity acute chronic renal failure history coronary disease history cerebrovascular disease current neoplasm recent travel history country endemic loa loa angola cameroon central african republic chad democratic republic congo ethiopia equatorial guinea gabon republic congo nigeria sudan current use cyp p gp inhibitor drug quinidine amiodarone diltiazem spironolactone verapamil clarithromycin erythromycin itraconazole ketoconazole cyclosporine tacrolimus indinavir ritonavir cobicistat use critical cypa substrate drug warfarin woman child bear age participate use safe contraceptive method entire period study month woman consider childbearing capacity post menopausal minimum  year menstruation undergo surgical sterilization month study trial currently plan single center clinica universidad de navarra navarra spain immunology sample analyze barcelona institute global health isglobal barcelona spain participant recruit investigator emergency room and/or covid- area cun remain trial period  day home patient mild disease interest public health contain transmission infection follow visit conduct participant home clinical trial team comprise nursing medical member home visit assess clinical laboratory parameter patient intervention comparator ivermectin administer treatment group mug kg dose include eu approve label stromectol scabioral control group receive placebo current datum efficacy ivermectin virus vivo use placebo control group ethically justified main outcomes primary proportion patient positive sars cov- pcr nasopharyngeal swab day  post treatment secondary .mean viral load determine pcr cycle threshold ct baseline day proportion patient fever cough day  proportion patient progress severe disease death trial proportion patient seroconversion day proportion drug relate adverse event trial median level igg igm iga measure luminex frequency innate sars cov specific t cell assess flow cytometry median level inflammatory activation marker measure luminex transcriptomic median kinetic igg igm iga level trial day randomisation eligible patient allocate ratio randomization list generate trial statistician block ensure balance group study identification code format saint-  generate sequence random number randomization number match subject identifier sequence code keep encrypted file accessible trial statistician physical copy keep locked cabinet cun accessible person administer drug enrol attend patient care separate set  envelope emergency unblinding keep study file blinding masking clinical trial team patient blind placebo visibly identical administer staff involve clinical care participant follow number randomised sample size sample size  patient  participant randomised treatment group  participant control group trial status current protocol version date  april recruitment envision begin th end june th trial registration eudract number register april st clinicaltrials.gov submit pende number protocol protocol attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol
1058,background effect chronic use renin angiotensin aldosterone system raas inhibitor severity covid- infection unclear patient hypertension aim investigate association chronic use angiotensin convert enzyme inhibitor aceis angiotensin ii receptor blocker arb covid related outcome hypertensive patient method single center study conduct  consecutive hypertensive subject present emergency department acute respiratory symptom and/or fever diagnose covid- infection   march result patient group accord chronic antihypertensive medication aceis n arb n raas inhibitor n statistical difference acei arb group term hospital admission rate oxygen therapy need noninvasive ventilation patient chronically treat raas inhibitor show significantly low rate admission semi intensive intensive care unit compare non raas population odd ratio confidence interval ci p similarly risk mortality low group reach statistical significance ci p conclusion datum suggest chronic use raas inhibitor negatively affect clinical course covid- hypertensive patient study need confirm finding determine raas inhibitor protective effect covid related morbidity mortality
1059,aim severity outcome covid- disproportionately high obese male smoker suffer hypertension kidney disease coronary heart disease chd and/or type  diabetes td examine serum level ace cellular entry point coronavirus sars cov- alter high risk group method association serum ace level hypertension td obesity chd smoker male single center population base study  icelanders age gene environment susceptibility reykjavik study ages rs elderly mean age years result smoker male individual td obesity alter serum level ace influence productive infection sars cov- high risk group conclusion ace level upregulate patient group comorbiditie link covid- emerge role circulate biomarker severity outcome covid-
1060,pandemic cause severe acute respiratory syndrome coronavirus  sars cov- result thousand death worldwide month patient die coronavirus disease  covid- comorbiditie hypertension diabetes chronic obstructive lung disease angiotensin convert enzyme  ace identify crucial factor facilitate sars cov bind enter host cell date study assess ace expression lung patient disease analyze  lung transcriptome sample patient comorbiditie associate severe covid- find ace highly express patient compare control individual finding suggest patient comorbiditie high chance develop severe covid- find gene raba important sars cov- infection lung correlation network analysis reveal potential regulator ace human lung include gene relate histone modification hat hdac kdmb fact epigenetic mark find ace locus compatible promote kdmb system biology approach offer possible explanation increase covid- severity patient certain comorbiditie
1061,objective coronavirus disease  covid- global pandemic involve  case worldwide culprit severe acute respiratory syndrome coronavirus- invade cell bind ace angiotensin convert enzyme majority patient mount appropriate antiviral response recover home progress respiratory distress require hospital admission supplemental oxygen severe case deterioration acute respiratory distress syndrome necessitate mechanical ventilation development severe thrombotic event cardiac injury dysfunction occur review highlight know date covid- cardiovascular risk focus putative role endothelium disease susceptibility pathogenesis approach result cytokine drive vascular leak lung alveolar endothelial interface facilitate acute lung injury setting viral infection give virus affect multiple organ include heart likely gain access systemic circulation infect pass respiratory epithelium endothelium viral dissemination cardiovascular complication covid- highly prevalent include acute cardiac injury myocarditis hypercoagulable state influence alter endothelial function notably disease course bad individual preexisting comorbiditie involve endothelial dysfunction link elevated ace expression diabetes mellitus hypertension cardiovascular disease conclusion rapidly emerge datum covid- result study severe acute respiratory syndrome coronavirus- provide insight endothelial dysfunction contribute pandemic paralyze globe turn inform design biomarker predictive disease course therapeutic target pathogenic endothelial response
1062,objective describe course time severe acute respiratory syndrome coronavirus  sars cov- infection french woman beginning pandemic mid april risk profile woman respiratory complication short term pregnancy outcome method collect case series pregnant woman covid- research network  french maternity unit march  april case sars cov- infection confirm positive result real time reverse transcriptase polymerase chain reaction test nasal sample and/or diagnose compute tomography chest scan include analyze primary outcome measure covid- require oxygen oxygen therapy noninvasive ventilation critical covid- require invasive mechanical ventilation extracorporeal membrane oxygenation ecmo demographic datum baseline comorbiditie pregnancy outcome collect result active case covid- increase exponentially march number fall april lockdown impose march shape curve active critical covid- mirror active case april  pregnant woman covid-  woman  ci require oxygen therapy   ci critical form covid- severity disease associate age old  year obesity preexisting diabetes previous preeclampsia gestational hypertension preeclampsia woman critical covid- die  ci woman give birth rate preterm birth woman non severe oxygen requiring critical covid-  week  week respectively neonate  ci .- critical group die prematurity conclusion covid- responsible significant rate severe acute potentially deadly respiratory distress syndrome vulnerable pregnant woman comorbiditie benefit particularly prevention measure lockdown
1063,epidemic cause sars coronavirus- sars cov- infection appear wuhan city december disease show clustering epidemic pattern family cluster onset main characteristic collect datum  case  cluster onset family cofs  case  solitary onset family sofs incidence  coronavirus disease covid- cofs significantly high sof study show patient exposure high risk factor respiratory droplet close contact advanced age comorbiditie likely develop covid- cofs addition advanced age elevate neutrophil lymphocyte ratio nlr risk factor death patient sars cov- infection cofs
1064,pandemic coronavirus disease covid- global threat public health functional impairment multiple organ report covid- include lung heart kidney liver brain vascular system patient metabolic associate precondition hypertension obesity diabetes susceptible experience severe symptom recent emerge evidence coagulation disorder covid- suggest vasculopathy appear independent risk factor promote disease severity mortality affected patient recently find decrease level low density lipoprotein cholesterol ldl c correlate disease severity covid- patient indicate pathological interaction dyslipidemia vasculopothy patient covid- clinical manifestation unintentionally underestimate physician scientific community metabolic associate morbidity generally accompany endothelial cell ec dysfunction pre existing condition ec vulnerable sars cov- attack mini review summarize metabolic vascular manifestation covid- emphasis association change ldl c level development severe symptom pathophysiologic mechanism underlie synergistic effect ldl c sars cov- ec injury vasculopathy
1065,covid- utilize ace pathway means infection early datum covid- suggest heterogeneity severity symptom transmission infection range symptom death source heterogeneity likely multifaceted genetic component demographic clinical comorbiditie associate severity infection suggest possible variant know influence renin angiotensin aldosterone raas system pathway particularly influence ace contribute heterogenous infection response ace ang(- product ace protective effect pulmonary cardiac system hypertension medication modulation alter ace ang(- particularly variant show influence raas system function clinically useful patient covid-
1066,introduction currently know contribute factor comprehensive method predict mortality risk intensive care unit icu admission patient novel coronavirus disease  covid objective aim study explore risk factor mortality icu admission patient covid compute tomography ct combine clinical laboratory datum patient method patient polymerase chain reaction confirm covid n university hospital tehran iran include patient undergo ct examination subsequently total ct score number involve lung lobe calculate compare collect laboratory clinical characteristic univariable multivariable proportional hazard analysis determine association ct laboratory clinical datum icu admission inhospital death result univariable analysis inhospital mortality high patient low oxygen saturation admission high ct score high number lung lobe involve diffuse parenchymal pattern multivariable analysis inhospital mortality high oxygen saturation admission high number lung lobe involve diffuse parenchymal pattern risk icu admission high patient comorbiditie hypertension ischemic heart disease arterial oxygen saturation pericardial effusion conclusion identify factor affect inhospital death icu admission covid- help clinician determine patient likely require icu admission inform strategic healthcare planning critical condition covid pandemic
1067,background information clinical characteristic mortality patient coronavirus disease  different age limited result old group patient dyspnea few patient fever muscle pain old patient underlying disease secondary infection myocardial injury renal dysfunction coagulation dysfunction immune dysfunction admission old patient receive immunoglobulin therapy mechanical ventilation proportion patient multiple organ injury critically ill patient death increase significantly age old group high cumulative death risk young group hypertension cerebrovascular disease comorbiditie acute cardiac injury shock complication independent predictor death conclusion symptom elderly patient atypical comorbiditie secondary infection organ injury immune dysfunction high risk critical illness old age important risk factor mortality method  patient diagnose coronavirus disease  january  february  enrol accord age patient divide group  /= year old clinical symptom laboratory result ct finding organ injury disease severity mortality analyze
1068,globally non steroidal anti inflammatory drug nsaids highly treat pain rise covid- pandemic safety nsaid use call question concern worthy review present compelling datum show nsaids worsen severity covid- symptom increase likelihood contract illness patient pain symptom potentially attribute covid- cough fever chill lethargy myalgias anosmia nsaids continue remain viable option provide analgesia patient need
1071,background morbidity mortality covid- cause novel coronavirus sars cov- accelerate worldwide novel clinical presentation covid- report range human cell tissue target sars cov- potential receptor associated regulating factor largely unknown aim study analyze expression known potential sars cov- receptor related molecule extensive collection primary human cell tissue healthy subject different age patient risk factor know comorbiditie covid- method perform rna sequencing explore available rna seq database study gene expression co expression ace cd bsg cd dpp direct indirect molecular partner primary human bronchial epithelial cell bronchial skin biopsy bronchoalveolar lavage fluid blood peripheral blood mononuclear cell pbmcs monocyte neutrophil dcs nk cell ilc ilc ilc cd(+ cd(+ t cell b cell plasmablast analyze material healthy child adult adult relation disease covid- risk factor status result ace tmprss coexpresse epithelial site lung skin cd bsg cyclophilin ppia andppib cd dpp relate molecule express epithelium immune cell observe distinct age relate expression profile gene pbmc t cell healthy child adult asthma copd hypertension smoking obesity male gender status generally lead high expression ace- cd relate gene bronchial biopsy bal blood additionally cd relate gene correlate positively age bmi interestingly observe high expression cd relate gene lesional skin patient atopic dermatitis conclusion datum suggest different receptor repertoire potentially involve sars cov- infection epithelial barrier immune cell alter expression receptor relate age gender obesity smoking disease status contribute covid- morbidity severity pattern
1072,objective lopinavir ritonavir modest antiviral activity severe acute respiratory syndrome coronavirus aim investigate viral kinetic factor associate viral clearance lopinavir ritonavir base combination treatment non severe patient patient method patient retrospectively enrol viral rna detect real time rt pcr assay sputum throat swab sample different time point pattern viral kinetic characterize factor associate rapid viral clearance define viral rna undetectable week analyze multivariate logistic regression analysis result patient achieve viral rna negativity discharge hospital furthermore   patient achieve rapid delay viral clearance respectively lymphocyte count rapid viral clearance patient x high compare delay viral clearance patient x p=. multivariate logistic analysis reveal high lymphocyte count /=.x l independent factor associate rapid viral clearance or=. ci=.- p=. conclusion viral shedding exhibit different pattern treatment immune insufficiency responsible delay viral clearance suggest immunomodulator consider promote viral clearance patient low lymphocyte count
1073,objective primary objective study assess safety single intravenous infusion mesenchymal stromal cells mscs patient acute respiratory distress syndrome ards covid- secondary objective determine effect msc important clinical outcome describe trial design realist covid  randomised placebo control triple blind trial participant study conduct intensive care units hospital united kingdom patient moderate severe ards define berlin definition receive invasive mechanical ventilation diagnosis covid- base clinical diagnosis pcr test eligible patient exclude following reason  hour onset ards age  attempt resuscitation order place treatment withdrawal imminent  hour prisoner decline consent non english speak patient adequately understand verbal write information interpreter available previously enrol realist trial intervention comparator intervention allogeneic donor cd enrich human umbilical cord derive mesenchymal stromal cell realist orbcel c supply sterile single use cryopreserved cell suspension fix dose  x cell ml volume dilute plasma lyte  total volume mls administration comparator placebo plasma lyte  solution infusion mls cellular product realist orbcel c develop patent orbsen therapeutics main outcome primary safety outcome incidence adverse event primary efficacy outcome oxygenation index oi day secondary outcome include oi day  respiratory compliance drive pressure pao fio ratio pf ratio day  sequential organ failure assessment sofa score day  extubation reintubation ventilation free day day duration mechanical ventilation length icu hospital stay -day mortality randomisation obtain informed consent patient randomise centralised automate telephone web base randomisation system chart centre healthcare randomised trials university aberdeen randomisation stratify recruitment centre vasopressor use patient allocate realist orbcel c placebo control ratio blinding masking investigator treat physician member site research team participant blind cell therapy facility clinical trial pharmacist unblinde facilitate intervention placebo preparation unblinded individual treatment information confidential infusion bag mask time preparation administer mask infusion set number randomised sample size sample size  patient  patient randomised intervention  control group possible recruitment continue  patient provide accurate definitive trial result total number patient recruit depend pandemic guide datum monitoring ethic committee dmec trial status realist phase  complete january  prior covid- pandemic open label dose escalation study realist orbcel c patient ards covid- pandemic emerge realist phase  plan commence investigator team decide repurpose phase  trial covid- specific trial decision discuss approve trial steering committee tsc dmec submission research ethics committee rec mhra amend protocol covid- specific patient population protocol amendment accept rec th march  mhra th march  respectively protocol change amendment include increase time onset ards   hour inclusion clinical outcome secondary outcome provision option telephone consent indicative sample size provision continue recruitment indicative sample size current protocol use version additional file urgent public health status award nihr  april  trial open recruitment recruit participant day time publication trial open recruitment  site uk belfast health social care trust king college london guys st thomas hospital london birmingham heartlands hospital queen elizabeth hospital birmingham  patient recruit site additional site plan open appropriate approval obtain estimate recruitment continue  month trial registration clinicaltrials.gov nct registered  feb eudract register  nov protocol protocol version attach additional file accessible trials website additional file interest expedite dissemination material familiar formatting eliminate letter serve summary key element protocol study protocol report accordance standard protocol items recommendation clinical interventional trials spirit guideline additional file
1074,objective estimate proportion total number general adult population high risk severe covid- brazil method include participant nationally representative household base health survey pns conduct brazil estimate proportion number adult  year risk severe covid- sex educational level race ethnicity state base presence follow risk factor age  year medical diagnosis cardiovascular disease diabetes hypertension chronic respiratory disease cancer stroke chronic kidney disease moderate severe asthma smoking status obesity results adult risk severe covid- brazil vary million million nationwide educate adult present high prevalence risk factor compare university graduate find difference sex race ethnicity sao paulo rio de janeiro minas gerais rio grande sul vulnerable state absolute relative term adult risk conclusion proportion total number adult risk severe covid- high brazil wide variation state adult subgroup finding consider design implement prevention measure brazil argue result support broad social isolation measure particularly testing capacity sars cov- limited
1075,coronavirus disease  covid- pandemic cause public health emergency worldwide risk severity mortality disease associate non communicable chronic disease diabetes mellitus accumulated evidence cause great concern country high prevalence morbidity brazil text show picture diabetes brazil follow epidemiological datum explanatory hypothesis association diabetes covid- emphasize burden morbidity middle income country aggravate pandemic scenario comprehension association biological plausibility help face pandemic future challenge
1076,sars cov- virus cause coronavirus disease covid- reach pandemic level result significant morbidity mortality affect inhabited continent large number patient require intensive care threaten overwhelm healthcare system globally likewise compelling need covid- disease severity test prioritize care resource patient elevated risk mortality integrate point care covid- severity score clinical decision support system present biomarker measurement c reactive protein crp n terminus pro b type natriuretic peptide nt probnp myoglobin myo d dimer procalcitonin pct creatine kinase myocardial band ck mb cardiac troponin ctni covid- severity score combine multiplex biomarker measurement risk factor statistical learning algorithm predict mortality covid- severity score train evaluate datum  hospitalize covid- patient wuhan china analysis find covid- severity scores significantly high group die versus group discharge median interquartile range score   respectively area curve ci analysis represent patient cardiac comorbiditie hypertension inclusion biomarker pathophysiologie implicate covid- e.g. d dimer thrombotic event crp infection inflammation pct bacterial co infection sepsis improve future prediction general population promising initial model pave way point care covid- severity score system impact patient care validation externally collect clinical datum clinical decision support tool covid- strong potential empower healthcare provider save life prioritize critical care patient high risk adverse outcome
1077,coronavirus disease  covid- result considerable morbidity mortality worldwide december order explore effect comorbid chronic disease clinical outcome covid- search conduct pubmed ovid medline embase cdc nih database april total  article include  covid- case select find diabetes present .% coronary artery disease cardiovascular disease cad cvd .% hypertension .% high chronic pulmonary disease specifically preexisting chronic condition strongly correlate disease severity odds ratio ci admit intensive care unit icu ci addition compare covid- patient preexist chronic disease covid- patient present diabetes hypertension cad cvd chronic pulmonary disease high risk develop severe disease ci ci ci ci respectively surprisingly find correlation chronic condition increase risk mortality ci take cardio metabolic disease diabetes hypertension cad cvd common chronic pulmonary disease covid- patient comorbid disease correlate increase disease severity active treatment increase risk mortality patient preexist chronic disease reduce
1078,background study aim investigate clinical characteristic laboratory index treatment regimen short term outcome severe critical coronavirus disease  covid- patient method consecutive severe critical covid- patient admit intensive care unit icu retrospectively multicenter study demographic feature medical history clinical symptom lung computerized tomography ct finding laboratory index admission collect post admission complication treatment regimen clinical outcome document result mean age year  male  female hypertension .% diabete common medical history fever .% dry cough .% common symptom blood routine index hepatic renal function index inflammation index commonly abnormal acute respiratory distress syndrome ards common post admission complication follow electrolyte disorder .% multiple organ dysfunction mods hypoproteinemia commonly antiviral drug lopinavir ritonavir tablet  .% patient die  .% patient heal discharge  .% patient remain hospital mean hospital stay death day mean hospital stay discharge patient day furthermore ards p mod p correlate increase mortality rate conclusion severe critical covid- present high mortality rate occurrence ards mod greatly increase mortality risk
1079,aim sars cov- virus bind angiotensin convert enzyme  ace receptor cell entry suggest angiotensin convert enzyme inhibitor acei angiotensin ii receptor blocker arb commonly patient hypertension diabetes raise tissue ace level increase risk severe covid- infection method result evaluate hypothesis consecutive cohort  acute inpatient covid- hospital multi ethnic catchment population london uk mean age   year male patient comorbidity overall  patient .% reach primary endpoint death transfer critical care unit organ support  day symptom onset total  patient .% take acei arb patient acei arb significantly old comorbiditie odd ratio primary endpoint patient acei arb adjustment age sex co morbidity confidence interval .- p conclusion evidence increase severity covid- hospitalise patient chronic treatment acei arb trend beneficial effect acei arb require evaluation large meta analysis randomised clinical trial
1080,objective clinical laboratory biomarker predict severity coronavirus disease  covid- essential pandemic situation resource allocation urgently prepare especially context respiratory support readiness lymphocyte count marker interest covid- publication conduct systematic review meta analysis order investigate association lymphocyte count admission severity covid- like analyze patient characteristic age comorbiditie affect relationship lymphocyte count covid- method comprehensive systematic literature search perform pubmed scopus europepmc proquest cochrane central databases google scholar research article adult patient diagnose covid- information lymphocyte count outcome interest include mortality acute respiratory distress syndrome ards intensive care unit icu care severe covid- include analysis inverse variance method obtain mean difference standard deviation maentel haenszel formula calculate dichotomous variable obtain odd ratio ors confidence interval random effect model meta analysis regardless heterogeneity restricted maximum likelihood random effect meta regression perform age gender cardiac comorbidity hypertension diabetes mellitus copd smoking result total  patient  study meta analysis show patient poor outcome low lymphocyte count mean difference mul p compare good outcome subgroup analysis show low lymphocyte count patient die mean difference mul p experience ards mean difference mul p receive icu care mean difference mul p severe covid- mean difference mul p lymphopenia associate severe covid- p meta regression show association lymphocyte count composite poor outcome affect age p conclusion meta analysis show lymphopenia admission associate poor outcome patient covid-
1081,study aim explore effect hypertension disease progression prognosis patient coronavirus disease  covid- total  patient diagnose covid- study comparison group patient hypertension hypertension demographic datum clinical manifestation laboratory indicator treatment method collect analyze total  patient include  patient hypertension  patient hypertension include analysis compare patient hypertension patient hypertension old likely diabete cerebrovascular disease likely transfer intensive care unit neutrophil count lactate dehydrogenase fibrinogen d dimer level hypertensive patient significantly high nonhypertensive patient p multivariate analysis adjust age sex fail hypertension independent risk factor covid- mortality severity covid- patient hypertension likely patient hypertension severe pneumonia excessive inflammatory reaction organ tissue damage deterioration disease patient hypertension give additional attention prevent worsen condition
1082,background covid- pandemic continue escalate urgent need stratify patient understand risk deterioration assist admission discharge decision help selection clinical study indicate risk therapy relate complication justify method observational cohort patient acutely admit london hospital covid- positive sars cov- swab result assess demographic detail clinical datum comorbiditie blood parameter chest radiograph severity score collect electronic health record endpoint assess critical care admission death risk score develop predict outcome finding analysis include patient old age male sex comorbiditie respiratory rate oxygenation radiographic severity high neutrophil high crp low albumin presentation predict critical care admission mortality non white ethnicity predict critical care admission death social deprivation predictive outcome risk score develop incorporate characteristic age male non white ethnicity oxygen saturation neutrophil count x()/l crp mg l albuminmicromol l diabetes mellitus hypertension chronic lung disease risk score  high correspond cumulative incidence critical care admission death ci versus ci score interpretation study identify predictor critical care admission death people admit hospital covid- predictor incorporate risk score inform clinical care stratify patient clinical trial
1083,objective investigate incidence clinical ultrasonographic biochemical finding relate pre eclampsia pe pregnancy covid- assess accuracy differentiate pe pe like feature associate covid- design prospective observational study setting tertiary referral hospital participant singleton pregnancy covid- week method consecutive pregnancy recruit classify group severe non severe covid- accord occurrence severe pneumonia uterine artery pulsatility index utapi angiogenic factor soluble fms like tyrosine kinase-/placental growth factor sflt-/plgf assess woman suspect pe main outcome measures incidence sign symptom relate pe hypertension proteinuria thrombocytopenia elevate liver enzyme abnormal utapi increase sflt-/plgf result thirty case classify non severe  severe covid- .% woman present sign symptom pe severe covid- case abnormal sflt-/plgf utapi demonstrate case case remain pregnant recovery severe pneumonia spontaneous resolution pe like syndrome conclusion pregnant woman severe covid- develop pe like syndrome distinguish actual pe sflt-/plgf ldh utapi assessment healthcare provider aware existence monitor pregnancy suspect pre eclampsia caution tweetable abstract study show pre eclampsia like syndrome present pregnancy severe covid-
1084,novel coronavirus severe acute respiratory syndrome coronavirus sars cov- cause coronavirus disease  covid- exhibit widespread community transmission world previous report evaluate risk illness civilian diagnose covid- similar report compile army active component ac population covid- reportable condition department defense  february morning  april total  case report disease reporting system internet army installation case total  .% identify army ac service member majority case require hospitalization n= .% common comorbiditie present nonhospitalize case include chronic illness .% neurologic disorder obesity overall  case require hospitalization hospitalize case history obesity .% neurologic disorder .% chronic illness .% hypertension comorbiditie present n= nonhospitalized case n= hospitalize case
1085,objective investigate meaningful subgroup share ct feature patient covid- pneumonia identify latent class analysis lca explore relationship lca derive subgroup clinical type method retrospective review include  patient confirmed covid- pneumonia february  march subgroup share ct feature identify lca univariate multivariate logistic regression model utilize analyze association clinical type lca derive subgroup result radiological subgroup identify lca  subject .% class   subject .% class ct finding class  small pulmonary infection volume peripheral distribution ggo maximum lesion range  cm small number lesion involvement lobe air bronchogram dilatation vessel hilar mediastinal lymph node enlargement pleural effusion ct finding class univariate analysis demonstrate old age therapy presence fever presence hypertension decrease lymphocyte count increase crp level significant parameter associate increase risk class multivariate analysis reveal patient clinically severe type disease .-fold risk class  patient clinically moderate type disease conclusion demographic clinical difference radiological subgroup base lca significantly different radiological subgroup significantly associate clinical moderate severe type key point radiological subgroup identify lca old age therapy presence fever presence hypertension decrease lymphocyte count increase crp level significant parameter increase risk class  define lca patient clinically severe type .-fold high risk class  define lca comparison patient show clinically moderate type disease
1088,limited datum exist date laboratory finding child covid- warrant conduction study pool currently available literature datum laboratory finding see child mild severe covid- follow extensive literature search identify  eligible study include total  pediatric case laboratory confirm covid- report datum  different biomarker perform meta analysis calculate pooled prevalence estimate ppe laboratory abnormality mild covid- datum limited child severe covid- allow pooling result present descriptively summary finding table datum inconsistent pattern change leukocyte index mild severe case covid- child specifically change leukocyte count observe mild pediatric case ppe increase decrease mild disease creatine kinase mb ck mb frequently elevate ppe severe disease c reactive protein crp procalcitonin pct lactate dehydrogenase ldh frequently elevate base datum obtain early covid- study leukocyte index child appear inconsistent differ report adult highlight specific leukocyte trend bring question utility reliability parameter monitor disease severity pediatric population instead suggest physician serially monitor crp pct ldh track course illness hospitalize child finally elevated ck mb mild pediatric covid- case indicative possible cardiac injury highlight importance monitor cardiac biomarker hospitalize patient need investigation marker cardiac troponin future study
1089,aim hypothesis coronavirus disease- covid- life threaten infection cause severe acute respiratory syndrome coronavirus- sars cov- virus diabetes rapidly emerge major comorbidity covid- severity phenotypic characteristic diabetes covid- patient unknown method conduct nationwide multicentre observational study people diabetes hospitalise covid-  french centre period march primary outcome combine tracheal intubation mechanical ventilation and/or death  day admission age- sex adjust multivariable logistic regression perform assess prognostic value clinical biological feature endpoint or report  sd increase standardisation result current analysis focus  participant .% man mean age year median bmi th th percentile kg m predominance type  diabetes microvascular macrovascular diabetic complication find .% .% case respectively primary outcome encounter ci participant die discharge day univariate analysis characteristic prior admission significantly associate primary outcome sex bmi previous treatment renin angiotensin aldosterone system raas blocker age type diabetes hbac diabetic complication glucose lower therapy multivariable analysis covariate prior admission bmi remained positively associate primary outcome admission dyspnoea lymphocyte count c reactive protein ast level independent predictor primary outcome finally age treat obstructive sleep apnoea microvascular macrovascular complication independently associate risk death day conclusion interpretation people diabetes hospitalise covid- bmi long term glucose control positively independently associate tracheal intubation and/or death  day trial registration clinicaltrials.gov nct
1090,background relative immunosuppression high prevalence comorbiditie patient eskd dialysis raise concern elevated risk severe coronavirus disease  covid- outcome covid- patient unclear method examine presentation outcome covid- patient eskd dialysis retrospectively collect clinical datum  patient dialysis hospitalize covid- wilcoxon rank sum fischer exact test compare patient die versus live result study  patient peritoneal dialysis  hemodialysis median age  year high prevalence hypertension diabetes patient die significantly old live median age  versus  year high median charlson comorbidity index versus common present symptom fever cough initial radiograph commonly show multifocal bilateral opacity end follow  patient die median  day hospitalization include patient require mechanical ventilation die advance directive intubation remain  patient discharge home median  day admission median initial white blood cell count significantly high patient die compare live versus c reactive protein versus  mg l conclusion association covid- high mortality patient eskd dialysis reinforce need appropriate infection control measure prevent covid- spread vulnerable population
1091,hypertension common comorbidity covid- patient association hypertension severity fatality covid- remain unclear present meta analysis relevant study report impact hypertension sars cov- infection identify search pubmed elsevier science direct web science wiley online library embase cnki  march result show  publication  covid- patient severe case include analysis disease severity severity rate covid- hypertensive patient high non hypertensive case .% vs .% pool ci pool or covid- severity hypertension vs. non hypertension ci ci age year  year patient respectively additionally study  death  covid- case include analysis disease fatality result show hypertensive patient carry nearly .-fold high risk die covid- ci pool or covid- fatality hypertension vs. non hypertension ci ci age year  year patient respectively considerable heterogeneity publication bias observe present analysis present result provide evidence hypertension significantly increase risk severity fatality sars cov- infection
1092,objective covid- varied clinical presentation elderly patient comorbiditie vulnerable severe disease study identify specific symptom comorbiditie predict severe covid- intensive care unit icu admission method literature search identify study index medline embase global health th march reviewer independently screen literature extract datum quality appraisal perform strobe criterion random effect meta analysis identify symptom comorbiditie associate severe covid- icu admission result seven study include  covid- patient include icu patient old year non icu year great proportion male dyspnoea symptom predictive severe disease por ci icu admission por ci copd strong predictive comorbidity severe disease por ci icu admission por ci follow cardiovascular disease hypertension conclusion dyspnoea symptom predictive severe covid- icu admission patient copd cardiovascular disease hypertension high risk severe illness icu admission
1093,objective outbreak highly contagious severe acute respiratory syndrome coronavirus  sars cov- sicken thousand people china purpose study explore early clinical characteristic covid- patient cardiovascular disease cvd method retrospective analysis patient covid- single centre patient undergo real time reverse transcription pcr sars cov- admission demographic clinical factor laboratory datum collect evaluate significant association result study include  patient covid- total  .% patient history cvd mortality patient cvd reach .% high overall population study .% patient cvd likely develop liver function abnormality elevated blood creatinine lactic dehydrogenase p symptom sputum production common patient cvd p=. lymphocyte haemoglobin albumin normal range pervasive cvd group p proportion critically ill patient cvd group .% significantly high non cvd group .% multivariable logistic regression analysis reveal cvd ci p=. associate critical covid- condition patient coronary heart disease likely reach recovery standard ci p=. conclusion consider high prevalence cvd thorough cvd assessment diagnosis early intervention recommend covid- patient cvd patient cvd vulnerable deterioration
1094,coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- spread rapid pace world health organization declare pandemic  march mycoplasma pneumoniae atypical bacterial pathogen commonly know cause respiratory illness human coinfection sars cov- mycoplasma pneumonia rarely report literature good knowledge present study   patient confirm covid- diagnose m. pneumoniae infection study describe clinical characteristic patient coinfection common symptom onset illness include fever patient .% patient cough shortness breath fatigue symptom myalgia .% gastrointestinal symptom alter mental status laboratory parameter include lymphopenia elevated erythrocyte sedimentation rate c reactive protein lactate dehydrogenase interleukin- serum ferritin d dimer patient chest x ray presentation show bilateral infiltrate patient describe electrocardiogram finding complication treatment hospitalization detail patient die hospital course
1096,novel small envelop rna virus typical characteristic family belong crown coronavirus appear december  wuhan china subdue world influence particular severity disease high mortality rate patient associate morbidity include hypertension obesity diabetes increase concern consequence pandemic review feature sars cov- address reason pose particular challenge diabetic patient highlight recent treatment strategy explore control pandemic emerge evidence demonstrate correct management diabetes patient infect sars cov- utmost importance viral disease progression importance blood glucose control address
1097,angiotensin convert enzyme  receptor ace express epithelial cell tissue include kidney identify interact human pathogenic coronaviruse include sars cov- diffuse alveolar damage acute respiratory failure main feature covid- infection recent study demonstrate kidney impairment hospitalize covid- patient common kidney involvement associate high risk hospital death interestingly study rat demonstrate high dietary sodium intake result regulation ace expression kidney tissue hypothesize low sodium status make kidney involvement course covid- infection likely upregulation membrane bind ace kidney propose sodium intake status monitor carefully severe covid- infection low sodium intake correct early course despite potential conflict common dietary recommendation restrict dietary sodium intake patient hypertension diabetes kidney disease
1098,background despite death rate covid- fatality rate severe critical case high accord world health organization screen severe critical case symptom occur effectively save medical resource method material study  case patient infect covid- shanghai march th retrospectively enrol divide training test dataset addition  clinical laboratory observation record collect clinical indicator associate severe critical symptom identify model severe critical symptom prediction develop result totally  clinical indicator significantly associate severe critical symptom identify clinical indicator mainly thyroxine immune relate cell product support vector machine svm optimize combination age gsh cd ratio total protein good performance discriminate mild severe critical case area receive operating curve auroc reach training testing dataset respectively cut value recall rate  training testing dataset separately cox multivariate regression survival analysis reveal model significantly discriminate severe critical case information select clinical indicator conclusion model robust effective predict severe critical covid case
1099,exposure agent act renin angiotensin system associate risk increase covid- infection  italian match case control study  nest hypertensive patient patient cardiovascular disease diabetes
1100,-year old male present cough fever myalgias  day vital include temperature degree c heart rate blood pressure mm hg respiration rate oxygen saturation room air past medical history hypertension community midst coronavirus disease  covid- pandemic patient hypoxic respond oxygen supplementation nasal cannula face mask chest x ray demonstrate multifocal infiltrate therapeutic agent currently available covid-
1101,background aim clinical evidence exist patient diabetes high risk coronavirus disease  covid- investigate physiological origin clinical observation link diabetes severity adverse outcome covid- method publication mining apply reveal common physiological context diabetes covid- investigate simultaneously overall acquire publication pubmed time span extract knowledge graph interconnect topic relate diabetes covid- result data mining reveal pathophysiological pathway link diabetes covid- pathway indicate high risk covid- dysregulation angiotensin convert enzyme important physiological link diabetes covid- liver dysfunction chronic systemic inflammation deep network analysis suggest clinical biomarker predict high risk hypertension elevate serum alanine aminotransferase high interleukin- low lymphocyte count conclusion reveal biomarker apply directly clinical practice newly infect patient medical history need check evidence long term chronic dysregulation biomarker particular patient diabetes prediabetic state deserve special attention
1102,study relationship clinical index severity coronavirus disease  covid- explore role predict severity covid- clinical datum  patient covid- admit hospital retrospectively analyze divide nonsevere group n severe group n accord condition clinical indicator compare different group difference sex age proportion patient combine heart disease leukocyte neutrophil lymphocyte ratio nlr neutrophil lymphocyte platelet d dimer c reactive protein crp procalcitonin lactate dehydrogenase albumin admission group statistically significant p multivariate logistic regression analysis show nlr crp independent risk factor severe covid- platelet independent protective factor severe covid- receiver operate characteristic roc curve analysis demonstrate area curve nlr platelet crp combination respectively nlr crp platelet effectively assess severity covid- nlr good predictor severe covid- combination clinical indicator predict severe covid-
1103,background current evidence suggest important role interleukin- il- pathway severe acute respiratory syndrome coronavirus  sars cov-)-relate cytokine release storm severely ill coronavirus disease  covid- patient inhibition il- pathway tocilizumab employ successfully patient data consistent case report series method perform systematic search pubmed embase medline nd april  th april  follow search term combination covid- coronavirus sars cov- covid anti interleukin- receptor antibody anti il- tocilizumab sarilumab siltuximab include study report individual patient datum extract analyze individual level datum baseline characteristic laboratory finding clinical outcome primary endpoint hospital mortality secondary endpoint include hospital complication recovery rate effect patient characteristic primary outcome change level inflammatory marker result record identify systematic search  study meet inclusion criterion single study currently review add observational study encompass  patient include present review male .% hypertension common comorbidity .% average hospital day primary endpoint occur  patient survive patient worsen disease recover common complication acute respiratory distress syndrome .% il- level significantly high initiation tocilizumab median interquartile range pg ml compare baseline pg ml p mean standard deviation level c reactive protein crp significantly decrease follow treatment mg l compare baseline mg l p baseline demographic significantly different survivor nonsurvivor fisher exact test conclusion covid- patient treat tocilizumab il- level significantly elevate supportive cytokine storm follow initiation tocilizumab elevation il- level crp level dramatically decrease suggest improvement hyperinflammatory state ongoing randomized control trial allow evaluation promise therapy importance recent datum indicate severe covid- cause cytokine release storm associate bad clinical outcome il- play important role suggestive anti il- result improvement hyperinflammatory state knowledge individual patient data systematic review perform summarize baseline characteristic clinical outcome covid- patient receive tocilizumab
1104,novel respiratory syndrome coronavirus- sars cov- cause cluster pneumonia case china end month lead pandemic spread country world
1105,background global coronavirus disease  pandemic highlight importance understand cardiovascular implication coronavirus infection severe disease cardiovascular co morbidity result cardiac manifestation myocardial injury arrhythmias heart failure design systematic review current knowledge effect coronavirus infection cardiovascular system human perform result summarize method database medline embase central scopus web science clinicaltrials.gov chinese knowledge resource integrated database chinese clinical trial registry search  march result total  study include involve severe acute respiratory syndrome middle east respiratory syndrome coronavirus disease  coronaviruse case report case series cohort study poor fair quality post mortem examination subject die infection half virus identify heart tissue severe acute respiratory syndrome middle east respiratory syndrome coronavirus disease cardiac manifestation report include tachycardia bradycardia arrhythmia myocardial injury secondary systemic infection treatment cardiac injury arrhythmia prevalent coronavirus disease elevated cardiac marker associate intensive care unit admission death severe acute respiratory syndrome middle east respiratory syndrome coronavirus disease comorbiditie hypertension diabetes mellitus heart disease associate intensive care unit admission mechanical ventilation mortality case misdiagnosis overlap presentation cardiovascular disease coronavirus infection lead hospital spread delay management life threaten condition conclusion review highlight way coronaviruse affect cardiovascular function interact pre existing cardiovascular disease
1106,effect angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb risk covid- infection disease progression investigate relationship acei arb use covid- infection systematically identify relevant study meet predetermined inclusion criterion unrestricted search pubmed embase cochrane library database conduct search strategy include clinical date publish article involve covid- case include estimate overall risk random effect model adopt result show acei arb exposure associate high risk covid- infection  ci p covid- infection acei arb exposure associate high risk have severe infection  ci p mortality  ci p acei arb exposure associate low risk mortality compare non acei arb antihypertensive drug  ci p conclusion current evidence confirm concern acei arb exposure harmful patientswith covid- infection study support current guideline discourage discontinuation aceis arb covid- patient setting covid- pandemic
1107,background december coronavirus disease  covid- emerge wuhan spread globe objective study build validate practical nomogram estimate risk severe covid- method cohort  patient laboratory confirm covid- develop prediction model datum collect  location sichuan province january  february primary outcome development severe covid- hospitalization absolute shrinkage selection operator lasso regression model reduce datum size select relevant feature multivariable logistic regression analysis apply build prediction model incorporate select feature performance nomogram c index calibration discrimination clinical usefulness assess internal validation assess bootstrappe result median age cohort  year severe patient old mild patient median  year fever cough dyspnea common severe patient individualized prediction nomogram include seven predictor body temperature admission cough dyspnea hypertension cardiovascular disease chronic liver disease chronic kidney disease model good discrimination area curve c index confidence interval good calibration high c index value reach interval validation decision curve analysis show prediction nomogram clinically useful conclusion establish early warning model incorporate clinical characteristic quickly obtain admission model help predict severe covid- identify patient risk develop severe disease
1110,coronavirus disease  covid- risk severe acute respiratory syndrome coronavirus  sars cov- pose particular risk people live preexisting condition impair immune response amplify pro inflammatory response low grade chronic systemic inflammation common people obesity associate development atherosclerosis type  diabetes hypertension know comorbiditie adversely affect outcome patient covid- risk stratification base edmonton obesity staging system eoss classify obesity base presence medical mental and/or functional complication body mass index bmi show well predictor cause mortality eoss stage well describe risk hyperinflammation patient covid- infection analyze group metabolic ill patient obesity eoss  find increase interleukin- linear regression analysis show positive correlation c reactive protein crp p waist hip ratio whr p physician aware finding patient covid- infection early identification possible hyperinflammation fundamental guide decision making hospitalization early respiratory support therapy immunosuppression improve mortality
1111,objective patient obesity increase risk exacerbation viral respiratory infection association obesity severity coronavirus disease  covid- unclear examine association datum referral hospital shenzhen china research design method total  consecutively hospitalize patient covid- admit  january   february  follow  march  people hospital shenzhen include underweight define bmi /= kg m result  patient .% normal weight .% underweight .% overweight .% obese admission obese patient tend symptom cough p fever p compare patient obese compare normal weight patient overweight .-fold odd develop severe covid- odd ratio ci p obese .-fold odd develop severe disease ci p adjust age sex epidemiological characteristic day disease onset hospitalization presence hypertension diabetes cardiovascular disease chronic obstructive pulmonary disease liver disease cancer drug treatment additionally similar adjustment man obese versus normal weight increase odd develop severe covid- ci p conclusion study obese patient increase odd progress severe covid- severe acute respiratory syndrome coronavirus  continue spread worldwide clinician pay close attention obese patient carefully manage prompt aggressive treatment
1112,"objective investigate association hypertension outcome patient coronavirus disease  covid- pneumonia method perform systematic literature search database study assess hypertension outcome covid- composite poor outcome comprise mortality severe covid- acute respiratory distress syndrome ards need intensive care unit icu care disease progression outcome interest result total  patient pool  study hypertension associate increase composite poor outcome risk ratio rr confidence interval ci p sub group include mortality rr p severe covid- rr p ards rr p i(),% p icu care rr p p disease progression rr p p meta regression analysis show gender p covariate affect association association strong study percentage male compare rr v. rr conclusion hypertension associate increase composite poor outcome include mortality severe covid- ards need icu care disease progression patient covid-"
1113,limited datum available clinical presentation outcome coronavirus disease covid- patient united states hospitalize normal caseload nonsurge condition retrospectively study  consecutive adult patient hospitalize covid-  hospital san francisco bay area california usa march -april death rate hospitalize covid- patient .% median length hospitalization day  total intensive care unit patient  .% die median length intensive care unit stay  day  patient  .% underlying cardiovascular disease  .% underlying pulmonary disease study death rate low report region united states experience high volume covid- patient
1114,investigate clinical course individual  novel coronavirus disease covid- transfer diamond princess cruise ship  local hospital condition clinical course patient pneumonia compare patient pneumonia  patient median age  year analyze major symptom fever .% cough .% general fatigue patient .% pneumonia high body temperature heart rate respiratory rate high lactate dehydrogenase ldh aspartate aminotransferase ast c reactive protein crp level low serum albumin level lymphocyte count associate presence pneumonia ground glass opacity find .% patient pneumonia patient administer neuraminidase inhibitor lopinavir ritonavir .% ciclesonide inhalation mechanical ventilation veno venous extracorporeal membrane oxygenation perform   patient respectively patient die median duration intubation  day patient covid- transfer local hospital outbreak severe condition need close monitoring severity covid- depend presence pneumonia high serum ldh ast crp level low serum albumin level lymphocyte count find predictor pneumonia challenge local hospital admit treat patient outbreak covid- assessment severity crucial manage large number patient
1116,background severe acute respiratory syndrome coronavirus  sars cov- associated coronavirus disease covid- spread china previous study predominantly focus place origin wuhan cause estimation disease severity selection bias analyze  confirm case zhejiang province determine epidemiological clinical virological characteristic covid- method epidemiological demographic clinical laboratory management datum qrt pcr confirm covid- patient january january collect follow multivariate logistic regression analysis independent predictor severe critical type covid- bioinformatic analysis feature sars cov- zhejiang province result  covid- patient median age  year hypertension diabetes chronic liver disease common comorbiditie history exposure epidemic area present  .%  .% patient cluster  family severe critical type covid- develop  patient fever cough common symptom diarrhea vomiting report  patient multivariate analysis reveal risk factor severe critical covid- glucocorticoids antibiotic administer  .% patient respectively bioinformatic show single amino acid mutation amino acid position loss sars cov- zhejiang province similarity human virus conclusion sars cov- show virological mutation human transmission zhejiang province indicate considerable epidemiological clinical change caution glucocorticoid antibiotic use advisable
1117,background coronavirus disease  covid- cause novel coronavirus designate sars cov- pandemic worldwide base current report hypertension associate increase risk sever condition hospitalize covid- patient angiotensin convert enzyme  ace recently identify functional receptor sars cov- previous experimental datum reveal ace level increase follow treatment ace inhibitor aceis angiotensin receptor blocker arb currently doctor concern commonly renin angiotensin system ras blocker aceis arb increase severity covid- method extract datum  hospitalize hypertension patient laboratory confirm covid- renmin hospital wuhan university feb  mar patient group ras blocker group group n= non ras blocker group group b accord basic blood pressure medication patient continue use pre admission antihypertensive drug clinical severity symptom laboratory chest ct finding etc clinical course short time outcome analyze hospital admission result seventeen .% group group b participant male p=. average age year p=. respectively blood pressure group effective control significant difference clinical severity clinical course hospital mortality group group b. serum cardiac troponin ctni p=. n terminal nt)-pro hormone bnp nt probnp p=. show significant low level group group b. patient ml elevate nt probnp level statistical significance group patient  year  year ctni nt probnp level show difference group conclusion observe obvious difference clinical characteristic ras blocker non ras blocker group datum suggest aceis arb effect increase clinical severe condition covid-
1118,coronavirus disease  covid- pandemic cause novel betacoronavirus severe acute respiratory syndrome coronavirus  sars cov- similar sars cov middle east respiratory syndrome mers cov cause acute respiratory distress syndrome case fatality covid- disease severity bad old obese patient comorbiditie diabetes hypertension cardiovascular disease chronic lung disease cell binding entry betacoronaviruse surface spike glycoprotein sars cov bind metalloprotease angiotensin convert enzyme  ace mers cov utilize dipeptidyl peptidase  dpp recent modeling structure sars cov- spike glycoprotein predict interact human dpp addition ace dpp ubiquitous membrane bind aminopeptidase circulate plasma multifunctional role nutrition metabolism immune endocrine system dpp activity differentially regulate glucose homeostasis inflammation enzymatic activity nonenzymatic immunomodulatory effect importance dpp medical community highlight approval dpp inhibitor gliptin treatment type  diabetes mellitus review discuss dysregulation dpp covid- comorbid condition dpp activity high old individual increase plasma dpp predictor onset metabolic syndrome dpp upregulation determinant covid- disease severity create interest use gliptin management covid- knowledge chemistry biology dpp utilize develop novel therapy block viral entry betacoronaviruse potentially include sars cov-
1119,aim investigate characteristic clinical significance myocardial injury patient severe coronavirus disease  covid- method result enrol  eligible hospitalize patient severe covid-  january  february median age  year clinical laboratory treatment datum collect compare patient die survivor risk factor death myocardial injury analyse multivariable regression model total  patient .% die myocardial injury .% vs. .% p survivor area receiver operate characteristic curve initial cardiac troponin ctni predict hospital mortality confidence interval ci .- sensitivity specificity p single cut point high level ctni predict risk hospital death hazard ratio hr ci p ci p respectively multivariable logistic regression senior age comorbiditie e.g. hypertension coronary heart disease chronic renal failure chronic obstructive pulmonary disease high level c reactive protein predictor myocardial injury conclusion risk hospital death patient severe covid- predict marker myocardial injury significantly associate senior age inflammatory response cardiovascular comorbiditie
1120,coronavirus disease  covid infectious disease cause novel strain coronavirus severe acute respiratory syndrome coronavirus  sarscov appear china december  spread globally evolve currently observe pandemic laboratory diagnosis sarscov infection currently base realtime reverse transcriptase polymerase chain reaction rtpcr testing imaging replace genetic testing patient suspect covid predominant respiratory manifestation covid particularly severe case chest imaging compute tomography ct play major role detect viral lung infection evaluate nature extent pulmonary lesion monitor disease activity role chest ct diagnostic tool increase laboratory testing capacity rtpcr prove inaccurate insufficient major outbreak disease setting rapid presumptive diagnosis covid potentially offer ct advantage addition obvious benefit delineate nature extent pulmonary lesion present paper diagnostic role chest ct patient covid
1123,recent outbreak covid- rapidly spread global scale date specific vaccine causative virus sars cov- effective medicine treat covid- raise concern respect effect risk factor clinical course pathophysiological parameter disease severity outcome patient covid- extract analyze available publish clinical datum identify major clinical characteristic associate increase disease severity mortality patient covid- specifically preexisting chronic condition hypertension cardiovascular disease chronic kidney disease diabete strongly associate increase risk develop severe covid- surprisingly find correlation chronic liver disease increase disease severity addition find acute cardiac injury acute kidney injury highly correlate increase risk covid related mortality give high risk comorbidity high mortality rate associate tissue damage organ function monitor closely patient diagnose covid- approach include establish new guideline manage high risk patient additional clinical datum need order determine supportive therapy help mitigate development severe potentially fatal complication study need identify pathophysiology mechanism underlie novel coronavirus associate infectious disease take finding provide new insight clinical strategy improve management outcome patient covid-
1124,objective identify marker associate hospital death patient coronavirus disease  covid-)-associated pneumonia patient method retrospective cohort study conduct  patient moderate critical covid associated pneumonia require oxygen supplementation admit hospital january february follow march union hospital wuhan china oxygen saturation spo measure test predictor hospital mortality survival analysis result  patient covid associated pneumonia  .% man median age  year patient spo value old likely man hypertension present dyspnea spo value great overall  patient .% die hospitalization median follow high spo level oxygen supplementation associate reduce mortality independently age sex hazard ratio -u spo ci p spo cutoff value .% yield sensitivity specificity prediction survival dyspnea independently associate death multivariable analysis hazard ratio ci p=. conclusion cohort patient covid- hypoxemia independently associate hospital mortality result help guide clinical management patient severe covid- particularly setting require strategic allocation limited critical care resource trial registration chictr.org.cn identifier chictr
1125,multiplication covid- severe acute respiratory syndrome case sars cov concern angiotensin convert enzyme  ace inhibitor acei angiotensin ii type  receptor blocker arb emerge ace angiotensin convert enzyme enzyme receptor allow sars cov entry cell fear pre existing treatment acei arb increase risk develop severe fatal severe acute respiratory syndrome case covid- infection present article discuss concern ace membrane bind enzyme carboxypeptidase contribute inactivation angiotensin ii physiologically counter angiotensin ii effect acei inhibit ace arb show regulate ace tissue expression experimental animal evidence consistent human study date evidence acei arb administration facilitate sars cov cell entry increase ace tissue expression animal human study finally study support hypothesis elevated ace membrane expression tissue activity administration arb and/or infusion soluble ace confer protective property inflammatory tissue damage covid- infection summary base currently available evidence advocate medical society acei arb discontinue concern covid- infection hemodynamic situation precarious case case adjustment require
1126,retrospective study aim analysis clinical characteristic outcome cancer patient novel coronavirus disease- covid- medical record laboratory result radiologic finding  cancer patient covid- collect clinical characteristic outcome summarize total  cancer patient covid- include median age  cancer patient covid-  year thirty .% patient mild  .% severe critical lung cancer frequent cancer type .% common symptom follow fever dry cough .% chest distress fatigue  .% patient comorbiditie common symptom hypertension .% .% patient develop pneumonia admission lymphocyte x decrease mild severe critical patient median level d dimer c reactive protein procalcitonin lactate dehydrogenase mg l mg l ng ml  u l respectively increase significantly severe critical patient compare mild patient interleukin- pg ml increase mild severe critical patient significant difference complication observe  patient liver injury .% acute respiratory distress syndrome .% sepsis .% myocardial injury .% renal insufficiency .% multiple organ dysfunction syndrome .% .% patient cancer die infection rate severe acute respiratory syndrome coronavirus  patient cancer high general population cancer patient covid- show deteriorate condition poor outcome
1127,clinical laboratory datum patient coronavirus disease  covid- beijing china remain extremely limited study summarize clinical characteristic patient covid- designate hospital beijing total  patient laboratory confirm sars cov- infection beijing  hospital enrol study demographic datum symptom comorbiditie laboratory value treatment clinical outcome collect retrospectively analyze total  .% patient severe symptom mean age year interquartile range iqr .- median incubation period day iqr total  .% patient exposure history wuhan  week  .% patient associate familial cluster eighteen .% patient underlying comorbiditie include hypertension common symptom illness fever  .% patient abnormal finding chest compute tomography laboratory finding show neutrophil count percentage lymphocyte percentage eosinophil eosinophil count erythrocyte sedimentation rate albumin serum ferritin potential risk factor patient poor prognosis total  patient .% hospitalize  .% patient discharge compare patient wuhan china symptom patient beijing relatively mild old age comorbiditie abnormal prominent laboratory marker associate severe condition basis antiviral drug observe antibiotic treatment appropriate dosage corticosteroid gamma globulin therapy significantly improve patient outcome early identification timely medical treatment important reduce severity patient covid-
1129,impact dietary pattern commensal microbiome susceptibility severity infection severe acute respiratory syndrome coronavirus  sars cov- virus largely ignore date perspective present rationale urgent need investigate possible impact therapeutic option covid- base dietary microbiome modification mitigate role nanotechnology relation impact sars cov- virus highlight
1130,recognition december covid- rapidly spread globally cause pandemic pre exist comorbiditie hypertension diabetes cardiovascular disease associate great severity high fatality rate covid- furthermore covid- contribute cardiovascular complication include acute myocardial injury result acute coronary syndrome myocarditis stress cardiomyopathy arrhythmias cardiogenic shock cardiac arrest cardiovascular interaction covid- similarity severe acute respiratory syndrome middle east respiratory syndrome influenza specific cardiovascular consideration necessary supportive treatment anticoagulation continue use renin angiotensin aldosterone system inhibitor arrhythmia monitoring immunosuppression modulation mechanical circulatory support
1132,rapid spread novel coronavirus severe acute respiratory syndrome coronavirus  sars cov- lead ongoing pandemic coronavirus disease  covid- recently angiotensin convert enzyme  ace show functional receptor sars cov- enter host target cell give angiotensin receptor blocker arb ace inhibitor acei upregulated ace expression animal study concern arise arb aceis increase morbidity mortality covid- hand animal datum suggest potential protective effect arb covid- pneumonia arb prevent aggravation acute lung injury mouse infect sars cov closely relate sars cov- importantly clinical experimental evidence support arb acei augment susceptibility sars cov- aggravate severity outcome covid- present datum available recommend arb acei medication continue treatment patient cardiovascular disease hypertension especially high risk accord guideline direct medical therapy base currently available evidence
1133,objective analyze clinical course outcome covid- case influence factor guangdong province provide basis formulation adjustment medical care epidemic control strategy covid- method collect demographic datum medical history clinical course outcome  covid- patient report guangdong  march  epidemiological investigation process tracking disease severity clinical course characteristic patient influence factor severe illness analyze study result  case covid- case guangdong  .%  .% mild ordinary case  .% severe case  .% critical case  .% fatal median duration illness  day p p  day median length hospitalization  day p p day severe case median time show severe manifestation th day onset p p th th day median time severe manifestation last  day p p  day  discharge fetal case mild case develop ordinary case severe case respectively admission ordinary case develop severe case critical case respectively admission severe case .% develop critical case influence factor severe illness worse include male ahr=. ci old age ahr=. ci seek medical care day onset ahr=. ci pre existing diabetes ahr=. ci hypertension ahr=. ci conclusion course illness length hospitalization covid- case generally long associate severity disease clinical outcome severe case mainly occur population high risk epidemic period classified management covid- case promote accord need control prevention isolation treatment purpose rational allocation medical resource
1134,angiotensin convert enzyme- ace receptor mediate entry cell strain coronavirus sars cov nl sars cov- ace receptor ubiquitous widely express heart vessel gut lung particularly type  pneumocyte macrophage kidney testis brain ace bind cell membrane scarcely present circulation soluble form important salutary function membrane bind soluble ace degradation angiotensin ii angiotensin- consequently ace receptor limit detrimental effect result binding angiotensin ii receptor include vasoconstriction enhance inflammation thrombosis increase generation angiotensin- trigger counter regulatory protective effect bind g protein couple mas receptor unfortunately entry sars cov cell membrane fusion markedly regulate ace receptor loss catalytic effect receptor external site membrane increased pulmonary inflammation coagulation report unwanted effect enhanced unopposed angiotensin ii effect ace-->angiotensin ii-->at receptor axis clinical report patient infect sars cov- feature associate infection severity disease i.e. old age hypertension diabetes cardiovascular disease share variable degree ace deficiency suggest ace regulation induce viral invasion especially detrimental people baseline ace deficiency associate condition additional ace deficiency viral invasion amplify dysregulation adverse ace-->angiotensin ii-->at receptor axis protective ace-->angiotensin--->mas receptor axis lung dysregulation favor progression inflammatory thrombotic process trigger local angiotensin ii hyperactivity unopposed angiotensin- setting recombinant ace angiotensin- angiotensin ii type  receptor blocker promise therapeutic approach patient sars cov- infection
1135,prevalence hypertension high patient affect coronavirus disease  covid- appear relate increase risk mortality show epidemiological study angiotensin convert enzyme ace system uniformly express human race current difference explain geographical discrepancy infection world furthermore animal study show ace receptor potential pathway host infection severe acute respiratory syndrome coronavirus  sars cov- causative agent covid- third hypertensive patient ace inhibitor angiotensin receptor blocker concern raise detrimental role current antihypertensive drug covid- report summarize recent evidence administration ace blockade covid- era
1136,background epidemic coronavirus disease  covid- begin december  trigger public health emergency international concern pheic aim find risk factor progression covid- help reduce risk critical illness death clinical help method datum covid- patient march  retrieve database statistically analyze risk factor critical mortal non critical covid- patient meta analysis result thirteen study include meta analysis include total number  patient sars cov- infection male old smoking risk factor disease progression patient covid- male or=. ci p  u l creatinine(cr /= mol l hypersensitive cardiac troponin i(hs ctni pg ml procalcitonin(pct ml lactatede hydrogenase(ldh u l d dimer l predict deterioration disease white blood cells(wbc u l or=. ci p /= mumol l or=. ci p=. hs ctni  pg ml or=. ci p  ng ml or=. ci p  u l or=. ci p  l or=. ci p wbc x()/l or=. ci p conclusion male age smoking patient face great risk develop critical mortal condition comorbiditie hypertension diabetes cardiovascular disease respiratory disease greatly affect prognosis covid- clinical manifestation fever shortness breath dyspnea laboratory examination wbc ast cr pct ldh hs ctni d dimer imply progression covid-
1137,background aim diabetes mellitus dm chronic condition devastating multi systemic complication associate severe form coronavirus disease  covid- conduct systematic review meta analysis order investigate association dm poor outcome patient covid- pneumonia method systematic literature search perform electronic database subject assess dm outcome covid- pneumonia outcome interest composite poor outcome include mortality severe covid- acute respiratory distress syndrome ards need intensive care unit icu care disease progression result total  patient  study meta analysis show dm associate composite poor outcome rr p /= year old rr compare rr compare rr subgroup analysis median age year old prevalence hypertension show strong association rr conclusion dm associate mortality severe covid- ards disease progression patient covid-
1138,objective explore clinical value immune inflammatory marker assess severity coronavirus disease  covid- method  consecutive hospitalize patient confirmed covid- enrol study classify non severe severe group demographic symptom underlie disease laboratory datum collect assess predictive value result  covid- patient  case .% classify severe group high level interleukin- il- c reaction protein crp hypertension independent risk factor severity covid- risk model base il- crp hypertension high area receiver operator characteristic curve auroc additionally baseline il- positively correlate immune inflammatory parameter dynamic change il- severe case parallel amelioration disease conclusion study show high level il- crp hypertension independent risk factor assess severity covid- risk model establish il- crp hypertension high predictability study il- play pivotal role severity covid- potential value monitor process severe case
1139,purpose ongoing pandemic covid- start hubei china result massive strain healthcare infrastructure lombardy italy management patient evolve material method single center observational cohort study critically ill patient infect covid- bedside clinician abstract daily patient datum history treatment short term course describe management propose severity scale treatment hospital result  patient enrol incomplete information  study patient male median age overweight obese hypertensive take ace inhibitor noninvasive ventilation perform patient icu stay provider infection patient receive antibiotic pneumonia patient receive lopinivir ritonavir hydroxychloroquine tocilizumab accord treatment algorithm  patient survive icu course transfer floor die icu conclusion icu patient covid- frequently hypertension manage noninvasive ventilation despite risk aerosolization use severity scale augment clinician management
1140,introduction coronavirus disease  covid cause severe acute respiratory syndrome coronavirus  sarscov infection spread worldwide objective aim study identify clinical characteristic risk factor associate severe incidence sars cov infection patient method adult patient median iqr age  year consecutively admit dabieshan medical center january  february  collect patient diagnose covid accord world health organization interim guidance include retrospective cohort study result total  patient covid retrospectively analyze twentyfive patient .% develop severe disease  patient die advanced age comorbiditie commonly hypertension high blood leukocyte count neutrophil count high creactive protein level ddimer level acute physiology chronic health evaluation ii apache ii score sequential organ failure assessment sofa score associate great risk covid low lymphocyte count albumin level multivariable regress ion show increase odd severe covid associate high sofa score odd ratio ci p lymphocyte count x ci p admission high sofa score ci p admission identify risk factor inhospital death conclusion lymphocytopenia high sofa score admission help clinician identify patient high risk develop severe covid related study need future
1141,covid- pandemic significant global event history infectious disease sars cov- appear originate bat easily transmissible human primarily droplet direct contact clinical feature covid- include high fever cough fatigue progress ards respiratory failure occur rapidly primary laboratory finding include lymphopenia eosinopenia elevated d dimer procalcitonin crp level correlate disease severity imaging finding include ground glass opacity patchy consolidation ct scan mortality high patient hypertension cardiac disease diabetes mellitus cancer copd elderly patient susceptible severe disease death child low rate infection low mortality diagnostic criterion identification person investigation evolve datum emerge approach diagnosis variable region region country country different hospital city importance clinical pathway implement effective relevant diagnostic strategy critical importance establish control virus responsible death day
1143,importance datum lack patient hypertension take angiotensin convert enzyme inhibitor aceis angiotensin receptor blocker arb increase severity risk mortality hospitalization coronavirus disease  covid- objective investigate association aceis arb severity illness mortality patient hypertension hospitalize covid- infection design setting participant retrospective single center case series  hospitalize patient covid- infection central hospital wuhan china january  march main outcomes measures covid- confirm real time reverse transcription polymerase chain reaction epidemiologic clinical radiologic laboratory drug therapy datum analyze patient percentage patient hypertension take acei arb compare severe vs nonsevere illness survivor vs nonsurvivor result  patient covid- median age year interquartile range year  .% man overall hospital mortality  patient hypertension .% total group median age year interquartile range year  .% man  .% take acei arb hospital mortality patient hypertension percentage patient hypertension take acei arb differ severe nonsevere infection .% vs .% p differ nonsurvivor survivor .% vs .% p similar finding observe datum analyze patient take acei take arb conclusion relevance study provide clinical datum association aceis arb outcome patient hypertension hospitalize covid- infection suggest aceis arb associate severity mortality covid- patient datum support current guideline societal recommendation treat hypertension covid- pandemic
1144,estimate .% adult increase risk complication coronavirus disease cardiovascular disease diabetes respiratory disease hypertension cancer rate increase age .% person year age .% person year age vary state race ethnicity health insurance status employment
1145,severe acute respiratory syndrome coronavirus  sars cov- infection cause acute respiratory distress syndrome hypercoagulability hypertension multiorgan dysfunction effective antiviral safe clinical profile urgently need improve overall prognosis analysis randomly collect cohort  patient covid- find hypercoagulability indicate elevated concentration d dimer associate disease severity virtual screening u.s. fda approve drug library identify anticoagulation agent dipyridamole dip silico suppress sars cov- replication vitro proof concept trial involve  patient covid- dip supplementation associate significantly decrease concentration d dimer p increase lymphocyte platelet recovery circulation markedly improve clinical outcome comparison control patient particular  dip treat severely ill patient show remarkable improvement  patient .% achieve clinical cure discharge hospital remain  patient .% clinical remission
1146,background report wuhan china december outbreak novel coronavirus know covid- spread globally case study characteristic outcome patient covid- publish recently conduct meta analysis evaluate risk factor covid- method medline sinomed embase cochrane library search clinical epidemiological study confirm case covid- result incidence fever cough fatigue dyspnea symptom ci ci ci ci prevalence diabetes ci hypertension ci cardiovascular disease ci malignancy ci complication include ards risk range pooled estimate ards risk aci ci aki ci shock ci risk severity mortality range .% pool estimate respectively percentage critical case diabetes hypertension ci ci respectively conclusion fever common symptom patient covid- prevalent comorbiditie hypertension diabete associate severity covid- ards aci main obstacle patient treatment recovery case severe rate mortality low sars mers
1147,introduction beginning covid- pandemic know severe course disease occur elderly rare child young adult comorbiditie particular diabete hypertension clearly associate age obesity smoke strongly associate need intensive treatment dismal outcome weak immunity elderly propose possible explanation uneven age distribution concern child treat cancer allso risk unfavourable course infection line anecdotal information wuhan china mention severe course covid- child treat leukaemia aim method flash survey covid- incidence severity child anticancer treatment respondent ask email fill short web base survey result receive report  country approximately patient risk follow time survey  child test positive covid- case asymptomatic mild disease diagnose covid- discuss preventive measure place take treatment option immunocompromised child covid- conclusion child receive anticancer chemotherapy mild asymptomatic course covid- underestimate risk develop severe course covid- observe intensity preventive measure cause delay obstruction oncological treatment
1148,background evidence covid- cardiac injury inconsistent objective aim summarize available datum severity difference acute cardiac injury acute cardiac injury mortality covid- outbreak method perform systematic literature search pubmed embase pre print december  march identify observational study report cardiac specific biomarker troponin creatine kinase mb fraction myoglobin nt probnp covid- infection extract datum patient demographic infection severity comorbidity history biomarker covid- infection possible datum pool meta analysis standard smd weighted wmd mean difference correspond confidence interval ci result include  confirm covid- infect patient  study severe covid- infection associate high mean troponin smd ci p similar trend creatine kinase mb myoglobin nt probnp acute cardiac injury frequent severe compare mild disease risk ratio p meta regression suggest cardiac injury biomarker difference severity relate history hypertension p covid relate cardiac injury associate high mortality summary risk ratio p hstni nt probnp level increase course hospitalization non survivor conclusion severity covid- associate acute cardiac injury acute cardiac injury associate death cardiac injury biomarker mainly increase non survivor highlight need effectively monitor heart health prevent myocarditis patient infect covid-
1149,significant aspect covid- pandemic remain obscure angiotensin convert enzyme  ace component renin angiotensin system expression dominate lung alveolar epithelial cell human cell receptor sars cov- causative agent covid- strongly encourage concept thorough consideration receptor ligand interaction keep heart scientific debate infection idea renin angiotensin system evaluate hypothesize factor relate ethnicity environment behavior associated illness medication involve complex system probably responsible situation regard anomalous epidemiological clinical point view take factor explain aspect current outbreak decide use analogy play speculate possible impact tragedy air pollution interference nitrogen dioxide ace expression dual role nicotine hypothetical involvement ace polymorphism relationship ethnic factor susceptibility cardiovascular disease intriguing impact severity infection hypertension related medication act renin angiotensin system finally possible helpful role chloroquine thank capacity modify ace affinity viral spike protein alter glycosylation hypothesis paper urgent development research program aim question putative protagonist tragedy real life actor covid-
1150,coronavirus disease  covid- currently pandemic mortality rate general population mortality rate significantly high elderly patient especially hospitalize comorbiditie hypertension diabetes coronary artery disease viral disease atypical presentation immunosuppressed patient course disease transplant patient population unknown management patient covid- area interest unique approach warrant report clinical feature treatment approach kidney transplant patient diagnosis covid- believe screen protocol sars cov- evaluate patient solid organ transplant
1151,"objective analyze epidemiological characteristic clinical feature patient infection nanyang city provide evidence clinical diagnosis treatment method epidemiology clinical symptom atory radiologic datum  patient infection admit designate hospital nanyang city january february  retrospectively analyze result  patient  ncov infection consist  man  woman median age year  generation case second generation case  generation case median incubation period generation case .+/- day second generation case .+/- day generation case majority severe patient common basic disease hypertension case diabetes case common symptom fever case show moderate fever cough sputum cases,% fatigue cases,% anorexia case headache diarrhea muscle soreness sore throat symptom average time onset symptom consultation .+/- day patient change peripheral blood cell mainly lymphonpenia case eosinophilia case lymphocyte count severe critically ill patient significantly reduce patient increase myocardial enzyme mainly ldh case patient liver function damage mainly manifest alt ast high patient renal impairment inflammation relate indicator main manifestation increase crp case esr case elevated d dimer patient  case different degree infective lesion chest ct examination  case  case side morphologically lesion patchy ground glass lesion accompany air bronchus sign consolidation pave stone sign case show white lung sever ill critically ill active treatment patient discharge accord discharge standard sever critically ill patient discharge degrade hospitalization average length hospitalization day conclusion history epidemiological exposure fever chest ct sign pneumonia normal decrease wbc lymphocytopenia eosinophilia clinical basis diagnosis disease sever patient generation case degree lymphocytopenia relate severity disease"
1152,objective explore ct imaging feature  novel coronavirus -ncov infection order summarize imaging characteristic disease improve ability imaging diagnosis early diagnosis disease method january  january total  patient infection diagnose treat suzhou fifth people hospital analyze retrospectively include  male  female average age year range   year old  case mild type  case common type  case severe type  case hypertension  case postoperative lung case diabetes  case chronic bronchitis  case bronchiectasis spss chi square test analyze distribution lesion lung lobe spss spearman correlation coefficient analyze image score clinical classification result  case .% normal lung  case novel coronavirus pneumonia(covid- infect patient distribution covid-  case .% involve bilateral lung  case .% unilateral lung statistically significant difference distribution lesion lobe correlation coefficient degree lesion distribution clinical classification highly correlate  case .% subpleural lesion  case .% central lesion kind lesion  case ground glass density shadow  case consolidation  case interstitial change  case interlobular septal thickening  case  case lesion  case change  case lesion conclusion patient infection pulmonary inflammation ct manifestation include multiple part subpleural area middle lateral field lung ground glass shadow consolidation coexistence case pleural thickening interlobular septal thickening ct image indicate diagnosis covid- provide important basis early detection disease monitoring
1153,background december coronavirus disease  covid- outbreak occur wuhan datum clinical characteristic outcome patient severe covid- limited objective seek evaluate severity admission complication treatment outcome patient covid- method patient covid- admit tongji hospital january february retrospectively enrol follow march potential risk factor severe covid- analyze multivariable binary logistic model cox proportional hazard regression model survival analysis severe patient result identify  .%  patient severe case admission old age underlie hypertension high cytokine level il r il- il- tnf alpha high lactate dehydrogenase level significantly associate severe covid- admission prevalence asthma patient covid- .% markedly low adult population wuhan estimate mortality nonsevere patient .% severe case average  day follow period survival analysis reveal male sex old age leukocytosis high lactate dehydrogenase level cardiac injury hyperglycemia high dose corticosteroid use associate death patient severe covid- conclusion patient old age hypertension high lactate dehydrogenase level need careful observation early intervention prevent potential development severe covid- severe male patient heart injury hyperglycemia high dose corticosteroid use high risk death
1154,background novel coronavirus disease covid- wuhan cause outbreak major public health issue china great concern international community myocarditis myocardial injury suspect consider lead cause death covid- patient focus condition heart seek provide firsthand evidence myocarditis myocardial injury cause covid- method enrol patient confirm diagnosis covid- retrospectively collect heart relate clinical datum mainly include cardiac imaging finding laboratory result clinical outcome serial test cardiac marker trace analysis potential myocardial injury myocarditis result  covid- patient enrol study evidence myocardial injury covid- patient  .% patient present abnormality similar myocarditis patient normal level troponin admission  .% patient increase hospitalization especially die troponin level significantly increase week precede death  .% patient present sign pulmonary hypertension typical sign myocarditis absent echocardiography electrocardiogram conclusion clinical evidence study suggest myocardial injury likely relate systemic consequence direct damage  novel coronavirus elevation cardiac marker probably secondary systemic consequence consider warning sign recent adverse clinical outcome patient
1155,give rapidly progress coronavirus disease  covid- pandemic report cohort  covid- patient stanford hospital datum risk factor severe disease obtain initial clinical presentation highly important immediately clinically relevant identify low present oxygen saturation predictive severe disease outcome diagnosis pneumonia acute respiratory distress syndrome admission intensive care unit replicate datum china suggest association hypertension disease severity clinician benefit tool rapidly risk stratify patient presentation likelihood progression severe disease
1156,background coronavirus disease  covid- pandemic rage urgent need identification clinical laboratory predictor progression severe fatal form illness study aim evaluate discriminative ability hematologic biochemical immunologic biomarker patient severe fatal form covid- methods electronic search medline pubmed interface scopus web science china national knowledge infrastructure cnki perform identify study report laboratory abnormality patient covid- study divide separate cohort analysis severity severe vs. non severe mortality i.e. non survivor vs. survivor datum pool meta analysis estimate weighted mean difference wmd confidence interval ci laboratory parameter result total number  study include total  patient  laboratory parameter  study n compare laboratory finding patient severe non severe covid- n compare survivor non survivor disease analyze separately patient severe fatal disease significantly increase white blood cell wbc count decrease lymphocyte platelet count compare non severe disease survivor biomarker inflammation cardiac muscle injury liver kidney function coagulation measure significantly elevate patient severe fatal covid- interleukin  il-  il- serum ferritin strong discriminator severe disease conclusion biomarker potentially aid risk stratification model predict severe fatal covid- identify hospitalize patient respiratory distress recommend clinician closely monitor wbc count lymphocyte count platelet count il- serum ferritin marker potential progression critical illness
1157,ongoing pandemic coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- matter global concern environmental factor air pollution smoking comorbid condition hypertension diabetes mellitus underlying cardio respiratory illness likely increase severity covid- rheumatic manifestation arthralgias arthritis prevalent seventh individual covid- result acute interstitial pneumonia myocarditis leucopenia lymphopenia thrombocytopenia see rheumatic disease like lupus sjogren syndrome severe disease subset patient drive cytokine storm possibly secondary hemophagocytic lymphohistiocytosis hlh akin systemic onset juvenile idiopathic arthritis adult onset disease absence high quality evidence emerge disease understanding pathogenesis help postulate potential therapy angiotensin convert enzyme  ace appear important viral entry pneumocyte dysbalance ace cause ace inhibitor ibuprofen predispose severe disease preliminary evidence suggest potential benefit chloroquine hydroxychloroquine antiviral drug like lopinavir ritonavir favipiravir remdesivir explore cytokine storm secondary hlh require heightened immunosuppressive regimen current international society recommendation suggest patient rheumatic disease immunosuppressive therapy stop glucocorticoid covid- infection minimum possible dose disease modify drug continue cessation consider infection episode standard practice development vaccine effective long term protection disease key points patient coronavirus disease  covid- feature mimic rheumatic disease arthralgias acute interstitial pneumonia myocarditis leucopenia lymphopenia thrombocytopenia cytokine storm feature akin secondary hemophagocytic lymphohistiocytosis preliminary result encouraging high quality clinical trial need well understand role drug commonly rheumatology like hydroxychloroquine tocilizumab covid- evidence emerge cautiously recommend continue glucocorticoid disease modify antirheumatic drug dmard patient receive therapy discontinuation dmard infection standard practice
1158,objective covid- pandemic rapidly spread worldwide notably europe north america obesity highly prevalent relation obesity severe acute respiratory syndrome coronavirus- sars cov- fully document method retrospective cohort study analyze relationship clinical characteristic include bmi requirement invasive mechanical ventilation imv  consecutive patient admit intensive care sars cov- single french center result obesity bmi severe obesity bmi present .% .% case respectively overall  patient .% require imv proportion patient require imv increase bmi category p  multivariate logistic regression need imv significantly associate male sex p  versus patient bmi  p conclusion present study show high frequency obesity patient admit intensive care sars cov- disease severity increase bmi obesity risk factor sars cov- severity require increase attention preventive measure susceptible individual
1159,objective december new type coronavirus infect pneumonia break wuhan spread rapidly part country purpose study investigate clinical feature coronavirus disease  covid- materials method retrospective analysis perform confirm case covid- admit north hospital changsha hospital changsha public health treatment center january  february result median age covid- patient  year range male patient account .% .% patient history exposure wuhan .% family aggregation median day onset incidence severe illness compare non severe group severe group show statistical significance old age hypertension bilateral lung plaque shadow decrease lymphocyte count increase c reactive protein crp aspartate aminotransferase ast lactate dehydrogenase creatine kinase conclusion age combine hypertension oxygenation index double lung patch decrease lymphocyte count elevated level c reactive protein aspartate aminotransferase lactate dehydrogenase creatine kinase predictor disease severity
1160,background outbreak coronavirus disease  covid- consistent considerable difference disease severity mortality rate patient treat hubei province compare part china observe seek compare clinical characteristic outcome patient treat inside outside hubei province explore factor underlie difference method collaborate national health commission establish retrospective cohort study hospitalise covid- case china clinical characteristic rate severe event death time critical illness invasive ventilation intensive care unit admission death compare patient outside hubei impact wuhan relate exposure presume key factor drive severe situation hubei wuhan epicentre administrative centre hubei province duration symptom onset admission prognosis determined result datum cut january  case  hospital  provincial administrative region collect core cohort overall rate severe case mortality .% respectively patient hubei predominantly wuhan relate exposure  .% old mean age versus year case comorbidity versus .% high symptomatic burden abnormal radiologic manifestation especially long wait time symptom onset admission versus day compare patient outside hubei patient hubei severe event rate versus .% death rate versus .% hr ci critical illness poor prognosis compare patient outside hubei adjust age comorbidity patient outside hubei duration symptom onset hospitalisation mean versus day prognosis hr similar patient wuhan relate exposure overall population wait time treat hubei wuhan relate exposure remain independent prognostic factor hr conclusion severe case poor outcome covid- patient treat hubei attribute prolonged duration symptom onset hospitalisation epicentre future study determine reason delay hospitalisation warrant
1161,background early study report electrolyte abnormality admission patient progress severe form coronavirus disease  covid- electrolyte imbalance impact patient care provide insight pathophysiology covid- aim analyse early datum report electrolyte covid- patient severe form method electronic search medline pubmed interface scopus web science perform article compare electrolyte sodium potassium chloride calcium covid- patient severe disease pooled analysis perform estimate weighted mean difference wmd confidence interval result study total sample size  covid- patient sodium significantly low patient severe covid- wmd mmol l ci mmol l similarly potassium significantly low covid- patient severe disease wmd mmol l ci mmol l i()=% chloride statistical difference observe patient severe non severe covid- wmd mmol l ci mmol l calcium statistically significant low concentration note patient severe covid- wmd mmol l ci mmol l conclusion pool analysis confirm covid- severity associate low serum concentration sodium potassium calcium recommend electrolyte measure initial presentation serially monitor hospitalization order establish timely appropriate corrective action
1162,introduction outbreak coronavirus disease  covid recognize clinical predictor severe fatal course disease identify enable risk stratification allocate limited resource optimally hypertension widely report associate increase disease severity study report different finding objective study aim evaluate association hypertension severe fatal covid patient method scopus medline web science database search identify study report rate hypertensive patient population diagnose severe nonsevere covid covid- survivor nonsurvivor obtain datum pool metaanalysis calculate odd ratio ors ci result hypertension associate nearly .fold increase risk severe covid ci similarly significant high mortality risk ci metaregression analysis correlation observe increase mean age patient severe covid increase log hypertension covid- severity p conclusion pool analysis current literature suggest hypertension associate .fold high risk severe fatal covid especially old individual
1163,outbreak novel coronavirus china sars cov- begin december  present significant urgent threat global health study conduct provide international community deep understanding new infectious disease epidemiological clinical feature laboratory finding radiological characteristic treatment clinical outcome  patient northeast chongqing collect analyze study total  hospitalize patient covid- enrol median age  year interquartile range significant gender difference .% man majority patient contact people wuhan area .% patient underlying disease primarily hypertension .% diabetes .% cardiovascular disease .% malignancy .% common symptom include fever cough fatigue chest compute tomography scan show bilateral patchy shadow ground glass opacity lung patient patient receive antiviral therapy kaletra interferon antibacterial therapy .% corticosteroid .% addition patient receive traditional chinese medicine tcm suggest patient receive kaletra early treat combination western chinese medicine compare mild case severe one low lymphocyte count high plasma level pt aptt d dimer lactate dehydrogenase pct alb c reactive protein aspartate aminotransferase study demonstrate clinic feature therapy  covid- patient kaletra tcm play important role treatment viral pneumonia study require explore role kaletra tcm treatment covid-
1164,objective evaluate cardiovascular damage patient covid- determine correlation serum n terminal pro b type natriuretic peptide nt probnp cardiac troponin ctni severity covid- impact concomitant cardiovascular disease severity covid- evaluate method cross sectional study design  consecutive patient covid- fever clinic tongji hospital wuhan january  february  include  mild case  case critical care univariate multivariate logistic regression analyze correlation past medical history include hypertension diabetes coronary heart disease chd level serum nt probnp ctni disease severity covid- patient result age hypersensitive c reactive protein(hs crp serum creatinine level patient high critical care case mild cases(all p prevalence male elevated nt probnp ctni hypertension coronary heart disease significantly high critical case care patient mild cases(all p univariate logistic regression analysis show age male elevated nt probnp elevated ctni elevated hs crp elevated serum creatinine hypertension chd significantly correlate critical disease status(all p multivariate logistic regression analysis show elevated ctni(or=.%ci chd or=.%ci .-.p=. independent risk factor critical disease status conclusion covid- significantly affect heart function lead myocardial injury past medical history chd increase level ctni  independent determinant clinical disease status patient covid-
1165,background coronavirus disease  covid- cause severe acute respiratory syndrome coronavirus  sars cov- infection widely spread aim investigate clinical characteristic allergy status patient infect sars cov- method electronic medical record include demographic clinical manifestation comorbiditie laboratory datum radiological material  hospitalize covid- patient confirm result sars cov- viral infection extract analyze result approximately ratio male .% female covid- patient find overall median age year patient community acquire case fever .% cough .% fatigue .% gastrointestinal symptom .% common clinical manifestation hypertension .% diabetes mellitus .% common comorbiditie drug hypersensitivity .% urticaria .% self report patient asthma allergic disease report patient chronic obstructive pulmonary disease copd .% patient current smoker .% rare bilateral ground glass patchy opacity .% common sign radiological finding lymphopenia .% eosinopenia .% observe patient blood eosinophil count correlate positively lymphocyte count severe r p nonsevere r p patient hospital admission significantly high level d dimer c reactive protein procalcitonin associate severe patient compare nonsevere patient p conclusion detailed clinical investigation  hospitalize covid- case suggest eosinopenia lymphopenia potential indicator diagnosis allergic disease asthma copd risk factor sars cov- infection old age high number comorbiditie prominent laboratory abnormality associate severe patient
1166,historically viral respiratory infection pregnant woman show increase risk morbidity mortality regard covid- information limited great risk severe morbidity mortality show compare general population pregnant woman comorbiditie obesity type  diabetes mellitus hypertension show great severity disease consistent general population comorbiditie risk vertical transmission appear low demonstrate case current outbreak covid- china previous epidemic similar coronaviruse sars cov mers cov exist study demonstrate presence virus genital fluid amniotic fluid maternal milk describe case infection newborn probably come horizontal transmission suggest breastfeed respiratory hygiene measure give covid- new disease extend world current knowledge insufficient mandatory continued accumulation datum discover depth action mechanism sars cov- virus responsible disease constant update mean prevention handling disease
